<SEC-DOCUMENT>0001193125-22-312702.txt : 20221227
<SEC-HEADER>0001193125-22-312702.hdr.sgml : 20221227
<ACCEPTANCE-DATETIME>20221227165525
ACCESSION NUMBER:		0001193125-22-312702
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		11
FILED AS OF DATE:		20221227
DATE AS OF CHANGE:		20221227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amprius Technologies, Inc.
		CENTRAL INDEX KEY:			0001899287
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		IRS NUMBER:				981591811
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-267691
		FILM NUMBER:		221490917

	BUSINESS ADDRESS:	
		STREET 1:		1180 PAGE AVENUE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		(800) 425-8803

	MAIL ADDRESS:	
		STREET 1:		1180 PAGE AVENUE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kensington Capital Acquisition Corp. IV
		DATE OF NAME CHANGE:	20211214
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d377019d424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML><HEAD>
<TITLE>424B3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(3)<BR>Registration No. 333-267691 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>16,825,366 Shares of Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377019g00a03.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">This prospectus relates to the offer and resale of up to 16,825,366 shares of our common stock, par value $0.0001 per share (&#147;Common
Stock&#148;), by B. Riley Principal Capital II, LLC (&#147;BRPC II&#148; or the &#147;Selling Stockholder&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">The shares of Common
Stock to which this prospectus relates have been or may be issued by us to BRPC II pursuant to a common stock purchase agreement, dated as of September&nbsp;27, 2022, we entered into with BRPC II (the &#147;Purchase Agreement&#148;). Such shares of
Common Stock include (i)&nbsp;up to 16,655,780 shares of Common Stock that we may, in our sole discretion elect to issue and sell to BRPC II, from time to time after the date of this prospectus, pursuant to the Purchase Agreement and (ii)&nbsp;up to
169,586 shares of Common Stock, consisting of 84,793 shares we issued to BRPC II in connection with the execution of the Purchase Agreement on September&nbsp;27, 2022 (the &#147;Initial Commitment Shares&#148;) and up to 84,793 shares that we will
issue to BRPC II upon our receipt of a certain amount of proceeds from the sale of shares of our Common Stock to BRPC II as set forth in the Purchase Agreement (the &#147;Additional Commitment Shares&#148; and together with the Initial Commitment
Shares, the &#147;Commitment Shares&#148;), with such 169,586 shares being issued as consideration for BRPC II&#146;s commitment to purchase shares of our Common Stock in one or more purchases that we may, in our sole discretion, direct them to
make, from time to time after the date of this prospectus, pursuant to the Purchase Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">We are not selling any shares of Common
Stock being offered by this prospectus and will not receive any of the proceeds from the sale of such shares by BRPC II. However, we may receive up to $200,000,000 in aggregate gross proceeds under the Purchase Agreement from sales of our Common
Stock we may elect to make to BRPC II pursuant to the Purchase Agreement after the date of this prospectus. See the section titled &#147;The Committed Equity Financing&#148; for a description of the Purchase Agreement and the section titled
&#147;Selling Stockholder&#148; for additional information regarding BRPC II. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">BRPC II may sell or otherwise dispose of the shares of
Common Stock included in this prospectus in a number of different ways and at varying prices. See the section titled &#147;Plan of Distribution (Conflict of Interest)&#148; for more information about how BRPC II may sell or otherwise dispose of the
Common Stock being offered in this prospectus. BRPC II is an &#147;underwriter&#148; within the meaning of Section&nbsp;2(a)(11) of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">We will pay the expenses incurred in registering under the Securities Act the offer and sale of the shares of Common Stock to which this
prospectus relates by the Selling Stockholder, including legal and accounting fees. We have also engaged Northland Securities, Inc. to act as a &#147;qualified independent underwriter&#148; in this offering, whose fees and expenses will be borne by
the Selling Stockholder. See the section titled &#147;Plan of Distribution (Conflict of Interest)&#148; beginning on page 157. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman">Our Common
Stock is listed on the New York Stock Exchange (&#147;NYSE&#148;) under the symbol &#147;AMPX,&#148; and our Public Warrants are listed on the NYSE under the symbol &#147;AMPX.W.&#148; On December&nbsp;23, 2022, the last quoted sale price for our
Common Stock as reported on the NYSE was $7.87 per share and the last quoted sale price for our Public Warrants as reported on the NYSE was $0.31 per warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman"><B>We are an &#147;emerging growth company,&#148; as defined under the federal securities laws, and, as such, may elect to comply with certain
reduced public company reporting requirements. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:11.5pt; font-family:Times New Roman"><B>Investing in our securities involves a high degree of risk. Before buying any
securities, you should carefully read the discussion of the risks of investing in our securities in the section titled &#147;<A HREF="#rom377019_5a">Risk&nbsp;Factors</A>&#148; beginning on page&nbsp;13 of this prospectus. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman"><B>You should rely only on the information contained in this prospectus or any prospectus supplement or amendment hereto. We have not
authorized anyone to provide you with different information. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:9.5pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is December&nbsp;27, 2022. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_1">About This Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">iv</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_2">Market and Industry Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">iv</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_3">Trademarks</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">iv</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_4">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_5">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_6">Cautionary Note Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_7">Committed Equity Financing</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_8">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_9">Market Price of and Dividends on the Registrant&#146;s Common Equity and Related
Stockholder Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_11">Management&#146;s Discussion and Analysis of Financial Condition and Results
 of Operations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_12">Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_13">Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_14">Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_15">Certain Relationships, Related Party and Other
Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_16">Principal Securityholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_17">Selling Stockholder</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_18">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_19">Securities Act Restrictions on Resale of Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_20">Material U.S. Federal Income Tax Consequences to <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_21">Plan of Distribution (Conflict of Interest) </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_22">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_23">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_24">Where You Can Find Additional Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377019_25">Index to Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained in this prospectus or in any prospectus supplement or free writing prospectus prepared by us
or on our behalf. We have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these securities in
any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus. Our business, financial condition, results of
operations and prospects may have changed since that date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;14, 2022 (the &#147;Closing Date&#148;), Amprius Technologies, Inc., a Delaware corporation (f/k/a Kensington Capital
Acquisition Corp. IV, a Cayman Islands exempted company incorporated with limited liability) (&#147;Amprius,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; or &#147;our&#148;), consummated the previously announced business combination
pursuant to that certain Business Combination Agreement, dated May&nbsp;11, 2022 (the &#147;Business Combination Agreement&#148;), by and among the Company, Kensington Capital Merger Sub Corp., a Delaware corporation and a wholly owned subsidiary of
the Company (&#147;Merger Sub&#148;), and Amprius Technologies Operating, Inc., a Delaware corporation (f/k/a Amprius Technologies, Inc., a Delaware corporation) (&#147;Legacy Amprius&#148;), following the approval at an extraordinary general
meeting of the Company&#146;s shareholders held on September&nbsp;13, 2022 (the &#147;Special Meeting&#148;). Kensington Capital Acquisition Corp. IV prior to the Business Combination is referred to herein as &#147;Kensington.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Business Combination Agreement, the Company changed its jurisdiction of incorporation by deregistering as an
exempted company incorporated with limited liability in the Cayman Islands and continuing and domesticating as a corporation incorporated under the laws of the State of Delaware (the &#147;Domestication&#148;), upon which the Company changed its
name to &#147;Amprius Technologies, Inc.,&#148; and a business combination between the Company and Legacy Amprius was effected through the merger of Merger Sub with and into Legacy Amprius, with Legacy Amprius surviving as a wholly owned subsidiary
of Amprius (the &#147;Merger&#148; and, together with the Domestication and the other transactions contemplated by the Business Combination Agreement, including the PIPE (as defined below), the &#147;Business Combination&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of and upon the effective time of the Domestication, each Class&nbsp;A Ordinary Share, par value $0.0001 per share, of the Company
(the &#147;Class&nbsp;A Ordinary Shares&#148;) and each Class&nbsp;B ordinary share, par value $0.0001, of the Company (the &#147;Class&nbsp;B Ordinary Shares&#148;) outstanding at the time of the Domestication converted into one share of Common
Stock, and each Class&nbsp;1 redeemable warrant to purchase Class&nbsp;A Ordinary Shares, exercisable for one Class&nbsp;A Ordinary Share at an exercise price of $11.50 (the &#147;Class&nbsp;1 Warrants&#148;), each Class&nbsp;2 redeemable warrant to
purchase Class&nbsp;A Ordinary Shares, exercisable for one Class&nbsp;A Ordinary Share at an exercise price of $11.50 (the &#147;Class&nbsp;2 Warrants&#148; and together with the Class&nbsp;1 Warrants, the &#147;Public Warrants&#148;) and each
warrant to purchase Class&nbsp;A Ordinary Shares owned by Kensington Capital Sponsor IV LLC (the &#147;Sponsor&#148;) or any of its affiliates, exercisable for one Class&nbsp;A Ordinary Share at an exercise price of $11.50 (the &#147;Private
Warrants&#148; and, together with the Public Warrants, the &#147;Warrants&#148;) outstanding at the time of the Domestication converted into a warrant exercisable for one share of Common Stock pursuant to the Warrant Agreement, dated as of
March&nbsp;1, 2022 (the &#147;Warrant Agreement&#148;), by and between Kensington and Continental Stock Transfer&nbsp;&amp; Trust Company, governing the Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of the Business Combination (the &#147;Closing&#148;), (1) the Company&#146;s units issued and sold in the Company&#146;s
initial public offering (the &#147;Original Units&#148;), consisting of (i)&nbsp;one Class&nbsp;A Ordinary Share, (ii)&nbsp;one Class&nbsp;1 Warrant and (iii)&nbsp;one Class&nbsp;2 Warrant and (2)&nbsp;the units existing as a result of the
separation of the Class&nbsp;1 Warrant from Original Unit (the &#147;New Units&#148; and, together with the Original Units, the &#147;Units&#148;) separated into their respective component parts, and such component parts were converted into Amprius
securities, with the Class&nbsp;A Ordinary Shares becoming shares of Common Stock, and the Class&nbsp;1 Warrants and the Class&nbsp;2 Warrants both becoming warrants to purchase Common Stock at an exercise price of $11.50 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Closing, the Company had $200,000 outstanding under working capital loans from the Sponsor, which the Sponsor elected to convert
into 400,000 working capital warrants to purchase shares of Common Stock at a price of $0.50 per warrant in connection with the Closing. As used in this prospectus, the term &#147;Private Warrants&#148; includes the working capital warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the consummation of the Domestication and in connection with the Closing, at the effective time of the Merger (the &#147;Effective
Time&#148;), (1) each share of Legacy Amprius common stock, par value $0.00001 per </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
share (&#147;Legacy Amprius Common Stock&#148;), outstanding immediately prior to the Effective Time was converted and exchanged for approximately 1.45590 shares of Common Stock (the
&#147;Exchange Ratio&#148;) and (2)&nbsp;each option to purchase shares of Legacy Amprius Common Stock (a &#147;Legacy Amprius Option&#148;) whether vested or unvested, converted into an option to purchase a number of shares of Common Stock equal to
the product (rounded down to the nearest whole number) of (x)&nbsp;the number of shares of Legacy Amprius Common Stock subject to such Legacy Amprius Option immediately prior to the Closing and (y)&nbsp;the Exchange Ratio, at an exercise price per
share (rounded up to the nearest whole cent) equal to (A)&nbsp;the exercise price per share of such Legacy Amprius Option immediately prior to the Closing divided by (B)&nbsp;the Exchange Ratio. At the Closing, Amprius issued an aggregate of
65,776,550 shares of Common Stock to the equityholders of Legacy Amprius, and the Legacy Amprius optionholders held options to receive an aggregate 14,223,410 shares of Common Stock, 6,664,919 of which remained subject to vesting obligations. No
fractional shares of Common Stock were issued upon the exchange of Legacy Amprius Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Closing, the Sponsor distributed
all of its securities in the Company to the owners of the Sponsor, including Justin Mirro, a director of the Company, in proportion to their respective ownership interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Closing Date, a number of investors (the &#147;PIPE Investors&#148;), including certain former officers and directors of the Company
and other members of the Sponsor, persons and entities that have previously invested in an affiliate of the Company, persons who currently serve on the Company&#146;s board of directors or their respective affiliates, and a customer of the Company,
purchased from the Company an aggregate of 2,052,500 PIPE Units (such transaction, the &#147;PIPE&#148;), pursuant to separate subscription agreements (each, a &#147;Subscription Agreement&#148;) entered into with the PIPE Investors. The terms of
the PIPE Warrants are governed by a warrant agreement, dated as of September&nbsp;14, 2022, between the Company and Continental Stock Transfer&nbsp;&amp; Trust Company, as warrant agent (the &#147;PIPE Warrant Agreement&#148;). The PIPE Warrants are
substantially identical to the Public Warrants, except that the exercise price of each PIPE Warrant is $12.50 per share (instead of $11.50 per share, which is the exercise price for the Public Warrants), and the average sales price of the Common
Stock will need to exceed $20.00 per share (instead of $18.00 per share for the Public Warrants) for the Company to be able to redeem the PIPE Warrants. The PIPE Warrants are not, and will not be, listed on any securities exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the open of trading on September&nbsp;15, 2022, the Common Stock and Public Warrants began trading on the NYSE under the symbols
&#147;AMPX&#148; and &#147;AMPX.W,&#148; respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> that we filed with the Securities and
Exchange Commission (the &#147;SEC&#148;) using the &#147;shelf&#148; registration process. Under this shelf registration process, the Selling Stockholder may, from time to time, sell the securities offered by it described in this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor the Selling Stockholder has authorized anyone to provide you with any information or to make any representations other than
those contained in this prospectus or any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. Neither we nor the Selling Stockholder takes responsibility for, and can
provide no assurance as to the reliability of, any other information that others may give you. Neither we nor the Selling Stockholder will make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also provide a prospectus supplement or post-effective amendment to the registration statement to add information to, or update or
change information contained in, this prospectus. You should read both this prospectus and any applicable prospectus supplement or post-effective amendment to the registration statement together with the additional information to which we refer you
in the section of this prospectus titled &#147;Where You Can Find Additional Information.&#148; </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_2"></A>MARKET AND
INDUSTRY DATA </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We obtained the industry and market data used throughout this prospectus from our own internal estimates and research,
as well as from independent market research, industry and general publications and surveys, governmental agencies, publicly available information and research, surveys and studies conducted by third parties. Internal estimates are derived from
publicly available information released by industry analysts and third-party sources, our internal research and our industry experience, and are based on assumptions made by us based on such data and our knowledge of our industry and market, which
we believe to be reasonable. In some cases, we do not expressly refer to the sources from which this data is derived. In addition, while we believe the industry and market data included in this prospectus is reliable and based on reasonable
assumptions, such data involve material risks and other uncertainties and are subject to change based on various factors, including those discussed in the section titled &#147;Risk Factors.&#148; These and other factors could cause results to differ
materially from those expressed in the estimates made by the independent parties or by us. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_3"></A>TRADEMARKS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our logo and trademark appearing in this prospectus are our property. This document contains references to trademarks and service
marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> or TM symbols, but such references are not
intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies&#146; trade names,
trademarks or service marks to imply a relationship with, or endorsement or sponsorship of it by, any other companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iv- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_4"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights information contained in greater detail elsewhere in this prospectus. This summary is not complete and does not
contain all of the information you should consider in making your investment decision. You should read the entire prospectus carefully before making an investment in our Common Stock and Warrants. You should carefully consider, among other things,
our financial statements and the related notes and the sections titled &#147;Risk Factors,&#148; &#147;Business,&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; included elsewhere in
this prospectus. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amprius has developed and, since 2018, been in commercial production of ultra-high energy density
<FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries for mobility applications leveraging a disruptive silicon nanowire anode. Our silicon nanowire anode technology enables batteries with higher energy density, higher power density, and
extreme fast charging capabilities over a wide range of operating temperatures, which results in its batteries providing superior performance compared to conventional graphite <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries. Our
silicon nanowire anode is a direct <FONT STYLE="white-space:nowrap">drop-in</FONT> replacement of the graphite anode in traditional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries, and our manufacturing process leverages the
manufacturing process for conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries and the related supply chain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Today,
our batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. We believe our proprietary technology has the potential for broad application in
electric transportation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our batteries and their performance specifications have been tested and validated for application by over 30
customers, including Airbus, AeroVironment, BAE Systems the U.S. Army and Teledyne FLIR, and we have shipped over 10,000 batteries to date, which have enabled mission critical applications. Our proprietary silicon nanowire anode structures, battery
cell designs and manufacturing processes are defended by our portfolio of patents, trade secrets and <FONT STYLE="white-space:nowrap">know-how</FONT> developed over 10 years of research and development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently manufacture batteries on <FONT STYLE="white-space:nowrap">kWh-scale</FONT> production lines at our headquarters in Fremont,
California, where demand for our batteries exceeds our manufacturing capacity. We are working to meet the expected demand in several rapidly growing addressable markets, including by designing and building a
<FONT STYLE="white-space:nowrap">large-scale</FONT> production facility that can manufacture at GWh+ scale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive
offices are located at 1180 Page Avenue, Fremont, California 94538, and our telephone number is (800) <FONT STYLE="white-space:nowrap">425-8803.</FONT> Our website is www.amprius.com. Information contained on, or that can be accessed through, our
website is not a part of, and is not incorporated into, this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Committed Equity Financing
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;27, 2022, we entered into the Purchase Agreement and a registration rights agreement (the &#147;Committed Equity
Registration Rights Agreement&#148;) with BRPC II. Under the Purchase Agreement, we have the right to issue and sell to BRPC II up to $200,000,000 shares of Common Stock, subject to certain conditions and limitations set forth in the Purchase
Agreement,&nbsp;from time to time during the term of the Purchase Agreement. Sales of Common Stock pursuant to the Purchase Agreement, and the timing of any sales, are solely at our option, and we are under no obligation to sell any securities to
BRPC II under the Purchase Agreement. In accordance with our obligations under the Committed Equity Registration Rights Agreement, we have filed the </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
registration statement that includes this prospectus with the SEC to register under the Securities Act the resale by BRPC II of up to 16,825,366 shares of Common Stock, consisting of (i)&nbsp;up
to 16,655,780 shares that we may, in our sole discretion, elect sell to BRPC II, from time to time after the Commencement Date (defined below) pursuant to the Purchase Agreement and (ii) 169,586 shares of Common Stock, 84,793 shares (the
&#147;Initial Commitment Shares&#148;) of which we issued to BRPC II upon our execution of the Purchase Agreement on September&nbsp;27, 2022 and 84,793 shares (the &#147;Additional Commitment Shares&#148; and, collectively with the Initial
Commitment Shares, the &#147;Commitment Shares&#148;) of which we will issue to BRPC II upon our receipt of a $100.0 million of gross proceeds from the sale of shares of our Common Stock to BRPC II as set forth in the Purchase Agreement, as
consideration for its commitment to purchase shares of Common Stock in one or more purchases that we may, in our sole discretion, direct them to make, from time to time after the date of this prospectus, pursuant to the Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the initial satisfaction of the conditions to BRPC II&#146;s purchase obligations set forth in the Purchase Agreement (the
&#147;Commencement&#148;), including that the registration statement that includes this prospectus be declared effective by the SEC, we will have the right, but not the obligation, from time to time at our sole discretion over the <FONT
STYLE="white-space:nowrap">24-month</FONT> period beginning on the date the Commencement occurs (the &#147;Commencement Date&#148;), to direct BRPC II to purchase a specified number of shares of Common Stock (each, a &#147;VWAP Purchase&#148;), not
to exceed the lesser of (such lesser number of shares, the &#147;Purchase Maximum Amount&#148;): (i) 5,000,000 shares of Common Stock and (ii) 10.0% or 20.0% (the applicable percentage to be specified by us in the applicable VWAP Purchase Notice (as
defined below) for such VWAP Purchase) of the total aggregate number (or volume) of shares of our Common Stock traded on the NYSE during the applicable VWAP Purchase Period (as defined below) for such VWAP Purchase (such specified number of shares
to be purchased by the Selling Stockholder in such VWAP Purchase, adjusted to the extent necessary to give effect to the applicable Purchase Maximum Amount and certain additional limitations set forth in the Purchase Agreement, the &#147;VWAP
Purchase Share Amount&#148;), by timely delivering written notice to BRPC II (each, a &#147;VWAP Purchase Notice&#148;) prior to 9:00 a.m., New York City time, on any trading day (each, a &#147;Purchase Date&#148;), so long as (a)&nbsp;the closing
sale price of the Common Stock on the NYSE on the trading day immediately prior to such Purchase Date is not less than $1.00, subject to adjustment as set forth in the Purchase Agreement (such price, as may be adjusted from time to time in
accordance with the Purchase Agreement, the &#147;Threshold Price&#148;) and (b)&nbsp;all shares of Common Stock subject to all prior VWAP Purchases and all prior Intraday VWAP Purchases (as defined below) effected by us under the Purchase Agreement
have been received by BRPC II prior to the time we deliver such VWAP Purchase Notice to BRPC II. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The per share purchase price that BRPC
II is required to pay for shares of Common Stock in a VWAP Purchase effected by us pursuant to the Purchase Agreement, if any, will be determined by reference to the volume weighted average price of the Common Stock (the &#147;VWAP&#148;),
calculated in accordance with the Purchase Agreement, for the period (the &#147;VWAP Purchase Period&#148;) beginning at the official open (or &#147;commencement&#148;) of the regular trading session on the NYSE Capital Market (the &#147;NYSE&#148;)
on the applicable Purchase Date for such VWAP Purchase, and ending at the earliest to occur of (i) 3:59 p.m., New York City time, on such Purchase Date or such earlier time publicly announced by the trading market as the official close of the
regular trading session on the NYSE on such Purchase Date, (ii)&nbsp;such time that the total aggregate number (or volume) of shares of Common Stock traded on the NYSE during such VWAP Purchase Period (calculated in accordance with the Purchase
Agreement) reaches the applicable share volume maximum amount for such VWAP Purchase (the &#147;VWAP Purchase Share Volume Maximum&#148;), calculated by dividing (a)&nbsp;the applicable VWAP Purchase Share Amount for such VWAP Purchase, by (b) 0.10
or 0.20 (the applicable percentage being the same percentage we specified in the applicable VWAP Purchase Notice for determining the applicable VWAP Purchase Share Amount for such VWAP Purchase), and (iii)&nbsp;if we so elect in the applicable VWAP
Purchase Notice for such VWAP Purchase (such election, a &#147;Limit Order Discontinue Election&#148;),&nbsp;such time that the trading price of a share of Common Stock on the NYSE during such VWAP Purchase Period (calculated in accordance with the
Purchase Agreement) falls below the applicable minimum price threshold for such VWAP Purchase specified by </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
us in the VWAP Purchase Notice for such VWAP Purchase, or if we do not specify a minimum price threshold in such VWAP Purchase Notice, a price equal to 75.0% of the closing sale price of the
Common Stock on the trading day immediately prior to the applicable Purchase Date for such VWAP Purchase (the &#147;Minimum Price Threshold&#148;), less a fixed 3.0% discount to the VWAP for such VWAP Purchase Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Purchase Agreement, for purposes of calculating the volume of shares of Common Stock traded during a VWAP Purchase Period, as well
as the VWAP for a VWAP Purchase Period, the following transactions, to the extent they occur during such VWAP Purchase Period, are excluded: (x)&nbsp;the opening or first purchase of Common Stock at or following the official open of the regular
trading session on the NYSE on the applicable Purchase Date for such VWAP Purchase, (y)&nbsp;the last or closing sale of Common Stock at or prior to the official close of the regular trading session on the NYSE on the applicable Purchase Date for
such VWAP Purchase, and (z)&nbsp;if we did not elect a Limit Order Discontinue Election in the applicable VWAP Purchase Notice for such VWAP Purchase, all purchases and sales of Common Stock on the NYSE during such VWAP Purchase Period at a price
per share that is less than the applicable Minimum Price Threshold for such VWAP Purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the regular VWAP Purchases
described above, after the Commencement, we will also have the right, but not the obligation, subject to the continued satisfaction of the conditions set forth in the Purchase Agreement, to direct BRPC II to purchase, on any trading day, including
the same Purchase Date on which a regular VWAP Purchase is effected (if any, although we are not required to effect an earlier regular VWAP Purchase on such trading day), a specified number of shares of Common Stock (each, an &#147;Intraday VWAP
Purchase&#148;), not to exceed the lesser of (such lesser number of shares, the &#147;Intraday VWAP Purchase Volume Maximum&#148;): (i) 5,000,000 shares of Common Stock and (ii) 10.0% or 20.0% (the applicable percentage to be specified by us in the
applicable Intraday VWAP Purchase Notice (as defined below) for such Intraday VWAP Purchase) of the total aggregate volume of shares of our Common Stock traded on the NYSE during the applicable &#147;Intraday VWAP Purchase Period&#148; (determined
in the same manner as for a regular VWAP Purchase) for such Intraday VWAP Purchase (such specified number of shares, adjusted to the extent necessary to give effect to the applicable Intraday VWAP Purchase Volume Maximum, the &#147;Intraday VWAP
Purchase Share Amount&#148;), by the delivery to BRPC II of an irrevocable written purchase notice, after 10:00&nbsp;a.m., New York City time (and after the VWAP Purchase Period for any prior regular VWAP Purchase (if any) and the Intraday VWAP
Purchase Period for the most recent prior Intraday VWAP Purchase effected on the same Purchase Date (if any) have ended), and prior to 3:30&nbsp;p.m., New York City time, on such Purchase Date (each, an &#147;Intraday VWAP Purchase Notice&#148;), so
long as, (i)&nbsp;the closing sale price of the Common Stock on the trading day immediately prior to such Purchase Date is not less than the Threshold Price and (ii)&nbsp;all shares of Common Stock subject to all prior VWAP Purchases and all prior
Intraday VWAP Purchases by BRPC II under the Purchase Agreement have been received by BRPC II prior to the time we deliver such Intraday VWAP Purchase Notice to BRPC II. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The per share purchase price for the shares of Common Stock that we elect to sell to BRPC II in an Intraday VWAP Purchase pursuant to the
Purchase Agreement, if any, will be calculated in the same manner as in the case of a regular VWAP Purchase (including the same fixed&nbsp;percentage discounts to the applicable VWAP as in the case of a regular VWAP Purchase, as described above),
provided that the VWAP for each Intraday VWAP Purchase effected on a Purchase Date will be calculated over different periods during the regular trading session on the NYSE on such Purchase Date, each of which will commence and end at different times
on such Purchase Date (the &#147;Intraday VWAP Purchase Period&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no upper limit on the price per share that BRPC II could
be obligated to pay for the Common Stock we may elect to sell to it in any VWAP Purchase or any Intraday VWAP Purchase under the Purchase Agreement. In the case of VWAP Purchases and Intraday VWAP Purchases effected by us under the Purchase
Agreement, if any, all share and dollar amounts used in determining the purchase price per share of Common Stock to be purchased by BRPC II in a VWAP Purchase or an Intraday VWAP Purchase (as applicable), or in
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determining the applicable maximum purchase share amounts or applicable volume or price threshold amounts in connection with any such VWAP Purchase or Intraday VWAP Purchase (as applicable), in
each case, will be equitably adjusted for any reorganization, recapitalization, <FONT STYLE="white-space:nowrap">non-cash</FONT> dividend, stock split, reverse stock split or other similar transaction occurring during any period used to calculate
such per share purchase price, maximum purchase share amounts or applicable volume or price threshold amounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after the
Commencement, we will control the timing and amount of any sales of Common Stock to BRPC II. Actual sales of shares of Common Stock to BRPC II under the Purchase Agreement will depend on a variety of factors to be determined by us from time to time,
including, among other things, market conditions, the trading price of the Common Stock and determinations by us as to the appropriate sources of funding for our business and operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the applicable NYSE rules, in no event may we issue to BRPC II under the Purchase Agreement more than 16,825,366 shares of Common Stock,
which number of shares is equal to 19.99% of the shares of Common Stock outstanding immediately prior to the execution of the Purchase Agreement (the &#147;Exchange Cap&#148;), unless we obtain stockholder approval to issue shares of Common Stock in
excess of the Exchange Cap in accordance with applicable NYSE rules. The Exchange Cap is not applicable to issuances and sales of Common Stock pursuant to VWAP Purchases and Intraday VWAP Purchases that we may effect pursuant to the Purchase
Agreement, to the extent such shares of Common Stock are sold in such VWAP Purchases and Intraday VWAP Purchases (as applicable) at a price equal to or in excess of the applicable &#147;minimum price&#148; (as defined in the applicable listing rules
of the NYSE) of the Common Stock, calculated at the time such VWAP Purchases and Intraday VWAP Purchases (as applicable) are effected by us under the Purchase Agreement, if any, as adjusted to take into account our issuance of the Commitment Shares
to BRPC II and our reimbursement of a certain amount of BRPC II&#146;s legal fees and expenses. Moreover, we may not issue or sell any shares of Common Stock to BRPC II under the Purchase Agreement that, when aggregated with all other shares of
Common Stock then beneficially owned by BRPC II and its affiliates (as calculated pursuant to Section&nbsp;13(d)&nbsp;of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), and
<FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> promulgated thereunder), would result in BRPC II beneficially owning more than 4.99% of the outstanding shares of Common Stock (the &#147;Beneficial Ownership Limitation&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The net proceeds to us from sales that we elect to make to BRPC II under the Purchase Agreement, if any, will depend on the frequency and
prices at which we sell shares of our stock to BRPC II. We expect that any proceeds received by us from such sales to BRPC II will be used for working capital and for general corporate purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no restrictions on future financings, rights of first refusal, participation rights, penalties or liquidated damages in the Purchase
Agreement or Committed Equity Registration Rights Agreement, other than a prohibition (with certain limited exceptions) on entering into specified &#147;Variable Rate Transactions&#148; (as such term is defined in the Purchase Agreement) during the
term of the Purchase Agreement. Such transactions include, among others, the issuance of convertible securities with a conversion or exercise price that is based upon or varies with the trading price of our Common Stock after the date of issuance,
or our effecting or entering into an agreement to effect an &#147;equity line of credit&#148; or other substantially similar continuous offering with a third party, in which we may offer, issue or sell Common Stock or any securities exercisable,
exchangeable or convertible into Common Stock at a future determined price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BRPC II has agreed that none of BRPC II, its sole member, any
of their respective officers, or any entity managed or controlled by BRPC II or its sole member will engage in or effect, directly or indirectly, for its own account or for the account of any other of such persons or entities, any short sales of the
Common Stock or hedging transaction that establishes a net short position in the Common Stock, Warrants or any other security of the company during the term of the Purchase Agreement. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement will automatically terminate on the earliest to occur of (i)&nbsp;the
first day of the&nbsp;month next following the <FONT STYLE="white-space:nowrap">24-month</FONT> anniversary of the Commencement Date, (ii)&nbsp;the date on which BRPC II shall have purchased from us under the Purchase Agreement shares of Common
Stock for an aggregate gross purchase price of $200,000,000, (iii)&nbsp;the date on which the Common Stock shall have failed to be listed or quoted on the NYSE or another U.S. national securities exchange identified as an &#147;eligible market&#148;
in the Purchase Agreement for a period of one trading day, (iv)&nbsp;the 30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>&nbsp;trading day after the date on which a voluntary or involuntary bankruptcy proceeding involving our company has
been commenced that is not discharged or dismissed prior to such trading day, and (v)&nbsp;the date on which a bankruptcy custodian is appointed for all or substantially all of our property or we make a general assignment for the benefit of
creditors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have the right to terminate the Purchase Agreement at any time after Commencement, at no cost or penalty, upon ten
(10)&nbsp;trading&nbsp;days&#146; prior written notice to BRPC II. BRPC II has the right to terminate the Purchase Agreement upon ten (10)&nbsp;trading&nbsp;days&#146; prior written notice to us upon the occurrence of certain events set forth in the
Purchase Agreement. We and BRPC II may also agree to terminate the Purchase Agreement by mutual written consent, provided that no termination of the Purchase Agreement will be effective during the pendency of any VWAP Purchase or Intraday VWAP
Purchase that has not then fully settled in accordance with the Purchase Agreement. Neither we nor BRPC II may assign or transfer our respective rights and obligations under the Purchase Agreement or the Committed Equity Registration Rights
Agreement, and no provision of the Purchase Agreement or the Committed Equity Registration Rights Agreement may be modified or waived by us or BRPC II. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As consideration for its commitment to purchase shares of our Common Stock at our direction and in our sole discretion, from time to time
after the date of this prospectus, upon the terms and subject to the conditions set forth in the Purchase Agreement, upon execution of the Purchase Agreement, we issued 84,793 Initial Commitment Shares to BRPC II. In addition, upon our receipt of
total aggregate gross cash proceeds equal to $100,000,000 from BRPC II under the Purchase Agreement, we will issue 84,793 additional shares of Common Stock to BRPC II as Additional Commitment Shares. Furthermore, we have agreed to reimburse BRPC II
for the reasonable legal fees and disbursements of BRPC II&#146;s legal counsel in an amount not to exceed (i) $100,000 upon our execution of the Purchase Agreement and Committed Equity Registration Rights Agreement and (ii) $7,500 per fiscal
quarter, in each case in connection with the transactions contemplated by the Purchase Agreement and the Committed Equity Registration Rights Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement and the Committed Equity Registration Rights Agreement contain customary representations, warranties, conditions and
indemnification obligations of the parties. Copies of the agreements have been filed as exhibits to the registration statement, of which this prospectus forms a part, and are available electronically on the SEC&#146;s website at www.sec.gov. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not know what the purchase price for our Common Stock will be and therefore cannot be certain as to the number of shares we might issue
to BRPC II under the Purchase Agreement after the Commencement Date. As of November&nbsp;1, 2022, there were 84,467,987 shares of our Common Stock outstanding, of which 15,241,793 shares were held by
<FONT STYLE="white-space:nowrap">non-affiliates</FONT> of our company. Although the Purchase Agreement provides that we may sell up to $200,000,000 of shares of our Common Stock to BRPC II, only 16,825,366 shares of our Common Stock are being
registered under the Securities Act for resale by BRPC II under the registration statement of which this prospectus forms a part, which represents (i)&nbsp;84,793 Initial Commitment Shares that we issued to BRPC II upon execution of the Purchase
Agreement on September&nbsp;27, 2022, (ii)&nbsp;84,793 Additional Commitment Shares that we may issue to BRPC II pursuant to the Purchase Agreement if certain conditions are met, and (iii)&nbsp;up to 16,655,780 shares of Common Stock that may be
issued to BRPC II from and after the Commencement, if and when we elect to sell shares to BRPC II under the Purchase Agreement. Depending on the market prices of our Common Stock at the time we elect to issue and sell shares to BRPC II under the
Purchase Agreement, we may need to register under the Securities Act additional shares of our Common Stock </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for resale by the Selling Stockholder in order to receive aggregate gross proceeds equal to the $200,000,000 available to us under the Purchase Agreement. If all of the 16,825,366 shares offered
by BRPC II for resale under this prospectus were issued and outstanding, such shares would represent approximately 16.6% of the total number of outstanding shares of Common Stock and approximately 52.5% of the total number of outstanding shares of
Common Stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> of our company, in each case as of November&nbsp;1, 2022. If we elect to issue and sell more than the 16,825,366 shares offered under this prospectus to BRPC II, which we
have the right, but not the obligation, to do, we must first register under the Securities Act such additional shares of Common Stock for resale by BRPC II, which could cause additional substantial dilution to our stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of Common Stock ultimately offered for resale by BRPC II through this prospectus is dependent upon the number of shares
of Common Stock, if any, we elect to sell to BRPC II under the Purchase Agreement from and after the Commencement Date. Issuances of our Common Stock to BRPC II pursuant to the Purchase Agreement will not affect the rights or privileges of our
existing stockholders, except that the economic and voting interests of each of our existing stockholders will be diluted. Although the number of shares of our Common Stock that our existing stockholders own will not decrease, the shares of our
Common Stock owned by our existing stockholders will represent a smaller&nbsp;percentage of our total outstanding shares of our Common Stock after any such issuance to BRPC&nbsp;II. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S. Department of Energy Cost Sharing Grant </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2022, we were awarded a $50 million cost sharing grant from the U.S. Department of Energy. This cost sharing grant is dependent on
the successful negotiation of a final contract, and among the terms to be finalized are the portion of relevant costs that will be covered by the grant. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Factors Summary </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business is subject to numerous risks and uncertainties, including those highlighted in the section titled &#147;Risk Factors&#148;
immediately following this prospectus summary. The following is a summary of the principal risks we face: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Risks Related to Our Technology, Products
and Manufacturing </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If our batteries fail to perform as expected, our ability to develop, market, and sell our batteries would be
adversely affected. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may not succeed in developing a new high-volume manufacturing line for the production of our silicon nanowire
anode that meets our requirements for cell quality, yield, throughput and other performance metrics. Additionally, assuming we are able to develop a high-volume manufacturing line, it may be unreliable, require regular and significant maintenance
and could be capital and resource intensive to operate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may not meet our manufacturing cost targets, which would limit the size of our market opportunities.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our establishment of a new <FONT STYLE="white-space:nowrap">GWH-scale</FONT> manufacturing facility is subject to
many risks, including, among others, risks relating to site acquisition, construction, permitting, delays, cost overruns, supply chain constraints, and operating in a new geographic area away from our current headquarters. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may not succeed in retaining and attracting key employees, particularly technical talent, needed to operate
and build our business successfully. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may encounter delays and technical obstacles in developing new battery products such as different cell formats
to meet varied market requirements. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Certain components of our batteries are hazardous and pose safety risks that may cause accidents in our
manufacturing facility. We may be subject to financial and reputational risks due to product recalls and product liability claims, and we could face substantial liabilities that exceed our resources. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may not be able to accurately estimate the future supply and demand for our batteries, which could result in a
variety of inefficiencies in our business and hinder our ability to generate revenue. If we fail to accurately predict our manufacturing requirements, we could incur additional costs or experience delays. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Risks Related to Our Business and Industry </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The battery market is intensely competitive. Competitors include new entrants and established companies, many of
which have significantly greater resources than us. Our products must compete with advances in new battery chemistries and manufacturing methods as well as continued improvements in conventional batteries and battery anodes. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our future sales opportunities depend in part on the growth of markets for battery-powered aviation applications.
These applications may develop slower or at a size that is less than expected, to the extent they develop at all. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Developments in alternative technology or other fossil fuel alternatives may adversely affect the demand for our
battery products. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have pursued and may continue to pursue development agreements and other strategic alliances, which could have
an adverse impact on our business if they are unsuccessful. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may require additional capital to support business growth, and this capital might not be available on
commercially reasonable terms or at all. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We are an early stage company with a history of financial losses and expect to incur significant expenses and
continuing losses for the foreseeable future. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We identified material weaknesses in our internal controls over financial reporting. If we are unable to develop
and maintain an effective system of internal controls and procedures required by Section&nbsp;404(a) of the Sarbanes-Oxley Act, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor
confidence in us and materially and adversely affect our stock price, business and operating results. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A significant portion of our business depends on sales to the public sector, and our failure to receive and
maintain government contracts or changes in the contracting or fiscal policies of the public sector could have a material adverse effect on our business. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Risks Related to Intellectual Property </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We rely heavily on our intellectual property portfolio. If we are unable to protect our intellectual property
rights, our business and competitive position would be harmed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may need to defend ourselves against intellectual property infringement claims, which may be time-consuming
and could cause us to incur substantial costs. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Risks Related to Litigation and Regulatory Compliance </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our operations expose us to litigation, environmental and other legal compliance risks. Compliance with laws and
regulations can be expensive, and our failure to comply with these laws and regulations may result in monetary damages and fines, adverse publicity and a material adverse effect on our business. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We are or will be subject to anti-corruption and anti-bribery and anti-money laundering and similar laws, and <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with such laws can subject us to administrative, civil and criminal fines and penalties, collateral consequences, remedial measures and legal expenses, all of which could adversely affect our
business, results of operations, financial condition and reputation. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Risks Related to Ownership of Our Common Stock </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The sale of all of the securities registered for resale in this prospectus and future sales of substantial
amounts of our Common Stock in the public markets, or the perception that such sales could occur, could cause the market price of our Common Stock to drop significantly, even if our business is doing well. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Risks Related to Our Warrants </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">There is no guarantee that the Public Warrants will be in the money at the time they become exercisable, and they
may expire worthless. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may redeem your unexpired Public Warrants prior to their exercise at a time that is disadvantageous to you,
thereby making your Public Warrants worthless. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Risks Related to this Offering </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">It is not possible to predict the actual number of shares we will sell under the Purchase Agreement to BRPC II,
or the actual gross proceeds resulting from those sales. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being an Emerging Growth Company and a Smaller Reporting Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the &#147;JOBS Act&#148;). We will remain an
emerging growth company until the earliest to occur of: the last day of the fiscal year in which we have more than $1.235&nbsp;billion in annual revenues; the date we qualify as a &#147;large accelerated filer,&#148; with at least $700&nbsp;million
of equity securities held by <FONT STYLE="white-space:nowrap">non-affiliates;</FONT> the issuance, in any three-year period, by us of more than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt securities; and the
last day of the fiscal year ending after the fifth anniversary of our initial public offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;107 of the JOBS Act provides
that an emerging growth company can take advantage of the extended transition period provided in Section&nbsp;7(a)(2)(B) of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), for complying with new or revised accounting
standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected not to opt out of such extended transition period, which
means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard. This may make comparison of our financial statements with certain other public companies difficult or impossible because of the potential differences in accounting standards used. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also a &#147;smaller reporting company&#148; as defined in Item 10(f)(1) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT>
Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the
fiscal year in which (i)&nbsp;the market value of our Common Stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $250&nbsp;million as of the prior June&nbsp;30 or (ii)&nbsp;our annual revenue exceeded $100&nbsp;million
during such completed fiscal year and the market value of our Common Stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700&nbsp;million as of the prior June&nbsp;30. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Issuer </P></TD>
<TD>Amprius Technologies, Inc. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common Stock offered by BRPC II </P></TD>
<TD>This prospectus relates to the offer and sale of up to 16,825,366 shares of Common Stock by BRPC II, consisting of: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Up to 169,586 shares of Common Stock (comprised of (i) 84,793 Initial Commitment Shares we issued to BRPC II on
September&nbsp;27, 2022 and (ii) 84,793 Additional Commitment Shares we will issue to BRPC II following our receipt from BRPC II of aggregate gross process under the Purchase Agreement of $100.0&nbsp;million from sales of Common Stock thereunder
pursuant to the terms of the Purchase Agreement) we may issue to BRPC II as Commitment Shares as consideration for its irrevocable commitment to purchase shares of our Common Stock at our election and in our sole discretion, from time to time after
the date of this prospectus, upon the terms and subject to the satisfaction of the conditions set forth in the Purchase Agreement, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Up to 16,655,780 shares of our Common Stock we may, at our election, issue and sell to BRPC II pursuant to the
Purchase Agreement from time to time after the Commencement, subject to satisfaction of specified conditions set forth on the Purchase Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Selling Stockholder </P></TD>
<TD>B. Riley Principal Capital II, LLC (&#147;BRPC II&#148;) </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Shares of Common Stock outstanding </P></TD>
<TD>84,467,987 shares of Common Stock (as of November&nbsp;1, 2022). </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Shares of Common Stock outstanding after giving effect to the issuance of the shares registered hereunder
</P></TD>
<TD>101,293,353 shares of Common Stock </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We will not receive any proceeds from the sales of Common Stock by BRPC II pursuant to this prospectus. However, we may receive up to $200,000,000 in aggregate gross proceeds from sales of our Common Stock to BRPC II that we may, in our
discretion, elect to make, from time to time after the date of this prospectus, pursuant to the Purchase Agreement. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The net proceeds from sales, if any, under the Purchase Agreement, will depend on the frequency and prices at which we sell shares of Common Stock to BRPC II after the date of this prospectus. To the extent we sell
Common Stock to BRPC II, we intend to use any proceeds therefrom for general corporate purposes, including working capital. Accordingly, we retain broad discretion over the use of the net proceeds from the sale of our Common Stock under the Purchase
Agreement. The precise amount and timing of the application of such proceeds will depend upon our liquidity needs and the availability and cost of other capital. See the section titled &#147;Use of Proceeds&#148;&nbsp;on page&nbsp;58 of this
prospectus. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Conflicts of Interest </P></TD>
<TD>BRPC II is an affiliate of B. Riley Securities, Inc. (&#147;BRS&#148;), a registered broker-dealer and FINRA member. BRS will act as an executing broker that will effectuate resales of our Common Stock that have been and may be acquired by BRPC
II from us pursuant to the Purchase Agreement to the public in this offering. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Because BRPC II will receive all the net proceeds from such resales of our Common Stock made to the public through BRS, BRS is deemed to have a &#147;conflict of interest&#148; within the meaning of Financial Industry
Regulatory Authority, Inc. (&#147;FINRA&#148;) Rule 5121. Consequently, this offering will be conducted in compliance with the provisions of FINRA Rule 5121, which requires that a &#147;qualified independent underwriter,&#148; as defined in FINRA
Rule 5121, participate in the preparation of the registration statement that includes this prospectus and exercise the usual standards of &#147;due diligence&#148; with respect thereto. Accordingly, we have engaged Northland Securities, Inc., a
registered broker-dealer and FINRA member (&#147;Northland&#148;), to be the qualified independent underwriter in this offering and, in such capacity, participate in the preparation of the registration statement that includes this prospectus and
exercise the usual standards of &#147;due diligence&#148; with respect thereto. BRPC II has agreed to pay Northland a cash fee of $50,000 upon completion of this offering as consideration for its services and to reimburse Northland up to $5,000 for
expenses incurred in connection with acting as the qualified independent underwriter in this offering. Northland will receive no other compensation for acting as the qualified independent underwriter in this offering. In accordance with FINRA Rule
5121, BRS is not permitted to sell shares of our Common Stock in this offering to an account over which it exercises discretionary authority without the prior specific written approval of the account holder. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See the section titled &#147;Plan of Distribution (Conflict of Interest).&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>See the section titled &#147;Risk Factors&#148; beginning on page&nbsp;13 and other information included in this prospectus for a discussion of factors that you should consider carefully before deciding to invest in our Common Stock.
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">NYSE Symbol </P></TD>
<TD>&#147;AMPX&#148; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of Common Stock outstanding is based on 84,467,987 shares of Common Stock as of
November 1, 2022 and excludes the following, in each case as of November 1, 2022, except as otherwise noted: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">14,216,131 shares of our Common Stock issuable upon the exercise of outstanding options under the Amprius
Technologies, Inc. 2016 Equity Incentive Plan (the &#147;2016 Plan&#148;), which were assumed by the Company in connection with the merger, with a weighted average exercise price of $1.34 per share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">16,400,000 shares of our Common Stock issuable upon the exercise of Private Warrants, with an exercise price of
$11.50 per share; </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">29,268,446 shares of our Common Stock issuable upon the exercise of Public Warrants, with an exercise price of
$11.50 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2,052,500 shares of our Common Stock issuable upon the exercise of PIPE Warrants, with an exercise price of
$12.50 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">9,907,279 shares of our Common Stock reserved for future issuance under the Amprius Technologies, Inc. 2022
Equity Incentive Plan (the &#147;2022 Plan&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">990,000 shares of our Common Stock reserved for future issuance under the Amprius Technologies, Inc. 2022
Employee Stock Purchase Plan (the &#147;ESPP&#148;). </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_5"></A><A NAME="rom377019_5a"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks
and uncertainties described below, together with all of the other information in this prospectus, including the section titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and our financial
statements and related notes thereto included elsewhere in this prospectus. Our business, financial condition, results of operations or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do not
believe are material. If any of the risks actually occur, our business, financial condition, results of operations and prospects could be adversely affected. In that event, the market price of our securities could decline, and you could lose part or
all of your investment. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Technology, Products and Manufacturing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If our batteries fail to perform as expected, our ability to develop, market and sell our batteries would be adversely affected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our batteries may contain defects in design and manufacture that may cause them to not perform as expected or that may require repairs, recalls
and design changes. Our batteries are inherently complex and incorporate technology and components that have not been used for certain applications and that may contain defects and errors, particularly when first introduced to such applications.
Although our batteries undergo quality control testing prior to release for shipment, there can be no assurance that we will be able to detect and fix all defects prior to shipment, and nonconformances, defects or errors could occur or be present in
batteries that we release for shipment to customers. If our batteries fail to perform as expected, our customers may delay deliveries, our customer may terminate orders or we may initiate product recalls, each of which could adversely affect our
sales and brand and could adversely affect our business, financial condition, prospects and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our battery
architecture is different from our peers&#146; and may behave differently in customer use applications, certain applications of which we have not yet evaluated. This could limit our ability to deliver to certain applications. In addition, our
historical data on the performance and reliability of our batteries is limited, and therefore our batteries could fail unexpectedly in the field resulting in significant warranty costs or brand damage in the market. Further, the silicon nanowire
anode structure of our battery is different from traditional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries and therefore our batteries could be susceptible to different and unknown failure modes leading our batteries to fail and
cause a safety event in the field. Such an event could result in the failure of our end customers&#146; product as well as the loss of life or property, resulting in severe financial penalties for us, including the loss of revenue, cancelation of
supply contracts and the inability to win new business due to reputational damage in the market. In addition, some of our supply agreements require us to bear certain costs relating to recalls and replacements of end products when such recalls and
replacements are due to defects of our battery products that are incorporated in such end products. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not succeed in developing a new
high-volume manufacturing line that meets our requirements for cell quality, yield, throughput and other performance metrics. Additionally, assuming we are able to develop a high-volume manufacturing line, it may be unreliable, require regular and
significant maintenance and could be capital and resource intensive to operate. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, we have manufactured on a <FONT
STYLE="white-space:nowrap">kWh-scale</FONT> capacity. Our ability to manufacture our batteries at scale depends on the successful development of an automated, high-volume manufacturing line for our silicon nanowire anode that meets our requirements
for cell quality, throughput, yield, and other performance metrics. Currently, we do not have a manufacturing line capable of producing our silicon nanowire anode batteries at scale. As part of our manufacturing expansion plans, in addition to
designing and building a <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility, we are in the process of developing an automated, high-volume manufacturing line. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Although we have received our first large-scale anode production machine, we are customizing the machine for our production processes and must then complete tuning and testing before the machine
goes online for production purposes. There is no guarantee that the customization, development and implementation of this manufacturing line will be successful. In addition, there is no guarantee that we will be able to correspondingly expand our
manufacturing capacity for other battery components following the installation and implementation of such large-scale anode production machine. We, our potential suppliers and other equipment vendors may encounter significant engineering challenges,
performance issues, delays, unforeseen development costs and other obstacles in building the high-volume manufacturing line, and if we are not successful, or if we encounter significant delays, our business, financial condition, prospects and
results of operations would be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in order for us to produce our batteries at scale and at a cost
advantage, we must achieve levels of cell quality, throughput, and yield demonstrated for mature battery production. As we have not produced our batteries at scale, our ability to achieve such rates is untested and subject to significant constraints
and uncertainties. Operational performance and costs can be difficult to predict and are often influenced by factors outside of our control, such as, but not limited to, failures by suppliers to deliver necessary components of our batteries in a
timely manner and at prices and volumes acceptable to us, environmental hazards and remediation costs, costs associated with commissioning of machines, difficulty or delays in obtaining governmental permits, damages or defects in electronic systems,
industrial accidents, fires, seismic activity and natural disasters, and problems with equipment vendors. Should operational risks materialize, they may result in lower yield, which would negatively affect our revenue growth and profitability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, the development of the manufacturing line will require us to make intensive capital expenditures before we are able to benefit
from such development. The manufacturing line may also suffer unexpected malfunctions from time to time and will depend on repairs and spare parts to resume operations, which may not be available when needed. Further, unexpected equipment
malfunctions may significantly affect the intended operational efficiency, thus materially and adversely affecting our business, financial condition, prospects and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not meet our manufacturing cost targets, which would limit the size of our market opportunities. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will require significant capital to develop and grow our business and expect to incur significant expenses, including those relating to the
expansion of our manufacturing capacity, development of our high-volume manufacturing line, raw material procurement, leases, sales and distribution as we build our brand and market our batteries, and general and administrative costs. Our
profitability will not only depend on our ability to successfully market our batteries, but also our ability to control our costs. Some of the processes in the manufacturing of our silicon nanowire anodes require chemical vapor deposition
(&#147;CVD&#148;), for which equipment is more costly than those involved in standard anode production techniques. If we are unable to cost efficiently design, manufacture, market, sell and distribute our batteries, our margins, profitability and
prospects would be materially and adversely affected. We have not yet commenced high-volume production of our batteries, and any cost advantage for the production of our batteries at scale, compared to conventional
<FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries, will require us to manufacture at rates of cell quality, throughput, and yield demonstrated for mature batteries and battery material that we have not yet achieved. If we are unable to
achieve these targeted rates, our business will be adversely impacted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely on, and will continue to rely on, complex equipment for our
operations, and production involves a significant degree of risk and uncertainty in terms of operational performance and costs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
rely heavily on, and will continue to rely heavily on, complex equipment for our operations and the production of our batteries, which involves a significant degree of uncertainty and risk in terms of operational performance and costs. Our
manufacturing equipment consists of many components, which may suffer unexpected malfunctions from time to time and may depend on repairs and spare parts to resume operations, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which may not be available when needed. Problems with our manufacturing equipment could result in the loss of manufacturing equipment, damage to manufacturing facilities, monetary losses, delays,
unanticipated fluctuations in production and personal injury to or death of workers. Should these precautions be inadequate or an event be larger than expected, we could have significant equipment or facility damage that would impact our ability to
deliver our battery products and require additional cash to recover. In addition, in some cases, operational problems may result in environmental damage, administrative fines, increased insurance costs and potential legal liabilities. Any of these
operational problems, or a combination of them could have a material adverse effect on our cash flows, business, financial condition, prospects or results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, manufacturing technology may evolve rapidly, and we may decide to update our manufacturing processes more quickly than expected.
Moreover, as we scale the commercial production of our batteries, our experience may cause us to discontinue the use of already installed equipment in favor of different or additional equipment. The useful life of any equipment that would be retired
early as a result would be shortened, causing the depreciation on such equipment to be accelerated, and our results of operations could be negatively impacted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our establishment of a volume manufacturing facility is subject to many risks, including, among others, risks relating to site acquisition,
construction, permitting, delays, cost overruns, supply chain constraints, and operating in a new geographic area away from our current headquarters. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently operate only at a <FONT STYLE="white-space:nowrap">kWh-scale</FONT> manufacturing capacity. As part of our manufacturing expansion
plans, we plan to design and build a <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility for our batteries, concurrently with the development of our high-volume manufacturing line for our silicon nanowire anode. We may not be
successful in establishing our <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility. To date, we have commenced site selection for the new facility, but we have not yet secured a location or obtained the necessary licenses or
permits for the manufacturing facility. In connection with the construction of the facility, we will need to identify and acquire the land or obtain leases for a suitable location appropriately zoned for activities involving hazardous materials,
which will limit where we are able to locate the facility and may require us to pay a premium. In addition, we will need to operate the manufacturing facility in a new geographic area away from our current headquarters. If we fail to select an
appropriate location, fail to complete the construction in an efficient manner, or fail to recruit the required personnel and generally manage our growth effectively, large-scale production of our batteries could be curtailed or delayed. Further,
because our silicon nanowire anode process requires different equipment than traditional anode manufacturing, our capital equipment costs are likely to be higher than equipment used for production of graphite anodes. Based on our current
expectations, we estimate that our capital equipment expenditures will range between $120.0&nbsp;million and $150.0&nbsp;million to achieve 1.0 GWh per year of manufacturing capacity, and that it will take approximately two years following the
Closing to start volume manufacturing. The actual costs and time to complete our silicon nanowire process may materially exceed such estimates, if we are able to at all. Even if we are successful in the establishment of the new facility, our
manufacturing capabilities could be affected by cost-overruns, unexpected delays, equipment failures, supply chain constraints, natural disasters, including earthquakes, fire, floods and typhoons, power failures, telecommunications failures, <FONT
STYLE="white-space:nowrap">break-ins,</FONT> war, riots, terrorist attacks and numerous other factors that could prevent us from realizing the intended benefits of our manufacturing strategy, or cause the loss or corruption of data or malfunctions
of software or hardware, and have a material adverse effect on our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not succeed in retaining and attracting key employees,
particularly technical talent, needed to operate and build our business successfully. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success depends on our ability to
attract and retain our executive officers, key employees and other qualified personnel, particularly technical talent, and as a relatively small company with key talent residing in a limited number of employees, our operations may be severely
disrupted if we lost their services. In particular, we are highly dependent on the services of Dr.&nbsp;Kang Sun, our Chief Executive Officer, and other senior technical and management personnel, including our executive officers, who would be
difficult to replace. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Dr.&nbsp;Sun or any other key personnel were to depart, we may not be able to
successfully attract and retain senior leadership necessary to grow our business. As we build our brand and becomes better known, there is increased risk that competitors or other companies will seek to hire our personnel. The failure to attract,
integrate, train, motivate and retain these personnel could seriously harm our business and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, large-scale
production in our new manufacturing facility will require us to hire and train highly-skilled personnel to operate the facility, including engineers, skilled workers and other laborers, and we may not be able to do so in the location at which our
new manufacturing facility will be located. Recruiting and training such skilled staff will take significant cost and time, and an inability to do so timely or at all will inhibit the successful operation of the new manufacturing facility, thus
negatively affecting our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain of our officers and other employees provide services to Amprius Holdings and other entities formerly
affiliated with Amprius Holdings. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our officers and other employees provide services to Amprius Holdings. Also,
Dr.&nbsp;Kang Sun, our Chief Executive Officer, serves on the boards of certain entities that were formerly affiliated with Amprius Holdings. As a result, there could be competition for the time and effort of these individuals. If such officers and
other employees do not devote sufficient attention to the management and operation of our business, our financial results may suffer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may
encounter delays and technical obstacles in developing new battery products such as different cell formats to meet varied market requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our customers often require unique battery configurations or custom designs for their products. Once we enter into contracts with customers to
produce batteries for their products, we expect to tailor the design of our batteries specifically to the products that these customers manufacture. This development process requires not only substantial lead time between the commencement of design
efforts for customized batteries and the commencement of volume shipments of the battery cells to the customer, but also the cooperation and assistance of the customer in order to determine the requirements for each specific application. Technical
problems may arise that affect the acceptance of our battery products by the customers. Our ability to tailor our batteries to meet the needs of our customers is affected by whether we can, amongst other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">receive and maintain necessary intellectual property protections; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain governmental approvals and registrations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">comply with governmental regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">further develop and refine our technology; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipate customer needs and preferences successfully. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are unable to design and develop new battery products that meet our customers&#146; requirements, we may lose opportunities to obtain
purchase orders, and our reputation and prospects may be damaged. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain components of our batteries are hazardous and pose safety risks that may
cause accidents in our manufacturing facility. We may be subject to financial and reputational risks due to product recalls and product liability claims, and we could face substantial liabilities that exceed our resources. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the high energy density inherent in <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries, our batteries can pose certain safety
risks, including the risk of fire. Accidents causing death or personal injury or property damage, can occur, and no high energy density battery will ever be 100% safe. For example, under certain abuse conditions,
<FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries can go into thermal runaway, which can result in fire. Although we incorporate safety procedures in the research, development, manufacture and transportation of batteries that are
designed to minimize safety risks, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
manufacture or use of our battery products may still cause accidents. Any accident, whether occurring at our manufacturing facilities or from the use of our battery products, may result in
significant production interruption, delays or claims for substantial damages caused by personal injuries or property damage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
addition, due to the harsh environments in which batteries are used&#151;extremely low temperature and pressure, and combat for military applications&#151;our batteries go through rigorous testing to ensure safe behavior under abuse-case conditions.
Although such tests been successful to date, we cannot assure you such tests will be successful in the future. If we have to make design changes to address any safety issues, we may have to delay or suspend our planned production, which could
materially damage our brand, business, financial condition, prospects and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Product liability claims, even those
without merit or those that do not involve our battery products, could harm our business, financial condition, prospects and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A successful product liability claim against us, resulting from safety issues or otherwise, could require us to pay a substantial monetary
award. We may not be able to cover any substantial monetary judgment against us. Moreover, a product liability claim against us or our competitors could generate substantial negative publicity about our battery products and could have a material
adverse effect on our brand, business, financial condition, prospects and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to accurately estimate the
future supply and demand for our batteries, which could result in a variety of inefficiencies in our business and hinder our ability to generate revenue. If we fail to accurately predict our manufacturing requirements, we could incur additional
costs or experience delays. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We anticipate being required to provide forecasts of our demand to our current and future suppliers
prior to the scheduled delivery of products to potential customers. Currently, there is limited historical basis for making judgments on the demand for our batteries and our ability to develop, manufacture, and deliver our battery products. Our
customers&#146; final purchase orders may not be consistent with our estimates. If we overestimate our requirements, our suppliers may have excess inventory, which indirectly would increase our costs and result in unprofitable sales or write-offs.
Given that our batteries are often customized to meet our customers&#146; specifications, they are susceptible to obsolescence due to their limited shelf life. Because we have no history of large-scale production, we may also be unable to forecast
accurately the pace of manufacturing or the <FONT STYLE="white-space:nowrap">take-up</FONT> of our battery products by our customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
we underestimate our requirements, our suppliers may have inadequate inventory, which could interrupt manufacturing of our battery products and result in delays in shipments and revenues. In addition, lead times for materials and components that our
suppliers order may vary significantly and depend on factors such as the specific supplier, contract terms and demand for each component at a given time. If we fail to order sufficient quantities of battery components in a timely manner, the
delivery of our batteries to our potential customers could be delayed, which would harm our business, financial condition and results of operations. Producing additional battery products to make up for any shortages within a short time frame may be
difficult, making us unable to fulfill the purchase orders, especially due to the customized nature of our batteries. In either case, our business, financial condition, prospects and results of operations may be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to establish supply relationships for necessary materials, components or equipment or may be required to pay more than anticipated
for components or equipment, which could negatively impact our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on third-party suppliers for components necessary
to develop and manufacture our batteries, including key supplies such as our silane gas, substrate foil, electrolytes, separators, and cathode materials. We face risks relating to the availability of these materials and components, including that we
will be subject to demand shortages and supply chain challenges and generally may not have sufficient purchasing power to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
eliminate the risk of price increases for the raw materials and lines we need. For example, we expect to procure the silane gas needed for our manufacturing from REC Silicon ASA, a global
supplier of silane and silicon materials; however, we expect that they will be unable to supply the volume required for highly scaled production. We are also in the process of collaborating with other key suppliers but have not yet entered into
agreements for the supply of scaled production quantities of these materials. To the extent that we are unable to enter into commercial agreements with these suppliers on beneficial terms, or these suppliers experience difficulties ramping up their
supply of materials to meet our requirements, high-volume production of our batteries will be delayed and we will not be able to meet our production timelines. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Separately, we may be subject to various supply chain requirements regarding, among other things, conflict minerals and labor practices. We
may be required to incur substantial costs to comply with these requirements, which may include locating new suppliers to replace existing ones. We may not be able to find any new suppliers for certain raw materials or components required for our
operations, or such suppliers may be unwilling or unable to provide us with products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to incur significant costs related to
procuring materials required to manufacture and assemble our batteries. We expect to use various materials in our batteries that will require us to negotiate purchase agreements and delivery lead-times on advantageous terms. We may not be able to
control fluctuation in the prices for these materials or negotiate agreement with suppliers on terms that are beneficial to us. Substantial increases in the prices for our raw materials, or our inability to reduce our raw material costs as we scale,
would negatively impact our prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any disruption in the supply of components or materials could temporarily disrupt research and
development activities or production of our batteries until an alternative supplier is able to supply the required material. Changes in business conditions, unforeseen circumstances, governmental changes, and other factors beyond our control or
which we do not presently anticipate, could also affect our suppliers&#146; ability to deliver components to us on a timely basis. Any of the foregoing could materially and adversely affect our business, financial condition, prospects and results of
operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are actively monitoring the impacts of Russia&#146;s invasion of Ukraine and continuing to assess its potential to
adversely affect our business. Our business has not been directly impacted by this ongoing military conflict, as we have no assets or operations, and we have not purchased materials from, Russia, Belarus or Ukraine. To date, we have not experienced
any material disruption in our business. Accordingly, we have not yet taken measures to mitigate potential adverse effects of such conflict. However, the length and outcome of Russia&#146;s invasion of Ukraine is highly unpredictable. The conflict
may continue to cause significant market and other disruptions, including significant volatility in commodity prices, supply of components and supply chain interruptions, which could adversely and adversely affect our business, financial condition,
prospects and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currency fluctuations, geopolitics, trade barriers, embargoes, tariffs or shortages and other
general economic or political conditions may limit our ability to obtain key components for our batteries or significantly increase freight charges, raw material costs and other expenses associated with our business, which could further materially
and adversely affect our business, financial condition, prospects and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Business and Industry </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The battery market is intensely competitive. Competitors include new entrants and established companies, many of which have significantly greater
resources than us. Our battery products must compete with advances in new battery chemistries and manufacturing methods as well as continued improvements in conventional batteries and battery anodes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The battery market in which we compete continues to evolve rapidly and is highly competitive. To date, we have focused our efforts on our
silicon nanowire technology, which is designed to outperform conventional </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery technology and other battery technologies. However, <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery technology has been
widely adopted and our current competitors have, and future competitors may have, greater resources than us and may also be able to devote greater resources to the development of their current and future technologies. These competitors also may have
greater access to customers and may be able to establish cooperative or strategic relationships amongst themselves or with third parties that may further enhance their resources and competitive positioning. In addition, <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> battery manufacturers may make improvements in energy density faster than they have historically, continue to reduce cost and expand supply of conventional batteries and therefore reduce our energy
density advantage and price premium, which would negatively impact the prospects for our business or negatively impact our ability to sell our battery products at a market-competitive price and sufficient margins. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are a number of companies seeking to develop alternative approaches to <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery
technology. We expect competition in battery technology to intensify. Developments in alternative technologies or improvements in batteries technology made by competitors may materially adversely affect the sales, pricing and gross margins of our
batteries. If a competing technology is developed that has superior operational or price performance, our business will be harmed. If we fail to accurately predict and ensure that our battery technology can address customers&#146; changing needs or
emerging technological trends, or if our customers fail to achieve the benefits expected from our silicon nanowire technology, our business will be harmed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to commit significant resources to scale our battery manufacturing capacity and maintain a competitive position, and these
commitments may be made without knowing whether such investments will result in products potential customers will accept. There is no assurance we will successfully identify new customer requirements, develop and bring our batteries to market on a
timely basis, or that products and technologies developed by others will not render our batteries obsolete or noncompetitive, any of which would adversely affect our business, financial condition and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customers will be less likely to purchase our batteries if they are not convinced that our business will succeed in the long term. Similarly,
suppliers and other third parties will be less likely to invest time and resources in developing business relationships with us if they are not convinced that our business will succeed in the long term. Accordingly, in order to build and maintain
our business, we must maintain confidence among current and future partners, customers, suppliers, analysts, ratings agencies and other parties in our long-term financial viability and business prospects. Maintaining such confidence may be
particularly complicated by certain factors including those that are largely outside of our control, such as our limited operating history, market unfamiliarity with our battery products, any delays in scaling manufacturing, delivery and service
operations to meet demand, competition and uncertainty regarding our production and sales performance compared with market expectations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our future
sales opportunities depend in part on the growth of markets for battery-powered aviation applications. These applications may develop slower or at a size that is less than expected, to the extent they develop at all. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our growth and future demand for our battery products is dependent in part upon the adoption by consumers of alternative fuel vehicles in
general and battery-powered aviation applications in particular. The market for new energy vehicles is still evolving, characterized by changing technologies, competitive pricing and competitive factors, evolving government regulation and industry
standards, and changing consumer demands and behaviors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Market estimates and growth forecasts are also subject to significant uncertainty
and are based on assumptions and estimates that may prove to be inaccurate. For example, if the assumptions that we base our market forecasts on, including the continued development and availability of high performance batteries at a competitive
price point, OEM investment in aircraft and software, consumer preference and, with respect to electric air transportation, regulatory approval and the requisite infrastructure, are incorrect, this expected growth may occur slower than expected, if
it occurs at all. If the market for battery-powered applications in general does not develop as expected, or develops more slowly than expected, our business, financial condition, prospects and results of operations could be harmed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Developments in alternative technology or other fossil fuel alternatives may adversely affect the
demand for our battery products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant developments in alternative technologies, such as fuel cell technology, advanced
diesel, ethanol or natural gas, or breathing batteries, may materially and adversely affect our business, financial condition, prospects and results of operations in ways that we may not currently anticipate. Existing and other battery technologies,
fuels or sources of energy may emerge as customers&#146; preferred alternatives to our battery products. Any failure by us to develop new or enhanced technologies or processes, or to react to changes in existing technologies, could materially delay
our development and introduction of new and enhanced alternative products, which could result in decreased revenue and adversely affect our prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research and development efforts may not be sufficient to adapt to changes in alternative fuels or aviation and EV technology. As
technologies evolve, we plan to develop more efficient manufacturing process, and advanced battery chemistry, which may also negatively impact the adoption of our other battery products. However, we may not compete effectively with alternative
systems if we are not able to develop, source and integrate the latest technology into our battery products. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have pursued and may continue to
pursue development agreements and other strategic alliances, which could have an adverse impact on our business if they are unsuccessful. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into development agreements and master supply agreements with certain of our customers, and may in the future enter into
similar arrangements and development agreements with our customers, including with Airbus and the U.S. Army. While offering potential benefits, these strategic alliances with OEMs and others could subject us to a number of risks, including risks
associated with sharing proprietary information, <FONT STYLE="white-space:nowrap">non-performance</FONT> by our partners and costs of establishing and maintaining new strategic alliances, any of which may materially and adversely affect our
business. We may have limited ability to monitor or control the actions of our partners and, to the extent any of them suffers negative publicity or harm to their reputation from events relating to their business, we may also suffer negative
publicity or harm to our reputation by virtue of our association with them. For example, if we rely on our partners&#146; manufacturing facilities, those operations would be outside of our control. We could experience delays if our partners do not
meet agreed-upon timelines or experience capacity constraints, and in turn, we could lose customers and face reputational harm. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ability to grow
will depend, in part, on our ability to contract with aviation and EV OEMs to incorporate our batteries in their products, which will require significant time and expense, and may not come to fruition. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success, and our ability to increase revenue and operate profitably, depends in part on our ability to contract with aviation and EV
OEMs.&nbsp;This process will require significant time and resources, especially for incorporation into EVs. For example, EV manufacturers frequently require several years of evaluation prior to incorporating new products, like our batteries, into
their EVs. This evaluation process includes, among other things, extensive safety and abuse tests, performance tests and cost modeling. We have not begun this process with any EV manufacturers. Thus, our efforts to expand our manufacturing and sales
to OEMs may not be successful, and may never result in products that achieve market acceptance, create additional revenue or become profitable, thus harming our business, financial condition, prospects and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research and development efforts strive to create products that are on the cutting edge of technology and meeting the evolving
requirements of our customers, but competition in our industry is high. To secure acceptance of our battery products, we must also constantly develop and introduce cost-effective, increasingly more scalable silicon nanowire batteries with enhanced
functionality and performance to meet evolving industry standards. If we are unable to retain and grow our existing customer relationships, or convert early trial deployments into meaningful orders, our business, financial condition, prospects and
results of operations could be materially adversely affected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If existing customers do not make subsequent purchases from us or renew their contracts with us, our
revenue could decline, and our results of operations would be adversely impacted. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We derive a significant portion of our revenue
from existing customers that expand their relationships with us. Increasing the size and number of the deployments of our existing customers is an important part of our growth strategy. We may not be effective in executing this or any other aspect
of our growth strategy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For our customers who individually represent 10% or more of period revenue, our top two customers together
represented 80% of our revenue for the year ended December&nbsp;31, 2021, our top three customers together accounted for 95% of our revenue for the year ended December 31, 2020, our top four customers together accounted for 83% of our revenue for
the nine months ended September 30, 2022 and our top two customers together accounted for 84% of our revenue for the nine months ended September 30, 2021. Certain of our customers, including customers that represent a significant portion of our
business, have in the past reduced their spend with us or terminated their agreements with us, which has reduced our anticipated future cash receipts or revenue from these customers. It is not possible for us to predict the future level of demand
from our larger customers for our battery products, and there can be no assurance that our existing customers will continue to purchase from us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Achieving renewal or expansion of deployments may require us to increasingly engage in sophisticated and costly sales efforts that may not
result in additional sales. In addition, our customers&#146; decisions to expand the use of our battery products depends on a number of factors, including general economic conditions, the functioning of our batteries, and our customers&#146;
satisfaction with our battery products. If our efforts to expand within our existing customer base are not successful, our business may suffer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We
may require additional capital to support business growth, and this capital might not be available on commercially reasonable terms or at all. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may need additional capital before we commence production at scale, and it may not be available on acceptable terms, if at all. For example,
our capital budget assumes, among other things, that our development timeline progresses as planned and our corresponding expenditures are consistent with current expectations, both of which are subject to various risks and uncertainties, including
those described herein, and, as needed, that we are able to utilize the Committed Equity Financing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">More specifically, we expect our
capital expenditures and working capital requirements to increase materially in the near future, as we design our automated, high-volume manufacturing line and scale up production. Through this process, we expect our operating expenses will increase
substantially on account of increased headcount and other general and administrative expenses necessary to support a rapidly growing company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result, we may need to access the debt and equity capital markets, including through the Committed Equity Financing, to obtain additional
financing in the future. However, these sources of financing may not be available on acceptable terms, or at all. Our ability to obtain additional financing will be subject to a number of factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">market conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the level of success with our current manufacturing capabilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our operating performance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investor sentiment; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to incur additional debt in compliance with any agreements governing our then-outstanding debt.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, the sale of a substantial number of shares of our Common Stock to BRPC II, or the anticipation of such
sales, could make it more difficult for us to sell equity or equity-related securities in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-21- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
future at a time and at a price that we might otherwise wish to effect sales. See &#147;&#151;Risks Related to Ownership of Our Common Stock&#151;The sale of all of the securities registered for
resale in this prospectus and future sales of substantial amounts of our Common Stock in the public markets, or the perception that such sales could occur, could cause the market price of our Common Stock to drop significantly, even if our business
is doing well.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, the military conflict between Russia and Ukraine, which began in February 2022, has had an adverse impact
on the global economy and financial markets. Although our business has not been directly impacted by this ongoing military conflict, as we have no assets or operations, and we have not purchased materials from, Russia, Belarus or Ukraine, it is
impossible to predict the extent to which our operations, or those of our customers, suppliers and manufacturers, will be impacted in the short and long term, or the ways in which the conflict may impact our business. The extent and duration of the
military action, sanctions and resulting market disruptions are impossible to predict, but could be material. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These factors may make the
timing, amount, terms or conditions of additional financings unattractive to us. If we raise additional funds by issuing equity, equity-linked or debt securities, those securities may have rights, references or privileges senior to the rights of our
currently issued and outstanding equity or debt, and our existing stockholders may experience dilution. If we are unable to generate sufficient funds from operations or raise additional capital, we may be forced to take actions to reduce our capital
or operating expenditures, including by eliminating redundancies, or reducing or delaying our production facility expansions, which may adversely affect our business, financial condition, prospects and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our future growth and success depend in part on our ability to grow our customer base and effectively sell to a wide variety of customers. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our potential customers are manufacturers of products that tend to be large enterprises or governmental agencies. Therefore, our future success
will depend on our ability to grow our customer base and effectively sell to a wide variety of customers. Sales to these <FONT STYLE="white-space:nowrap">end-customers</FONT> involve risks that may not be present (or that are present to a lesser
extent) with sales to smaller customers. These risks include, but are not limited to, (i)&nbsp;increased purchasing power and leverage held by large customers in negotiating contractual arrangements with us and (ii)&nbsp;longer sales cycles and the
associated risk that substantial time and resources may be spent on a potential <FONT STYLE="white-space:nowrap">end-customer</FONT> that elects not to purchase our solutions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Large organizations often undertake a significant evaluation process that results in a lengthy sales cycle. In addition, product purchases by
large organizations are frequently subject to budget constraints, multiple approvals and unanticipated administrative, processing and other delays. Finally, large organizations typically have longer implementation cycles, require greater product
functionality and scalability, require a broader range of services, demand that vendors take on a larger share of risks, require acceptance provisions that can lead to a delay in revenue recognition and expect greater payment flexibility. All of
these factors can add further risk to business conducted with these potential customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if we were unable to maintain or
increase our customer retention rates or generate new customers in a cost-effective manner, our business, financial condition and results of operations would likely be adversely affected. We cannot assure you that we will be able to maintain or grow
our customer base in a cost-effective way. If we are unable to develop high quality products at scale, or introduce new products, we may fail to attract new customers or lose our existing customers, which could adversely affect our growth and
profitability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our business model has yet to be tested and any failure to realize our strategic plans would have an adverse effect on our operating
results and business, harm our reputation and could result in substantial liabilities that exceed our resources. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is
additional risk associated with new enterprises like Amprius, that are encountering new challenges and issues for the first time, many of which are beyond our control, including substantial risks and expenses in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-22- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the course of establishing or entering new markets, organizing operations and undertaking marketing activities. The likelihood of our success must be considered in light of these risks, expenses,
complications, delays and the competitive environment in which we operate. There is, therefore, nothing at this time upon which to base an assumption that our business plan will prove successful, and we may not be able to generate significant
revenue, raise additional capital or operate profitably. We will continue to encounter risks and difficulties frequently experienced by early commercial stage companies, including scaling up our infrastructure and headcount, and may encounter
unforeseen expenses, difficulties or delays in connection with our growth. In addition, as a result of the capital requirements of our business, we can be expected to continue to sustain substantial operating expenses without generating sufficient
revenue to cover expenditures. Any investment in our company is therefore highly speculative and could result in the loss of your entire investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is difficult to predict our future revenues and appropriately budget for our expenses, and we have limited insight into trends that may
emerge and affect our business. In the event that actual results differ from our estimates or we adjust our estimates in future periods, our business, financial condition, prospects and results of operations could be materially affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are an early stage company with a history of financial losses and expect to incur significant expenses and continuing losses for the foreseeable
future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred significant operating losses since our inception. We incurred a net loss of approximately
$9.9&nbsp;million and $11.3&nbsp;million during the year ended December&nbsp;31, 2021 and the nine months ended September&nbsp;30, 2022, respectively. We believe that we will continue to incur operating and net losses each quarter until at least the
time we begin scaled production of our batteries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect the rate at which we will incur losses to be significantly higher in future
periods as we, among other things: continues to incur significant expenses in connection with building out our high-volume manufacturing facility and manufacturing line; hiring the experienced scientific, quality-control, and manufacturing personnel
needed to operate our scaled manufacturing processes; building up inventories of components for our batteries; increasing our sales and marketing activities; develop our distribution infrastructure; and increasing our general and administrative
functions to support our growing operations. We may find that these efforts are more expensive than we currently anticipate or that these efforts may not result in revenues, which would further increase our losses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to effectively manage our future personnel growth, we may not be able to market and sell our batteries successfully. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future success depends upon our ability to grow, and if we are unable to manage our personnel growth effectively, we may incur unexpected
expenses and be unable to meet our eventual customers&#146; requirements, all of which could materially adversely affect our business, financial condition, prospects and results of operations. To manage our current and anticipated future growth
effectively, we must continue to maintain and enhance our infrastructure, financial and accounting systems and controls. We must also attract, train and retain a significant number of scientists, engineers, sales and marketing personnel, technical
and manufacturing personnel and management personnel, and the availability of such personnel may be constrained. For more information, see &#147;<I>&#151;</I>We may not succeed in retaining and attracting key employees, particularly technical
talent, needed to operate and build our business successfully.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As we continue to grow, including from the integration of employees
and businesses acquired in connection with future acquisitions, we may find it difficult to maintain important aspects of our corporate culture, which could negatively affect our profitability and our ability to retain and recruit qualified
personnel who are essential for our future success. If we do not effectively manage our growth, we may not be able to execute on our growth plan, respond to competitive pressures, take advantage of market opportunities, satisfy customer requirements
or manufacture high-quality battery products. Additionally, we may not be able to expand and upgrade our infrastructure to accommodate future growth. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-23- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Failure to effectively manage our growth could also lead us to over-invest or under-invest
in development and operations; result in weaknesses in our infrastructure, systems or controls; give rise to operational mistakes, financial losses, loss of productivity or business opportunities; and result in loss of employees and reduced
productivity of remaining employees. Our growth is expected to require significant capital expenditures, which may lower our earnings, and may divert financial resources from other projects such as the development of new products and services. If we
are unable to manage our growth effectively, our expenses may increase more than expected, our revenue may not increase or may grow more slowly than expected and we may be unable to implement our business strategy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have been, and may in the future be, adversely affected by the global <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and/or any other
pandemic. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We face various risks related to epidemics, pandemics and other outbreaks, including the recent <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. The impact of <FONT STYLE="white-space:nowrap">COVID-19,</FONT> including changes in consumer and business behavior, pandemic fears and market downturns, and restrictions on business and
individual activities, has created significant volatility in the global economy and led to reduced economic activity. If a significant portion of our workforce is unable to work due to <FONT STYLE="white-space:nowrap">COVID-19</FONT> illness,
quarantine or other government restrictions in connection with <FONT STYLE="white-space:nowrap">COVID-19,</FONT> our operations may be negatively impacted. The spread of <FONT STYLE="white-space:nowrap">COVID-19</FONT> has also impacted our
potential customers and suppliers by disrupting the manufacturing, delivery and overall supply chain of battery and device manufacturers. As a result, the effects of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic could impact the
availability of materials and resources necessary for our operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pandemic has resulted in government authorities implementing
numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">stay-at-home</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">shelter-in-place</FONT></FONT> orders, and business shutdowns. For example, some employees at our headquarters located in Fremont, California were subject to a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">stay-at-home</FONT></FONT> order from the state government for a period of time. These measures have and may continue to adversely impact our employees and operations and the operations of our suppliers, vendors and
business partners, and may negatively impact our sales and marketing activities. In addition, various aspects of our business cannot be conducted remotely. These measures by government authorities may remain in place for a significant period of time
and could adversely affect our future manufacturing plans, sales and marketing activities, business and results of operations. We may take further actions as may be required by government authorities or that we determine are in the best interests of
our employees, suppliers, vendors and business partners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The extent to which the <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic continues to impact our business, financial condition, prospects and results of operations will depend on future developments, which are highly uncertain and cannot be predicted, including the duration and spread of the pandemic, its
severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating activities can resume. Even after the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic has subsided, we may
continue to experience an adverse impact to our business as a result of its global economic impact, including any recession that has occurred or may occur in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no comparable recent events that may provide guidance as to the effect of the spread of
<FONT STYLE="white-space:nowrap">COVID-19</FONT> and a pandemic, and, as a result, the ultimate impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic or a similar health epidemic is highly uncertain. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain members of our management do not have experience in operating a public company. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our executive officers do not have experience in the management of a publicly traded company. Our management team may not
successfully or effectively manage our recent transition to being a public company due to significant regulatory oversight and reporting obligations under federal securities laws and the continuous scrutiny of securities analysts and investors. We
may not have adequate personnel with the appropriate level of knowledge, experience, and training in the policies, practices or internal controls over </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-24- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financial reporting required of public companies in the United States. As a result, we may be required to pay higher outside legal, accounting or consulting costs than our competitors, and our
management team members may have to devote a higher proportion of their time to issues relating to compliance with the laws applicable to public companies, both of which might put us at a disadvantage relative to competitors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our insurance coverage may not be adequate to protect us from all business risks. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may be subject, in the ordinary course of business, to losses resulting from products liability, accidents, acts of God, and other claims
against us, for which we may have no insurance coverage. As a general matter, the policies that we do have may include significant deductibles or self-insured retentions, and we cannot be certain that our insurance coverage will be sufficient to
cover all future losses or claims against us. A loss that is uninsured or which exceeds policy limits may require us to pay substantial amounts, which could adversely affect our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We identified material weaknesses in our internal controls over financial reporting. If we are unable to develop and maintain an effective system of
internal controls and procedures required by Section&nbsp;404(a) of the Sarbanes-Oxley Act, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and
adversely affect our stock price, business and operating results. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective internal control over financial reporting is necessary
for us to provide reliable financial reports in a timely manner. In connection with the audit of Legacy Amprius&#146; financial statements for the year ended December&nbsp;31, 2021, we identified two material weaknesses in our internal control over
financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial
statements will not be prevented or detected on a timely basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The first material weakness related to Legacy Amprius not designing or
maintaining an effective control environment specific to the areas of its financial reporting and close process, including ineffective review, analysis and approval of journal entries and ineffective review of monthly financial statements. This
material weakness resulted in misstatements that were corrected prior to the completion and issuance of Legacy Amprius&#146; audited financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The second material weakness related to inadequate segregation of incompatible duties due to the small size of Legacy Amprius&#146; accounting
and finance team. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to address these identified material weaknesses, we are in the process of increasing re<I>s</I>ources within
our finance department, including the expansion of our accounting, control and compliance functions to develop and implement continued improvements and enhancements to address the overall deficiencies that led to the material weaknesses. Our
management believes that these actions will enable us to address the material weaknesses that were identified in a timely manner and maintain properly designed and effective system of internal control over financial reporting and provide appropriate
segregation of duties. However, these remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately have the intended effects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We plan to continue to assess our internal controls and procedures and intend to take further action as necessary or appropriate to address
any other matters we identify. We cannot assure you that the measures we have taken to date and may take in the future, will be sufficient to remediate the control deficiencies that led to our material weaknesses in internal control over financial
reporting or that it will prevent or avoid potential future material weaknesses. The effectiveness of our internal control over financial reporting is subject to various inherent limitations, including cost limitations, judgments used in decision
making, assumptions about the likelihood of future events, the possibility of human error and the risk of fraud. If we are unable to remediate the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-25- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material weaknesses, our ability to record, process and report financial information accurately, and to prepare financial statements within the time periods specified by the forms of the SEC,
could be adversely affected which, in turn, to may adversely affect our reputation and business and the market price of our Common Stock. In addition, any such failures could result in litigation or regulatory actions by the SEC or other regulatory
authorities, loss of investor confidence, delisting of our securities and harm to our reputation and financial condition, or diversion of financial and management resources from the operation of our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, it is possible that control deficiencies could be identified by our management or by our independent registered public accounting
firm in the future or may occur without being identified. Such a failure could result in regulatory scrutiny and cause investors to lose confidence in our reported financial condition, lead to a default under future indebtedness and otherwise have a
material adverse effect on our business, financial condition, cash flow or results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company, we are required,
pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things, the effectiveness of its internal control over financial reporting for future annual reports on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> to be filed with the SEC. This assessment will need to include disclosure of any material weaknesses identified by our management in our internal control over financial reporting. Eventually, it is
possible that our independent registered public accounting firm will also be required to audit the effectiveness of our internal control over financial reporting in future annual reports on Form <FONT STYLE="white-space:nowrap">10-K</FONT> to be
filed with the SEC. We are required to disclose changes made in our internal control over financial reporting on a quarterly basis. Failure to comply with the Sarbanes-Oxley Act could potentially subject us to sanctions or investigations by the SEC,
the applicable stock exchange or other regulatory authorities, which would require additional financial and management resources. We have begun the process of compiling the system and processing documentation necessary to perform the evaluation
needed to comply with Section&nbsp;404 in the future, but we may not be able to complete our evaluation, testing and any required remediation in a timely fashion. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ability to utilize our net operating losses, tax credit carryforwards, and certain other tax attributes to offset future taxable income may be
subject to certain limitations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, under Section&nbsp;382 of the Code, a corporation that undergoes an &#147;ownership
change&#148; is subject to limitations on its ability to use its <FONT STYLE="white-space:nowrap">pre-change</FONT> net operating loss carryforwards, or NOLs, to offset future taxable income. The limitations apply if a corporation undergoes an
&#147;ownership change,&#148; which is generally defined as a greater than 50 percentage point change (by value) in its equity ownership by certain stockholders over a three-year period. If Legacy Amprius experienced an ownership change at any time
since its incorporation, we may already be subject to limitations on our ability to utilize Legacy Amprius&#146; existing NOLs and other tax attributes to offset taxable income or tax liability. In addition, future changes in our stock ownership,
which may be outside of our control, may trigger an ownership change. Similar provisions of state tax law may also apply to limit our use of accumulated state tax attributes. As a result, even if we earn net taxable income in the future, our ability
to use our or Legacy Amprius&#146; <FONT STYLE="white-space:nowrap">pre-change</FONT> NOL carryforwards and other tax attributes to offset such taxable income or tax liability may be subject to limitations, which could potentially result in
increased future income tax liability to us. Further, because Legacy Amprius and Amprius Holdings were members of a consolidated group for U.S. federal income tax purposes up to the Closing Date, NOLs and other tax attributes of Legacy Amprius are
available to be utilized by any member of the consolidated group. Accordingly, our existing NOLs and other tax attributes may not be available to offset future income tax liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is also a risk that changes in law or regulatory changes made in response to the need for some jurisdictions to raise additional revenue
to help counter the fiscal impact from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic or for other unforeseen reasons, including suspensions on the use of net operating losses, tax credits, and other tax attributes, possibly with
retroactive effect, may result in our and Legacy Amprius&#146; existing net operating losses, tax credits, or other tax attributes expiring or otherwise being unavailable to offset future income tax liabilities. Also, starting in fiscal year 2022,
the Tax Cuts and Jobs Act requires taxpayers to capitalize research and development expenditures and to amortize domestic expenditures over five years and foreign expenditures over </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-26- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
15 years. If Congress does not modify or repeal this provision, it may result in the acceleration of future taxable income (and associated income tax liabilities) for us, beginning in fiscal year
2022. Any resulting income tax liabilities may reduce our cash flows beginning in fiscal year 2022. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Internal Revenue Service (&#147;IRS&#148;)
or other taxing authority could assert income tax liability against the Company, notwithstanding the provisions of the Tax Sharing Agreement. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Tax Sharing Agreement with Amprius Holdings, Amprius Holdings generally would be required to indemnify the Company for the U.S.
federal income tax liabilities of the U.S. federal consolidated group of which Amprius Holdings and Legacy Amprius were members (and any similar consolidated, combined or unitary tax group for state tax purposes) for taxable periods prior to (and
including) the Closing Date (a &#147;Consolidated Return Year&#148;). The Tax Sharing Agreement also provides that Amprius Holdings will generally control any tax returns and any tax audits or other proceedings for the taxes addressed by the Tax
Sharing Agreement. However, the Tax Sharing Agreement is not binding on the IRS or other state taxing authority, and does not prevent the IRS or other state taxing authority from asserting a tax claim against Legacy Amprius or the Company for any
unpaid income tax liabilities of Legacy Amprius or Amprius Holdings for any Consolidated Return Year. If that were to occur, the Company would be required to seek indemnification against Amprius Holdings for payment of any amounts on such claims,
and Amprius Holdings&#146; ability to satisfy such claims may depend on whether Amprius Holdings is able to sell sufficient shares of the Company to satisfy the tax liability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The unavailability, reduction or elimination of government and economic incentives could have a material adverse effect on our business, financial
condition, prospects and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently, and expect to continue to, benefit from certain government subsidies
and economic incentives including tax credits, rebates and other incentives that support the development and adoption of clean energy technology. For example, the Inflation Reduction Act of 2022 introduces or extends a number of tax credits to
promote clean energy development. We cannot assure you that we will be able to benefit from such programs or that these subsidies and incentive programs will be available to us at the same or comparable levels in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Specifically, in October 2022, we were awarded a $50 million cost sharing grant from the U.S. Department of Energy. The cost sharing grant is
dependent on the successful negotiation of a final contract, and among the terms to be finalized are the portion of relevant costs that will be covered by the grant. Even if we are able to successfully negotiate a final contract, we may not receive
any funding if we are not able to satisfy the terms of the grant, including any matching requirements. In addition, such funding may still be insufficient to complete the project. See &#147;Risks Related to Our Business and Industry&#151;We may
require additional capital to support business growth, and this capital might not be available on commercially reasonable terms or at all.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any reduction, elimination or discriminatory application of government subsidies and economic incentives because of policy changes, or the
reduced need for such subsidies and incentives due to the perceived success of clean and renewable energy products or other reasons, may require us to seek additional financing, which may not be obtainable on commercially attractive terms or at all,
and may result in the diminished competitiveness of the battery cell industry generally or our silicon nanowire battery cells in particular. Any change in the level of subsidies and incentives from which we benefit could materially and adversely
affect our business, financial condition, prospects and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>A significant portion of our business depends on sales to the public
sector, and our failure to receive and maintain government contracts or changes in the contracting or fiscal policies of the public sector could have a material adverse effect on our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently rely on U.S. government contracts (as a prime contractor or subcontractor) for a material portion of our revenue and to partially
fund our research and development activities, and we believe that the success and growth of our business will continue to depend on our successful procurement of government contracts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-27- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales to government agencies are subject to a number of challenges and risks. Selling to
government agencies can be highly competitive, expensive, and time-consuming, often requiring significant upfront time and expense without any assurance that these efforts will generate a sale. We also must comply with laws and regulations relating
to the formation, administration, and performance of contracts, which provide public sector customers rights, many of which are not typically found in commercial contracts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, our business, financial condition, prospects and results of operations may be adversely affected by certain events or activities,
including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in fiscal or contracting policies or decreases in available government funding; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in government programs or applicable requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the political environment, including before or after a change to the leadership within the government
administration, and any resulting uncertainty or changes in policy or priorities and resultant funding; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appeals, disputes, or litigation relating to government procurement, including but not limited to bid protests by
unsuccessful bidders on potential or actual awards of contracts to us or our partners by the government; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the adoption of new laws or regulations or changes to existing laws or regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">influence by, or competition from, third parties with respect to pending, new, or existing contracts with
government customers; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased or unexpected costs or unanticipated delays caused by other factors outside of our control, such as
performance failures of our subcontractors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Any such event or activity, among others, could cause governments and governmental agencies to delay or refrain
from purchasing our battery products in the future, reduce the size or payment amounts of purchases from existing or new government customers, or otherwise have an adverse effect on our business, financial condition, prospects and results of
operations. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Government contracts often also contain provisions and are subject to laws and regulations that provide
government customers with additional rights and remedies not typically found in commercial contracts. These rights and remedies allow government customers, among other things, to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">terminate existing contracts for convenience; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce orders under or otherwise modify contracts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for contracts subject to the Truth in Negotiations Act, reduce the contract price or cost where it was increased
because a contractor or subcontractor furnished cost or pricing data during negotiations that was not complete, accurate, and current; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for some contracts, (i)&nbsp;demand a refund, make a forward price adjustment, or terminate a contract for
default if a contractor provided inaccurate or incomplete data during the contract negotiation process and (ii)&nbsp;reduce the contract price under triggering circumstances, including the revision of price lists or other documents upon which the
contract award was predicated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decline to exercise an option to renew a multi-year contract; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">claim rights in solutions, systems, or technology produced by us, appropriate such work-product for their
continued use without continuing to contract for our services, and disclose such work-product to third parties, including other government agencies and our competitors, which could harm our competitive position; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibit future procurement awards with a particular agency due to a finding of organizational conflicts of
interest; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-28- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">suspend or debar us from doing business with the applicable government; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">control or prohibit the export of our battery products and technology. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Government contracts are also generally subject to greater scrutiny by the government, which can initiate reviews, audits and investigations
regarding our compliance with government contract requirements. Current and new regulations or procurement requirements (including, for example regulations regarding counterfeit and corrupt parts, supply chain diligence, mandatory socioeconomic
compliance requirements and cybersecurity) or changes to current requirements could increase our costs and risk of <FONT STYLE="white-space:nowrap">non-compliance.</FONT> Failure to comply with government contracting laws, regulations and contract
requirements, or adverse findings from a government audit or investigation can lead to criminal, civil or administrative proceedings (including pursuant to the False Claims Act), termination of contracts, forfeiture of profits, suspension of
payments, adverse media coverage, fines and suspension or debarment from doing business with U.S. government agencies, all of which may have an adverse effect on our reputation, business, financial condition, prospects and results of operations.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our technology and our website, systems, and data we maintain may be subject to intentional disruption, security breaches and other security
incidents, or alleged violations of laws, regulations, or other obligations relating to data handling that could result in liability and adversely impact our reputation and future sales. We may be required to expend significant resources to continue
to modify or enhance our protective measures to detect, investigate and remediate vulnerabilities to security breaches and incidents. Any actual or alleged failure to comply with applicable cybersecurity or data privacy legislation or regulation
could have a material adverse effect on our business, reputation, results of operations or financial condition. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to face
significant challenges with respect to information security and maintaining the security and integrity of our systems and other systems used in our business, as well as with respect to the data stored on or processed by these systems. We also
anticipate receiving and storing confidential business information of our partners and customers. Advances in technology, an increased level of sophistication and expertise of hackers, and new discoveries in the field of cryptography can result in a
compromise or breach of the systems used in our business or of security measures used in our business to protect confidential information, personal information, and other data. We may be a target for attacks designed to disrupt our operations or to
attempt to gain access to our systems or to data that we possess, including proprietary information that we obtain from our partners pursuant to our agreements with them. We also are at risk for interruptions, outages and breaches of our and our
outsourced service providers&#146; operational systems and security systems, our integrated software and technology, and data that we or our third-party service providers process or possess. These may be caused by, among other causes, physical
theft, viruses, or other malicious code, denial or degradation of service attacks, ransomware, social engineering schemes, and insider theft or misuse. We have suffered security incidents in the past. In December 2021, we experienced a ransomware
incident and notified certain employees of such incident. The security risks we and our outsourced service providers face could also be elevated in connection with the Russian invasion of Ukraine, as we and our outsourced service providers are
vulnerable to a heightened risk of cyberattacks from or affiliated with nation-state actors, including retaliatory attacks from Chinese or Russian actors against U.S.-based companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The availability and effectiveness of our silicon nanowire anode technology and our ability to conduct our business and operations depend on
the continued operation of information technology and communications systems, some of which we have yet to develop or otherwise obtain the ability to use. Systems we currently use or may use in the future in conducting our business, including data
centers and other information technology systems, will be vulnerable to damage or interruption. Such systems could also be subject to <FONT STYLE="white-space:nowrap">break-ins,</FONT> sabotage and intentional acts of vandalism, as well as
disruptions and security breaches and security incidents as a result of <FONT STYLE="white-space:nowrap">non-technical</FONT> issues, including intentional or inadvertent acts or omissions by employees, service providers, or others. We currently
use, and may use in the future, outsourced service providers to help provide certain services, and any such outsourced service providers face similar security and system disruption risks as us. Our ability to monitor our outsourced service
providers&#146; security measures is limited, and, in any event, third parties may be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-29- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
able to circumvent those security measures, resulting in the unauthorized access to, misuse, acquisition, disclosure, loss, alteration, or destruction of personal, confidential, or other data,
including data relating to individuals. Some of the systems used in our business will not be fully redundant, and our disaster recovery planning cannot account for all eventualities. Any data security incidents or other disruptions to any data
centers or other systems used in our business could result in lengthy interruptions in our service and may adversely affect our reputation, business, financial condition, prospects and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant capital and other resources may be required in efforts to protect against information security breaches, security incidents, and
system disruptions, or to alleviate problems caused by actual or suspected information security breaches and other data security incidents and system disruptions. The resources required may increase over time as the methods used by hackers and
others engaged in online criminal activities and otherwise seeking to obtain unauthorized access to systems or data, and to disrupt systems, are increasingly sophisticated and constantly evolving. In particular, ransomware attacks have become more
prevalent in the industrial sector, which could materially and adversely affect our ability to operate and may result in significant expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we may face increased compliance burdens regarding such requirements with regulators and customers regarding our battery products
and also incur additional costs for oversight and monitoring of our supply chain. These additional compliance and logistical burdens are attenuated through our international partnerships. We also cannot be certain that these systems, networks, and
other infrastructure or technology upon which we rely, including those of our third-party suppliers or service providers, will be effectively implemented, maintained or expanded as planned, or will be free from bugs, defects, errors,
vulnerabilities, viruses, ransomware, or other malicious code. We may be required to expend significant resources to make corrections or to remediate issues that are identified or to find alternative sources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any failure or perceived failure by us or our service providers to prevent information security breaches or other security incidents or system
disruptions, or any compromise of security that results in or is perceived or reported to result in unauthorized access to, or loss, theft, alteration, release or transfer of, our information, or any personal information, confidential information,
or other data could result in loss or theft of proprietary or sensitive data and intellectual property, could harm our reputation and competitive position and could expose us to legal claims, regulatory investigations and proceedings, and fines,
penalties, and other liability. Any such actual or perceived security breach, security incident or disruption could also divert the efforts of our technical and management personnel and could require us to incur significant costs and operational
consequences in connection with investigating, remediating, eliminating and putting in place additional tools, devices, policies, and other measures designed to prevent actual or perceived security breaches and other incidents and system
disruptions. Moreover, we could be required or otherwise find it appropriate to expend significant capital and other resources to respond to, notify third parties of, and otherwise address the incident or breach and its root cause, and most
jurisdictions have enacted laws requiring companies to notify individuals, regulatory authorities and others of security breaches involving certain types of data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, we cannot assure that any limitations of liability provisions in our current or future contracts that may be applicable would be
enforceable or adequate or would otherwise protect us from any liabilities or damages with respect to any particular claim relating to a security breach or other security-related matter. We also cannot be sure that our existing insurance coverage
will continue to be available on acceptable terms or will be available in sufficient amounts to cover claims related to a security breach or incident, or that the insurer will not deny coverage as to any future claim. The successful assertion of
claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or <FONT STYLE="white-space:nowrap">co-insurance</FONT>
requirements, could have a material adverse effect on our business, including our reputation, financial condition, and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, laws, regulations, and other actual and potential obligations relating to privacy, data hosting and other processing of data,
data protection, and data security are evolving rapidly, and we expect to potentially </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-30- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be subject to new laws and regulations, or new interpretations of laws and regulations, in the future in various jurisdictions. These laws, regulations, and other obligations, and changes in
their interpretation, could require us to modify our operations and practices, restrict our activities, and increase our costs. Further, these laws, regulations, and other obligations are complex and evolving rapidly, and we cannot provide assurance
that we will not be subject to claims, allegations, or other proceedings related to actual or alleged obligations relating to privacy, data protection, or data security. It is possible that these laws, regulations, and other obligations may be
inconsistent with one another or be interpreted or asserted to be inconsistent with our business or practices. We anticipate needing to dedicate substantial resources to comply with laws, regulations, and other obligations relating to privacy and
data security in order to comply. Any failure or alleged or perceived failure to comply with any applicable laws, regulations, or other obligations relating to privacy, data protection, or data security could also result in regulatory investigations
and proceedings, and misuse of or failure to secure data relating to individuals could also result in claims and proceedings against us by governmental entities or others, penalties and other liability, and damage to our reputation and credibility,
and could have a negative impact on our business, financial condition, prospects and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>UBS Securities LLC (&#147;UBS&#148;),
one of the underwriters in Kensington&#146;s initial public offering (the &#147;IPO&#148;), was to be compensated, in part, on a deferred basis for already-rendered underwriting services in connection with the IPO, yet UBS gratuitously, and without
any consideration from Kensington, waived such compensation. As a result, UBS disclaims any responsibility for the Company&#146;s registration statement on Form S-4 and the related proxy statement/prospectus filed in connection with the Business
Combination and will not be associated with the disclosure or underlying business analysis related to the Business Combination. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UBS acted as an underwriter in the IPO. The underwriters in the IPO received an underwriting discount of $0.20 per unit, or $4.6 million in the
aggregate, upon the closing of the IPO. Subject to certain limitations, an additional fee of $0.18 per unit, or approximately $4.0 million in the aggregate, was agreed to be paid to the underwriters for deferred underwriting commissions at the
consummation of the Business Combination. Prior to the consummation of the Business Combination, on September 6, 2022, UBS sent Kensington a letter stating that it is resigning, and is ceasing and refusing to act, as an underwriter in connection
with the Business Combination and the related registration statement on Form S-4. In addition, following the delivery of such resignation letter, UBS gratuitously, and without any consideration from Kensington, waived its claim to the deferred
underwriting commission, despite having performed all of its obligations to obtain the fee upon closing of the Business Combination. UBS did not communicate to Kensington its reasons for its resignation or waiving the deferred underwriting
commission, and Kensington did not correspond with UBS about the reasons for its resignation or waiver. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company does not currently
have any ongoing relationship with UBS. UBS was not involved in the preparation of any disclosure included in the Company&#146;s proxy statement/prospectus filed with the SEC on September 1, 2022 relating to the Business Combination. Further, UBS
did not assist in the preparation or review of any materials for Kensington or Legacy Amprius in connection with the Business Combination and did not participate in any other aspect of the Business Combination. As such, the resignation by UBS did
not impact Kensington&#146;s evaluation of the Business Combination. However, investors should be aware that a fee waiver for services already rendered is unusual. As a result of such resignation, UBS disclaims any responsibility for the
Company&#146;s registration statement on Form S-4 and the related proxy statement/prospectus filed in connection with the Business Combination and will not be associated with the disclosure or underlying business analysis related to the Business
Combination. You should not put any reliance on the fact that UBS was previously involved with any aspect of the Business Combination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-31- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely heavily on our intellectual property portfolio. If we are unable to protect our intellectual property rights, our business and competitive
position would be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not be able to prevent unauthorized use of our intellectual property, which could harm our
business and competitive position. We rely upon a combination of various intellectual property protections afforded by patent, copyright, trademark and trade secret laws in the United States and other jurisdictions, as well as contractual
protections afforded by license agreements and other agreements, to establish, maintain and enforce rights in our proprietary technologies. In addition, we seek to protect our intellectual property rights through nondisclosure and invention
assignment agreements with our employees and consultants, and through <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements with business partners and other third parties. Despite our efforts to protect our proprietary rights, third
parties may, without proper authorization, attempt to copy or otherwise obtain and use our intellectual property or be able to design around our intellectual property. Monitoring unauthorized use of our intellectual property is difficult and costly,
and the steps we have taken or will take to prevent misappropriation may not be adequate, sufficient, or effective. Any enforcement efforts we undertake, including litigation, could be time-consuming and expensive and could divert management&#146;s
attention, which could harm our business, results of operations and financial condition. Moreover, certain proprietary technology that is stored on computer systems could be penetrated by intruders and potentially misappropriated. There is no
guarantee that our efforts to protect our computer systems will be effective. In addition, existing intellectual property laws and contractual remedies may afford less protection than needed to safeguard our intellectual property portfolio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patent, copyright, trademark and trade secret laws vary significantly throughout the world. A number of foreign countries do not protect
intellectual property rights to the same extent as do the laws of the United States. Therefore, our intellectual property rights may not be as strong or as easily enforced outside of the United States and efforts to protect against the unauthorized
use of our intellectual property rights, technology and other proprietary rights may be more expensive and difficult outside of the United States. Further, we have not established our intellectual property rights in all countries in the world, and
competitors may copy our designs and technology and operate in countries in which it has not prosecuted our intellectual property. Failure to adequately protect our intellectual property rights could result in our competitors using our intellectual
property to offer products, and competitors&#146; ability to design around our intellectual property would enable competitors to offer similar or better batteries, in each case potentially resulting in the loss of some of our competitive advantage
and a decrease in our revenue which, would adversely affect our business, financial condition, prospects and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may need to
defend ourselves against intellectual property infringement claims, which may be time-consuming and could cause us to incur substantial costs. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Companies, organizations or individuals, including our current and future competitors, may hold or obtain patents, trademarks or other
proprietary rights that would prevent, limit or interfere with our ability to make, use, develop, distribute, or sell our battery products, which could make it more difficult for us to operate our business. From time to time, we may receive
inquiries from holders of patents or trademarks inquiring whether we are infringing their proprietary rights and/or seek court declarations that they do not infringe upon our intellectual property rights. Companies holding patents or other
intellectual property rights relating to batteries, electric motors or electronic power management systems may bring suits alleging infringement by our battery products of such rights or otherwise asserting their rights and seeking licenses. In
addition, if we are determined to have infringed upon a third party&#146;s intellectual property rights, we may be required to do one or more of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cease selling, incorporating or using products that incorporate the challenged intellectual property;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pay substantial damages; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain a license from the holder of the infringed intellectual property right, which license may not be available
on reasonable terms or at all; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">redesign our batteries. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-32- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have in the past experienced infringement claims from
<FONT STYLE="white-space:nowrap">non-practicing</FONT> organizations (sometimes referred to as &#147;patent trolls&#148;) filing lawsuits for patent infringement. For example, in December 2020, we settled a patent infringement case against us and
agreed to make licensing payments in connection with such settlement. We may be subject to additional infringement claims in the future, and even if we believe such claims are without merit, such claims are time-consuming, expensive to litigate or
settle and can divert management&#146;s resources and attention. An adverse determination could require that we pay damages, which could be substantial, or stop using technologies found to be in violation of a third-party&#146;s rights and could
prevent us from selling our batteries. In order to avoid these restrictions, we may have to seek a license for the technology. Any such license may not be available on reasonable terms or at all, could require us to pay significant royalties and may
significantly increase our operating expenses or otherwise seriously harm our business or operating results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a successful
claim of infringement against us and our failure or inability to obtain a license to the infringed technology, our business, financial condition, prospects and results of operations could be materially adversely affected. In addition, any litigation
or claims, whether or not valid, could result in substantial costs and diversion of resources and management&#146;s attention. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also
license patents and other intellectual property from third parties, and we may face claims that our use of this intellectual property infringes the rights of others. In such cases, we may seek indemnification from our licensors under our license
contracts with them. However, our rights to indemnification may be unavailable or insufficient to cover our costs and losses, depending on our use of the technology, whether we choose to retain control over conduct of the litigation, and other
factors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our patent applications may not result in issued patents or our patent rights may be contested, circumvented, invalidated or limited in
scope, any of which could have a material adverse effect on our ability to prevent others from interfering with our commercialization of our batteries. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our patent applications may not result in issued patents, which may have a material adverse effect on our ability to prevent others from
commercially exploiting products similar to ours. The status of patents involves complex legal and factual questions and the breadth of claims allowed is uncertain. As a result, we cannot be certain that the patent applications that we file will
result in patents being issued, or that our patents and any patents that may be issued to us will afford protection against competitors with similar technology. Numerous patents and pending patent applications owned by others exist in the fields in
which we have developed and is and will be developing our technology. In addition to those who may claim priority, any of our existing or pending patents may also be challenged by others on the basis that they are otherwise invalid or unenforceable.
Furthermore, patent applications filed in foreign countries are subject to laws, rules and procedures that differ from those of the United States, and thus we cannot be certain that foreign patent applications related to issued U.S. patents will be
issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if our patent applications succeed and we are issued patents in accordance with them, it is still uncertain whether these
patents will be contested, circumvented, invalidated or limited in scope in the future. The rights granted under any issued patents may not provide us with meaningful protection or competitive advantages, and some foreign countries provide
significantly less effective patent enforcement than what the United States provides. In addition, the claims under any patents that issued to us may not be broad enough to prevent others from developing technologies that are similar or that achieve
results similar to ours. The intellectual property rights of others could also bar or limit us from licensing, exploiting, or enforcing any patents issued to us. In addition, patents issued to us may be infringed upon or designed around by others
and others may obtain patents that it needs to license or design around, either of which would increase costs and may adversely affect our business, financial condition, prospects and results of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-33- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may obtain licenses on technology that has not been commercialized or has been commercialized only
to a limited extent, and the success of our business may be adversely affected if such technology does not perform as expected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, we may license from third parties technologies that have not been commercialized or which have been commercialized only to a
limited extent. These technologies may not perform as expected within our silicon nanowire battery cells and related products. If the cost, performance characteristics, manufacturing process or other specifications of these licensed technologies
fall short of our targets, our expected sales, costs, time to market, competitive advantage, future product pricing and potential operating margins may be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Litigation and Regulatory Compliance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our operations expose us to litigation, environmental and other legal compliance risks. Compliance with laws and regulations can be expensive, and our
failure to comply with these laws and regulations may result in monetary damages and fines, adverse publicity and a material adverse effect on our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to a variety of litigation, environmental, health and safety, investment screening and national security laws, and other legal
compliance risks. These risks include, among other things, possible liability relating to product liability matters, personal injuries, intellectual property rights, contract-related claims, health and safety liabilities, employment-related
liabilities, environmental matters, investment screening and national security laws, and compliance with U.S. and foreign laws, competition laws and laws governing improper business practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our operations in the United States are subject to numerous environmental laws and regulations, including federal, state and local laws and
regulations relating to, among other things: water; natural resources; discharges; emissions; chemicals; solid and hazardous waste storage, treatment and disposal; remediation of releases of hazardous materials; and contamination. Compliance with
these laws can be difficult and costly. For example, battery life cycle management regulations and regulations governing the transport of batteries may impose substantial requirements on our operations in the United States. Our operations may be
required to obtain and comply with environmental permits, many of which may be difficult and expensive to obtain and must be renewed on a periodic basis. A failure to comply with these laws, regulations or permits could result in substantial
liabilities, including fines, penalties, the suspension or loss of permits, and possibly orders to cease the <FONT STYLE="white-space:nowrap">non-compliant</FONT> operations. Our manufacturing process will have hazards such as, but not limited to,
hazardous materials, machines with moving parts, and high voltage and/or high current electrical systems typical of large manufacturing equipment and related safety incidents. There may be safety incidents that damage machinery or manufacturing
components, slow or stop production, or harm employees. Consequences may include litigation, regulation, fines, increased insurance premiums, mandates to temporarily halt production, workers&#146; compensation claims, or other actions that impact
our brand, finances or ability to operate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a business with international reach, we are subject to complex laws and regulations,
including investment screening laws, in jurisdictions in which we operate. Those laws and regulations may be interpreted in different ways. They may also change from time to time, as may related interpretations and other guidance. Changes in laws or
regulations could result in higher expenses and payments, and uncertainty relating to laws or regulations may also affect how we conduct our operations and structure our investments and could limit our ability to enforce our rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Changes in environmental and climate laws or regulations, including laws relating to greenhouse gas emissions, could lead to new or additional
investment in manufacturing designs, subject us to additional costs and restrictions, including increased energy and raw materials costs, and could increase environmental compliance expenditures. We are subject to various environmental laws and
regulations on air emission, waste water discharge, solid waste, noise and the disposal of hazardous materials. Cobalt and lithium are toxic materials that are important raw materials in our batteries. We also use, generate and discharge other
toxic, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-34- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
volatile and hazardous chemicals and wastes in our research, development and manufacturing activities. Under U.S. environmental regulations, we are required to maintain the pollutant emission
levels at the facility within the levels prescribed by the relevant governmental authorities and obtain a pollution discharge permit for water and air emissions. Future changes to environmental laws or permit requirements could require us to install
new control equipment or otherwise change operations in order to comply with any such change in laws or permit requirements. In addition, certain laws and regulations require enterprises like us that generate hazardous wastes to engage companies
which are licensed and qualified to process the hazardous wastes, and to collect, store, dispose of and transfer the hazardous waste. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
we fail to comply with national and local environmental protection laws and regulations, the relevant governmental authorities may impose fines or deadlines to cure instances of noncompliance, and may even order us to cease operations if we fail to
comply with their requirements. In particular, any breach by us in connection with requirements relating to the handling of hazardous wastes may subject us to monetary damages and fines. In addition, if any third party suffers any loss as a result
of our pollutant emission practices, our improper handling of hazardous wastes or our noncompliance with environmental regulations, such third parties may seek damages from us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot assure you that we will be able to comply with all environmental laws and regulations at all times as the environmental legal regime
is evolving and becoming more stringent, especially in the United States. Therefore, if these or other governments where we do business impose more stringent regulations in the future, we will have to incur additional substantial costs and expenses
in order to comply with new regulations, which may negatively affect our results of operations. If we fail to comply with any of the present or future environmental regulations in any material aspect or cause any loss to any third parties due to our
pollutant emission practices, improper handling of hazardous wastes or other environmental noncompliance, we may suffer from negative publicity and may be required to pay substantial fines, pay damages to such third parties, or suspend or even cease
operations, all of which may materially and adversely affect our business, financial condition, prospects and results of operations. Environmental laws and regulations may become more stringent in the future, which could increase costs of compliance
or require us to manufacture with alternative technologies and materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may be subject to review and enforcement actions under
domestic and foreign laws that screen investments and to other national-security-related laws and regulations. In certain jurisdictions, these legal and regulatory requirements may be more stringent than in the United States and may impact battery
companies more specifically. As a result of these laws and regulations, investments by particular investors may need to be filed with local regulators, which in turn may impose added costs on our business, impact our operations, and/or limit our
ability to engage in strategic transactions that might otherwise be beneficial to us and our investors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to a variety of laws and
regulations related to the safety and transportation of our batteries. Our failure to comply with these laws and regulations may have a material adverse effect on our business and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many federal, state and local authorities require certification by Underwriters Laboratory, Inc., an independent, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> corporation engaged in the testing of products for compliance with certain public safety standards, or other safety regulation certification prior to marketing
battery cells. Foreign jurisdictions also have regulatory authorities overseeing the safety of consumer products. Our batteries may not meet the specifications required by these authorities. A determination that any of our battery products are not
in compliance with these rules and regulations could result in the imposition of fines or an award of damages to private litigants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
addition, lithium batteries have been identified as a Class&nbsp;9 dangerous good during transport. To be safely transported (by air, sea, rail or roadways), they must meet various international, national, state and local authorities, including, for
example, the provisions laid out in United Nations standard UN 38.3. This standard </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-35- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applies to batteries transported either on their own or installed in a device. UN 38.3 has been adopted by regulators and competent authorities around the world, thus making it a requirement for
global market access. Our failure to manage the transportation of our batteries could subject us to increased costs or future liabilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Failure
to comply with certain health and production safety laws and regulations governing hazardous materials could materially adversely affect our business and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the sourcing of our battery products throughout the world, we process, store, dispose of and otherwise use large amounts of hazardous
materials. As a result, we are subject to extensive and evolving health and production safety laws and regulations governing, among other things: the health of our employees and safety production requirements regarding the generation, handling,
storage, use and transportation of hazardous materials. Compliance with these laws and regulations results in ongoing costs. Failure to comply with these laws or regulations, or to obtain or comply with the relevant permits, could result in fines,
criminal charges or other sanctions by regulators. Furthermore, we may be ordered to rectify a noncompliance within a stipulated deadline; and if we fail to do so, we may be ordered to cease operations. Our ongoing compliance with health and safety
laws, regulations and permits could require us to incur significant expenses, limit our ability to modify or expand our facilities or continue manufacturing and make other capital improvements. In addition, private parties, including current or
former employees, could bring personal injury or other claims against us due to the presence of, or exposure to, hazardous substances used, stored or disposed of by us or contained in our batteries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are or will be subject to anti-corruption and anti-bribery and anti-money laundering and similar laws, and
<FONT STYLE="white-space:nowrap">non-compliance</FONT> with such laws can subject us to administrative, civil and criminal fines and penalties, collateral consequences, remedial measures and legal expenses, all of which could adversely affect our
business, results of operations, financial condition and reputation. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to the FCPA, the U.S. domestic bribery statute
contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, and possibly other anti-bribery and anti-corruption laws and anti-money laundering laws in various jurisdictions in which we conduct, or in the future may conduct, activities. Anti-corruption
and anti-bribery laws have been enforced aggressively in recent years and are interpreted broadly to generally prohibit us and our officers, directors, employees, business partners agents, representatives and third-party intermediaries from
corruptly offering, promising, authorizing or providing, directly or indirectly anything of value to recipients in the public or private sector. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may leverage third parties to sell our battery products and conduct our business abroad. We, our officers, directors, employees, business
partners agents, representatives and third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities and we may be held liable for the corrupt or other
illegal activities of these employees, agents, representatives, business partners or third-party intermediaries even if we do not explicitly authorize such activities. We cannot assure you that all of our officers, directors, employees, business
partners agents, representatives and third-party intermediaries will not take actions in violation of applicable law, for which we may be ultimately held responsible. As our international activities and sales expand, our risks under these laws may
increase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These laws also require companies to make and keep books, records and accounts that accurately reflect transactions and
dispositions of assets and to maintain a system of adequate internal accounting controls and compliance procedures designed to prevent any such actions. While we have certain policies and procedures to address compliance with such laws, we cannot
assure you that none of our officers, directors, employees, business partners agents, representatives and third-party intermediaries will take actions in violation of our policies and applicable law, for which we may be ultimately held responsible.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any allegations or violation of the FCPA or other applicable anti-bribery and anti-corruption laws and anti-money laundering laws could
subject us to whistleblower complaints, adverse media coverage, investigations, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-36- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
settlements, prosecutions, enforcement actions, fines, damages, loss of export privileges, and severe administrative, civil and criminal sanctions, suspension or debarment from government
contracts, collateral consequences, remedial measures and legal expenses, all of which could materially and adversely affect our reputation, business, financial condition, prospects and results of operations. Responding to any investigation or
action will likely result in a materially significant diversion of management&#146;s attention and resources and significant defense costs and other professional fees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to governmental export and import controls that could impair our ability to compete in international markets or subject us to liability
if we violate these controls. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our battery products may be subject to U.S. export control laws and regulations including the Export
Administration Regulations (&#147;EAR&#148;), the International Traffic in Arms Regulations (&#147;ITAR&#148;), and trade and economic sanctions maintained by the Office of Foreign Assets Control (&#147;OFAC&#148;). As such, an export license may be
required to export, reexport, or transfer our battery products to certain countries, <FONT STYLE="white-space:nowrap">end-users,</FONT> and <FONT STYLE="white-space:nowrap">end-uses.</FONT> If we were to fail to comply with such U.S. export controls
laws and regulations, U.S. economic sanctions, or other similar laws, we could be subject to both civil and criminal penalties, including substantial fines, possible incarceration for employees and managers for willful violations, and the possible
loss of our export or import privileges. Obtaining the necessary export license for a particular sale or offering may not be possible and may be time-consuming and may result in the delay or loss of sales opportunities. Furthermore, U.S. export
control laws and economic sanctions prohibit the export of products to certain U.S. embargoed or sanctioned countries, governments, and persons, as well as for prohibited <FONT STYLE="white-space:nowrap">end-uses.</FONT> Even though we take
precautions to ensure that we and our partners comply with all relevant export control laws and regulations, any failure by us or our partners to comply with such laws and regulations could have negative consequences for us, including reputational
harm, government investigations and penalties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Changes in our battery products or changes in export and import regulations in such
countries may create delays in the introduction of our products into international markets, prevent our <FONT STYLE="white-space:nowrap">end-customers</FONT> with international operations from deploying our battery products globally or, in some
cases, prevent or delay the export or import of our battery products to certain countries, governments or persons altogether. Any change in export or import laws or regulations, economic sanctions or related legislation, shift in the enforcement or
scope of existing export, import or sanctions laws or regulations, or change in the countries, governments, persons, or technologies targeted by such export, import or sanctions laws or regulations, could result in decreased use of our battery
products by, or in our decreased ability to export or sell our battery products to, existing or potential <FONT STYLE="white-space:nowrap">end-customers</FONT> with international operations. Any decreased use of our battery products or limitation on
our ability to export to or sell our battery products in international markets could adversely affect our business, financial condition, and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be subject to U.S. foreign investment regulations which may impose conditions on or limit certain investors&#146; ability to purchase our stock,
potentially making the stock less attractive to investors. Our future investments in U.S. companies may also be subject to U.S. foreign investment regulations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain investments that involve the acquisition of, or investment in, a U.S. business by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
investor may be subject to review and approval by the Committee on Foreign Investment in the United States (&#147;CFIUS&#148;). Whether CFIUS has jurisdiction to review an acquisition or investment transaction depends on, among other factors, the
nature and structure of the transaction, including the level of beneficial ownership interest and the nature of any information or governance rights involved. For example, investments that result in &#147;control&#148; of a U.S. business by a
foreign person always are subject to CFIUS jurisdiction. Significant CFIUS reform legislation, which was fully implemented through regulations that became effective on February&nbsp;13, 2020, expanded the scope of CFIUS&#146;s jurisdiction to
investments that do not result in control of a U.S. business by a foreign person but afford certain foreign investors certain information or governance rights in a U.S. business that has a nexus to &#147;critical technologies,&#148; &#147;critical
infrastructure&#148; and/or &#147;sensitive personal data.&#148; Based on its export control classification, our battery technology is considered a &#147;critical technology.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-37- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CFIUS could choose to review past or proposed transactions involving new or existing foreign
investors in us or in Amprius Holdings, even if a filing with CFIUS is or was not required at the time of the transaction. Any review and approval of an investment or transaction by CFIUS may have outsized impacts on transaction certainty, timing,
feasibility, and cost, among other things. CFIUS policies and practices are rapidly evolving, and in the event that CFIUS reviews one or more proposed or existing investment by investors, there can be no assurances that such investors will be able
to maintain, or proceed with, such investments on terms acceptable to such investors. CFIUS could seek to impose limitations or restrictions on, or prohibit, investments by such investors (including, but not limited to, limits on purchasing our
stock, limits on information sharing with such investors, requiring a voting trust, governance modifications, or forced divestiture, among other things). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recent and potential tariffs imposed by the U.S. government or a global trade war could increase the cost of our products, which could have a material
adverse effect on our business, financial condition and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The U.S. government has and continues to make
significant changes in U.S. trade policy and has taken certain actions that could negatively impact U.S. trade, including imposing tariffs on certain goods imported into the United States. In retaliation, China has implemented, and continues to
evaluate imposing additional tariffs on a wide range of American products. There is also a concern that the imposition of additional tariffs by the United States could result in the adoption of tariffs by other countries as well, leading to a global
trade war. More specifically, the U.S. government has from time to time imposed significant tariffs on certain product categories imported from China. Such tariffs, if expanded to other categories, could have a significant impact on our business,
particularly the importation of parts of our batteries and certain production equipment that are manufactured in China. If we attempt to renegotiate prices with suppliers or diversify our supply chain in response to tariffs, such efforts may not
yield immediate results or may be ineffective. We might also consider increasing prices to the end consumer; however, this could reduce the competitiveness of our products and adversely affect net sales. If we fail to manage these dynamics
successfully, gross margins and profitability could be adversely affected. As of the date of this report, tariffs have not had a material impact on our business, but increased tariffs or trade restrictions implemented by the United States or other
countries in connection with a global trade war could have a material adverse effect on our business, financial condition and results of operations. We cannot predict what actions may ultimately be taken with respect to tariffs or trade relations
between the United States and China or other countries, what products may be subject to such actions, or what actions may be taken by the other countries in retaliation. Any further deterioration in the relations between the United States and China
could exacerbate these actions and other governmental intervention. For example, a future event that created additional U.S.-China tensions could potentially increase the risks associated with the business and operations of U.S.-based technology
companies in China. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The U.S. or foreign governments may take additional administrative, legislative, or regulatory action that could
materially interfere with our ability to sell products in certain countries. Sustained uncertainty about, or worsening of, current global economic conditions and further escalation of trade tensions between the United States and its trading
partners, especially China, could result in a global economic slowdown and long-term changes to global trade, including retaliatory trade restrictions that restrict our ability to operate in China. Any alterations to our business strategy or
operations made in order to adapt to or comply with any such changes would be time-consuming and expensive, and certain of our competitors may be better suited to withstand or react to these changes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>From time to time, we may be involved in legal proceedings and commercial or contractual disputes, which could have an adverse impact on our
profitability and financial position. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may be involved in legal proceedings and commercial or contractual disputes that, from
time to time, are significant. These are typically claims that arise in the normal course of business including, without limitation, commercial or contractual disputes, including warranty claims and other disputes with potential customers and
suppliers, intellectual property matters, personal injury claims, environmental issues, tax matters and employment matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-38- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, our predecessor, Kensington Capital Acquisition Corp. IV, was a special purpose
acquisition company (&#147;SPAC&#148;). SPACs have been subject to increased regulatory oversight and scrutiny, including from the SEC. Any governmental or regulatory investigation or inquiry related to the Business Combination or otherwise could
have a material adverse effect on our business and negatively affect our reputation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is difficult to predict the outcome or ultimate
financial exposure, if any, represented by these matters, and there can be no assurance that any such exposure will not be material. Such claims may also negatively affect our reputation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Ownership of Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There can be no assurance that we will be able to comply with the continued listing standards of the NYSE. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Stock and Public Warrants are listed on the NYSE under the symbols &#147;AMPX&#148; and &#147;AMPX.W,&#148; respectively. If the
NYSE delists our securities from trading on its exchange for failure to meet the listing standards and we are not able to list such securities on another national securities exchange, we expect such securities could be quoted on an <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market. If this were to occur, we and our stockholders could face significant material adverse consequences including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a limited availability of market quotations for our securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced liquidity for our securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a determination that our Common Stock is a &#147;penny stock,&#148; which will require brokers trading our Common
Stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for shares of our Common Stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a limited amount of analyst coverage; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a decreased ability to issue additional securities or obtain additional financing in the future.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Anti-takeover provisions in our certificate of incorporation, Bylaws and Delaware law could make an acquisition of us more
difficult, limit attempts by stockholders to replace or remove our management and limit the market price of our Common Stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
certificate of incorporation (the &#147;Certificate of Incorporation&#148;), Bylaws and Delaware law contain provisions that could have the effect of rendering more difficult, delaying or preventing an acquisition deemed undesirable by our Board.
These provisions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authorizing &#147;blank check&#148; preferred stock, which could be issued by our Board without stockholder
approval and may contain voting, liquidation, dividend and other rights superior to our Common Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limiting the liability of, and providing indemnification to, our directors and officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibiting cumulative voting in the election of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing that vacancies on our Board may be filled only by majority of directors then in office of the Board,
even though less than a quorum; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibiting the ability of our stockholders to call special meetings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing an advance notice procedure for stockholder proposals to be brought before an annual meeting,
including proposed nominations of persons for election to the Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">dividing directorships of our Board into three classes, each to be elected for a term of three years, so that
only one class of directorships is up for election at each annual meeting of the stockholders; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">specifying that special meetings of our stockholders can be called only by a majority of the Board, the chair of
the Board, or our Chief Executive Officer. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-39- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These provisions may frustrate or prevent any attempts by stockholders to replace or remove
our current management by making it more difficult for stockholders to replace members of our Board, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, it is governed by the
provisions of Section&nbsp;203 of the DGCL, which generally prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any &#147;interested&#148; stockholder for a period of three years following the date on
which the stockholder became an &#147;interested&#148; stockholder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Bylaws provide, subject to limited exceptions, that the Court of Chancery
of the State of Delaware and the federal district courts of the United States will be the sole and exclusive forum for certain stockholder litigation matters, which could limit our stockholders&#146; ability to obtain a chosen judicial forum for
disputes with us or our directors, officers, employees or stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Bylaws provide that, unless otherwise consented to by
us in writing, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) shall, to the fullest extent
permitted by law, be the sole and exclusive forum for the following types of actions or proceedings: (i)&nbsp;any derivative action or proceeding brought on behalf of us; (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by,
or otherwise wrongdoing by, any of our directors, officers, or other employees to us or our stockholders; (iii)&nbsp;any action arising pursuant to any provision of the DGCL or our Certificate of Incorporation or our Bylaws; (iv)&nbsp;any action to
interpret, apply, enforce or determine the validity of our Certificate of Incorporation or our Bylaws; or (v)&nbsp;any other action asserting a claim that is governed by the internal affairs doctrine, in all cases subject to the court having
jurisdiction over indispensable parties named as defendants. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction.
The Bylaws further provide that, unless otherwise consented to by us in writing, the federal district courts of the United States will be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the
Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person or entity purchasing or otherwise acquiring any interest in our securities shall be deemed to have notice of
and consented to this provision. This choice of forum provision may limit a stockholder&#146;s ability to bring a claim in a judicial forum of its choosing for disputes with us or any of our directors, officers, other employees or stockholders,
which may discourage lawsuits with respect to such claims. There is uncertainty as to whether a court would enforce such provisions, and the enforceability of similar choice of forum provisions in other companies&#146; charter documents has been
challenged in legal proceedings. It is possible that a court could find these types of provisions to be inapplicable or unenforceable, and if a court were to find the choice of forum provision contained in the Bylaws to be inapplicable or
unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results and financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Concentration of ownership among our executive officers, directors and affiliates may prevent new investors from influencing significant corporate
decisions. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of November 1, 2022, our executive officers, directors and affiliates as a group beneficially own approximately
82.0% of the Common Stock outstanding. Additionally, certain of our executive officers and directors own interests in Amprius Holdings, which owns approximately 77.6% of our Common Stock outstanding as of November 1, 2022, and certain of our
directors are members of Amprius Holdings&#146; board of directors. As a result, these stockholders are able to exercise a significant level of control over all matters requiring stockholder approval, including the election of directors, any
amendment of the Certificate of Incorporation and approval of significant corporate transactions. This control could have the effect of delaying or preventing a change of control of us or changes in our management and will make the approval of
certain transactions difficult or impossible without the support of these stockholders and of their votes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-40- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will incur significant increased expenses and administrative burdens as a public company, which
could have an adverse effect on our business, financial condition and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company, we face
increased legal, accounting, administrative and other costs and expenses that Legacy Amprius did not face as a private company. The Sarbanes-Oxley Act of 2002 (the &#147;Sarbanes-Oxley Act&#148;), including the requirements of Section&nbsp;404, as
well as rules and regulations subsequently implemented by the SEC, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the rules and regulations promulgated and to be promulgated thereunder, the PCAOB and the securities
exchanges, impose additional reporting and other obligations on public companies. The development and implementation of the standards and controls necessary for us to achieve the level of accounting standards required of a public company in the
United States may require costs greater than expected. It is likely that we will expand our employee base and hire additional employees to support our operations as a public company, which will increase our operating costs in future periods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compliance with public company requirements has increased costs and made certain activities more time-consuming. A number of these
requirements require us to carry out activities Legacy Amprius had not done previously. For example, our Board has committees that did not exist on the Legacy Amprius board of directors, and we have adopted new internal controls and disclosure
controls and procedures. In addition, we are incurring expenses associated with SEC reporting requirements. Furthermore, if any issues in complying with those requirements are identified (for example, if the auditors identify a material weakness or
significant deficiency in the internal control over financial reporting), we could incur additional costs rectifying those issues, and the existence of those issues could adversely affect our reputation or investor perceptions of us. As a public
company, it is also more expensive to obtain director and officer liability insurance. The additional reporting and other obligations imposed by these rules and regulations have and will continue to increase legal and financial compliance costs and
the costs of related legal, accounting and administrative activities. These increased costs will require us to spend money that could otherwise be used on our research and development programs and to achieve strategic objectives. Advocacy efforts by
stockholders and third parties may also prompt additional changes in governance and reporting requirements, which could further increase costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We
do not expect to declare any dividends in the foreseeable future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not anticipate declaring any cash dividends to holders of
our Common Stock in the foreseeable future. Consequently, investors may need to rely on sales of their shares after price appreciation, which may never occur, as the only way to realize any future gains on their investment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our market, or if they change their
recommendations regarding our securities adversely, the price and trading volume of our securities could decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading
market for our securities will be influenced by the research and reports that industry or securities analysts may publish about us, our business, market or competitors. If any of the analysts who may cover us change their recommendation regarding
our Common Stock adversely, or provide more favorable relative recommendations about our competitors, the price of our Common Stock and Warrants would likely decline. If any analyst who may cover us were to cease coverage of us or fail to regularly
publish reports on us, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We qualify as an &#147;emerging growth company&#148; and a &#147;smaller reporting company&#148; within the meaning of the Securities Act, and if we
take advantage of certain exemptions from disclosure requirements available to emerging growth companies or smaller reporting companies, this could our securities less attractive to investors and may make it more difficult to compare our performance
with other public companies. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We qualify as an &#147;emerging growth company&#148; as defined in Section&nbsp;2(a)(19) of the
Securities Act, as modified by the JOBS Act. As such, we are eligible for and intend to take advantage of certain exemptions from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-41- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
various reporting requirements applicable to other public companies that are not emerging growth companies for as long as we continue to be an emerging growth company, including (i)&nbsp;the
exemption from the auditor attestation requirements with respect to internal control over financial reporting under Section&nbsp;404(b) of the Sarbanes-Oxley Act, (ii)&nbsp;the exemptions from <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">say-on-pay,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-frequency</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-golden</FONT></FONT>
parachute voting requirements and (iii)&nbsp;reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. As a result, our stockholders may not have access to certain information they may deem
important. We will remain an emerging growth company until the earliest of (i)&nbsp;the last day of the fiscal year in which the market value of our Common Stock that are held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds
$700&nbsp;million as of June&nbsp;30 of that fiscal year, (ii)&nbsp;the last day of the fiscal year in which we have total annual gross revenue of $1.235&nbsp;billion or more during such fiscal year (as indexed for inflation), (iii) the date on
which we have issued more than $1&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt in the prior three-year period or (iv)&nbsp;December&nbsp;31, 2027. In addition, Section&nbsp;107 of the JOBS Act also provides that an
emerging growth company can take advantage of the exemption from complying with new or revised accounting standards provided in Section&nbsp;7(a)(2)(B) of the Securities Act as long as we are an emerging growth company. An emerging growth company
can therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected not to opt out of such extended transition period and, therefore, we may not be subject to the same
new or revised accounting standards as other public companies that are not emerging growth companies. Investors may find our Common Stock less attractive because we rely on these exemptions, which may result in a less active trading market for our
Common Stock and its price may be more volatile. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we qualify as a &#147;smaller reporting company&#148; as defined in Item
10(f)(1) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We
expect to remain a smaller reporting company until the last day of the fiscal year in which (i)&nbsp;the market value of our Common Stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $250,000,000 as of the prior
June&nbsp;30, or (ii)&nbsp;our annual revenues exceeded $100,000,000 during such completed fiscal year and the market value of our Common Stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700,000,000 as of the prior June
30. To the extent we take advantage of such reduced disclosure obligations, comparison of our financial statements with other public companies may be difficult or impossible. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The sale of all of the securities registered for resale in this prospectus and future sales of substantial amounts of our Common Stock in the public
markets, or the perception that such sales could occur, could cause the market price of our Common Stock to drop significantly, even if our business is doing well. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of a substantial number of shares of our Common Stock in the public market could occur at any time. This prospectus registers up to
16,825,366 shares of Common Stock for resale by BRPC II that we may issue to BRPC II from time to time during the term of the Purchase Agreement. The purchase price for the shares that we may sell to BRPC II pursuant to this prospectus will
fluctuate based on the price of our Common Stock. Depending on market liquidity at the time, sales of such shares may cause the trading price of our Common Stock to fall. If and when we do sell shares to BRPC II, after BRPC II has acquired the
shares, BRPC II may resell all, some, or none of those shares at any time or from time to time in its discretion. Therefore, sales to BRPC II by us could result in substantial dilution to the interests of other holders of our Common
Stock.&nbsp;Additionally, the sale of a substantial number of shares of our Common Stock to BRPC II, or the anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a
price that we might otherwise wish to effect sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;27, 2022, in connection with the Business Combination, we filed a
registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (the &#147;Business Combination <FONT STYLE="white-space:nowrap">S-1&#148;)</FONT> registering up to 105,680,194 shares of Common Stock constituting approximately 96.6% of
our issued and outstanding Common Stock as of November 1, 2022 (assuming the exercise in full of all of the warrants registered on such registration statement. Further, we intend to file a registration statement to register shares served for future
issuance under our equity compensation plans and the 14,216,131 shares issuable upon exercise of the options outstanding under the 2016 Plan. Upon effectiveness of the registration statements, subject to the satisfaction of applicable vesting
restrictions and the expiration and any <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions, the shares registered thereunder will be available for immediate resale in the public market. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-42- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These sales, any future sales of a substantial number of shares of our Common Stock in the
public market or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our Common Stock. Despite such a decline in the public trading price, certain securityholders may
still experience a positive rate of return on the securities they purchased due to the lower price that they purchased their shares compared to other public investors and be incentivized to sell its securities when others are not. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of November 1, 2022, approximately 89.5% of our outstanding shares of Common Stock are subject to
<FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions. Sales of our Common Stock following the expiration of these <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions or pursuant to the exercise of registration rights may make it
more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. These sales could also cause the market price of our Common Stock to decline if such equity holders sell or are perceived by the market
as intending to sell any such securities, and make it more difficult for you to sell your shares of Common Stock at a time and price that you deem appropriate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may issue additional shares of Common Stock under an employee incentive plan (including the 2022 Plan and the ESPP), or may issue preferred stock.
Any such issuances would dilute the interest of our stockholders and likely present other risks. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may issue a substantial number
of additional share of Common Stock under our employee incentive plan (including the 2022 Plan and the ESPP) or we may issue preferred stock. The issuance of additional securities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may significantly dilute the equity interests of our investors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may subordinate the rights of our stockholders if preferred stock is issued with rights senior to those afforded
our Common Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">could cause a change in control if a substantial number of securities are issued, which may affect, among other
things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may adversely affect prevailing market prices for our Common Stock and/or Warrants. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Warrants are exercisable for Common Stock, which would increase the number of shares eligible for future resale in the public market and result in
dilution to our stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Outstanding Warrants to purchase an aggregate of 47,935,224 shares of Common Stock are exercisable
in accordance with the terms of the warrant agreement governing those securities. The exercise price of the Private Warrants and Public Warrants is $11.50 per share, and the exercise price of the PIPE Warrants is $12.50 per share. To the extent the
Warrants are exercised, additional shares of Common Stock will be issued, which will result in dilution to the holders of Common Stock and increase the number of shares eligible for resale in the public market. Shares of Common Stock issuable
pursuant to the Warrants are not subject to <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions. As such, once the warrants are exercised, the holder of such shares issuable upon the exercise of the warrants will be able to resell the
shares to the market, subject to other applicable laws. Sales of substantial numbers of such shares in the public market or the fact that such Warrants may be exercised could adversely affect the market price of our Common Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to this Offering </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>It is not possible
to predict the actual number of shares we will sell under the Purchase Agreement to BRPC II, or the actual gross proceeds resulting from those sales. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;27, 2022, we entered into the Purchase Agreement with BRPC II, pursuant to which BRPC II committed to purchase up to
$200,000,000 of shares of our Common Stock, subject to certain limitations and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-43- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conditions set forth in the Purchase Agreement. The shares of our Common Stock that may be issued under the Purchase Agreement may be sold by us to BRPC II at our discretion from time to time
over the <FONT STYLE="white-space:nowrap">24-month</FONT> period beginning on the date of the Commencement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generally have the right
to control the timing and amount of any sales of our shares of Common Stock to BRPC II under the Purchase Agreement. Sales of our Common Stock, if any, to BRPC II under the Purchase Agreement will depend upon market conditions and other factors to
be determined by us. We may ultimately decide to sell to BRPC II all, some or none of the shares of our Common Stock that may be available for us to sell to BRPC II pursuant to the Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any shares of Common Stock issued in the Committed Equity Financing to BRPC II other than the Commitment Shares will be purchased by BRPC II
at current market prices less a 3.0% fixed discount. Because the purchase price per share to be paid by BRPC II for the shares of Common Stock that we may elect to sell to BRPC II under the Purchase Agreement, if any, will fluctuate based on the
market prices of our Common Stock at the time we elect to sell shares to BRPC II pursuant to the Purchase Agreement, if any, it is not possible for us to predict, prior to any such sales, the number of shares of Common Stock that we will sell to
BRPC II under the Purchase Agreement, the purchase price per share that BRPC II will pay for shares purchased from us under the Purchase Agreement, or the aggregate gross proceeds that we will receive from those purchases by BRPC II under the
Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although the Purchase Agreement provides that we may sell up to an aggregate of $200,000,000 of our Common Stock to
BRPC II, only 16,825,366 shares of our Common Stock are being registered for resale under the registration statement that includes this prospectus. If it becomes necessary for us to issue and sell to BRPC II under the Purchase Agreement more than
the 16,825,366 shares being registered for resale under the registration statement that includes this prospectus in order to receive aggregate gross proceeds equal to $200,000,000 under the Purchase Agreement, we must first file with the SEC one or
more additional registration statements to register under the Securities Act the resale by BRPC II of any such additional shares of our Common Stock we wish to sell from time to time under the Purchase Agreement, which the SEC must declare effective
before we may elect to sell any additional shares of our Common Stock to BRPC II under the Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the applicable NYSE
rules, in no event may the Company issue to BRPC II under the Purchase Agreement more than the Exchange Cap, unless the Company obtains stockholder approval to issue shares of Common Stock in excess of the Exchange Cap in accordance with the
applicable NYSE rules. The Exchange Cap is not applicable to issuances and sales of Common Stock pursuant to VWAP Purchases and Intraday VWAP Purchases that we may effect pursuant to the Purchase Agreement, to the extent such shares of Common Stock
are sold in such VWAP Purchases and Intraday VWAP Purchases (as applicable) at a price equal to or in excess of the applicable &#147;minimum price&#148; (as defined in the applicable listing rules of the NYSE) of the Common Stock, calculated at the
time such VWAP Purchases and Intraday VWAP Purchases (as applicable) are effected by us under the Purchase Agreement, if any, as adjusted to take into account our issuance of the Commitment Shares to BRPC II and our reimbursement of a certain amount
of BRPC II&#146;s legal fees and expenses. Moreover, the Company may not issue or sell any shares of Common Stock to BRPC II under the Purchase Agreement which, when aggregated with all other shares of Common Stock then beneficially owned by BRPC II
and its affiliates (as calculated pursuant to Section&nbsp;13(d) of the Exchange Act and Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> thereunder), would result in BRPC II beneficially owning more than 4.99% of the outstanding shares of Common
Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any issuance and sale by us under the Purchase Agreement of a substantial amount of shares of Common Stock, including the
16,825,366 shares of Common Stock being registered for resale by BRPC II under this prospectus and the securities registered on the Business Combination <FONT STYLE="white-space:nowrap">S-1</FONT> could cause additional substantial dilution to our
stockholders. The number of shares of our Common Stock ultimately offered for sale by BRPC II is dependent upon the number of shares of Common Stock, if any, we ultimately elect to sell to BRPC II under the Purchase Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-44- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Investors who buy shares at different times will likely pay different prices. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Purchase Agreement, we will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares sold
to BRPC II. If and when we do elect to sell shares of our Common Stock to BRPC II pursuant to the Purchase Agreement, after BRPC II has acquired such shares, BRPC II may resell all, some or none of such shares at any time or from time to time in its
discretion and at different prices. As a result, investors who purchase shares from BRPC II in this offering at different times will likely pay different prices for those shares, and so may experience different levels of dilution and in some cases
substantial dilution and different outcomes in their investment results. Investors may experience a decline in the value of the shares they purchase from BRPC II in this offering as a result of future sales made by us to BRPC II at prices lower than
the prices such investors paid for their shares in this offering. In addition, if we sell a substantial number of shares to BRPC II under the Purchase Agreement, or if investors expect that we will do so, the actual sales of shares or the mere
existence of our arrangement with BRPC II may make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect such sales. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our management team will have broad discretion over the use of the net proceeds from our sale of shares of Common Stock to the Selling Stockholder, if
any, and you may not agree with how we use the proceeds and the proceeds may not be invested successfully. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management team
will have broad discretion as to the use of the net proceeds from our sale of shares of Common Stock to the Selling Stockholder, if any, and we could use such proceeds for purposes other than those contemplated at the time of commencement of this
offering. Accordingly, you will be relying on the judgment of our management team with regard to the use of those net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used
appropriately. It is possible that, pending their use, we may invest those net proceeds in a way that does not yield a favorable, or any, return for us. The failure of our management team to use such funds effectively could have a material adverse
effect on our business, financial condition, operating results and cash flows. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-45- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_6"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain statements in this prospectus may constitute &#147;forward-looking statements&#148; for purposes of the federal securities laws. Such
forward-looking statements include, but are not limited to, statements regarding our and our management team&#146;s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to forecasts or
other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words &#147;anticipate,&#148; &#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148;
&#147;expect,&#148; &#147;intends,&#148; &#147;may,&#148; &#147;might,&#148; &#147;plan,&#148; &#147;possible,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;should,&#148; &#147;will,&#148; &#147;would&#148; and similar
expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this prospectus may include, for example, statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expected benefits of the Business Combination; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s financial and business performance, including financial and business metrics;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the Company&#146;s strategy, future operations, financial position, estimated revenues and losses,
projected costs, prospects and plans; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to develop a high-volume manufacturing line and otherwise scale in a cost-effective
manner; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expected addressable market for the Company&#146;s products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments relating to the Company&#146;s competitors and industry; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of health epidemics, including the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, on the
Company&#146;s business and the actions the Company may take in response thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s expectations regarding its ability to obtain and maintain intellectual property protection and
not infringe on the rights of others; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s future capital requirements and sources and uses of cash; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to obtain funding for its operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s business, expansion plans and opportunities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome of any known and unknown litigation and regulatory proceedings. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These forward-looking statements are based on information available as of the date of this prospectus, and current expectations, forecasts and
assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update
forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those
expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of the Company to execute its business model, including scaling production and the increase in
addressable market for its products and services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s ability to raise capital; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome of any legal proceedings that may be instituted against the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to maintain the listing of our securities on the NYSE; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-46- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of the Company to recognize the anticipated benefits of the Business Combination, which may be
affected by, among other things, competition and the ability of the Company to grow and manage growth profitably; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in applicable laws or regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on the Company&#146;s business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that the Company may be adversely affected by other economic, business, and/or competitive
factors; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other risks and uncertainties described in this prospectus, including those under the section titled &#147;Risk
Factors&#148; beginning on page&nbsp;13. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should one or more of the risks or uncertainties described in this prospectus,
or the underlying assumptions, prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-47- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_7"></A>COMMITTED EQUITY FINANCING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following description of the offering is a summary of certain material attributes and characteristics, which does not purport to be complete in every
detail and is qualified in its entirety by reference to the Purchase Agreement and the Committed Equity Registration Rights Agreement. The following summary uses words and terms that are defined in the Purchase Agreement and the Committed Equity
Registration Rights Agreement. For more information regarding the terms of the offering, reference is made to the Purchase Agreement and Committed Equity Registration Rights Agreement, which have been filed as exhibits to the registration statement
of which this prospectus forms a part. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;27, 2022, we entered into the Purchase Agreement and the Committed Equity
Registration Rights Agreement with BRPC II. Under the Purchase Agreement, from and after the Commencement Date, we have the right to issue and sell to BRPC II up to $200,000,000 shares of Common Stock, subject to certain conditions and limitations
set forth in the Purchase Agreement,&nbsp;from time to time during the term of the Purchase Agreement. Sales of Common Stock by us to BRPC II under the Purchase Agreement, and the timing of any sales, are solely at our option, and we are under no
obligation to sell any securities to BRPC II under the Purchase Agreement. In accordance with our obligations under the Committed Equity Registration Rights Agreement, we have filed the registration statement that includes this prospectus with the
SEC to register under the Securities Act the resale by BRPC II of up to 16,825,366 shares of Common Stock, consisting of (i)&nbsp;up to 16,655,780 shares that we may, in our sole discretion, elect to sell to BRPC II, from time to time from and after
the Commencement Date pursuant to the Purchase Agreement and (ii) 169,586 Commitment Shares, which is comprised of 84,793 Initial Commitment Shares that we issued to BRPC II upon our execution of the Purchase Agreement on September&nbsp;27, 2022 and
up to 84,793 Additional Commitment Shares that we will issue to BRPC II upon our receipt of $100.0&nbsp;million of gross proceeds from the sale of shares of our Common Stock to BRPC II as set forth in the Purchase Agreement, as consideration for its
commitment to purchase shares of Common Stock in one or more purchases that we may, in our sole discretion, direct them to make, from time to time after the date of this prospectus, pursuant to the Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not have the right to commence any sales of our Common Stock to BRPC II under the Purchase Agreement until the Commencement Date, which
is the date on which all of the conditions to BRPC II&#146;s purchase obligation set forth in the Purchase Agreement have initially been satisfied, including that the registration statement that includes this prospectus be declared effective by the
SEC. From and after the Commencement Date, we will have the right, but not the obligation, from time to time at our sole discretion until the first day of the month next following the <FONT STYLE="white-space:nowrap">24-month</FONT> period beginning
on the Commencement Date, to direct BRPC II to purchase up to a specified maximum amount of shares of Common Stock in one or more Purchases and Intraday VWAP Purchases as set forth in the Purchase Agreement, by timely delivering a written VWAP
Purchase Notice for each VWAP Purchase, and timely delivering a written Intraday VWAP Purchase Notice for each Intraday VWAP Purchase, if any, to BRPC II in accordance with the Purchase Agreement on any trading day we select as the Purchase Date
therefor, so long as (i)&nbsp;the closing sale price of our Common Stock on the trading day immediately prior to such Purchase Date is not less than the Threshold Price and (ii)&nbsp;all shares of Common Stock subject to all prior VWAP Purchases and
all prior Intraday VWAP Purchases effected by us under the Purchase Agreement have been received by BRPC II prior to the time we deliver such notice to BRPC II. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after Commencement, we will control the timing and amount of any sales of Common Stock to BRPC II. Actual sales of shares of our
Common Stock to BRPC II under the Purchase Agreement will depend on a variety of factors to be determined by us from time to time, including, among other things, market conditions, the trading price of our Common Stock and determinations by us as to
the appropriate sources of funding for our company and its operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the applicable NYSE rules, in no event may we issue to BRPC
II under the Purchase Agreement shares of Common Stock in excess of the Exchange Cap, which is 16,825,366 shares of Common Stock (such number of shares equal to 19.99% of the shares of Common Stock outstanding immediately prior to the execution of
the Purchase Agreement), unless we obtain stockholder approval to issue shares of Common Stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-48- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in excess of the Exchange Cap in accordance with applicable the NYSE rules. The Exchange Cap is not applicable to issuances and sales of Common Stock pursuant to VWAP Purchases and Intraday VWAP
Purchases that we may effect pursuant to the Purchase Agreement, to the extent such shares of Common Stock are sold in such VWAP Purchases and Intraday VWAP Purchases (as applicable) at a price equal to or in excess of the applicable &#147;minimum
price&#148; (as defined in the applicable listing rules of the NYSE) of the Common Stock, calculated at the time such VWAP Purchases and Intraday VWAP Purchases (as applicable) are effected by us under the Purchase Agreement, if any, as adjusted to
take into account our issuance of the Commitment Shares to BRPC II and our reimbursement of a certain amount of BRPC II&#146;s legal fees and expenses. Moreover, we may not issue or sell any shares of Common Stock to BRPC II under the Purchase
Agreement that, when aggregated with all other shares of Common Stock then beneficially owned by BRPC II and its affiliates (as calculated pursuant to Section&nbsp;13(d) of the Exchange Act and Rule <FONT STYLE="white-space:nowrap">13d-3</FONT>
thereunder), would result in BRPC II beneficially owning shares of Common Stock in excess of the Beneficial Ownership Limitation, which is defined in the Purchase Agreement as 4.99% of the outstanding shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The net proceeds to us from sales that we elect to make to BRPC II under the Purchase Agreement, if any, will depend on the frequency and
prices at which we sell shares of our stock to BRPC II. We expect that any proceeds received by us from such sales to BRPC II will be used for working capital and general corporate purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor BRPC II may assign or transfer our respective rights and obligations under the Purchase Agreement or the Committed Equity
Registration Rights Agreement, and no provision of the Purchase Agreement or the Committed Equity Registration Rights Agreement may be modified or waived by us or BRPC&nbsp;II. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As consideration for BRPC II&#146;s commitment to purchase shares of Common Stock at our direction upon the terms and subject to the
conditions set forth in the Purchase Agreement, upon execution of the Purchase Agreement, we issued 84,793 Initial Commitment Shares to BRPC II. In addition, upon our receipt of total aggregate gross cash proceeds equal to $100,000,000 from BRPC II
under the Purchase Agreement, we will issue 84,793 additional shares of Common Stock to BRPC II as Additional Commitment Shares Furthermore, we have agreed to reimburse BRPC II for the reasonable legal fees and disbursements of BRPC II&#146;s legal
counsel in an amount not to exceed (i) $100,000 upon our execution of the Purchase Agreement and Committed Equity Registration Rights Agreement and (ii) $7,500 per fiscal quarter, in each case in connection with the transactions contemplated by the
Purchase Agreement and the Committed Equity Registration Rights Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement and the Committed Equity Registration
Rights Agreement contain customary representations, warranties, conditions and indemnification obligations of the parties. Copies of the agreements have been filed as exhibits to the registration statement of which this prospectus forms a part and
are available electronically on the SEC&#146;s website at www.sec.gov. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Purchases of Common Stock Under the Purchase Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>VWAP Purchases </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after the
Commencement Date, we will have the right, but not the obligation, from time to time at our sole discretion, until the first day of the month next following the <FONT STYLE="white-space:nowrap">24-month</FONT> anniversary of the Commencement Date,
to direct BRPC II to purchase a specified number of shares of Common Stock (each, a &#147;VWAP Purchase&#148;), not to exceed the Purchase Maximum Amount, in a VWAP Purchase under the Purchase Agreement, by timely delivering a written VWAP Purchase
Notice to BRPC II, prior to 9:00 a.m., New York City time, on any trading day we select as the Purchase Date for such VWAP Purchase, so long as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the closing sale price of our Common Stock on the trading day immediately prior to such Purchase Date is not less
than the Threshold Price; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-49- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all shares of Common Stock subject to all prior VWAP Purchases and all prior Intraday VWAP Purchases effected by
us under the Purchase Agreement have been received by BRPC II prior to the time we deliver such VWAP Purchase Notice to BRPC II. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Maximum Amount applicable to such VWAP Purchase will be equal to the lesser of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">5,000,000 shares of Common Stock; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">10.0% or 20.0% (the applicable percentage to be specified by us in the applicable VWAP Purchase Notice for such
VWAP Purchase) of the total number (or volume) of shares of our Common Stock traded on the NYSE during the applicable VWAP Purchase Period for such VWAP Purchase. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The actual number of shares of Common Stock that BRPC II will be required to purchase in a Purchase, which we refer to as the Purchase Share
Amount, will be equal to the number of shares that we specify in the applicable VWAP Purchase Notice, subject to adjustment to the extent necessary to give effect to the applicable Purchase Maximum Amount and other applicable limitations set forth
in the Purchase Agreement, including the Beneficial Ownership Limitation and, if then applicable, the Exchange Cap. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The per share
purchase price that BRPC II will be required to pay for shares of Common Stock in a VWAP Purchase effected by us pursuant to the Purchase Agreement, if any, will be equal to the volume weighted average price of the Common Stock (the
&#147;VWAP&#148;), calculated in accordance with the Purchase Agreement, for the applicable VWAP Purchase Period on the Purchase Date for such VWAP Purchase, less a fixed 3.0% discount to the VWAP for such VWAP Purchase Period. The VWAP Purchase
Period for a VWAP Purchase is defined in the Purchase Agreement as the period beginning at the official open (or &#147;commencement&#148;) of the regular trading session on the NYSE on the applicable Purchase Date for such VWAP Purchase, and ending
at the earliest to occur of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3:59 p.m., New York City time, on such Purchase Date or such earlier time publicly announced by the trading
market as the official close of the regular trading session on the NYSE on such Purchase Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such time that the total aggregate number (or volume) of shares of Common Stock traded on the NYSE during such
VWAP Purchase Period (calculated in accordance with the Purchase Agreement) reaches the applicable VWAP Purchase Share Volume Maximum for such VWAP Purchase, which will be determined by dividing (a)&nbsp;the applicable VWAP Purchase Share Amount for
such VWAP Purchase, by (b) 0.10 or 0.20 (the applicable percentage being the same percentage we specified in the applicable VWAP Purchase Notice for determining the applicable VWAP Purchase Share Amount for such VWAP Purchase); and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if we elect a Limit Order Discontinuation Election in the applicable VWAP Purchase Notice for such VWAP
Purchase,&nbsp;such time that the trading price of a share of Common Stock on the NYSE during such VWAP Purchase Period (calculated in accordance with the Purchase Agreement) falls below the applicable Minimum Price Threshold, less a fixed 3.0%
discount to the VWAP for such VWAP Purchase Period. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Purchase Agreement, for purposes of calculating the
volume of shares of Common Stock traded during a VWAP Purchase Period, including for purposes of determining whether the applicable VWAP Purchase Share Volume Maximum for a VWAP Purchase has been reached, for purposes of calculating the VWAP of our
Common Stock for the applicable VWAP Purchase Period, and to the extent that we specify in the applicable VWAP Purchase Notice that the Limit Order Discontinue Election will apply, the following transactions, to the extent they occur during such
VWAP Purchase Period, are excluded: (x)&nbsp;the opening or first purchase of Common Stock at or following the official open of the regular trading session on the NYSE on the applicable Purchase Date for such VWAP Purchase, (y)&nbsp;the last or
closing sale of Common Stock at or prior to the official close of the regular trading session on the NYSE on the applicable Purchase Date for such VWAP Purchase, and (z)&nbsp;if we did not elect a Limit Order Discontinue Election in the applicable
VWAP Purchase Notice for such VWAP Purchase, all purchases and sales of Common Stock on the NYSE during such VWAP Purchase Period at a price per share that is less than the applicable Minimum Price Threshold for such VWAP Purchase. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-50- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Intraday VWAP Purchases </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the regular VWAP Purchases described above, after the Commencement, we will also have the right, but not the obligation, subject
to the continued satisfaction of the conditions set forth in the Purchase Agreement, to direct BRPC II to purchase, on any trading day we select as the Purchase Date therefor (including the same Purchase Date on which an earlier regular VWAP
Purchase was effected by us (as applicable), although we are not required to effect an earlier regular VWAP Purchase on such Purchase Date in order to effect an Intraday VWAP Purchase on such Purchase Date), a specified number of shares of Common
Stock, not to exceed the applicable Intraday VWAP Purchase Maximum Amount, in an Intraday VWAP Purchase under the Purchase Agreement, by timely delivering a written Intraday VWAP Purchase Period&#148; (determined in the same manner as for a regular
VWAP Purchase) for such Intraday VWAP Purchase Notice to BRPC II, after 10:00&nbsp;a.m., New York City time (and after the VWAP Purchase Period for any prior regular VWAP Purchase (if any) and the Intraday VWAP Purchase Period for the most recent
prior Intraday VWAP Purchase effected on the same Purchase Date (if any) have ended), and prior to 3:30&nbsp;p.m., New York City time, on such Purchase Date, so long&nbsp;as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the closing sale price of our Common Stock on the trading day immediately prior to such Purchase Date is not less
than the Threshold Price; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all shares of Common Stock subject to all prior Purchases and prior Intraday VWAP Purchases effected by us under
the Purchase Agreement have been received by BRPC II prior to the time we deliver such Intraday VWAP Purchase Notice to BRPC II. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Intraday VWAP Purchase Maximum Amount applicable to such Intraday VWAP Purchase will be equal to the lesser of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">5,000,000 shares of Common Stock; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">10.0% or 20.0% (the applicable percentage to be specified by us in the applicable Intraday VWAP Purchase Notice
for such Intraday VWAP Purchase) of the total aggregate number (or volume) of shares of Common Stock traded on the NYSE during the applicable Intraday VWAP Purchase Period for such Intraday VWAP Purchase. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The actual number of shares of Common Stock that BRPC II will be required to purchase in an Intraday VWAP Purchase, which we refer to as the
Intraday VWAP Purchase Share Amount, will be equal to the number of shares that we specify in the applicable Intraday VWAP Purchase Notice, subject to adjustment to the extent necessary to give effect to the applicable Intraday VWAP Purchase Maximum
Amount and other applicable limitations set forth in the Purchase Agreement, including the Beneficial Ownership Limitation and, if then applicable, the Exchange Cap. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The per share purchase price that BRPC II will be required to pay for the Intraday VWAP Purchase Share Amount in an Intraday VWAP Purchase
effected by us pursuant to the Purchase Agreement, if any, will be calculated in the same manner as in the case of a regular VWAP Purchase, except that the VWAP used to determine the purchase price for shares of Common Stock to be purchased in an
Intraday VWAP Purchase will be equal to the VWAP, calculated in accordance with the Purchase Agreement, for the applicable Intraday VWAP Purchase Period on the Purchase Date for such Intraday VWAP Purchase, less a fixed 3.0% discount to the VWAP for
such Intraday VWAP Purchase Period. The Intraday VWAP Purchase Period for an Intraday VWAP Purchase is defined in the Purchase Agreement as the period during the regular trading session on the NYSE on such Purchase Date, beginning at the latest to
occur of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such time of confirmation of BRPC II&#146;s receipt of the applicable Intraday VWAP Purchase Notice;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such time that the VWAP Purchase Period for any prior regular VWAP Purchase effected on the same Purchase Date
(if any) has ended; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such time that the Intraday VWAP Purchase Period for the most recent prior Intraday VWAP Purchase effected on the
same Purchase Date (if any) has ended, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-51- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">and ending at the earliest to occur of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3:59 p.m., New York City time, on such Purchase Date or such earlier time publicly announced by the trading
market as the official close of the regular trading session on the NYSE on such Purchase Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such time that the total aggregate number (or volume) of shares of Common Stock traded on the NYSE during such
Intraday VWAP Purchase Period (calculated in accordance with the Purchase Agreement) reaches the applicable Intraday VWAP Purchase Share Value Maximum for such Intraday VWAP Purchase, which will be determined by dividing (a)&nbsp;the Intraday VWAP
Purchase Share Amount to be subscribed for and purchased by BRPC II in such Intraday VWAP Purchase-Type A, by (b) 0.10 or 0.20 (the applicable percentage being the same percentage we specified in the applicable Intraday VWAP Purchase Notice for
determining the applicable Intraday Purchase Share Amount for such Intraday VWAP Purchase; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if we elect a Limit Order Discontinue Election in the applicable Intraday VWAP Purchase Notice for such Intraday
VWAP Purchase, such time that the trading price of our Common Stock on the NYSE during such Intraday VWAP Purchase Period (calculated in accordance with the Purchase Agreement) falls below the applicable Minimum Price Threshold.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As with regular VWAP Purchases, for purposes of calculating the volume of shares of Common Stock traded during an
Intraday VWAP Purchase Period, including for purposes of determining whether the applicable Intraday VWAP Purchase Share Volume Maximum for an Intraday VWAP Purchase has been reached, for purposes of calculating the VWAP of our Common Stock for the
applicable Intraday VWAP Purchase Period, the following transactions, to the extent they occur during such VWAP Purchase Period, are excluded: (x)&nbsp;the opening or first purchase of Common Stock at or following the official open of the regular
trading session on the NYSE on the applicable Purchase Date for such Intraday VWAP Purchase, (y)&nbsp;the last or closing sale of Common Stock at or prior to the official close of the regular trading session on the NYSE on the applicable Purchase
Date for such Intraday VWAP Purchase, and (z)&nbsp;if we did not elect a Limit Order Discontinue Election in the applicable Intraday VWAP Purchase Notice for such Intraday VWAP Purchase, all purchases and sales of Common Stock on the NYSE during
such Intraday VWAP Purchase Period at a price per share that is less than the applicable Minimum Price Threshold for such Intraday VWAP Purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may, in our sole discretion, timely deliver multiple Intraday VWAP Purchase Notices to BRPC II prior to 3:30&nbsp;p.m., New York City time,
on a single Purchase Date to effect multiple Intraday VWAP Purchases on such same Purchase Date, provided that the VWAP Purchase Period for any such earlier regular VWAP Purchase effected on the same VWAP Purchase Date as such Intraday VWAP Purchase
(if any) and the Intraday VWAP Purchase Period for the most recent prior Intraday VWAP Purchase effected on the same Purchase Date as such Intraday VWAP Purchase (if any) have ended prior to 3:30&nbsp;p.m., New York City time, on such Purchase Date,
so long as all shares of Common Stock subject to all prior VWAP Purchases and all prior Intraday VWAP Purchases effected by us under the Purchase Agreement, including those effected earlier on the same Purchase Date as such Intraday VWAP Purchase,
have been received by BRPC II prior to the time we deliver to BRPC II a new Intraday VWAP Purchase Notice to effect an Intraday VWAP Purchase on the same Purchase Date as a regular VWAP Purchase and/or Intraday VWAP Purchase effected by us earlier
on such Purchase Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms and limitations that will apply to each subsequent Intraday VWAP Purchase effected on the same Purchase
Date will be the same as those applicable to any earlier regular VWAP Purchase (as applicable) and any earlier Intraday VWAP Purchase effected on the same Purchase Date as such subsequent Intraday VWAP Purchase, and the per share purchase price for
the shares of Common Stock that we elect to sell to BRPC II in each subsequent Intraday VWAP Purchase effected on the same Purchase Date as an earlier regular VWAP Purchase (as applicable) and/or earlier Intraday VWAP Purchase effected on such
Purchase Date will be calculated in the same manner as in the case of such earlier regular VWAP Purchase (as applicable) and such earlier Intraday VWAP Purchase(s)&nbsp;effected on the same Purchase Date as such subsequent Intraday VWAP Purchase,
with the exception that the Intraday VWAP Purchase Period for each subsequent Intraday VWAP </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-52- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Purchase will begin and end at different times (and may vary in duration) during the regular trading session on such Purchase Date, in each case as determined in accordance with the Purchase
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of VWAP Purchases and Intraday VWAP Purchases effected by us under the Purchase Agreement, if any, all share and
dollar amounts used in determining the purchase price per share of Common Stock to be purchased by BRPC II in any such VWAP Purchase or Intraday VWAP Purchase (as applicable), or in determining the applicable maximum purchase share amounts or
applicable volume or price threshold amounts in connection with any such VWAP Purchase or Intraday VWAP Purchase (as applicable), in each case will be equitably adjusted for any reorganization, recapitalization,
<FONT STYLE="white-space:nowrap">non-cash</FONT> dividend, stock split, reverse stock split or other similar transaction occurring during any period used to calculate such per share purchase price, maximum purchase share amounts or applicable volume
or price threshold amounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to 5:30&nbsp;p.m., New York City time, on the applicable Purchase Date for a VWAP Purchase and/or
Intraday VWAP Purchase, BRPC II will provide us with a written confirmation for such VWAP Purchase and/or Intraday VWAP Purchase, as applicable, setting forth the applicable purchase price (both on a per share basis and the total aggregate purchase
price) to be paid by BRPC II for the shares of Common Stock purchased by BRPC II in such VWAP Purchase and/or Intraday VWAP Purchase, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The payment for, against delivery of, shares of Common Stock purchased by BRPC II in a VWAP Purchase and any Intraday VWAP Purchase under the
Purchase Agreement will be fully settled within two trading&nbsp;days immediately following the applicable Purchase Date for such VWAP Purchase and Intraday VWAP Purchase, as set forth in the Purchase Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conditions Precedent to Commencement and Each Purchase </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BRPC II&#146;s obligation to accept VWAP Purchase Notices and Intraday VWAP Purchase Notices that are timely delivered by us under the Purchase
Agreement and to purchase shares of our Common Stock in VWAP Purchases and Intraday VWAP Purchases under the Purchase Agreement, are subject to (i)&nbsp;the initial satisfaction, at the Commencement, and (ii)&nbsp;the satisfaction, at the applicable
&#147;Purchase Condition Satisfaction Time&#148; (as such terms are defined in the Purchase Agreement) on the applicable Purchase Date for each VWAP Purchase or Intraday VWAP Purchase, respectively, after the Commencement, of the conditions
precedent thereto set forth in the Purchase Agreement, all of which are entirely outside of BRPC II&#146;s control, which conditions include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the accuracy in all material respects of the representations and warranties of the Company included in the
Purchase Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company having performed, satisfied and complied in all material respects with all covenants, agreements and
conditions required by the Purchase Agreement to be performed, satisfied or complied with by the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the registration statement that includes this prospectus (and any one or more additional registration statements
filed with the SEC that include shares of Common Stock that may be issued and sold by the Company to BRPC II under the Purchase Agreement) having been declared effective under the Securities Act by the SEC, and BRPC II being able to utilize this
prospectus (and the prospectus included in any one or more additional registration statements filed with the SEC under the Committed Equity Registration Rights Agreement) to resell all of the shares of Common Stock included in this prospectus (and
included in any such additional prospectuses); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the SEC shall not have issued any stop order suspending the effectiveness of the registration statement that
includes this prospectus (or any one or more additional registration statements filed with the SEC that include shares of Common Stock that may be issued and sold by the Company to BRPC II under the Purchase Agreement) or prohibiting or suspending
the use of this prospectus (or the prospectus included in any one or more additional registration statements filed with the SEC under the Committed </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-53- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Equity Registration Rights Agreement), and the absence of any suspension of qualification or exemption from qualification of the Common Stock for offering or sale in any jurisdiction;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FINRA shall not have provided an objection to, and shall have confirmed in writing that it has determined not to
raise any objections with respect to the fairness and reasonableness of, the terms and arrangements of the transactions contemplated by the Purchase Agreement and the Committed Equity Registration Rights Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there shall not have occurred any event and there shall not exist any condition or state of facts, which makes
any statement of a material fact made in the registration statement that includes this prospectus (or in any one or more additional registration statements filed with the SEC that include shares of Common Stock that may be issued and sold by the
Company to BRPC II under the Purchase Agreement) untrue or which requires the making of any additions to or changes to the statements contained therein in order to state a material fact required by the Securities Act to be stated therein or
necessary in order to make the statements then made therein (in the case of this prospectus or the prospectus included in any one or more additional registration statements filed with the SEC under the Committed Equity Registration Rights Agreement,
in the light of the circumstances under which they were made) not misleading; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this prospectus, in final form, shall have been filed with the SEC under the Securities Act prior to
Commencement, and all reports, schedules, registrations, forms, statements, information and other documents required to have been filed by the Company with the SEC pursuant to the reporting requirements of the Exchange Act shall have been filed with
the SEC; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">trading in the Common Stock shall not have been suspended by the SEC or the NYSE, the Company shall not have
received any final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> notice that the listing or quotation of the Common Stock on the NYSE shall be terminated on a date certain (unless, prior to such date, the Common Stock is listed or
quoted on any other Eligible Market, as such term is defined in the Purchase Agreement), and there shall be no suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC with
respect to the Common Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company shall have complied with all applicable federal, state and local governmental laws, rules,
regulations and ordinances in connection with the execution, delivery and performance of the Purchase Agreement and the Committed Equity Registration Rights Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any statute, regulation, order, decree, writ, ruling or injunction by any court or governmental
authority of competent jurisdiction which prohibits the consummation of or that would materially modify or delay any of the transactions contemplated by the Purchase Agreement or the Committed Equity Registration Rights Agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any action, suit or proceeding before any arbitrator or any court or governmental authority
seeking to restrain, prevent or change the transactions contemplated by the Purchase Agreement or the Committed Equity Registration Rights Agreement, or seeking material damages in connection with such transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of the shares of Common Stock that may be issued pursuant to the Purchase Agreement shall have been approved
for listing or quotation on the NYSE (or if the Common Stock is not then listed on the NYSE, on any Eligible Market), subject only to notice of issuance; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no condition, occurrence, state of facts or event constituting a Material Adverse Effect (as such term is defined
in the Purchase Agreement) shall have occurred and be continuing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any bankruptcy proceeding against the Company commenced by a third party, and the Company shall
not have commenced a voluntary bankruptcy proceeding, consented to the entry of an order for relief against it in an involuntary bankruptcy case, consented to the appointment of a custodian of the Company or for all or substantially all of its
property in any bankruptcy proceeding, or made a general assignment for the benefit of its creditors; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-54- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the receipt by BRPC II of the legal opinions and negative assurances, bring-down legal opinions and negative
assurances, and audit comfort letters as required under the Purchase Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Termination of the Purchase Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless earlier terminated as provided in the Purchase Agreement, the Purchase Agreement will terminate automatically on the earliest to occur
of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the first day of the month next following the <FONT STYLE="white-space:nowrap">24-month</FONT> anniversary of the
Commencement Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which BRPC II shall have purchased shares of Common Stock under the Purchase Agreement for an
aggregate gross purchase price equal to $200&nbsp;million; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which the Common Stock shall have failed to be listed or quoted on the NYSE or any other Eligible
Market for a period of one (1)&nbsp;trading day; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the 30th trading day after the date on which a voluntary or involuntary bankruptcy proceeding involving our
company has been commenced that is not discharged or dismissed prior to such trading day; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which a bankruptcy custodian is appointed for all or substantially all of our property, or we make a
general assignment for the benefit of our creditors. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have the right to terminate the Purchase Agreement at any time
after Commencement, at no cost or penalty, upon ten (10)&nbsp;trading&nbsp;days&#146; prior written notice to BRPC II. We and BRPC II may also terminate the Purchase Agreement at any time by mutual written consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BRPC II also has the right to terminate the Purchase Agreement upon ten (10)&nbsp;trading&nbsp;days&#146; prior written notice to us, but only
upon the occurrence of certain events, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the occurrence and continuation of a Material Adverse Effect (as such term is defined in the Purchase Agreement);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the occurrence of a Fundamental Transaction (as such term defined in the Purchase Agreement) involving our
company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if any registration statement is not filed by the applicable Filing Deadline (as defined in the Committed Equity
Registration Rights Agreement) therefor or declared effective by the SEC by the applicable Effectiveness Deadline (as defined in the Committed Equity Registration Rights Agreement), or we are otherwise in breach or default in any material respect
under any of the other provisions of the Committed Equity Registration Rights Agreement, and, if such failure, breach or default is capable of being cured, such failure, breach or default is not cured within ten (10)&nbsp;trading days after notice
of such failure, breach or default is delivered to us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if we are in breach or default in any material respect of any of our covenants and agreements in the Purchase
Agreement or in the Committed Equity Registration Rights Agreement, and, if such breach or default is capable of being cured, such breach or default is not cured within ten (10)&nbsp;trading days after notice of such breach or default is delivered
to us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effectiveness of the registration statement of which this prospectus forms a part or any additional
registration statement we file with the SEC pursuant to the Committed Equity Registration Rights Agreement lapses for any reason (including the issuance of a stop order by the SEC), or this prospectus or the prospectus included in any additional
registration statement we file with the SEC pursuant to the Committed Equity Registration Rights Agreement otherwise becomes unavailable to BRPC II for the resale of all of the shares of Common Stock included therein, and such lapse or
unavailability continues for a period of forty (40)&nbsp;consecutive trading days or for more than an aggregate of ninety (90)&nbsp;trading days in any <FONT STYLE="white-space:nowrap">365-day</FONT> period, other than due to acts of BRPC II; or
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-55- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">trading in the Common Stock on the NYSE (or if the Common Stock is then listed on an Eligible Market, trading in
the Common Stock on such Eligible Market) has been suspended for a period of five (5)&nbsp;consecutive trading days. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No
termination of the Purchase Agreement by us or by BRPC II will become effective prior to the fifth (5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) trading day immediately following the date on which any pending VWAP Purchase and any
pending Intraday VWAP Purchase has been fully settled in accordance with the terms and conditions of the Purchase Agreement, and no termination will affect any of our respective rights and obligations under the Purchase Agreement with respect to any
pending VWAP Purchase, any pending Intraday VWAP Purchase, the Initial Commitment Shares, the Additional Commitment Shares, and any fees and disbursements of BRPC II&#146;s legal counsel in connection with the transactions contemplated by the
Purchase Agreement and the Committed Equity Registration Rights Agreement. Both we and BRPC II have agreed to complete our respective obligations with respect to any such pending VWAP Purchase and any pending Intraday VWAP Purchase under the
Purchase Agreement. Furthermore, no termination of the Purchase Agreement will affect the Committed Equity Registration Rights Agreement, which will survive any termination of the Purchase Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Short-Selling or Hedging by the Selling Stockholder </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BRPC II has agreed that none of BRPC II, its officers, its sole member or any entity managed or controlled by BRPC II or its sole member will
engage in or effect, directly or indirectly, for its own account or for the account of any other of such persons or entities, any (i)&nbsp;&#148;short sale&#148; (as such term is defined in Rule&nbsp;200 of Regulation SHO of the Exchange Act) of the
Common Stock or (ii)&nbsp;hedging transaction, which establishes a net short position with respect to the Common Stock, our warrants or any of our other securities during the term of the Purchase Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prohibition of Variable Rate Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to specified exceptions included in the Purchase Agreement, we are limited in our ability to enter into specified &#147;Variable Rate
Transactions&#148; (as such term is defined in the Purchase Agreement) during the term of the Purchase Agreement. Such transactions include, among others, the issuance of convertible securities with a conversion or exercise price that is based upon
or varies with the trading price of our Common Stock after the date of issuance, or our effecting or entering into an agreement to effect an &#147;equity line of credit&#148; or other substantially similar continuous offering with a third party, in
which we may offer, issue or sell Common Stock or any securities exercisable, exchangeable or convertible into Common Stock at a future determined price. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Effect of Sales of our Common Stock under the Purchase Agreement on our Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All shares of Common Stock that may be issued or sold by us to BRPC II under the Purchase Agreement that are being registered under the
Securities Act for resale by BRPC II in this offering are expected to be freely tradable. The shares of Common Stock being registered for resale in this offering may be issued and sold by us to BRPC II from time to time at our discretion until the
first day of the month next following the 24-month anniversary of the Commencement. The resale by BRPC II of a significant amount of shares registered for resale in this offering at any given time, or the perception that these sales may occur, could
cause the market price of our Common Stock to decline and to be highly volatile. Sales of our Common Stock, if any, to BRPC II under the Purchase Agreement will depend upon market conditions and other factors to be determined by us. We may
ultimately decide to sell to BRPC II all, some or none of the shares of our Common Stock that may be available for us to sell to BRPC II pursuant to the Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If and when we do elect to sell shares of our Common Stock to BRPC II pursuant to the Purchase Agreement, after BRPC II has acquired such
shares, BRPC II may resell all, some or none of such shares at any time or from time to time in its discretion and at different prices. As a result, investors who purchase shares from BRPC II in this offering at different times will likely pay
different prices for those shares, and so may experience </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-56- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
different levels of dilution and in some cases substantial dilution and different outcomes in their investment results. Investors may experience a decline in the value of the shares they purchase
from BRPC II in this offering as a result of future sales made by us to BRPC II at prices lower than the prices such investors paid for their shares in this offering. In addition, if we sell a substantial number of shares to BRPC II under the
Purchase Agreement, or if investors expect that we will do so, the actual sales of shares or the mere existence of our arrangement with BRPC II may make it more difficult for us to sell equity or equity-related securities in the future at a time and
at a price that we might otherwise wish to effect such sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because the purchase price per share to be paid by BRPC II for the shares
of Common Stock that we may elect to sell to BRPC II under the Purchase Agreement, if any, will fluctuate based on the market prices of our Common Stock during the applicable VWAP Purchase Period for each VWAP Purchase, and during the applicable
Intraday VWAP Purchase Period for each Intraday VWAP Purchase, made pursuant to the Purchase Agreement, if any, as of the date of this prospectus it is not possible for us to predict the number of shares of Common Stock that we will sell to BRPC II
under the Purchase Agreement, the actual purchase price per share to be paid by BRPC II for those shares, or the actual gross proceeds to be raised by us from those sales, if any. As of November&nbsp;1, 2022, there were 84,467,987 shares of our
Common Stock outstanding, of which 15,241,793 shares were held by <FONT STYLE="white-space:nowrap">non-affiliates.</FONT> Although the Purchase Agreement provides that we may sell up to an aggregate of $200,000,000 of shares of our Common Stock to
BRPC II, only 16,825,366 shares of our Common Stock (representing the maximum number of shares of Common Stock we may issue and sell under the Purchase Agreement under the Exchange Cap limitation and inclusive of (i)&nbsp;the 84,793 Initial
Commitment Shares we issued to BRPC II as consideration for its commitment to purchase shares of our Common Stock at our election and in our sole discretion, from time to time after the date of this prospectus, upon the terms and subject to the
satisfaction of the conditions set forth in the Purchase Agreement and (ii)&nbsp;the up to 84,793 Additional Commitment Shares we may issue prior to the commencement of any sales of Common Stock to BRPC II pursuant to the terms of the Purchase
Agreement are being registered for resale under the registration statement that includes this prospectus. If all of the 16,825,366 shares offered for resale by BRPC II under this prospectus were issued and outstanding, such shares would represent
approximately 16.6% of the total number of shares of our Common Stock outstanding and approximately 52.5% of the total number of outstanding shares held by <FONT STYLE="white-space:nowrap">non-affiliates,</FONT> in each case as of November&nbsp;1,
2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If it becomes necessary for us to issue and sell to BRPC II under the Purchase Agreement more shares than are being registered for
resale under this prospectus in order to receive aggregate gross proceeds equal to $200,000,000 under the Purchase Agreement, we must first (i)&nbsp;obtain stockholder approval to issue shares of Common Stock in excess of the Exchange Cap under the
Purchase Agreement in accordance with applicable NYSE rules and (ii)&nbsp;file with the SEC one or more additional registration statements to register under the Securities Act the resale by BRPC II of any such additional shares of our Common Stock
we wish to sell from time to time under the Purchase Agreement, which the SEC must declare effective, in each case before we may elect to sell any additional shares of our Common Stock to BRPC II under the Purchase Agreement. The number of shares of
our Common Stock ultimately offered for sale by BRPC II is dependent upon the number of shares of Common Stock, if any, we ultimately sell to BRPC II under the Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The issuance of our Common Stock to BRPC II pursuant to the Purchase Agreement will not affect the rights or privileges of our existing
stockholders, except that the economic and voting interests of each of our existing stockholders will be diluted. Although the number of shares of our Common Stock that our existing stockholders own will not decrease, the shares of our Common Stock
owned by our existing stockholders will represent a smaller&nbsp;percentage of our total outstanding shares of our Common Stock after any such issuance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-57- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the amount of gross proceeds we would receive from BRPC II
from our sale of shares of Common Stock to BRPC II under the Purchase Agreement at varying purchase prices: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Assumed<BR>Average<BR>Purchase&nbsp;Price<BR>Per Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number of<BR>Registered<BR>Shares&nbsp;to be<BR>Issued if
Full<BR>Purchase<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Percentage&nbsp;of&nbsp;Outstanding<BR>Shares After Giving
Effect<BR>to the Issuance to the<BR>Selling Stockholder<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Gross&nbsp;Proceeds&nbsp;from&nbsp;the&nbsp;Sale&nbsp;of<BR>Shares&nbsp;to&nbsp;the&nbsp;Selling&nbsp;Stockholder<BR>Under the Purchase
Agreement</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">$8.00</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16,655,780</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16.5%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">$133,246,240</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">$9.00</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16,655,780</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16.5%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">$149,902,020</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">$10.00</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16,655,780</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16.5%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">$166,557,800</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">$10.50<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16,655,780</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16.5%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">$174,885,690</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">$11.00</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16,655,780</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16.5%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">$183,213,580</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">$12.00</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16,655,780</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">16.5%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">$199,869,360</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">$13.00</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">15,384,615</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">15.4%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">$200,000,000</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Excluding the 84,793 Initial Commitment Shares that we issued to BRPC II upon the execution of the Purchase
Agreement on September&nbsp;27, 2022 and the 84,793 Additional Commitment Shares that we will issue upon our receipt of a certain amount of proceeds from the sale of shares of our Common Stock to BRPC II as set forth in the Purchase Agreement.
Although the Purchase Agreement provides that we may sell up to $200,000,000 of our Common Stock to BRPC II, we are only registering 16,825,366 shares under the registration statement of which this prospectus forms a part, which may or may not cover
all of the shares we ultimately sell to BRPC II under the Purchase Agreement. We will not issue more than an aggregate of 16,825,366 shares of our Common Stock (unless otherwise approved by our stockholders or if sales of our common stock are made
by us to BRPC II at a price equal to or greater than the applicable <FONT STYLE="white-space:nowrap">&#147;mini-mum</FONT> price&#148; (as defined in the applicable listing rules of the NYSE) of the Common Stock, calculated at the time VWAP
Purchases and Intraday VWAP Purchases are effected by us under the Purchase Agreement, if any, as adjusted to take into account our issuance of the Commitment Shares to BRPC II and our reimbursement of a certain amount of BRPC II&#146;s legal fees
and expenses, such that the Exchange Cap limitation would not apply under applicable NYSE rules). The number of shares to be issued as set forth in this column (i)&nbsp;gives effect to the Exchange Cap and (ii)&nbsp;is without regard for the
Beneficial Ownership Limitation. The assumed average purchase prices are solely for illustration and are not <FONT STYLE="white-space:nowrap">in-tended</FONT> to be estimates or predictions of future stock performance. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The denominator is based on 84,253,709 shares of Common Stock (which includes the 84,793 Initial Commitment
Shares, but excludes the 84,793 Additional Commitment Shares), adjusted to include the issuance of the number of shares set forth in the adjacent column that we would have sold to BRPC II, assuming the average purchase price in the first column. The
numerator is based on the number of shares issuable under the Purchase Agreement (that are the subject of this offering) at the corresponding assumed average purchase price set forth in the first column. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The closing sale price of our Common Stock on the NYSE on November 10, 2022. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-58- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_8"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus relates to the offer and resale of up to 16,825,366 shares of Common Stock by BRPC II. All of the shares of Common Stock
offered by BRPC II pursuant to this prospectus will be sold by BRPC II for its own account. We will not receive any of the proceeds from these sales. We may receive up to $200,000,000 in aggregate gross proceeds under the Purchase Agreement from any
sales we make to BRPC II pursuant to the Purchase Agreement. The net proceeds from sales, if any, under the Purchase Agreement will depend on the frequency and prices at which we sell shares of Common Stock to BRPC II after the date of this
prospectus. See the section titled &#147;Plan of Distribution (Conflict of Interest)&#148; included elsewhere in this prospectus for more information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend that any funds we receive from our sale of shares to BRPC II under the Purchase Agreement will be used for general corporate
purposes, including working capital. The precise amount and timing of the application of such proceeds will depend upon our liquidity needs and the availability and cost of other capital. Accordingly, we will have broad discretion in the way that we
use these proceeds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BRPC II will pay any underwriting discounts and commissions and expenses incurred by it for brokerage, accounting,
tax or legal services or any other expenses incurred by it in disposing of the Common Stock. We will bear all other costs, fees and expenses incurred in effecting the registration of the Common Stock covered by this prospectus, including, without
limitation, all registration and filing fees and fees and expenses of our counsel and our accountants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have engaged Northland, a
registered broker-dealer and FINRA member, to be the qualified independent underwriter in this offering and, in such capacity, participate in the preparation of the registration statement that includes this prospectus and exercise the usual
standards of &#147;due diligence&#148; with respect thereto. BRPC II has agreed to pay Northland a cash fee of $50,000 upon the completion of this offering as consideration for its services and to reimburse Northland up to $5,000 for expenses
incurred in connection with acting as the qualified independent underwriter in this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-59- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_9"></A>MARKET PRICE OF AND DIVIDENDS ON THE REGISTRANT&#146;S COMMON
EQUITY AND RELATED STOCKHOLDER MATTERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market Information and Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Stock and the Public Warrants are currently listed on the NYSE under the symbols &#147;AMPX&#148; and &#147;AMPX.W,&#148;
respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of November&nbsp;1, 2022, there were 84,467,987 shares of Common Stock issued and outstanding held of record by 63
holders and 47,720,946 Warrants (consisting of 29,268,446 Public Warrants, 16,400,000 Private Warrants and 2,052,500 PIPE Warrants) issued and outstanding held of record by 87 holders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividend Policy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not paid any
cash dividends on the Common Stock to date. The payment of cash dividends on Common Stock in the future will be dependent upon the revenues and earnings, if any, capital requirements and general financial condition of the Company. In addition, the
Company&#146;s ability to pay cash dividends may be limited by covenants of any indebtedness or other contractual limitations of the Company or its subsidiaries. The payment of any cash dividends on Common Stock will be within the discretion of the
Board. The Board is not currently contemplating and does not anticipate declaring dividends on Common Stock in the foreseeable future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-60- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_11"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>As a result of the Closing, the financial statements of Legacy Amprius are now the financial
statements of Amprius. Thus, the following discussion and analysis of our financial condition and results of operations of Legacy Amprius prior to the Business Combination and Amprius following the completion of the Business Combination should be
read in conjunction with Legacy Amprius&#146; financial statements and the notes thereto appearing elsewhere in this prospectus. Some of the information contained in this discussion and analysis or set forth elsewhere in this prospectus, including
information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. You should read the sections titled &#147;Risk Factors&#148; and &#147;Cautionary Note Regarding
Forward-Looking Statements&#148; for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and
analysis. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Company Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amprius Technologies, Inc. has developed and, since 2018, been in commercial production of ultra-high energy density <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> batteries for mobility applications leveraging a disruptive silicon nanowire anode. Our silicon nanowire anode technology enables batteries with higher energy density, higher power density, and extreme
fast charging capabilities over a wide range of operating temperatures, which results in our batteries providing superior performance compared to conventional graphite <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries. Our silicon
nanowire anode is a direct <FONT STYLE="white-space:nowrap">drop-in</FONT> replacement of the graphite anode in traditional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries, and our manufacturing process leverages the manufacturing
process for conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries and the related supply chain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Today, our batteries
are primarily used for existing and emerging aviation applications, including unmanned aerial systems (&#147;UAS&#148;), such as drones and high-altitude pseudo satellites (&#147;HAPS&#148;). We believe our proprietary technology has the potential
for broad application in electric transportation. Our batteries and their performance specifications have been tested and validated for application by over 30 customers, including Airbus, AeroVironment, BAE Systems, the U.S. Army and Teledyne FLIR,
and we have shipped over 10,000 batteries to date, which have enabled mission critical applications. Our proprietary silicon nanowire anode structures, battery designs and manufacturing processes are defended by our portfolio of patents, trade
secrets and <FONT STYLE="white-space:nowrap">know-how</FONT> developed over 10&nbsp;years of research and development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently
manufacture our batteries on a <FONT STYLE="white-space:nowrap">kWh-scale</FONT> manufacturing line at our headquarters in Fremont, California, where we believe demand for our batteries exceeds our manufacturing capacity. We are working to meet the
expected demand in several rapidly growing addressable markets, including by designing and building a large-scale manufacturing facility that can manufacture at GWh+ scale, including an automated, high-volume manufacturing line for our silicon
nanowire anode. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;14, 2022, we consummated the Business Combination. The Business Combination was accounted for as a reverse recapitalization
for financial statement reporting purposes with Legacy Amprius deemed to be the acquirer and Kensington deemed to be the acquiree. As a result, the assets, liabilities and results of operations of Legacy Amprius became the historical financial
statements after the Business Combination. Our assets and liabilities continued to be stated at historical cost and there were no goodwill or other intangible assets recorded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We received net proceeds from the Business Combination and the PIPE totaling $70.9 million, after deducting transaction and issuance costs.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-61- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Committed Equity Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;27, 2022, we entered into the Purchase Agreement and the Committed Equity Registration Rights Agreement with BRPC&nbsp;II.
Pursuant to the Purchase Agreement, subject to the satisfaction of the conditions set forth therein, we have the right, but not the obligation, to sell to BRPC&nbsp;II up to $200,000,000 of newly issued shares of Common Stock (subject to certain
conditions and limitations) from time to time during the term of the Purchase Agreement. Sales of Common Stock pursuant to the Purchase Agreement, and the timing of any sales, are solely at our option, and we are under no obligation to sell any
securities to BRPC&nbsp;II under the Purchase Agreement. As consideration for BRPC&nbsp;II&#146;s commitment to purchase shares of Common Stock at our direction upon the terms and subject to the conditions set forth in the Purchase Agreement, upon
execution of the Purchase Agreement, we issued 84,793 Initial Commitment Shares to BRPC&nbsp;II. Upon our receipt of total aggregate gross cash proceeds equal to $100,000,000 from BRPC&nbsp;II under the Purchase Agreement, we will issue 84,793
additional Commitment Shares to BRPC&nbsp;II. Also, any shares of Common Stock issued in the Committed Equity Financing to BRPC&nbsp;II other than the Commitment Shares will be purchased by BRPC&nbsp;II at current market prices less a 3.0% fixed
discount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the applicable NYSE rules, in no event may we issue to BRPC&nbsp;II under the Purchase Agreement more than the Exchange
Cap, unless we obtain stockholder approval to issue shares of Common Stock in excess of the Exchange Cap in accordance with the applicable NYSE rules. The Exchange Cap is not applicable to issuances and sales of Common Stock pursuant to VWAP
Purchases and Intraday VWAP Purchases that we may effect pursuant to the Purchase Agreement, to the extent such shares of Common Stock are sold in such VWAP Purchases and Intraday VWAP Purchases (as applicable) at a price equal to or in excess of
the applicable &#147;minimum price&#148; (as defined in the applicable listing rules of the NYSE) of the Common Stock, calculated at the time such VWAP Purchases and Intraday VWAP Purchases (as applicable) are effected by us under the Purchase
Agreement, if any, as adjusted to take into account our issuance of the Commitment Shares to BRPC II and our reimbursement of a certain amount of BRPC II&#146;s legal fees and expenses. Moreover, we may not issue or sell any shares of Common Stock
to BRPC&nbsp;II under the Purchase Agreement which, when aggregated with all other shares of Common Stock then beneficially owned by BRPC&nbsp;II and its affiliates (as calculated pursuant to Section&nbsp;13(d) of the Exchange Act and
Rule&nbsp;13d-3 thereunder), would result in BRPC&nbsp;II beneficially owning more than 4.99% of the outstanding shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the Commencement, we will have the right, but not the obligation, from time to time at our sole discretion over the <FONT
STYLE="white-space:nowrap">24-month</FONT> period from and after the Commencement, to direct VWAP Purchases by delivering written notice to BRPC&nbsp;II prior to the commencement of trading of the Common Stock on the NYSE on any trading day, so long
as (i)&nbsp;the closing sale price of the Common Stock on the trading day immediately prior to such Purchase Date is not less than the specified threshold price as set forth in the Purchase Agreement and (ii)&nbsp;all shares of Common Stock subject
to all prior VWAP Purchases and all prior Intraday VWAP Purchases by BRPC&nbsp;II under the Purchase Agreement have been received by BRPC&nbsp;II prior to the Company&#146;s delivery of such applicable purchase notice to BRPC&nbsp;II. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the regular VWAP Purchases described above, after the Commencement, we will also have the right, but not the obligation,
subject to the continued satisfaction of the conditions set forth in the Purchase Agreement, to direct Intraday VWAP Purchases by the delivery to BRPC&nbsp;II of an irrevocable written purchase notice, after 10:00 a.m., New York City time, and prior
to 3:30 p.m., New York City time, on such Purchase Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after Commencement, we will control the timing and amount of any sales
of Common Stock to BRPC II. Actual sales of shares of Common Stock to BRPC II under the Purchase Agreement will depend on a variety of factors to be determined by us from time to time, including, among other things, market conditions, the trading
price of the Common Stock and determinations by us as to the appropriate sources of funding for us and our operations. See &#147;Committed Equity Financing&#148; for more information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-62- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Department of Energy Cost Sharing Grant </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2022, we were awarded a $50.0 million cost sharing grant from the U.S. Department of Energy. This cost sharing grant is dependent on
the successful negotiation of a final contract, and among the terms to be finalized are the portion of relevant costs that will be covered by the grant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Known Trends, Demands, Commitments, Events, or Uncertainties Impacting Our Business </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our performance and future success depends on several factors that present significant opportunities for us but also pose risks
and challenges, including those discussed below and in the section titled &#147;Risk Factors.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Establishing Manufacturing Capacity
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While we have manufactured on a kWh-scale capacity to date, we have started our phased build out of capacity with parallel paths.
We have received the first large-scale anode production machine from Centrotherm at our current facility in Fremont. We are customizing the machine for our production processes and must then complete tuning and testing before the machine goes online
for production purposes. We expect this machine to increase our capacity for silicon anode production to approximately 2&nbsp;MWh by the end of 2023. This is expected to accelerate our development of technological processes for building batteries at
a GWh-scale as we prepare, in parallel, for the design and build of our high volume manufacturing facility using the proceeds obtained from the Business Combination and, if any, the Committed Equity Financing. Achieving capacity at commercial scale
of high energy density <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries will require us to make significant capital expenditures to scale our production capacity and improve our supply chain processes. Based on our current expectations,
we estimate that our capital equipment expenditures will range between $120.0&nbsp;million and $150.0&nbsp;million to achieve 1.0 GWh per year of manufacturing capacity, and that it will take approximately two years following the Closing to start
volume manufacturing. Because our silicon nanowire anode process requires different equipment than traditional anode manufacturing, our capital equipment costs are likely to be higher than equipment used for production of graphite anodes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have begun selection of sites for a <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility, and we plan to procure
manufacturing equipment that allows for cathode fabrication, battery assembly, and battery testing from equipment suppliers. To achieve capacity at commercial scale, we need to establish supply relationships for necessary materials, components and
equipment to mass produce the silicon nanowire technology for our prospective markets, which will allow us to develop an automated, high-volume manufacturing line to increase production volume. The capacity and timing of our future manufacturing
requirements, and related capital expenditures, remain uncertain and will depend on a variety of factors, including our ability to design and construct new manufacturing sites and develop an automated, high-volume manufacturing line for our silicon
nanowire anode, to mitigate supply chain constraints and manage a new labor force, to utilize planned capacity in our existing facilities, and to operate in new geographic areas apart from our current headquarters. Our potential suppliers and other
equipment vendors may also encounter delays, additional costs, and other obstacles in building our manufacturing line, which are currently unknown. To the extent we are unable to develop an automated, high-volume manufacturing line for our silicon
nanowire anode, our ability to grow will be adversely affected. Additionally, although we have tested and validated the performance of our products on one supplier&#146;s platform, there is uncertainty as to whether our planned manufacturing line
will be successful. We expect our capital expenditures to increase each as we ramp up our manufacturing capacity and expand operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reducing
Costs of Manufacturing </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe the focus on reducing the manufacturing costs of our batteries on a $/kWh basis is an important
factor to accelerate the demand for our batteries and the expansion of our customer base. As a result, we will continue to work to develop further and validate our manufacturing processes to enable high volume manufacturing and reduce manufacturing
costs. The production of our silicon nanowire anode requires different </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-63- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
equipment than traditional graphite anode manufacturing. Therefore, our capital equipment costs are likely to be initially higher than equipment used for the production of graphite anodes. As we
scale, we believe we will benefit from reduced <FONT STYLE="white-space:nowrap">per-unit</FONT> fixed costs, such as overhead, labor and capital expenditures, tool utilization improvements and volume pricing for equipment and materials. We will also
seek to reduce costs by optimizing material utilization, throughput and yield. This is complemented by further intentions to continue to invest in research and development to improve both battery performance and manufacturing processes. However,
until we are able to successfully design and implement an automated, high-volume manufacturing line for our silicon nanowire anode and manufacture our batteries at scale, we cannot accurately forecast our manufacturing costs, which may adversely
affect our ability to achieve reduced costs in our manufacturing processes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Highly Competitive Market </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our competition includes both established manufacturers and new entrants that are developing new battery technologies and chemistries to
address the growing market for electrified transportation solutions. We believe the manufacturers of these batteries will continue to invest funds, time and effort to improve the capabilities of their batteries with the recent developments of
silicon batteries as a potential alternative to conventional graphite batteries. Currently, we are the only known manufacturer using a 100% silicon anode that is free of any inactive additives. We believe we are the leading company in the market
that has a high-performance battery that can meet the requirements of aviation applications. The EV battery industry has a limited number of commercially available batteries that meet the minimum performance specifications. This creates a
fast-growing and highly competitive industry for many battery manufacturers to claim market share for commercially acceptable batteries. We believe that there is significant room for improvement in the EV industry in driving range and fast charging
capabilities that our silicon nanowire technology can address. To compete in the EV industry, the reduction of manufacturing costs is a significant objective in addition to improving cycle life, increasing form factors and improving production
quantity. A primary concern is that many of our competitors and potential future entrants may be better capitalized to expand production capacities, have greater resources to commercialize and have greater access to customers. As such, we may be at
a competitive disadvantage and be unable to retain or grow our market share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Product Development </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to continue investing in the development of battery technology with the goal of enabling commercial production after the completion
of our new <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility. We continue to develop customized battery solutions and deliver standardized samples (i.e., prototypes) of batteries to industry leading manufacturers as well as
the federal government. We plan to focus our research and development on the following key areas: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Improving battery life:</B> To
continue to meet the specific needs of our customers and drive adoption of our batteries in new areas of electrified transportation, including the EV space. We are working with chemical compounds as potential additives to the silane gas we use to
produce our silicon nanowire anodes, which have demonstrated the potential to improve cycle life without negatively impacting other performance characteristics such as energy density. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Further improvements to energy density: </B>We are engaged in ongoing development activities to explore different cathode materials,
including a conversion cathode, to further improve the energy density of our batteries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Larger cell form factors: </B>The batteries we
have developed and are developing for our customers are typically approximately <FONT STYLE="white-space:nowrap">2-15Ah</FONT> for <FONT STYLE="white-space:nowrap">small-sized</FONT> aircraft. As we expand our customer base, we expect to develop
larger form factor batteries for broader electrified transportation applications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of these efforts, our goal is to fully
realize the benefits of our silicon nanowire anode technology and develop the highest performing products in the market. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-64- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Regulatory Landscape </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We operate in an industry that is subject to many established environmental regulations, which have generally become more stringent over time.
As we process, store, dispose of, transport, and use large amounts of hazardous materials, we are subject to laws and regulations surrounding battery safety and transportation, as well as health and production safety laws and regulations governing
hazardous materials. We expect that environmental regulations under the Biden administration could, if adopted, facilitate market demand and revenue growth, while other potential regulations, if adopted, could result in additional operating costs.
If we fail to comply with existing and future laws and regulations, our business and results of operations could be adversely affected, such as the imposition of fines, litigation, criminal charges, sanctions by regulators, or other liabilities. As
future regulatory changes are uncertain, we are unable to measure the impact of such changes on our business and our results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Global
Risks </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rapid global spread of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> coronavirus since December 2019 has caused
business disruption affecting production and sales across a range of industries. While the disruption is currently expected to be temporary, the extent of the impact of <FONT STYLE="white-space:nowrap">COVID-19</FONT> on our operational and
financial performance will depend on certain developments, including the duration and spread of the virus, and the impact on our customers, employees and vendors. Our customers may experience significant adverse effects on their cash flow and
operations, leading to potential difficulty with purchasing and paying for our products, and therefore, a reduction in our revenues. We also experienced a 10% reduction in workforce as a result of the <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic and the related temporary closure during the year ended December&nbsp;31, 2020. However, during the year ended December 31, 2021 and continuing into 2022, our workforce numbers were restored, showing signs of recovery and growth of
production activities and the continued flow of supply chains. From December 31, 2021 to September 30, 2022, we grew our workforce by 41%. The ultimate outcome of the pandemic is uncertain and, accordingly, the impact on our financial condition or
results of operations is also uncertain. To date, and as a result of us not commencing full-scale commercial production activities, <FONT STYLE="white-space:nowrap">COVID-19</FONT> has not had a material impact on our interim unaudited condensed
financial statements and audited financial statements or our liquidity. We have not materially altered any terms with contractors, suppliers, customers, other business partners or our financing sources as a result of
<FONT STYLE="white-space:nowrap">COVID-19.</FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, the military conflict between Russia and Ukraine, which began in February
2022, has had an adverse impact on the global economy and financial markets. Although our business has not been directly impacted by this ongoing military conflict, as we have no assets or operations, and we have not purchased materials from,
Russia, Belarus or Ukraine, it is impossible to predict the extent to which our operations, or those of our customers, suppliers and manufacturers, will be impacted in the short and long term, or the ways in which the conflict may impact our
business. The extent and duration of the military action, sanctions and resulting market disruptions and inflationary pressures, and the impact of such changes on our business and our results </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">of operations are impossible to predict, but could be material. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Comparability of Financial Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future results of operations and financial position may not be comparable to historical results as a result </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">of the Business Combination. Since the Business Combination close, we have incurred, and expect to continue to incur, higher capital expenditures related to
both the design and build out of our new GWh-scale manufacturing facility and the development of an automated, high-volume manufacturing line for our silicon nanowire anode, as well as higher costs for continued research and development efforts,
compliance with regulatory matters and other general and administrative expenses, including those related to being a public company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis of
Presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audited financial statements as of and for the years ended December&nbsp;31, 2021 and 2020 and the interim unaudited
condensed financial statements as of and for the nine months ended September 30, 2022 and 2021 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-65- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
were prepared in accordance with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;). We carry on our business through one operating segment. Given
that Amprius Holdings, which held approximately 99.6% of the Legacy Amprius Common Stock prior to the Business Combination, has not historically prepared financial statements for Legacy Amprius, the historical results for Legacy Amprius have been
prepared from the financial records of Amprius Holdings on a <FONT STYLE="white-space:nowrap">carve-out</FONT> basis derived from the accounting records of Amprius Holdings using the historical results of operations and the historical basis of
assets and liabilities of our business, adjusted as necessary to conform to U.S. GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Refer to &#147;Critical Accounting Policies and
Estimates&#148; for further details on certain material assumptions and judgments applied in preparing our <FONT STYLE="white-space:nowrap">carve-out</FONT> financial statements separate from Amprius Holdings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of Our Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently operate a <FONT STYLE="white-space:nowrap">kWh-scale</FONT> manufacturing line at our headquarters in Fremont, California. To meet
the demand for our batteries, we are in the process of designing and then building a <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility, designing our automated, high-volume manufacturing line, and scaling up production. As a
result, we expect our capital expenditures and working capital requirements to increase materially in the near future. Our ability in the future to generate revenue sufficient to achieve profitability will depend largely on our ability to scale
production to meet the expected market demand for our products. Accordingly, the drivers of our future financial results, as well as the components of such results, may not be comparable to our historical results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Revenues </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have historically
generated revenues from providing both design services for the development of customized silicon-anode <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery technology and selling our batteries to our customers. Our contracts typically contain
a single performance obligation. Revenue is recognized at the point in time when final milestones are met (i.e., a final working prototype is delivered and meets all required specifications) or when the customer obtains control of the product, which
is generally upon shipment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cost of Revenues </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues includes materials, direct labor, allocated depreciation expense, and other direct and indirect costs related to revenue
contracts. Labor consists of personnel-related expenses such as salaries and benefits, and stock-based compensation. Stock-based compensation expense included within cost of revenues is allocated based on the proportion of time spent by personnel in
relation to manufacturing batteries and fulfilling customer contracts. Cost of revenues are expected to continue to increase as we incur expenses related to the design and buildout of our <FONT STYLE="white-space:nowrap">GWh-scale</FONT>
manufacturing facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expense costs in the period incurred unless the costs meet three criteria to be capitalized as an asset: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">when the costs relate directly to a customer contract; we expect to generate or enhance resources of the business </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">from performing the contract that will be used in satisfying future performance obligations; and we expect to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">recover such benefits. We recognize deferred costs as cost of revenues in the period when the related revenue is </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">recognized. Cost of revenues also includes costs incurred that was in excess of the recoverable amount. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development (&#147;R&amp;D&#148;) Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">R&amp;D expenses mainly consist of salaries and benefits, including stock-based compensation expense and other related personnel costs,
depreciation, contract services, materials and supplies, other expenses from outside contractors and suppliers plus an allocation of indirect costs. These costs relate to the conceptual formulation and design of preproduction experimental prototypes
and models, including the cost of equipment and material for which there is no alternative future use. R&amp;D expenses are expensed as incurred. Stock-based compensation expense included within R&amp;D expense is allocated based on the proportion
of time spent by personnel in relation to innovating and introducing new batteries to our product line. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-66- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We anticipate that R&amp;D expenses will increase for the foreseeable future as we continue
to invest in activities to enhance product capabilities, build battery prototypes that meet our customers&#146; specifications, and test batteries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Selling, General and Administrative Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expenses consist primarily of costs incurred for salaries and personnel-related expenses, including
stock-based compensation expense, outside contractor and professional service fees, audit and compliance expenses, legal, accounting and other advisory services, as well as allocated facilities and information technology costs including
depreciation. Stock-based compensation expense included within selling, general and administrative expense is allocated based on the proportion of time spent by personnel in relation to marketing, administrative and corporate services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect that our selling, general and administrative expenses will increase due to our operations as a public company, including expenses
related to compliance with the rules and regulations applicable to companies listed on a national securities exchange and related to compliance and reporting obligations pursuant to the rules and regulations of the SEC, as well as increased expenses
for insurance (including director and officer insurance), investor relations activities and other administrative and professional services such as accounting, legal, regulatory and tax. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Income (Expense), Net </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other
income (expense), net consists primarily of interest income and the gain on the forgiveness of a loan received from the Paycheck Protection Program (the &#147;PPP Loan&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provision for Income Taxes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
provision for income tax consists of an estimate for U.S. federal and state income taxes based on enacted rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities, and changes in
the tax law. We maintain a valuation allowance against the full value of our U.S. and state net deferred tax assets because it is not more likely that our deferred tax assets will be recoverable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-67- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Three and Nine Months Ended September 30, 2022 and 2021 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our results of operations during the three and nine months ended September 30, 2022 and 2021 (in thousands):
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended<BR>September 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended<BR>September 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,617</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,556</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,061</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,986</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,468</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,656</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,831</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,434</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(397</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">148</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">117</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,137</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,186</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,394</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,920</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,474</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2075</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(608</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(84</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,244</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,103</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,082</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost and operating expenses reported above include stock-based compensation as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended<BR>September 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended<BR>September 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2021&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2021&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(14</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">296</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">141</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">202</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Revenue </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenue increased by $0.5 million, or 147%, and $2.1 million, or 132%, to $0.8 and $3.6 million during the three and nine months ended
September 30, 2022, respectively, compared to the same periods in 2021. The increase was primarily due to the completion of customization design services of $0.3 million and $1.3 million during the three and nine months ended September 30, 2022,
respectively. In addition, sales of standard battery cells increased by $0.2 million and $0.8 million during the three and nine months ended September 30, 2022, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cost of Revenues </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues
increased by $0.3 million, or 15%, and $2.5 million, or 49%, during the three and nine months ended September 30, 2022, respectively, compared to the same periods in 2021. The increase during the three months ended September 30, 2022 was primarily
due to a $0.3 million increase in costs to fulfill design service contracts. The increase during the nine months ended September 30, 2022 was primarily due to a $1.6 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-68- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
million increase in costs to fulfill design service contracts and a $0.9 million net increase in production costs, which was mostly attributed to the expansion of our production capacity and
increase in personnel involved in production. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expense </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expenses increased by $0.2 million, or 49%, and $0.4 million, or 37%, during the three and nine months ended September
30, 2022, respectively, compared to the same periods in 2021. The increase was primarily due to the increase in headcount and related increases in payroll and employee benefit costs, including stock-based compensation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Selling, General and Administrative Expense </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expense increased by $1.2 million, or 105%, and $3.7 million, or 148%, during the three and nine months
ended September 30, 2022, respectively, compared to the same periods in 2021. The increase was primarily due to an increase in headcount as we prepared to become a public entity including increases of $0.3 million and $1.0 million during the three
and nine months ended September 30, 2022, respectively, in personnel-related costs and increases of $0.4 million and $1.3 million, during the same periods respectively, in stock-based compensation expense. Additionally, our professional fees, which
primarily include legal and accounting support, increased by $0.4 million and $1.2 million during the three and nine months ended September 30, 2022, respectively, as we prepared to operate as a public company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years Ended December&nbsp;31, 2021 and 2020 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our results of operations for the years ended December&nbsp;31, 2021 and 2020 (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,679</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,907</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(41</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,695</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,016</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,313</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(10,623</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,449</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,174</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(100</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on forgiveness of PPP Loan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(52</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(144</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,245</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,896</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,478</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-69- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As stock-based compensation is a key factor in the discussion of our Results of Operations
for the years ended December&nbsp;31, 2021 and 2020, the below table illustrates the impact of stock-based compensation on the expense categories to which the total is allocated (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,467</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,229</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,123</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,916</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Revenues </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Total revenues decreased by $1.9&nbsp;million, or 41%, to $2.8&nbsp;million for the year ended December&nbsp;31, 2021 compared to
$4.7&nbsp;million for the year ended December&nbsp;31, 2020. Our revenue from design services decreased by $2.3&nbsp;million, or 59%, for the year ended December&nbsp;31, 2021, $1.7&nbsp;million of the decrease of which is attributable to the
completion of certain prototypes for a large customer in 2020 and $0.6&nbsp;million of the decrease is attributable to revenue recognized in 2020 from the completion of a contract with a division of the federal government. The decrease in revenue
was partially offset by an increase in revenues from battery shipments of $0.4&nbsp;million for the year ended December&nbsp;31, 2021 primarily due to sales of additional batches of standardized batteries to a commercial customer for whom we
previously completed a prototype, as well as the opening of our second manufacturing line during July 2021, which increased our production capacity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cost of Revenues </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues
increased by $0.4&nbsp;million, or 6%, to $7.1&nbsp;million for the year ended December&nbsp;31, 2021, compared to $6.7&nbsp;million for the year ended December&nbsp;31, 2020. This increase is primarily related to higher payroll and stock-based
compensation costs of $0.7&nbsp;million due to a higher number of employees to address our additional capacity requirements from our second manufacturing line that went into service during July 2021. Additionally, depreciation expense increased by
$0.1&nbsp;million from the use of the new manufacturing line. The increase is offset by a decrease of $0.4&nbsp;million due to deferral of costs incurred to fulfill design services contracts expected to be completed in the future periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expense </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">R&amp;D
expense increased by $0.1&nbsp;million, or 9%, to $1.5&nbsp;million for the year ended December&nbsp;31, 2021, compared to $1.4&nbsp;million for the year ended December&nbsp;31, 2020. This increase is due to additional stock-based compensation for
personnel directly involved with R&amp;D activities during the last quarter of 2021. Additionally, higher labor costs allocated to R&amp;D activities were incurred as a result of increased headcount related to increased efforts as we continue to
invest in developing our technology. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Selling, General and Administrative Expense </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expense increased by $0.7&nbsp;million, or 18%, to $4.8&nbsp;million for the year ended December&nbsp;31,
2021, compared to $4.1&nbsp;million for the year ended December&nbsp;31, 2020. The increase is primarily due to a $2.2&nbsp;million increase in payroll-related costs, including an increase of $0.7&nbsp;million in salaries, bonus and fringe benefits,
and an increase of $1.5&nbsp;million in stock-based compensation expense. The payroll-related costs were the result of an increase of headcount in our finance and business development departments by three personnel during the second half of the year
ended December&nbsp;31, 2021 as we prepare to function as a public entity. Our stock-based compensation expense increased as a result of option awards granted to employees during </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-70- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the last three quarters of 2021 that incorporated an increased grant date fair value due to increases in the valuation of our common stock compared to prior periods. Additionally, we incurred
additional costs of $0.3&nbsp;million for recruiting and placement costs for talent acquisitions and $0.4&nbsp;million for contract labor and accounting, finance and advisory consultants to prepare for the reporting requirements of a public entity.
The increase of selling, general and administrative expense also incorporates an increase of $0.1&nbsp;million in common area maintenance costs associated with our rented facilities. These increases were offset by a decrease of $2.3&nbsp;million in
legal costs. The majority of the legal costs incurred were related to a patent infringement claim filed against us in August 2019, which led to a large increase in legal costs during the year ended December&nbsp;31, 2020. Total legal costs of
$3.0&nbsp;million were incurred during the year ended December&nbsp;31, 2020, of which $2.8&nbsp;million related to the settlement of the claim, while during the year ended December&nbsp;31, 2021, $0.7&nbsp;million in total legal costs were
incurred, of which $0.1&nbsp;million was related to the settlement of the claim. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Gain on Forgiveness of PPP Loan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gain on forgiveness of PPP Loan was $0.7&nbsp;million for the year ended December&nbsp;31, 2021 due to the forgiveness of the PPP Loan in June
2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sources
and Uses of Liquidity </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements
of its business operations, including working capital needs, debt service, acquisitions, contractual obligations and other commitments. We assess liquidity in terms of our cash flows from operations and their sufficiency to fund our operating and
investing activities. To meet our contractual obligations, we must continually have sufficient highly liquid assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the
Business Combination, we have financed our operations primarily through capital contributions from Amprius Holdings and revenue generated from operations. We do not expect to receive additional capital contributions from Amprius Holdings as we
expect to rely on the cash on hand from the Business Combination, the PIPE and proceeds from the Committed Equity Financing, if any. Our ability to become profitable is dependent upon future events, including obtaining adequate financing to fund our
business plan, completing the design and build out of our <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility, obtaining adequate supplier relationships, building our customer base, successfully executing our business and
marketing strategy and hiring appropriate personnel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect our capital expenditures and working capital requirements to increase
materially in the near future. We currently operate a <FONT STYLE="white-space:nowrap">kWh-scale</FONT> manufacturing line at our headquarters in Fremont, California, which we are working to expand to achieve production on a MWh-scale. To meet the
demand for our batteries, we are in the process of designing and then building a <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility. Based on our current expectations, we estimate that our capital equipment expenditures will
range between $120.0&nbsp;million and $150.0&nbsp;million to achieve 1.0 GWh per year of manufacturing capacity, and that it will take approximately two years following the Closing to start volume manufacturing. We plan to build in a modular form
where we can incrementally increase our manufacturing capacity and operate a MWh-scale manufacturing line at our Fremont headquarters until we achieve approximately 0.5 to 1.0 GWh per year of manufacturing capacity at our new GWh-scale manufacturing
facility and then to further expand as needed through a Copy Exact methodology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September 30, 2022, we had $73.8 million of cash
and cash equivalents, which included the $70.9&nbsp;million net proceeds from the consummation of the business combination on September 14, 2022. We believe that our cash on hand from the Business Combination, the PIPE, proceeds from the Committed
Equity Financing, if any, and funding from the government, will be sufficient to meet our working capital and capital expenditure requirements for a period of at least twelve months. We may, however, need additional cash as a result of being able to
access all or a portion of the capacity of the Committed Equity Financing and/or if there are material changes to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-71- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
our business conditions or other developments, including unanticipated delays in the development of our high-volume manufacturing line, supply chain challenges, delays or unavailability of
government funding, disruptions due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, competitive pressures, and regulatory developments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Actual sales, if any, of shares of Common Stock to BRPC II under the Committed Equity Financing will depend on a variety of factors to be
determined by us from time to time, including, among other things, market conditions, the trading price of our Common Stock and determinations by us as to appropriate sources of funding for our business and operations. We cannot guarantee the extent
to which we may utilize the Committed Equity Financing. See &#147;&#151;Committed Equity Financing&#148; for more information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may
receive up to approximately $289.4 million from the exercise in full of all of the Warrants for cash. However, the exercise price of the Public Warrants and Private Warrants is $11.50 per share, and the exercise price of the PIPE Warrants is $12.50
per share, each of which exceeds $10.50, the closing price of our Common Stock on the NYSE on November 10, 2022. The likelihood that warrant holders will exercise the Warrants and any cash proceeds that we would receive is dependent upon the market
price of our Common Stock. If the market price for our Common Stock is less than $11.50 per share, in the case of the Private Warrants and Public Warrants, or $12.50 per share, in the case of the PIPE Warrants, we believe warrant holders will be
unlikely to exercise their Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that our resources are insufficient to satisfy our cash requirements, we may need to
seek additional equity or debt financing. If the financing is not available, or if the terms of financing are less desirable than we expect, we may be forced to take actions to reduce our capital or operating expenditures, including by reducing or
delaying our production facility expansion, which may adversely affect our business, operating results, financial condition and prospects. For example, because we expect to expand through a Copy Exact methodology, to the extent we have less cash
than expected and additional financing is unavailable on acceptable terms, we expect that we would reduce the initial production capacity of our large-scale facility and thereafter add capacity as appropriate. Any such reduction or delay may have an
adverse impact on our business plan and our results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred net losses to date. For the three and nine months
ended September 30, 2022, we incurred a net loss of $4.2 million and $11.3 million, respectively. We expect to incur additional losses and increased expenses in future periods, including those associated with the design and build out of our
GWh-scale manufacturing facility, continued research and development efforts and increased employee headcount. We believe that building and operating a high-volume manufacturing facility will facilitate profitability. Management believes that its
cash and cash equivalents on hand as of September 30, 2022 will be sufficient to fund our operating activities for at least the next twelve months. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contractual and Other Obligations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We had operated under a space and facility sharing arrangement, categorized as an operating lease, with Amprius Holdings in Fremont,
California. Pursuant to the agreement, we used equipment owned by and space leased by Amprius Holdings in our operations. The current lease has an expiration date of June&nbsp;30, 2024, with a single option to extend the lease for 60 months, which
we are reasonably certain to exercise on behalf of Amprius Holdings. Effective May&nbsp;1, 2022, we assumed this lease, which was initially entered into by Los Altos Fields, LLC and Amprius Holdings, and, as a result of the assignment, the space and
facility sharing arrangement was terminated. Our expected minimum lease payments through June&nbsp;30, 2024 are $0.9&nbsp;million. If we elect to extend the lease, the additional expected minimum lease payments would be $3.1&nbsp;million through
June&nbsp;30, 2029. See Note 11 &#147;Leases&#148; to the accompanying interim unaudited condensed financial statements as of and for the nine months ended September&nbsp;30, 2022 and Note 11 &#147;Commitments and Contingencies&#148; to the
accompanying audited financial statements of Legacy Amprius as of and for the year ended December&nbsp;31, 2021 included elsewhere in this prospectus for further information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-72- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also enter into other contracts in the normal course of business with various vendors
that generally provide for contract termination following a certain notice period. These contracts generally do not contain any minimum purchase commitments. Payments due upon cancellation under these contracts generally consist only of payments for
services provided, expenses incurred up to the date of cancellation and de minimis termination penalties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows</I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our cash flows from operating, investing and financing activities for the periods presented (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended<BR>September 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended</B><br><B>December 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,184</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,307</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,016</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,044</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(747</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(609</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(527</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71,578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,573</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows Used in Operating Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Comparison of the Nine Months Ended September&nbsp;30, 2022 and 2021 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our cash flows used in operating activities to date have been primarily comprised of various personnel expenses related to expanding our
business, as well as costs to support our increased production capacity related to our second manufacturing line that was placed into service in July 2021. We expect our expenses related to personnel, research and development and selling, general
and administrative activities to increase to support our transition into a public company, as well as to support our plans to increase manufacturing capacity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities during the nine months ended September 30, 2022 was $8.2 million, consisting primarily of our net loss
of $11.3 million, adjusted for positive non-cash adjustments of $3.7 million and cash used by changes in our operating assets and liabilities of $0.6 million. The non-cash adjustments were primarily driven by $2.1 million in stock-based compensation
expense and $1.1 million in depreciation and amortization expense. Net cash used by changes in our operating assets and liabilities of $0.6 million was primarily driven by an increase of $2.2 million in prepaid expenses attributed to prepaid
insurance as insurance premiums, including director and officer insurance, increased for a public company, an increase of $0.5 million in accounts receivable primarily due to timing of invoices issued based on milestones achieved of our
customization design services and additional standard cell shipments completed within the periods, and a decrease of $0.4 million in rental payments for our operating lease. These outflows were primarily offset by an increase of $2.3 million in
accounts payable primarily attributable to payments of the transaction costs upon Closing of the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in
operating activities during the nine months ended September 30, 2021 was $6.3 million, consisting primarily of our net loss of $6.2 million, adjusted for positive non-cash adjustments of $1.0 million and cash used by changes in our operating assets
and liabilities of $1.1 million. The non-cash adjustments were primarily driven by $1.1 million in depreciation and amortization expense, and $0.7 million in stock-based compensation expense. This was offset by a $0.7 million gain on forgiveness of
the PPP loan in June 2021. Net cash used by changes in our operating assets and liabilities of $1.1 million was predominantly driven by a decrease of $1.8 million in accounts payable due to the payment of a significant portion of our legal
obligations in the first quarter of 2021. Additionally, we experienced a further increase of $1.0 million in deferred costs primarily attributable to capitalized costs for design services contracts with two major customers. These outflows were
primarily offset by a $1.5 million increase in deferred revenue from amounts invoiced as progress payments in advance of revenue recognition for the same two design services customers that resulted in the increased deferred costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-73- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Comparison of the Years Ended December&nbsp;31, 2021 and 2020 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities during the year ended December&nbsp;31, 2021 was $8.0&nbsp;million, as opposed to $5.0&nbsp;million in
the year ended December&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities during the year ended December&nbsp;31, 2021 was
$8.0&nbsp;million, consisting primarily of our net loss of $9.9&nbsp;million, adjusted for positive <FONT STYLE="white-space:nowrap">non-cash</FONT> adjustments of $3.4&nbsp;million and cash used by changes in our operating assets and liabilities of
$1.5&nbsp;million. The <FONT STYLE="white-space:nowrap">non-cash</FONT> adjustments were primarily driven by $2.5&nbsp;million in stock-based compensation expense and $1.4&nbsp;million in depreciation expense, which were offset by $0.7&nbsp;million
from a gain on forgiveness of PPP Loan. Net cash used by changes in our operating assets and liabilities of $1.5&nbsp;million was driven primarily by an increase in deferred costs of $1.5&nbsp;million primarily attributed to design services
contracts that were expected to be completed in the future. We also experienced a decrease of $1.8&nbsp;million in accounts payable due to the payment of a significant portion of our payables. The outflows were offset by a $1.2&nbsp;million increase
in deferred revenue primarily attributed to amounts invoiced as progress payments in advance of revenue recognition for federal government contracts that were to be completed. In addition, the outflows were offset by a $0.5&nbsp;million increase in
accrued liabilities primarily attributed to higher payroll accruals to be paid as a result of headcount increases during the year ended December&nbsp;31, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities during the year ended December&nbsp;31, 2020 was $5.0&nbsp;million, consisting primarily of our net loss
of $7.4&nbsp;million, adjusted for positive <FONT STYLE="white-space:nowrap">non-cash</FONT> adjustments of $1.4&nbsp;million and cash provided by changes in our operating assets and liabilities of $1.0&nbsp;million. The <FONT
STYLE="white-space:nowrap">non-cash</FONT> adjustments were primarily driven by $1.2&nbsp;million in depreciation expense. Net cash provided by changes in our operating assets and liabilities of $1.0&nbsp;million was predominantly driven by an
increase in accounts payable of $1.8&nbsp;million significantly comprised of the payment of the accrual related to our patent infringement claim filed against us in August 2019. The inflow was offset by a decrease of $0.7&nbsp;million in accrued
liabilities primarily attributed to the settlement of $1.0&nbsp;million for a patent infringement claim filed against Amprius Holdings in August 2019 covering two of our technologies, the silicon nanowire anode and the silicon composite anode, that
had been initiated in the previous year. Additionally, the inflow was offset by an increase of $0.1&nbsp;million in inventory primarily attributed to the completion of a limited number of batteries to be sold in current contracts that were
finalized. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows Used in Investing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Comparison of the Nine Months Ended September&nbsp;30, 2022 and 2021 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities during the nine months ended September 30, 2022 was $0.7 million, in comparison to $0.3 million in the
nine months ended September 30, 2021. The increase in purchases in property and equipment during the nine months ended September 30, 2022 was primarily due to two advanced payments made for construction in progress during the third quarter of 2022.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Comparison of the Years Ended December&nbsp;31, 2021 and 2020 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities during the year ended December&nbsp;31, 2021 was $0.6&nbsp;million, in comparison to $0.5&nbsp;million in
the year ended December&nbsp;31, 2020, as purchases in property and equipment remained relatively consistent year over year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows (Used in)
Provided by Financing Activities </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have historically financed our operations primarily through contributions from Amprius
Holdings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Comparison of the Nine Months Ended September&nbsp;30, 2022 and 2021 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities during the nine months ended September 30, 2022 was $71.6 million, as compared to net cash provided
by financing activities of $19.7 million in the nine months ended September 30, 2021. The increase in net cash provided by financing activities was primarily attributable to $71.1 million in proceeds from the reverse recapitalization and PIPE
financing, net of transaction costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-74- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the nine months ended September&nbsp;30, 2021, cash provided by financing activities
was primarily attributable to cash contributed from Amprius Holdings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Comparison of the Years Ended December&nbsp;31, 2021 and 2020 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities during the year ended December&nbsp;31, 2021 was $20.1&nbsp;million, as compared to $5.6&nbsp;million
during the year ended December&nbsp;31, 2020. The increase in cash provided by financing activities was primarily due to a $15.3&nbsp;million increase in capital contributions from Amprius Holdings. Additionally, there were no new loans obtained for
financing during the year ended December&nbsp;31, 2021, as opposed to $0.7&nbsp;million in proceeds received during the year ended December&nbsp;31, 2020 when the PPP Loan was obtained. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Party Transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We entered
into related party transactions with Amprius Holdings in the ordinary course of business. On February&nbsp;27, 2017, we entered into the Intercompany Services Agreement with Amprius Holdings, pursuant to which Amprius Holdings agreed to provide
certain services to us, including financial and external reporting services, tax and general accounting services, engineering services, legal and patent-related services, services related to business development, information technology and human
resources and other administrative services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the distribution of Amprius Holdings&#146; subsidiaries in late January and early
February 2022, the general and administrative expenses of Amprius Holdings were allocated among each subsidiary, including Amprius. After the distribution, such costs incurred by the Amprius Holdings were wholly allocated to Amprius as the only
remaining subsidiary. For the one month ended January 31, 2022 and the year ended December 31, 2021, the fee for Amprius Holdings&#146; services pursuant to the Intercompany Services Agreement was 25% of total costs incurred by Amprius Holdings in
connection with the services provided under the agreement. From February 2022, the fee for Amprius Holdings&#146; services pursuant to the Intercompany Services Agreement was 100% of total costs incurred by Amprius Holdings in connection with the
services provided under the agreement. Pursuant to the termination agreement entered into by Amprius Holdings and the Legacy Amprius on June 8, 2022, the Intercompany Services Agreement was terminated upon the closing of the Business Combination on
September 14, 2022. Allocated service costs were $0.1 million for the three months ended September 30, 2022 and 2021, and $0.7 million and $0.4 million for the nine months ended September 30, 2022 and 2021, respectively, including costs related to
stock-based compensation. Allocated services costs amount to $1.4 million and $0.4 million for the year ended December 31, 2021 and 2020, respectively, including costs related to stock-based compensation. The service costs allocated to us were
accounted for as capital contributions by Amprius Holdings to Amprius. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Business Combination, Amprius Holdings contributed
capital to support our operations. Amprius Holdings provided $0.1 million and $14.7 million in capital contributions during the three months ended September 30, 2022 and 2021, and $0.9 million and $19.8 million during the nine months ended September
30, 2022 and 2021, respectively, in addition to the amounts allocated to us under the Intercompany Services Agreement. Amprius Holdings made capital contributions of $20.2 million and $4.5 million in capital contributions during the year ended
December 31, 2021 and 2020, respectively, in addition to the amounts allocated to us under the Intercompany Services Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we purchased and may continue to purchase raw materials and development materials from two former subsidiaries of Amprius
Holdings. In early 2022, ownership of each of these entities was transferred to the Amprius Holdings stockholders so that each could pursue its business separately. Following the spin-offs, Dr. Sun, our Chief Executive Officer and a member of our
Board, has continued to serve on the boards of each of these entities and their respective holding companies. For periods prior to distribution of the subsidiaries of Amprius Holdings during the nine months ended September 30, 2022, such purchases
recorded as cost of revenues totaled $0.1 million. For the year ended December 31, 2021 and 2020, such purchases recorded as cost </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-75- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of revenues totaled $0.3 million and $0.4 million, respectively. There is no commitment on either party to continue such sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information regarding our related party transactions, see Note 13 &#147;Related Party Transactions&#148; to the accompanying interim
unaudited condensed financial statements as of and for the nine months ended September&nbsp;30, 2022 and see Note 12 &#147;Related Party Transactions&#148; and Note 14 &#147;Subsequent Events&#148; to the audited financial statements as of and for
the year ended December&nbsp;31, 2021 included elsewhere in this prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Emerging Growth Company and Smaller Reporting Company Status </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an emerging growth company as defined in the JOBS Act and may take advantage of reduced reporting requirements that are otherwise
applicable to public companies. Section 107 of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with those standards. This
means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, we have the option to adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and
can do so until such time that we either (i) irrevocably elect to &#147;opt out&#148; of such extended transition period or (ii) no longer qualify as an emerging growth company. We have elected to use the extended transition period for complying
with new or revised accounting standards unless we otherwise early adopt select standards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also a &#147;smaller reporting
company&#148; as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will
remain a smaller reporting company until the last day of the fiscal year in which (i) the market value of our Common Stock held by non-affiliates exceeds $250.0 million as of the prior June 30 or (ii) our annual revenue exceeded $100.0 million
during such completed fiscal year and the market value of our Common Stock held by non-affiliates exceeds $700.0 million as of the prior June 30. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies and Significant Management Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management&#146;s discussion and analysis of our financial condition and results of operations is based on our audited financial statements
and interim unaudited condensed financial statements included elsewhere in this prospectus, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that
affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported income (loss) generated, and expenses incurred during the reporting
periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and
liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material. While our significant accounting policies are more fully
described in Note 2 to our audited financial statements and our interim unaudited condensed financial statements, each included elsewhere in this prospectus, we believe that the accounting policies discussed below are critical to understanding our
historical and future performance, as these policies relate to the more significant areas involving management&#146;s judgments and estimates and have a more significant impact on our financial statements due to the size of the financial statement
elements and prevalence of their application. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of some of the more critical accounting policies and estimates.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis of Presentation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
Amprius Holdings has historically prepared financial statements for us, our financial statements have been prepared from the financial records of Amprius Holdings on a <FONT STYLE="white-space:nowrap">carve-out</FONT> basis derived from the
accounting </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-76- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
records of Amprius Holdings using the historical results of operations and our historical bases of assets and liabilities, adjusted as necessary to conform to U.S. GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">More specifically, the balance sheets include all our legal assets, those assets provided by Amprius Holdings, and both liabilities incurred
by us and allocated from Amprius Holdings. The statements of operations for each of the periods presented reflect all expenses and activities directly attributable to us, as well as an allocation of Amprius Holdings&#146; general and administrative
expenses. We did not share facilities or costs with the other three operating subsidiaries with the exception of expenses at the Amprius Holdings level for the payroll related expenses for two executive employees of Amprius Holdings and other legal,
tax, insurance and accounting fees which were not identifiable as related to a specific subsidiary (&#147;Shared Expenses&#148;). Amprius Holdings&#146; executives supported the subsidiary group with governance, management, and investor relations.
The Shared Expenses were allocated based on the time incurred by Amprius Holdings&#146; executives to support each subsidiary as other metrics such as revenue, headcount or assets had no correlation to the services provided to the subsidiaries.
Prior to the distribution of the subsidiaries of Amprius Holdings in late January and early February 2022, the general and administrative expenses were allocated to each subsidiary, including us. After such subsidiary distribution, costs incurred by
Amprius Holdings on behalf of us were wholly allocated to us as the only remaining subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During all periods presented, our
operations were funded by Amprius Holdings. The source of financing consisted of proceeds received by Amprius Holdings from its issuance of preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe the expense allocation methodology and results are reasonable and consistently applied for all comparative periods presented.
However, these allocations may not be indicative of the actual expenses that would have been incurred by an independent company or of the costs to be incurred in the future. The financial statements may not be indicative of our future performance
and do not necessarily reflect what the financial position, results of operations, and cash flows would have been had we operated as a standalone company during the periods presented. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Revenue Recognition </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We recognize
revenue under ASC Topic 606, <I>Revenue from Contracts with Customers </I>(&#147;ASC 606&#148;), when a customer obtains control of promised goods or services in an amount that reflects the consideration which we expect to receive in exchange for
those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, we perform the following five steps: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. Identification of the contract(s) with a customer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. We generally enter into
fixed-price agreements with our customers which outline the terms of the business relationship between the parties. Additionally, we may receive purchase orders from customers or enter into statements of work that indicate pricing, performance and
delivery obligations, progress payments (if any) and the timing for each transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We account for a contract when it has approval and
commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. At contract inception, we also evaluate prior incomplete
contracts to determine whether the contract with the customer should be combined and accounted for as a single contract with any prior contract. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.
Identification of the performance obligations in the contract; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The promises within each contract for customization design services may
vary depending on the customer requirements. However, those contracts contain promises which generally include (a)&nbsp;custom battery design to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-77- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conform with customer requirements, (b)&nbsp;design progress reporting, (c)&nbsp;development of preliminary batteries, (d)&nbsp;testing of battery design and performance and (e)&nbsp;delivery of
final battery prototypes that meet <FONT STYLE="white-space:nowrap">pre-defined</FONT> customer specifications along with test results of the delivered batteries. Those promises are generally inputs to a combined output to deliver a single final
prototype battery and are therefore accounted for as a single performance obligation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contracts for standard battery products for commercial sales are
generally ready-made with no customization. Within these contracts, each battery product is a distinct performance obligation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Determination of the
transaction price, including the constraint on variable consideration </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment terms for our contracts are generally based on the
achievement of defined milestones. Since revenue is generally recognized at the point in time when control transfers to the customer upon final delivery of the prototype battery or completion of the service at the end of the contract as discussed
below in Step 5&#151;<I>Recognize revenue when, or as, a performance obligation is satisfied</I>, the variable consideration is not considered to be constrained at the inception of the contract and the transaction price equals the cumulative
payments to which we are entitled at the end of the contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We elected to use the practical expedient to disregard the effect of the
time value of money in a significant financing component when its payment terms are less than one year. In cases when there is a period of more than one year, we only adjust the transaction price when the financing component is significant and
beyond the mitigating effect of the progress payments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. Allocation of the transaction price to the performance obligations in the contract </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transaction price is allocated to the performance obligations. Our contracts generally contain a single performance obligation; therefore,
allocation is not necessary. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. Recognition of revenue when, or as, performance obligations are satisfied. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our customized design services contracts, control generally transfers upon the completion of the battery design and delivery of the final
prototype batteries. For <FONT STYLE="white-space:nowrap">follow-on</FONT> orders and standalone commercial sales of standard battery products to customers, control generally transfers upon shipment of the product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under ASC 606, assuming all other revenue recognition criteria have been met, we will recognize revenue for arrangements upon the transfer of
control of our performance obligations to our customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generate revenue from both our contracts for customization design services
for the development of silicon-anode <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery technology and delivery of prototypes as well as providing finished battery products to our customers. Payment terms for our contracts are generally
based on defined milestones. The customization design services generally provide design and development efforts to configure our existing battery technology towards a customer&#146;s required specifications. The development of these battery
prototypes is a single performance obligation as the individual customization activities performed through delivery of the prototype batteries are not distinct. Revenue is recognized at the point in time when control transfers to the customer upon
final delivery of prototype batteries or completion of the defined service. We recognize revenue from <FONT STYLE="white-space:nowrap">follow-on</FONT> orders and standalone commercial sales of battery products to customers at the point in time that
control of the battery product has been transferred to the customer which is generally upon shipment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Leases </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;1, 2022, we adopted ASC 842, <I>Leases</I> (&#147;ASC 842&#148;). For more information, refer to Note 2 &#147;Summary of
Significant Accounting Policies&#148; to our interim unaudited condensed financial statements as of and for the nine months ended September&nbsp;30, 2022. As a result, reporting periods beginning in 2022 are presented under ASC 842. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-78- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon adoption of ASC 842, we recorded our operating lease on the balance sheet as an
operating right of use asset, current portion of operating lease liability and <FONT STYLE="white-space:nowrap">non-current</FONT> operating lease liability. Operating lease liabilities are initially recognized based on the net present value of the
fixed portion of our lease components through the lease term. To calculate the net present value, we apply an incremental borrowing rate (&#147;IBR&#148;). The determination of the IBR requires complex judgment, and it involves using a portfolio
approach based on the rate of interest we would pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. We recognize operating lease assets based on lease liabilities and initial direct costs, less any
tenant allowance incentives. We test operating lease assets for impairment in the same manner as long-lived assets and include the related operating lease liability and operating lease payments in our analysis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
measure stock options and other stock-based awards granted to qualified employees, directors and contract workers based on their fair value on the date of grant and recognize compensation expense of those awards over the requisite service period. We
recognize the impact of forfeitures on stock-based compensation expense as forfeitures occur. We apply the straight-line method of expense recognition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the formation and incorporation of Legacy Amprius, qualified employees, directors and contract workers participated in Amprius
Holdings&#146; equity incentive plan, including stock option awards. For those employees, directors and contract workers who were transferred to us or continued to provide services to us and previously received awards under Amprius Holdings&#146;
equity incentive plan, costs of those awards are recorded as share-based compensation and a corresponding contribution from Amprius Holdings based on the grant date fair value of the awards. Stock-based compensation expense attributable to grants
made under Amprius Holdings&#146; stock plan totaled $0.4&nbsp;million and $0.1&nbsp;million for the nine months ended September&nbsp;30, 2022 and 2021, respectively, and $1.5&nbsp;million and $0.1&nbsp;million during the years ended
December&nbsp;31, 2021 and 2020, respectively. Upon its incorporation, Legacy Amprius established the 2016 Plan separate from the equity incentive plan of Amprius Holdings. Certain qualified employees, directors and contract workers of Amprius
Holdings have received stock option awards under the 2016 Plan. We recorded the cost of the share-based compensation of these awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
estimate the fair value of each stock option grant on the date of grant using the Black-Scholes option-pricing model, which requires the use of highly subjective assumptions including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Term</I>&#151;The expected term of stock options represents the period that our share-based awards
are expected to be outstanding. As we do not have sufficient historical experience for determining the expected term, the expected term has been derived based on the simplified method for awards that qualify as plain-vanilla options.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Volatility</I>&#151;As we are privately held, there is no observable market for our common stock, and
accordingly, expected volatility has been estimated based on the volatilities of similar publicly-traded companies. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Risk-Free Interest Rate</I>&#151;We base the risk-free interest rate on the implied yield available on the
U.S. Treasury zero coupon issues with a remaining term equivalent to the expected term of the option. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Dividend</I>&#151;The expected dividend assumption is based on our current expectations about our
anticipated dividend policy. We have not paid dividends since inception and currently do not anticipate a dividend. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Common Stock
Valuations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Business Combination, we recorded stock-based compensation for grantees based on the common stock
valuations of Legacy Amprius Common Stock or the common stock of Amprius Holdings, as applicable. We recorded stock-based compensation based on the valuation of Amprius Holdings&#146; common stock as outlined in the Critical Accounting Policy for
&#147;Stock-Based Compensation&#148; above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-79- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As there was no public market for Legacy Amprius Common Stock and Amprius Holdings&#146;
common stock prior to the Business Combination, the estimated fair value of Legacy Amprius Common Stock and Amprius Holdings&#146; common stock was determined by the respective board of directors, or compensation committee thereof, as of the date of
each option grant, with input from management, considering the most recently available third-party valuations of common stock and the respective board of directors&#146; assessment of additional objective and subjective factors that it believed were
relevant and which may have changed from the date of the most recent valuation through the date of the grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These third-party
valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#146; Accounting and Valuation Guide, <I>Valuation of Privately-Held-Company Equity Securities Issued as Compensation
</I>(the &#147;Practice Aid&#148;). The Practice Aid identifies various available methods for allocating the enterprise value across classes of capital stock in determining the fair value of Legacy Amprius Common Stock at each valuation date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the Practice Aid, the probability-weighed expected return method (&#147;PWERM&#148;) and the Option Pricing Method
(&#147;OPM&#148;) were the most appropriate methods for determining the fair value of Legacy Amprius Common Stock and Amprius Holdings&#146; common stock based on Legacy Amprius&#146; stage of development and other relevant factors. The valuation of
Legacy Amprius and Amprius Holdings as of December 2020 were based on the Discounted Cash Flow Method, and the analyses as of March 2022 contemplated the Hybrid Method, which is a combination of the PWERM and the OPM to allocate the value to the
securities based, in part, on the terms of Amprius Holdings&#146; most recent financing&#151;the Series <FONT STYLE="white-space:nowrap">E-2</FONT> convertible preferred stock financing completed in June 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to considering the results of the third-party valuations, the respective board of directors considered various objective and
subjective factors to determine the fair value of such common as of each grant date, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rights, preferences, and privileges of Amprius Holdings&#146; preferred securities as compared to those of
Legacy Amprius Common Stock and Amprius Holdings&#146; common stock, including liquidation preferences of Amprius Holdings&#146; preferred stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">stage of development; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">external market conditions affecting the industry and trends within the industry, including a review of the
performance and metrics of guideline public companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the respective company&#146;s financial position, including cash on hand, and historical and forecasted
performance and operating results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lack of an active public market for such common stock and Amprius Holdings&#146; preferred stock;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the likelihood of achieving a liquidity event, such as a Special Purpose Acquisition Company (&#147;SPAC&#148;)
transaction or sale of our company in light of prevailing market conditions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an analysis of initial public offerings and the market performance of similar companies in the industry.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Valuation of Legacy Amprius </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our valuations were performed using the OPM, PWERM or the Hybrid Method. The method selected was based on the availability and the quality of
information to develop the assumptions for the methodology, based on the facts and circumstances applicable to each valuation date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">OPM&#151;The OPM treats common stock and preferred stock as call options on the total equity value of a company, with exercise prices based on
the value thresholds at which the allocation among the various holders of a company&#146;s securities changes. The common stock is modeled as a call option on the underlying equity value at </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-80- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a predetermined exercise price. In the model, the exercise price is based on a comparison with the total equity value rather than, as in the case of a regular option, a comparison with a per
share stock price. Thus, common stock is considered to be a call option with a claim on the enterprise at an exercise price equal to the remaining value immediately after the preferred stock liquidation preference is paid. The OPM uses the
Black-Scholes option pricing model to price the call options. This model defines the fair value of securities as functions of the current fair value of the subject company and uses assumptions such as the anticipated timing of a potential liquidity
event and the estimated volatility of the equity securities. The OPM might be used to determine the enterprise value of an entity by using a &#147;backsolve method.&#148; By considering the sales price of shares in a recent arms-length financing,
the aggregate equity value (and, by implication, enterprise value) can be &#147;back-solved&#148; using an option pricing theory-based model that gives consideration to the subject company&#146;s capitalization structure and rights of the holders of
preferred stock and common stock. This methodology is most applicable when a valuation is conducted close to the date of a financing transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PWERM&#151;Under the PWERM, the fair value of the common stock is estimated based upon an analysis of future values for the company, assuming
various scenario outcomes. The common stock value is based on the probability weighted present value of expected future investment returns considering each of the possible outcomes available, as well as the rights of each class of stock under each
scenario. The future value of the common stock under each outcome is discounted back to the valuation date at an appropriate risk-adjusted discount rate and probability to arrive at an indication of value for the common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Hybrid Method&#148;&#151;The Hybrid Method is a PWERM where the equity value in one or more of the scenarios is calculated using an OPM.
In considering valuation approaches for Legacy Amprius, the third-party valuation specialist applied the Hybrid Method in our March 2022 valuation of Legacy Amprius to determine the implied equity value of Legacy Amprius in various scenarios, based
in part on the latest round of financing&#151;Amprius Holdings&#146; Series <FONT STYLE="white-space:nowrap">E-2</FONT> convertible preferred stock financing completed in June 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To determine the fair value of common stock as of the grant date for options granted during the period, we performed a linear interpolation
between the December&nbsp;31, 2020 and March&nbsp;29, 2022 valuation dates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Valuation as of December&nbsp;31, 2020 </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The third-party valuation specialist relied solely on an Income Approach (discounted cash flow analysis) to value the equity of Legacy Amprius
as of this valuation date. In addition, given the simplified capital structure, a per share value was determined by dividing the estimated equity value by the number of shares outstanding. The fair value of Legacy Amprius Common Stock was estimated
at $2.58 per share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Valuation as of March&nbsp;29, 2022 </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In considering valuation approaches for Legacy Amprius, the third-party valuation specialist applied the Hybrid Method in our March 2022
valuation of Legacy Amprius to determine the implied equity value of Legacy Amprius in various scenarios, based in part on the latest round of financing of Amprius Holdings&#151;Series <FONT STYLE="white-space:nowrap">E-2</FONT> convertible
preferred stock. The third-party valuation specialist, based on discussions with management, gave consideration to the following scenarios: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Two SPAC term sheet values that we received; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Backsolve OPM based on Amprius Holdings&#146; Series <FONT STYLE="white-space:nowrap">E-2</FONT> convertible
preferred stock financing completed in June 2021; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A discounted cash flow analysis as of the March 2022 valuation date. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The relative probability of each type of future-event scenario was determined based on management&#146;s best estimate as of the date of
valuation, including then-current expectations as to the timing and likely prospects of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-81- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the future event scenarios. Based on discussions with management, the two SPAC scenarios were weighted 12.5% each, the Backsolve analysis based on the Series
<FONT STYLE="white-space:nowrap">E-2</FONT> financing was weighted 25%, and the discounted cash flow analysis was weighted 50%. The weighted average implied equity value was then used to determine the common stock value based on an OPM. The fair
value of Legacy Amprius Common Stock was estimated at $3.79 per share, an increase of approximately 46.9% over the per share estimate in December 2020. The most significant development relating to the increase in value was the two term sheets
received from SPAC acquirers in February and March of 2022. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Valuation of Amprius Holdings </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To determine the fair value of common stock as of the grant date for options granted during the period, we performed a linear interpolation
between the December&nbsp;31, 2020, June&nbsp;30, 2021, and March&nbsp;29, 2022 valuation dates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Valuation of Amprius Holdings as of December&nbsp;31,
2020 </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The third-party valuation specialist estimated Amprius Holdings&#146; equity value based on both a market approach (Guideline
Public Company Method) and an Income Approach (discounted cash flow analysis), applying weightings to each value to arrive at an equity value estimate. This value estimate was then allocated to the various securities in the capital structure based
on an OPM. The fair value of Amprius Holdings&#146; common stock was estimated at $2.34 per share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Valuation of Amprius Holdings as of June&nbsp;30,
2021 </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similar to the prior date, the third-party valuation specialist estimated Amprius Holdings&#146; equity value based on a market
approach (Guideline Public Company Method) and an Income Approach (discounted cash flow analysis). In addition, consideration was given to the implied equity value from the Backsolve analysis based on Amprius Holdings&#146; Series <FONT
STYLE="white-space:nowrap">E-2</FONT> financing. The specialist applied weightings to each value to arrive at an equity value estimate. Based on discussions with management, the two market approaches were weighted a combined 37.5%, the discounted
cash flow analysis was weighted 12.5%, and the Backsolve analysis based on the Series <FONT STYLE="white-space:nowrap">E-2</FONT> financing was weighted 50%. The weighted average implied equity value was then used to determine the common stock value
based on an OPM. The fair value of Amprius Holdings&#146; common stock was estimated at $2.55 per share, an increase of approximately 9% from the previous valuation date. One significant development since the previous valuation analysis was Amprius
Holdings&#146; Series <FONT STYLE="white-space:nowrap">E-2</FONT> funding round, which raised approximately $36&nbsp;million from investors from February 2021 to June 2021. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Valuation of Amprius Holdings as of March&nbsp;29, 2022 </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subsequent to Amprius Holdings&#146; divestiture of three entities in early 2022, its only assets were the shares of Legacy Amprius Common
Stock it owned and cash. As such, the third-party valuation specialist adjusted the value from the analysis performed for Amprius, making an adjustment for cash to value the equity based on an asset-based approach. This value was then allocated to
the securities in the capital structure based on an OPM, in order to estimate the value of the common stock in Amprius Holdings as of the valuation date. The resultant value estimate was $1.43 per share as of this valuation date, with the decrease
primarily attributable to the divestiture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amprius Holdings noted that for determining its stock-based compensation for option grants in
December 2021, the March&nbsp;29, 2022 value estimate was adjusted upwards to reflect the fact that the three entities had not been divested at that point in time in order to derive an interpolated value for stock-based compensation expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The assumptions underlying these valuations represented our management&#146;s and Amprius Holdings&#146; management&#146;s best estimates,
which involved inherent uncertainties and the application of the respective management&#146;s judgment. As a result, if we had used significantly different assumptions or estimates, the fair value of our common stock and our stock-based compensation
expense could have been materially different. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-82- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A public trading market for our Common Stock was established in connection with the closing
of the Business Combination, and it is no longer necessary for our Board to estimate the fair value of our Common Stock in connection with our accounting for granted stock options and other such awards we may grant, as the fair value of our Common
Stock is determined based on the quoted market price of shares of our Common Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Accounting Pronouncements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See Note 2 &#147;Summary of Significant Accounting Policies&#148; to the interim unaudited condensed financial statements of the Company as of
and for the nine months ended September&nbsp;30, 2022 and the audited financial statements of the Company as of and for the year ended December&nbsp;31, 2021 included elsewhere in this prospectus for further information about recent accounting
pronouncements, the timing of their adoption, and our assessment, to the extent we have made one, of their potential impact on our financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative and Qualitative Disclosures about Market Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to a variety of market-related risks, which broadly includes interest rate risk, credit risk, and inflation risk. These risks
may affect our results of operations and cash flows. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Rate Risk </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are exposed to interest-rate risk related to our interest-bearing bank deposits. Adverse changes in interest rates may affect our results of
operations. Cash and cash equivalents as of September&nbsp;30, 2022 was $73.8 million. Hypothetically, if our cash and cash equivalents remain the same and if the interest rate changes by 100 basis points, our interest income may change by
approximately $0.8 million on a per annum basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have no interest-bearing borrowings as of September 30, 2022. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Credit Risk </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are exposed to
credit risk from our customers. Our customers may default on their obligations to us due to bankruptcy, lack of liquidity or other reasons. Although we regularly review our credit exposure to our customers, default risk may arise from events or
circumstances that are difficult to foresee. We rely primarily on the creditworthiness of our customers and have limited recourse for collection. Our inability to assess creditworthiness of our customers could adversely affect our operating results
and cash flows. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Inflation Risk </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">High inflation may affect our operating results and cash flows. However, we do not believe that inflation had a materially impact on our
operating results and cash flows during the three and nine months ended September&nbsp;30, 2022. If our costs become subjected to significant inflationary pressures, we may not be able to fully offset such higher costs through increase in prices of
products we sell. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-83- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_12"></A>BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have developed and, since
2018, been in commercial production of an ultra-high energy density <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery for mobility applications leveraging a disruptive silicon nanowire anode. Our silicon nanowire anode technology enables
batteries with higher energy density, higher power density, and extreme fast charging capabilities over a wide range of operating temperatures, which results in our batteries providing superior performance compared to conventional graphite <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> batteries. Our silicon nanowire anode is a direct <FONT STYLE="white-space:nowrap">drop-in</FONT> replacement of the graphite anode in traditional <FONT STYLE="white-space:nowrap">lithium-ion</FONT>
batteries, and our manufacturing process leverages the manufacturing process for conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries and the related supply chain. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Today, our batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems (&#147;UAS&#148;),
such as drones and high-altitude pseudo satellites (&#147;HAPS&#148;). We believe our proprietary technology has the potential for broad application in electric transportation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our batteries and their performance specifications have been tested and validated for application by over 30&nbsp;customers, including Airbus,
AeroVironment, BAE Systems the U.S. Army and Teledyne FLIR, and we have shipped over 10,000 batteries to date, which have enabled mission critical applications. Our proprietary silicon nanowire anode structures, battery cell designs and
manufacturing processes are defended by our portfolio of patents, trade secrets and <FONT STYLE="white-space:nowrap">know-how</FONT> developed over 10 years of research and development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently manufacture batteries on <FONT STYLE="white-space:nowrap">kWh-scale</FONT> production lines at our headquarters in Fremont,
California, where demand for our batteries exceeds our manufacturing capacity. We are working to meet the expected demand in several rapidly growing addressable markets, including by designing and building a large-scale production facility that can
manufacture at GWh+ scale. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Industry Background </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Traditional transportation has been powered by fossil fuel-based engines which have led to significant greenhouse gas emissions. A rising focus
on sustainable energy use in transportation is leading to increased investments in technology, government incentives and consumer demand for the electrification of passenger and payload mobility. Among the mobility mediums experiencing a shift to
electrification due to these trends are aircraft such as UAS, which includes drones and HAPS, and eVTOL planes, as well as ground-based EVs. Critical and breakthrough battery technologies can facilitate and, in certain cases, enable the mass
adoption of these electric transportation mediums by improving energy density, accelerating fast charging capabilities, extending battery life, and improving safety. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Aviation Industry </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Unmanned Aerial
Systems:</I></B>&nbsp;UAS are aircraft that operate with no crew or passengers onboard and are guided by remote control or autonomously. Examples of UAS include drones and HAPS. UAS are the next generation aerial transportation technology utilized
for surveillance, assessment, logistics, delivery, communications, and imaging, among other uses. Emerging technologies, such as Amprius&#146; silicon anode battery, offer lighter weight and/or more energy dense batteries, potentially overcoming
current battery technology barriers and enabling faster adoption of UAS. Based on an Insider Intelligence article from April 2022, a Stratistics report from March 2022 and management estimates, the total addressable market for UAS batteries is
expected to reach approximately $38.2&nbsp;billion by 2025. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Drones: </I></B>Drones are the most common type of UAS that are
increasingly being utilized in various industries, including military and defense, agricultural, construction and logistics.&nbsp;One of the key barriers to wider adoption is the existing battery technology, which limits the flight range and payload
capacity. Our batteries offer higher energy density, which enables longer range endurance, and, depending on customer specifications, lighter weight, which facilitates higher payload capacity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-84- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>High Altitude Pseudo Satellites: </I></B>HAPS are alternatives for traditional
satellites. When deployed, HAPS typically operate at stratospheric altitudes, approximately 12 miles (approximately 65,000 feet) above sea level. HAPS are being increasingly utilized to provide high-quality broadcast features, particularly in remote
regions, which have limited terrestrial network coverage.&nbsp;HAPS generally use solar energy and battery storage as the power source to operate for long durations of time. As a result, lightweight, higher energy density batteries with the ability
to operate in extreme temperature and pressure conditions are critical enablers. Amprius offers advanced battery technology suitable for application in HAPS, which is currently in use by prominent aerospace companies, like Airbus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Electric Air Transportation: </I></B>Population growth and urbanization are key megatrends that are stretching ground transportation
infrastructure to its limits and resulting in significant greenhouse gas emissions. A potential mitigation strategy is expanding travel into the air, which is offered by eVTOL vehicles, a passenger aircraft that uses electric power to hover,
takeoff, and land vertically. Historically, the electrification of passenger and cargo aircraft has lagged the adoption of electric automobiles in part because of the greater technical challenges. However, over the last few years there have been
significant advancements in the key enabling technologies for eVTOL aircraft, such as the high energy density and robust performance batteries offered by Amprius. Continued improvements in battery energy density could allow eVTOL aircraft to
increase their range, speed and payload, dramatically expanding the range of trips and further accelerating the adoption of electric air mobility. Based on Morgan Stanley&#146;s May 2021 report and management estimates, the total global addressable
electric air mobility battery market is forecasted to reach approximately $11.1&nbsp;billion by 2025. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EV Industry </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The electrification of ground transportation is being accelerated by regulatory pressure to meet sustainability benchmarks and growing consumer
preference. Some of the largest global automotive OEMs expect to be 100% EV by 2035. Market and Market&#146;s February 2021 report estimates that the global electric vehicle battery market is expected to reach $67.2&nbsp;billion by 2025.
McKinsey&nbsp;&amp; Company estimated in October 2021 that 2030 EV battery requirements will be 3,900 GWh in 2030, of which 2,400 GWh will be needed for passenger cars alone. While multiple battery chemistries exist today that meet current EV
specifications, there is room for significant improvement. According to a recent Deloitte survey, two of the key consumer concerns with EV adoption are driving range and lack of charging infrastructure. Our batteries, which have been tested and
validated by the U.S. Advanced Battery Consortium (&#147;USABC&#148;), as further described below, have the potential to help address both these concerns. As such, while our EV capable cell needs to be improved with respect to cycle life, form
factor, cost and production quantity for our batteries to compete with existing commercially available EV batteries, we believe that, as we grow and improve, we may be able to compete in the EV battery market. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Battery Requirements for Electric Transportation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Current battery technology creates a barrier in the near-term for the electric transportation market, especially for electric air mobility
applications, as battery weight, size and recharging times would need to be improved for these operations to become commercial.&nbsp;The battery system must fulfill several key requirements: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">high energy density and specific energy in order to achieve long range endurance while enabling lighter weight;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">high power density to provide sufficient power at a specific instance, such as during aircraft <FONT
STYLE="white-space:nowrap">take-off</FONT> or landing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fast charging capabilities to enable high infrastructure throughput; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">operational in wide temperature and pressure ranges; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">safe to operate in a wide variety of conditions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a long calendar life and cycle life; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acceptable cost, which varies by application. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-85- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amprius&#146; Solution </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Today&#146;s batteries typically utilize graphite as the anode material. Based on management&#146;s estimates, we believe that graphite anodes
have reached their theoretical limits for energy storage. We estimate that graphite anodes can only provide up to 355 mAh/g capacity for lithium storage, which can further degrade in extreme environments. Any additional increases in the energy
density for <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries can be made only by using active materials that have a higher capacity for lithium storage. Among such active materials, silicon is known to have the highest lithium storage
capacity per unit mass or volume than any other element besides lithium itself. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our batteries, we have replaced the graphite anode
with a highly engineered silicon material that has a lithium storage capacity of approximately 3,400 mAh/g&#151;nearly 10 times the highest capacity of known graphite anodes. By replacing graphite with silicon nanowire in the anode, we have
significantly enhanced performance in batteries across energy density, power, charging time, safety and ability to operate in extreme environments. Our anodes are 100% silicon (actual percentage of silicon is
<FONT STYLE="white-space:nowrap">99.5-99.9%,</FONT> which is within the range of acceptable purity levels for materials that are considered 100%) free of any inactive additives, such as binders, conductive carbon or matrix/shell protective
materials, which enables full utilization of the capacity of silicon at the anode level. Our silicon nanowire anode has enabled us to design batteries that can meet the following performance specifications, depending on the application: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>High specific energy and energy density</I></B>: Ultra-high gravimetric and volumetric energy density is
crucial for maximizing the amount of payload that a vehicle can carry and extend flight radius. Currently, our highest energy density commercial batteries have up to 450 Wh/kg gravimetric energy density (&#147;specific energy&#148;) and 1,150 Wh/L
volumetric energy density (&#147;energy density&#148;), which is over 50% higher than any known commercial graphite cells. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>High specific power</I></B>: High specific power, which correlates to a high discharge rate, is required to
generate sufficient power for vertical <FONT STYLE="white-space:nowrap">take-off</FONT> and landing functionality. Our batteries have a maximum discharge rate of up to 10C (i.e., our batteries can sustain currents 10 times higher than the
cell&#146;s nominal capacity). Although graphite cells with a discharge rate of 10C are commercially available, our proprietary silicon nanowire cells with an equivalent discharge rate offer over 50% higher specific energy than graphite cells. This
combination of high power and high energy density is critical for electric flight applications. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Fast charging</I></B>: Our battery cells have the ability to charge to 80% of battery cell capacity in less
than six minutes. Compared to graphite, silicon nanowire anodes have higher volumetric capacity and are consequently thinner and allow for faster <FONT STYLE="white-space:nowrap">lithium-ion</FONT> diffusion between the nanowires, which facilitates
faster charging. Additionally, the silicon nanowire anode operates at a voltage that is at least 100 mV higher than that of graphite anodes. This electrochemical property allows silicon nanowire battery cells to charge at higher rates compared to
graphite cells. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Ability to operate safely at low temperatures</I></B>: Our battery cells are capable of operating safely at
low temperatures, which is critical for aviation applications such as HAPS. As described above, our silicon nanowire anode operates at a voltage that is at least 100 mV higher than that of graphite anodes. This voltage difference not only allows
faster charging, but also results in a greater margin of safety from dangerous lithium plating effects, allowing for safe operation at low temperatures. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Quality assurance</I></B>: Our batteries are designed to be ultra-resilient and undergo rigorous abuse
testing, including air cargo certification and military specific tests. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our silicon nanowire anode is a high capacity
and high power cell component that has been tested and validated for advanced aerospace, defense and EV applications. We match our silicon nanowire anode with commercial cathodes, advanced separators and electrolyte formulations. Products using high
voltage LCO cathodes are tailored to customer specifications ranging from our High Energy Products for HAPS, consumer electronics and military portable power applications, to High Power Products with a continuous power density of 1.5 kW/kg for
drones and eVTOL applications. Our customers have shown interest in our Balanced Energy/</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-86- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Power Products (which are made with either LCO or NMC cathodes) due to their wide power range (i.e., power density of over 1 kW/kg) and specific energy of over 400 Wh/Kg. This level of
performance is the target level for both eVTOL applications, and potentially, long-range EVs. The graph below reflects the minimal tradeoff between specific energy and specific power for our different cell designs. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377019g01g02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The performance levels achieved by our proprietary silicon nanowire anode battery cells, as shown in the
graphic below, enable our customers to demonstrate and deliver products that far surpass equivalent products powered by graphite batteries. For instance, a direct replacement battery based on silicon nanowire anode was shown to increase the
endurance of a reconnaissance drone from 24 minutes to 42 minutes. A large consumer electronics OEM that tested a replacement smartwatch battery based on silicon nanowire anode confirmed that the talk time was almost doubled, without reaching the
battery low state. A military wearable powered by our batteries has doubled the energy content compared to graphite anode batteries, without increasing the battery weight or volume, providing power for longer mission time. Similarly, we estimate
that a direct replacement of graphite cells with silicon nanowire batteries in EVs would increase the driving range by about 75%. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377019g01g01.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-87- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on a survey of 18650 technical datasheets (ex. Panasonic NCR18650G) and iFixit reports on iPhone and
Samsung batteries. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on an Amprius High Energy cell. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Customer-reported data based on a Teledyne FLIR drone. For graphite, based on the currently utilized graphite
battery for Teledyne FLIR drone. For Amprius, based on an Amprius Balanced Energy/Power cell. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on customer-reported data on a smart watch. For Amprius, device used an Amprius High Energy cell.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Results relate to a U.S. Army conformable wearable battery. For graphite, based on a currently fielded
conformable wearable graphite battery. For Amprius, the device used an Amprius High Energy cell. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Graphite estimate based on a Tesla Model 3 long-range battery. Amprius estimate based on an Amprius High Energy
cell. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Technology </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our proprietary silicon nanowire anode technology solves for the inherent limitations of silicon anodes in
<FONT STYLE="white-space:nowrap">lithium-ion</FONT> cells. Silicon has historically been investigated as an anode material due to its intrinsic capability to store larger quantities of lithium per unit mass and volume compared to graphite. The main
barrier preventing silicon from becoming more widely adopted across the battery industry is that the silicon material expands during charging as it absorbs lithium ions. For example, silicon particles may expand up to 300% during charging. After
multiple charge and discharge cycles, silicon particles will crack, causing anode degradation and device breakdown. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our proprietary
silicon nanowire anode technology solves for the material expansion inherent with silicon. As depicted below, our nanowires start with a metal foil that is layered with a nanowire template and metallurgically attached to the metal foil substrate by
a growth process. The nanowire template is coated with a <FONT STYLE="white-space:nowrap">low-density</FONT> silicon and then encased by a thin layer of high-density silicon. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377019g01g07.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Actual percentage of silicon is <FONT STYLE="white-space:nowrap">99.5-99.9%,</FONT> which is within the range
of acceptable purity levels for materials that are considered 100%. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-88- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our silicon anode generally contains more than 1,000,000 nanowires per square centimeter.
The following SEM (scanning electron microscope) image, with a magnification of 250x, shows the typical cross section of the anode structure. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377019g01z05.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The nano-porosity of the <FONT STYLE="white-space:nowrap">low-density</FONT> layer of silicon on each
nanowire and the micro-porosity between the wires in our technology allows the silicon to expand at nano- and micro- meter levels when the anode is charged, with little to no damage to the nanowires and to the anode. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377019g00m04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our nanowire structure also enables ions and electrons to travel in a straight path between and through the
nanowires. In contrast, a particle structure results in ions and electrons traveling in a nonlinear, tortuous path. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-89- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The straight path of our nanowires facilitates high electric and ionic conductivity, enabling high power and fast charging. Nanowires are always in electrical contact with the metal foil due to
their growth rooted fabrication, while particles have to rely on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">particle-to-particle</FONT></FONT> contact for electron transfer, which can easily be broken during cycling. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377019g01g05.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our silicon nanowire anode is a direct <FONT STYLE="white-space:nowrap">drop-in</FONT> replacement of the
graphite anode in traditional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries. The silicon nanowire in our products is much thinner, by over 30%, than typical graphite anodes, but with a much higher capacity. Our proprietary anode is
100% silicon, free of any inactive additives, such as binders, conductive carbon, or matrix/shell protective materials, which enables full utilization of the capacity of silicon at the anode level. The high capacity of our silicon nanowire anodes
permits us also to use higher capacity cathodes than those used in graphite cells. This further increases the specific energy and energy density of our cells compared to graphite anode cells. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377019g01g04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing and Supply </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amprius invented the silicon nanowire anode and its fabrication process. Our silicon nanowire anode is fabricated using CVD technology, and
consists of three sequential steps. First, the nanowire template is grown by a thermally activated chemical reaction. Second, a <FONT STYLE="white-space:nowrap">low-density</FONT> silicon coating is deposited by PECVD. Third, a high-density, thin
surface layer is deposited by a thermally activated CVD process. These three steps replace all powder processing steps typically used in making graphite anodes, including powder mixing, slurry mixing, slurry coating, electrode drying and electrode
calendaring. After fabrication, the anode does not need further processing. After fabrication, the product is the fully processed anode. This anode does not need further processing and can then be assembled in cells with cathodes produced by
manufacturing lines similar to those used in graphite anode cells. This fabrication process has been in commercial operation since 2018 with a <FONT STYLE="white-space:nowrap">kWh-scale</FONT> manufacturing line at our headquarters in Fremont,
California. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-90- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To develop the high volume anode fabrication tool needed for a <FONT
STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing line, we have partnered with Centrotherm, a leading global supplier of tools used to produce wafers for solar cells. In October 2022, we received the first large-scale anode production
machine, which is expected to increase our capacity for silicon anode production at our Fremont headquarters to approximately 2 MWh by the end of 2023. We have successfully fabricated silicon nanowire anodes with a solar wafer production tool made
by Centrotherm, but we will need make certain modifications to the equipment for our needs. One modification is that we will replace wafers with large format foils, which we use in our <FONT STYLE="white-space:nowrap">kWh-scale</FONT> production.
This requires design and development of automated material handling for the foils. This is one of the principal engineering tasks in adapting the solar cell production equipment to our needs and will be undertaken in collaboration with an
engineering design firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Completing design and development of the tool, the automated material handling and high volume production
processes requires significant engineering. The ability to do so successfully and the timing of this effort may be subject to unforeseen complexities, component supply delays and other risks. Moreover, our manufacturing costs will depend not only on
the cost of the tools but also on throughput, yield, efficiency of silane gas utilization and other factors. For more information, see &#147;Risk Factors&#151;Risks Related to Our Technology, Products and Manufacturing&#151;We may not succeed in
developing a new high-volume manufacturing line that meets our requirements for cell quality, yield, throughput and other performance metrics. Additionally, assuming we are able to develop a high-volume manufacturing line, it may be unreliable,
require regular and significant maintenance and could be capital and resource intensive to operate.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although our anode process
differs from traditional anode manufacturing, the cathode and the rest of the cell&#151;including electrolytes and separators&#151;use conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery manufacturing tools and materials, as
depicted below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377019g01g03.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have begun the site selection process for a <FONT STYLE="white-space:nowrap">GWh-scale</FONT>
manufacturing facility and will procure manufacturing equipment for cathode fabrication, cell assembly, and cell testing from established equipment suppliers. We currently expect to build the <FONT STYLE="white-space:nowrap">GWh-scale</FONT>
manufacturing facility in Texas or Georgia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The dominant raw materials for the silicon anode include silane gas, which is used in making
the silicon nanowires, and electrodeposited nickel foil, which is used for the anode current collector substrate. As we increase manufacturing capacity, we expect to procure the silane gas from REC Silicon, a global supplier of silane and silicon
materials, and will procure nickel foil from global suppliers of electrodeposited metals. Both silane gas and nickel foil are abundant commodity materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to its high capacity to store lithium relative to cathode materials, and to further increase the available lithium in the cell, the
silicon anode can be prelithiated to a certain level (i.e., <FONT STYLE="white-space:nowrap">10-20%)</FONT> of its capacity before cell </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-91- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assembly. Prelithiation can be done electrochemically at low scale and by physical vapor deposition for large manufacturing volume. Equipment vendors have
<FONT STYLE="white-space:nowrap">scaled-up</FONT> or are scaling lithium evaporation equipment to GWh+ manufacturing volumes. Amprius uses electrochemical prelithiation in its current production and will integrate lithium evaporation steps in the
anode manufacturing line. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Competitive Strengths </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Performance greatly exceeds conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries commercially available today.
</I></B>The battery cells that we ship to our customers today significantly outperform commercially available conventional graphite battery cells. In particular, as shown in the table below, our batteries have approximately double the specific
energy and energy density of graphite battery cells, and enable significantly faster charging time. We believe other next-generation battery technologies will require significant additional research, development and investment prior to being
commercially viable. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377019g00s01.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Other than cycle life, based on a survey of 18650 technical datasheets (ex. Panasonic NCR18650G) and iFixit
reports on iPhone and Samsung batteries. For cycle life, based on Shmuel <FONT STYLE="white-space:nowrap">De-Leon:</FONT> <FONT STYLE="white-space:nowrap">Li-Ion</FONT> NCA/NMC Cylindrical Hard Case Cells Market 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Anode capacity for Graphite Anode Battery (full cells) uses typical N/P ratio of 1.05&#151;1.10.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes released Amprius products with energy and power cell designs. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on Amprius&#146; High Power cells. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Unique suitability for aviation markets that require high power, specific energy and energy density. </I></B>We believe the increased
performance of our batteries enable certain electric aviation applications. Specifically, our batteries have high specific energy and energy density, to maximize payload and reduce weight, thereby extending flight radius; high power density, to
enable vertical <FONT STYLE="white-space:nowrap">take-off</FONT> and landing functionality; fast charge, to minimize the time required to recharge a battery; wide operating temperature, for high altitude applications operating in extremely low
temperatures; and cycle life parity with graphite batteries, depending on customer specifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>First mover advantage in
emerging aviation markets. </I></B>As a result of our success with Airbus and other <FONT STYLE="white-space:nowrap">tier-one</FONT> customers, we have become an established market pioneer in providing high performance batteries to the aviation
industry. Our reputation and commitment to delivering ultra-high performance batteries have enabled us to enter into several development and master supply arrangements with our customers. Over 30 of our customers have tested and confirmed that our
batteries exceed the technical requirements for their applications, and we believe our market leadership in aviation will enable us to continue to grow our customer base. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Proven performance in demanding and abuse-tested environments. </I></B>Safety is recognized as one of the most important factors of <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> battery technology. Our silicon nanowire anode operates at a voltage that is at least 100 mV higher than that of graphite anodes, which not only enables faster charging but also cell operation
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-92- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
at lower temperatures, thereby improving cell safety and mitigating the risk of overcharging. Our batteries are also designed to be ultra-resilient and undergo rigorous abuse testing, including
air cargo certification and specific tests for defense applications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Robust IP portfolio and
<FONT STYLE="white-space:nowrap">know-how</FONT> related to our silicon nanowire ecosystem. </I></B>Our silicon nanowire anode technology has been refined and improved upon for over 10 years, and is protected by over 75 issued patents and pending
applications. Core aspects of our technologies and processes are also protected by <FONT STYLE="white-space:nowrap">know-how</FONT> and trade secrets developed by our team for more than 10 years. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Products and Customers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As evidenced
by customer validation, design wins and recurring orders with Airbus, AeroVironment, Teledyne FLIR, among others, our battery technology is well positioned to address the rapidly growing markets within the aviation industry, specifically UAS and
eVTOL. UAS and eVTOL applications have historically used conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries as a means to promote product prototypes, but market participants are seeking advancements in battery technology. We
believe that our silicon nanowire anode technology can be part of the solution, as we currently offer three product platforms: High Energy, High Power, and Balanced Energy/Power. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>High Energy Products</I></B>. Our High Energy Products are designed to maximize specific energy for applications that do not have high
power requirements. For applications that have a continuous discharge rate of less than C/2, our High Energy cells deliver a specific energy of over 425 Wh/kg, and at C/10, up to 450 Wh/kg. This product has been most frequently used by HAPS, which
are frequently designed to carry a payload at high altitudes for extended periods, typically for weeks or months at a time, because they rely on solar power for operations during the day and need to store sufficient energy in the battery to keep the
aircraft aloft during the night. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, our battery is the energy storage technology aboard the Zephyr S, a HAPS by Airbus. The
Zephyr S is a stratospheric vehicle that is designed to fly for months at a time, at an altitude of approximately 70,000 feet. In 2018, after integrating our battery cells into the Zephyr S, Airbus set an endurance and altitude record by flying
continuously for over 25 days. We continue to support the Zephyr S program and were presented the 2021 Innovative Supplier of the Year Award by Airbus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>High Power Products</I></B>. Our High Power Products are designed for applications that place a premium on high power capabilities. For
conventional high power <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries, specific energy typically ranges between <FONT STYLE="white-space:nowrap">100-200</FONT> Wh/kg at 1C. In comparison, our High Power cells offer 350 Wh/kg at 1C
and are over 300 Wh/kg at 5C. In addition, these High Power cells are capable of fast charging such that they can charge from 0% to 80% in less than 6 minutes without performance degradation to cycle life or energy density. This level of power
capability, energy density, and fast charge capability is optimal for the air transportation industry. The air transportation industry consists of either fixed-wing or eVTOL solutions, both of which require high power capabilities to lift the craft
from the ground into the air. After the craft has reached &#147;cruising altitude,&#148; the requirements shift from power to energy, which determines the range the aircraft can travel. Once the vehicle has landed, the turnaround time to get the
vehicle back into the air becomes critical, which is why we have designed our High Power Products with fast charge capabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2020,
we began design and verification discussions with potential eVTOL customers. In 2021, we began a technical evaluation engagement with a <FONT STYLE="white-space:nowrap">tier-one</FONT> eVTOL provider to develop an eVTOL-optimized battery system to
support the development and commercialization of their eVTOL fleet. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Balanced Energy/Power Products</I></B>. Our Balanced
Energy/Power Products are designed for applications that desire a balance between power and energy. Rated for up to 3C continuous discharge, our balanced cell gravimetric energy ranges between 410 Wh/kg at 0.2C discharge rate and 320 Wh/kg at 3C
discharge rate. This range of power capability is important to our UAS customers and our products typically meet UAS devices high </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-93- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
initial power requirement (between <FONT STYLE="white-space:nowrap">1-3C</FONT> for takeoff and landing), and operational requirement at C/2 for cruise or hover states. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since 2021, our Balanced Energy/Power Products have been designed into programs at AeroVironment and Teledyne FLIR, with commercial shipments
beginning in 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">EV-Capable</FONT> Products in Development</I></B>. We are currently developing
an EV capable cell. Competition in the EV industry is intense, with high production volume requirements, low pricing, and balanced performance criteria, creating a high barrier to entry against the incumbent solutions. Prior to us being able to
effectively compete in the EV space, we will need to further improve cycle life, increase cell form factors, increase production quantity and reduce our costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since 2017, we have been sampling our batteries with USABC, which has independently verified that we have met or exceeded the majority of
their 2023 EV cell performance goals, including usable energy density, usable specific energy, power density and charge time. In 2022, we were awarded a contract from USABC in collaboration with the U.S. Department of Energy to develop a <FONT
STYLE="white-space:nowrap">low-cost,</FONT> fast-charge silicon nanowire battery that meets all of their 2025 EV cell characteristic targets. This program is scheduled to conclude in 2024 when we intend to deliver cells with a 99mm x 300mm (W x L)
footprint and a capacity of at least 80Ah, having a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">beginning-of-life</FONT></FONT> specific energy of no less than 400 Wh/kg, energy density of no less than 950 Wh/L, and a cycle
life of 1,000 cycles. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Growth Strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our goal is to become the market leader in high performance <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries for the
transportation industry. In order to achieve that goal, we are pursuing the following growth strategies: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Complete large-scale
manufacturing facility to meet customer demand and optimize costs. </I></B>We operate a <FONT STYLE="white-space:nowrap">kWh-scale</FONT> manufacturing line at our headquarters in Fremont, California, which we are working to expand to achieve
production on a MWh-scale. To meet the demand for our batteries, we are in the process of designing and then building a <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility. We plan to build in a modular form where we can
incrementally increase our manufacturing capacity and operate a MWh-scale manufacturing line at our Fremont headquarters until we achieve approximately 0.5 to 1.0 GWh per year of manufacturing capacity at our new GWh-scale manufacturing facility and
then to further expand as needed through a Copy Exact methodology. Our ability to grow depends on the successful establishment of our <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility, which, in turn, will depend on our
ability to raise additional capital. Prior to the Business Combination, we have financed our operations primarily through capital contributions from Amprius Holdings and revenue generated from operations. We do not expect to receive additional
capital contributions from Amprius Holdings as we expect to rely on the cash on hand from the Business Combination, the PIPE and proceeds from the Committed Equity Financing, if any. As of September 30, 2022, we had $73.8 million of cash and cash
equivalents, which included the $70.9 million net proceeds from the consummation of the Business Combination on September 14, 2022. We believe that our cash on hand from the Business Combination, the PIPE, proceeds from the Committed Equity
Financing, if any, and funding from the government, will be sufficient to meet our working capital and capital expenditure requirements for a period of at least twelve months. However, to the extent that our resources are insufficient to satisfy our
cash requirements, we may need to seek additional equity or debt financing. Additional capital may not be available on acceptable terms, if at all. This prospectus registers up to 16,825,366 shares of Common Stock for resale by BRPC II that we may
issue to BRPC II from time to time during the term of the Purchase Agreement. The sale of all of the securities registered for resale in this prospectus and future sales of substantial amounts of our Common Stock in the public markets could have a
significant negative impact on the trading price of our Common Stock, which may make it more difficult for us to raise capital at a time and at a price that we deem appropriate. Further, the likelihood that warrant holders will exercise the Warrants
and any cash proceeds that we would receive is dependent upon the market price of our Common Stock. The exercise price of the Public Warrants and Private Warrants is $11.50 per share, and the exercise price of the PIPE
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-94- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Warrants is $12.50 per share, each of which exceeds $10.50, the closing price of our Common Stock on the NYSE on November 10, 2022. If the market price for our Common Stock is less than $11.50
per share, in the case of the Private Warrants and Public Warrants, or $12.50 per share, in the case of the PIPE Warrants, we believe warrant holders will be unlikely to exercise their Warrants. To the extent we are unable to raise additional
capital and we are unable to install a larger scale manufacturing process, our ability to grow will be adversely affected. For more information, see &#147;Risk Factors&#151;Risks Related to Our Technology, Products and Manufacturing&#151;Our
establishment of a volume manufacturing facility is subject to many risks, including, among others, risks relating to site acquisition, construction, permitting, delays, cost overruns, supply chain constraints, and operating in a new geographic area
away from our current headquarters&#148; and &#147;Risk Factors&#151; Risks Related to Our Business and Industry&#151;We may require additional capital to support business growth, and this capital might not be available on commercially reasonable
terms or at all&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Liquidity and Capital Resources.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Reduce our costs</I></B>. We believe our ability to reduce the costs of our batteries on a $/kWh basis will accelerate the adoption of
our batteries and allow us to further broaden our customer base. As we scale, we believe we will benefit from reduced <FONT STYLE="white-space:nowrap">per-unit</FONT> fixed costs, including overhead, labor and capital expenditures, improved tool
utilization and volume pricing for equipment and materials. We will also seek to reduce costs by optimizing material utilization, throughput and yield. However, until we are able to complete our optimization process, including designing and
implementing our silicon nanowire anode production process, we cannot accurately forecast our manufacturing costs. Based on our current expectations, we estimate that our capital equipment expenditures will range between $120.0&nbsp;million and
$150.0&nbsp;million to achieve 1.0 GWh per year of manufacturing capacity, and that it will take approximately two years following the Closing to start volume manufacturing. Because our silicon nanowire anode process requires different equipment
than traditional anode manufacturing, our capital equipment costs are likely to be higher than equipment used for production of graphite anodes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Extend first-mover advantage to become the market leader in <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries for aviation.
</I></B>We believe we are the leading company in the market today with a high-performance battery that can meet the requirements of aviation applications. We have built a strong reputation in the industry by delivering ultra-high performance
batteries with high safety standards that meet or exceed industry standards and customer requirements. We expect to extend our presence in the aviation market, while also serving other transportation-related markets that require improvements in
their electrification solutions. We are engaged with 50 interested potential customers, 30 of which have tested and validated that our batteries exceed the technical requirements for their applications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Further improve performance characteristics of our anode and battery cells</I></B>. We believe we have the highest-performing
commercially available batteries in the market. We intend to maintain our performance advantage by continuing to invest in our anode and cathode chemistries. We expect to continue to work to increase the performance characteristics of our batteries,
particularly around power, energy density and cycle life. For example, we have successfully produced batteries that have specific energy of up to 500 Wh/kg and energy density of up to 1,400 Wh/L. In addition, we will continue to invest in optimizing
combinations of these performance characteristics as well as the requisite form factors to meet the specific needs of our customers and drive adoption of our battery cells in other areas of electrified transportation. As a result of these efforts,
our goal is to fully realize the benefits of our silicon nanowire anode technology and develop the highest performing product in the market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Expand our end markets and applications</I></B>. As we increase our production capabilities, we will be able to supply our batteries in
larger volumes to fulfill our customers&#146; battery prototyping and procurement requirements. Our current customer base consists primarily of aviation and other air transportation companies. We believe the batteries we have developed for the
aviation industries can be adapted for larger form factors and, when we are able to improve the cycle life, increase form factors, reduce cost and improve production quantity for our EV capable cells, we believe our batteries will be able to meet
the energy density and fast-charge requirements of the EV market. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-95- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our original silicon nanowire technology was developed at Stanford University in 2008, and for more than 10 years, we have refined and improved
upon the technology for use in commercial applications. We have conducted research and development initiatives focused on improving certain performance characteristics and expanding the applications of our silicon nanowire anode battery technology.
We expect to continue our research and development efforts in the following areas: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Improving battery life</B>: we are working with chemical compounds as potential additives to the silane gas we
use to produce our silicon nanowire anodes which have demonstrated the potential to improve cycle life without negatively impacting other performance characteristics such as energy density. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Further improvements to energy density</B>: we are engaged in ongoing development activities to explore
different cathode materials, including a conversion cathode, to further improve the energy density of our batteries. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Larger cell form factors</B>: the batteries we have developed and are developing for our customers are
typically approximately <FONT STYLE="white-space:nowrap">1.4-15Ah</FONT> for <FONT STYLE="white-space:nowrap">small-sized</FONT> aircraft. As we expand our customer base, we are in the process of developing larger form factor batteries for broader
aviation application and for EV customers. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We utilize our research and development capabilities not only to improve
existing products but also to build custom-designed batteries for our customers. We have generated revenue from these design services. However, as we grow our manufacturing capacity, we expect that the relative percentage of our revenue from these
activities will decrease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our proprietary silicon nanowire anode technology, including the related processes, design and manufacturing, is protected by our patent
portfolio and <FONT STYLE="white-space:nowrap">know-how</FONT> and trade secrets. As of September&nbsp;30, 2022, 62 patents had been issued (29 in the U.S. and 33 in the EU, Korea, Japan, China, Taiwan and Israel), 15 patents are applications
pending (six in the U.S. and nine in the EU, Japan, Korea, Taiwan and China) and two issued U.S. patents are licensed from Stanford University. Our issued patents expire between 2027 and 2040. As of September&nbsp;30, 2022, we also held nine
registered trademarks (two in the U.S. and seven in Europe, Japan, Korea and China). Our patents cover: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">silicon nanowire structures&#151;rooted nanowire template, tapered morphology, silicon dopants and multi-layered
structure; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">materials technologies&#151;solid electrolyte interphase formation, electrolyte formulations and scalable
prelithiation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">silicon anode manufacturing processes, design and equipment. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we rely on <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements with employees, independent contractors, customers
and other third parties to protect our intellectual property and proprietary rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Circumstances outside our control could pose a
threat to our intellectual property rights. For more information, see &#147;Risk Factors&#151;Risks Related to Intellectual Property&#151;We rely heavily on our intellectual property portfolio. If we are unable to protect our intellectual property
rights, our business and competitive position would be harmed.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We compete directly and indirectly with current battery manufacturers and with an increasing number of companies that are developing new
battery technologies and chemistries to address the growing market for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-96- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
electrified mobility solutions. Specifically, within the aviation markets, we primarily compete with conventional graphite anode batteries and silicon composite anode batteries. Silicon
composites are graphite-based anodes that incorporate some silicon, typically in the form of particles of silicon or silicon monoxide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Graphite anode battery companies include <FONT STYLE="white-space:nowrap">tier-one</FONT> manufacturers such as Amperex Technology Limited
(ATL), Contemporary Amperex Technology Co., Limited (CATL), LG Chem Ltd., Murata Manufacturing Co., Ltd., Panasonic Industry Co., Ltd., and Samsung SDI Co., Ltd., which provide higher quality and higher performance solutions, and <FONT
STYLE="white-space:nowrap">tier-two</FONT> manufacturers which provide lower cost solutions. We expect the manufacturers of those batteries will continue to invest in improving the capabilities of their batteries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While we are currently the only known battery manufacturer making 100% silicon anodes, there are many companies making or developing silicon
composite batteries or anode materials and companies seeking to develop 100% silicon anodes. Companies making or developing silicon composite anodes include both large manufacturers as well as many well-funded new technology companies. These include
BTR New Energy Material Ltd., Enevate Corporation, Enovix Corporation, Group 14 Technologies, Inc., Nexeon Ltd., Sila Nanotechnologies Inc., Shanshan Corporation, Storedot Ltd., and Amprius (Nanjing) Co., Ltd. (&#147;Amprius Nanjing&#148;), a former
subsidiary of Amprius Holdings, among others. Dr.&nbsp;Sun, our Chief Executive Officer and a member of the Amprius Board, serves on the board of Amprius Nanjing and its holding company. Silicon composite anodes may offer higher energy density and
other improvements over conventional graphite anodes, and may be less expensive to manufacture than our silicon nanowire anodes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
aviation applications, we believe that the defining characteristics of our battery cells (e.g., industry-leading specific energy and energy density, high power density, low operating temperature and fast charge capability), in addition to commercial
validation, significantly differentiates us from graphite anode and silicon composite anode alternatives, thus making our silicon nanowire anode technology the only battery technology currently available and suitable for broad aviation adoption.
However, we expect additional competitors to enter the market as their battery technologies continue to improve. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The EV battery industry
is fast-growing and highly competitive. Unlike the aviation industry, where there are a limited number of commercially available batteries that meet the minimum performance specifications, there are many battery manufacturers in the EV industry that
can produce commercially acceptable batteries, and they can produce those batteries at lower cost and higher volumes than we are currently able to. Future entrants may include companies developing different technologies, such as lithium metal
anodes, which are not yet in commercial production. In order to compete in the EV industry, we would need to improve cycle life, increase form factors, improve production quantity and reduce our manufacturing costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of our competitors and potential future entrants, both in the aviation and EV industries, may be better capitalized and have greater
resources to commercialize and expand their production capacities. These competitors may have greater access to customers and may be able to establish cooperative or strategic relationships amongst themselves or with third parties that may further
enhance their resources and competitive positioning. If there are significant advances in battery chemistries that we cannot adapt, or if competitors are able to scale their production capacities before we are able to, our business may be materially
impacted. For more information, see &#147;Risk Factors&#151;Risks Related to Our Business and Industry&#151;The battery market is intensely competitive. Competitors include new entrants and established companies, many of which have significantly
greater resources than us. Our battery products must compete with advances in new battery chemistries and manufacturing methods as well as continued improvements in conventional batteries and battery anodes.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Government Regulation and Compliance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
business activities are global and are subject to various federal, state, local, and foreign laws, rules and regulations. For example, there are various government regulations pertaining to battery safety, transportation of batteries, use of
batteries in cars, factory safety, and disposal of hazardous materials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-97- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In many cases, our products are or may in the future be subject to trade and export control
laws and regulations in the United States and other jurisdictions where we do business. Such laws may include the Export Administration Regulations, the International Traffic in Arms Regulations, trade and economic sanctions maintained by the Office
of Foreign Asset Control as well as foreign direct investment rules and regulations, tariffs and quotas, and other related regulations in jurisdictions in which we operate. In particular, an export license may be required to export or <FONT
STYLE="white-space:nowrap">re-export</FONT> our products and technology to certain countries or <FONT STYLE="white-space:nowrap">end-users</FONT> or for certain <FONT STYLE="white-space:nowrap">end-uses</FONT> or may be prohibited. Additionally, we
may be required to register with the Directorate of Defense Trade Controls in order to conduct some aspects of our future business activities and we may be required to obtain licenses in order to conduct development activities. Obtaining the
necessary export license for a particular sale or offering or business activity may not be possible or may be time-consuming and may result in the delay or loss of sales opportunities. Any failure to adequately address these legal obligations could
result in civil fines or suspension or loss of our export privileges, any of which could materially adversely affect our business, financial condition, and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our business may be subject to the Foreign Corrupt Practices Act and other anti-corruption, anti-bribery, and anti-money
laundering laws and regulations in the jurisdictions in which we have offices or do business, both domestic and abroad. Any failure to adequately comply with any of these obligations, or future changes with respect to any of these legal regimes,
could cause us to incur significant costs, including the potential for new overhead costs, fines, sanctions, and third-party claims. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a
government contractor and/or subcontractor, we must comply with laws, regulations, and contractual provisions relating to the formation, administration, and performance of government contracts and grants, which affect how we and our partners do
business with government agencies. Government contracts often contain provisions and are subject to laws and regulations that provide government customers with additional rights and remedies not typically found in commercial contracts. Ensuring
compliance with government contracting laws, regulations, or contractual provisions may impose other added costs on our business, and failure to comply with these or other applicable regulations and requirements could lead to claims for damages,
civil or criminal penalties, termination of contracts and/or suspension or debarment from obtaining government contracts and grants. Any such damages, penalties, disruption, or limitation in our ability to do business with a government could have a
material adverse effect on our business, results of operations, financial condition, public perception and growth prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Human Capital </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our success is driven by our team of technology innovators and experienced business leaders.&nbsp;Many on our leadership team
have been with Amprius over a decade.&nbsp;We seek to hire and develop employees who are dedicated to our strategic mission. As of October&nbsp;1, 2022, we employed 54 full time employees, one part time employee, one temporary employee and one
contractor based in our headquarters in Fremont, California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our employees are the foundation of developing and commercializing our
silicon nanowire anode technology. 40 of our staff are involved with battery manufacturing and production, nine with engineering, research and development and seven with SG&amp;A. Of our technical and operations staff, approximately 20% hold Ph.D.
advanced degrees across material science, chemical, aerospace, structural and nanoscale engineering as well as physics and chemistry. We are committed to maintaining equitable compensation programs including equity participation. We offer
market-competitive salaries and strong equity compensation aimed at attracting and retaining team members capable of making exceptional contributions to our success. Our compensation decisions are guided by the external market, role criticality, and
the contributions of each team member. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, we have not experienced any work stoppages and we consider our relationship with our
employees to be good. None of our employees are either represented by a labor union or subject to a collective bargaining agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-98- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Facilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our corporate headquarters is located in Fremont, California, where we lease approximately 26,000 square feet under a lease that expires in
June 2024. In order to meet increased demand for our products, we have commenced site selection for, and are in the process of designing, our <FONT STYLE="white-space:nowrap">GWh-scale</FONT> manufacturing facility, as described above. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, we
may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an
adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-99- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_13"></A>MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers and Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table sets forth the names, ages, and positions of our executive officers and directors as of November&nbsp;1, 2022: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="59%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Position</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Kang Sun</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">67</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>President, Chief Executive Officer and Class&nbsp;III Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sandra Wallach</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">58</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Financial Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jonathan&nbsp;Bornstein</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">64</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Operating Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Ionel Stefan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">50</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Technology Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald&nbsp;R.&nbsp;Dixon (1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">75</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chair and Class&nbsp;III Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Steven Chu (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">74</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Class&nbsp;II Director</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Wen&nbsp;Hsieh (1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">49</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Class&nbsp;I Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Justin Mirro (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">54</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Class&nbsp;II Director</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the audit committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the compensation committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the nominating and corporate governance committee. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Dr.</B><B></B><B>&nbsp;Kang Sun </B>has served as our Chief Executive Officer and as a Class&nbsp;III director since September 2022, as
Legacy Amprius&#146; President and Chief Executive Officer since February 2017 and as a director on the Legacy Amprius board of directors since December 2016. Dr.&nbsp;Sun has also served as President, Chief Executive Officer and a director of
Amprius Holdings since March 2010. He also has served as a director of Amprius (Nanjing) Co.&nbsp;Ltd. since 2017 and Amprius (Wuxi) Co. Ltd. since November 2014, both entities of which were spun off from Amprius in 2022. Prior to joining Amprius
Holdings, Dr.&nbsp;Sun led two business ventures in the renewable energy space, serving as President and Chief Operating Officer of JA Solar Co. Ltd., a manufacturer of high-performance photovoltaic products, and as chairman and Chief Executive
Officer of RayTracker Inc., an advanced solar tracking system company that was acquired by First Solar Inc. Prior to that, he has held senior executive positions in several large business enterprises and technology
<FONT STYLE="white-space:nowrap">start-ups,</FONT> including Vice President and General Manager at Honeywell International Inc. and Vice President of Technology at Canon Production Printing (formerly Oce, N.V.). Dr.&nbsp;Sun holds a Ph.D. in
Chemistry from Brown University, an M.S. degree in Chemistry from the University of Georgia and a B.S. degree in Chemistry from Nanjing University, China. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Dr.&nbsp;Sun is qualified to serve on our Board because of the perspective and experience he brings as Legacy Amprius&#146; Chief
Executive Officer, his leadership experience in the energy industry and his strong scientific knowledge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Sandra Wallach</B> has served
as our Chief Financial Officer since September 2022 and as Legacy Amprius&#146; Chief Financial Officer since August 2021. Prior to joining Legacy Amprius, Ms.&nbsp;Wallach served as the Chief Financial Officer of Identiv, Inc., a publicly held
authentication and security solutions company from February 2017 to August 2021. Prior to that, she served as Vice President of Finance for MiaSole, a thin film solar technology company, from June 2013 to February 2017. Ms.&nbsp;Wallach has also
previously served as Chief Financial Officer of UBM Tech, a wholly owned subsidiary of UBM LLC, and Vice President of Finance at Juniper Networks, Inc., and has held different financial management positions with Intuit. Prior to Intuit,
Ms.&nbsp;Wallach served as Chief Financial Officer of General Electric&#146;s (GE) Industrial Systems, Drives&nbsp;&amp; Controls division. Ms.&nbsp;Wallach holds a B.A. degree in Economics and Public Policy from the University of California at
Berkeley. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Jonathan Bornstein </B>has served as our Chief Operating Officer since September 2022 and as Legacy Amprius&#146; Chief
Operating Officer since February 2015. Mr.&nbsp;Bornstein has also served as Amprius Holdings&#146; Senior Director of Engineering since March 2013. Prior to joining Amprius Holdings, Mr.&nbsp;Bornstein served as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-100- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Senior Director of Technology Development and Integration at Ampulse Corporation, where he led the development of a photovoltaic cell on flexible metal foil substrate. Mr.&nbsp;Bornstein has also
previously served as a Manager of Process Integration and Development at Intel Corporation and Director of Engineering Operations at Brion Technologies. Mr.&nbsp;Bornstein holds a M.S. degree in Materials Science from Stanford University and a B.S.
degree in Chemistry from Antioch College. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Dr.</B><B></B><B>&nbsp;Ionel Stefan</B> has served as our Chief Technology Officer since
September 2022 and as Legacy Amprius&#146; Chief Technology Officer since August 2015. Dr.&nbsp;Stefan is a recognized expert in electrochemistry and energy storage and leads Amprius&#146; scientific research and development activities for advancing
lithium ion cell performance. Dr.&nbsp;Stefan has also served as a Senior Scientist at Amprius Holdings since November 2009 and as Director of Battery Technology since November 2012. Prior to joining Amprius Holdings, Dr.&nbsp;Stefan was a Scientist
Electrochemist at Nanosys Inc. Dr.&nbsp;Stefan holds a Ph.D. in Chemistry from Case Western Reserve University, a M.S. degree in Electrochemistry and Analytical Chemistry from Babes-Bolyai University, and a B.S. degree in Chemistry from Babes-Bolyai
University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Donald R. Dixon </B>has served as a Class&nbsp;III director since September 2022 and as the Chair of the Legacy Amprius
board of directors since December 2016. Mr.&nbsp;Dixon has also served as a director of Amprius Holdings since June 2009. In 1993, he <FONT STYLE="white-space:nowrap">co-founded,</FONT> and has since served as Managing Director of, Trident Capital,
a venture capital fund, and in 2015, he <FONT STYLE="white-space:nowrap">co-founded,</FONT> and has since served as the Managing Director of, ForgePoint Capital, an investment firm focused on cybersecurity. Prior to Trident Capital, Don was the <FONT
STYLE="white-space:nowrap">Co-President</FONT> at Partech International, a private equity fund associated with Banque Paribas, a Managing Director at Alex. Brown&nbsp;&amp; Sons, and a Vice President at Morgan Stanley. Mr.&nbsp;Dixon currently
serves as a director of IronNet, Inc., a publicly held cybersecurity company, and as a director of several privately held companies. Mr.&nbsp;Dixon has previously served on the boards of directors of the publicly held companies Qualys, Inc. and Top
Image Systems Ltd. Mr.&nbsp;Dixon is a member of the Leadership Council of the Princeton University School of Engineering and Applied Sciences and serves on the Advisory Board of the Harvard Kennedy School Center for Public Leadership.
Mr.&nbsp;Dixon holds a B.S.E. degree in Aerospace Engineering from Princeton University and an M.B.A. from the Stanford Graduate School of Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Mr.&nbsp;Dixon is qualified to serve on our Board because of his extensive investment experience in the technology industry and
extensive expertise and skills in strategy, finance and management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Dr.</B><B></B><B>&nbsp;Steven Chu </B>has served as a
Class&nbsp;II director since September 2022 and as a director on the Legacy Amprius board of directors since December 2016. Dr.&nbsp;Chu has also served as a director of Amprius Holdings since January 2014. Dr.&nbsp;Chu has served as the William R.
Kenan, Jr., Professor of Physics and Professor of Molecular&nbsp;&amp; Cellular Physiology in the Medical School at Stanford University since May 2013. Dr.&nbsp;Chu is a <FONT STYLE="white-space:nowrap">co-recipient</FONT> of the 1997 Nobel Prize in
Physics for his contributions to laser cooling and atom trapping and has received numerous other awards. Dr.&nbsp;Chu w<SUP STYLE="font-size:75%; vertical-align:top">as</SUP> the 12th U.S. Secretary of Energy from January 2009 to April 2013. Prior
to his cabinet post, he was director of the Lawrence Berkeley National Laboratory, where he was active in pursuit of alternative and renewable energy technologies, and Professor of Physics and Applied Physics at Stanford University, where he helped
launch <FONT STYLE="white-space:nowrap">Bio-X,</FONT> a multi-disciplinary institute combining the physical and biological sciences with medicine and engineering. Prior to that, he was head of the Quantum Electronics Research Department at AT&amp;T
Bell Laboratories. He is a member of the National Academy of Sciences, the American Philosophical Society, the American Academy of Arts and Sciences, the Academia Sinica, a foreign member of the Royal Society, the Royal Academy of Engineering, the
Chinese Academy of Sciences, the Korean Academy of Sciences and Technology and the National Academy of Sciences, Belarus, and the Chair of the American Association for the Advancement of Science. Dr.&nbsp;Chu currently serves on the board of
directors of Zymergen Inc., a publicly held biotechnology company, and Oatly Group AB, a publicly held oat milk company. Dr.&nbsp;Chu holds an A.B. degree in Mathematics and a B.S. degree in Physics from the University of Rochester, and a Ph.D. in
Physics from the University of California at Berkeley, and has 33 honorary degrees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Dr.&nbsp;Chu is qualified to serve on our
Board because of his extensive background in sciences, academia&nbsp;and government. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-101- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Dr.</B><B></B><B>&nbsp;Wen Hsieh</B> has served as a Class&nbsp;I director since
September 2022 and as a director on the Legacy Amprius board of directors since December 2016. Dr.&nbsp;Hsieh has been a General Partner at Kleiner Perkins Caufield&nbsp;&amp; Byers, a venture capital firm, where he focuses on hardware-related
investments, since February 2006. Prior to joining Kleiner Perkins, Dr.&nbsp;Hsieh was an Associate Principal at McKinsey&nbsp;&amp; Company San Francisco and a leader of McKinsey&#146;s Asia semiconductor practice. During his time at McKinsey,
Dr.&nbsp;Hsieh focused primarily on serving leading companies across the global semiconductor value chain. Earlier in his career, Dr.&nbsp;Hsieh founded OnChip Technologies, a startup developing MEMS microfluidic biochips. Dr.&nbsp;Hsieh currently
serves on the board of directors of public companies Desktop Metal, Inc. and AEye, Inc., and as a director of several privately held companies. Dr.&nbsp;Hsieh holds a B.S., M.S. and Ph.D. in Electrical Engineering with a Biology Minor from
California Institute of Technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Dr.&nbsp;Hsieh is qualified to serve on our Board because of his extensive investment
experience in the technology industry, extensive expertise and skills in strategy, finance and management and strong scientific knowledge. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Justin Mirro</B> has served as a Class&nbsp;II director since September 2022. Mr.&nbsp;Mirro has over 30 years of operating, M&amp;A and
financing experience in the automotive and automotive-related sector. He began his career at General Motors Company as a Tool and Die Manufacturing Engineer, with successive positions at Car and Driver Magazine, Toyota Motor Corporation and Itochu
International Inc. prior to transitioning to automotive investment banking at Schroder&nbsp;&amp; Co. Inc./Salomon Smith Barney, Inc./ABN Amro Inc. in 1996. In 1999, Mr.&nbsp;Mirro formed Kensington Capital Partners, LLC, where he has served as
President since 2015, to invest in automotive and automotive-related sector businesses. In 2005, Mr.&nbsp;Mirro transitioned to Jefferies&nbsp;&amp; Company, Inc. as Head of Automotive Investment Banking, and later served as the Head of Automotive
Investment Banking at Moelis&nbsp;&amp; Company, LLC and RBC Capital Markets, LLC from 2008 to 2011 and 2011 to 2014, respectively. From 2016 to 2019, Mr.&nbsp;Mirro served as Chairman of the board of directors and audit committee of Pure Power
Technologies, Inc., one of the largest aftermarket suppliers of diesel fuel injectors, which was later sold to Stanadyne LLC. Mr.&nbsp;Mirro served as the Chairman and Chief Executive Officer of Kensington Capital Acquisition Corp. from April 2020
until it consummated its initial business combination with QuantumScape Corp. in November 2020. Mr.&nbsp;Mirro served as the Chairman and Chief Executive Officer of Kensington Capital Acquisition Corp. II from January 2021 until it consummated its
business combination with Wallbox N.V., in October 2021. He has served as the Chairman and Chief Executive Officer of Kensington Capital Acquisition Corp. V since March 2021. Mr.&nbsp;Mirro has served on the board of QuantumScape from 2020 through
April 2022, Cooper-Standard Holdings Inc. from 2015 through May 2022, and Transtar Industries, Inc., from 2017 through January 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
believe Mr.&nbsp;Mirro is qualified to serve on our board of directors due to his extensive experience in strategy, finance and management. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Family
Relationships </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our directors and executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Composition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business and
affairs are organized under the direction of the Board. Our Board currently consist of five members, with Mr.&nbsp;Dixon serving as Chair. Our Board is divided into three classes, Class&nbsp;I, Class&nbsp;II and Class&nbsp;III, with only one class
of directors being elected in each year and each class serving a three-year term. The primary responsibilities of our Board are to provide oversight, strategic guidance, counseling and direction to our management. Our Board meets on a regular basis
and additionally as required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the terms of our Bylaws, each director, including a director elected to fill a vacancy,
will hold office until the expiration of the term for which elected and until such director&#146;s successor is elected and qualified or until such director&#146;s earlier death, resignation or removal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-102- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any director may be removed from office by the stockholders as provided in
Section&nbsp;141(k) of the DGCL. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Independence </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board has determined that each of our directors other than Dr.&nbsp;Sun qualifies as an independent director, as defined under the rules of
the NYSE, and our Board consists of a majority of &#147;independent directors,&#148; as defined under the rules of the SEC and the NYSE relating to director independence requirements. In addition, we are subject to the rules of the SEC and the NYSE
relating to the membership, qualifications, and operations of the audit committee, as discussed below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Role of the Board in Risk Oversight/Risk
Committee </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the key functions of our Board is informed oversight of our risk management process. Our Board does not have a
standing risk management committee, but administers this oversight function directly through our Board as a whole, as well as through various standing committees of our Board that address risks inherent in their respective areas of oversight. In
particular, our Board is responsible for monitoring and assessing strategic risk exposure and our audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management will take to monitor and
control such exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee also monitors compliance with legal and regulatory requirements. Our compensation committee also assesses and monitors
whether our compensation plans, policies and programs comply with applicable legal and regulatory requirements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board has three standing committees&#151;an audit committee, a compensation committee, and a nominating and corporate governance committee.
Copies of the charters for each committee are available on our investor relations website. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee consists of Mr.&nbsp;Dixon and Dr.&nbsp;Hsieh. Our Board has determined that each of the members of the audit committee
satisfies the independence requirements of the NYSE and Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act and is able to read and understand fundamental financial statements in accordance with the NYSE audit committee
requirements. In arriving at this determination, our Board has examined each audit committee member&#146;s scope of experience and the nature of their prior and/or current employment. We currently rely on the
<FONT STYLE="white-space:nowrap">phase-in</FONT> provisions of Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> of the Exchange Act and the NYSE transition rules applicable to companies completing an initial listing, and we plan to have an audit
committee comprised of at least three directors that are entirely independent by March&nbsp;1, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Dixon serves as the chair
of the audit committee. Our Board has determined that Mr.&nbsp;Dixon qualifies as an audit committee financial expert within the meaning of SEC regulations and meets the financial sophistication requirements of the NYSE rules. In making this
determination, our Board considered formal education and previous experience in financial roles. Our independent registered public accounting firm and management periodically meet privately with our audit committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The functions of this committee include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance, independence and qualifications of our independent auditors and determining whether
to retain our existing independent auditors or engage new independent auditors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing our financial reporting processes and disclosure controls; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-103- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the engagement of our independent auditors to perform audit services and any permissible <FONT
STYLE="white-space:nowrap">non-audit</FONT> services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the adequacy and effectiveness of our internal control policies and procedures, including the
responsibilities, budget, staffing and effectiveness of our internal audit function; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with the independent auditors the annual audit plan, including the scope of audit activities and all
critical accounting policies and practices to be used by the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtaining and reviewing at least annually a report by our independent auditors describing the independent
auditors&#146; internal quality control procedures and any material issues raised by the most recent internal quality-control review; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the rotation of partners of our independent auditors on our engagement team as required by law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to engagement of any independent auditor, and at least annually thereafter, reviewing relationships that
may reasonably be thought to bear on their independence, and assessing and otherwise taking the appropriate action to oversee the independence of our independent auditor; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing our annual and quarterly financial statements and reports, including the disclosures contained in
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; and discussing the statements and reports with our independent auditors and management; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with our independent auditors and management significant issues that arise regarding accounting
principles and financial statement presentation and matters concerning the scope, adequacy, and effectiveness of our financial controls and critical accounting policies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with management and our auditors any earnings announcements and other public announcements regarding
material developments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing procedures for the receipt, retention and treatment of complaints received by the Company regarding
financial controls, accounting, auditing or other matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the report that the SEC requires in our annual proxy statement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and providing oversight of any related party transactions in accordance with our related party
transaction policy and reviewing and monitoring compliance with legal and regulatory responsibilities, including our code of ethics; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing our major financial risk exposures, including the guidelines and policies to govern the process by
which risk assessment and risk management is implemented; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and evaluating on an annual basis the performance of the audit committee and the audit committee
charter. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The composition and function of our audit committee complies with all applicable requirements of the
Sarbanes-Oxley Act and all applicable SEC rules and regulations. We will comply with future requirements to the extent they become applicable to us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
compensation committee consists of Mr.&nbsp;Dixon and Dr.&nbsp;Hsieh. Dr.&nbsp;Hsieh serves as the chair of our compensation committee. Our Board has determined that each of the members of the compensation committee is a <FONT
STYLE="white-space:nowrap">non-employee</FONT> director, as defined in Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act and satisfies the independence requirements of the NYSE. The functions of the committee
include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the corporate objectives that pertain to the determination of executive compensation;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-104- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the compensation and other terms of employment of our executive officers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving performance goals and objectives relevant to the compensation of our executive officers
and assessing their performance against these goals and objectives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">making recommendations to our Board regarding the adoption or amendment of equity and cash incentive plans and
approving amendments to such plans to the extent authorized by our Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to our Board regarding the type and amount of compensation to be paid or
awarded to our <FONT STYLE="white-space:nowrap">non-employee</FONT> board members; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and assessing the independence of compensation consultants, legal counsel and other advisors as
required by Section&nbsp;10C of the Exchange Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">administering our equity incentive plans, to the extent such authority is delegated by our Board;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the terms of any employment agreements, severance arrangements, change in control
protections, indemnification agreements and any other material arrangements for our executive officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with management our disclosures under the caption &#147;Compensation Discussion and Analysis&#148; in
our periodic reports or proxy statements to be filed with the SEC, to the extent such caption is included in any such report or proxy statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing an annual report on executive compensation that the SEC requires in our annual proxy statement; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and evaluating on an annual basis the performance of the compensation committee and recommending such
changes as deemed necessary with our Board. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The composition and function of its compensation committee will comply with
all applicable requirements of the Sarbanes-Oxley Act and all applicable SEC and the NYSE rules and regulations. We will comply with future requirements to the extent they become applicable to the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our nominating and corporate governance committee consists of Dr.&nbsp;Chu and Mr.&nbsp;Mirro. Our Board has determined that each of the
members of our nominating and corporate governance committee satisfies the independence requirements of the NYSE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Chu serves as
the chair of our nominating and corporate governance committee. The functions of this committee include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying, reviewing and making recommendations of candidates to serve on the Board; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance of the Board, committees of the Board and individual directors and determining whether
continued service on the Board is appropriate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating nominations by stockholders of candidates for election to the Board; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the current size, composition and organization of the Board and its committees and making
recommendations to the Board for approvals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing a set of corporate governance policies and principles and recommending to the Board any changes to
such policies and principles; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing issues and developments related to corporate governance and identifying and bringing to the attention
of the Board current and emerging corporate governance trends; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-105- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing periodically the nominating and corporate governance committee charter, structure and membership
requirements and recommending any proposed changes to the Board, including undertaking an annual review of its own performance. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The composition and function of the nominating and corporate governance committee will comply with all applicable requirements of the
Sarbanes-Oxley Act and all applicable SEC and the NYSE rules and regulations. We will comply with future requirements to the extent they become applicable to the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the members of our compensation committee has ever been an executive officer or employee of the Company. None of our executive officers
currently serves, or has served during the last completed fiscal year, on the compensation committee or board of directors of any other entity that has one or more executive officers that serve as a member of our Board or compensation committee.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation on Liability and Indemnification of Directors and Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Certificate of Incorporation limits our directors&#146; liability to the fullest extent permitted under the DGCL. The DGCL provides that
directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any transaction from which the director derives an improper personal benefit; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any unlawful payment of dividends or redemption of shares; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any breach of a director&#146;s duty of loyalty to the corporation or its stockholders.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of
directors, then the liability of our directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. The DGCL and the Bylaws provide that we will, in certain situations, indemnify our directors and officers and
may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to advancement, direct payment, or reimbursement of reasonable expenses (including
attorneys&#146; fees and disbursements) in advance of the final disposition of the proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have entered into separate
indemnification agreements with our directors and officers. These agreements, among other things, require us to indemnify its directors and officers for certain expenses, including attorneys&#146; fees, judgments, fines, and settlement amounts
incurred by a director or officer in any action or proceeding arising out of their services as one of our directors or officers or any other company or enterprise to which the person provides services at our request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain a directors&#146; and officers&#146; insurance policy pursuant to which our directors and officers are insured against liability
for actions taken in their capacities as directors and officers. We believe these provisions in our Certificate of Incorporation and Bylaws and these indemnification agreements are necessary to attract and retain qualified persons as directors and
officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers, or control
persons, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-106- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Business Conduct and Ethics for Employees, Executive Officers, and Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board has adopted a code of business conduct and ethics (the &#147;Code of Conduct&#148;), applicable to all of our employees, executive
officers and directors. The Code of Conduct is available on our investor relations website, ir.amprius.com. Information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this
prospectus is an inactive textual reference only. Our Board, or a duly appointed committee thereof, is responsible for overseeing the Code of Conduct and must approve any waivers of the Code of Conduct for employees, executive officers and
directors. We expect that any amendments to the Code of Conduct, or any waivers of its requirements, will be disclosed on our website. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board reviews director compensation periodically to ensure
that director compensation remains competitive such that we are able to recruit and retain qualified directors. We have adopted a <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation program that is designed to align
compensation with our business objectives and the creation of stockholder value, while enabling us to attract, retain, incentivize and reward directors who contribute to the long-term success of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-107- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_14"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To achieve our goals, we have designed our compensation and benefits program to attract, retain, incentivize and reward deeply talented and
qualified executives who share its philosophy and desire to work towards achieving these goals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe our compensation program
should promote the success of the company and align executive incentives with the long-term interests of our stockholders. Our current compensation programs reflect its startup origins in that they consist primarily of salary, bonuses and stock
option awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are considered an emerging growth company for purposes of the SEC&#146;s executive compensation disclosure rules. In
accordance with such rules, this section provides an overview of our executive compensation programs, including a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table
below. Further, our reporting obligations extend only to the individuals serving as our chief executive officer and our two other most highly compensated executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Legacy Amprius board of directors, with input from its Chief Executive Officer, has historically determined the compensation for our named
executive officers during their service to Legacy Amprius prior to the Business Combination. For the year ended December&nbsp;31, 2021, our named executive officers were: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dr.&nbsp;Kang Sun, President and Chief Executive Officer and director </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Sandra Wallach, Chief Financial Officer </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dr.&nbsp;Ionel Stefan, Chief Technology Officer </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The share numbers and exercise prices included in this &#147;Executive Compensation&#148; section reflect the historical pre-Business
Combination share numbers and exercise prices, and have not been adjusted to reflect the accounting of the Business Combination as a reverse recapitalization. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
table sets forth information concerning the compensation of the named executive officers for the year ended December&nbsp;31, 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name and Principal Position</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Kang Sun</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>President, Chief Executive Officer and Director</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">90,254&nbsp;</TD>
<TD NOWRAP VALIGN="top">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">40,000&nbsp;</TD>
<TD NOWRAP VALIGN="top">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4,199,272&nbsp;</TD>
<TD NOWRAP VALIGN="top">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">4,329,526</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sandra Wallach</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Financial Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">117,126</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">35,507</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">1,283,082</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">1,435,714</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Ionel Stefan</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Technology Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">224,700</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">501,827&nbsp;</TD>
<TD NOWRAP VALIGN="top">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">801,527</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents annual bonuses earned during 2021 and paid in 2022. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts in this column represent the aggregate grant-date fair value of awards granted to each named
executive officer in fiscal 2021, calculated in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC Topic 718, Compensation&#151;Stock Compensation (&#147;ASC&nbsp;718&#148;). Such grant-date fair
value does not take into account any estimated forfeitures related to service-vesting conditions. The assumptions used in determining the grant date fair value of the stock options reported are set forth in Note 2 to Legacy Amprius&#146; audited
financial statements included elsewhere in this prospectus. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the portion of base salary and bonus allocated to Legacy Amprius by Amprius Holdings. Dr.&nbsp;Sun
provided services to both Legacy Amprius and Amprius Holdings. For the year ended December&nbsp;31, 2021, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-108- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Dr.&nbsp;Sun&#146;s salary and bonus were paid by Amprius Holdings and the portion allocated to Legacy Amprius was 25%. For the year ended December&nbsp;31, 2021, the portion of
Dr.&nbsp;Sun&#146;s salary and bonus paid by Amprius Holdings was $270,762 and $120,000, respectively. Effective May 2022, Dr.&nbsp;Sun&#146;s entire salary and bonus was paid by Legacy Amprius. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 25% of the grant-date fair value of 2,687,350 options to purchase Amprius Holdings common stock that
was allocated to Legacy Amprius. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes the grant-date fair value of 201,110 options to purchase Amprius Holdings common stock, 100% of which
was allocated to Legacy Amprius. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Narrative Disclosure to Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Confirmatory Employment Letters with Amprius&#146; Named Executive Officers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination, we entered into confirmatory employment letters with each of our named executive officers to
confirm the current terms of their employment, as outlined below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dr.&nbsp;Kang Sun </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In September 2022, the Company entered into a confirmatory employment letter with Dr.&nbsp;Sun (the &#147;Sun Confirmatory Employment
Letter&#148;). The Sun Confirmatory Employment Letter has no specific term and provides for an annual base salary, eligibility to receive an annual target bonus, and eligibility to participate in employee benefit plans maintained from time to time
by the Company. The Sun Confirmatory Employment Letter supersedes all existing agreements and understandings that Dr.&nbsp;Sun may have entered into concerning his employment relationship with Legacy Amprius. Dr.&nbsp;Sun&#146;s current annual base
salary is $365,000 and he is eligible for a target annual cash bonus opportunity of $160,000. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Sandra Wallach </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In September 2022, the Company entered into a confirmatory employment letter with Ms.&nbsp;Wallach (the &#147;Wallach Confirmatory Employment
Letter&#148;). The Wallach Confirmatory Employment Letter has no specific term and provides for an annual base salary, eligibility to receive an annual target bonus, and eligibility to participate in employee benefit plans maintained from time to
time by the Company. The Wallach Confirmatory Employment Letter supersedes all existing agreements and understandings that Ms.&nbsp;Wallach may have entered into concerning her employment relationship with Legacy Amprius. Ms.&nbsp;Wallach&#146;s
current annual base salary is $300,000 and she is eligible for a target annual cash bonus opportunity of 30% of her annual base salary. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dr.&nbsp;Ionel
Stefan </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In September 2022, the Company entered into an amended and restated confirmatory employment letter with Dr.&nbsp;Stefan (the
&#147;Stefan Confirmatory Employment Letter. The Stefan Confirmatory Employment Letter has no specific term and provides for an annual base salary, eligibility to receive an annual target bonus, and eligibility to participate in employee benefit
plans maintained from time to time by the Company. The Stefan Confirmatory Employment Letter supersedes all existing agreements and understandings that Dr.&nbsp;Stefan may have entered into concerning his employment relationship with Legacy Amprius.
Dr.&nbsp;Stefan&#146;s current annual base salary is $250,000 and he is eligible for a target annual cash bonus opportunity of 30% of his annual base salary. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Bonus </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cash bonuses were
determined by the Legacy Amprius Board based on the performance of Legacy Amprius and the named executive officer. Pursuant to their respective confirmatory employment letters, Dr.&nbsp;Sun, Ms.&nbsp;Wallach and Dr.&nbsp;Stefan are each eligible to
receive an annual cash bonus, the amount of which will be determined by the Board or its authorized committee based on the applicable performance objectives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-109- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Potential Payments upon Termination or Change in Control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Sun Confirmatory Employment Letter, if the Company or any successor corporation terminates Dr.&nbsp;Sun&#146;s employment other
than for cause (as defined in the Sun Confirmatory Employment Letter), death or disability or Dr.&nbsp;Sun terminates his employment with the Company or any successor corporation for good reason (as defined in the Sun Confirmatory Employment
Letter), Dr.&nbsp;Sun will be eligible to receive, subject to executing a release of claims, the following severance benefits: (i)&nbsp;continuing payments of severance pay at a rate equal to his base salary, as then in effect, for a period of six
months following the date of such termination, and (ii)&nbsp;the unvested portion of his outstanding stock options to the Company stock that would normally vest over the following six months from the date of termination will immediately vest before
such termination and become exercisable, provided that if such termination occurs upon or within six months following the closing of a change in control (as defined in the Company&#146;s 2022 Equity Incentive Plan), then 100% of his outstanding
stock options will immediately vest and become exercisable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Wallach Confirmatory Employment Letter, if the Company or any
successor corporation terminates Ms.&nbsp;Wallach&#146;s employment other than for cause (as defined in the Wallach Confirmatory Employment Letter), death or disability or Ms.&nbsp;Wallach terminates her employment with the Company or any successor
corporation for good reason (as defined in the Wallach Confirmatory Employment Letter), Ms.&nbsp;Wallach will be eligible to receive, subject to executing a release of claims, continuing payments of severance pay at a rate equal to her base salary,
as then in effect, for a period of three months following the date of such termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Stefan Confirmatory Employment
Letter, if the Company or any successor corporation terminates Dr.&nbsp;Stefan&#146;s employment other than for cause (as defined in the Stefan Confirmatory Employment Letter), death or disability or Dr.&nbsp;Stefan terminates his employment with
the Company or any successor corporation for good reason (as defined in the Stefan Confirmatory Employment Letter), Dr.&nbsp;Stefan will be eligible to receive, subject to executing a release of claims, continuing payments of severance pay at a rate
equal to his base salary, as then in effect, for a period of three months following the date of such termination. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amprius Technologies, Inc. 2016
Equity Incentive Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2017, the Legacy Amprius board of directors adopted and Legacy Amprius stockholders approved the 2016
Plan. The 2016 Plan provided for the grant of incentive stock options, within the meaning of Section&nbsp;422 of the Code, to employees of Legacy Amprius and its parent and subsidiary corporations, and for the grant of nonstatutory stock options,
restricted stock, restricted stock units and stock appreciation rights to employees, directors, and consultants of Legacy Amprius and employees and consultants of Legacy Amprius&#146; parent and subsidiary corporations. Upon the Closing, the 2016
Plan was terminated as of immediately before the 2022 Plan became effective, and no additional awards will be granted under the 2016 Plan. However, the 2016 Plan continues to govern the terms and conditions of the outstanding awards previously
granted under the 2016 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of November 1, 2022, stock options covering 14,216,131 shares of Common Stock were outstanding under the
2016 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Authorized Shares</I>. Subject to the adjustment provisions contained in the 2016 Plan, the maximum aggregate number of
shares of Common Stock that may be subject to awards and sold under the 2016 Plan is 11,250,000. Shares granted under the 2016 Plan may be authorized but unissued, or reacquired shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an award expires or becomes unexercisable without having been exercised in full, is surrendered pursuant to an exchange program described
in the following paragraph, or, with respect to restricted stock or restricted stock units is forfeited to or repurchased by us due to failure to vest, the unpurchased shares (or for awards other than stock options or stock appreciation rights, the
forfeited or repurchased shares) will become available for future grant or sale under the 2016&nbsp;Plan (unless the 2016 Plan has terminated). With respect to stock appreciation rights, only the net shares actually issued will cease to be available
under the 2016 Plan and all remaining shares under stock appreciation rights will remain available for future grant or sale under the 2016 Plan (unless the 2016 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-110- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Plan has terminated). Shares used to pay the exercise price of an award or satisfy the tax withholding obligations related to an award will become available for future grant or sale under the
2016 Plan. To the extent an award is paid out in cash rather than shares, such cash payment will not result in a reduction in the number of shares available for issuance under the 2016 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Plan Administration</I>. The Board or one or more committees appointed by the Board administers the 2016 Plan. Different committees may
administer the 2016 Plan with respect to different service providers. Subject to the provisions of the 2016 Plan, the administrator has the power to administer the 2016 Plan and make all determinations deemed necessary or advisable for administering
the 2016 Plan, including the power to determine the fair market value of Common Stock, select the service providers to whom awards may be granted, determine the number of shares covered by each award, approve forms of award agreements for use under
the 2016 Plan, determine the terms and conditions of awards (such as the exercise price, the time or times at which awards may be exercised, any vesting acceleration or waiver or forfeiture restrictions and any restriction or limitation regarding
any award or the shares relating to the award), construe and interpret the terms of the 2016 Plan and awards granted under it, prescribe, amend and rescind rules relating to the 2016 Plan (including relating to
<FONT STYLE="white-space:nowrap">sub-plans),</FONT> modify, or amend each award, such as the discretionary authority to extend the post-termination exercisability period of awards and to extend the maximum term of an option, and allow a participant
to defer the receipt of payment of cash or the delivery of shares that would otherwise be due to such participant under an award. The administrator also has the authority to institute an exchange program by which outstanding awards may be
surrendered or cancelled in exchange for awards of the same type (which may have a higher or lower exercise price and/or different terms), awards of a different type, and/or cash, by which participants would have the opportunity to transfer
outstanding awards to a financial institution or other person or entity selected by the administrator, or by which the exercise price of an outstanding award is increased or reduced. The administrator&#146;s decisions, interpretations, and other
actions are final and binding on all participants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stock Options</I>. The per share exercise price of options granted under the 2016
Plan generally must be at least equal to the fair market value of a share of Amprius common stock on the date of grant. The term of an option may not exceed 10 years. With respect to any incentive stock option granted to an employee who owns more
than 10% of the voting power of all classes of Amprius&#146; (or any parent or subsidiary of Amprius) outstanding stock, the term of the incentive stock option must not exceed five years and the per share exercise price of the incentive stock option
must equal at least 110% of the fair market value of a share of Amprius common stock on the grant date. The administrator determines the methods of payment of the exercise price of an option, which may include cash, shares, or other property
acceptable to the administrator to the extent permitted by applicable law. After termination of a participant&#146;s service, he or she may exercise the vested portion of his or her option for six months following a termination due to death or
disability, for 30 days following a termination for any other reason, or for any longer period specified in the applicable option agreement. An option, however, may not be exercised later than the expiration of its term. Subject to the provisions of
the 2016 Plan, the administrator determines the other terms of options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-Transferability</FONT> of
Awards</I>. Unless the administrator provides otherwise, the 2016 Plan generally does not allow for the transfer of awards (other than by will or the laws of descent or distribution), and only the recipient of an award may exercise an award during
his or her lifetime. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Certain Adjustments</I>. In the event of certain changes in the Company&#146;s capitalization, to prevent
diminution or enlargement of the benefits or potential benefits available under the 2016 Plan, the administrator will adjust the number and class of shares that may be delivered under the 2016 Plan and/or the number, class, and price of shares
covered by each outstanding award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Dissolution or Liquidation</I>. In the event of the Company&#146;s proposed liquidation or
dissolution, the administrator will notify participants before the effective date of such transaction, and to the extent not exercised, all awards will terminate immediately before the consummation of such proposed transaction, unless the
liquidation or dissolution is part of a restructuring where the Company and its business is being rolled into and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-111- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acquired by Amprius Holdings (or one of its affiliates), in which case an award may be treated as described in the &#147;Merger or Change in Control of the Company or Amprius Holdings&#148;
section below as if the transaction were a merger of the Company with or into Amprius Holdings or one of its affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Merger or
Change in Control of the Company or Amprius Holdings.</I> The 2016 Plan provides that in the event of a merger or change in control of the Company or Amprius Holdings, each as described under the 2016 Plan, each outstanding award will be treated as
the administrator determines, without a participant&#146;s consent. The administrator may provide that awards granted under the 2016 Plan will be assumed or substituted by substantially equivalent awards, be terminated immediately before the merger
or change in control, become vested and exercisable or payable and be terminated in connection with the merger or change in control, be terminated in exchange for cash or other property, be continued by the Company if it is the surviving company
(and, in the case of a merger or change in control of Amprius Holdings, the acquiring or succeeding corporation or its affiliate does not have a class of securities that is publicly traded) subject to the limitations set forth in the 2016 Plan), or
any combination of the above. The administrator is not required to treat all awards, all awards held by a participant, or all awards of the same type similarly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a successor corporation does not continue, assume or substitute for any outstanding award, then the participant will fully vest in and have
the right to exercise all of his or her outstanding options and stock appreciation rights, all restrictions on restricted stock and restricted stock units will lapse, and for awards with performance-based vesting, all performance goals or other
vesting criteria will be deemed achieved at 100% of target levels and all other terms and conditions met. If an option or stock appreciation right is not assumed or substituted in the event of a change in control, the administrator will notify the
participant in writing or electronically that such option or stock appreciation right will be exercisable for a period of time determined by the administrator in its sole discretion and the option or stock appreciation right will terminate upon the
expiration of such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Amendment; Termination</I>. As noted above, the 2016 Plan was terminated as of immediately before the 2022
Plan becoming effective, and no additional awards will be granted under the 2016 Plan. However, the 2016 Plan continues to govern the terms and conditions of the outstanding awards previously granted under the 2016 Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amprius Technologies, Inc. 2022 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2022 Plan was adopted in connection with the Business Combination and became effective upon the Closing. The 2022 Plan replaces the 2016
Plan, which expired as to future grants as of the Closing. The 2022 Plan allows us to grant&nbsp;awards of stock options, stock appreciation rights, restricted stock, restricted stock units, and performance awards to employees, directors and
consultants of ours or any parent or subsidiary corporation of ours, provided that incentive stock options may only be granted to employees of the Company or any parent or subsidiary corporation of ours. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Authorized Shares </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the
adjustment provisions contained in the 2022 Plan and the evergreen provision described below, as of November 1, 2022, a total of 9,907,279 shares of Common Stock is reserved for issuance pursuant to the 2022 Plan. In addition, the shares reserved
for issuance under the 2022 Plan include any assumed awards that, on or after the date of the Closing, were cancelled, expired or otherwise terminated without having been exercised in full, were tendered to or withheld by the Company for payment of
an exercise price or for tax withholding obligations, or were forfeited to or repurchased by the Company due to failure to vest (provided that the maximum number of shares that may be added to the 2022 Plan pursuant to this sentence is 15,000,000
shares). The number of shares available for issuance under the 2022 Plan also include an annual increase, or the evergreen feature, on the first day of each of our fiscal years, beginning with our fiscal year 2023, equal to the least of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">30,000,000 shares of our Common Stock; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-112- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a number of shares of Common Stock equal to 5% of the total number of shares of all classes of our common stock
outstanding as of the last day of the immediately preceding fiscal year; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such number of shares of our Common Stock as the administrator of the 2022 Plan may determine no later than the
last day of our immediately preceding fiscal year. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares issuable under the 2022 Plan may be authorized, but unissued,
or reacquired shares of Common Stock. If an award expires or becomes unexercisable without having been exercised in full, is surrendered pursuant to an exchange program (as described below), or, with respect to restricted stock, restricted stock
units, or performance awards, is forfeited to or repurchased due to failure to vest, the unpurchased shares (or for awards other than stock options or stock appreciation rights, the forfeited or repurchased shares) will become available for future
grant or sale under the 2022 Plan. With respect to stock appreciation rights, only the net shares actually issued will cease to be available under the 2022 Plan and all remaining shares under stock appreciation rights will remain available for
future grant or sale under the 2022 Plan. Shares that actually have been issued under the 2022 Plan under any award will not be returned to the 2022 Plan; except if shares issued pursuant to awards of restricted stock, restricted stock units, or
performance awards are repurchased or forfeited due to failure to vest, such shares will become available for future grant under the 2022 Plan. Shares used to pay the exercise price of an award or satisfy the tax liabilities or withholding
obligations related to an award (which withholdings may be in amounts greater than the minimum statutory amount required to be withheld as determined by the administrator of the 2022 Plan) will become available for future grant or sale under the
2022 Plan. To the extent an award is paid out in cash rather than shares, such cash payment will not result in a reduction in the number of shares available for issuance under the 2022 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any dividend or other distribution (whether in cash, shares, other securities, or other property), recapitalization, stock split, reverse
stock split, reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination, reclassification, repurchase, or exchange of shares or other securities of the
Company, or other change in the corporate structure of the Company affecting the shares (other than any ordinary dividends or other ordinary distributions), the administrator of the 2022 Plan, to prevent diminution or enlargement of the benefits or
potential benefits intended to be made available under the 2022 Plan, will adjust the number and class of shares that may be delivered under the 2022 Plan; the number, class, and price of shares covered by each outstanding award; and the numerical
share limits contained in the 2022 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Plan Administration </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board or one or more committees appointed by our Board has authority to administer the 2022 Plan. Our compensation committee will initially
administer the 2022 Plan. In addition, to the extent it is desirable to qualify transactions under the 2022 Plan as exempt under <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3&nbsp;of</FONT> the Exchange Act, such transactions will be structured
to satisfy the requirements for exemption under <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3.&nbsp;Subject</FONT> to the provisions of the 2022 Plan, the administrator has the power to administer the 2022 Plan and make all determinations deemed
necessary or advisable for administering the 2022 Plan, including the power to determine the fair market value of our Common Stock, select the service providers to whom awards may be granted, determine the number of shares or dollar amounts covered
by each award, approve forms of award agreements for use under the 2022 Plan, determine the terms and conditions of awards (including the exercise price, the time or times at which awards may be exercised, any vesting acceleration or waiver or
forfeiture restrictions and any restriction or limitation regarding any award or the shares relating thereto), construe and interpret the terms of the 2022 Plan and awards granted under it, prescribe, amend and rescind rules and regulations relating
to the 2022 Plan, including <FONT STYLE="white-space:nowrap">creating&nbsp;sub-plans,&nbsp;modify</FONT> or amend each award, and allow a participant to defer the receipt of payment of cash or the delivery of shares that otherwise would be due to
such participant under an award. The administrator also has the authority to allow participants the opportunity under an exchange program to transfer outstanding awards granted under the 2022 Plan to a financial institution or other person or entity
selected by the administrator, and to institute an exchange program by which outstanding awards granted under the 2022 Plan may be surrendered or cancelled in exchange for awards of the same type, which may have a higher or lower exercise price and
different terms, awards of a different type or cash, or by which the exercise price of an outstanding award granted </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-113- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under the 2022 Plan is increased or reduced. The administrator&#146;s decisions, interpretations and other actions are final and binding on all participants and will be given the maximum
deference permitted by applicable law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stock Options </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock options may be granted under the 2022 Plan. The per share exercise price of options granted under the 2022 Plan generally must be equal
to at least 100% of the fair market value of a share of Common Stock on the date of grant. The term of an option may not exceed ten years. With respect to any participant who owns more than 10% of the voting power of all classes of our (or any of
our parent&#146;s or subsidiary&#146;s) outstanding stock, the term of an incentive stock option granted to such participant must not exceed five years and the per share exercise price must equal at least 110% of the fair market value of a share of
Common Stock on the grant date. The administrator will determine the methods of payment of the exercise price of an option, which may include cash, certain shares of Common Stock, cashless exercise, net exercise, as well as other types of
consideration permitted by applicable law. After the cessation of service of an employee, director or consultant, he or she may exercise his or her option for the period of time stated in his or her option agreement. In the absence of a specified
time in an award agreement, if such cessation is due to death or disability, the option will remain exercisable for six months. In all other cases, in the absence of a specified time in an award agreement, the option will remain exercisable for
three months following the cessation of service. An option, however, may not be exercised later than the expiration of its term. Subject to the provisions of the 2022 Plan, the administrator determines the terms of options. Until shares are issued
under an option, the participant will not have any right to vote or receive dividends or have any other rights as a stockholder with respect to such shares, and no adjustment will be made for a dividend or other right for which the record date is
before the date such shares are issued, except as provided in the 2022 Plan, as summarized further above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stock Appreciation Rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock appreciation rights may be granted under the 2022 Plan. Stock appreciation rights allow the recipient to receive the appreciation in the
fair market value of Common Stock between the exercise date and the date of grant. The term of a stock appreciation right may not exceed ten years. After the cessation of service of an employee, director or consultant, he or she may exercise his or
her stock appreciation right for the period of time stated in his or her stock appreciation rights agreement. In the absence of a specified time in an award agreement, if such cessation is due to death or disability, the stock appreciation rights
will remain exercisable for six months following the cessation of service. In all other cases, in the absence of a specified time in an award agreement, the stock appreciation rights will remain exercisable for three months following the cessation
of service. However, in no event may a stock appreciation right be exercised later than the expiration of its term. Subject to the provisions of the 2022 Plan, the administrator determines the terms of stock appreciation rights, including when such
rights become exercisable and whether to pay any increased appreciation in cash or with shares of Common Stock, or a combination of both, except that <FONT STYLE="white-space:nowrap">the&nbsp;per-share&nbsp;exercise</FONT> price for the shares to be
issued pursuant to the exercise of a stock appreciation right generally will be no less than 100% of the fair market value per share on the date of grant. Until shares are issued under a stock appreciation right, the participant will not have any
right to vote or receive dividends or have any other rights as a stockholder with respect to such shares, and no adjustment will be made for a dividend or other right for which the record date is before the date such shares are issued, except as
provided in the 2022 Plan, as summarized further above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock may be granted under the 2022 Plan. Restricted stock awards are grants of shares of Common Stock that may have vesting
requirements under any such terms and conditions established by the administrator. The administrator will determine the number of shares of restricted stock granted to any employee, director or consultant and, subject to the provisions of the 2022
Plan, will determine the terms and conditions of such awards. The administrator may impose whatever restrictions on transferability, forfeiture provisions or other restrictions or vesting conditions (if any) it determines to be appropriate (for
example, the administrator may set restrictions based on the achievement of specific performance goals or continued service to us). The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-114- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
administrator, in its sole discretion, may accelerate the time at which any restrictions will lapse or be removed. The administrator may determine that an award of restricted stock will not be
subject to any period of restriction and consideration for such award is paid for by past services rendered as a service provider. Recipients of restricted stock awards generally will have voting rights and rights to dividends and other
distributions with respect to such shares upon grant, unless the administrator provides otherwise. If such dividends or distributions are paid in shares, the shares will be subject to the same restrictions on transferability and forfeitability as
the share of restricted stock with respect to which they were paid. Shares of restricted stock that do not vest are subject to the right of repurchase or forfeiture. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Units </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock
units may be granted under the 2022 Plan. Each restricted stock unit is a bookkeeping entry representing an amount equal to the fair market value of one share of Common Stock. Subject to the provisions of the 2022 Plan, the administrator determines
the terms and conditions of restricted stock units, including any vesting criteria and the form and timing of payment. The administrator may set vesting criteria based upon the achievement of company-wide, divisional, business unit, or individual
goals (including continued employment or service), applicable federal or state securities laws or any other basis determined by the administrator in its discretion. The administrator, in its sole discretion, may pay earned restricted stock units in
the form of cash, shares, or a combination of both. Notwithstanding the foregoing, the administrator, in its sole discretion, may accelerate the time at which any restrictions will lapse or be removed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Performance Awards </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Performance awards
may be granted under the 2022 Plan. Performance awards are awards that may be earned in whole or in part on the attainment of performance goals or other vesting criteria that the administrator may determine, and that may be denominated in cash or
stock. Each performance award will have an initial value that is determined by the administrator. Subject to the terms and conditions of the 2022 Plan, the administrator determines the terms and conditions of performance awards, including any
vesting criteria and form and timing of payment. The administrator may set vesting criteria based upon the achievement of company-wide, divisional, business unit, or individual goals (including continued employment or service), applicable federal or
state securities laws or any other basis determined by the administrator in its discretion. The administrator, in its sole discretion, may pay earned performance awards in the form of cash, shares, or a combination of both. Notwithstanding the
foregoing, the administrator, in its sole discretion, may accelerate the time at which any restrictions will lapse or be removed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT
STYLE="white-space:nowrap">Non-Employee&nbsp;Directors</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">All&nbsp;non-employee&nbsp;directors</FONT> will be eligible to receive all types of awards (except for
incentive stock options) under the 2022 Plan. The 2022 Plan provides that in any given fiscal year of the Company, no outside director may be granted any equity awards (including equity awards under the 2022 Plan) (the value of which will be based
on their grant date fair value) and be provided any other compensation (such as any cash retainers and fees) that in the aggregate exceed $750,000. For the purposes of this maximum limit provision, the grant date fair values of awards granted under
the 2022 Plan will be determined according to GAAP. Any awards or other compensation provided to an individual for his or her services as an employee or a consultant (other than an outside director), or before the Closing, will not count toward this
limit. This maximum limit provision does not reflect the intended size of any potential grants or a commitment to make grants to the outside directors under the 2022 Plan in the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-Transferability&nbsp;of</FONT> Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the administrator provides otherwise, the 2022 Plan generally will not allow for the transfer of awards other than by will or the laws
of descent and distribution, and only the recipient of an award may exercise an award during his or her lifetime. If the administrator makes an award transferable, such award will contain such additional terms and conditions as the administrator
deems appropriate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-115- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dissolution or Liquidation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If there is a proposed liquidation or dissolution of the Company, the administrator will notify participants at such time before the effective
date of such event as the administrator determines and all awards, to the extent that they have not been previously exercised, will terminate immediately before the consummation of such event. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Merger or Change in Control </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2022
Plan provides that in the event of the Company&#146;s merger or change in control, as defined in the 2022 Plan, each outstanding award will be treated as the administrator determines, without a participant&#146;s consent. The administrator may
provide that awards granted under the 2022 Plan will be assumed or substituted by substantially equivalent awards, be terminated immediately before the merger or change in control, become vested and exercisable or payable and be terminated in
connection with the merger or change in control, be terminated in exchange for cash or other property or any combination of the above. The administrator is not required to treat all awards, all awards held by a participant, all portions of awards,
or all awards of the same type, similarly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a successor corporation does not so assume or substitute a substantially equivalent award
for any outstanding award (or a portion of such award), then such award (or its applicable portion) will fully vest, all restrictions on such award (or its applicable portion) will lapse, all performance goals or other vesting criteria applicable to
such award (or its applicable portion) will be deemed achieved at 100% of target levels and such award (or its applicable portion) will become fully exercisable, if applicable, for a specified period before the transaction, unless specifically
provided otherwise under the applicable award agreement or other written agreement with the participant authorized by the administrator. The award (or its applicable portion) will then terminate upon the expiration of the specified period of time.
If an option or stock appreciation right is not assumed or substituted, the administrator will notify the participant that such option or stock appreciation right will be exercisable for a period of time determined by the administrator in its sole
discretion and the option or stock appreciation right will terminate upon the expiration of such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in the event of a
change in control, awards granted to <FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director</FONT> will fully vest, all restrictions on such awards will lapse, all performance goals or other vesting criteria applicable to such awards
will be deemed achieved at 100% of target levels and such awards will become fully exercisable, if applicable, unless specifically provided otherwise under the applicable award agreement or other written agreement with
<FONT STYLE="white-space:nowrap">the&nbsp;non-employee&nbsp;director</FONT> authorized by the administrator. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Forfeiture and Clawback </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards are subject to any clawback policy that we are required to adopt under the listing standards of any national securities exchange or
association on which our securities are listed or as is otherwise required by applicable laws. The administrator also may specify in an award agreement that the participant&#146;s rights, payments and benefits with respect to an award will be
subject to reduction, cancellation, forfeiture, recoupment, reimbursement, or reacquisition upon the occurrence of certain specified events. The administrator may require a participant to forfeit or return to the Company or reimburse the Company for
all or a portion of the award and any amounts paid under the award in order to comply with any clawback policy of the Company as described in the first sentence of this paragraph or with applicable laws. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Amendment or Termination </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2022 Plan
will continue in effect until terminated by the administrator. However, no incentive stock options may be granted after <FONT STYLE="white-space:nowrap">the&nbsp;ten-year&nbsp;anniversary</FONT> of the adoption by the Board of the 2022 Plan, and the
evergreen feature of the 2022 Plan will terminate on <FONT STYLE="white-space:nowrap">the&nbsp;ten-year&nbsp;anniversary</FONT> of the Board approval of the 2022 Plan. In addition, the administrator will have the authority to amend, suspend, or
terminate the 2022 Plan or any part of the 2022 Plan, at any time and for any reason, but such action generally may not materially impair the rights of any participant without his or her written consent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-116- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amprius 2022 Employee Stock Purchase Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP was adopted in connection with the Business Combination and became effective upon the Closing, but the first offering period will
commence at a later date determined by the administrator of the ESPP. The ESPP provides eligible employees an opportunity to purchase Common Stock at a discount through accumulated contributions of their earned compensation.. The ESPP permits the
administrator of the ESPP to grant purchase rights that qualify for preferential tax treatment under Section&nbsp;423 of the Code. In addition, the ESPP authorizes the grant of purchase rights that do not qualify under Code Section&nbsp;423 pursuant
to rules, procedures <FONT STYLE="white-space:nowrap">or&nbsp;sub-plans&nbsp;adopted</FONT> by the administrator that are designed to achieve desired tax or other objectives. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Shares Available for Issuance </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
maximum number of shares of Common Stock available for issuance under the ESPP is 990,000 shares of Common Stock. The number of shares of Common Stock available for issuance under the ESPP will be increased on the first day of each fiscal year
beginning with fiscal year 2023 in an amount equal to the least of (i) 5,000,000 shares of Common Stock, (ii)&nbsp;a number of shares of Common Stock equal to 1% of the total number of shares of all classes of Common Stock outstanding on the last
day of the immediately preceding fiscal year, or (iii)&nbsp;such number of shares determined by the administrator no later than the last day of the immediately preceding fiscal year. Shares issuable under the ESPP may be authorized, but unissued, or
reacquired shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP provides that in the event that any dividend or other distribution (whether in the form of
cash, shares, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">consolidation,&nbsp;split-up,&nbsp;spin-off,&nbsp;combination,</FONT></FONT> reclassification, repurchase or exchange of Common Stock or other securities of the Company or other
change in its corporate structure affecting the Common Stock occurs (other than any ordinary dividends or other ordinary distributions), to prevent diminution or enlargement of the benefits or potential benefits intended to be provided under the
ESPP, the administrator will make adjustments to the number and class of shares that may be delivered under the ESPP and the purchase price per share and number and class of shares covered by each option granted under the ESPP that has not yet been
exercised, and the numerical share limits under the ESPP. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Administration </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board, or a committee appointed by our Board, has authority to administer the ESPP. Unless and until determined otherwise by our Board, the
compensation committee of our Board will administer the ESPP. The administrator has full and exclusive discretionary authority to construe, interpret and apply the terms of the ESPP, delegate ministerial duties to any of employees of the Company,
designate separate offerings under the ESPP, designate any subsidiaries of the Company as participating in the ESPP, determine eligibility, adjudicate all disputed claims filed under the ESPP and establish procedures that it deems necessary or
advisable for the administration of the ESPP, including adopting such <FONT STYLE="white-space:nowrap">procedures,&nbsp;sub-plans&nbsp;and</FONT> appendices to the enrollment agreement as are necessary or appropriate to permit participation in the
ESPP by employees who <FONT STYLE="white-space:nowrap">are&nbsp;non-U.S.&nbsp;nationals</FONT> or employed outside the U.S. The administrator&#146;s findings, decisions and determinations will be final and binding on all participants to the maximum
extent permitted by law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Eligibility </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, any of the Company&#146;s employees are eligible to participate in the ESPP if they are customarily employed by the Company or any
of its participating subsidiaries for at least 20&nbsp;hours per week and more than five months in any calendar year. The administrator, in its discretion, before an enrollment date for all options granted on such enrollment date in an offering, may
determine that an employee who (i)&nbsp;has not completed at least two years of service (or a lesser period of time determined by the administrator) since the employee&#146;s last hire date, (ii)&nbsp;customarily works not more than 20 hours per
week (or a lesser period of time determined by the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-117- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
administrator), (iii) customarily works not more than five months per calendar year (or a lesser period of time determined by the administrator), (iv) is a highly compensated employee within the
meaning of Code Section&nbsp;414(q) or (v)&nbsp;is a highly compensated employee within the meaning of Code Section&nbsp;414(q) with compensation above a certain level or who is an officer or subject to disclosure requirements under
Section&nbsp;16(a) of the Exchange Act, is not eligible to participate in an offering. However, an employee may not be granted an option to purchase stock under the ESPP if the employee (i)&nbsp;immediately after the grant, would own stock and/or
hold outstanding options to purchase such stock possessing 5% or more of the total combined voting power or value of all classes of capital stock of the Company or any parent or subsidiary of the Company; or (ii)&nbsp;holds rights to purchase stock
under all of employee stock purchase plans of the Company that accrue at a rate that exceeds $25,000 worth of stock for each calendar year during which his or her right to purchase shares is outstanding at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participants may end their participation at any time during an offering period and will be paid their accrued contributions that have not yet
been used to purchase shares of Common Stock. Participation ends automatically upon termination of employment with the Company (or its participating subsidiaries). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Offering Periods and Purchase Periods </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP includes a component (the &#147;423 Component&#148;) that is intended to qualify as an &#147;employee stock purchase plan&#148; under
Code Section&nbsp;423, and a component that does not comply with Code Section&nbsp;423 <FONT STYLE="white-space:nowrap">(the&nbsp;&#147;Non-423&nbsp;Component).&#148;</FONT> For purposes of this summary, a reference to the ESPP generally will mean
the terms and operations of the 423 Component. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP provides for offering periods with a duration and start and end dates as
determined by the administrator, provided that no offering period will have a duration exceeding 27 months. Unless determined otherwise by the administrator, each offering period will have one purchase period with the same duration as the offering
period. The administrator is authorized to change the duration of future offering periods and purchase periods under the ESPP, including the starting and ending dates of offering periods and purchase periods and the number of purchase periods in any
offering periods. Unless determined otherwise by the administrator and to the extent an offering period provides for more than one purchase date in such offering period, if the fair market value of a share of Common Stock on a purchase date is less
than the fair market value of a share of Common Stock on the first trading day of the offering period, participants in that offering period will be withdrawn from that offering period following their purchase of shares on such purchase date and
automatically will be enrolled in a new offering period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Contributions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP permits participants to purchase shares of Common Stock through payroll deductions of up to 15% of their eligible compensation, which
includes a participant&#146;s base straight time gross earnings but excludes payments for overtime and shift premium, incentive compensation, bonuses, commissions, equity compensation and other similar compensation. The administrator may change the
compensation eligible for contribution under the ESPP on a uniform and nondiscriminatory basis for future offering periods. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exercise of Purchase Right
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amounts deducted and accumulated by a participant under the ESPP are used to purchase shares of Common Stock at the end of each
purchase period. The purchase price of the shares will be 85% of the lower of (i)&nbsp;the fair market value of a share of Common Stock on the first trading day of the offering period or (ii)&nbsp;the fair market value of a share of Common Stock on
the exercise date. A participant will be permitted to purchase a maximum of 2,000 shares during each offering period, provided that the administrator may increase or decrease such maximum number of shares for each purchase period or offering period.
Until shares of Common Stock are issued (as evidenced by the appropriate entry on the books of the Company or the books of a duly authorized </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-118- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transfer agent of the Company) to a participant, the participant will have only rights of an unsecured creditor with respect to such shares, and no right to vote or receive dividends or any other
rights as a stockholder with respect to such shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Termination of Participation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participation in the ESPP generally will terminate when a participating employee&#146;s employment with the Company or a participating
subsidiary of the Company ceases for any reason, the employee withdraws from the ESPP or the Company terminates or amends the ESPP such that the employee no longer is eligible to participate. An employee may withdraw his or her participation in the
ESPP at any time in accordance with procedures, and prior to any applicable deadline, specified by the administrator. Upon withdrawal from the ESPP, generally the employee will receive all amounts credited to his or her account without interest
(unless otherwise required under applicable law) and his or her payroll withholdings or contributions under the ESPP will cease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT
STYLE="white-space:nowrap">Non-Transferability</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A participant is not permitted to transfer the contributions credited to his or
her ESPP account or rights granted under the ESPP, other than by will or the laws of descent and distribution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dissolution or Liquidation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of the Company&#146;s proposed dissolution or liquidation, any offering period in progress will be shortened by setting a new
purchase date and will terminate immediately before the completion of such proposed transaction, unless determined otherwise by the administrator. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Merger or Change in Control </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event
of a merger or change in control of the Company, as defined in the ESPP, a successor corporation may assume or substitute for each outstanding option. If the successor corporation does not assume or substitute for the options, the offering period
then in progress under the ESPP will be shortened, and a new exercise date will be set to occur before the date of the proposed merger or change in control. The administrator will notify each participant that the exercise date has been changed and
that the participant&#146;s option will be exercised automatically on the new exercise date unless prior to such date the participant has withdrawn from the offering period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Amendment; Termination </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP became
effective upon the Closing. The administrator has the authority to modify, amend, suspend or terminate the ESPP, except that, subject to certain exceptions described in the ESPP, no such action may adversely affect any outstanding rights to purchase
shares of our Common Stock under the ESPP. The ESPP will automatically terminate 20 years after the date of the Closing, unless the administrator of the ESPP terminates it earlier. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Executive Incentive Compensation Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the Closing, the Board considered and approved the Executive Incentive Compensation Plan (the &#147;Incentive Compensation
Plan&#148;), which had been previously approved by the board of directors of Legacy Amprius prior to the Closing. The Executive Incentive Compensation Plan allows the Company to grant incentive awards, generally payable in cash, to employees
selected by the administrator of the Incentive Compensation Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Incentive Compensation Plan, the administrator determines the
performance goals applicable to any award. As determined by the administrator, the performance goals may be based on generally accepted </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-119- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
accounting principles, or GAAP, or <FONT STYLE="white-space:nowrap">non-GAAP</FONT> results and any actual results may be adjusted by the administrator for
<FONT STYLE="white-space:nowrap">one-time</FONT> items or unbudgeted or unexpected items and/or payments of actual awards under the Incentive Compensation Plan when determining whether the performance goals have been met. The goals may be on the
basis of any factors the administrator determines relevant, such as on an individual, divisional, portfolio, project, business unit, segment or company-wide basis. Any criteria used may be measured on such basis as the administrator determines. The
performance goals may differ from participant to participant and from award to award. The administrator also may determine that a target award or a portion thereof will not have a performance goal associated with it but instead will be granted (if
at all) in the compensation committee&#146;s sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Incentive Compensation Plan is administered by our Board or a committee
appointed by the Board. Until our Board determines otherwise, our compensation committee will administer the Incentive Compensation Plan. The administrator of the Incentive Compensation Plan may, in its sole discretion and at any time before payment
of an award, increase, reduce or eliminate a participant&#146;s actual award and/or increase, reduce or eliminate the amount allocated to the bonus pool for a particular performance period. The actual award may be below, at or above a
participant&#146;s target award, in the discretion of the administrator. The administrator may determine the amount of any increase, reduction or elimination on the basis of such factors as it deems relevant, and it is not required to establish any
allocation or weighting with respect to the factors it considers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Actual awards generally will be paid in cash (or its equivalent) only
after they are earned and approved. Unless otherwise determined by the administrator, to earn an actual award a participant must be employed by the Company through the date the actual award is paid. The administrator will have the right to settle an
actual award with a grant of an equity award, which may have such terms and conditions (including vesting) as the administrator determines. Payment of awards occurs after they are earned, but no later than the dates set forth in the Incentive
Compensation Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All awards under the Incentive Compensation Plan will be subject to reduction, cancellation, forfeiture or recoupment
in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the securities of the Company are listed or as is otherwise required by the
Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable laws. In addition, the administrator may impose such other clawback, recovery or recoupment provisions with respect to an award under the Incentive Compensation Plan as it
determines necessary or appropriate, such as a reacquisition right in respect of previously acquired cash, stock or other property provided with respect to an award. Recovery of compensation under a clawback policy generally will not give the
participant the right to resign for &#147;good reason&#148; or &#147;constructive termination&#148; (or similar term) under any agreement with the Company. Additionally, the administrator may specify when providing for an award under the Incentive
Compensation Plan that the participant&#146;s rights, payments and benefits with respect to the award will be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of specified events, in addition to any otherwise
applicable vesting or performance conditions of the award. In the event of an accounting restatement, the recipient of an award will be required to repay a portion of the proceeds received with respect to an award earned or accrued under certain
circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The administrator will have the authority to amend, suspend or terminate the Incentive Compensation Plan, provided such
action does not impair the existing rights of any participant with respect to any earned awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Retirement Benefits </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company maintains a 401(k) retirement savings plan for the benefit of employees of the Company and its participating affiliates who satisfy
certain eligibility requirements. Under the 401(k) plan, eligible employees may elect to defer a portion of their compensation, within the limits prescribed by the Code, on a <FONT STYLE="white-space:nowrap">pre-tax</FONT> or <FONT
STYLE="white-space:nowrap">after-tax</FONT> (Roth) basis, through contributions to the 401(k) plan. The 401(k) plan authorizes discretionary employer matching and/or <FONT STYLE="white-space:nowrap">non-elective</FONT> contributions. The 401(k) plan
is intended to qualify under Sections&nbsp;401(a) and 501(a) of the Code. As a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan, <FONT STYLE="white-space:nowrap">pre-tax</FONT> contributions to the 401(k)
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-120- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
plan and earnings on those <FONT STYLE="white-space:nowrap">pre-tax</FONT> contributions are not taxable to the employees until distributed from the 401(k) plan, and earnings on Roth
contributions are not taxable when distributed from the 401(k) plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at 2021 Year End </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information regarding outstanding equity awards held by our named executive officers as of December&nbsp;31, 2021.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Exercisable<BR>(#)&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Unexercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)&nbsp;(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Kang Sun&nbsp;(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">03/16/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">03/15/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Kang Sun&nbsp;(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">875,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/16/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sandra Wallach&nbsp;(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">08/23/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">08/22/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Ionel Stefan&nbsp;(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">03/16/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">03/15/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Ionel Stefan&nbsp;(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/17/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/11/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Ionel Stefan&nbsp;(8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/26/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">03/19/2028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Ionel Stefan&nbsp;(9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/16/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All stock options were granted pursuant to the 2016 Plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This column represents the fair market value of a share of Common Stock on the date of the grant, as determined
by the Board. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1/48th of the shares subject to the option vested monthly beginning on March&nbsp;1, 2015.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1/48th of the shares subject to the option began vesting monthly on June&nbsp;17, 2021, subject to the
holder&#146;s continuous service through each vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1/4th of the shares subject to the option vests on July&nbsp;26, 2022,<SUP
STYLE="font-size:75%; vertical-align:top"> a</SUP>nd 1/36th vests monthly thereafter, subject to the holder&#146;s continuous service through each vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1/48th of the shares subject to the option vested monthly beginning on March&nbsp;1, 2015.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1/48th of the shares subject to the option vested monthly beginning on January&nbsp;1, 2017.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1/48th of the shares subject to the option vested monthly beginning on March&nbsp;1, 2018.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1/48th of the shares subject to the option began vesting monthly on June&nbsp;17, 2021, subject to the
holder&#146;s continuous service through each vesting date. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below summarizes the compensation of each person serving as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director of Legacy
Amprius for the year ended December&nbsp;31, 2021. For the year ended December&nbsp;31, 2021, no directors received any compensation. Dr.&nbsp;Kang Sun, our Chief Executive Officer, did not receive any additional compensation for his service as a
director in 2021. The compensation of Dr.&nbsp;Sun as a named executive officer is set forth above under &#147;&#151;Summary Compensation Table.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned<BR>or Paid in<BR>Cash<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Options<BR>($)&nbsp;(1)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald R. Dixon</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Wen Hsieh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Steven Chu</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts reported represent the aggregate grant-date fair value of the stock options awarded to the
directors in fiscal 2021, calculated in accordance ASC 718. Such grant-date fair value does not take into </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-121- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
account any estimated forfeitures related to service-vesting conditions. The assumptions used in determining the grant date fair value of the stock options reported are set forth in Note 2 to
Legacy Amprius&#146; audited financial statements included elsewhere in this prospectus. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The following lists all outstanding equity awards held by <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors as of December&nbsp;31, 2021: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Number of<BR>Shares<BR>Underlying<BR>Outstanding<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald R. Dixon</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Wen Hsieh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Steven Chu</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Outside Director Compensation Policy</I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2022, the Legacy Amprius Board retained Compensia, a third-party compensation consultant, to provide the Legacy Amprius Board with an
analysis of publicly available market data regarding practices and compensation levels at comparable companies and assistance in determining compensation to be provided to the Company&#146;s <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors. Based on the discussions with and assistance from the compensation consultant, in connection with the Business Combination, we have adopted an Outside Director Compensation Policy that provides for certain compensation to our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cash Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Outside Director Compensation Policy provides for the following cash compensation program for our
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$40,000 per year for service as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$40,000 per year for service as <FONT STYLE="white-space:nowrap">non-executive</FONT> chair of the Board;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$15,000 per year for service as a lead independent director of the Board; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$20,000 per year for service as chair of our audit committee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$10,000 per year for service as a member of our audit committee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$15,000 per year for service as chair of our compensation committee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$7,500 per year for service as a member of our compensation committee; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$10,000 per year for service as chair of our nominating and corporate governance committee; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$5,000 per year for service as a member of our nominating and corporate governance committee.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Each&nbsp;non-employee</FONT> director who serves as a committee chair of Board will
receive the cash retainer fee as the chair of the committee but not the cash retainer fee as a member of that committee, provided that <FONT STYLE="white-space:nowrap">the&nbsp;non-employee&nbsp;director</FONT> who serves as <FONT
STYLE="white-space:nowrap">the&nbsp;non-employee&nbsp;chair</FONT> of Board will receive the annual retainer fees for such role as well as the annual retainer fee for service as
<FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director.</FONT> These fees to our <FONT STYLE="white-space:nowrap">non-employee&nbsp;directors</FONT> will be paid quarterly in arrears on a prorated basis. The above-listed fees for service
<FONT STYLE="white-space:nowrap">as&nbsp;non-employee&nbsp;chair</FONT> of Board or a chair or member of any committee are payable in addition to <FONT STYLE="white-space:nowrap">the&nbsp;non-employee&nbsp;director</FONT> retainer. Under the Outside
Director Compensation Policy, we also will reimburse <FONT STYLE="white-space:nowrap">its&nbsp;non-employee&nbsp;directors</FONT> for reasonable travel expenses to attend meetings of the Board and its committees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-122- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Equity Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Initial Award </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Outside
Director Compensation Policy, each person who first becomes a <FONT STYLE="white-space:nowrap">non-employee</FONT> director on or after the effective date of such policy will receive, on the first trading day on or after the date that the person
first becomes a <FONT STYLE="white-space:nowrap">non-employee</FONT> director, an initial equity award of restricted stock units covering shares of Common Stock (the &#147;Initial Award&#148;). The Initial Award will have a value on the date of
grant equal to $300,000, with the number of shares subject to the Initial Award rounded to the nearest whole share. Each Initial Award will, vest in equal installments on each of the first 3 anniversaries of the date that a person first becomes a <FONT
STYLE="white-space:nowrap">non-employee</FONT> director, subject to continued service to the Company through the date of vesting. If the person was a member of Board and also an employee, then becoming
<FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director</FONT> due to termination of employment will not entitle the person to an Initial Award. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual Award </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">Each&nbsp;non-employee&nbsp;director</FONT> will receive, on the first trading day after each annual meeting of our stockholders (an &#147;Annual Meeting&#148;) that occurs following the effective date of the Outside
Director Compensation Policy, an annual equity award of restricted stock units covering shares of Common Stock (the &#147;Annual Award&#148;). The Annual Award will have an aggregate value on the date of grant equal to $170,000 (provided that if an
individual began service as <FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director</FONT> after the date of the Annual Meeting that occurred immediately prior to such Annual Meeting (or if there is no such prior Annual Meeting, then
after the Closing Date), then the Annual Award granted to <FONT STYLE="white-space:nowrap">such&nbsp;non-employee&nbsp;director</FONT> will be prorated based on the number of whole months that the individual served as a <FONT
STYLE="white-space:nowrap">non-employee</FONT> director prior to the Annual Award&#146;s grant date during the <FONT STYLE="white-space:nowrap">12-month</FONT> period immediately preceding such Annual Meeting), with the number of shares subject to
the Annual Award rounded to the nearest whole share. Each Annual Award will vest on the earlier of (a)&nbsp;the first anniversary of the date the Annual Award is granted, or (b)&nbsp;the day prior to the date of the Annual Meeting next following the
date the Annual Award is granted, subject to continued service to the Company through the applicable vesting date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Award Terms </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Initial Award and Annual Award will be granted under the 2022 Plan (or its successor plan, as applicable) and form of award agreement
under such plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Change in Control </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of the Company&#146;s change in control, as defined in the 2022 Plan,
<FONT STYLE="white-space:nowrap">each&nbsp;non-employee</FONT> director&#146;s then outstanding equity awards covering shares of Common Stock will accelerate vesting in full, provided that he or she remains
<FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director</FONT> as of immediately before such change in control. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Director Compensation
Limits </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Outside Director Compensation Policy provides that in any given fiscal year of the Company, no outside director may be
granted any equity awards (including equity awards under the 2022 Plan) (the value of which will be based on their grant date fair value) and be provided any other compensation (such as any cash retainers and fees) that in the aggregate exceed
$750,000. For the purposes of this maximum limit provision, the grant date fair values of awards granted under the 2022 Plan will be determined according to GAAP. Any awards or other compensation provided to an individual for his or her services as
an employee or a consultant (other than an outside director), or before the Closing, will not count toward this limit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-123- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Business Combination, on April&nbsp;13, 2022, Legacy Amprius granted the following stock options, to our named executive officers
and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to Dr.&nbsp;Sun, options to acquire 500,000 shares of Legacy Amprius Common Stock, of w<SUP
STYLE="font-size:75%; vertical-align:top">hi</SUP>ch 1/48th vested or will vest monthly beginning on January&nbsp;1, 2022, and options to acquire 375,000 shares of Legacy Amprius Common Stock, of which 1/48 vests monthly beginning on January&nbsp;1,
2023, in each case, subject to the holder&#146;s continuous service through each vesting date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to Ms.&nbsp;Wallach, options to acquire 100,000 shares of Legacy Amprius Common Stock, of which 1/48 vests
monthly beginning on January&nbsp;1, 2023, subject to the holder&#146;s continuous service through each vesting date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to Dr.&nbsp;Stefan, options to acquire 150,000 shares of Legacy Amprius Common Stock, of which 1/48 vests monthly
beginning on January&nbsp;1, 2023, subject to the holder&#146;s continuous service through each vesting date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to Mr.&nbsp;Dixon, options to acquire 185,625 shares of Legacy Amprius Common Stock, of w<SUP
STYLE="font-size:75%; vertical-align:top">hi</SUP>ch 1/48th vested or will vest monthly beginning on January&nbsp;1, 2022 and vest immediately upon a Change in Control (as defined in the 2016 Plan), subject to the holder&#146;s continuous service
through each vesting date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to Dr.&nbsp;Hsieh, options to acquire 185,625 shares of Legacy Amprius Common Stock, of w<SUP
STYLE="font-size:75%; vertical-align:top">hi</SUP>ch 1/48th vested or will vest monthly beginning on January&nbsp;1, 2022 and vest immediately upon a Change in Control (as defined in the 2016 Plan), subject to the holder&#146;s continuous service
through each vesting date; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to Dr.&nbsp;Chu, options to acquire 185,625 shares of Legacy Amprius Common Stock, of w<SUP
STYLE="font-size:75%; vertical-align:top">hi</SUP>ch 1/48th vested or will vest monthly beginning on January&nbsp;1, 2022 and vest immediately upon a Change in Control (as defined in the 2016 Plan), subject to the holder&#146;s continuous service
through each vesting date. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;16, 2022, Ms.&nbsp;Wallach received a cash bonus of $100,000 in connection
with the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 14, 2022, Amprius Holdings made a cash bonus payment of approximately $2.31 million to Dr.&nbsp;Sun. The
payment of such cash bonus by Amprius Holdings has no effect on our cash or operating results. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-124- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_15"></A>CERTAIN RELATIONSHIPS, RELATED PARTY AND OTHER TRANSACTIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sponsor Support Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the Business Combination Agreement, the Company, Legacy Amprius and the Sponsor entered into a Sponsor
Support Agreement (the &#147;Sponsor Support Agreement&#148;), pursuant to which, among other things, the Sponsor reaffirmed its obligations in existing arrangements to vote in favor of each of the proposals to be voted upon at the Special Meeting,
including approval of the Business Combination Agreement and the transactions contemplated thereby, and agreed to be bound by the terms of the <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions in our Bylaws. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business Combination Registration Rights Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Closing Date, the Company, Amprius Holdings and the Sponsor entered into a registration rights agreement (the &#147;Business Combination
Registration Rights Agreement&#148;). Pursuant to the terms of the Business Combination Registration Rights Agreement, we are obligated to file a registration statement to register the resale of certain Company securities held by the parties to the
Business Combination Registration Rights Agreement. In addition, pursuant to the terms of the Business Combination Registration Rights Agreement and subject to certain requirements and customary conditions, including with regard to the number of
demand rights that may be exercised, the parties to the Business Combination Registration Rights Agreement may demand at any time or from time to time, that we file a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (or on
Form <FONT STYLE="white-space:nowrap">S-1</FONT> if Form <FONT STYLE="white-space:nowrap">S-3</FONT> is not available) to register the Company securities held by such holders. The Business Combination Registration Rights Agreement also provides the
holders with &#147;piggy-back&#148; registration rights, subject to certain requirements and customary conditions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PIPE Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Closing Date, certain former directors and officers of the Company and persons who currently serve on the Company&#146;s board of
directors, or their respective affiliates, purchased from the Company an aggregate of 2,052,500 PIPE Units at a price of $10.00 per PIPE Unit. The PIPE Warrants are substantially identical to the Public Warrants, except that the exercise price of
each PIPE Warrant is $12.50 per share (instead of $11.50 per share, which is the exercise price for the Public Warrants), and the average sales price of the Common Stock will need to exceed $20.00 per share (instead of $18.00 per share for the
Public Warrants) for the Company to be able to redeem the PIPE Warrants. The PIPE Warrants are not, and will not be, listed on any securities exchange. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Working Capital Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection
with the Closing, the Sponsor elected to convert $200,000 in working capital loans made to the Company into 400,000 Private Warrants to purchase shares of Common Stock at a price of $0.50 per warrant. On the Closing Date, such Private Warrants were
issued equally to Justin Mirro, Kensington&#146;s Chief Executive Officer and Chairman prior to the Business Combination and a member of the Company&#146;s board of directors, and Daniel Huber, Kensington&#146;s Chief Financial Officer prior to the
Business Combination, who had each advanced <FONT STYLE="white-space:nowrap">one-half</FONT> of such amount to the Sponsor in order for the loan to be made. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Pre-Business</FONT> Combination Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Legacy Amprius was a majority owned subsidiary of Amprius Holdings, which owned approximately 99.6% of the outstanding Legacy Amprius Common
Stock prior to the Business Combination. Amprius Holdings was formed in 2008 to pursue silicon nanowire anode technology conceived at Stanford. In 2015, Amprius Holdings formed Legacy Amprius to be the entity that focused on development of the
silicon nanowire anode. Since its inception, Legacy Amprius&#146; operating resources such as cash, equipment, facilities, personnel and management had been provided by Amprius Holdings. Certain directors and executive officers of the Company own
Amprius Holdings securities or options to purchase Amprius Holdings securities, and all directors of Legacy Amprius prior to the Business Combination are also directors of Amprius Holdings and members of our Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-125- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At various times Amprius Holdings also formed and invested in subsidiaries to pursue
battery-related businesses in China. Because the nature of the different businesses varied widely, ownership of each of these entities was transferred to the Amprius Holdings stockholders in early 2022 so that each could pursue its business
separately. One of the former subsidiaries holds a majority interest in Amprius (Wuxi) Co., Ltd. (&#147;Amprius Wuxi&#148;), a manufacturing joint venture in Wuxi, China that manufactures conventional batteries for the China market. Another builds
battery packs for maritime and other markets. A third, Amprius Nanjing, is developing powders for silicon composite anodes. Following the spin-offs, Dr.&nbsp;Sun, our Chief Executive Officer and a member of our Board, has continued to serve on the
boards of each of these entities and their respective holding companies. The Company&#146;s silicon nanowire anode technology has not been shared with the former subsidiaries, and in 2022, all intellectual property related to such technology was
assigned to the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intercompany Services Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;27, 2017, Legacy Amprius entered into the Intercompany Services Agreement with Amprius Holdings, pursuant to which Amprius
Holdings agreed to provide certain services to Legacy Amprius, including financial and external reporting services, tax and general accounting services, engineering services, legal and patent-related services, services related to business
development, information technology and human resources and other administrative services. The cost attributable to Legacy Amprius was calculated using a percentage allocation of total cost incurred. For the one month ended January&nbsp;31, 2022 and
the years ended December&nbsp;31, 2021 and 2020, the fee for Amprius Holdings&#146; services pursuant to the Intercompany Services Agreement was 25% of total costs incurred by Amprius Holdings in connection with the services provided under the
agreement. From February 2022, the fee for Amprius Holdings&#146; services pursuant to the Intercompany Services Agreement was 100% of total costs incurred by Amprius Holdings in connection with the services provided under the agreement. The
Intercompany Services Agreement terminated in connection with the Closing. Service costs allocated to Legacy Amprius under the Intercompany Services Agreement, including costs related to stock-based compensation, were approximately
$1.4&nbsp;million, $0.4&nbsp;million and $0.4&nbsp;million for the years ended December&nbsp;31, 2021, 2020 and 2019, respectively. For the nine months ended September 30, 2022, service costs allocated to Legacy Amprius, including costs related to
stock-based compensation, were approximately $0.9&nbsp;million. The service costs allocated to Legacy Amprius were accounted for as capital contributions by Amprius Holdings to Legacy Amprius. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Capital Contributions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the
years ended December&nbsp;31, 2021, 2020 and 2019, Amprius Holdings made contributions to Legacy Amprius of approximately $20.2&nbsp;million, $4.5&nbsp;million and $9.7&nbsp;million, respectively, in addition to the amounts allocated under the
Intercompany Services Agreement, to support Legacy Amprius&#146; operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Assignment of Lease </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;1, 2022, Legacy Amprius and Amprius Holdings entered into the Assignment and Assumption of Lease, pursuant to which Amprius
Holdings assigned to Legacy Amprius all its rights, title and interest under the lease agreement for the Company&#146;s headquarters in Fremont, California, and Legacy Amprius assumed all obligations as a lessee under the lease agreement. Under the
terms of the lease agreement, rent is payable in monthly installments on the first day of every calendar month. The current monthly rent payment under the lease agreement is approximately $44,000 and increases to approximately $46,000 by the end of
the lease term. The lease agreement expires on June&nbsp;30, 2024, and the Company&#146;s has the option to extend the lease term for 60 months. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Transactions with Affiliate Subsidiaries </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Legacy Amprius has purchased, and the Company may continue to purchase, raw materials and development materials from Amprius Nanjing and
Amprius Wuxi. For the years ended December&nbsp;31, 2021, 2020 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-126- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and 2019, aggregate purchases from Amprius Nanjing and Amprius Wuxi totaled approximately $0.3&nbsp;million, $0.4&nbsp;million and $0.3&nbsp;million, respectively. From January 1, 2022 through
September&nbsp;30, 2022, aggregate purchases from Amprius Nanjing totaled approximately $0.3 million. There is no commitment on either party to continue such sales. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax Sharing Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the Business Combination Agreement, Legacy Amprius and Amprius Holdings entered into the Tax Sharing
Agreement, a copy of which is included as an exhibit to the registration statement of which this prospectus is a part. The Tax Sharing Agreement generally provides that, with respect to any U.S. federal consolidated group of which Amprius Holdings
and Legacy Amprius were members, Amprius Holdings will be responsible for and will indemnify the Company for the tax liability of such group. In addition, Amprius Holdings will be responsible for and will indemnify the Company for taxes of any
consolidated, combined or unitary tax return for state tax purposes for a group that included Amprius Holdings and Legacy Amprius. The Tax Sharing Agreement also provides that Amprius Holdings will generally control any tax returns and any tax
audits or other proceedings for the taxes addressed by the Tax Sharing Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Support Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the Business Combination Agreement, the Company and Amprius Holdings entered into the Stockholder Support
Agreement pursuant to which, among other things, Amprius Holdings agreed to vote all of its shares of Legacy Amprius Common Stock in favor of the approval and adoption of the Business Combination within 24 hours after the Company&#146;s Registration
Statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> filed in connection with the Special Meeting was declared effective by the SEC. Additionally, Amprius Holdings agreed not to (a)&nbsp;transfer any of its shares of Legacy Amprius Common
Stock (or enter into any arrangement with respect thereto) or (b)&nbsp;enter into any voting arrangement that was inconsistent with the Stockholder Support Agreement. The Stockholder Support Agreement terminated in accordance with its terms upon the
consummation of the Business Combination. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Possible Consolidation with Amprius Holdings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that Amprius Holdings will evaluate its options to facilitate Amprius Holdings&#146; stockholders holding our Common Stock directly
rather than holding it indirectly through Amprius Holdings. Among the options that we believe that Amprius Holdings is considering is a possible transaction whereby Amprius Holdings would be acquired by or merge with a wholly owned subsidiary of the
Company, whereby Amprius Holdings&#146; stockholder would receive shares of Common Stock in exchange for their interests in Amprius Holdings. The terms of any such transaction would be subject to negotiation and approval by our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Party Transactions with Sponsor </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;31, 2021, the Sponsor purchased 7,475,000 Class&nbsp;B Ordinary Shares for an aggregate purchase price of $25,000. On
November&nbsp;30, 2021, the Company effected a share issue of 2,382,142 shares with respect to the Class&nbsp;B Ordinary Shares, resulting in the Sponsor holding an aggregate of 9,857,142 Class&nbsp;B Ordinary Shares. Prior to the initial investment
of $25,000 by the Sponsor, the Company had no assets, tangible or intangible. The number of Class&nbsp;B Ordinary Shares issued was determined based on the expectation that such Class&nbsp;B Ordinary Shares held by the Sponsor would represent 20% of
the outstanding shares upon consummation of the IPO. The Sponsor&#146;s Class&nbsp;B Ordinary Shares (including the Class&nbsp;A Ordinary Shares issuable upon exercise thereof) could not, subject to certain limited exceptions, be transferred,
assigned or sold by the holder. In connection with the Domestication, each Class&nbsp;B Ordinary Share was converted into one share of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor purchased an aggregate of 16,000,000 Private Warrants for a purchase price of $0.50 per Private Warrant simultaneously with the
consummation of the IPO. As such, the Sponsor&#146;s interest in the IPO </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-127- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
was valued at $8,000,000. Each Private Warrant entitled the holder to purchase one Class&nbsp;A Ordinary Share at $11.50 per share, subject to adjustment as provided herein. The Private Warrants
(including the warrants that may be issued upon conversion of working capital loans and the Class&nbsp;A Ordinary Shares issuable upon exercise of such warrants) could not, subject to certain limited exceptions, be transferred, assigned or sold by
the holder. There are no redemption rights or liquidating distributions with respect to the Class&nbsp;B Ordinary Shares or Private Warrants. In connection with the Domestication, the Private Warrants were converted into warrants to purchase one
share of Common Stock at $11.50 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than the payment to an affiliate of Daniel Huber, Kensington&#146;s Chief Financial
Officer prior to the Business Combination, of service and administrative fees of $20,000 per month for 18 months (upon completion of the Business Combination, any portion of the amounts due that were not yet paid were accelerated), no compensation
of any kind, including finder&#146;s and consulting fees, were paid by the Company to the Sponsor, officers and directors, or any of their respective affiliates, for services rendered prior to or in connection with the consummation of the Business
Combination. There was no cap or ceiling on the reimbursement of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by such persons in connection with activities on the Company&#146;s
behalf. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor purchased an aggregate of $32,675,000 Original Units in the IPO, or approximately 16.3% of the Original Units offered
in the IPO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;24, 2021 the Sponsor agreed to loan the Company up to $300,000 to cover the expenses related to the IPO
pursuant to a promissory note. This loan was <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing and payable upon the completion of the IPO; provided that amounts due under the promissory note were, at the option of the Sponsor, convertible
into working capital loans. The Company borrowed $200,000 under the promissory note, and the Sponsor elected to convert the promissory note into a working capital loan on March&nbsp;4, 2022. Prior to the Business Combination, the Sponsor had made
working capital loans of $200,000. Such working capital loans could be repaid out of the proceeds of the trust account holding a portion of the proceeds of the IPO and the concurrent sale of the Private Warrants, or converted into warrants of the
post-Business Combination entity at a price of $0.50 per warrant, such warrants to be identical to the Private Warrants. At the Closing, the working capital loan was converted into 400,000 Private Warrants, as described above. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Letter Agreement </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;1,
2022, the Sponsor and the Company&#146;s officers and directors entered into a Letter Agreement with the Company, pursuant to which they agreed to waive their redemption rights with respect to any Sponsor Shares and any Public Shares held by them in
connection with the completion of the Company&#146;s initial business combination. Pursuant to the Letter Agreement, the Sponsor and the Company&#146;s officers and directors agreed not to transfer any Class&nbsp;B Ordinary Shares until the earlier
of (i)&nbsp;one year after the completion of the Business Combination and (ii)&nbsp;(x) if the last reported sale price of the Common Stock equals or exceeds $12.00 per share for any 20 trading days
<FONT STYLE="white-space:nowrap">within&nbsp;any&nbsp;30-trading&nbsp;day&nbsp;period</FONT> commencing at least 150 days after Business Combination or (y)&nbsp;the date on which the Company completes a liquidation, merger, share exchange,
reorganization or other similar transaction. Pursuant to the Letter Agreement, the Sponsor and the Company&#146;s officer and directors also agreed not to transfer any Private Warrants until 30 days after the completion of the Business Combination.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Person Transactions Policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a written Related Person Transactions Policy that sets forth our policies and procedures regarding the identification, review,
consideration and oversight of &#147;related person transactions.&#148; For purposes of the policy only, a &#147;related person transaction&#148; is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or
relationships) in which the Company or any of its subsidiaries are participants involving an amount that exceeds $120,000, in which any &#147;related person&#148; has a material interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-128- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions involving compensation for services provided to the Company as an employee,
consultant or director will not be considered related person transactions under this policy. A related person is any executive officer, director, nominee to become a director or a holder of more than 5% of any class of our voting securities
(including Common Stock), including any of their immediate family members and affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the policy, the related person in
question or, in the case of transactions with a holder of more than 5% of any class of our voting securities, an officer with knowledge of a proposed transaction, must present information regarding the proposed related person transaction to our
audit committee (or, where review by our audit committee would be inappropriate, to another independent body of the Board) for review. To identify related person transactions in advance, we will rely on information supplied by our executive
officers, directors and certain significant stockholders. In considering related person transactions, our audit committee will take into account the relevant available facts and circumstances, which may include, but are not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks, costs, and benefits to the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact on a director&#146;s independence in the event the related person is a director, immediate family
member of a director or an entity with which a director is affiliated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms of the transaction; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of other sources for comparable services or products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms available to or from, as the case may be, unrelated third parties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee will approve only those transactions that it determines are fair to us and in the Company&#146;s best interests. All of
the transactions described above were entered into prior to the adoption of such policy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into separate indemnification agreements with our directors and executive officers, in addition to the indemnification provided
for in the Certificate of Incorporation and the Bylaws. These agreements, among other things, require us to indemnify our directors and executive officers for certain expenses, including attorneys&#146; fees, judgments, fines and settlement amounts
incurred by a director or executive officer in any action or proceeding arising out of their services as one of our directors or executive officers or as a director or executive officer of any other company or enterprise to which the person provides
services at the Company&#146;s request. For more information regarding these indemnification arrangements, see the section titled &#147;Management&#151;Limitation on Liability and Indemnification of Directors and Officers.&#148; We believe that
these charter provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The limitation of liability and indemnification provisions in the Certificate of Incorporation and the Bylaws may discourage stockholders from
bringing a lawsuit against directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action, if successful, might benefit us and our stockholders. A
stockholder&#146;s investment may decline in value to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-129- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_16"></A>PRINCIPAL SECURITYHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the beneficial ownership of our Common Stock as of November 1, 2022 by: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person known to the Company to be the beneficial owner of more than 5% of outstanding Common Stock;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of the Company&#146;s named executive officers and directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of the executive officers and directors of the Company as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a
security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Common Stock issuable upon exercise of options and
warrants currently exercisable within 60 days are deemed outstanding solely for purposes of calculating the percentage of total voting power of the beneficial owner thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, the Company believes that each beneficial owner named in the table below has the sole voting and investment power
with respect to all shares of Common Stock beneficially owned by such beneficial owner and the business address of each of the following entities or individuals is 1180 Page Avenue, Fremont, California 94538. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:9pt; font-family:Times New Roman; "><B>Name of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Common<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Five Percent Holders</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amprius Holdings&nbsp;(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,515,552</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Directors and Named Executive Officers</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Kang Sun&nbsp;(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,440,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sandra Wallach&nbsp;(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">206,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Ionel Stefan&nbsp;(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">828,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald R. Dixon&nbsp;(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">261,932</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Wen Hsieh&nbsp;(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61,932</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Steven Chu&nbsp;(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,932</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Justin Mirro&nbsp;(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,619,142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>All Directors and Executive Officers as a Group&nbsp;(8&nbsp;Individuals)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>13,668,815</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>15.3</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than 1%. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Certain directors and executive officers of the Company own Amprius Holdings securities or options to purchase
Amprius Holdings securities, and certain directors of Amprius are also directors of Amprius Holdings, but none of our directors or executive officers are deemed to have or share beneficial ownership with respect to any shares of Common Stock owned
by Amprius Holdings. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of shares of Common Stock underlying options that are exercisable within 60 days of November 1, 2022.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 61,932 shares of Common Stock underlying options that are exercisable within 60 days of
November 1, 2022, (ii) 100,000 shares of Common Stock purchased in the PIPE held by The Dixon Revocable Trust, of which Mr.&nbsp;Dixon is <FONT STYLE="white-space:nowrap">co-trustee,</FONT> and (iii) 100,000 shares of Common Stock issuable upon the
exercise of the PIPE Warrants held by The Dixon Revocable Trust. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 61,932 shares of Common Stock underlying options that are exercisable within 60 days of
November 1, 2022, (ii) 2,500 shares of Common Stock purchased in the PIPE and (iii) 2,500 shares of Common Stock issuable upon the exercise of PIPE Warrants. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-130- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 1,000,000 shares of Common Stock held by Mr.&nbsp;Mirro as trustee of the Justin E. Mirro
Qualified Annuity Trust dated 6/27/20, (ii) 200,000 shares of Common Stock issuable upon exercise of Private Warrants held by Mr.&nbsp;Mirro, (iii) 2,608,142 shares of Common Stock, including 111,000 shares of Common Stock purchased in the PIPE,
held by Kensington Capital Partners, LLC, (iv) 4,700,000 shares of Common Stock issuable upon the exercise of Private Warrants held by Kensington Capital Partners, LLC and (v) 111,000 shares of Common Stock issuable upon the exercise of the PIPE
Warrants held by Kensington Capital Partners, LLC. Mr.&nbsp;Mirro is the managing member of Kensington Capital Partners, LLC. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please see the sections titled &#147;Management,&#148; &#147;Executive Compensation&#148; and &#147;Certain Relationships, Related Party and
Other Transactions&#148; for information regarding material relationships with our principal securityholders within the past two years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-131- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_17"></A>SELLING STOCKHOLDER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus relates to the offer and sale by BRPC II of up to 16,825,366 shares of our Common Stock that have been and may be issued by us
to BRPC II under the Purchase Agreement. For additional information regarding the shares of our Common Stock included in this prospectus, see the section titled &#147;Committed Equity Financing&#148; above. We are registering the shares of our
Common Stock included in this prospectus pursuant to the provisions of the Committed Equity Registration Rights Agreement we entered into with BRPC II on September&nbsp;27, 2022 in order to permit the Selling Stockholder to offer the shares included
in this prospectus for resale from time to time. Except for the transactions contemplated by the Purchase Agreement and the Committed Equity Registration Rights Agreement and as set forth in the section titled &#147;Plan of Distribution (Conflict of
Interest)&#148; in this prospectus, BRPC II has not had any material relationship with us within the past three years. As used in this prospectus, the term &#147;Selling Stockholder&#148; means BRPC II. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below presents information regarding the Selling Stockholder and the shares of our Common Stock that may be resold by the Selling
Stockholder from time to time under this prospectus. This table is prepared based on information supplied to us by the Selling Stockholder, and reflects holdings as of November&nbsp;1, 2022. The number of shares in the column &#147;Maximum Number of
Shares of Common Stock to be Offered Pursuant to this Prospectus&#148; represents all of the shares of our Common Stock being offered for resale by the Selling Stockholder under this prospectus. The Selling Stockholder may sell some, all or none of
the shares being offered for resale in this offering. We do not know how long the Selling Stockholder will hold the shares before selling them and, except as set forth in the section titled &#147;Plan of Distribution (Conflict of Interest)&#148; in
this prospectus, we are not aware of any existing arrangements between the Selling Stockholder and any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the shares of our Common Stock being offered for
resale by this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with Rule <FONT STYLE="white-space:nowrap">13d-3(d)</FONT>
promulgated by the SEC under the Exchange Act, and includes shares of our Common Stock with respect to which the Selling Stockholder has sole or shared voting and investment power. The percentage of shares of our Common Stock beneficially owned by
the Selling Stockholder prior to the offering shown in the table below is based on an aggregate of 84,467,987 shares of our Common Stock outstanding on November 1, 2022. Because the purchase price to be paid by the Selling Stockholder for shares of
our Common Stock, if any, that we may elect to sell to the Selling Stockholder in one or more VWAP Purchases and one or more Intraday VWAP Purchases from time to time under the Purchase Agreement will be determined on the applicable Purchase Dates
therefor, the actual number of shares of our Common Stock that we may sell to the Selling Stockholder under the Purchase Agreement may be fewer than the number of shares being offered for resale under this prospectus. The fourth column assumes the
resale by the Selling Stockholder of all of the shares of our Common Stock being offered for resale pursuant to this prospectus. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Selling Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of Shares of<BR>Common Stock<BR>Beneficially Owned<BR>Prior to Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum<BR>Number of<BR>Shares of<BR>Common<BR>Stock to be<BR>Offered<BR>Pursuant to<BR>this<BR>Prospectus</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of Shares<BR>of Common Stock<BR>Beneficially<BR>Owned After<BR>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">B.Riley Principal Capital II, LLC (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,825,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than 1%. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the 84,793 shares of our Common Stock we issued to B.Riley Principal Capital II, LLC (&#147;BRPC
II&#148;) on September&nbsp;27, 2022 as Initial Commitment Shares in consideration for entering into the Purchase Agreement with us. In accordance with Rule <FONT STYLE="white-space:nowrap">13d-3(d)</FONT> under the Exchange Act, we have excluded
from the number of shares beneficially owned prior to the offering (i)&nbsp;all of the shares of our Common Stock that </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-132- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
BRPC II may be required to purchase under the Purchase Agreement, because the issuance of such shares is solely at our discretion and is subject to conditions contained in the Purchase Agreement,
the satisfaction of which are entirely outside of BRPC&nbsp;II&#146;s control, including the registration statement that includes this prospectus becoming and remaining effective, and (ii) 84,793 shares of our Common Stock that we may issue to BRPC
II as Additional Commitment Shares, because the issuance of the Additional Commitment Shares to BRPC II is subject to our election to sell a certain amount of shares of our Common Stock to BRPC II pursuant to the Purchase Agreement as set forth in
the Purchase Agreement, which is entirely at our discretion and subject to satisfaction of conditions contained in the Purchase Agreement that are outside of BRPC II&#146;s control. Furthermore, the VWAP Purchases and the Intraday VWAP Purchases of
our Common Stock under the Purchase Agreement are subject to certain agreed upon maximum amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement prohibits us from issuing and selling any shares of our Common Stock to
BRPC II to the extent such shares, when aggregated with all other shares of our Common Stock then beneficially owned by BRPC II, would cause BRPC II&#146;s beneficial ownership of our Common Stock to exceed the 4.99% Beneficial Ownership Limitation.
The Purchase Agreement also prohibits us from issuing or selling shares of our Common Stock under the Purchase Agreement in excess of the 19.99% Exchange Cap, unless we obtain stockholder approval to do so, or unless sales of our Common Stock are
made by us to BRPC II at a price equal to or greater than the applicable &#147;minimum price&#148; (as defined in the applicable listing rules of the NYSE) of the Common Stock, calculated at the time VWAP Purchases and Intraday VWAP Purchases are
effected by us under the Purchase Agreement, if any, as adjusted such that the Exchange Cap limitation would not apply under applicable NYSE rules. Neither the Beneficial Ownership Limitation nor the Exchange Cap (to the extent applicable under NYSE
rules) may be amended or waived under the Purchase Agreement. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The business address of BRPC II is 11100 Santa Monica Blvd., Suite 800, Los Angeles, California 90025. BRPC
II&#146;s principal business is that of a private investor. BRPC II is a wholly-owned subsidiary of B. Riley Principal Investments, LLC (&#147;BRPI&#148;). As a result, BRPI may be deemed to indirectly beneficially own the securities of the company
held of record by BRPC II. B. Riley Financial, Inc. (&#147;BRF&#148;) is the parent company of BRPC II and BRPI. As a result, BRF may be deemed to indirectly beneficially own the securities of the company held of record by BRPC II and indirectly
beneficially owned by BRPI. Bryant R. Riley is the <FONT STYLE="white-space:nowrap">Co-Chief</FONT> Executive Officer and Chairman of the Board of Directors of BRF. As a result, Bryant R. Riley may be deemed to indirectly beneficially own the
securities of the company held of record by BRPC II and indirectly beneficially owned by BRPI. Each of BRF, BRPI and Bryant R. Riley expressly disclaims beneficial ownership of the securities of the company held of record by BRPC II, except to the
extent of its/his pecuniary interest therein. We have been advised that none of BRF, BRPI or BRPC II is a member of the Financial Industry Regulatory Authority, Inc. (&#147;FINRA&#148;) or an independent broker-dealer; however, each of BRF, BRPI,
BRPC II and Bryant R. Riley is an affiliate of BRS, a registered broker-dealer and FINRA member, and Bryant R. Riley is an associated person of BRS. BRS will act as an executing broker that will effectuate resales of our Common Stock that have been
and may be acquired by BRPC II from us pursuant to the Purchase Agreement to the public in this offering. See &#147;Plan of Distribution (Conflict of Interest)&#148; for more information about the relationship between BRPC II and BRS.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-133- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_18"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary of the material terms of our securities as of the date of this prospectus as specified in our Certificate of
Incorporation and Bylaws. Because the following description is only a summary, it does not contain all of the information that may be important to you. For a complete description of matters set forth in this section titled &#147;Description of
Capital Stock,&#148; you should refer to the Certificate of Incorporation and Bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The authorized capital stock of the Company consists of 1,000,000,000 shares, $0.0001 par value per share, of which: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">950,000,000 shares are designated as Common Stock; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">50,000,000 shares are designated as preferred stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of November&nbsp;1, 2022, we had outstanding 84,467,987 shares of Common Stock and no shares of preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Certificate of
Incorporation authorizes the Common Stock. The material terms of our Common Stock are discussed in greater detail below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividend Rights
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of Common Stock will
be entitled to receive dividends out of funds legally available if the Board, in its discretion, determines to issue dividends and then only at the times and in the amounts that the Board may determine. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Common
Stock are entitled to one vote for each share held as of the record date for the determination of the stockholders entitled to vote on such matters, except as otherwise required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of holders of any series of preferred stock with respect to the election of directors, the number of directors that
constitutes our Board will be fixed solely by resolution of our Board. Our Board is divided into three classes, Class&nbsp;I, Class&nbsp;II and Class&nbsp;III, with only one class of directors being elected in each year and each class serving a
three-year term. There is no cumulative voting with respect to the election of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Right to Receive Liquidation Distributions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we become subject to a liquidation, dissolution, or <FONT STYLE="white-space:nowrap">winding-up,</FONT> the assets legally available for
distribution to our stockholders would be distributable ratably among the holders of our Common Stock and any participating series of our preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities
and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Matters
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of our Common Stock will be fully paid and nonassessable. Our Common Stock is not entitled to preemptive
rights and is not be subject to redemption or sinking fund provisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-134- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board is authorized, subject to limitations prescribed by the DGCL, to issue preferred stock in one or more series, to establish from time
to time the number of shares to be included in each series, and to fix the designation, powers, preferences, and rights of the shares of each series and any of its qualifications, limitations, or restrictions, in each case without further vote or
action by our stockholders. Our Board is empowered to increase or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding, without any further vote or action by our
stockholders. Our Board is able to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of Common Stock. The issuance of preferred stock, while
providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring, or preventing a change in control of the Company and might adversely affect the market
price of our Common Stock and the voting and other rights of the holders of our Common Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain provisions of Delaware law, our Certificate of Incorporation and our Bylaws, which are summarized below, may have the effect of
delaying, deferring, or discouraging another person from acquiring control of the Company. They are also designed, in part, to encourage persons seeking to acquire control of the Company to negotiate first with our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Section&nbsp;203 of the DGCL </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
are governed by the provisions of Section&nbsp;203 of the DGCL. In general, Section&nbsp;203 of the DGCL prohibits a public Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a
period of three years after the date of the transaction in which the person became an interested stockholder, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">either the business combination or the transaction that resulted in the stockholder becoming an interested
stockholder was approved by the board of directors prior to the time that the stockholder became an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the
interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding shares owned by directors who are also officers of the corporation and shares owned by employee stock plans
in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at or subsequent to the time the stockholder became an interested stockholder, the business combination was
approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding voting stock
which is not owned by the interested stockholder. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203 defines a &#147;business
combination&#148; to include mergers, asset sales, and other transactions resulting in financial benefit to a stockholder and an &#147;interested stockholder&#148; as a person who, together with affiliates and associates, owns, or, within the prior
three years, did own, 15% or more of the corporation&#146;s outstanding voting stock. These provisions may have the effect of delaying, deferring, or preventing changes in control of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-135- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certificate of Incorporation and Bylaws Provisions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Certificate of Incorporation and Bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in
control of the Board or management team, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Board of Directors vacancies</U>. Our Certificate of Incorporation and Bylaws authorize only a majority of the
remaining members of our Board, although less than a quorum, to fill vacant directorships, including newly created seats. In addition, subject to the rights of holders of any series of preferred stock, the number of directors constituting our Board
will be permitted to be set only by a resolution of our Board. These provisions would prevent a stockholder from increasing the size of our Board and then gaining control of our Board by filling the resulting vacancies with its own nominees. This
will make it more difficult to change the composition of our Board and will promote continuity of management. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Board or Directors divided into three classes</U>. Our Board is divided into three classes, Class&nbsp;I,
Class&nbsp;II and Class&nbsp;III, with only one class of directors being elected in each year and each class serving for three-year terms. As a result, in most circumstances, a person can gain control of our Board only by successfully engaging in a
proxy contest at two or more annual meetings. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Stockholder action; special meeting of stockholders</U>. Our Certificate of Incorporation and Bylaws provide
that our stockholders may not take action by written consent but may only take action at annual or special meetings of the stockholders. As a result, a holder controlling a majority of our capital stock would not be able to amend the Bylaws, amend
the Certificate of Incorporation or remove directors without holding a meeting of our stockholders called in accordance with the Certificate of Incorporation and Bylaws. The Certificate of Incorporation and Bylaws further provide that special
meetings of our stockholders may be called only by a majority of our Board, the chair of our Board, the President of the Company or the Chief Executive Officer of the Company, thus prohibiting stockholder action to call a special meeting. These
provisions might delay the ability of our stockholders to force consideration of a proposal or for stockholders controlling a majority of our capital stock to take any action, including the removal of directors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Advance notice requirements for stockholder proposals and director nominations</U>. The Bylaws provide advance
notice procedures for stockholders seeking to bring business before the annual meeting of stockholders or to nominate candidates for election as directors at the annual meeting of stockholders. The Bylaws also specify certain requirements regarding
the form and content of a stockholder&#146;s notice. These provisions might preclude our stockholders from bringing matters before the annual meeting of stockholders or from making nominations for directors at the annual meeting of stockholders if
the proper procedures are not followed. These provisions may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#146;s own slate of directors or otherwise attempting to obtain control of the
Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>No cumulative voting</U>. The DGCL provides that stockholders are not entitled to cumulate votes in the
election of directors unless a corporation&#146;s certificate of incorporation provides otherwise. The Certificate of Incorporation does not provide for cumulative voting. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Amendment of charter and bylaws provisions</U>. Any amendment of the above provisions in the Certificate of
Incorporation and Bylaws will require approval by holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the voting power of our then outstanding capital stock. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Issuance of preferred stock</U>. Our Certificate of Incorporation provides that our Board will have the
authority, without further action by our stockholders, to issue up to 50,000,000 shares of preferred stock with rights and preferences, including voting rights, designated from time to time by the Board. The existence of authorized but unissued
shares of preferred stock would enable the Board to render more difficult or to discourage an attempt to obtain control of the Company by means of a tender offer, proxy contest, or other means. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-136- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Exclusive forum</U>. Our Bylaws provide that, unless otherwise consented to by the Company in writing, the
Court of Chancery of the of Delaware (or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) shall, to the fullest extent permitted by law be the sole and
exclusive forum for the following types of actions or proceedings: (i)&nbsp;any derivative action or proceeding brought on behalf of the Company; (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by, or otherwise wrongdoing
by, any of our directors, officers, or other employees to the Company or its stockholders; (iii)&nbsp;any action arising pursuant to any provision of the DGCL or the Certificate of Incorporation or the Bylaws; or (iv)&nbsp;any other action asserting
a claim that is governed by the internal affairs doctrine, in all cases subject to the court having jurisdiction over indispensable parties named as defendants. This provision would not apply to suits brought to enforce a duty or liability created
by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction. The Bylaws further provide that, unless otherwise consented to by the Company in writing, the federal district courts of the United States will be
the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. Any person or entity purchasing or otherwise acquiring any interest in our securities shall be deemed to have notice of
and consented to this provision. These provisions may have the effect of discouraging lawsuits against the Company or its directors and officers. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of November 1, 2022, we had
outstanding 47,720,946 Warrants, consisting of 29,268,446 Public Warrants, 16,400,000 Private Warrants and 2,052,500 PIPE Warrants. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Public Warrants
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each whole warrant entitles the registered holder to purchase one share of Common Stock at a price of $11.50 per share, subject to
adjustment as discussed below, except as described below. Pursuant to the Warrant Agreement, a warrant holder may exercise its warrants only for a whole number of shares of Common Stock. The Warrants will expire five years after the completion of
the Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not be obligated to
deliver any shares of Common Stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock
underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration. No warrant will be exercisable and we will not be obligated to issue
shares of Common Stock upon exercise of a warrant unless the Common Stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the
warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire
worthless. In no event will we be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price
for the unit solely for the share of Common Stock underlying such unit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed that as soon as practicable, but in no event later
than 20 business days, after the closing of the Business Combination, we will use our commercially reasonable efforts to file, and within 60 business days following the Business Combination to have declared effective, a post-effective amendment to
the registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-265740),</FONT> which was declared effective by the SEC on September&nbsp;1, 2022, or a new registration statement for
the registration, under the Securities Act, covering the issuance of the shares of Common Stock issuable upon exercise of the warrants. We will use our commercially reasonable efforts to maintain the effectiveness of such registration statement, and
a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the Warrant Agreement. If a registration </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-137- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statement covering the Common Stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the Business Combination, warrant holders may, beginning
on the 61st business day after such closing and ending upon such time as there is an effective registration statement, and during any period when we will have failed to maintain an effective registration statement, exercise warrants on a
&#147;cashless basis&#148; in accordance with Section&nbsp;3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Common Stock is at the time of any exercise of a warrant not listed on a national securities exchange
such that it satisfies the definition of a &#147;covered security&#148; under Section&nbsp;18(b)(1) of the Securities Act, we may, at our option, require holders of Public Warrants who exercise their warrants to do so on a &#147;cashless basis&#148;
in accordance with Section&nbsp;3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, but we will be required to use our best efforts to register or qualify the
shares under applicable blue sky laws to the extent an exemption is not available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Redemption of warrants when the price per share of
Common Stock equals or exceeds $18.00.</I><B><I></I></B>&nbsp;Once the warrants become exercisable, we may redeem the outstanding warrants (except for the Private Warrants): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in whole and not in part; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a price of $0.01 per warrant; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon not less than 30 days&#146; prior written notice of redemption (the
<FONT STYLE="white-space:nowrap">&#147;30-day</FONT> redemption period&#148;) to each warrant holder; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the last reported sale price of our Common Stock equals or exceeds $18.00 per share (as adjusted
for stock splits, stock dividends, reorganizations, recapitalizations and the like and as described under the heading &#147;&#151;Anti-dilution Adjustments&#148; below) for any 20 trading days within a
<FONT STYLE="white-space:nowrap">30-trading</FONT> day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not redeem the warrants unless a registration statement under the Securities Act covering the issuance of the shares of Common Stock
issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Common Stock is available throughout <FONT STYLE="white-space:nowrap">the&nbsp;30-day&nbsp;redemption</FONT> period, except if the warrants may
be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the
underlying securities for sale under all applicable state securities laws. As a result, we may redeem the warrants as set forth above even if the holders are otherwise unable to exercise the warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have established the $18.00 per share (subject to adjustment) redemption criteria discussed above to prevent a redemption call unless there
is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise its warrant prior to the
scheduled redemption date. However, the price of our Common Stock may fall below the $18.00 redemption trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $11.50 (for whole
shares) warrant exercise price after the redemption notice is issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we call the Public Warrants for redemption for cash as described
above, our management will have the option to require any holder that wishes to exercise its warrant to do so on a &#147;cashless basis.&#148; In determining whether to require all holders thereof to exercise their warrants on a &#147;cashless
basis,&#148; our management will consider, among other factors, our cash position, the number of warrants that are outstanding and the dilutive effect on our stockholders of issuing the maximum number of shares of Common Stock issuable upon the
exercise of our warrants. If our management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of Common Stock equal to the quotient obtained by dividing
(x)&nbsp;the product of the number of shares of Common Stock underlying the warrants, multiplied by the excess of the &#147;fair market value&#148; (defined below) over the exercise price of the warrants by
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-138- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(y)&nbsp;the fair market value. The &#147;fair market value&#148; shall mean the average last reported sale price of our Common Stock for the 10&nbsp;trading days ending on the third trading day
prior to the date on which the notice of redemption is sent to the holders of warrants. If our management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Common
Stock to be received upon exercise of the warrants, including the &#147;fair market value&#148; in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a
warrant redemption. We believe this feature is an attractive option to us if we do not need the cash from the exercise of the warrants after our initial business combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the Private Warrants will be redeemable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Exercise Limitation.</I><B><I></I></B>&nbsp;A holder of a warrant may notify us in writing in the event it elects to be subject to a
requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person&#146;s affiliates), to the warrant agent&#146;s actual knowledge, would
beneficially own in excess of 4.8% or 9.8% (or such other amount as a holder may specify) of the shares of Common Stock outstanding immediately after giving effect to such exercise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Anti-Dilution Adjustments</I>. If the number of outstanding shares of Common Stock is increased by a stock dividend payable in shares of
Common Stock, or <FONT STYLE="white-space:nowrap">by&nbsp;a&nbsp;split-up&nbsp;of&nbsp;shares</FONT> of Common Stock or other similar event, then, on the effective date of such stock dividend,
<FONT STYLE="white-space:nowrap">split-up&nbsp;or&nbsp;similar</FONT> event, the number of shares of Common Stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding shares of Common Stock. A
rights offering to holders of Common Stock entitling holders to purchase shares of Common Stock at a price less than the fair market value will be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i)&nbsp;the
number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Common Stock) multiplied by (ii)&nbsp;one (1)&nbsp;minus
the quotient of (x)&nbsp;the price per share of Common Stock paid in such rights offering divided by (y)&nbsp;the fair market value. For these purposes (i)&nbsp;if the rights offering is for securities convertible into or exercisable for Common
Stock, in determining the price payable for Common Stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii)&nbsp;fair market value means the
volume weighted average price of Common Stock as reported during the ten (10)&nbsp;trading day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market,
regular way, without the right to receive such rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if we, at any time while the warrants are outstanding and unexpired,
pay a dividend or make a distribution in cash, securities or other assets to the holders of Common Stock on account of such shares of Common Stock (or other securities into which the warrants are convertible), other than (a)&nbsp;as described above
or (b)&nbsp;certain ordinary cash dividends, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid
on each share of Common Stock in respect of such event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the number of outstanding shares of Common Stock is decreased by a
consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number
of shares of Common Stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever the number of shares of Common Stock purchasable upon the exercise of the warrants is adjusted as described above, the warrant
exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x)&nbsp;the numerator of which will be the number of shares of Common Stock purchasable upon the exercise of the warrants
immediately prior to such adjustment, and (y)&nbsp;the denominator of which will be the number of shares of Common Stock so purchasable immediately thereafter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-139- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case of any reclassification or reorganization of the outstanding shares of Common Stock
(other than those described above or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the
continuing corporation and that does not result in any reclassification or reorganization of our outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as
an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and
in lieu of the shares of Common Stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon
such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such
event. However, (i)&nbsp;if the holders of our Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of
securities, cash or other assets for which each warrant will become exercisable will be deemed to be the weighted average of the kind and amount received per share by such holders of Common Stock in such consolidation or merger that affirmatively
make such election, and (ii)&nbsp;if a tender, exchange or redemption offer has been made to and accepted by such holders under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any
group (within the meaning of <FONT STYLE="white-space:nowrap">Rule&nbsp;13d-5(b)(1)&nbsp;under</FONT> the Exchange Act (or any successor rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the
meaning of <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2&nbsp;under</FONT> the Exchange Act (or any successor rule)) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of <FONT
STYLE="white-space:nowrap">Rule&nbsp;13d-3&nbsp;under</FONT> the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of Common Stock, the holder of a warrant will be entitled to receive the highest amount of cash,
securities or other property to which such holder would actually have been entitled as a stockholder if such warrant holder had exercised the warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common
Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in the
Warrant Agreement. Additionally, if less than 70% of the consideration receivable by the holders of Common Stock in such a transaction is payable in the form of common stock in the successor entity that is listed for trading on a national securities
exchange or is quoted in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">an&nbsp;established&nbsp;over-the-counter&nbsp;market,&nbsp;or</FONT></FONT> is to be so listed for trading or quoted immediately following such event, and if
the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the Warrant Agreement based on the Black-Scholes value
(as defined in the Warrant Agreement) of the warrant. The warrants will be issued in registered form under the Warrant Agreement between Continental Stock Transfer&nbsp;&amp; Trust Company, as warrant agent, and us. You should review a copy of the
Warrant Agreement, a copy of which is filed as an exhibit to the registration statement of which this prospectus is a part, for a complete description of the terms and conditions applicable to the warrants. The Warrant Agreement provides that the
terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the then outstanding Public Warrants to make any change that
adversely affects the interests of the registered holders of Public Warrants and, solely with respect to any amendment to the terms of the Private Warrants or any provision of the Warrant Agreement with respect to the Private Warrants, 50% of the
number of the then outstanding Private Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The warrant holders do not have the rights or privileges of holders of Common Stock or
any voting rights until they exercise their warrants and receive shares of Common Stock. After the issuance of shares of Common Stock upon exercise of the warrants, each holder will be entitled to one (1)&nbsp;vote for each share held of record on
all matters to be voted on by stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-140- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the
warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number of shares of Common Stock to be issued to the warrant holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to the
Warrant Agreement will be brought and enforced in the courts of the State of New&nbsp;York or the United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will be the
exclusive forum for any such action, proceeding or claim. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of
America are the sole and exclusive forum. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Private Warrants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Private Warrants (including the Common Stock issuable upon exercise of such Warrants) were not transferable or saleable prior to the 30<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> day after the completion of the Business Combination (except that, among other limited exceptions made to our officers and directors and other persons or entities affiliated with or related to the
Sponsor, each of which will be subject to the same transfer restrictions). The Sponsor, or its permitted transferees, has the option to exercise the Private Warrants on a cashless basis and the Sponsor and its permitted transferees will also have
certain registration rights related to the Private Warrants (including the shares of Common Stock issuable upon exercise of the Private Warrants), as described below. In addition, none of the Private Warrants will be redeemable by us. Otherwise, the
Private Warrants have terms and provisions that are identical to those of the Public Warrants, including as to exercise price, exercisability and exercise period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If holders of the Private Warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering their
warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x)&nbsp;the product of the number of shares of Common Stock underlying the warrants, multiplied by the excess of the &#147;sponsor fair market value&#148;
(defined below) over the exercise price of the warrants by (y)&nbsp;the sponsor fair market value. The &#147;sponsor fair market value&#148; shall mean the average last reported sale price of our Common Stock for the 10 trading days ending on the
third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>PIPE Warrants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the PIPE Warrants are governed by the PIPE Warrant Agreement. The PIPE Warrants are substantially identical to the Public
Warrants, except that (i)&nbsp;the exercise price of each PIPE Warrant is $12.50 per share (instead of $11.50 per share, which is the exercise price for the Public Warrants) and (ii)&nbsp;the average sales price of the Common Stock will need to
exceed $20.00 per share (instead of $18.00 per share for the Public Warrants) for the Company to be able to redeem the PIPE Warrants. The PIPE Warrants are also not listed on any securities exchange. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Form <FONT STYLE="white-space:nowrap">S-8</FONT> Registration Statement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to file one or more registration statements on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act to register
the shares of Common Stock issued or issuable under the 2016 Plan, the 2022 Plan and the ESPP. Any such <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> registration statement will become effective automatically upon filing. We expect that the
initial registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> will cover shares of Common Stock underlying the 2016 Plan, the 2022 Plan and the ESPP. Once these shares are registered, they can be sold in the public market upon
issuance, subject to <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions, Rule 144 limitations applicable to affiliates and vesting restrictions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-141- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_19"></A>SECURITIES ACT RESTRICTIONS ON RESALE OF SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Shares Eligible for Future Sale </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Future
sales of our Common Stock in the public market, or the availability of such shares for sale in the public market, could adversely affect market prices of our Common Stock prevailing from time to time. Sales of our Common Stock in the public market,
or the perception that those sales may occur, could adversely affect the prevailing market price at such time and our ability to raise equity capital in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus registers up to 16,825,366 shares of Common Stock for resale by BRPC II that we may issue to BRPC II from time to time during
the term of the Purchase Agreement. As a result of the registration statement of which this prospectus forms a part, if and when we do sell shares to BRPC II, up to 16,825,366 shares of Common Stock will be freely tradable, subject to compliance
with applicable securities law requirements (in addition to the 3,215,224 shares of Common Stock and 22,947,724 Warrants already freely tradable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 144 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Rule 144, a person
who has beneficially owned restricted shares of our Common Stock or Warrants for at least six months would be entitled to sell their securities provided that (i)&nbsp;such person is not deemed to have been one of our affiliates at the time of, or at
any time during the three months preceding, a sale and (ii)&nbsp;we are subject to the Exchange Act periodic reporting requirements for at least three months before the sale and have filed all required reports under Section&nbsp;13 or 15(d) of the
Exchange Act during the 12 months (or such shorter period as we were required to file reports) preceding the sale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Persons who have
beneficially owned restricted shares of our Common Stock or Warrants for at least six months but who are our affiliates at the time of, or at any time during the three months preceding, a sale, would be subject to additional restrictions, by which
such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1% of the total number of shares of such securities then-outstanding; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average weekly reported trading volume of such securities during the four calendar weeks preceding the filing
of a notice on Form 144 with respect to the sale. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales by our affiliates under Rule 144 are also limited by manner of
sale provisions and notice requirements and to the availability of current public information about us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restrictions on the Use of Rule 144 by Shell
Companies or Former Shell Companies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rule 144 is not available for the resale of securities initially issued by shell companies (other
than business combination related shell companies) or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following conditions are met: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuer of the securities that was formerly a shell company has ceased to be a shell company;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuer of the securities is subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange
Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuer of the securities has filed all Exchange Act reports and materials required to be filed, as
applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form <FONT STYLE="white-space:nowrap">8-K;</FONT> and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC
reflecting its status as an entity that is not a shell company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-142- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While we were formed as a shell company, since the completion of the business combination,
we are no longer a shell company, and so, once the conditions set forth in the exceptions listed above are satisfied, Rule 144 will become available for the resale of the above noted restricted securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Lock-up</FONT> Restrictions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">lock-up</FONT> provision in our Bylaws provides that, without the prior unanimous consent of our Board and
subject to certain customary exceptions, including exceptions that carve out transactions involving securities purchased in the PIPE or in the IPO, each holder of Common Stock issued (i)&nbsp;as consideration pursuant to the Business Combination
Agreement, (ii)&nbsp;upon the exercise of warrants or other convertible securities outstanding following the Effective Time in respect of warrants or convertible securities of Amprius outstanding immediately prior to the Effective Time (iii)&nbsp;to
directors, officers and employees upon the settlement or exercise of stock options, restricted stock units, or other equity awards outstanding as of immediately following the Closing in respect of awards of Amprius outstanding immediately prior to
the Effective Time or (iv)&nbsp;held by the Sponsor and the Insiders (as defined in the Letter Agreement, dated March&nbsp;1, 2022, by and among the Company, the Sponsor or the other signatories thereto) outstanding immediately following the
Effective Time, will not, through September&nbsp;13, 2023, directly or indirectly, lend, sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, their shares
of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, following February 11, 2023, the closing price per share of Common Stock for any 20&nbsp;trading days within any 30
consecutive trading day period is at least $12.50, the <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions will no longer apply. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-143- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_20"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a general discussion of the material U.S. federal income tax
consequences <FONT STYLE="white-space:nowrap">to&nbsp;non-U.S.&nbsp;holders</FONT> (as defined below) with respect to their purchase, ownership and disposition of our Common Stock purchased in this offering. This discussion is for general
information purposes only, is not tax advice and does not purport to be a complete analysis of all the potential tax considerations. This discussion is based upon the provisions of the Internal Revenue Code of 1986, as amended, or the Code, existing
and proposed Treasury Regulations promulgated thereunder, current administrative rulings and judicial decisions, all in effect as of the date hereof. These authorities may be changed, possibly retroactively, so as to result in U.S. federal income
tax consequences different from those set forth below. We have not sought any ruling from the Internal Revenue Service, or IRS, with respect to the statements made and the conclusions reached in the following summary, and there can be no assurance
that the IRS will agree with such statements and conclusions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion does not address the tax considerations arising under the
laws of any&nbsp;U.S. state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction or under U.S. federal gift and estate tax laws. In addition, this discussion does not address any tax considerations applicable to an investor&#146;s
particular circumstances or to investors that may be subject to special tax rules, including, without limitation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">banks, insurance companies, regulated investment companies, real estate investment trusts or other financial
institutions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons subject to the alternative minimum tax or the Medicare contribution tax on net investment income;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt&nbsp;organizations</FONT> or governmental organizations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">controlled foreign corporations, passive foreign investment companies and corporations that accumulate earnings
to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brokers or dealers in securities or currencies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">traders in securities that elect to use
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">a&nbsp;mark-to-market&nbsp;method</FONT></FONT> of accounting for their securities holdings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons that own, or are deemed to own, more than five percent of our Common Stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain former citizens or long-term residents of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">partnerships or other entities or arrangements classified as partnerships for U.S. federal income tax purposes or
other pass-through entities (and investors therein); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons whose functional currency is not the U.S. dollar; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who hold our Common Stock as a position in a hedging transaction, &#147;straddle,&#148; &#147;conversion
transaction&#148; or other risk reduction transaction or integrated investment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who hold or receive our Common Stock pursuant to the exercise of any warrant or option or otherwise as
compensation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who hold or receive our Common Stock pursuant to conversion rights under convertible instruments;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who do not hold our Common Stock as a capital asset within the meaning of Section&nbsp;1221 of the Code;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons deemed to sell our Common Stock under the constructive sale provisions of the Code; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons subject to special tax accounting rules as a result of any item of gross income with respect to our
Common Stock being taken into account in an &#147;applicable financial statement&#148; as defined in Section&nbsp;451(b) of the Code. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-144- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if a partnership, entity or arrangement classified as a partnership for U.S.
federal income tax purposes holds our Common Stock, the tax treatment of a partner generally will depend on the status of the partner and upon the activities of the partnership. Accordingly, entities classified as partnerships for U.S. federal
income tax purposes and other pass-through entities that hold our Common Stock, as well as partners or members in such entities, should consult their tax advisors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You are urged to consult your tax advisor with respect to the application of the U.S. federal income tax laws to your particular situation,
as well as any tax consequences of the purchase, ownership and disposition of our Common Stock arising under the U.S. federal estate or gift tax laws or under the laws of any state,
<FONT STYLE="white-space:nowrap">local,&nbsp;non-U.S.&nbsp;or</FONT> other taxing jurisdiction or under any applicable tax treaty. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT
STYLE="white-space:nowrap">Non-U.S.&nbsp;Holder</FONT> Defined </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, you are <FONT
STYLE="white-space:nowrap">a&nbsp;non-U.S.&nbsp;holder</FONT> if you are any holder of our Common Stock other than a partnership (or other entity or arrangement classified as a partnership for U.S. federal income tax purposes) or: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States (for U.S. federal income tax purposes);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation or other entity taxable as a corporation created or organized in or under the laws of the United
States, any state thereof or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate whose income is subject to U.S. federal income tax regardless of its source; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust if it (i)&nbsp;is subject to the primary supervision of a U.S. court and one or more U.S. persons have
the authority to control all substantial decisions of the trust or (ii)&nbsp;has made a valid election under applicable Treasury Regulations to be treated as a U.S. person. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Distributions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described in the
section titled &#147;Market Price of And Dividends on the Registrant&#146;s Common Equity and Related Stockholder Matters&#151;Dividend Policy,&#148; we have never declared or paid cash dividends on our Common Stock. However, if we do make
distributions on our Common Stock, those payments will constitute dividends for U.S. tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. To the extent those
distributions exceed both our current and our accumulated earnings and profits, they will constitute a return of capital and will first reduce your basis in our Common Stock, but not below zero, and then will be treated as gain from the sale of
stock as described below under &#147;&#151;Gain on Disposition of Common Stock.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below on effectively
connected income, backup withholding and Foreign Account Tax Compliance Act, or FATCA, withholding, any dividend paid to you generally will be subject to U.S. withholding tax either at a rate of 30% of the gross amount of the dividend or such lower
rate as may be specified by an applicable income tax treaty. In order to receive a reduced treaty rate, you must provide us with an IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN,&nbsp;IRS</FONT> <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E&nbsp;or</FONT></FONT> other appropriate version of IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8&nbsp;certifying</FONT> qualification for the reduced rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends received by you that are effectively connected with your conduct of a U.S. trade or business (and, if required by an applicable
income tax treaty, attributable to a permanent establishment maintained by you in the United States) are generally exempt from the withholding tax described in the previous paragraph, subject to the discussion below on backup withholding. In order
to obtain this exemption, you must provide us with an IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI&nbsp;or</FONT> other applicable IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8&nbsp;properly</FONT> certifying such exemption. Such
effectively connected dividends, although not subject to withholding tax, are taxed at the same graduated rates applicable to U.S. persons, net of certain deductions and credits, subject to an applicable income tax treaty providing otherwise. In
addition, if you are a <FONT STYLE="white-space:nowrap">corporate&nbsp;non-U.S.&nbsp;holder,</FONT> dividends you receive that are effectively connected with your </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-145- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conduct of a U.S. trade or business may also be subject to a branch profits tax at a rate of 30% or such lower rate as may be specified by an applicable income tax treaty. You should consult your
tax advisor regarding any applicable tax treaties that may provide for different rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you hold our Common Stock through a financial
institution or other agent acting on your behalf, you will be required to provide appropriate documentation to the agent, which then will be required to provide certification to us or our paying agent, either directly or through other
intermediaries. You may be eligible to obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Gain on Disposition of Common Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below on backup withholding and FATCA withholding on Common Stock held by or through foreign entities, you generally
will not be required to pay U.S. federal income tax on any gain realized upon the sale or other disposition of our Common Stock unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with your conduct of a U.S. trade or business (and, if required by an
applicable income tax treaty, the gain is attributable to a permanent establishment maintained by you in the United States); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are <FONT STYLE="white-space:nowrap">a&nbsp;non-resident&nbsp;alien</FONT> individual who is present in the
United States for a period or periods aggregating 183 days or more during the calendar year in which the sale or disposition occurs and certain other conditions are met; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are treated as a &#147;United States real property holding corporation,&#148; or USRPHC, for U.S. federal
income tax purposes within the meaning of Section&nbsp;897(c)(2) of the Code at any time within the shorter of the five-year period preceding your disposition of, or your holding period for, our Common Stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that we are not currently and will not become a USRPHC. However, because the determination of whether we are a USRPHC depends on
the fair market value of our U.S. real property relative to the fair market value of our other business assets, there can be no assurance that we will not become a USRPHC in the future. Even if we become a USRPHC, however, as long as our Common
Stock is regularly traded on an established securities market, your Common Stock will be treated as U.S. real property interests only if you actually or constructively hold more than five percent of such regularly traded Common Stock at any time
during the shorter of the five-year period preceding your disposition of, or your holding period for, our Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are <FONT
STYLE="white-space:nowrap">a&nbsp;non-U.S.&nbsp;holder</FONT> described in the first bullet above, you will be required to pay tax on the net gain derived from the sale under regular graduated U.S. federal income tax rates, and a <FONT
STYLE="white-space:nowrap">corporate&nbsp;non-U.S.&nbsp;holder</FONT> described in the first bullet above also may be subject to the branch profits tax at a 30% rate, or such lower rate as may be specified by an applicable income tax treaty. If you
are an <FONT STYLE="white-space:nowrap">individual&nbsp;non-U.S.&nbsp;holder</FONT> described in the second bullet above, you will be subject to tax at 30% (or such lower rate specified by an applicable income tax treaty) on the gain derived from
the sale, which gain may be offset by U.S. source capital losses for the year (provided you have timely filed U.S. federal income tax returns with respect to such losses). You should consult any applicable income tax or other treaties that may
provide for different rules. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Backup Withholding and Information Reporting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, we must report annually to the IRS the amount of dividends paid to you, your name and address, and the amount of tax withheld, if
any. A similar report will be sent to you. Pursuant to applicable income tax treaties or other agreements, the IRS may make these reports available to tax authorities in your country of residence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments of dividends or of proceeds on the disposition of stock made to you may be subject to information reporting and backup withholding at
a current rate of 24% unless you establish an exemption, for example, by properly certifying <FONT STYLE="white-space:nowrap">your&nbsp;non-U.S.&nbsp;status</FONT> on an IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN,&nbsp;IRS</FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E&nbsp;or</FONT></FONT> another appropriate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-146- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
version of IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8.&nbsp;Notwithstanding</FONT> the foregoing, backup withholding and information reporting may apply if either we or our paying agent
has actual knowledge, or reason to know, that you are a U.S. person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under current U.S. federal income tax law, U.S. information
reporting and backup withholding requirements generally will apply to the proceeds of a disposition of our Common Stock effected by or through a U.S. office of any broker, U.S. or foreign, except that information reporting and such requirements may
be avoided if the holder provides a properly executed and appropriate <FONT STYLE="white-space:nowrap">IRS&nbsp;Form&nbsp;W-8&nbsp;or&nbsp;otherwise</FONT> meets documentary evidence requirements or establishing
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder status or otherwise establishes an exemption. Generally, U.S. information reporting and backup withholding requirements will not apply to a payment of disposition proceeds <FONT
STYLE="white-space:nowrap">to&nbsp;a&nbsp;non-U.S.&nbsp;holder&nbsp;where</FONT> the transaction is effected outside the U.S.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">through&nbsp;a&nbsp;non-U.S.&nbsp;office&nbsp;of&nbsp;a&nbsp;non-U.S.&nbsp;broker.</FONT></FONT> Information reporting and backup withholding requirements may, however, apply to a
payment of disposition proceeds if we or the broker has actual knowledge, or reason to know, that you are, in fact, a U.S. person. For information reporting purposes, certain brokers with substantial U.S. ownership or operations will generally be
treated in a manner similar to U.S. brokers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax; rather, the U.S. federal income tax liability
of persons subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, you may be able to obtain a refund or credit from the IRS, provided that the required information is furnished
to the IRS in a timely manner. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Additional Withholding Requirements under the Foreign Account Tax Compliance Act (FATCA) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Foreign Account Tax Compliance Act and the rules and regulations promulgated thereunder, collectively FATCA, generally impose withholding
tax at a rate of 30% on dividends on, and gross proceeds from the sale or other disposition of, our Common Stock paid to a &#147;foreign financial institution&#148; (as specially defined under these rules), unless such institution enters into an
agreement with the U.S. government to, among other things, withhold on certain payments and to collect and provide to the U.S. tax authorities substantial information regarding the U.S. account holders of such institution (which includes certain
equity and debt holders of such institution, as well as certain account holders that are foreign entities with U.S. owners) or otherwise establishes an exemption. FATCA also generally imposes a U.S. federal withholding tax of 30% on dividends on and
gross proceeds from the sale or other disposition of our Common Stock paid to <FONT STYLE="white-space:nowrap">a&nbsp;&#147;non-financial&nbsp;foreign</FONT> entity&#148; (as specially defined under these rules) unless such entity provides the
withholding agent with a certification identifying certain substantial direct and indirect U.S. owners of the entity, certifies that there are none or otherwise establishes an exemption. The withholding provisions under FATCA generally apply to
dividends on our Common Stock, and, subject to the proposed regulations described in the next sentence, will apply to gross proceeds of a sale or other disposition of our Common Stock. The Treasury Department has released proposed regulations (the
preamble to which specifies that taxpayers are permitted to rely on them pending finalization) which, if finalized in their present form, would eliminate FATCA withholding on gross proceeds of a disposition of our Common Stock. Under certain
circumstances, <FONT STYLE="white-space:nowrap">a&nbsp;non-U.S.&nbsp;holder</FONT> might be eligible for refunds or credits of such taxes. An intergovernmental agreement between the United States and an applicable foreign country may modify the
requirements described in this paragraph. You should consult your tax advisors regarding the possible implications of FATCA on your investment in our Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The preceding discussion of U.S. federal tax considerations is for general information only. It is not tax advice. Each prospective
investor should consult its tax advisor regarding the particular U.S. federal, state and local <FONT STYLE="white-space:nowrap">and&nbsp;non-U.S.&nbsp;tax</FONT> consequences of purchasing, holding and disposing of our Common Stock, including the
consequences of any proposed change in applicable laws. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-147- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_21"></A>PLAN OF DISTRIBUTION (CONFLICT OF INTEREST) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of our Common Stock offered by this prospectus are being offered by the Selling Stockholder, B.&nbsp;Riley Principal Capital II,
LLC (&#147;BRPC II&#148;). The shares may be sold or distributed from time to time by the Selling Stockholder directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at
the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed. The sale of the shares of our Common Stock offered by this prospectus could be effected in one or more of the
following methods: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokers&#146; transactions;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transactions involving cross or block trades;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through brokers, dealers, or underwriters who may act solely as agents;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;at the market&#148; into an existing market for our Common Stock;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in other ways not involving market makers or established business markets, including direct sales to purchasers
or sales effected through agents;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in privately negotiated transactions; or</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any combination of the foregoing.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to comply with the securities laws of certain states, if applicable, the shares may be sold only through registered or licensed
brokers or dealers. In addition, in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from the state&#146;s registration or qualification requirement is available and
complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BRPC II is an &#147;underwriter&#148; within the meaning of Section&nbsp;2(a)(11) of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BRPC II has informed us that it presently anticipates using, but is not required to use, B. Riley Securities, Inc. (&#147;BRS&#148;), a
registered broker-dealer and FINRA member and an affiliate of BRPC II, as a broker to effectuate resales, if any, of our Common Stock that it may acquire from us pursuant to the Purchase Agreement, and that it may also engage one or more other
registered broker-dealers to effectuate resales, if any, of such Common Stock that it may acquire from us. Such resales will be made at prices and at terms then prevailing or at prices related to the then current market price. Each such registered
broker-dealer will be an underwriter within the meaning of Section&nbsp;2(a)(11) of the Securities Act. BRPC II has informed us that each such broker-dealer it engages to effectuate resales of our Common Stock on its behalf, excluding BRS, may
receive commissions from BRPC II for executing such resales for BRPC II and, if so, such commissions will not exceed customary brokerage commissions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BRPC II is an affiliate of BRS, a registered broker-dealer and FINRA member, which will act as an executing broker that will effectuate
resales of our Common Stock that may be acquired by BRPC II from us pursuant to the Purchase Agreement to the public in this offering. Because BRPC II will receive all the net proceeds from such resales of our Common Stock made to the public through
BRS, BRS is deemed to have a &#147;conflict of interest&#148; within the meaning of FINRA Rule 5121. Consequently, this offering will be conducted in compliance with the provisions of FINRA Rule 5121, which requires that a &#147;qualified
independent underwriter,&#148; as defined in FINRA Rule 5121, participate in the preparation of the registration statement that includes this prospectus and exercise the usual standards of &#147;due diligence&#148; with respect thereto. Accordingly,
we have engaged Northland Securities, Inc. (&#147;Northland&#148;), a registered broker-dealer and FINRA member, to be the qualified independent underwriter in this offering and, in such capacity, participate in the preparation of the registration
statement that includes this prospectus and exercise the usual standards of &#147;due diligence&#148; with respect thereto. BRPC II has agreed to pay Northland a cash fee of $50,000 upon the completion of this offering as consideration for its
services and to reimburse Northland up to $5,000 for expenses incurred in connection </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-148- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with acting as the qualified independent underwriter in this offering. In accordance with FINRA Rule 5110, such cash fee and expense reimbursement to be paid to Northland for acting as the
qualified independent underwriter in this offering are deemed to be underwriting compensation in connection with sales of our Common Stock by BRPC II to the public. Northland will receive no other compensation for acting as the qualified independent
underwriter in this offering. In accordance with FINRA Rule 5121, BRS is not permitted to sell shares of our Common Stock in this offering to an account over which it exercises discretionary authority without the prior specific written approval of
the account holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth above, we know of no existing arrangements between the Selling Stockholder and any other
stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the shares of our Common Stock offered by this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Brokers, dealers, underwriters or agents participating in the distribution of the shares of our Common Stock offered by this prospectus may
receive compensation in the form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent, of the shares sold by the Selling Stockholder through this prospectus. The compensation paid to any such
particular broker-dealer by any such purchasers of shares of our Common Stock sold by the Selling Stockholder may be less than or in excess of customary commissions. Neither we nor the Selling Stockholder can presently estimate the amount of
compensation that any agent will receive from any purchasers of shares of our Common Stock sold by the Selling Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may from
time to time file with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms a part to amend, supplement or update information contained in this prospectus, including, if and
when required under the Securities Act, to disclose certain information relating to a particular sale of shares offered by this prospectus by the Selling Stockholder, including with respect to any compensation paid or payable by the Selling
Stockholder to any brokers, dealers, underwriters or agents that participate in the distribution of such shares by the Selling Stockholder, and any other related information required to be disclosed under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay the expenses incident to the registration under the Securities Act of the offer and sale of the shares of our Common Stock covered
by this prospectus by the Selling Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As consideration for its irrevocable commitment to purchase our Common Stock under the
Purchase Agreement, we have agreed to issue to BRPC II up to 169,586 shares of our Common Stock as Commitment Shares, which Commitment Shares have a total aggregate value equal to 1.0% of BRPC II&#146;s $200,000,000 total dollar amount purchase
commitment under the Purchase Agreement (assuming a purchase price of $11.7934 per Commitment Share, representing the average of the daily volume weighted average prices per share of our Common Stock for the five-consecutive trading day period
ending on the date of the Purchase Agreement), 84,793 of which Commitment Shares we issued as Initial Commitment Shares upon our execution of the Purchase Agreement and the Committed Equity Registration Rights Agreement, and 84,793 of which
Commitment Shares we will issue to BRPC II as Additional Commitment Shares when we have received aggregate gross proceeds of $100,000,000 from sales of our Common Stock to BRPC II under the Purchase Agreement (if any). In accordance with FINRA Rule
5110, the 169,586 Commitment Shares are deemed to be underwriting compensation in connection with sales of our Common Stock by BRPC II to the public.&nbsp;In addition, we have agreed to reimburse BRPC II for the reasonable legal fees and
disbursements of BRPC II&#146;s legal counsel in an amount not to exceed (i) $100,000 upon our execution of the Purchase Agreement and Committed Equity Registration Rights Agreement and (ii) $7,500 per fiscal quarter, in each case in connection with
the transactions contemplated by this Agreement and the Committed Equity Registration Rights Agreement. In accordance with FINRA Rule 5110, these reimbursed fees and expenses are deemed to be underwriting compensation in connection with sales of our
Common Stock by BRPC II to the public. Moreover, in accordance with FINRA Rule 5110, the 3.0% fixed discount to current market prices of our Common Stock reflected in the purchase prices payable by BRPC II for our Common Stock that we may require it
to purchase from us from time to time under the Purchase Agreement is deemed to be underwriting compensation in connection with sales of our Common Stock by BRPC II to the public. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-149- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The total underwriting compensation to be received in connection with sales of our Common
Stock by BRPC II to the public, as determined under FINRA Rule 5110, will not exceed 8.0% of the maximum aggregate offering price of all shares of our Common Stock that may be sold by BRPC II to the public through this prospectus. Accordingly, the
total amount of any specific item of underwriting compensation described herein that may be received in connection with sales of our Common Stock by BRPC II to the public shall, in each case, be subject to the limitation on the total underwriting
compensation to be received in connection with sales of our Common Stock by BRPC II to the public, as determined under FINRA Rule 5110, described in the immediately preceding sentence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also have agreed to indemnify BRPC II and certain other persons against certain liabilities in connection with the offering of shares of
our Common Stock offered hereby, including liabilities arising under the Securities Act or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. BRPC II has agreed to indemnify us against
liabilities under the Securities Act that may arise from certain written information furnished to us by BRPC II specifically for use in this prospectus or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of
such liabilities. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised that in the opinion of the SEC this indemnification is against
public policy as expressed in the Securities Act and is therefore, unenforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that the total expenses for the offering,
excluding any fees or other compensation to be received by BRPC II under the Purchase Agreement (other than the legal fee reimbursement costs described herein), will be approximately $0.8 million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BRPC II has represented to us that at no time prior to the date of the Purchase Agreement has BRPC II, its sole member, any of their
respective officers, or any entity managed or controlled by BRPC II or its sole member, engaged in or effected, in any manner whatsoever, directly or indirectly, for its own account or for the account of any of its affiliates, any short sale (as
such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our Common Stock or any hedging transaction, which establishes a net short position with respect to our Common Stock. BRPC II has agreed that during the term of the Purchase
Agreement, none of BRPC II, its sole member, any of their respective officers, or any entity managed or controlled by BRPC II or its sole member, will enter into or effect, directly or indirectly, any of the foregoing transactions for its own
account or for the account of any other such person or entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have advised the Selling Stockholder that it is required to comply with
Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M precludes the Selling Stockholder, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution from bidding for or
purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of the distribution until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the
price of a security in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered by this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This offering will terminate on the date that all shares of our Common Stock offered by this prospectus have been sold by the Selling
Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Stock is currently listed on the New York Stock Exchange under the symbol &#147;AMPX&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BRPC II and/or one or more of its affiliates has provided, currently provides and/or from time to time in the future may provide various
investment banking and other financial services for us and/or one or more of our affiliates that are unrelated to the transactions contemplated by the Purchase Agreement and the offering of shares for resale by BRPC II to which this prospectus
relates, for which investment banking and other financial services they have received and may continue to receive customary fees, commissions and other compensation from us, aside from any discounts, fees and other compensation that BRPC II has
received and may receive in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-150- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection with the transactions contemplated by the Purchase Agreement, including (i)&nbsp;the up to 169,586 Commitment Shares we have agreed to issue to BRPC II as consideration for its
irrevocable commitment to purchase shares of our Common Stock from us under the Purchase Agreement, (ii)&nbsp;the 3.0% fixed discount to current market prices of our Common Stock reflected in the purchase prices payable by BRPC II for our Common
Stock that we may require it to purchase from us from time to time under the Purchase Agreement, and (iii)&nbsp;our reimbursement of up to an aggregate of $160,000 of BRPC II&#146;s legal fees ($100,000 upon execution of the Purchase Agreement and
$7,500 per fiscal quarter for the maximum two year term of the Purchase Agreement) in connection with the transactions contemplated by the Purchase Agreement and the Committed Equity Registration Rights Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-151- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_22"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the Securities offered hereby has been passed upon for us by Wilson Sonsini Goodrich&nbsp;&amp; Rosati, Professional
Corporation, Palo Alto, California. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_23"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements of Amprius as of December&nbsp;31, 2021 and 2020 and for each of the years in
<FONT STYLE="white-space:nowrap">the&nbsp;two-year&nbsp;period</FONT> ended December&nbsp;31, 2021 have been audited by SingerLewak&nbsp;LLP, an independent registered public accounting firm, as stated in their report thereon and included in this
prospectus in reliance upon such report and upon the authority of such firm as experts in accounting and auditing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_24">
</A>WHERE YOU CAN FIND ADDITIONAL INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registration statement of which this prospectus forms a part, including the
attached exhibits and schedules, contains additional relevant information about us and our capital stock. The rules and regulations of the SEC allow us to omit from this prospectus certain information included in the registration statement. For
further information about us and the Securities, you should refer to the registration statement of which this prospectus forms a part and the exhibits and schedules filed with the registration statement. With respect to the statements contained in
this prospectus regarding the contents of any agreement or any other document, in each instance, the statement is qualified in all respects by the complete text of the agreement or document, a copy of which has been filed as an exhibit to the
registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to the informational reporting requirements of the Exchange Act. We file reports, proxy statements
and other information with the SEC under the Exchange Act. Our SEC filings are available over the Internet at the SEC&#146;s website at http://www.sec.gov. Our website address is www.amprius.com. We also make available, free of charge, on our
investor relations website at ir.amprius.com under &#147;SEC Filings,&#148; our Annual Reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> Current Reports on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> and amendments to these reports as soon as reasonably practicable after electronically filing or furnishing those reports to the SEC. The information on, or that can be accessed through, our website is not part
of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-152- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377019_25"></A>INDEX TO FINANCIAL STATEMENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Amprius Technologies, Inc. Audited Financial Statements</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_1">Report of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">F-2</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_2">Balance Sheets as of December&nbsp;31, 2021 and 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">F-3</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_3">Statements of Operations for the years ended December&nbsp;
31, 2021 and 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">F-4</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_4">Statements of Stockholders&#146; Equity for the years ended December&nbsp;
31, 2021 and 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">F-5</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_5">Statements of Cash Flows for the years ended December&nbsp;
31, 2021 and 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">F-6</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_6">Notes to Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">F-7</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Amprius Technologies, Inc. Unaudited Condensed Financial Statements</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_7">Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December&nbsp;31,
 2021</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">F-31</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_8">Unaudited Condensed Statements of Operations for the three and nine months ended
 September 30, 2022 and 2021</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">F-32</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_9">Unaudited Condensed Statements of Stockholders&#146; Equity for the three and
 nine months ended September 30, 2022 and 2021</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">F-33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_10">Unaudited Condensed Statements of Cash Flows for the three and nine months ended
September 30, 2022 and 2021</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">F-35</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377019_11">Notes to Unaudited Condensed Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">F-36</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_1"></A>Report of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders and the Board of Directors of Amprius Technologies, Inc. (a <FONT STYLE="white-space:nowrap">carve-out</FONT> of Amprius, Inc.) </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion on the Financial Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the
accompanying balance sheets of Amprius Technologies, Inc. (a <FONT STYLE="white-space:nowrap">carve-out</FONT> of Amprius, Inc.) (the Company) as of December&nbsp;31, 2021 and 2020, the related statements of operations, stockholders&#146; equity,
and cash flows for each of the two years in the period ended December&nbsp;31, 2021, and the related notes to the financial statements (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material
respects, the financial position of the Company as of December&nbsp;31, 2021 and 2020, and the results of its operations and its cash flows for each of the two years in the period ended December&nbsp;31, 2021, in conformity with accounting
principles generally accepted in the United States of America. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the Company&#146;s financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance
with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to
obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial reporting. Accordingly, we express no such opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used
and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ SingerLewak LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the Company&#146;s
auditor since 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Jose, CA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;21, 2022,
except for the reverse recapitalization described in Note 1 as to which the date is </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;16, 2022 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MPRIUS</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A C<SMALL>ARVE</SMALL><FONT STYLE="white-space:nowrap">-O</FONT><SMALL>UT</SMALL> <SMALL>OF</SMALL> A<SMALL>MPRIUS</SMALL>,
I<SMALL>NC</SMALL>.) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_2"></A>B<SMALL>ALANCE</SMALL> S<SMALL>HEETS</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">As of December&nbsp;31, 2021 and 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In thousands, except share and par value data) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSETS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventories, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred costs, current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred costs, noncurrent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,659</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LIABILITIES AND STOCKHOLDERS&#146; EQUITY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">805</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue, current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other liabilities, current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue, noncurrent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commitments and contingencies (Note 11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; equity<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.0001 par value; 950,000,000 shares authorized; 65,772,001 and 65,742,883 shares
issued and outstanding <BR>as of December&nbsp;31, 2021 and 2020, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(75,401</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(65,505</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities and stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,659</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Restated for the retroactive application to reflect the effect of the Exchange Ratio established in the
Business Combination as described in Note 1. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial
statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MPRIUS</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A C<SMALL>ARVE</SMALL><FONT STYLE="white-space:nowrap">-O</FONT><SMALL>UT</SMALL> <SMALL>OF</SMALL> A<SMALL>MPRIUS</SMALL>,
I<SMALL>NC</SMALL>.) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_3"></A>S<SMALL>TATEMENTS</SMALL> <SMALL>OF</SMALL> O<SMALL>PERATIONS</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended December&nbsp;31, 2021 and 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In thousands, except share and par value data) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,679</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,695</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,016</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(10,623</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,449</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on forgiveness of PPP loan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,896</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average common shares
outstanding<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,764,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,693,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share of common
stock<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.11</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Restated for the retroactive application to reflect the effect of the Exchange Ratio established in the
Business Combination as described in Note 1. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial
statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MPRIUS</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A C<SMALL>ARVE</SMALL><FONT STYLE="white-space:nowrap">-O</FONT><SMALL>UT</SMALL> <SMALL>OF</SMALL> A<SMALL>MPRIUS</SMALL>,
I<SMALL>NC</SMALL>.) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_4"></A>S<SMALL>TATEMENTS</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCKHOLDERS</SMALL>&#146;
E<SMALL>QUITY</SMALL> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended December&nbsp;31, 2021 and 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In thousands, except share and par value data) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR><FONT STYLE="white-space:nowrap">Paid-in</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;</B><br><B>Equity</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,106,145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61,761</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(58,087</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retroactive application of business combination (Note 1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,563,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January 1, 2020, as adjusted (Note&nbsp;1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,670,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(58,087</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contributed capital from Parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of common stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contribution from Parent related to stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,742,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(65,505</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contributed capital from Parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of common stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contribution from Parent related to stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,896</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,896</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,772,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(75,401</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MPRIUS</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_5"></A>S<SMALL>TATEMENTS</SMALL> <SMALL>OF</SMALL> C<SMALL>ASH</SMALL> F<SMALL>LOWS</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">For the years ended December&nbsp;31, 2021 and 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In thousands, except share and par value data) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,896</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,236</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for inventory reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from disposal of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on forgiveness of PPP loan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(26</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(58</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(42</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,455</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(26</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,804</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(684</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other liabilities, current</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,016</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,044</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from investing activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(609</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(527</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(609</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(527</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from financing activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from exercise of employee stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital contributions from parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from notes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,573</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, beginning of year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, end of year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supplemental disclosures of cash flow information:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supplemental disclosure of <FONT STYLE="white-space:nowrap">non-cash</FONT> investing and
financing information:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment accrued but unpaid</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MPRIUS</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A C<SMALL>ARVE</SMALL><FONT STYLE="white-space:nowrap">-O</FONT><SMALL>UT</SMALL> <SMALL>OF</SMALL> A<SMALL>MPRIUS</SMALL>,
I<SMALL>NC</SMALL>.) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_6"></A>N<SMALL>OTES</SMALL> <SMALL>TO</SMALL> F<SMALL>INANCIAL</SMALL>
S<SMALL>TATEMENTS</SMALL> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>D<SMALL>ECEMBER</SMALL>&nbsp;31, 2021 <SMALL>AND</SMALL> 2020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In thousands, except share and par value data) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NATURE OF OPERATIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Nature of Operations </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Amprius Technologies, Inc. (f/k/a Kensington Capital Acquisition Corp.&nbsp;IV, a Cayman Islands exempted company incorporated with limited
liability) (the &#147;Company&#148; or &#147;Amprius&#148;) was initially incorporated as a Cayman Islands exempted company on March&nbsp;19, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset
acquisition, share purchase, reorganization or similar business combination with one or more businesses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;14, 2022 (the
&#147;Closing Date&#148;), the Company completed a business combination pursuant to the Business Combination Agreement, dated May&nbsp;11, 2022 (the &#147;Business Combination Agreement&#148;), by and among the Company, Kensington Capital Merger Sub
Corp., a wholly owned subsidiary of the Company (&#147;Merger Sub&#148;), and Amprius Technologies Operating, Inc. (f/k/a&nbsp;Amprius Technologies, Inc., a Delaware corporation) (&#147;Legacy Amprius&#148;). Pursuant to the terms of the Business
Combination Agreement, the Company changed its jurisdiction of incorporation by domesticating as a corporation incorporated under the laws of the State of Delaware (the &#147;Domestication&#148;), upon which the Company changed its name to
&#147;Amprius Technologies, Inc.,&#148; and a business combination between the Company and Legacy Amprius was effected through the merger of Merger Sub with and into Legacy Amprius, with Legacy Amprius surviving as a wholly owned subsidiary of
Amprius (together with the Domestication and the other transactions contemplated by the Business Combination Agreement, the &#147;Business Combination&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Business Combination was treated as a reverse recapitalization. Legacy Amprius was determined as the accounting acquirer and Kensington as
the accounting acquiree for financial reporting purposes based on evaluation of the following facts and circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the stockholders of Legacy Amprius owned a majority of the shares of the Company following the Business
Combination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the board of directors of the Company following the Business Combination was comprised of all of the board
members of Legacy Amprius; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the senior management of the Company following the Business Combination was the senior management of Legacy
Amprius; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Legacy Amprius is larger than Kensington in terms of existing operations and number of employees.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Unless the context otherwise provides, the &#147;Company&#148; and &#147;Amprius&#148; refer (i)&nbsp;prior to the
Closing Date, to Legacy Amprius and (ii)&nbsp;after the Closing Date, to Amprius Technologies, Inc. and its subsidiaries, including Legacy Amprius. Kensington Capital Acquisition Corp. IV prior to the Business Combination is referred to herein as
&#147;Kensington.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Amprius has developed and, since 2018, been in commercial production of an ultra-high energy density <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> battery for mobility applications leveraging a disruptive silicon nanowire anode. The Company was incorporated in the state of Delaware on March&nbsp;16, 2015. The Company is a majority owned subsidiary
of Amprius, Inc. (the &#147;Parent&#148;) which was incorporated in the state of Delaware on May&nbsp;19, 2008. As of December&nbsp;31, 2021 and 2020, the Parent&#146;s ownership of capital stock represented 99.6% and 99.7%, respectively, of the
Company. The Company was established as a separate entity to continue the development operations of the silicon anode begun by the Parent and for the Parent to transition to a holding company. After the Company&#146;s incorporation, the Parent and
the Company entered into an intercompany </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
agreement to license the intellectual property rights to continue to develop the silicon nanowire technology. Prior to January 2020, the Company operated as a division of the Parent with an
intercompany services agreement. Operating resources such as cash, equipment, facilities, personnel and management were provided by the Parent. Assets such as employees, cash, equipment, intellectual property and facilities were assigned or
contributed starting in 2020 and, effective from May 2022, all the operating assets are owned by the Company, including the lease that is entirely for the benefit of the Company and was assigned officially to the Company subsequently. See Note 14
&#150; Subsequent event, transfer of lease. The Company&#146;s sole location and headquarters is in Fremont, California, and is <FONT STYLE="white-space:nowrap">co-located</FONT> with the Parent&#146;s corporate office. The Parent was the owner in
other subsidiaries until February 2022, at which point the Parent had completed the distribution of the equity interests it held in each such subsidiary to the Parent&#146;s stockholders and optionees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company believes its core technology, the silicon nanowire anode for <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries, is a
breakthrough development in terms of enabling the use of silicon as an anode in <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries. The Company produces high specific energy density batteries for a variety of applications that require a
superior power to weight ratio, which is a critical attribute for batteries used in aerospace and military applications. The Company has manufacturing capability utilizing pilot scale equipment to produce limited quantities of batteries for sale to
the aerospace industry and military. In order to scale production to meet the demand of its addressable market, the Company is dependent on the establishment of a high-volume manufacturing facility and the further development of automated anode
production equipment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In connection with the subsequent closing of the Business Combination on September&nbsp;14, 2022, whereby Legacy
Amprius was determined as the accounting acquirer for accounting and reporting purposes, the accompanying financial statements reflect Legacy Amprius&#146; equity structure, which has been retroactively restated in all comparative periods up to the
Closing Date to reflect the number of shares of the Company&#146;s common stock issued to Legacy Amprius stockholders. As such, the shares, corresponding capital amounts, and net loss per share related to Legacy Amprius common stock have been
retroactively restated to reflect the effect of the exchange ratio of approximately 1.45590 (the &#147;Exchange Ratio&#148;) established in the Business Combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Liquidity and Capital Resources </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has an accumulated deficit of $75,401, as of December&nbsp;31, 2021, which represents the
<FONT STYLE="white-space:nowrap">carved-out</FONT> portion of costs incurred by the Company from the inception of the Parent. Since inception, the Company has incurred recurring operating losses and cash flow deficits from operations. Management
expects to continue to incur additional losses and increased operating expenses in future periods due to negative margins on development contracts, research and development and increase in personnel costs. The Company believes that building and
operating a high-volume manufacturing plant will facilitate the Company achieving profitability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;12, 2022, the Company
entered into the Business Combination Agreement with Kensington and Merger Sub (see Note 14). Kensington expects to use the available cash following the closing of the Business Combination to fund the design and
<FONT STYLE="white-space:nowrap">build-out</FONT> of a high-volume manufacturing facility. In the event that the Merger is not consummated, the Company believes its current cash resources and estimated proceeds from revenues are sufficient to meet
its cash requirements for at least twelve months after the issuance of these financial statements. Additionally, the Parent is committed to contributing $2,800 of cash in the event that the Company&#146;s liquidity is constrained. Besides the
retroactive restatement of Legacy Amprius&#146; equity structure disclosed in Note 1, the financial statements do not include any other adjustments that might result from the outcome of this Business Combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Technology Risk </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To date, the Company has only produced batteries on a pilot-scale production line for sale in limited quantities. The Company must develop
high-volume anode production equipment, methods and processes to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
achieve profitability. The production equipment to manufacture the proprietary silicon anode in high volume has yet to be developed; however, the Company is actively collaborating with a supplier
of high-volume production equipment using existing technology with similar manufacturing processes. The Company&#146;s current prototype anode production process utilizes technologies that are available from existing equipment providers, but this
technology must be adapted to the Company&#146;s production requirements to develop this equipment. The equipment required to produce the remainder of the battery components and perform assembly and testing uses existing production equipment and is
readily available from multiple suppliers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Employee Retention Risk </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s success and competitiveness depend on the continued service of key research, engineering, manufacturing, executive and
administrative personnel. If the Company is unable to retain, attract and motivate management and key personnel, it may adversely affect business objectives and overall profitability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Other Risk and Uncertainties </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the <FONT STYLE="white-space:nowrap">two-year&nbsp;period</FONT> ended December&nbsp;31, 2021, and subsequently afterward, the Company
continued to experience the results of the worldwide <FONT STYLE="white-space:nowrap">COVID-19&nbsp;pandemic.</FONT> The <FONT STYLE="white-space:nowrap">COVID-19&nbsp;outbreak</FONT> in the United States of America (&#147;U.S.&#148;) has caused
business disruption through mandated and voluntary closings of businesses and shelter in place orders. In response, the U.S.&nbsp;Government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#147;CARES Act&#148;), which included
significant provisions to provide relief and assistance to affected organizations. While the disruption is currently expected to be temporary, there is considerable uncertainty around potential future closings, shelter in place orders, containment
of the recent <FONT STYLE="white-space:nowrap">COVID-19</FONT> variants, and the ultimate impact of the CARES Act and other government initiatives. The <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and its resulting economic and other
effects could result in significant adverse effects on our customers&#146; cash flow and their ability to manufacture, distribute, and sell products. This in turn may cause customers to be less able to pay invoices for customization design service
or the purchase of finished batteries, or may result in a reduction in the revenue from customization design services or sales of finished batteries that the Company earns which are often dependent on the demand from the customer for the scope of
the customized service or number of units to be purchased. This reduction could cause adverse effects on the business, results of operations, financial condition, cash flows and ability to raise operating capital. To date, this matter has not
negatively impacted the Company. However, the financial impact and duration cannot be reasonably estimated at this time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Additionally,
U.S. and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions and the start of the military conflict between Russia and Ukraine. On February&nbsp;24, 2022, a full-scale military invasion of
Ukraine by Russian troops was reported. Although the length and impact of the ongoing military conflict is highly unpredictable, the conflict in Ukraine could lead to market disruptions, including significant volatility in commodity prices, credit
and capital markets, as well as supply chain interruptions. The Company is continuing to monitor the situation in Ukraine and globally and assessing its potential impact on its business. The recent military conflict in Ukraine has led to sanctions
and other penalties being levied by the U.S., the European Union and other countries against Russia. Additional potential sanctions and penalties have also been proposed and/or threatened. Russian military actions and the resulting sanctions could
adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets, potentially making it more difficult for the Company to obtain additional funds. Although the Company&#146;s business has not
been materially impacted by the ongoing military conflict between Russian and Ukraine to date, it is impossible to predict the extent to which its operations, or those of its customers&#146; suppliers and manufacturers, will be impacted in the short
and long term, or the ways in which the conflict may impact its business. The extent and duration of the military action, sanctions and resulting market disruptions are impossible to predict, but could be substantial. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Basis of Presentation </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of
America (&#147;U.S. GAAP&#148;). As the Parent has not historically prepared financial statements for the Company, these financial statements have been prepared from the financial records of the Parent on a
<FONT STYLE="white-space:nowrap">carve-out</FONT> basis derived from the accounting records of the Parent using the historical results of operations and the historical basis of assets and liabilities of the Company, adjusted as necessary to conform
to U.S. GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">More specifically, the balance sheets include all the Company&#146;s legal assets, those assets provided by the Parent and
liabilities incurred by the Parent on behalf of the Company. The statements of operations for each of the&nbsp;years ended December&nbsp;30, 2021 and 2020, reflect all expenses and activities directly attributable to the Company, as well as an
allocation of the Parent&#146;s general and administrative expenses. The Company did not share facilities or costs with the other three operating subsidiaries with the exception of expenses at Parent for the payroll related expenses for two
executive employees of Parent and other legal, tax, insurance and accounting fees which were not identifiable as related to a specific subsidiary (&#147;Shared Expenses&#148;). The Parent executives supported the subsidiary group with governance,
management, and investor relations. The Shared Expenses were allocated to the Company based on the time incurred by the Parent executives to support each subsidiary as the level of effort required was not correlated to the level of activity at each
subsidiary, revenue, or other financial operating metrics for the subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Management&#146;s estimate of incremental expenses that
would have been incurred on a standalone basis for the year ended December 31, 2021 and 2020 were approximately $3,479 and $895, respectively. These expenses consisted of incremental compensation and benefits associated with certain senior
executives necessary to depict the Company on a standalone basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the years ended December 30, 2021 and 2020, the Company&#146;s
operations were funded by the Parent. The source of financing consisted of proceeds received by the Parent from its issuance of preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Management believes the expense allocation methodology and results are reasonable and consistently applied for all comparative periods
presented. However, these allocations may not be indicative of the actual expenses that would have been incurred by an independent company or of the costs to be incurred in the future. The financial statements may not be indicative of the
Company&#146;s future performance and do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the period presented. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The significant accounting policies described below, together with other notes that follow, are an integral part of the financial statements.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Emerging Growth Company </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company is an &#147;emerging growth company&#148; as defined in Section&nbsp;2(a) of the Securities Act, and it may take advantage of
certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Further, Section&nbsp;102(b)(1) of the Jumpstart Our Business Startups (&#147;JOBS Act&#148;) exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to <FONT STYLE="white-space:nowrap">non-emerging</FONT> growth companies, but any such election to opt out is irrevocable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has elected not to opt out of such extended transition period. This means that when a standard is issued or revised and it has
different application dates for public or private companies, the Company, as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
an&nbsp;emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Use of Estimates </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on
current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources. Actual results could
materially differ from management estimates using different assumptions or under different conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Significant accounting estimates
made by the Company include the following useful lives of property and equipment; evaluation of impairment of long-lived assets; valuation of deferred taxes; valuation of inventory; <FONT STYLE="white-space:nowrap">carve-out</FONT> of financial
statements including the allocation of assets, liabilities and expenses; and the valuation of the fair value of common stock used to determine stock-based compensation expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Fair Value of Financial Instruments </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The accounting guidance for fair value provides a framework for measuring fair value, clarifies the definition of fair value, and expands
disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date.
The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">Level&nbsp;1&nbsp;-</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Inputs that are unadjusted, quoted prices in active markets for identical assets or liabilities at the
measurement date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">Level&nbsp;2&nbsp;-</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Inputs (other than quoted prices included in Level&nbsp;1) that are either directly or indirectly observable
for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#146;s anticipated life. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="9%" VALIGN="top" ALIGN="left">Level&nbsp;3&nbsp;-</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unobservable inputs that are supported by little or no market activity and that are significant to the fair
value of the assets or liabilities, and which reflect management&#146;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation
technique and the risk inherent in the inputs to the model. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There were no financial assets or financial liabilities
measured at fair value on a recurring basis as of December&nbsp;31, 2021 and 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Cash </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company considers all highly liquid investments with an original maturity of 90 days or less at the date of purchase to be cash and cash
equivalents. During the year ended December 31, 2020, cash was provided to the Company by the Parent on a &#147;as needed&#148; basis by drawing on a cash sweep account maintained by the Parent. Subsequent to January&nbsp;1, 2021, upon cash
contributions from the Parent of $16,200, the Company maintained a balance in its operating cash account to fund operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Concentration of Credit Risk </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and account receivables. The
Company&#146;s cash as of December&nbsp;31, 2021 consists of a demand deposit </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
account. Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Depository Insurance Coverage of $250. As of December&nbsp;31, 2021 and 2020, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable mainly consist of amounts due from U.S. government agencies or sponsored entities and large public entities, which limits
the Company&#146;s credit risk. Through December&nbsp;31, 2021, the Company has not experienced any credit losses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the year ended
December&nbsp;31, 2021, two customers represented 56%, and 24% of the Company&#146;s revenues. For the year ended December&nbsp;31, 2020, three customers represented 49%, 36% and 10% of the Company&#146;s revenues. As of the year ended
December&nbsp;31, 2021, five customers accounted for 25%, 19%, 19%, 18%, and 15% of the Company&#146;s accounts receivable balance. As of December&nbsp;31, 2020, two customers accounted for 86% and 14% of the Company&#146;s accounts receivable
balance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Segment Reporting </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has determined that the Chief Executive Officer is its Chief Operating Decision Maker. The Company&#146;s Chief Executive Officer
reviews financial information presented on an aggregate basis for the purposes of assessing the Company&#146;s performance and making decisions on how to allocate resources. Accordingly, the Company has determined that it operates in a single
operating and reportable segment. All of the Company&#146;s revenues are geographically earned in the United States and the Company&#146;s property and equipment are located in the United States. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Accounts Receivable </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable is recorded at the invoiced amount less any estimated allowances for doubtful accounts. These allowances are based on the
Company&#146;s assessment of the collectability of accounts by considering the age of each outstanding invoice and the collection history of each customer, and an evaluation of the potential risk of loss associated with delinquent accounts. Payment
terms&nbsp;and conditions vary by contract type, although the Company&#146;s terms generally include a requirement of payment within&nbsp;30&nbsp;to&nbsp;60&nbsp;days. Accounts receivable balances deemed to be uncollectible are written off against
previously established allowances. The Company does not accrue interest on past due balances and requires no collateral. Through December&nbsp;31, 2021, the Company has not experienced any credit losses from accounts receivable. The Company had no
allowance for doubtful accounts as of December&nbsp;31, 2021 and 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Inventories </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Inventories are stated at the lower of cost or net realizable value. Cost is determined using the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-first-out</FONT></FONT></FONT> cost method. The inventory consists of raw materials as well as finished goods and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">work-in-process</FONT></FONT> that include material, labor and manufacturing overhead costs. The Company routinely evaluates inventory levels in light of current market conditions in
order to identify excess and obsolete inventory, and the Company provides a write-down for certain inventories to their estimated net realizable value. Manufacturing cost of finished goods generally exceed the sales price charged to customers. All
products are built to customer orders, as such finish goods are valued no higher than the sale price less selling costs of the customer order. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Work-in-process</FONT></FONT> and raw
materials are valued at the sale price of the customer orders less the estimated cost to complete and selling costs. The Company assesses raw materials and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">work-in-process</FONT></FONT> for impairment if the expected finished good has a cost above its estimated selling price less selling costs. When a write-down is recorded, a new lower
cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in the new cost basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recorded a reduction to the value of inventories to cost of revenue of $75 and
$58 during the years ended December&nbsp;31, 2021 and 2020, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Property and Equipment, Net </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment are stated at cost, net of accumulated depreciation. These assets are depreciated on a straight-line basis over their
estimated useful lives. The useful lives of the property and equipment are as follow: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="94%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="70%"></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pilot&nbsp;production&nbsp;equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">4-7</FONT> years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lab equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4 years</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computers and software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>5 years</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lesser of their useful lives or the term of the lease</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Certain custom assets are recorded as construction in progress as they are being constructed. Completed
assets are transferred to their respective asset classes, and depreciation begins when an asset is ready for its intended use. Maintenance and repairs are charged to operations as incurred. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Impairment of Long-Lived Assets </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company periodically evaluates the carrying value of long-lived assets to be held and used when indicators of impairment exist. The
carrying value of a long-lived asset to be held and used is considered impaired when the estimated separately identifiable undiscounted cash flows expected to result from the use of the asset and its eventual disposition are less than the carrying
value of the asset. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. Fair value is determined primarily using the estimated cash flows discounted at a rate
commensurate with the risk involved. No impairment charges were recorded for the years ended December&nbsp;31, 2021 and 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Warranty Liability </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company warrants the batteries sold to customers will meet the published or agreed upon specification upon receipt. Batteries that do not
meet specification are replaced at no charge to the customer. Based on the experience of historical claims and no pending claims and returns of which the Company is aware, the Company had not recorded a warranty liability as of December&nbsp;31,
2021 or 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Loss Contingencies </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In the normal course of business, the Company may be involved in claims and legal proceedings. The Company records a liability for such matters
when it is probable that a loss has been incurred and the amounts can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better
estimate than any other amount within the range, the minimum amount in the range is accrued. Legal costs associated with these loss contingencies are expensed as incurred. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Deferred</U></B><B><I><U> </U></I></B><B><U>Costs&nbsp; </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Capitalization of certain costs are recognized as an asset when the costs relate directly to a customer contract, generate or enhance resources
of the Company that will be used in satisfying future performance obligations, and are expected to be recovered. If these three criteria are not met, the costs are expensed in the period incurred. Deferred costs are recognized as cost of revenues in
the period when the related revenue is recognized, except when such costs incurred are in excess of the amount expected to be recoverable, in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
which case they are expensed as incurred into cost of revenues. The recoverable amount equals the amount of consideration that the entity expects to receive in the future and that the entity has
received but has not recognized as revenue, in exchange for the goods or services to which the asset relates, less the costs that relate directly to providing those goods or services and that have not been recognized as expenses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Cost of Revenues&nbsp; </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues include materials, direct labor, allocated depreciation expense, and other direct and indirect costs related to revenue
contracts. The costs are recognized as and when incurred during the period revenue is recognized.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Research and Development
Costs&nbsp; </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Research and development (&#147;R&amp;D&#148;) costs mainly consist of salaries and benefits, including stock-based
compensation expense and other related personnel costs, depreciation, contract services, materials and supplies, other expenses from outside contractors and suppliers plus an allocation of indirect costs. These costs relate to the conceptual
formulation and design of preproduction experimental prototypes and models, including the cost of equipment and material for which there is no alternative future use. The Company capitalizes equipment related to its pilot line used in R&amp;D as it
determined that the equipment has alternative future uses in future R&amp;D projects. R&amp;D cost are expensed as incurred.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Advertising Costs </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Advertising costs were $44 and $10 for the years ended December&nbsp;31, 2021 and 2020, respectively, and have been expensed as incurred as
selling, general and administrative expense within the statements of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Stock-Based Compensation </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Prior to the formation and incorporation of the Company, qualified employees, directors, and contract workers participated in the Parent&#146;s
equity incentive plan, including stock option awards. For those employees, directors and contract workers who were transferred to the Company or continued to provide services to the Company and received awards under the Parent&#146;s incentive plan;
costs of those awards are recorded as stock-based compensation with a corresponding contribution from the Parent based on the grant date fair value of the awards. After incorporation, the Company established its new equity incentive plan separate
from the original equity incentive plan from the Parent. Certain qualified employees, directors and contract workers of the Parent have received stock option awards of the Company. The cost of the stock-based compensation of these awards was
recorded by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company measures stock-based compensation expense for all stock-based payment awards based on the estimated
fair value of the awards on the date of grant. The fair value of each employee stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The Company recognizes compensation costs for all employee stock-based
compensation awards on a straight-line basis over the period from the date of hire or of the grant to the date the award is fully vested. The Company has elected to account for forfeitures as they occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company estimates the fair value of stock options granted using the Black Scholes option-pricing model. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><I>Expected Term</I>&#151;The expected term of stock options represents the period that the Company&#146;s stock-based awards are expected to
be outstanding. As the Company does not have sufficient historical experience for determining the expected term, the expected term has been derived based on the simplified method for awards that qualify as plain-vanilla options. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><I>Expected Volatility&#151;</I>As the Company is privately held, there is no observable
market for the Company&#146;s common stock, and, accordingly, expected volatility has been estimated based on the volatilities of similar publicly-traded companies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><I>Risk-Free Interest Rate&#151;</I>The Company bases the risk-free interest rate on the implied yield available on the U.S. Treasury zero
coupon issues with a remaining term equivalent to the expected term of the option. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><I>Expected Dividend&#151;</I>The expected dividend
assumption is based on the Company&#146;s current expectations about its anticipated dividend policy. The Company has not paid dividends since inception and, currently, management does not anticipate a dividend. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the extent that future evidence regarding these variables is available and provides estimates that the Company determines are more
indicative of actual trends, the Company may refine or change its approach to derive these input estimates. These changes could significantly impact the stock-based compensation expense recorded in the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Income Taxes </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
Company accounts for income taxes in accordance with ASC 740, Income Taxes (&#147;ASC 740&#148;). Income taxes in the Company&#146;s financial statements have been allocated in a manner that is systematic, rational, and consistent. The
Company&#146;s operations have historically been included in the Parent&#146;s combined U.S. income tax returns. Income tax expense included in the financial statements has been calculated following the separate return method, as if the Company was
a stand-alone enterprise and a separate taxpayer for the periods presented. As a result, actual tax transactions included in the consolidated financial statements of the Parent may not be included in these financial statements. Further, the
Company&#146;s tax results may not be reflective of the results that the Company expects to generate in the future. The tax treatment of certain items reflected in the financial statements may not be reflected in the consolidated financial
statements and tax returns of the Parent. It is conceivable that items such as net operating losses, other deferred taxes, uncertain tax positions and valuation allowances may exist in the financial statements that may not exist in these financial
statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Since the Company&#146;s results are included in the Parent&#146;s historical tax returns, payments to certain tax
authorities are made by the Parent, and not by the Company. For tax jurisdictions where the Company is included with the Parent in a consolidated tax filing, the Company does not maintain taxes payable to or from the Parent and the payments are
deemed to be settled immediately with the legal entities paying the tax in the respective tax jurisdictions through changes in the Parent company contributions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the Business Combination Agreement, the Company and the Parent entered into the Tax Sharing Agreement. The
Tax Sharing Agreement generally provides that, with respect to any U.S. federal consolidated group of which the Parent and the Company are members, the Parent will be responsible for and will indemnify the Company for the tax liability of such
group. In addition, the Parent will be responsible for and will indemnify the Company for state taxes of any consolidated, combined or unitary tax group for state tax purposes that includes the Parent and the Company. The Tax Sharing Agreement also
provides that the Parent will generally control any tax returns and any tax audits or other proceedings for the taxes addressed by the Tax Sharing Agreement. The Tax Sharing Agreement terminates on the termination of the Business Combination
Agreement. The Company does not expect the Tax Sharing Agreement to have a material impact on the results of the Company&#146;s operations on a <FONT STYLE="white-space:nowrap">go-forward</FONT> basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company follows the asset and liability method of accounting for income taxes. Deferred tax balances are recognized for the estimated
future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets are also recognized for temporary differences that
arise from net operating losses and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected
to be recovered or settled. The effect on deferred tax balances of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to
the amount expected to be realized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement
recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be <FONT STYLE="white-space:nowrap">more-likely-than-not</FONT> to be sustained upon examination by
taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Net Loss Per Share </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Basic net loss per share is computed using the weighted-average number of common stock outstanding during the period. Diluted net loss per
share is computed by dividing the net loss by the weighted-average number of shares of common stock and potentially dilutive securities outstanding for the period. The Company&#146;s potentially dilutive shares consist of shares issuable upon the
exercise of stock options. These have been excluded from the diluted loss per share calculation because their effect is&nbsp;anti-dilutive. The basic and diluted loss per share are therefore the same. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Recently Adopted Accounting Pronouncements </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December&nbsp;2019, the Financial Accounting Standards Board ("FASB") issued ASU
<FONT STYLE="white-space:nowrap">2019-12,</FONT><I>&nbsp;Income Taxes</I> <I>(Topic 740):</I> <I>Simplifying the Accounting for Income Taxes</I> (&#147;ASU 2019-02&#148;), which is intended to simplify various aspects related to accounting for
income taxes. ASU <FONT STYLE="white-space:nowrap">2019-12</FONT> removes certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for
fiscal years, and interim periods within those fiscal years, beginning after December&nbsp;15, 2020, with early adoption permitted. The Company adopted this standard on January&nbsp;1, 2021, and it did not have a material impact on the
Company&#146;s financial statements or the related disclosures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Accounting Pronouncements Not Yet Effective </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In February 2016, the FASB issued Accounting Standards Update (&#147;ASU&#148;) <FONT STYLE="white-space:nowrap">2016-02</FONT><I>, Leases</I>
(<I>Topic&nbsp;842</I>) (&#147;ASU 2016-02&#148;) and subsequent amendments to the initial guidance: ASU <FONT STYLE="white-space:nowrap">2017-13,</FONT> <FONT STYLE="white-space:nowrap">ASU&nbsp;2018-10,</FONT> ASU
<FONT STYLE="white-space:nowrap">2018-11,</FONT> ASU <FONT STYLE="white-space:nowrap">2018-20</FONT> and ASU <FONT STYLE="white-space:nowrap">2019-01</FONT> (collectively, &#147;Topic 842&#148;). Lessees will need to recognize almost all leases on
their balance sheet as a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and a lease liability. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as
either operating or finance. Classification will be based on criteria that are largely similar to those applied in current lease accounting. Lessor accounting is similar to the current model but updated to align with certain changes to the lessee
model and the new revenue recognition standard. Existing sale-leaseback guidance, including guidance for real estate, is replaced with a new model applicable to both lessees and lessors. ASU&nbsp;2016-02 will be effective beginning after
January&nbsp;1, 2022. Early adoption is permitted. Management currently estimates the recognition of&nbsp;right of use (&#147;ROU&#148;) assets of&nbsp;$3,059 and lease liabilities for operating leases of $3,256 as of January&nbsp;1, 2022, with a
cumulative impact to accumulative deficit of $154. The ROU assets will be adjusted per Topic 842 transition guidance for the existing deferred rent balance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In November 2019, the FASB issued ASU <FONT STYLE="white-space:nowrap">2019-10,</FONT> <I>Financial Instruments&#151;Credit Losses (Topic
326), Targeted Transition Relief</I> (&#147;ASU <FONT STYLE="white-space:nowrap">2019-10&#148;),</FONT> which amends the transition guidance for ASU <FONT STYLE="white-space:nowrap">2016-13.</FONT>
<FONT STYLE="white-space:nowrap">ASU&nbsp;2019-10</FONT> provides entities with the option to irrevocably elect the fair value option in Subtopic <FONT STYLE="white-space:nowrap">825-10</FONT> on an <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">instrument-by-instrument</FONT></FONT> basis. <FONT STYLE="white-space:nowrap">ASU&nbsp;2019-10</FONT> is effective for years beginning after December&nbsp;15, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
2022, with early adoption permitted. The Company is currently evaluating the impact ASU <FONT STYLE="white-space:nowrap">2019-10</FONT> will have on the Company&#146;s financial statements and
related disclosures.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2021, the FASB issued ASU <FONT STYLE="white-space:nowrap">2021-07,</FONT> <I>Compensation&#151;Stock
Compensation (Topic 718): Determining the Current Price of an Underlying Share for Equity-Classified Share-Based Awards</I> <FONT STYLE="white-space:nowrap">(&#147;ASU&nbsp;2021-07&#148;).</FONT> The practical expedient is effective prospectively
for all qualifying awards granted or modified during fiscal years beginning after December&nbsp;15, 2021, and interim periods within fiscal years beginning after December&nbsp;15, 2022. Early application, including application in an interim period,
is permitted for financial statements that have not yet been issued or made available for issuance as of October&nbsp;25, 2021. The Company is currently evaluating the impact <FONT STYLE="white-space:nowrap">ASU&nbsp;2021-07</FONT> will have on the
Company&#146;s financial statements and related disclosures.</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>REVENUE RECOGNITION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes revenue in accordance with ASC 606, Revenue Recognition, (&#147;ASC 606&#148;), which outlines a single comprehensive
model to use in accounting for revenue arising from contracts with customers. Revenue is recognized when control of a product or service is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to
in exchange for those promised products or services. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Overall </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company generates revenue from both its arrangements for customization design services for the development of silicon-anode <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> battery technology and from delivery of prototypes and providing finished battery products to its customers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The customization design services generally provide design and development efforts to configure the Company&#146;s existing battery technology
towards a customer&#146;s required specifications, including the delivery of prototypes. The development and delivery of these battery prototypes is a single performance obligation as the individual customization activities performed through
delivery of the prototype batteries are not distinct. Revenue is recognized at the point in time when control transfers to the customer, upon final delivery of prototype batteries or completion of the defined service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes revenue from <FONT STYLE="white-space:nowrap">follow-on</FONT> orders and standalone sales of battery products to
customers at the point in time that control of the product has been transferred to the customer which is generally upon shipment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To
achieve the core principle of revenue recognition, the Company applies the following steps: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><I>1.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Identify the Contract with the Customer</I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. The Company generally
enters into fixed-price agreements with its customers which outline the terms of the business relationship between the customer and the Company. Additionally, the Company may receive purchase orders from customers or enter into statements of work
that indicate pricing, performance and delivery obligations, progress payments (if any) and the timing for each transaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The Company
accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. At
contract inception, the Company also evaluates prior incomplete contracts to determine whether the contract with the customer should be combined and accounted for as a single contract with any prior contract. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><B><I>2.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Identify the Performance Obligations in the Contract</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The promises within each contract for customization design services may vary depending on the customer requirements, however, those contracts
contain promises which generally include (a)&nbsp;custom battery design to conform with customer&#146;s requirements, (b)&nbsp;design progress reporting, (c)&nbsp;development of preliminary batteries, (d)&nbsp;testing of battery design and
performance, and (e)&nbsp;delivery of final battery prototypes that meet <FONT STYLE="white-space:nowrap">pre-defined</FONT> customer specifications along with test results of the delivered batteries. Those promises are generally inputs to a
combined output to deliver a single final prototype battery and accounted as a single performance obligation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Contracts for standard
batteries for commercial sales are generally ready-made with no customization. Within these contracts, each battery is a distinct performance obligation. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><B><I>3.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Determine the Transaction Price</I></B><B> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Payment terms for the Company&#146;s development contracts are generally based on the achievement of defined milestones. Since revenue is
generally recognized at the point in time when control transfers to the customer upon final delivery of prototype battery or completion of the service at the end of the contract (as discussed below in Step 5 - Recognize revenue when, or as, a
performance obligation is satisfied), the variable consideration is not considered to be constrained at the inception of the contract and the transaction price equals the cumulative payments to which the Company is entitled to at the end of the
contract. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The Company elected to use the practical expedient to disregard the effect of the time value of money in a significant
financing component when its payment terms are less than one year. In cases when there is a period of more than one year, the Company only adjusts the transaction price when the financing component is significant and beyond the mitigating effect of
the progress payments. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><B><I>4.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Allocate the Transaction Price to the Performance Obligations in the Contract</I></B><B>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The transaction price is allocated to the performance obligations. The Company&#146;s revenue contracts generally
contain a single performance obligation; therefore, allocation is not necessary. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><B><I>5.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Recognize Revenue When, or as, a Performance Obligation is Satisfied</I></B><B>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Under the Company&#146;s customized design services arrangements, control generally transfers upon the completion
of the battery design and delivery of the final prototype batteries. For <FONT STYLE="white-space:nowrap">follow-on</FONT> orders and standalone sales of battery products to customers, control generally transfers upon shipment of the product. In
some instances, customers may request that the Company bill them for a product but the Company retains physical possession of the product until later delivery, commonly known as
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;bill-and-hold&#148;</FONT></FONT> arrangements. The Company has an agreement with one customer where title to products ordered through the agreement transfers to the customer
when the product is ready for delivery, the customer has requested this arrangement and the batteries are specific to the customer&#146;s order. In these
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;bill-and-hold&#148;</FONT></FONT> arrangements, the Company recognizes revenue when the product is identified separately as belonging to the customer and the product is ready
for delivery to the customer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Sales and Transaction Taxes </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Sales and other taxes collected from customers and remitted to governmental authorities on revenue producing transactions are reported on a net
basis and are therefore excluded from revenue in the statements of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Contract Balances </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The timing of revenue recognition, billings and cash collections can result in billed accounts receivable, unbilled receivables (contract
assets), and deferred revenue (contract liabilities). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Contract assets primarily relate to the rights to consideration for progress on
contractual requirements performed but not billed at the reporting date. The contract assets are transferred to accounts receivable when the rights become unconditional. As of December&nbsp;31, 2021 and 2020, the Company did not have contract assets
recorded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable is the Company&#146;s right to consideration that is unconditional. A right to consideration is
unconditional if only the passage of time is required before payment of that consideration is due. As of December&nbsp;31, 2021 and 2020, the accounts receivable balance was $262 and $348, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Contract liabilities primarily consist of deferred revenue. Deferred revenue is the amount invoiced as progress payments in advance of revenue
recognition; and is recognized as revenue when the recognition criteria are met. The Company&#146;s contracts generally permit invoicing based on <FONT STYLE="white-space:nowrap">pre-defined</FONT> milestones as outlined in the contract. As of
December&nbsp;31, 2021 and 2020, the total deferred revenue balance was $2,864 and $1,661, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Deferred revenue is classified
as long term when the performance obligation is estimated to be satisfied more than twelve months following the balance sheet date. As of December&nbsp;31, 2021 and 2020, $501 and $1,545 of the total deferred revenue balance was considered
long-term, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2021, the aggregate amount of the transaction price allocated to the remaining
performance obligations related to customer contracts that were unsatisfied or partially unsatisfied was $4,321. Given the applicable contract terms, $3,277 is expected to be recognized as revenue within one year and $1,044 is expected to be
recognized between two to five years. This amount does not include contracts to which the customer is not committed. The estimated timing of the recognition of remaining unsatisfied performance obligations is subject to change and is affected by
changes to scope, changes in timing of delivery of products and services, or contract modifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended
December&nbsp;31, 2021 and 2020, revenue recognized for the performance obligation of customized design services was $1,621 and $3,956, respectively. For the years ended December&nbsp;31, 2021 and 2020, revenue recognized for performance obligation
of battery shipments was $1,151 and $723, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended December&nbsp;31, 2021 and 2020, revenue recognized <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">under&nbsp;bill-and-hold&nbsp;arrangements</FONT></FONT> was $670&nbsp;and $409, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table reflects the changes in the Company&#146;s contract liabilities, which is classified as deferred revenue, as of December
31: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue, beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unconditional rights to invoice but not yet</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue recognized from prior period deferred</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(567</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,006</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue, end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Deferred Costs </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Capitalization of certain costs are recognized as an asset when the costs relate directly to a customer contract, generate or enhance resources
of the Company that will be used in satisfying future performance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
obligations, and are expected to be recovered. Judgement is applied to determine the eligibility of these costs. If the criteria for capitalization above are not met, the costs are expensed in
the period incurred. These costs primarily consist of direct labor, cathode and electrolyte materials, freight and other deferred fulfillment costs eligible for capitalization related to the Company&#146;s customized design service revenue. These
costs are recognized when the related revenue is recognized, which is at the completion of the customized design services and delivery of the prototype batteries. At the end of the reporting period, the Company evaluates its deferred costs for
impairment. The Company recognizes impairment of deferred costs when it is determined that the costs are no longer recoverable. Deferred costs of $238 and $429 were recognized as costs of revenue in the statements of operations for the years ended
December&nbsp;31, 2021 and 2020, respectively. Deferred costs were $1,910 and $455 as of December&nbsp;31, 2021 and 2020, respectively. For the years ended December 31, 2021 and 2020, cost of revenues also includes costs incurred on certain
customized design service contracts that were in excess of the amount expected to be recovered. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INVENTORY </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Inventory balances were comprised of the following as of December 31: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raw material</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Work in process</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finished goods</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recorded a reduction in the value of inventories to cost of revenue of $75 and $58 for the years
ended December&nbsp;31, 2021 and 2020, respectively. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PROPERTY AND EQUIPMENT, NET </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment, net consisted of the following as of December 31: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pilot production equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lab equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Construction in progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computers and software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,799</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,464</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Construction in progress is primarily comprised of the construction of new production pilot equipment. The
construction was complete in the third quarter of the year ended December&nbsp;31, 2021 and assets amounting to $1,865 were placed in service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Depreciation expense related to property and equipment was $1,441 and $1,236 for the years ended December&nbsp;31, 2021 and 2020,
respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACCRUED LIABILITIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accrued liabilities consisted of the following as of December 31: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payroll accrued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">805</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NOTES PAYABLE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During May 2020, the Company received a loan pursuant to the Paycheck Protection Program (&#147;PPP&#148;), a program implemented by the U.S.
Small Business Administration (&#147;SBA&#148;) under the CARES Act, from a qualified lender, for an aggregate principal amount of $738 (the &#147;PPP loan&#148;). The PPP loan bore interest at a fixed rate of 1.0% per annum, with the first six
months of interest deferred, payable monthly commencing November 2020 upon request from the lender. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On June&nbsp;30, 2021, the Company
received a notification from its bank that the SBA approved the Company&#146;s PPP loan forgiveness application, effective June&nbsp;29, 2021, for the entire unpaid PPP loan balance of $738 and unpaid accrued interest of $5. As a result, the Company
recorded a $743 gain on forgiveness of the PPP loan as part of the other income in its statement of operations for the year ended December&nbsp;31, 2021. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>STOCKHOLDERS&#146; EQUITY </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Consolidated Statement of Stockholders&#146; Equity has been retroactively adjusted for all periods presented to reflect the Business
Combination and reverse recapitalization as described in Note 1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2021 and 2020, the Company was authorized to
issue 950,000,000 shares of common stock at par value $0.0001 and 65,772,001 and 65,742,883 shares were issued and outstanding as of December&nbsp;31, 2021 and 2020, respectively. Each holder of common stock is entitled to one vote for each share
held and is entitled to receive dividends when and if declared by the board of directors. Through and as of December&nbsp;31, 2021, the Company has not declared any dividends. </P>
<P STYLE="margin-top:15pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Equity Incentive Plans </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>2008 Stock Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Prior to
the formation of the Company, the Parent granted options under its 2008 Stock Plan (the &#147;2008 Plan&#148;) to qualified employees, directors and consultants and some grantees later transferred to the Company upon incorporation of the Company of
thereafter. The 2008 Plan provides for the granting of incentive and nonqualified stock options and restricted stock awards to qualified employees, directors and consultants. The options expire 10 years from the date of grant or 90 days from the
termination of the recipient, generally vest over two to four years, and are exercisable for shares of the Parent&#146;s common stock. All stock-based compensation costs associated with those awards in the Parent are recorded by the Company as
stock-based compensation and contribution from the Parent. Additionally, the Parent grants options under the 2008 Plan to its employees, directors and consultants. These costs are corporate administrative costs that are subsequently allocated to the
Company and are recognized as sales, general and administrative expenses on a <FONT STYLE="white-space:nowrap">carve-out</FONT> basis. As of December&nbsp;31, 2021, there were 12,642,364 shares of common stock reserved for the 2008 Plan, with
375,546 shares available to be issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The disclosures of option activity under the 2008 Plan includes all option activity under the plan
although the allocation of expense to the Company solely relates to options issued to employees of the Parent providing services to the Company and employees of the Company that have options outstanding under the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
2008 Plan. A summary of option activity under the 2008 Plan for the years ended December&nbsp;31, 2021 and 2020 and is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Available<BR>for Grant</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Outstanding<BR>Stock<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Exercise&nbsp;Price<BR>Per Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Remaining<BR>Contractual<BR>Life (Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Intrinsic<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,927,978</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,558,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,393,713</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,393,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,475,713</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,475,713</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,009,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,473,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,609,610</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,609,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,291</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,975,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,975,178</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">375,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,056,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options vested and exercisable as of December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,327,678</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options vested and expected to vest as of December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,056,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>2016 Equity Incentive Plan</B><SUP STYLE="font-size:75%; vertical-align:top"></SUP><FONT
STYLE="font-family:Times New Roman; font-size:6.5pt"><SUP STYLE="font-size:75%; vertical-align:top">(1)<B></B></SUP><B> </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
Company grants stock-based compensation under its 2016 Equity Incentive Plan (the &#147;2016 Plan&#148;). The 2016 Plan provides for the granting of incentive and nonqualified stock options and restricted stock awards to qualified employees,
directors and consultants. The options expire 10 years from the date of grant or 90&nbsp;days from the termination of the recipient, generally vest over four years, and are exercisable for shares of the Company&#146;s common stock. As of
December&nbsp;31, 2021, there were 16,378,888 shares of common stock reserved for the 2016 Plan, with 5,749,559 shares available to be issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A summary of option activity under the 2016 Plan for the years ended December&nbsp;31, 2021 and 2020 is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Available<BR>for Grant</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Outstanding<BR>Stock<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Exercise&nbsp;Price<BR>Per Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Remaining<BR>Contractual<BR>Life (Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Intrinsic<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,124,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,000,484</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(72,795</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">196,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(196,544</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,321,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,731,145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares Authorized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,099,380</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,707,235</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,707,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(29,118</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options expired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(36,397</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,749,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,372,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options vested and exercisable as of December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,348,921</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options vested and expected to vest as of December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,372,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Number of shares and exercise price disclosed are restated for the retroactive application to reflect the
effect of the Exchange Ratio established in the Business Combination in Note 1. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Stock-Based Compensation </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>2008 Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The total
intrinsic value of stock options exercised was $28 and $1 for the years ended December&nbsp;31, 2021 and 2020, respectively. The fair value of options vested for the years ended December&nbsp;31, 2021 and 2020 was $273 and $9 respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2021, there was approximately $404 of total unrecognized compensation cost related to outstanding stock options. That
cost is expected to be recognized over a weighted-average period of approximately 0.8 years. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>2016 Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The total intrinsic value of stock options exercised was $54 and $29 for the years ended December&nbsp;31, 2021 and 2020, respectively. The
fair value of options vested during the years ended December&nbsp;31, 2021 and 2020 was $859 and $42 respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31,
2021, there was approximately $4,436 of total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted-average period of approximately 3.3 years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The table below shows stock-based compensation expense recognized from both the 2008 Plan and 2016 Plan in the statements of operations for
the years ended December&nbsp;31: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Valuation Assumptions </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>2008 Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The
weighted-average assumptions for options granted to calculate the grant date fair value of grants issued under the 2008 Plan were as follows for the years ended December 31: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52.18</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50.27</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.19</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.14</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The weighted-average grant-date fair value of options granted for the years ended December&nbsp;31, 2021 and
2020 was $2.50 and $1.73 per share, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>2016 Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company did not grant any awards to grantees during the year ended December&nbsp;31, 2020. The weighted-average assumptions for options
granted to calculate the grant date fair value of grants issued under the 2016 Plan were as follows for the year ended December&nbsp;31, 2021: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51.75</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.07</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The weighted-average grant-date fair value of options granted for the year ended December&nbsp;31, 2021 was
$1.14 per share<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Restated for the retroactive application to reflect the effect of the Exchange Ratio established in the
Business Combination in Note 1. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NET LOSS PER SHARE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders for the years ended
December 31: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,896</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,418</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average number of common shares
outstanding<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,764,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,693,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per common
share<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.11</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the outstanding shares of potentially dilutive securities that were excluded
from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive for the years ended December&nbsp;31: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,372,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,731,145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Restated for the retroactive application to reflect the effect of the Exchange Ratio established in the
Business Combination in Note 1. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>INCOME TAXES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company did not file separate tax returns as they were included in the consolidated tax reporting of the Parent entity, within the
respective entity&#146;s tax jurisdiction. Accordingly, the income tax provision included in these carve out financial statements was calculated using a method consistent with a separate return basis, as if the Company had been a separate taxpayer.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The components of loss before income taxes for the years ended December&nbsp;31, 2021 and
2020 were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,896</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,623</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended December&nbsp;31, 2021 and 2020, there was no provision (benefit) for income taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The effective tax rate of the Company&#146;s provision (benefit) for income taxes differs from the federal statutory rate as follows for the
years ended December 31: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Statutory rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.14</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.33</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.40</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.44</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(27.48</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(28.41</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1.06</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.36</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Significant components of the Company&#146;s net deferred taxes were as follows as of December 31: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating loss carryforwards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accruals, reserves and others</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capitalized R&amp;D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(85</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(85</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net deferred taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In assessing the realizability of deferred tax assets, management considers whether it is <FONT
STYLE="white-space:nowrap">more-likely-than-not</FONT> that some portion or all the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in
which those temporary differences will become deductible. The Company assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A
significant piece of objective negative evidence is the cumulative losses incurred since inception supported by negative subjective evidence of no expectations of future taxable income. Based on this evaluation, as of December&nbsp;31, 2021, and
2020, the Company determined that its federal and state net deferred tax assets of approximately $20,697 and $17,978, respectively, are subject to a full valuation allowance, as it is <FONT STYLE="white-space:nowrap">more-likely-than-not</FONT> that
the net deferred tax assets will not be realized. The net change in total valuation allowance is an increase of $2,719 and $2,165 for the years ended December&nbsp;31, 2021, and 2020, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Net operating losses and tax credit carryforwards were as follows as of December 31, 2021:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Expiration</B><br><B>Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses, federal (Post December&nbsp;31, 2017)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,759</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Do&nbsp;Not&nbsp;Expire</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses, federal (Pre January&nbsp;1, 2018)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2028-2037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses, state</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2029-2041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credits, federal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2034-2041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credits, state</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Utilization of net operating losses and tax credit carryforwards are subject to certain limitations under
Section&nbsp;382 of the Internal Revenue Code of 1986, as amended, in the event of a change in the Company&#146;s ownership, as defined in current income tax regulations. Federal and state laws impose substantial restrictions on the utilization of
net operating loss and tax credit carryforwards in the event of an ownership change for tax purposes, as defined in Section&nbsp;382 of the Internal Revenue Code. As a result of such ownership changes, the annual limitation may result in the
expiration of net operating losses and credits before utilization. The Company and its Parent performed a Section&nbsp;382 analysis through March&nbsp;15, 2021. The Company and its Parent have experienced ownership changes in the past. The ownership
changes will not result in a limitation that will materially reduce the total amount of net operating loss carryforwards and credits that can be utilized. Subsequent ownership changes may affect the limitation in future years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;1, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions based on tax positions related to 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions for tax positions of prior years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions based on tax positions related to 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions for tax positions of prior years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">709</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The entire amount of the unrecognized tax benefits would not impact the Company&#146;s effective tax rate if
recognized and there would be no cash tax impact. The Company has elected to include interest and penalties as a component of tax expense. For the years ended December&nbsp;31, 2021 and 2020, the Company did not recognize accrued interest and
penalties related to unrecognized tax benefits. The Company does not anticipate that the amount of existing unrecognized tax benefits will significantly increase or decrease during the next 12 months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Parent files income tax returns in the U.S. federal and California tax jurisdictions. The federal and state income tax returns from
inception to December&nbsp;31, 2021 remain subject to examination. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>COMMITMENTS AND CONTINGENGIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Leases Obligations </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has a space and facility sharing arrangement with the Parent to use the equipment owned by the Parent and the facilities leased by
the Parent as its administrative and sales office, research and development laboratory, and production and engineering facilities. The lease is entirely for the benefit of the Company and, although the legal obligation is with the Parent, the
substance of transaction resulted in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Company recording the lease obligation and commitments in these <FONT STYLE="white-space:nowrap">carve-out</FONT> financial statements. For the years ended December&nbsp;31, 2021 and 2020, the
Company paid the Parent an average monthly fee of $42 to share the facilities. In addition, the Company is responsible for variable utilities and common expenses for the facility incurred by the landlord. The Company recognizes rent on a
straight-line basis over the lease term and recognizes any differences in rent paid and expense as deferred rent within accrued liabilities on the balance sheets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The current lease has an expiration date of June&nbsp;30, 2024, with a single option to extend the lease for 60&nbsp;months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The future minimum lease commitments as of December&nbsp;31, 2021 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year ending December&nbsp;31:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,341</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Other Matters </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of its business activities. The
Company accrues contingent liabilities when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. In the opinion of management, there are no pending claims for which the outcome is expected to
result in a material adverse effect on the financial position, results of operations or cash flows of the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>RELATED PARTY TRANSACTIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Related Party Transactions with the Parent </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Officers and directors of the Company were the same individuals as the officers and directors of the Parent for the year ended
December&nbsp;31, 2020. During the year ended December&nbsp;31, 2021, the Company hired a Chief Financial Officer (&#147;CFO&#148;) separately from that of the Parent, and the board of directors of the Company was comprised of four members, who were
also members of the board of directors of the Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has the following arrangements with the Parent regarding general
financing activities, sharing the facilities, services and licensing to support the operation of the Company in the ordinary course of its business: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company has a service agreement for the Parent to provide certain services such as administration, management
service, information technology and engineering services to support the operation of its business. The cost attributable to the Company is calculated using a percentage allocation of total cost incurred. Allocated services costs amounted to $1,363
and $399 for the years ended December&nbsp;31, 2021 and 2020, respectively, out of which $967 was related to stock compensation for the year ended December&nbsp;31, 2021. The stock-based compensation included in allocated service cost is immaterial
for the year ended December&nbsp;31, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">For the year ended December&nbsp;31, 2021, the Company recorded capital contributions of $21,584, which is the
sum of the contributed capital from the Parent of $20,111 and the contribution from the Parent related to stock-based compensation of $1,473 in the statements of stockholders&#146; equity. For the year ended December&nbsp;31, 2020, the Company
recorded capital contributions of $4,866, which is the sum of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
the contributed capital from the Parent of $4,826 and the contribution from the Parent related to stock-based compensation of $40 in the statements of stockholders&#146; equity. The total capital
contributions since inception were $88,009 and $66,425 as of December&nbsp;31, 2021 and 2020, respectively. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company&#146;s board of directors formally approved the treatment of all intercompany advances as forgiven in
March 2021. In substance, since inception and for the year ended December&nbsp;31, 2020, the intercompany transactions between the Company and the Parent have been included in these financial statements and are determined to be forgiven at the time
the transaction occurs, as the intent of the arrangement from inception was capital contributions. Intercompany transactions subsequent to March 2021 were also made in the form of capital contributions. The total net effect of the settlement of
these transactions is presented as financing activities within the statements of cash flows and represented within additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital on the balance sheets. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company has a licensing agreement with the Parent to use patents and licenses owned by the Parent.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">See Note 11 for the related party lease transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Related Party Transactions with Affiliate Subsidiaries </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company also purchases raw materials and development materials from two subsidiaries under common control of the Parent, Amprius Wuxi and
Amprius Nanjing. As of December&nbsp;31, 2021, the outstanding payables balance from affiliate subsidiaries totaled $18. As of December&nbsp;31, 2020, there were no outstanding payables from affiliate subsidiaries. For the years ended
December&nbsp;31, 2021 and 2020, such purchases recorded as cost of revenues totaled $264 and $447, respectively. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EMPLOYEE BENEFIT PLAN </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company maintains a defined contribution savings plan (the &#147;401(k)&nbsp;Plan&#148;) to provide retirement income to all qualified
employees of the Company. The Company is not required to make, and did not make, any contributions to the 401(k)&nbsp;Plan for the years ended December&nbsp;31, 2021 and 2020. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>SUBSEQUENT EVENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Distribution of China Subsidiaries by Parent </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the first quarter of 2022, the Parent distributed shares in all of its other subsidiaries: (i)&nbsp;Amprius (Hong Kong) Limited, owner
of Amprius (Nanjing) Co., Ltd., (ii) Amprius (Hong <FONT STYLE="white-space:nowrap">Kong-2)</FONT> Limited, owner of Amprius (Wuxi) Co., Ltd. and (iii)&nbsp;Amprius Energy, Inc. to stockholders and optionees of the Parent. Distributions with respect
to each of the distributed entities were made in proportion to current equity holdings in the Parent. All Parent equity holders received common stock in each such entity in proportion to their percentage holdings of the Parent shares on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis. Parent preferred holders also received a <FONT STYLE="white-space:nowrap">non-convertible</FONT> preferred stock in each such entity with liquidation preferences in proportion to the relative
preference amounts of their preferred stock held. At the conclusion of the distribution, the Parent&#146;s sole assets were cash and ownership in the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Grants<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP> </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Subsequent to December&nbsp;31, 2021 and through the date these financial statements were available to be issued, the Company granted 3,744,386
new options under the 2016 Plan at an average exercise price of $2.60 per share. The options vest over a 4-year period commencing on the options vesting start date and expire in ten years. The fair value of the options issued was approximately $2.01
per share. There is approximately $7,519 of total unrecognized compensation expense related to these grants. To determine the fair value of common stock as of the grant date for options granted subsequent to December 31, 2021, the Company performed
a linear interpolation between the March 29, 2022 valuation date and the fair value implied by the current Business Combination assuming an exchange ratio of 1.45823 shares of common stock of New Amprius, the surviving entity upon completion of the
Business Combination, for each share of the common stock of the Company expected to be outstanding and an estimated date for the completion of the Business Combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Business Combination </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Effective May 12, 2022, the Company entered into the Business Combination Agreement with Kensington and Merger Sub. Pursuant to the terms of
the Business Combination Agreement, subject to customary closing conditions, including shareholder approval, the Merger will be consummated, Kensington will domesticate as a corporation under the laws of the state of Delaware, and Kensington will
change its name to &#147;Amprius Technologies, Inc.&#148; The transactions contemplated by the Business Combination Agreement are subject to numerous conditions, and there can be no assurance that such conditions will be satisfied. In connection
with the closing, the cash held in trust by Kensington (following satisfaction of redemption by public stockholders) will become available for general corporate purposes, along with any additional proceeds that may be received from any related
equity financing that closes in connection with the closing of Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company is expected to be the accounting
acquirer and the Business Combination is expected to be accounted for as a &#147;reverse recapitalization,&#148; whereby the financial statements of the combined entity represent the continuation of the financial statements of the Company.
Accordingly, the assets, liabilities and results of operations of the Company are expected to become the historical financial statements of the post-combination company, and Kensington&#146;s assets, liabilities and results of operations is expected
to be consolidated with Amprius beginning on the acquisition date. Operations prior to the Business Combination will be presented as those of the Company in future reports. The net assets of the Company are expected to be recognized at carrying
value, with no goodwill or other intangible assets recorded. The Business Combination was consummated on September 14, 2022 as disclosed in Note 1. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Transfer of Lease </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Effective May&nbsp;1, 2022, the Parent assigned the Company the office lease that covers the facilities that the Company uses in its
operations. Historically, the Company recognized this lease in its <FONT STYLE="white-space:nowrap">carved-out</FONT> financial statements, as it is the sole user of the underlying facilities in its operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Transfer of Intellectual Property </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Effective May&nbsp;12, 2022, the Parent assigned to the Company all patents and patent applications, as well as registered trademarks and
trademark applications, used by the Company in its operations under an Intellectual Property Rights agreement. This transfer of intellectual property does not have any financial impact on the Company&#146;s balance sheet. </P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Restated for the retroactive application to reflect the effect of the Exchange Ratio established in the
Business Combination in Note 1. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><U>Termination of Intercompany Agreements </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On June&nbsp;8, 2022, the Parent and the Company entered an agreement to terminate the intercompany service and license agreements
(&#147;Intercompany Agreements&#148;) upon the closing date of the Business Combination. The Parent and the Company will be released and discharged from any and all past, present and future claims; causes of action; damages; liabilities; costs and
expenses; and compensation of any nature that either the Parent or the Company may assert or exercise against the other resulting from any Intercompany Agreements. The Parent and the Company will also waive and relinquish any rights to bring any
action, suit, or proceeding for any claims against the other with respect to any and all matters related to the Intercompany Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company considers events or transaction that occur after the balance sheet date, but before the financial statements were available to be
issued to provide additional evidence relative to certain estimates or identify matters that require additional disclosure. The Company has evaluated subsequent events through June&nbsp;21, 2022, which is the date these financial statements were
available to be issued. Management is not aware of any material events other than those mentioned above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MPRIUS</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A C<SMALL>ARVE</SMALL>-O<SMALL>UT</SMALL> <SMALL>OF</SMALL> A<SMALL>MPRIUS</SMALL>, I<SMALL>NC</SMALL>.) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_7"></A>C<SMALL>ONDENSED</SMALL> B<SMALL>ALANCE</SMALL> S<SMALL>HEETS</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Unaudited, in thousands, except per share amounts) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,<BR>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ASSETS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventories, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77,819</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,830</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LIABILITIES AND STOCKHOLDERS&#146; EQUITY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,641</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,577</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commitments and contingencies (Note 12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.0001 par value, 950,000 shares authorized as of September&nbsp;30, 2022 and
December&nbsp;31, 2021, 84,254 and 65,772 shares were issued and outstanding as of September&nbsp;30, 2022 and December&nbsp;31, 2021, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">162,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(86,831</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(75,401</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities and stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these condensed financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MPRIUS</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A C<SMALL>ARVE</SMALL>-O<SMALL>UT</SMALL> <SMALL>OF</SMALL> A<SMALL>MPRIUS</SMALL>, I<SMALL>NC</SMALL>.) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_8"></A>C<SMALL>ONDENSED</SMALL> S<SMALL>TATEMENTS</SMALL> <SMALL>OF</SMALL> O<SMALL>PERATIONS</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Unaudited, in thousands, except per share amounts) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,617</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,556</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,986</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,468</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,656</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,831</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,434</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,137</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,394</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,920</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income and other, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(17</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on forgiveness of PPP loan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,244</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average common shares outstanding:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share of common stock:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.06</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.05</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.17</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.09</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these condensed financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MPRIUS</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A C<SMALL>ARVE</SMALL>-O<SMALL>UT</SMALL> <SMALL>OF</SMALL> A<SMALL>MPRIUS</SMALL>, I<SMALL>NC</SMALL>.) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_9"></A>C<SMALL>ONDENSED</SMALL> S<SMALL>TATEMENTS</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCKHOLDERS</SMALL>&#146;
E<SMALL>QUITY</SMALL> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Unaudited, in thousands) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended September&nbsp;30, 2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional</B><br><B><FONT STYLE="white-space:nowrap">Paid-in</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Stockholders&#146;</B><br><B>Equity</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of July&nbsp;1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91,117</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(82,587</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retroactive conversion of common stock due to business combination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of July&nbsp;1, 2022, as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(82,587</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of common stock in connection with business combination and PIPE investment, net of
issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of common stock in connection with a stock purchase agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contribution from Amprius Holdings related to stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,244</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,244</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of September&nbsp;30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">162,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(86,831</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended September&nbsp;30, 2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional</B><br><B><FONT STYLE="white-space:nowrap">Paid-in</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Stockholders&#146;</B><br><B>Equity</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(75,401</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retroactive conversion of common stock due to business combination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2022, as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(75,401</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cumulative effect adjustment from the adoption of ASC 842</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(154</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(154</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of common stock in connection with business combination and PIPE investment, net of
issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of common stock in connection with a stock purchase agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital contribution from Amprius Holdings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contribution from Amprius Holdings related to stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of September&nbsp;30, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">162,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(86,831</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended September&nbsp;30, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional</B><br><B><FONT STYLE="white-space:nowrap">Paid-in</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Stockholders&#146;</B><br><B>Equity</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of July&nbsp;1, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,558</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,491</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retroactive conversion of common stock due to business combination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of July&nbsp;1, 2021, as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(68,558</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,491</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital contribution from Amprius Holdings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contribution from Amprius Holdings related to stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of September&nbsp;30, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(71,699</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended September&nbsp;30, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional</B><br><B><FONT STYLE="white-space:nowrap">Paid-in</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Stockholders&#146;</B><br><B>Equity</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(65,505</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retroactive conversion of common stock due to business combination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of January&nbsp;1, 2021, as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(65,505</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital contribution from Amprius Holdings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,692</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,692</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contribution from Amprius Holdings related to stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of September&nbsp;30, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(71,699</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these condensed financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MPRIUS</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A C<SMALL>ARVE</SMALL>-O<SMALL>UT</SMALL> <SMALL>OF</SMALL> A<SMALL>MPRIUS</SMALL>, I<SMALL>NC</SMALL>.) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_10"></A>C<SMALL>ONDENSED</SMALL> S<SMALL>TATEMENTS</SMALL> <SMALL>OF</SMALL> C<SMALL>ASH</SMALL> F<SMALL>LOWS</SMALL>
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Unaudited, in thousands) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from operating activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-cash</FONT> operating lease expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">417</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on forgiveness of PPP loan and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(520</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(465</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,206</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,020</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,837</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">380</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(282</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,184</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,307</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from investing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(747</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(747</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of common stock in connection with business combination and PIPE
investment, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71,090</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital contributions from Amprius Holdings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,692</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of costs in connection with a stock purchase agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(25</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71,578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net increase in cash and cash equivalents</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash, cash equivalents, and restricted cash, beginning of period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash, cash equivalents, and restricted cash, end of period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Components of cash, cash equivalents, and restricted cash:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash included in other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cash, cash equivalents, and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these condensed financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>MPRIUS</SMALL> T<SMALL>ECHNOLOGIES</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(A C<SMALL>ARVE</SMALL>-O<SMALL>UT</SMALL> <SMALL>OF</SMALL> A<SMALL>MPRIUS</SMALL>, I<SMALL>NC</SMALL>.) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377019_11"></A>N<SMALL>OTES</SMALL> <SMALL>TO</SMALL> C<SMALL>ONDENSED</SMALL> F<SMALL>INANCIAL</SMALL> S<SMALL>TATEMENTS</SMALL>
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Unaudited, in thousands, except per share amounts) </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 1 </B><I>&#151;</I><B> ORGANIZATION </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business
Combination </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amprius Technologies, Inc. (f/k/a Kensington Capital Acquisition Corp. IV, a Cayman Islands exempted company incorporated
with limited liability) (the &#147;Company&#148; or &#147;Amprius&#148;) was initially incorporated as a Cayman Islands exempted company on March&nbsp;19, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange,
asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;14, 2022
(the &#147;Closing Date&#148;), the Company completed a business combination pursuant to the Business Combination Agreement, dated May&nbsp;11, 2022 (the &#147;Business Combination Agreement&#148;), by and among the Company, Kensington Capital
Merger Sub Corp., a wholly owned subsidiary of the Company (&#147;Merger Sub&#148;), and Amprius Technologies Operating, Inc. (f/k/a Amprius Technologies, Inc., a Delaware corporation) (&#147;Legacy Amprius&#148;). Pursuant to the terms of the
Business Combination Agreement, the Company changed its jurisdiction of incorporation by domesticating as a corporation incorporated under the laws of the State of Delaware (the &#147;Domestication&#148;), upon which the Company changed its name to
&#147;Amprius Technologies, Inc.,&#148; and a business combination between the Company and Legacy Amprius was effected through the merger of Merger Sub with and into Legacy Amprius, with Legacy Amprius surviving as a wholly owned subsidiary of
Amprius (together with the Domestication and the other transactions contemplated by the Business Combination Agreement, the &#147;Business Combination&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination was treated as a reverse recapitalization. Legacy Amprius was determined as the accounting acquirer and Kensington as
the accounting acquiree for financial reporting purposes based on evaluation of the following facts and circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the stockholders of Legacy Amprius owned a majority of the shares of the Company following the Business
Combination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the board of directors of the Company following the Business Combination was comprised of all of the board
members of Legacy Amprius; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the senior management of the Company following the Business Combination was the senior management of Legacy
Amprius; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">legacy Amprius is larger than Kensington in terms of existing operations and number of employees.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context otherwise provides, the &#147;Company&#148; and &#147;Amprius&#148; refer (i)&nbsp;prior to the
Closing Date, to Legacy Amprius and (ii)&nbsp;after the Closing Date, to Amprius Technologies, Inc. and its subsidiaries, including Legacy Amprius. Kensington Capital Acquisition Corp. IV prior to the Business Combination is referred to herein as
&#147;Kensington.&#148; Please see Notes 2 and Note 3 below for further details. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nature of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amprius has developed, and since 2018, been in commercial production of <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries for
mobility applications leveraging a disruptive silicon nanowire anode. The Company&#146;s silicon nanowire anode technology is intended to enable batteries with higher energy density, higher power density, and fast charging capabilities over a wide
range of operating temperatures. Amprius&#146; sole location and headquarters is in Fremont, California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company previously had an
intercompany agreement with Amprius, Inc. (&#147;Amprius Holdings&#148;) to license intellectual property rights to continue to develop silicon nanowire technology. Under this agreement, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Amprius Holdings provided resources and rights to use its assets to the Company, such as rights to the use of intellectual property, cash, equipment, manufacturing and office facilities,
personnel, and management oversight. Amprius Holdings assigned or contributed those assets to the Company beginning in 2020 and effective May 2022, the operating assets are owned by the Company and the Company treated them as contributions from
Amprius Holdings. The intercompany agreement with Amprius Holdings was terminated effective May 2022. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has an accumulated deficit of $86,831 as of September&nbsp;30, 2022, which represents the
<FONT STYLE="white-space:nowrap">carved-out</FONT> portion of costs incurred by the Company from the inception of Amprius Holdings. Since inception, the Company has incurred recurring operating losses and cash flow deficits from operations. For the
three and nine months ended September&nbsp;30, 2022, the Company incurred a net loss of $4,244 and $11,276, respectively. The Company expects to incur additional losses and increased expenditures in future periods, including those associated with
the design and build out of a manufacturing facility, continued research and development efforts and increased employee headcount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of
September&nbsp;30, 2022, we had $73,803 of cash and cash equivalents, which includes the $70,938 net proceeds from the consummation of the Business Combination. On September&nbsp;27, 2022, the Company entered into a Common Stock Purchase Agreement
(the &#147;Purchase Agreement&#148;) with B. Riley Principal Capital II, LLC (&#147;BRPC II&#148;), pursuant to which the Company has the option to sell up to $200,000 of its common stock over a <FONT STYLE="white-space:nowrap">24-month</FONT>
period from the date of initial satisfaction of the conditions to BRPC II&#146;s purchase obligation set forth in the Purchase Agreement, subject to certain contractual terms (the &#147;Committed Equity Financing&#148;). However, there can be no
assurance that the Company will be able to raise $200,000 over the <FONT STYLE="white-space:nowrap">24-month</FONT> period as the Committed Equity Financing contains certain limitations and conditions. In addition, effective October&nbsp;19, 2022,
the U.S. Department of Energy&#146;s (&#147;DOE&#148;) Office of Manufacturing and Energy Supply Chains (&#147;MESC&#148;) awarded us a $50,000 grant. This cost sharing grant is dependent on the successful negotiation of a final contract, and among
the terms to be finalized are the portion of relevant costs that may be covered by the grant. There can be no assurance that negotiation of the final contract will be successful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company believes its current cash and cash equivalents will be sufficient to fund its operations for at least the next 12 months from the
date these financial statements are issued. If sufficient capital is not raised, the Company may need to reduce its spending on building the manufacturing facility, as well as research and development and other operations, and this may negatively
affect its ability to achieve corporate growth goals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Risk and Uncertainties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The global spread of the <FONT STYLE="white-space:nowrap">COVID-19&nbsp;pandemic</FONT> has caused business disruption affecting production and
sales across a range of industries. In response, the U.S.&nbsp;Government enacted the CARES Act, which included significant provisions to provide relief and assistance to affected organizations. While the disruption is currently expected to be
temporary, there is considerable uncertainty around potential future closings, shelter in place orders, containment of the recent <FONT STYLE="white-space:nowrap">COVID-19&nbsp;variants,</FONT> and the ultimate impact of the CARES Act and other
government initiatives. The <FONT STYLE="white-space:nowrap">COVID-19&nbsp;pandemic</FONT> and its resulting economic and other effects could result in significant adverse effects on the Company&#146;s customers&#146; cash flow and their ability to
manufacture, distribute, and sell products. This in turn may cause customers to be less able to pay invoices for customization design service or the purchase of finished batteries or may result in a reduction in the revenue from customization design
service or sales of finished battery that the Company earns which are often dependent on the demand from the customer for the scope of the customized service or number of units to be purchased. This reduction could cause adverse effects on the
business, results of operations, financial condition, cash flows and ability to raise operating capital. To date, this matter has not had a significant adverse impact on the Company. However, the financial impact and duration cannot be reasonably
determined.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, the U.S. and global markets are experiencing volatility and disruption following the geopolitical tensions and
military conflict between Russia and Ukraine. The ongoing military conflict is highly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
unpredictable and has impacted commodity prices, volatility in credit and capital markets, and supply chain interruptions. The Company continues to monitor the situation and assess its potential
impact on its business. This geopolitical conflict has led to sanctions and other penalties being levied by the United States, the European Union and other countries against Russia. Such sanctions could adversely affect the global economy and
financial markets and lead to instability and lack of liquidity in capital markets, potentially making it more difficult for the Company to obtain additional funds. Although the Company has not been adversely impacted by this ongoing military
conflict to date, it is impossible to predict the extent to which its operations, or those of its customers&#146; suppliers and manufacturers, will be impacted in the short and long term, or the ways in which the conflict may impact its business.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 2 </B><I>&#151;</I><B> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis of Presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying
unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the closing of the Business Combination, whereby Legacy Amprius was determined as the accounting acquirer for accounting
and reporting purposes, the historical financial statements of Legacy Amprius became the historical financial statements of the combined company and no goodwill or other intangible assets were recorded. As a result, the accompanying condensed
financial statements reflect (i)&nbsp;the assets and liabilities of Legacy Amprius at their historical cost; (ii)&nbsp;the historical operating results of Legacy Amprius prior to the Business Combination; (iii)&nbsp;the combined results of the
Company and Legacy Amprius following the closing of the Business Combination; and (iv)&nbsp;Legacy Amprius&#146; equity structure, which has been retroactively restated in all comparative periods up to the Closing Date to reflect the number of
shares of the Company&#146;s common stock issued to Legacy Amprius stockholders. As such, the shares, corresponding capital amounts, and net loss per share related to Legacy Amprius common stock have been retroactively restated to reflect the effect
of the exchange ratio of 1.45590 (the &#147;Exchange Ratio&#148;) established in the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying condensed
financial statements have been prepared from the financial records of Amprius Holdings on a <FONT STYLE="white-space:nowrap">carve-out</FONT> basis. The <FONT STYLE="white-space:nowrap">carve-out</FONT> basis is derived from the accounting records
of Amprius Holdings using the historical results of operations and the historical basis of assets and liabilities of the Company adjusted as necessary to conform to U.S. GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">More specifically, the accompanying condensed balance sheets include all of the Company&#146;s owned assets, assets provided by Amprius
Holdings, and liabilities incurred by Amprius Holdings on behalf of the Company. The accompanying condensed statements of operations reflect all activities directly attributable to the Company, as well as an allocation of Amprius Holdings&#146;
general and administrative expenses. The Company did not share facilities or costs with the other subsidiaries of Amprius Holdings prior to them being distributed by Amprius Holdings with the exception of expenses at Amprius Holdings for payroll
related expenses for two executive employees of Amprius Holdings and other legal, tax, insurance and accounting fees, which were not identifiable as related to a specific subsidiary (&#147;Shared Expenses&#148;). Amprius Holdings executives
supported the Company and other subsidiaries of Amprius Holdings with governance, management, and investor relations. The Shared Expenses were allocated to the Company based on the time incurred by Amprius Holdings executives to support each of its
subsidiaries as the level of effort required was not correlated to the level of activity, revenue, or other financial operating metrics for the subsidiaries. This allocation methodology resulted in an equal allocation of Shared Expenses to each
subsidiary. Prior to the distribution of the subsidiaries of Amprius Holdings in late January and early February 2022, the general and administrative expenses of Amprius Holdings were allocated among each subsidiary, including the Company. After the
distribution, such costs incurred by Amprius Holdings were wholly allocated to the Company as the only remaining subsidiary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Closing of the Business Combination, the Company&#146;s operations were funded
by Amprius Holdings. The source of financing consisted of proceeds received by Amprius Holdings from its issuance of preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management believes the expense allocation methodology and results are reasonable and consistently applied for all comparative periods
presented. However, these allocations may not be indicative of the actual expenses that would have been incurred by an independent company or of the costs to be incurred in the future. The unaudited condensed financial statements presented may not
be indicative of the Company&#146;s future performance and do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the period presented. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The significant accounting policies described below, together with other notes that follow, are an integral part of the condensed financial
statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unaudited Interim Condensed Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The condensed balance sheet as of December&nbsp;31, 2021, which has been derived from audited financial statements as filed in the
Company&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> with the Securities and Exchange Commission (&#147;SEC&#148;) on September&nbsp;30, 2022, and the unaudited interim condensed financial statements have been
prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in
the Accounting Standards Codification (&#147;ASC&#148;), and Accounting Standards Updates (&#147;ASU&#148;) issued by the Financial Accounting Standards Board (&#147;FASB&#148;). The condensed financial statements have been prepared on a basis
consistent with the audited annual financial statements. In management&#146;s opinion, all adjustments made during the periods were normal or recurring in nature and necessary for the fair statement of the Company&#146;s financial position as of
September&nbsp;30, 2022, its results of operations for the three and nine months ended September&nbsp;30, 2022 and 2021 and its cash flows for the nine months ended September&nbsp;30, 2022 and 2021. The financial data and the other financial
information disclosed in the notes to these condensed financial statements related to the three-month and nine-month periods are also unaudited. The results of operations for the three and nine months ended September&nbsp;30, 2022 are not
necessarily indicative of the results to be expected for the full fiscal year or any other period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain information and note
disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make
the information not misleading. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Emerging Growth Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is an emerging growth company as defined in Section&nbsp;2(a) of the Securities Act of 1933 (as amended), and it may take advantage
of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Further, Section&nbsp;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to
comply with new or revised accounting standards until private companies are required to comply with such standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the
requirements that apply to <FONT STYLE="white-space:nowrap">non-emerging</FONT> growth companies but any such election to opt out is irrevocable. The Company has elected to not opt out of such extended transition period. This means that when a
standard is issued or revised and it has different application dates for public or private companies, the Company, as an&nbsp;emerging growth company, can adopt the new or revised standard at the time private companies adopt such new or revised
standard unless the Company is no longer deemed an emerging growth company. As a result, these condensed financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company
effective dates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. These
estimates are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources.
Actual results could materially differ from management estimates using different assumptions or under different conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant
accounting estimates made by the Company include useful lives of property and equipment, valuation of deferred taxes, valuation of inventory, <FONT STYLE="white-space:nowrap">carve-out</FONT> of condensed financial statements including the
allocation of assets, liabilities and expenses, incremental borrowing rate used in calculating lease obligations and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset, and fair value of common stock
used to determine stock-based compensation expense prior to the merger with Kensington, and other inputs used to value stock-based compensation awards. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash, Cash Equivalents, and Restricted Cash </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents consist of deposits at banks and a money market fund with original maturities of 90 days or less from the date of
purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted cash pertains to cash collateral required by the Company&#146;s lessor to satisfy a letter of credit requirement
under its lease agreement. As of September&nbsp;30, 2022, restricted cash was $333 and is included in other assets in the accompanying condensed balance sheet. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Accounts Receivable </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable
are recorded at the invoiced amount less any estimated allowance for doubtful accounts. An allowance for doubtful accounts is based on the Company&#146;s assessment of the collectability of accounts by considering the age of outstanding invoices and
the collection history of the customer, as well as an evaluation of potential risk of loss. A receivable deemed to be uncollectible is written off against a previously established allowance and recoveries are recognized when the cash is received.
The Company has not experienced any significant losses from accounts receivable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fair Value Measurements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The carrying amounts of cash, accounts receivable, accounts payable, and accrued liabilities approximate fair value because of the short-term
nature of these items. Assets and liabilities recorded at fair value in the financial statements are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels, which are directly
related to the amount of subjectivity, associated with the inputs to the valuation of these assets or liabilities are as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Inputs that are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Inputs (other than quoted prices included in Level&nbsp;1) that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the
instrument&#146;s anticipated life.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, and which reflect management&#146;s best estimate of what market participants would
use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In determining fair value, the Company utilizes valuation techniques that maximize the use
of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company had $72,828 of cash equivalents measured at Level&nbsp;1 fair value on a recurring basis as of September&nbsp;30, 2022. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concentration of Credit Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial
instruments that potentially subject the Company to concentration of credit risk consist of cash and accounts receivable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cash is
deposited with a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250. As of September&nbsp;30, 2022 and December&nbsp;31, 2021, the Company has not experienced losses on this account and management
believes the Company is not exposed to significant risks of loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable mainly consist of amounts due from U.S. government
agencies or sponsored entities and large public entities which limits the Company&#146;s credit risk. Through September&nbsp;30, 2022, the Company has not experienced any credit losses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three months ended September&nbsp;30, 2022 and 2021, two customers and one customer represented 82% and 82% of the Company&#146;s
revenues, respectively. For the nine months ended September&nbsp;30, 2022 and 2021, four and two customers represented 83% and 84% of the Company&#146;s revenues, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September&nbsp;30, 2022 and December&nbsp;31, 2021, three and five customers represented 76% and 96%, respectively, of the
Company&#146;s total accounts receivable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Segment Reporting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has determined that the Chief Executive Officer is its Chief Operating Decision Maker (CODM). The CODM reviews financial
information presented on an aggregate basis for the purposes of assessing the Company&#146;s performance and making decisions on how to allocate resources. Accordingly, the Company has determined that it operates in a single operating and reportable
segment. All of the Company&#146;s revenues are geographically earned in the United States and the Company&#146;s property and equipment are located in the United States. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Revenue Recognition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company
recognizes revenue under ASC Topic 606, <I>Revenue from Contracts with Customers</I>, when a customer obtains control of promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for
those goods or services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company generates revenue from both its arrangements for customization design services for the development
of silicon-anode <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery technology and delivery of prototypes and providing finished battery products to its customers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The customization design services generally provide design and development efforts to configure the Company&#146;s existing battery technology
towards a customer&#146;s required specifications, including the delivery of the prototypes. The development and delivery of these battery prototypes is a single performance obligation as the individual customization activities performed through
delivery of the prototype batteries are not distinct. Revenue is recognized at the point in time when control transfers to the customer upon final delivery of prototype batteries or completion of the defined service. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes revenue from <FONT STYLE="white-space:nowrap">follow-on</FONT> orders
and standalone sales of battery products to customers at the point in time that control of the product has been transferred to the customer which is generally upon shipment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To achieve the core principle of revenue recognition, the Company applies the following steps: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Identify the contract with the customer. </I></B>A contract is defined as an agreement between two or
more parties that creates enforceable rights and obligations. The Company generally enters into fixed-price agreements with its customers which outline the terms of the business relationship between the customer and the Company. Additionally, the
Company may receive purchase orders from customers or enter into statements of work that indicate pricing, performance and delivery obligations, progress payments (if any) and the timing for each transaction. The Company accounts for a contract when
it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. At contract inception, the Company
also evaluates prior incomplete contracts to determine whether the contract with the customer should be combined and accounted for as a single contract with any prior contract. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Identify the performance obligations in the contract. </I></B>The promises within each contract for
customization design services may vary depending on the customer requirements; however, those contracts contain promises which generally include (i)&nbsp;custom battery design to conform with customer&#146;s requirements, (ii)&nbsp;design progress
reporting, (iii)&nbsp;development of preliminary batteries, (iv)&nbsp;testing of battery design and performance, and (v)&nbsp;delivery of final battery prototypes that meet <FONT STYLE="white-space:nowrap">pre-defined</FONT> customer specifications
along with test results of the delivered batteries. Those promises are generally inputs to a combined output to deliver a single final prototype battery and are accounted for as a single performance obligation. Contracts for standard batteries for
commercial sales are generally ready-made with no customization. Within these contracts, each battery is a distinct performance obligation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Determine the transaction price</I></B>. Payment terms for the Company&#146;s development contracts are
generally based on the achievement of defined milestones. Since revenue is generally recognized at the point in time when control transfers to the customer upon final delivery of prototype battery or completion of the service at the end of the
contract as discussed below in Step 5<I>, Recognize revenue when, or as, a performance obligation is satisfied</I>, the variable consideration is not considered to be constrained at the inception of the contract and the transaction price equals the
cumulative payments to which the Company is entitled to at the end of the contract. The Company elected to use the practical expedient to disregard the effect of the time value of money in a significant financing component when its payment terms are
less than one year. In cases when there is a period of more than one year, the Company only adjusts the transaction price when the financing component is significant and beyond the mitigating effect of the progress payments. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Allocate the transaction price to the performance obligations in the contract</I></B>. The transaction
price is allocated to the performance obligations. The Company&#146;s revenue contracts contain a single performance obligation; therefore, allocation is not necessary. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Recognize revenue when, or as, a performance obligation is satisfied</I></B>. Under the Company&#146;s
customized design services arrangements, control generally transfers upon the completion of the battery design and delivery of the final prototype batteries. For <FONT STYLE="white-space:nowrap">follow-on</FONT> orders and standalone sales of
battery products to customers, control generally transfers upon shipment of the product. In some instances, customers may request that the Company bill them for a product but the Company retains physical possession of the product until later
delivery, commonly known as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;bill-and-hold&#148;</FONT></FONT> arrangements. The Company has a customer that has requested an arrangement whereby the Company may store finished
product until the customer&#146;s employees arrive at a specific site for a customer flight test. The finished products for such customer are stored in a storage area that are identified separately as belonging to such customer and are ready for
immediate shipment upon the customer&#146;s request. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Additionally, title and risk of loss has passed to the customer. as such, the Company does not have the ability to use the finished products or direct them to other customers. In these <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;bill-and-hold&#148;</FONT></FONT> arrangements, the Company recognizes revenue when the product is identified separately as belonging to the customer and the product is ready for
delivery to the customer. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sales and Transaction Taxes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales and other taxes collected from customers and remitted to governmental authorities on revenue producing transactions are reported on a net
basis and are therefore excluded from revenue in the condensed statements of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Deferred Costs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain costs, which consist primarily of payroll-related costs, are initially deferred when (i)&nbsp;the costs relate directly to a customer
contract, (ii)&nbsp;generate or enhance resources of the Company that will be used in satisfying future performance obligations, and (iii)&nbsp;are expected to be recovered. If these three criteria are not met, the costs are expensed into cost of
revenue in the period incurred. Deferred costs are recognized as cost of revenues in the period when the related revenue is recognized, except when such costs incurred are in excess of the amount expected to be recoverable, in which case they are
expensed as incurred into cost of revenues. The recoverable amount equals the total of the amount of consideration that the entity expects to receive in the future and that the entity has received but has not recognized as revenue, in exchange for
the goods or services to which the asset relates, less the costs that relate directly to providing those goods or services and that have not been recognized as expenses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cost of Revenues </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues
primarily includes cost of materials, direct labor costs, and allocation of indirect costs, such as facilities and overhead expenses. Costs are recognized when incurred during the period revenue is recognized. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock-Based Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the
formation of the Company, certain employees, directors, and contract workers were granted stock option awards under Amprius Holdings&#146; equity incentive plan. The stock-based compensation costs of those stock option awards to employees, directors
and contract workers, who were transferred to the Company or continued to provide services to the Company, were recorded by the Company with a corresponding increase to additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2016, the Company adopted its equity incentive plan separate from the equity incentive plan of Amprius Holdings. Certain qualified
employees, directors and contract workers of Amprius Holdings have received stock option awards of the Company. The cost of the stock-based compensation of those awards was recorded by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company measures stock-based compensation expense for all stock-based payment awards based on the estimated fair value of the awards on
the date of grant. The fair value of each employee stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The Company recognizes compensation costs for all employee stock-based compensation awards on a
straight-line basis over the period from the date of the grant to the date the award is fully vested. The Company has elected to account for forfeitures as they occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Black-Scholes option-pricing model requires the use of highly subjective assumptions which determine the fair value of stock-based awards.
These assumptions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Expected Term &#151; The expected term of stock options represents the period that the Company&#146;s stock-based
awards are expected to be outstanding. As the Company does not have sufficient historical </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
experience for determining the expected term, the expected term has been derived based on the simplified method for awards that qualify as plain-vanilla options. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Expected Volatility &#151; The Company estimates volatility for option grants by evaluating the average
historical volatility of a peer group of companies for the period immediately preceding the option grant for a term that is approximately equal to the option&#146;s expected term. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Risk-Free Interest Rate &#151; The Company bases the risk-free interest rate on the implied yield available on
the U.S. Treasury zero coupon issues with a remaining term equivalent to the expected term of the option. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Expected Dividend &#151; The expected dividend assumption is based on the Company&#146;s current expectations
about its anticipated dividend policy. The Company has not paid dividends since inception and currently, management does not anticipate a dividend. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that future evidence regarding these variables is available and provides estimates that the Company determines are more
indicative of actual trends, the Company may refine or change its approach to derive these input estimates. These changes could significantly impact the stock-based compensation expense recorded in the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company
classified the common stock warrants as equity in accordance with FASB ASC Topic <FONT STYLE="white-space:nowrap">815-40,</FONT> <I>Derivatives and Hedging&#151;Contracts in Entity&#146;s Own Equity</I>. The classification is determined based upon
the Company&#146;s assessment that the common stock warrants are considered indexed to the Company&#146;s own stock and the Company has the ability to settle them by issuing shares of the Company&#146;s common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recently Adopted Accounting Standards </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
February 2016, FASB issued ASU <FONT STYLE="white-space:nowrap">2016-02,</FONT> <I>Leases,</I> and subsequent amendments to the initial guidance: ASU <FONT STYLE="white-space:nowrap">2017-13,</FONT>
<FONT STYLE="white-space:nowrap">ASU&nbsp;2018-10,</FONT> <FONT STYLE="white-space:nowrap">ASU&nbsp;2018-11,</FONT> ASU <FONT STYLE="white-space:nowrap">2018-20</FONT> and ASU <FONT STYLE="white-space:nowrap">2019-01</FONT> (collectively,
&#147;Topic 842&#148;). Lessees will need to recognize almost all leases on their balance sheet as a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and a lease liability. For income statement
purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Classification will be based on criteria that are largely similar to those applied in current lease accounting. Lessor accounting is similar
to the current model but updated to align with certain changes to the lessee model and the new revenue recognition standard. Existing sale-leaseback guidance, including guidance for real estate, is replaced with a new model applicable to both
lessees and lessors. The Company adopted Topic 842 on January&nbsp;1, 2022, using the modified retrospective approach, therefore, the effects of adoption on comparative periods have not been and are not required to be restated or disclosed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the adoption date, the Company accounts for its leases under ASC 842, <I>Leases</I>. Under this guidance, lessees classify arrangements
meeting the definition of a lease as operating or financing leases, and leases are recorded on the balance sheet as both <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">a&nbsp;right-of-use&nbsp;asset</FONT></FONT> and lease
liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#146;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and
the right of use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">the&nbsp;right-of-use&nbsp;asset</FONT></FONT>
result in straight-line rent expense over the lease term. For finance leases, interest on the lease liability and the amortization of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">the&nbsp;right-of-use&nbsp;asset</FONT></FONT>
results in front-loaded expense over the lease term. Variable lease expenses, including common maintenance fees, insurance and property tax, are recorded when incurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In calculating <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">the&nbsp;right-of-use&nbsp;asset</FONT></FONT> and lease
liability, the Company elects to combine lease <FONT STYLE="white-space:nowrap">and&nbsp;non-lease&nbsp;components</FONT> for its real estate lease. The Company will assess this election for other asset classes as they arise. The Company excludes
short-term leases having initial terms of 12 months or less as an accounting policy election, and instead recognizes rent expense on a straight-line basis over the lease term. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has a single lease of a real estate asset, which includes administrative and
sales offices, research and development space, manufacturing and a dry room. This lease also requires the Company to pay maintenance, utilities, taxes, insurance, and other operating expenses associated with the leased space. The Company elected the
transition package of three practical expedients which allow companies not to reassess whether agreements contain leases, the classification of leases, and the capitalization of initial direct costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the adoption of Topic 842, the lease continued to be classified as an operating lease, and the Company recognized the following
on January&nbsp;1, 2022: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Operating lease liabilities of $3,256, which represents the present value of the remaining lease payments, as of
the date of adoption, discounted using the Company&#146;s incremental borrowing rate of 7.9%. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Operating lease <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT>
(&#147;ROU&#148;) assets of $3,059, which represents the operating lease liabilities of $3,256, adjusted for deferred rent of $240 and prepaid rent of $43. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The adoption of the new lease accounting standard increased the Company&#146;s accumulated deficit by $154.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The adoption of Topic 842 did not have any other impact on the Company&#146;s condensed balance sheet as of
September&nbsp;30, 2022, operating results for the three and nine months ended September&nbsp;30, 2022, and condensed cash flows for the nine months ended September&nbsp;30, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2021, the FASB issued ASU <FONT STYLE="white-space:nowrap">2021-10,</FONT> <I>Government Assistance</I> (Topic 832),
<I>Disclosures by Business Entities About Government Assistance</I>, which requires entities to provide disclosures on material government transactions for annual reporting periods. The disclosures include information around the nature of the
assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#146;s financial statements, and any significant terms and conditions of the agreements, including commitments
and contingencies. The ASU is effective for financial statements issued for annual periods beginning after December&nbsp;15, 2021, with early adoption permitted. The Company adopted this guidance on January&nbsp;1, 2022, with no impact on the
Company&#146;s condensed financial statements and related disclosures as the Company does not have any government assistance accounted for by applying a grant or contribution accounting model by analogy in the periods presented. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Accounting Pronouncements Not Yet Adopted </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2019, the FASB issued ASU <FONT STYLE="white-space:nowrap">2019-10,</FONT> <I>Financial Instruments &#150; Credit Losses</I> (Topic
326), <I>Targeted Transition Relief</I> (&#147;ASU <FONT STYLE="white-space:nowrap">2019-10&#148;),</FONT> which amends the transition guidance for ASU <FONT STYLE="white-space:nowrap">2016-13.</FONT>
<FONT STYLE="white-space:nowrap">ASU&nbsp;2019-10</FONT> provides entities with the option to irrevocably elect the fair value option in Subtopic <FONT STYLE="white-space:nowrap">825-10</FONT> on an <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">instrument-by-instrument</FONT></FONT> basis. <FONT STYLE="white-space:nowrap">ASU&nbsp;2019-10</FONT> is effective for years beginning after December&nbsp;15, 2022, with early adoption permitted. The Company is currently
evaluating the impact of ASU <FONT STYLE="white-space:nowrap">2019-10</FONT> on its financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 3 </B><I>&#151; </I><B>BUSINESS
COMBINATION</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;14, 2022, the Company completed the Business Combination, discussed above, which was treated as a
reverse recapitalization. The effects of the Business Combination include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Company&#146;s certificate of incorporation was amended and restated to, among other things, authorize the
issuance of 1,000,000 shares, of which 950,000 shares are designated as common stock, $0.0001 par value per share, and 50,000 shares are designated as preferred stock, $0.0001 par value per share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all outstanding shares of Legacy Amprius&#146; common stock were exchanged for a number of the Company&#146;s
common stock equal to the number of Legacy Amprius&#146; shares multiplied by the Exchange Ratio of approximately 1.45590, or for an aggregate of 65,777 shares of the Company&#146;s common stock; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each option to purchase Legacy Amprius&#146; common stock (a &#147;Legacy Amprius Option&#148;), whether vested
or unvested, was converted into an option to purchase a number of the Company&#146;s common stock (an &#147;Option&#148;), subject to substantially the same terms and conditions as were applicable prior to the merger, equal to the product of the
number of shares of Legacy Amprius&#146; common stock subject to such Legacy Amprius Option immediately prior to the closing and the Exchange Ratio, at an exercise price per share calculated by dividing the exercise price per share of such Legacy
Amprius Option immediately prior to the Business Combination by the Exchange Ratio. At closing, the Legacy Amprius Options were converted to Options to receive an aggregate of 14,223 shares of common stock, of which 6,665 shares remained subject to
vesting obligations. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Closing Date, a number of investors (the &#147;PIPE Investors&#148;) purchased from the
Company an aggregate of 2,052 PIPE units at a price of $10.00 per share (such transaction, the &#147;PIPE&#148;), pursuant to separate subscription agreements (each, a &#147;Subscription Agreement&#148;) entered into with the PIPE Investors. Each
PIPE unit consists of (i)&nbsp;one share of common stock and (ii)&nbsp;one warrant (each, a &#147;PIPE Warrant&#148;) to purchase one share of common stock. The PIPE Warrants are substantially identical to the Public Warrants, except that the
exercise price of each PIPE Warrant is $12.50 per share, and the average sales price of the common stock will need to exceed $20.00 per share for the Company to be able to redeem the PIPE Warrants. The PIPE was consummated immediately prior to the
closing of the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately after giving effect to the Business Combination and the PIPE, the Company&#146;s shares
of common stock consisted of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock &#151; Legacy Amprius</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock &#151; PIPE investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock &#151; Kensington</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total shares of common stock immediately after Business Combination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company received net proceeds from the Business Combination and the PIPE totaling $70,938, after deducting
transaction and issuance costs. Transaction costs paid by the Company, which consisted of direct and incremental costs, such as legal, consulting and advisory fees incurred in connection with the Business Combination, totaled $6,794 during the nine
months ended September 30, 2022. These costs were initially deferred and subsequently classified as a reduction to additional paid-in capital in the accompanying condensed balance sheet upon the consummation of the Business Combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 4 </B><I>&#151;</I><B> REVENUE</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contract Balances
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The timing of revenue recognition, billings and cash collections can result in billed accounts receivable, unbilled receivables
(contract assets), and deferred revenue (contract liabilities). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Contract assets primarily relate to the rights to consideration for
progress on contractual requirements performed but not billed at the reporting date. The contract assets are transferred to accounts receivable when the rights become unconditional. As of September&nbsp;30, 2022 and December&nbsp;31, 2021, the
Company did not have contract assets recorded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable is the Company&#146;s right to consideration that is unconditional. A
right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. As of September&nbsp;30, 2022 and December&nbsp;31, 2021, the accounts receivable balances were $782 and $262, respectively.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Contract liabilities primarily consist of deferred revenue. Deferred revenue is the amount invoiced as progress payments in advance of
revenue recognition; and is recognized as revenue when the recognition criteria are met. The Company&#146;s contracts generally permit invoicing based on <FONT STYLE="white-space:nowrap">pre-defined</FONT> milestones as outlined in the contract. As
of September&nbsp;30, 2022 and December&nbsp;31, 2021, the total deferred revenue balances were $2,582 and $2,864, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Deferred revenue is classified as long term when the performance obligation is to be
satisfied more than twelve months following the balance sheet date. As of September&nbsp;30, 2022 and December&nbsp;31, 2021, $1,787 and $501 of the total deferred revenue balance was considered long-term, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September&nbsp;30, 2022, the aggregate amount of the transaction price allocated to the remaining performance obligations related to
customer contracts that were unsatisfied or partially unsatisfied was $8,447. Given the applicable contract terms, $3,110 is expected to be recognized as revenue within one year and $5,337 is expected to be recognized between two to five years. This
amount does not include contracts to which the customer is not committed. The estimated timing of the recognition of remaining unsatisfied performance obligations, all of which are recognized at a point in time, is subject to change and is affected
by changes to scope, changes in timing of delivery of products and services, or contract modifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three and nine months
ended September&nbsp;30, 2022, $340 and $736 was recognized under <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">bill-and-hold</FONT></FONT> arrangements, respectively. For the three and nine months ended September&nbsp;30, 2021,
$270 and $670 was recognized <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">under&nbsp;bill-and-hold&nbsp;arrangements,</FONT></FONT> respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table reflects the changes in the Company&#146;s contract liabilities, which is classified as deferred revenue: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,<BR>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenues, beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unconditional rights to invoice but not yet recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue recognized from prior period deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,663</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(567</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenues, end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,582</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Deferred Costs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the three and nine months ended September&nbsp;30, 2022, $286 and $1,182 of deferred costs, respectively, were recognized as costs of
revenue in the condensed statements of operations. During each of the three and nine months ended September&nbsp;30, 2021, $211 of deferred costs were recognized as costs of revenue in the condensed statement of operations. Deferred costs were
$1,837 and $1,910 as of September&nbsp;30, 2022 and December&nbsp;31, 2021, respectively. During the nine month period ended September&nbsp;30, 2022 and 2021, cost of revenues also includes costs incurred on certain customized design service
contracts that were in excess of the amount expected to be recovered; however, those costs were not material. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 5 </B><I>&#151;
</I><B>INVENTORY</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Inventory consisted of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,<BR>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raw materials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Work in progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finished goods</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventories, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 6 </B><I>&#151; </I><B>PROPERTY AND EQUIPMENT, NET</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Property and equipment, net consisted of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,<BR>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pilot production equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture, fixtures, and other equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, at cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: accumulated depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,845</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,799</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pilot production equipment, above, includes construction in progress of $384 as of September&nbsp;30, 2022.
Depreciation and amortization expense was $386 and $441 for the three months ended September&nbsp;30, 2022 and 2021, respectively, and $1,116 and $1,068 for the nine months ended September&nbsp;30, 2022 and 2021, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 7 </B><I>&#151;</I><B> ACCRUED AND OTHER CURRENT LIABILITIES</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accrued and other current liabilities consisted of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,<BR>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued offering costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">399</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued property tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 8 </B><I>&#151;</I><B> STOCKHOLDERS&#146; EQUITY </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September&nbsp;30, 2022, the Company was authorized to issue 1,000,000 shares of stock, of which 950,000 shares are designated as common
stock, $0.0001 par value per share, and 50,000 shares are designated as preferred stock, $0.0001 par value per share. Holders of common stock are entitled to one vote for each share held and are entitled to receive dividends when and if declared by
the board of directors. Through and as of September&nbsp;30, 2022, the Company has not declared any dividends. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Incentive Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2008 Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the formation
of the Company, Amprius Holdings granted stock options under its 2008 Stock Plan (the &#147;2008 Plan&#148;) to its qualified employees, including those employees who later transferred to the Company following the incorporation of the Company. Stock
option grants under the 2008 Plan expire 10 years from the date of grant or 90 days from the termination of the employee, generally vest over two to four years, and are exercisable for shares of Amprius Holdings&#146; common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stock-based compensation under the 2008 Plan associated with those awards granted to the Company&#146;s employees and Amprius
Holdings&#146; employees who provide services to the Company is recorded by the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as stock-based compensation and as contribution from Amprius Holdings. The completion of the merger with Kensington did not affect the terms of the outstanding options under the 2008 Plan. There
were no options granted, exercised, or expired under the 2008 Plan during the nine months ended September&nbsp;30, 2022. As of September&nbsp;30, 2022, there were 12,642 shares of common stock reserved for the 2008 Plan, with 376 available to be
issued. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2016 Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to
the closing of the merger with Kensington, the Company maintained the 2016 Equity Incentive Plan (the &#147;2016 Plan&#148;), which was adopted effective December&nbsp;1, 2017. The 2016 Plan permitted the grant of incentive stock options, <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options, restricted stock awards, and restricted stock unit awards to the Company and its affiliates&#146; employees, consultants and directors. Options granted under the 2016 Plan during the
nine months ended September&nbsp;30, 2022 totaled 3,875 shares with a weighted average exercise price of $2.62 per share. The 2016 Plan was terminated concurrently with the adoption of the 2022 Equity Incentive Plan (the &#147;2022 Plan&#148;). As a
result, no additional awards will be granted under the 2016 Plan. However, the 2016 Plan continues to govern the terms and conditions of the outstanding awards previously granted under the 2016 Plan. As of September&nbsp;30, 2022, a total of 14,216
stock options were outstanding under the 2016 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2022 Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company adopted the 2022 Plan effective September&nbsp;14, 2022. The 2022 Plan authorizes awards in the form of stock options, stock
appreciation rights, restricted stock, restricted stock units, or performance awards and may be granted to directors, employees or consultants. Subject to the adjustment provisions and the evergreen provisions contained in the 2022 Plan, a total of
9,900 shares of the Company&#146;s common stock is reserved for issuance pursuant to the 2022 Plan. In addition, the shares reserved for issuance under the 2022 Plan include any assumed awards that, on or after the Closing Date, were cancelled,
expired or otherwise terminated without having been exercised in full, were tendered to or withheld by the Company for payment of an exercise price or for tax withholding obligations, or were forfeited to or repurchased by the Company due to failure
to vest (provided that the maximum number of shares that may be added to the 2022 Plan is 15,000 shares). The number of shares available for issuance under the 2022 Plan may be increased annually beginning on January&nbsp;1, 2023 subject to certain
limitations under the 2022 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2022 Plan provides for stock options to be granted to employees at an exercise price not less than
100% of the fair value at the grant date, unless the optionee is a 10% stockholder, in which case the option price will not be less than 110% of such fair market value. Options granted generally have a maximum term of 10 years from grant date and
are exercisable upon vesting. There were no grants under the 2022 Plan during the three months ended September&nbsp;30, 2022. As of September&nbsp;30, 2022, a total of 9,907 shares of common stock were reserved for issuance under the 2022 Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>ESPP </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company adopted the 2022
Employee Stock Purchase Plan (&#147;ESPP&#148;) effective September&nbsp;14, 2022. Under the ESPP, the Company the maximum number of shares available for issuance is 990 shares of common stock, which number may be increased annually beginning
January&nbsp;1, 2023, subject to certain limitations under the ESPP. The ESPP is intended to qualify under Section&nbsp;423 of the Internal Revenue Code of 1986 (as amended) and will provide eligible employees an opportunity to purchase the
Company&#146;s common stock at a discount through payroll deductions. Under the ESPP, the Company may specify offering periods, provided that no offering period will have a duration exceeding 27 months. The purchase price per share is equal to 85%
of the fair market value of a share of the Company&#146;s common stock on the (i)&nbsp;offering date or (ii)&nbsp;purchase date, whichever is lower. The Company has not established an offering under the ESPP as of September&nbsp;30, 2022. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Incentive Compensation Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;14, 2022, the Company&#146;s board of directors approved the Company&#146;s Executive Incentive Compensation Plan, which will
allow the Company to grant incentive awards to certain executive employees, generally payable in cash, based upon achieving specified goals. The Company has the right to settle the award by granting an equity award, which may be subject to vesting
conditions. All awards under the Executive Incentive Compensation Plan will be subject to reduction, cancellation, forfeiture, or recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to applicable laws. As
of September&nbsp;30, 2022, there were no awards granted under the Executive Incentive Compensation Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock-Based Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below shows stock-based compensation expense recognized for both the 2008 and 2016 Plans for the three and nine months ended
September&nbsp;30, 2022 and 2021: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2022&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2021&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2022&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2021&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September&nbsp;30, 2022, there was approximately $9,164 of unrecognized compensation cost related to the
2016 Plan, which is expected to be recognized over a weighted-average period of approximately 3.3 years. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each redeemable warrant to purchase Kensington ordinary shares, exercisable for one ordinary share at an exercise price of $11.50 per share
(the &#147;Public Warrants&#148;) and each warrant to purchase ordinary shares owned by Kensington, exercisable for one ordinary share at an exercise price of $11.50 (the &#147;Private Warrants&#148; and, together with the Public Warrants, the
&#147;Warrants&#148;) outstanding at the time of the Business Combination converted into a warrant exercisable for one share of the Company&#146;s common stock pursuant to the Warrant Agreement, dated as of March&nbsp;1, 2022 (the &#147;Warrant
Agreement&#148;). At closing, there were 29,483 Public Warrants and 16,400 Private Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrent to the closing of the Business
Combination, a number of PIPE Investors purchased from the Company an aggregate of 2,052 PIPE units at a price of $10.00 per share, which consist of (i)&nbsp;one share of common stock and (ii)&nbsp;one PIPE warrant to purchase one share of common
stock. The PIPE Warrants are substantially identical to the Public Warrants, except that the exercise price of each PIPE Warrant is $12.50 per share, and the average sales price of the common stock will need to exceed $20.00 per share for the
Company to be able to redeem the PIPE Warrants. The PIPE was consummated immediately prior to the closing of the Business Combination. As of September&nbsp;30, 2022, the Company had 2,052 PIPE warrants outstanding. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock Purchase Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
September&nbsp;27, 2022, the Company entered into the Purchase Agreement with BRPC II, pursuant to which the Company, at its option, has the right to sell to BRPC II up to $200,000 of its common stock from time to time over a period of 24 months
from and after the effective date of the registration statement related to the offering and resale of such shares of common stock. The purchase price will be determined by reference to the volume weighted average price of the Company&#146;s common
stock (as defined in the Purchase Agreement), less a discount of 3%. The Company cannot issue to BRPC II more than 19.99% of the aggregate number of shares of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the common stock issued and outstanding immediately prior to the execution of the Purchase Agreement, except in limited circumstances. Proceeds from the sale of the Company&#146;s common stock to
BRPC II will depend upon the frequency and the market price of the Company&#146;s common stock on the date of sale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company issued 85
shares of common stock to BRPC II upon execution of the Purchase Agreement as consideration for BRPC II&#146;s commitment to purchase shares of the Company&#146;s common stock. The Company incurred a total of $272 in costs related to the execution
of the Purchase Agreement and the issuance of the initial commitment shares and such amount is initially recorded as deferred stock issuance costs and included in other assets in the accompanying condensed balance sheet. There were no other shares
issued under the Purchase Agreement as of September&nbsp;30, 2022. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 9 </B><I>&#151;</I><B> INCOME TAXES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company had no income tax expense as a result of the continued generation of net operating losses (&#147;NOLs&#148;)&nbsp;offset by a full
valuation allowance recorded on such NOLs, as the Company determined it is not <FONT STYLE="white-space:nowrap">more-likely-than-not&nbsp;that</FONT> its NOLs will be utilized. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 10 </B><I>&#151;</I><B> NET LOSS PER SHARE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders for the three and nine
months ended September&nbsp;30, 2022 and 2021: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Numerator:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,244</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,141</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Denominator:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average number of common shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Basic and diluted net loss per common share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.06</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.05</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.17</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.09</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the outstanding shares of potentially dilutive securities as of the periods
presented that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,831</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47,935</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,831</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 11 </B><I>&#151;</I><B> LEASES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company had a space and facility sharing arrangement with Amprius Holdings to use the equipment owned by Amprius Holdings and the spaces
leased by Amprius Holdings as its administrative and sales office, research and development laboratory, and production and engineering facilities. Effective May&nbsp;1, 2022, Amprius Holdings assigned to the Company the office lease that covers all
facilities that the Company uses in its operations. For the period from January&nbsp;1, 2022 until May&nbsp;1, 2022 and the nine months ended September&nbsp;30, 2021, the Company paid Amprius Holdings an average monthly fee to share the facilities
of $43 and $42, respectively. The current lease has an expiration date of June&nbsp;30, 2024, with a single option to extend the lease </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for 60 months that the Company determined it is reasonably certain to exercise. The Company had no leases that were classified as a financing lease as of September&nbsp;30, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Operating lease expense under ASC 842 for the three and nine months ended September&nbsp;30, 2022 amounted to $139 and $417, respectively.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The total amount paid for amounts included in the measurement of operating lease liabilities was $132 and $350 during the three and nine
months ended September&nbsp;30, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Future operating lease payments as of September&nbsp;30, 2022 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Year Ending December 31:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022 (remaining three months)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2026</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2027</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less &#151; Present value adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(921</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Operating lease disclosures for the Company&#146;s single operating lease are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,<BR>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remaining lease term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discount rate for operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 12 </B><I>&#151;</I><B> COMMITMENTS AND CONTINGENCIES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, the Company may be involved in lawsuits, claims or legal proceedings that arise in the ordinary course of business. The
Company accrues a contingent liability when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. Management believes that there are no claims against the Company for which the outcome is expected to
have a material effect on the financial position, results of operations or cash flows of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 13 </B><I>&#151;</I><B> RELATED PARTY
TRANSACTIONS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Party Transactions with Amprius Holdings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the closing of the Business Combination, the Company had intercompany arrangements with Amprius Holdings regarding sharing the
facilities, service, and licensing to support the operation of the Company in the ordinary course of its business, as further described below. Pursuant to a termination agreement entered into by Amprius Holdings and the Company on June&nbsp;8, 2022,
the intercompany services agreements were terminated upon the Closing of Business Combination on September&nbsp;14, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company had
a service agreement for Amprius Holdings to provide certain services such as administration, management service, information technology and engineering services to support the operation of its business. Prior to the distribution of the subsidiaries
of Amprius Holdings to its stockholders in late January </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and early February 2022, the general and administrative expenses of Amprius Holdings were allocated among each subsidiary, including the Company. After the distribution, such costs incurred by
Amprius Holdings were wholly allocated to the Company as the only remaining subsidiary. The Company received financing for these amounts through capital contributions from Amprius Holdings as Amprius Holdings does not intend to demand repayment of
the funds received. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The composition of the capital contributions from Amprius Holdings for the three and nine months ended
September&nbsp;30, 2022 and 2021 were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other allocated corporate costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capital contributions from Amprius Holdings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,734</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,808</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s board of directors formally approved the treatment of all intercompany advances as forgiven
in March 2021. In substance, since inception and during the nine months ended September&nbsp;30, 2022, the intercompany transactions between the Company and Amprius Holdings have been included in these condensed financial statements and are
determined to be forgiven at the time the transaction occurs as the intent of the arrangement from inception was capital contributions. Intercompany transactions subsequent to March 2021 were also made in the form of capital contributions. The total
net effect of the settlement of these transactions is presented as financing activities within the statement of cash flows and shown as additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital on the condensed balance sheet. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Business Combination, the Company had a licensing agreement with Amprius Holdings to use patents and licenses owned by Amprius
Holdings. Effective May&nbsp;12, 2022, Amprius Holdings assigned to the Company all patents and patent applications, as well as registered trademarks and trademark applications, used by the Company in its operations under an Intellectual Property
Rights agreement. This transfer of intellectual property does not have any financial impact on the Company&#146;s balance sheet. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Party
Transactions with Affiliate Subsidiaries </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company also purchases raw materials and development materials from two subsidiaries that
were owned and controlled by Amprius Holdings. Amprius Holdings distributed all of its shares in the two subsidiaries to its stockholders and optionees in February 2022. For the <FONT STYLE="white-space:nowrap">two-month</FONT> period prior to the
distribution of the subsidiaries of Amprius Holdings during the nine months ended September&nbsp;30, 2022, such purchases recorded as cost of revenues totaled $86. For the three and nine months ended September&nbsp;30, 2021, such purchases recorded
as cost of revenues totaled $69 and $144, respectively. As of December&nbsp;31, 2021, the outstanding payables balance from affiliate subsidiaries totaled $18. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTE 14 &#151; SUBSEQUENT EVENTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bonus Payout
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;5, 2022, Amprius Holdings&#146; board of directors approved the acceleration of a cash bonus payment of approximately
$2,310 to Dr.&nbsp;Kang Sun, the Chief Executive Officer of Amprius Holdings and the Company. The payment of such cash bonus by Amprius Holdings has no effect on the cash or operating results of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Department of Energy (&#147;DOE&#148;) Grants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;11, 2022, the DOE&#146;s Advanced Manufacturing Office awarded the Company a $1,000 grant, which will be used to further mature
the Company&#146;s process for manufacturing nanowire-based silicon anodes. The grant will promote the maturation of its technology to achieve the Company&#146;s goal of high volume, <FONT STYLE="white-space:nowrap">low-cost</FONT> ultra-high energy
density battery production that significantly increases yield and throughput. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;19, 2022, the DOE&#146;s Office of
Manufacturing and Energy Supply Chains awarded the Company a $50,000 cost sharing grant in connection with the U.S. government&#146;s infrastructure spending plan to expand domestic manufacturing of batteries for electric vehicles and electrical
grid. This cost sharing grant is dependent on the successful negotiation of a final contract, and among the terms to be finalized are the portion of relevant costs that will be covered by the grant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-54 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g377019g00a03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377019g00a03.jpg
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M  $  P$! 0              !P@)"@8%_\0 *A   00#  ( !0,%
M!0,$!@<! @@ "1$3%!4A$A91"B0U>;;_Q  = 0$  04! 0$
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M7#C5N2X1%X1,U19\K6KJ#/\ ]FEQ6#QK?&_.?)4CE_.50H0>%2Y_%J].$0;
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MR3&,+B(DS*9[1$8X 1&(IO+>>Y]_YZUN3=F3=ELM8%:2<P5)57K*[Y14J5D
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IF?Z:U4\:MT\::>--,XQG\9Q\<?QGQIIC&,?C&/AC^,>--/&FGC37_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g377019g00m04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377019g00m04.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $0 8(# 1$  A$! Q$!_\0
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M;V@ZRLDZ/B+&3+J$=E*G2:[(DLW(F)QL"1MLM&$KF ;%"MP<$\T[?8/Z>_\
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M5J]]LOV4L-5PV3\7O#3%0XN7&*]W>VV<="L./GH<\V-QXJI$HCI6*7/G9FK
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M9PZ(-N';VY<CMVTLU61GJLX]ZHNQ\BPGHW8\B.8#_!SH.M3P&ZXR\;0AXW>
MFQ_'';LV-W#2AIY^O7D7;^[:M>/Z7PMGAFB4RCH>]BWE/-S$V)/=YT9I(6JW
M5@N0;XM';FHW(74U%W/K>15)4Z_P0\U%..X;0:$YE;@LG#2C+3CS8TS RHYL
M+,"H==0-)@%,H==0A+J\FL;D*V5HULA4?K@M1"1">.I3W#QN 2!)$X:.1>2
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MM3FK]1ZJMDV)1[9/3!47$B5T<C:!5PF28F%DK-%"D,3<%4\1%F]FAGDQ\T.
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M>YD(*=7L!"!QT7-%8#>RQ*N%R$F/V#?DBNU[LV*ANUHK%4SM'%*ZK+"G7/#
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M#+++2%..NNN*PAMIMM&,K6XXM6$(0G&5*5G"4XSG.,=<@$D  DD@  <DD]@
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M@5,=E+ST<DD-S#K1XA\ZK<'5%'"*R1NQC?JA7N9&"*[$EN=9/^SWX=^ V?\
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MXP[3;# [.SJ(TPRPTC#;3+33<VEMMIMM*4-MH2E"$)PE.,)QC'4TA>  %X
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MQ9_FY:0_V9UCKR[H_P IMQ?S[E_^(6->C!?^!X;^:L=_Z2'5.WK>?^=O'O\
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M''U6/[2"2?VGN?MTP_#O_!'XL_S<M(?[,ZQU6=T?Y3;B_GW+_P#$+&J9@O\
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M0WR^\?CH_!:\X?S/A_I(U?\ KETZU^?W'\-.AOE]X_'1^"UYP_F?#_21J_\
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M2R*_X9=8:6BS?%V2:/ 8\HQ6%\K&DP'/UF]TM/$#QZ@=$AX/;J"GCD#C(GV
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MQ]KZ-IXZ*&W!+)CJ[O\ 1<M)WD,FV[TG-I.; XM!UPZ4.DY/6-DDJKY&X0M
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MW6[$#8G,Y[8Q^*EN+4I6,_3*<9PK&4]\9N/9\/G[IV_'QSQEJ,I'V03I.?V
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M-:H-8=?4CHVOJ]RIV76]4B. T.N6 B&&C,E$%, 6480'-S'%4:M9*!AK.J3
M':6XXTPP"VR.K+*$+7 GC+':6UA)^IFIM7M0I'RO0EE9$>5PO(;JEB>%222.
M(@%X(;G9M[ .8Q$&%\0\8E>&//C*8>]9N".06+&(EJ6*]*LTI)B,-.[#D)4C
M0+('OR-(74Q]$!_L[C^3_P"[_7U"GF-^C_5_U:V'?27\K[]6O>D1+"57EGJX
M8Q]V,8DI:RQ&"!T96HTR;J,F, $\E,5+K]LDYH,1Y3&8K#3#F'B)005LG!&1
M7@_:$N#R-;R/+-?)>8TP#<3&Q!'P"22O7$(0I"D (4)4%BS:HO;SH,/$C:N;
M;(-9&3VDM-*+F+G'IBLG<;F-4"R""Y)D9)5:8.S3I95)#&BQ0[$K)7X6V5Z<
MJ]C!9DZ_8XB1@YN.(4M#)T3*"/!2 KJVEMNMH?%?=;RXTXVZWY>;3B%I2K$N
M:P8U@"Y(P%7<W1?UT/)+FO4V>>8H&"R'"GVZ<-,GL0*77R<))==6 AE]YTC&
M'W77EN.83E7BG&7Q72W%NHO,S/!/0J24P2"L4*!XI(T (Z0;,<\I!^L6E+<]
M)4#<+[$>:P[>"L=''00U\AC=S9N'/O&CI+=OV'@N5+<[,2LK#$6,=11X^$$=
M)8ROF)(S,9]G<?R?_=_KZC/S&_1_J_ZM9?\ TE_*^_5_OH9S8D5N:R5Q]]X%
MR6U;., !-)RMB3,B[/"2#BG_ !B2EM^T&Z<2EY4S%"I?0IA0\D^0*@'*GPTM
M>\[/QH\CR/=WM5N &Z92EF1S,I8GGS&D/602HE#@< =*Z4_:\Q[T?'C=T[Y!
ML@V7@PN5YD,1EII-B*E:.@XB"A5JQU$6N'42FH:[R&1W,LFHWJ_=8SZKDY$\
MXIO3^_?V#H0#CI#_  =!IMY-LW('DG%Z5Q-)N5AMD&S#4J%74+.1.F0Z:FZ3
M)J(* <\I6.;;%2PXT65:65W))0RGT;&F)3IJU[+393+ICO,]XEGB$=:,P3&5
MH_()?ED/+H O!#-DCX<>!='>7A^=]7;'B3=\W<&:P,.+\//#*WOCW$X7'8B^
M]W-WAF<5%0AN?2Z155CAL+Q4LLTI=7AB4'J+6>3A-%-Q*-67N^P=AM] ;<LV
MOKCK*LSNO;_&[0U^5IH\:*V60L"V$3&SUUX9F&:AIN-=;#)'L8X\69E_';NR
M9X\:(_<K5F*6>KS/5L4H9*EI+E5L>P2XW3.TETQ!8Q'*AZ2)@J-SJG^SABJM
M_?C6SNO [?OX[#[@9<7N'"[HRE#<6WK.UMPQ;UKRVML1BQB(Z>UER4KW7NT;
M*--%+C9)+< CTF/3'K;5+U!LJC2->O\ 7+Y0MN,438HFRK!KV?L3TQ4--Z@@
M:JIA6L5N52/@X_6 5$@X@=@@TTUJ)<FY"0/*E7"G.G9T(K4+E9HK4-FK?%:V
MMR6I+,9*^/H10<&ES L24EJQ1@%F81F5W9I"QJGM09)\WO';.=K9';V2P&X-
MGOGMMS;9Q^X\?C4I9C>F\K^6$@W2%RUB_/NF?/WKDDD<$$#VUHUZU>*HL2O_
M ,0O[U]U_G0\T_\ >^W?U5<%_B5C^>=P_P#'LEJ//%__ "IPO^BWP2_Y.;$U
M*/JLZBW68WUCM?('Y.UFT-MY2S;=40#K[N,=L.2<).V6)(3W_+EN-:AN^<]L
M]EX3V[)QG.-WB[6,.Y*MA5!6WBX&8\<GS89[$3#]D8A_IX^&MF/L>[A+^&>3
MQ<C_ %\3NN^L:<\]-6[0QMM#P>..JRUSL"?0GMSJIC[,H_AS_1U%?)_0'^J=
M98?2P^9^[\=:O?2GJ.*IPSI#_MY;7:[->[*YY)\5.9Q93:ZRZK';&<X6-7F,
MH5G]\U[:DYRC*>LI/#"OY&SZ+E>DVK%ZP1QQZ67KJ>/M2NI'V<:U4^U1E_I;
MQDS:!^M,5C<%C4(/( ^C(,BZ_$<K+D) P'HW4#];D:L<ZD'6.FL=//\ UPW6
MN8V^P\-Y:3)7/%J3C"<X2O-TB(NW.N)S]V?-Z:=RO./I[GFG[\9QC$C?E8U-
MW9V((.'N"R#TD\^^0Q6R>?CR9SS]O(UN"\ ]RC(^#VPY2Y9JV&^BCW!*C#6[
M6)53WY'"4EX!_B])'8C4//LRC^'/]'5H\G] ?ZIU+_TL/F?N_'6V'BW5_L7Q
MMT-5U-Y9>B-1Z_8,;SCME,BY6(TF3[X[8[9S(/$JSC.._P!?KWSWSUF3MFO[
MIMW!UR.EH\50#CCCB1JT;2=OA^49NW].M+/BAE/IKQ'WWE W6ES=N?DA;GGF
MNN3LQUN_QXKI$/EV[<#2?YEU'%YXI\@*Y[7ON/:MM<H,SA/DITZN1SMD ;;3
M^5U1L2/AK_.91GKHW?5]\VQG8 .ICC+4J+QSU25XS8C 'S+Q*!]NO?X-Y<X/
MQ4V!D>OH5-T8JK*_/ 2#(V5QMAF/Z*P6Y"W\D'U]-8OOLRC^'/\ 1UA[R?T!
M_JG6Y?Z6'S/W?CJ<GIN:_3-<T=*>3:G6(:3L=D(5V[I9^0TVPR(;JOX,?,V0
M6TY_(XXCJ]?#NN;.\<,I0!8I+%ACTGMY%2Q(IY^V147]9U"'M';B%/P9WJ%<
MB2[6QV-C'(Y?W_,X^O,H[_"J\[G^2IUKUZRPUJ-T=--8E.2VM45#D/O"MI;R
MPQ%;7OK +>$X3CY8NS23\6M*<?1*78YT5U*<?<E>,?DZPTW)6-/<&;JA %AR
MEY$^K_Y7O,AB/[8RI_;K=7X;;G&6\/=D9%I"\EK:N!>=N>?[Y7&5H[2\D@DK
M8252?B1SIE&JIEYQMEE*W775H::;0G*EN..*PA"$)QC.5*6K.$I3C&<YSG&,
M?7/5& 9B%$8))  "GDDG@ ?K.KT;,(BL[OTHBEF9B JJH)9B2>   22?0:W8
M4JOMU.FU*JLX2EFLUF!K[24=L(PW#10D<WA&,?3"<)&QA/;Z=NW6;=. 5:E6
ML/2O6@@'ZH8EC'^[K1GFL@V6S&6RKDE\GD[^0<GU+7+4MEB>?CS(>?MU'7G3
M4$WGB%R!@5-^[[>NY6QI1V\LY<I;HUR:4E/T[K0Y H6C&.ZO-./'&<]L9M_>
MU7WO:>>BXZNG'RV0/F:96X/Z# #J0_ W,'!^+FP+X;HZMPU<<6YXX7,I+AG!
M/P!2^P/PX)Y('?6-;[,H_AS_ $=8A\G] ?ZIUN+^EA\S]WXZGYZ8FOTRO-/4
MQ:FU.C5MJYV,K'CWPCX*DV 4%W.>V<)PW+G1RO+./KGLG&<*4G.+[\-:YL;Q
MQ9*#IKK<L,0OIT4YU0\GTXE>/^K[=0)[36X16\&-V0J_3+DGPV.CY/'/G9O'
MRSJ!SW+58+ X^7)] 0=;O656M3.CIIHZ::.FFCIIHZ::0FSUT)G7UO)V@+6S
M=?APAA]I%MXL8;7'8P!.#%8E!)AMV-(:2\PTMELIM:5%)8]M.7O;Z::PBS$(
MJ4E9&2R.TG)YA!BD#CCCL-J(=4ZIM@<5E@8=EO*LH:8'9:89;2EMIM"$I3C$
M/?$7E;MSRL[$F_)+RPY($RI,J@A(_JJL@5?JGA5 ZY/\(^Y[P$SRS>#GAZ45
M(A#MVM3*Q@!2U"2:D\A!FG/7*]=I93UJ&E=R(:P(KQ<[[+*Q]?9[=OKW\<?3
MM^7Z?P=6Q%$TTD<,75)+*Z1Q(JDL\CL%1%'(^LS$ ?:=2M:W!!4K6+=N=8:M
M6":Q9FDZ1'%7AC:2:20]^$2-69SP?J@ZU8^E73(+5/%55VL%C@ E['MQ4Z::
M_8*N[&@,#C"0T+&/2@)KV19'+0[CQD),&-2D5(EDAO1H)/Q"7\WH$>."%)&Z
MY$BC21R22[J@#-R>YZF!/)[]]:%LA-#9OW;%>(05Y[=F:"$*JB&&69WBB"KP
MJB-&5 JCI ' [ :]SU2K'JF:X=34THJA6><L$A"Q.JY_QK=B-2^?8(=ZTDTJ
M4<;D'1UKK<<<W*'0;J'$,(90^^G]RQUX\Q$9\1E(064S8Z[$&4\,#)6E0%3T
M2\$<]CY<G![]#?FFN;)N#';SVCD&C25:.Y\#<,<@ZHY!6RM28HZB>KU(P3AA
M[S7Y!(\^+\]<H7V55_(?ZN/ZNL*N%_2^XZWJ?3!_2/W:[E:IQ)<_#A"Y!$)D
M) :/'(DY "&CFGCG$B-K/EI0D.,C DK>PHJ0D2Q00V,.$%D,L-N.)OKPVKS3
M;QQ30%N(!;GG9>0%@%2:-NKN/JN\D<7'?EI%Y''.L?\ VH-P48O!3=U>\4=L
MB</1HQ.%)EO-F:%F(Q\@@2015I[?/8A*[E3U< [<M6,T+16HM4:YE[G6H=NO
M4BKP@#T]/5R)>EG6A P5%L8;)'"-6?)O>*7P,D-EE$H\'RGG\.NY6:U":J5]
M;-="?JVJ(9@&JKV7,S!,B;(L1T(Y=/L1#"&L1HQ<K@9=@9K)$Y+FN@A9+:B3
M9(0UY#+Y4>IP:Q_$>(R[-S #,H1:DI"GCJ$=ZLQ#?4<](_/X 7DJ 712S"?/
M9BR QOC=LN8I&WFOF:H9UZC$;& RD?7&#/ @D()B#.9>E9&9()I1&ASM_957
M\A_JXZQ1X7]+_9.MO_TP?TC]VGVXT:>3LO=^NM?/FB1(5LM$+$R)1<G Q641
MSTB-DW *[$0/&'2[@J7F8B(4DLJ7D'6(X*//)(;%<F'P<KS',9:RA8UHL:L$
MIX(7SY[4,D'/?@MY=>QQVY )XX!/.%7MM9RC/LK9^*D*-D[&Z)<A5)"^:M&C
MB;E>_P!!'UA&UC)8WK'/2S+&2"4'&VAZY4J/FA*H1:ZN%8B58'!K;T[$C31"
MD"X+PP)#N%(.=4D+&"<-LCJS@7'O>.&L>760NM;.LM_J[#T27Y39C*+'U89Z
M&I\<J\KK4;"B/&7^5EYV2F2K&5%"M$2-AS&D0:3GI5\@YK/9MW*%Y7C,+^,L
M750P<Q=@([EN+I'=2988W#$=!^LOD$*?,7@,WU'YZH\Y?8@RHI;@W[3Z$YMX
M?#61*1^544KMN(QJ3.H$<AO!I![O*2T41\Z#CHL58_957\A_JXZ@'A?TO]DZ
MV+?3!_2/W:M+])+4C=GY10T^88$,)K:,F+8V Y(P+<B?*%1K\)')&A)(CYK(
M@C9-?,.D(4 K,.4Q%9,*CU'ANKR0\(8)HMN6Y7+>38RLSUP>>"L=>M%)(HY(
M :5&C/8$M$W/;@ZUA>V?EZ.3\3<-!7,;W,;M&E7R,BA>M9)\EE+E:M*0 Q>.
MM/'84$D".VA4\E@-2L5=*;/21<+"6RLS,P"S\0=$Q4]%2,D&/E]T7WRP!"GB
MAV<DLO#^Z\TA&7VG6?+W&UIQ*VL0=8X>>P5$G>5VVW-91U6"I,9, PD.-2XV
M$C:VAV)A8P*9= 8@!AHUW)%@:EGB#&TN.%OK6ZZ\ZK/GG'CQCAXS6*F+GB3%
MF(*>Z@PVYV) "#@GSAR>MB> .E  7V5>Q-F5@V-NW'A41X=UK;:15_*2"YB*
M,*AV,S<K'[BW0HKQ*I=SYL[.RPP]^RJOY#_5QU$'"_I?[)UFC],'](_=J]?T
M4M5-+O&R-GE&!976*PBG148W)0+\@A^Q20LG(R!L-DAVQQHS8\4,)%2F PXN
M261,A-&%/ %#,Y7^',$U?9V'6?J#2)9GC#<\B">Y8E@(Y]%>)UD4<_FN/3T&
MGWVF<I1R_C9O2U0\MHXIL71L21!0)+V/PV/IWNKI YDBLPR5Y2PZO,A8$D $
MZ+^KWU VJ=^<<=O O?K)=*@MA2.8S7^L7]*+HU.U7/ZQ(V&=L&TB7=CE1-72
M,,GZ_0UP3%>:K3Z#HB%4+FU$0!CUN$<&ZL+<BY(Y,-6BMOT5:9QYK5Z,M(VV
MM3BR,W+81I8JQB$(A(:.,@3F)C.I&LR/ NQL6'P_>+.7]NUA:W#NA-[C/9G=
MF/W1'MROM[%2X.3PHI82U#CLCGUOR9)\G&T%RZ)?HB/(0IAYEE$R^>9[<?Q/
MVTX32JW?(XH6K1<S$W""FK/58:"F+Q68N<O\_ 5MX:QR<7K"*++V,2S E!R[
M::M@@$^/>92</7]S.$P=XM6AM(RPI)'/%)-#'%)9A22U+%"1*Z4D9K;")ED'
MD<JZ$=0ACP#KM9\6MHI%G,GM^S%+EK5*YAK]+%Y:[?IX+*6Z&W\=D,DDF-JV
M]TVX8=M1/D(IJ;'+&.>"PCF"5J?3.=@&]&7*#J$;1RZ96=Q6R&JVTM=U>T5*
ML;VC\P=4DBMH,QUSGK382Y'YO(2-%E9<BS6 "0,I*U1$HY&M#C"^+9YB&-L1
M5TK-7AR$\<-VI#-!#DE\J!VNA+$L\I?S'>L\AFE5VK'H?H 5;L]IQ,@V^\->
MS%K.Q9K*;,Q%W*[5W'E<5E\IL*Q[_EZT.U7LX7'XK&PUA3K5L]4IQXO'6*T.
M<5;E1;322S/AQ"_O7W7^=#S3_P![[=_52P7^)6/YYW#_ ,>R6K$\7_\ *G"_
MZ+?!+_DYL34H^JSJ+=4O^KY1/FL;I.YM,XSF/.N-8-=\>_EB2'A)6+;RKMWQ
M[?RN74G'Y?=5GZ=OK#/B[1\R+"70!^3DN57/'//FK!+$.3QQQY4W;X\_9K,G
MV2,\:=G>F&9O\8@P^3A4GT]VDNU;+ ?'J]ZJ GX= ]>>U(7V7S_$Q_1G^KJ$
MO=S\A_0/QUFM]+'YC[_QU</S+Y-[<X!<$N,%?TN%%1M^O$-$PI=IF8L:98IR
MT5EBTV!8$*<AR-,G#9B6RP$[+BG1S P\BX1'$D.#K8GC,9N[LS9NVX**(EJS
M6@B>9T605W-=;,_1&P*-(TLI"F170*')0L5(Q*\%?#':/C]XZ^)N0WK/:LX#
M!V[=Z+$T[4M*3,ALF^+QZSW8"+4-""G5\R=:DM>R\LE98[,<:RK)R/1W]0+D
M+RAMVS=2<A)>/N\K6JBQ?:U>1JU!U>32&U.1T!+0,R'5XV'KY;>7)F,,B"&(
MD(YO#$H@Q^00X/D+M\.]XY+<%F[C\FZV)(*PMQ61#'"_2)4A>*184CB;O(C1
MD1JPXDZB_(Z??[8WL_>'?A=B=L;N\/*=C!U,GEY,#D\%)DK^4JF9J-B_4OTI
MLM9N9&)@M.U#<C>W/ QDJM"E8K()V\]5/7OPO)*.LS3'[C<==UXYY[Q[8<D8
M@V7@'V\Y[?C+:CXZ*5G/Y$O-X_)U9GBG0\O<D=E5'%S'5Y&;@=Y(7FKL.3QW
M$<47["-57V7-Q&3PYL8QG'5B-PY"!$))*U[<%.^C<<]E>Q8M #YHQ^.J\JEK
M@FUVJLU81O/Q5EL$- #>">ZOB)F2&CF?'';/=7N$I\<=L]\]L=1[4H-;MU:J
M =5FQ#77@#GJFD6,?'YL-9 Y;<J8K%9/*2LHBQN/N7Y220!'3K26')//8=,9
MYU9UZO'/[D/Q1NNL]'<<S(N@XD]=AW>6O9%<@[1*+&>GIZL1=9A ;/'R]?!8
M!:K)!DH43#G&D_,(UL-Z.0*1DZ</$#>&2VY:HXK%%*@>DEEK)ABF?H,LM>."
M))DDB4(("SEHV8]:!2@4]6.?L@^S_P"'7BOA=S;Y\1X;6X/=-Q38.G@(\C?Q
M542I0H92UD[UC%6*>0G>=LG'#5BBNUX8_=K+3I9,L8@D]Z67*_9/-OCCL$;>
MJ(R0N=2L)E"F;+$Q0L,/;("P5UDL0\Z(!:8B1)EKXJ2"/;B10HUX=H!YH$=U
MU_"ZWL?<%G=>%O)D0KSPR/2EF1%C6>*> $,R( BR ,ZN(U5"H0A02=1?[5/A
M-MKP2\1]OR;$:S7PN8QT.>IXRW;FNR8B_C\C)#-7@MV&>W-2?RJT]=K<L]E)
M'L1O/(J1D4,2]$+A9:4AC6L(,B9$V,+1XYQXD@$NBOI[9QWQXNM+QVS]<=NV
M>L<)J;P2RPN 'AD>)QP.S1L48>OP(.LY*>?2[4JW(6!AMUX+,1YYYBGB66,\
M@]^5<'G5F_I.Z[R[OJWW!YCN-5-<G"LN^/\ <I6QS,0,+^-G';'G& S:>WWY
M^O;Z85WDSPHH%L]<N$#IJ8YU! ':6S-$J^GSB2;]_3&GVJ]Q<;%Q&'5P),KN
M*"5U!_.JXZG;DE[?'BS/2/R'ZR-5Y[,]:/G,C>L[/5.:JM6UQ!6V1$CM/F4:
MM2<65!1DHZ.S'V:R%QSMV>EBQ&$HECX2RPK*35ON18D>Q[;"?-=\4-P#)S20
M/#!4BL.B4&K0NC1QR%0LTS(;)D95XD:*:,=1)14' &2>V?8L\"FV)0H9>CE<
MKN6_B*TUG>,.=RE6U#?LU4D>QB\;#83!K4BFD)J07L9><PK&MF:>3JD.O6A6
MMF]T6EW@<-V/'N53KEK8 ?7AQ\%FPPX<NT&\YA*,+=&08EEQ>$(PI:%*PE.,
M]L9"5+ MU:UI5*+9KPV I/)431K(%)^) ;@G[-:@<_BGP.=S6#DF2Q)ALMD<
M5)8C4K'.^.N34VF126*I*T)=5+$A6 )/'.LV/J,:Z^3\L]AGM,X0-:PZM:!L
M=OOR77(Z./<[]OK[LM%R+F<_DRK./R=8V>(N/\C=F1<* EI*MI.0/X]:..0\
MGCGF:*0_MX]0=;'/9XW&UOPHV_79PTF*FRF,D)/H(LC9LP+QSVZ*EJNOV\<_
M'4?^/.L<W'>VH*VMCW1Y/8M20>C"?+_R4/-!F2R_'..V<-1@Y;F<9^F<(SY9
MQCOGJW]O8XW,[B*W2"LN1J"0<+_@EG1YCZGTB5SZ=^-7[X@[H.(V-N[(B0(]
M;;V6,!Y(_OJ2E-#47GGMU69(EY^'/(!]-2Q]6'U*N4^@^0:-&\?YN+UM$5JK
MUN>F;2Y5*W;)ZT2=B'7)989Q;XJ=AH^"CQ,BA(:$B423T@W).O22AEC"L2KO
MW?.7PV8^BL;(E1((()9)S!#/+,\RE^![Q'+&L2KTJ L8<N')<J558W]DSV:?
M"K?WAZ^^?$*C:W-;R>4R6/I8I<ME,30Q5;'2+6\QSAK="[8OV)O-F+37&JI6
M:LJ51()99+)O3YY"W#G'PQ,L&U@HUBYE%7G4EQ/BPL1T5876H@1*)\>,0I;0
M"SH:QA(DA1<I"^:CR#H# 0;K (UX;4R\N[=L2R7503R>^8RRR+T)*3$%\WH'
M(7KBG7K5>%ZPY154A%QJ]H7P\P_@=XSQ8[:<]F3"QPX/=V&KVIC8M8Y'MS$X
M^2TP5YQ7N8Z=JTLH,_NDE=9Y)IEDGESFETTD$HD(H?+)09#PI+*L?C-/CN*:
M>;5]/WR'$*3G_IQGK&1ZKQNR.H5T9D92!R&4D,#W]001K83#FUGBBGB=7BFC
M26-P>S1R*'1AW]&4@C]>K5?23UYG]F38EV<9\F:UKU$&VOQ_%:/M<]'OL.85
MG'=+F0:U)M)[9QW0Z[W[]OI*GA-0YS&1NE05K8\0 \#M);GC93R.>#Y=:5?M
M#'6+?M7[B)V?M["!P'R6X#=903R\&*HV(W4CGNHGR59S\F5=: .I]U@1HZ::
M.FFCIIHZ::.FFN;,0T/88LZ$L$5&SD+)CN"2<1, BR<7(".8[.C' &M/B%CN
M8QV<9(:<:5C'XR<]--8UMNU:F(W%MT+7)@TI1XW9%M!K$@(2@T4J(:EB,BK%
M*;0VT2&C"E,AECHR*6,TV2*Z^PXA]S''Q4HQIN59PS$VJ%>5E,*(B,C20%4D
M5%,Q*Q+([2-)(IDZ.L1K'&FQKV6MP2OX;249$BC&+SN0K1.MR:::>*=*][S9
MJ\MAUIA9+4E>*.O'7@E2 S>4UA[$\S63,'B-CGREMYSA.$MX[8[8PIU6&TYS
MG"L9QC&5=_I]<Y[8_+U;^RL,N2W-BX1*L8AG%UF9$<E:?]\="HZ.C,[(%^NI
M502W<J 9 \:-Z_P=\-=T6U@>U)=HMAHD2::)4?,'Z/,TLM>Q#/''"D[R<PN'
M>18XN55V=>YSAW;<@:YH76U;ILOKZH06F:7)05?D@/@XE^8G8=B0F]A#H'RB
M,MLM=U%M6!5E<#%>'^8.01C!#L8^IR:=_;PM[:BJUJ-=?>+\<K)=F :* 1,B
ML(XB.F6?ZX8>8?+C!4LDH;I&-GLE^SYM3QER.:S6\LQ(,)M6W0BL;7Q\C5K^
M9>['--"]N^K"6CBN:[PR&FGOEIA+'#:H-$)9/-P$W 9-TG?.B=S2%8,UB7K3
M8>PH:9LP<(S8J[LL& %^S9=3GG8U<VN6EBX@*OKA RWG9*(D3PQ _%*\9\'A
MMN7)9R/(TLC(UOW0),MJ3AI.FTSK[NY5.AE!CD>,R,7Z6:-08HU6.\?;;\'_
M  _\.KVS=T;#HUMMKGULXNYMS'\I1\["102+FJJ26GGAGFAM5*MU*T*UFE@B
MNS,M^Y/+:Y 5;R2(,1AM./>8:=[)SA:<>:,*RG"O+/?QSGMG/?.>^,]\]^H.
MS6/CJY?)UE=W6"_;B5Y(4A>1$G<*YB1(TCZU 8(D:( 0$15X R0V;N63)[2V
MSD)8XJ\MW XJS+!!<DN102RTH7DA2U-8GFG\IR8S+/--,S*3-+))U.5MJV.C
M([=6GQ9BE/;!!+V!5L%4AI(^<VUI4V$RBO9;*:)%(;E7G$"D#DLJ8?8<6PXI
MM+JG$2?X1XD>^9/+>8O$$"44B"H69IV69W9BA=%5845>AEZRS]?9 &QA]K;>
M'7A]M;36N[&[=FSDUHRS+'&M"-Z<$$:).(IWD:[,\OGQ.(%CB,1ZY6:.)'+K
M?&U=E;HV&=*%3,;(_:62#==D@R(J7" !+=:C802&)?+^R4;%"I:$'KXK[N(Y
M+>14/I;PMM79OC?V5K9*WA<<&QJ4Y!'-9Y'O=@]*2*T9/ KP,&#(4YDE3I8R
M(K&/4R>RM[+7AEDMGX/Q,WT:N^;FX*<EK'8"7J7;V%C\V>K)%>@20/E\K$T;
MI,MHI1I3=<24Y[$$5W5F5$VJSOGTV#SMTNU!6R=-[%U_K[4$Z,#"0]QE:XS'
M$C?9&03&QHIIE<&B\V"8'QA38;TF-\8:0^5#+4[?.(OS;HV5)/>_(R6J5RO+
M-'"DID-<20M92%XC$SR/&S]$<;(LG*Q=+* N(OBUM+"^#/M$3X;:#^^XO$YW
M"Y;'4;-Z6 4(\NM?)18.:_#?-T04(;D=1;5ZS%:GJJDUT2QRM+/%?%5SG'?"
M.^,_7&<8QVSC^'[^L8364$@\@@D$%0"".Q!![@@^HUL7&8# ,K@J0""'!!!'
M(((?@@CN".Q&GFXT3RM>[D-L8%#*O%CJ>N[W/5)H:&8L6:S<0*\1(5RYN0)&
M,HDVZ\<RRZTEMX0@,PAB39(PY'MMNY"^%&*%+"6K_F*QR=KZJ*B#RXZ7F0KU
M.$$C.\CRDHSM&BA&C"O)*6U[^U7NPYS>V,P2P21IMG&$-.\LK"Q8S KVW\J$
MS/72**"&JHFCBBL32-+'8:2*O5$=6-RW-M"P7-5IQ*R#,BQ.9F2")9SYW*3$
MF@GWW2K(5+H-5*ND/84HD<O#S#F5JP0DE:<.YL;->)>;GR(-+G%UJ=@A:G"-
M-*8F*LMYG!ZB>&#0*JQQD\'S'19=9Z>%?L<>#N#V7-%NI*^_\]N;#H)MPO+/
M#C\9'=A2>&7:D%>:,U_*+1219::66];"%E-.I9FHZN0W[=X?>>D>)&W[-]E&
M=_; KE^;VFS768N.,F@X&?Q&5VWVB+B@Q6V+)*X$+"+,-]MV5R(KX$8<4#(4
M=?V^1],[#BR$RO7E:+%Y'R$B$O$E@1"2!FEB\V*.-;#NTJ^2Y\H(Y*.\;X&>
M#T<6P?:%S&U\?:CRV/I93>&U(\I-:%0V*>*L7%JY*.*I<:I9GMG&PJM1GN0
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M#2$B.,4_G/;\5 XSCK[BO\5#:E?DZ@_&XQ[V0I4^AN+-J"!B.KZJ22*KMS\
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MDD4GOQD*ONS](^0.,7JX[ N">[=VI]/766)3D(%9'A\Y&HM:GIU*UI[M_'R
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MRM][##++;I+Q!2T*))?=<I][#X[)-&]VJMAHE*Q];R@(&/+<*DZKR3QRW')
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MPR)*%)'(#%&;@D=P#ZZ]%['9+&.D>1H6Z#RJ7C2W!/7:1 >DLBRA"R@]B1R
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M7Z)[Q_\ )NO9UGY#[_QU2>H_N6_ZM<N9JG+2N@.RL_QZWC"QC*VFWI"4UG<
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M>2O[4E%383:L]\]OAXN> ';3].S+3?T_+FX/#>^;^U:G426J3VJA)]>%E,R
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MED8)&BCXL[L%4?$D#3 2]+H];8XYOQ\2] YU[M_5Y;@U6":/L9BY6T5\:<P
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MW")CV\JSCNG"\)L;F$=\X5E.7/'&<85VM_P=D=<OEH6YZ9,;'+Z<#F&U&@^
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M5/U/<K,367_-'I1>VO//;JY/('&HM>MGM!QSF@BNMO9PBFZDHT(IOSRE*'I
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MKYFPL$F3$%&QT\FR2P_QQ!#!LE:'@#7&&B9:3<=7.6Q;TV0VIB+$\0A=8'K
M*@C1XJ<TE6*54'8=<4*EN JF3K9%"%1K!?QVV]4VSXK[OQ5*S):B:]#D7\V5
MIYH+.7J5\I:JR2L.IS!8MR)'U%Y%A\I)7:99"8[4"5^R%-K]=2]C*HT!*7LH
MQE"<E$..%EY2EQ:EXQ\20[]5>.5?OO;:[^VF(\QG5O9.[:0D1RSMY8+ GRT
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MELPO<6"8ABDQJ><L;*K%792.D\,(-\#MOWLOO6/(0^'F9\2<?@<9F[EO!8K
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M W'KU$*KJ_8&PWK;5[4-4(DNO7C7\G&1\RY6K ,S/HK\HS-P\_%2D.T5(/G
MI=!0='E%EN GL-'',E94Y?;&'WC5Q]ZX)HIC5BDALU719##.BS")_,CE22,%
MRZ_5#*S,58!F!UN>%GC]XA^SOE-SX#;J8?*XJ7+VHLC@]PU;=BD,ECY'H-D*
MKT;N/MU+CQ0)!.5L-!8BBA6Q7D:"N\3CZ7XXZC]/WC/?J]J9N97%5N"N>RK%
M9+4>-)66RST965D/2LR8&#%QZ,, 0H00@,;&Q\>(,-C*!LE/F%$^FIBL?L_
M9!<>'$=:M<OS33LKS32Q5BQDE95C0<+$JJJ(B*!V7DLQMK>WB1N[V@?$O!9+
M=C4EMY*[AMM8[&XF":MC,90LY((E6E#/8MV6+V+L\\T]FU8LS2RD-+Y4<,46
M4I5E=6I2UN+4M:LJ4I2E94I2LYRI6<Y<[YSG.<YSG/WYZQ+-DDDD\D]R3ZD_
M,_5UM*&,   0     <  =@ !V  [ #TU9%Z5>P,QW*P* 6]E*+O0[A7TM*S^
M*Z_'LA6]';&59Q[B&:R0I*L8\L(R[C&?%2L9D?PLR'E[J2#J[7:%ROQ\S&$M
MCCL.X%5N_KQR/B=8Y^U)M_WCPLFR CY.$SN(OEP.Z)8>;$'DC^*SY*,$'L6"
M'U"ZFW>/0^X9WG<)^UGR-HP,;,V!VS3FKJ]9H4*@GGE&+/D!!L/UDJTP\+)E
M..K+C(FR")$:=6+!/PPJ!F1Y3L^&>V[60>\PN1I+*9I:<4T:UG=FZW4<PM-'
M&[$ED29>D$B(QJ% A_!>W%XS8+9L&TXXMJW[-+'+C*&Z<CC+TVX*]>*$5Z\T
MGEY2'$W+M6)4$-JYC)C,Z"6^EV5I'DN!!!#C @XV.%8"CX\4<$$(5I#(P@8C
M2&!A1V6\)0TP.PVAIEI"<(;;0E"<8QC&.I 55151%"HBA450 JJH 55 [
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MPEI*QI+"2AL-X'=''6TI*H,\5K,:93%P@,)5H/(['D*T<EAUC4'S."RM%*6
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M7Z[V)FMN^I(<U-0<@]W:WC:+H&]Z_P!=%R$JYBZV*WQTN_.KJZF$H>B*3,Q
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MR5J0\11Q5Q&S>;/!'+O5ZRJUH3T=--'331TTT=--'334.>?4W?Z_Q0VX=KZ
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MWD61L:U7VZ; D2-9P=0KIEF8*B=)Z0J]JE*K78H=^=GP8%Y$'(H,!D&G\7T
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3OG1TTT=--'331TTT=--'337_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g377019g00s01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377019g00s01.jpg
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M 0$! 0$! 0'_P  1" #$ =\# 1$  A$! Q$!_\0 '@ !  (" @,!
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M:4XQ!51-IF[BQ*32F(CZ^)+JRLN);"RL=AD>&"]WTA/O&CIO&8_''SSB,Y0
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M",J2 +@FU[:BQX<1J=-#]-+\8[B.(S%=NV7\O-F?[8*_J,-S2/Y#[_@QE?\
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MFF2V():78FJHB7,M\ MM#CR99507+:I6I,8^2BFL<E/5Z:13RB1FM2\)C-B
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M"S=51&\J2$@:&UU$\"-_J-N>EHR=%^4>O#J-T]L4_P!PIY!;>[,R#REMS]4
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MH<XBDR3$^ZP[*N5ARDTJ4IKE5,J^AM]AN8^&2U+(?0W,*E&)=U]IAYQQEO\
M.>CY*3R@&O?320[!G^!&E[8LK;L?[4!?56P3$S]I<S'&<%O:',DW;^?;$9]6
MX*>M\^C;::BO.5Q\I&"<3C$WF^6KR_ZE\7_5O.;\OR_B/.\_^?F^=;_^G)F\
MSY?X?/']'E_XLO\ #X? $TT3LO\ &' 7^61X;?TJ=^+$\:)_3!1B/A/Z<*8E
MS3^IB9^%^#'F@F;M*1^RKGWV/XPPXA&ES*Q817VT42F4D' 7,ZF : 0QBZW5
M4(RF8GO2-QP $-:IN'Y-]Z$R(F'^&C95$/'A)J2&%6  *5),T(@,/WBZM&GL
MU'HVFB+<UPM"DI[B51"?0I"()6-(7D4A!"0O)A%03,6&DDA'OA@XZZ73"[*L
MW*BK])NBHMJBD$?>^QX<>$6PXB0XA#B$.(0XA#B$0+)^O$,E?8VI>SA I)D)
MU3=;6W5T:#LW8M.)OP-R%:Y+R9X<9+AW!=P78.:R!)@UV!L:S;H/"VK]B246
M9J,46^A&Y!]K]S&O]G^K,,[11V$LCDJGM9SJJITRLVH+AJDL*"V/6,Z9B"\=
M5+@',@!R:-$QQJ-2 [&91%Y7&Y!&)(!+.V1,2LIHS<M$ ;>M]"#P(Z'EO$5C
MNAT>=1^HF%F7]V*NJ55'V? =LF$_LF5PYX<.6)'(:?@PR,+ @,#!06(U:W#2
M)XJC!ZVBD+33*Z9,9(J$R!QV61<W&P N+:#@+]3RN;FWVM.:G7:$J]FE>U*I
M&1JSQ:@\]=E0"CD3O"E(3FP-[&V([CM@^3&\CW,[[,MW.Q[(G83G[C(?TKSO
M,HE]+>M_WWBF4&\E'4,'.UT)UNSL=)NN5,V4QMVF^G\GF,0>T)7,Y"&W$FB&
M[%1G F%KR.)5[(UDCU>0*9V;(HE%RC)@JF,=H#V#9HBYSKPN18FVI!Z=+D<8
MG);HG4RW7[MOUQVDEAXA7<N6]C9C9A;4I&_:@ 3[.:D=9TA!GF8KD4.8A\$U
M_9-,^&DCAEG1+UNY.?9W^VB9C<'_ ,;6^T2&'ZN0(+>587\U,RY27U1UQDW6
M./#'#X-M&WL$E<KK.7D#!EJF"2)N)8B2JN/H,WK(N/#ILGIA-8&X779.&"%]
M+<KW^G[Z[?6]10ODIZYK\?2^](]B>RU&32F*\LJGFME00M3Y26S2I;6M!>WY
M/"9:TL"G)G#4_0IJOZ?%Y-%HI&Y2"UTTQZV>J:ZJ81<QUN ;D&QO:X^A'+WY
MQ)M#>3EICKWOU.5B4RMH\MT]BO9.)5TYF<BCIEY)F/:.7@)I8#ZPWK:(C79T
MN,*QUFG&7PM8#E)LN\R?3D#Q;1VD@5$WX"Y!L.&@(%O2QC6CWDQ*>> ?LQ"S
MKOK*S@_9Z^.V==WG!Y%#VEF5G8_8X\:-VC'8]ZT@I2&FJOD"!US'G\&G$2E3
M8H ;CTR[U^7'M#"*&8\P"+!-M;$"UN=[Z<01SC(R+R=4=DT"K,:3[+]IW5Z4
M_84PM&O>V1">1(S>$?E-@"U 4U$MF!F OZ?2K&2 =D0;ZHVU6MJ_2',F*S$(
MT--_7.R&;4Z"QTMK;TYW^][^MKB+74/3[FD8"G#"%KVU=AA<T9D9RQ;IDH^1
MS,V7.NO2G>NB8$)&(G&0#+S:-042AD7CL8!LD]4F(O1=5VY<HA-SP ]!PZW,
M82D^MT"HI:XUXRZ.G=[L[ S;LC(\2U4,1U"SV=,8^/)-8OA@%%98 F",<9["
M$GV29ELHX>97-.M%4M$4";V]!:*Z27R;%*R&"3J)-IK;T7D,H[;S#NY$;5BT
MDC@RQZ=OR8JKX>&:V?[Q%S']8^V%OS,;]FIK'9DP+QD^:$2/)E-VFH@_?>+F
M/IPRD:V(]=;^Q$>\C\GP'GW7N74=:79GL_9LCEEHP.Z6U[2F7072RX+9%7R2
M'RROR=:  U="J=A(*-'80'>HQ(76'J(FLY,O3;8D7*N"?$,VMP -"+:V(-P;
MZWUN=;WVX")AKCJE'8#= WL"3LFT+(M5OUMA_68U(YV]AN^LKC40G<FL5*9G
M&,4A46:I3LQ(983U*KA=!,5U':,V@N*C=D-UU42YM;E<FWJ;#^T06?\ )ETV
M2AN0D<L6Z:]GP;M+=W;^MKPA4CBH^TZIMF_Y/+)'8;")NGD*?Q,G7A=K-#L1
M?P:;125C3<26092%4L4:-3"*+F)() T 3;D0-];^Q$6KZ_TL\HN$O8N6N.Y+
MWD!J2E9=(K&O"4#I%+"9@NBQ;K-!C".@HK"X9%1[8<U;@X9!XK'8T+UPY=Z#
MU2I$J2?HA-^0'H+_ -R3[GI$X\1(<0BNG;+^7^??]8I_6T;YI'\A]_P8RO\
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M22I044KZQAY64.LX')H%*<ZAK89^7"U__;4  \Q<@7$6+[5>5WD76^S\T([
M]0@=SUE0T!N2^Q]X]MEJ7AI.531D6<I4GUM-&*I(GK/DZ^(^4>H3&5QB!18.
M-(1#$B29$Y(HP%(SETOK8D@6&IMS.MARTOWB0(;Y3JU>P'8'KY475?K2*G4+
MNSJ%0O<^1VA9%G;5\UJ:LK1L69PZ5@3H$?$I4YD4]"-HL@TBD?!N]6LAD#DR
MH0+AH_'5"9! IM>YX$C07N>5N&AWVX QM+;RE4A6C+*$JU *2[;*=\DNC)&C
MO;%YL*9D,$E9XXN5([F.ZGG%:9ZJ(;]@&I#V83PMKOI$LN,.<;$.(9?73+FO
M:WIO_P"6G$[^D3%Y1^[;4J&H*KBM*21A +.[-=FJ0ZK1FU28=C(FM1XN ^Z;
M&[%0CQ3780=/!HZ'+LX:),><2\FI..IDD7C/[YBZ02 3KJ "2-[<![VOZ7MK
M'$@'5L]U-D#V[R/>7MW9-80^ 34Q<->=@9?&KAC\J2$ UBR$Q!O%X@(/UP5C
MVS-^37%0)PPCQQ+* O()HW0SA="]Q:PO<6/"WIZ_?7UBD?47RV@'L?>?7^NS
M83KH/BW;%.4:U,'J?LV.MN_*F) X@5GL?"]H:J:0D$P@SZ;18*0UPM#Y7,&T
M'F6K.#2G;+U[J4112FU^-T\=+#C;0\]?I?;2(9Z1=@[H=C?([GY+/KALY27]
M N_UB6'&59I)Y*:N*6P"2]>58DY/LRQ=9.:S-@B3+B(>0D.[U\-5.O6K!VT2
M(N\*HJ@/^IH-' !Z#Y]!Z:#VB9ZR[U7QW]ZJ=B-HG$J= R$;!X0<*U[UR[$S
M&8]HH. -RL<M;E'3^KY34%/3BL;S1JQA-8_%I(#>.1I6?+M6\)(Y=#TRNB(4
MA)''F+D "XX$&Y!&NO\ O&XW3158"V_9:SZJI BUKZX.D'4V+]=EZD@[Z-S0
MKV#@LCOUK1*4($L6 R3P":5NR-TLH$DI\?&1%;"$&;^1D@@,!(E&")<Z:ZW-
M[[&W'KIQ^\=S422D2$5C*,P<LGDM1CX9*4NQNGW0YU(DQS;0VY8)_83^[9+D
M\.E6NGW>GV$-D]?L:^;[.$9C8.(17;ME_+S9G^V"OZC#<TC^0^_X,97_ !/V
M_(BQ/,QJ'$(<0AQ"/SKQ6,3;M'-NQ5K1JJV5K1UMV9OFO69GL!Y6WM#UWE4:
MTJ*PS=8/XK$J)Z[45*()4L#$E(>^<PQF2+[SHV&?MY9+GKM^:T<[(WH+ GD#
MHA)_D =22"=#].0TX1+UF(SSL79?5NC9]<MY,ZS!W]Y5* &(_".U-DGRDE@M
M0&Z6<0&NSO8J*R$#95F1B"OY$]&QR;O9 ,G!:,,D0QQXT9%I(!=(7M<@#_3Q
M2-CR-QK[<QRBZ%G=4(7$>[O5:@(19W9^&T;>=-]II_<=9A>U_8W<;.3]"%NO
M3*N]DY*5LTC/80S3VN:3+RMI6\LAZ,\3'1X;,M38@;LP<( _*387!2!H-+YB
M>6O"VO:*[^4#C3[IG_B&C/7:R+QA,7L+R3'E ;5) 25^73/FL?M2BI'UP'UY
M9$">6'.Y48K^7#QEM2X>^(0TD%T+);BG#]!9^)8NTD5(!M<#^:!PMHJ]P;?3
M\Q<Z6=8NE:E 'KCSV)N9'?%8$9DCV0:=]NR+4NF\3C2Q9&PFAAK>2441VT=:
MZFD 380G#$_-J&0C6@+&HC",@FX  )X6*0?>XBJG1>(RON]/3)_MI.[T*O6/
M0WR9<_)UM';KMVG8AI:=MU9;!JQID9B]53"#_?'S+\.TW5$O]\AQKC=RIL'V
M)(,70]&E6%K <5:D D@'3C$9]W()=_4C6XJ]@O8:ZY!"R_D_/+$7+201S9=H
M'995HN.0+HMI"HUO-9',I#,)B9K:<.;3DM;2TJ56/0H'8"L8 N6K1ALHY038
MV) _FV#H+'^5]+: @"XYD7CMJ[8]AZUC?D_[XM$9=41#HN^K=D$H1.1,^%M7
M#Z2DZM,9B"\1.,"FKM[)"1MP-UC.H1=4P],+L4A6JK]5OKLC &H%N>H_,=5$
M)C-DWI:-C$W3L%VQ91JO^JH9I I+Y1/M7U%/]?";_JQ4LJDD=)UE#( 1A-@J
M6,5DFUKZ7&Q,G'A?>7+1!^_0?0YVQ:/W]_?[QHV'IJ?]*3?YCPO;@+"W>)2Z
MD1Z9)=R#VD9A=AK/^L1@?&;)I*6]MW7:FOJRAW;Z'1+4=:_7ZV+/1$S70S#B
M=#/5K*J.8OF#P3#["FI>LT7+X\+ADJ0/#EKP-K<.1TX:\N8%^&EB-NJO9X$*
M[J&G,;J*32+MG!&M?E*^C%C6.>K&9V7)&!:OCO9&P6-U;.7U2QH/7#V-!"U'
M56_L1!>*0Q$4&)R M@1HV1+CY>.GN-;V&_H3;4\!':9!8TI"X1#H<L7?2!:)
MQ6/1I4^3SYR1M0$(9B]RY#.=U<Y?$MFN7KO.5%/.X64S]O?_ -649C:N(0XA
M#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.
M(173ME_+_/O^L4_K:-\TC^0^_P"#&5_Q/V_(BQ?,QJ'$(K!VUZL1?MY68*MY
M//;*K'>*VE6EQQ2=5*0B8V;1N>5+*&<QA90:O-H?.HYOHQ/,&;M9N_C;W1?"
M&J><Z:YWQLB@V-].?'4:BT5E1\EE4\G=S@IV'O3L]VU-S*D+1Z\L2M]SR%;8
MKVL[I9#A]GLZZ#5-6M51P!(9>U#!42<M=ARLCP@''M&Q%NR2W;*HN;A8 6-]
M-QPN;WC,U)Y-V-5]:\1N&P.R_9SL5(X%2$^ZZ0\1<9JHT8F#J:P5X5N5$HA:
MMI^M=US^B,##-W$Q<O59&=UW6VD;XMAD!T#(9M+  :@Z7N2+V-R3N>&D8(3Y
M+F"BNK$7ZH[]D.SQ6+U5854V)UZGI2052I8O7I[1CL,[J8%7SMG4;*+%X]$\
MA4V^R%C12;D2[5Z^1(DE<:CLCD,VN:PN;WXZWO?G<7OR(C;+ \GFPE<L!V7"
M^U7:>E;@5J*%TC;=L5A(*G0E78.&0/4CM'RUJC)944JA"=C#79V2OA-B0")0
M>0 U),88B5&H;U:,&H@/*P(];Z?2Q!][Q.T ZJ0.N[NQ?@R36,<FO^&JL.K:
MVLQE.LJ;OX-5$MFLR!24R7+CEYB=L,N6G9CVIDQJ4/TS2:31QN-0)9?/WJ!-
M_<G;C;[<HIS4'2*QS/E(K'\H'?D1J"#DQ55ITO4$1JBP)K8.LJ72.GVZM_V-
MM)X'78R-V3M53H+5(T0$'R39G'5I(S=R=VRU#)ZOW\_V_OQBD_+E%SK<W 'V
MXG3GRUY<XOKV'Z]U=VDJ63TM< 5V8ADGR,=Y5$E7\>DD=D$?*,ST5F$0DHE9
ML6C4NB<A'#CL=.C7"3EB29([;87;;N&RR("4FX_?0^D5MJ7H5[#S=C-;7[:]
MNNTVD?C$EAL3A=[6##L5X* 2T2H .J2.&U37M8"+2D#X$NY%;G[72FJ[=)PH
M^'(,#'F)80OL /47O[DFWVM'CKKT"'=;)-"=XMVA[72BGZF&%0=-]<IE8$3<
MU)7@(F+<!&0%9<# 8_9%D H:&<9%5X'MJ?SIA#FK<>NQ05*BA))@@3?D+\SK
M<];>P$<*M/)L4K5(7K0%BTYN9'7JK0M\=>:X*ZRP",D#F)=@W$*=2V0FS<>B
M05^WG %>!AUH6>BBL82"KJO'+D>2<^A+,D"HF_\ [&Y^NO<QLO77HK'J%N*3
MWY(;TOGL3;1VLQ5+BYI>A.M79:,U2'D2DK;15LM6E9UKB2O')[9!Z2EL[Q*I
M8[U8LVZ9=LAZ;H]12JXL  +WTOJ?J23%Y^(S#B$.(17;ME_+S9G^V"OZC#<T
MC^0^_P"#&5_Q/V_(BQ/,QJ'$(<0AQ"*R3CI/TTLZ5$9U9/4CK'84W+N-71:8
MSBA:KEDJ)NM-=--')&0GHH0+O7&FB>FFJSEXJIKKIIKC;&-<8PBW/"YMM<Q*
M47IJH(0H%5A=4UM$%8TH>5CJD7@T7 * %92@,;2=0+N)%M-A2DC;!0[<]NQR
MAL70$C$B&7";!KJDB1MSN,QM^?#2M]'PCV4QQ@;%1Z2NQ+!P? BY*H(5D8T,
M96;[D1;"0*@ *AMFQ<H-RJ@01N_37V&L\HH17CM]UF!]IJ O"I,*Q^*S6UJ)
MM6C0-J/HJSD1N#A;6#M6!S5EGT@666".R(F.ES4>9G!;0XZCH;=VKA<<Q7;(
MH-B/J#[1\U^C?2MY)]IP0ZA=72$Z6?>M7,U>=?ZG<RQT8V5^_4++R)>)J&%2
M2KG.SG=\H]W=;+[95V6RIG.V4,RN%S;:Y_>0BQ+&+QD8<-28;'00^22-H&82
M&0,1 ]H</,8YJ_TCS(T6;MTWY1H!T*E- S9\X71%ZDG^K'1##QQA1$CT(1**
MEC8Z2E8S'R<C#AST>$'R 8:]-BP$J5#K2@&.*N6RCYB'DBT> *GAC9=)D85!
MAU""#C88RR@A%:@?07HK&)"XEL;Z7=3X_*7:9!)S) O7:HA9U=(NW7:%DU2K
M*((/M]"C1TY:DM<K_9?-W"Z+K"J:RFNR+F5:US;:YM[1M-A=/>I-MOAI.UNK
M?7.S20<0P ""%A4C6<T?"@(I+" L(-=R2,$EV(@:AC"+ :U429LTL83;HIZ?
MAQ"Y' D?>)%K&G*BI,"M%:9JNN*CB[A[N27C=8P>,0("N142304?K!XJ+$CU
M7JB***.[K=OLOLDDFGLIG337&$"2>))^NL2/Q$AQ"'$(<0BL'M9)/&G_ ,;/
MZ<Y[#8>PC@N=S[F'M9)/&G_QL_IQ8;#V$+G<^YA[623QI_\ &S^G%AL/80N=
MS[F'M9)/&G_QL_IQ8;#V$+G<^YA[623QI_\ &S^G%AL/80N=S[F'M9)/&G_Q
ML_IQ8;#V$+G<^YA[623QI_\ &S^G%AL/80N=S[F'M9)/&G_QL_IQ8;#V$+G<
M^YA[623QI_\ &S^G%AL/80N=S[F'M9)/&G_QL_IQ8;#V$+G<^YA[623QI_\
M&S^G%AL/80N=S[F'M9)/&G_QL_IQ8;#V$+G<^YA[623QI_\ &S^G%AL/80N=
MS[F'M9)/&G_QL_IQ8;#V$+G<^YA[623QI_\ &S^G%AL/80N=S[F'M9)/&G_Q
ML_IQ8;#V$+G<^YA[623QI_\ &S^G%AL/80N=S[F'M9)/&G_QL_IQ8;#V$+G<
M^YA[623QI_\ &S^G%AL/80N=S[F'M9)/&G_QL_IQ8;#V$+G<^YA[623QI_\
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M'E>WK'#%>4 #R4W4!.)0+$CJ6UEJ&'.9>/?V0YEM?'.Q(&(&X&'G(=A2Q"G
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M\7BB(J-/;JLOA:6JDQ@]3F*UR3501)>>9%U4W,H;+2EK6]9<0 +7G\Z=513
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M]I';/2FTWE@JX+,IQ*<0"HYI)@LDS )6V!,Y5*\U]&S4<K]9VT*#VQW<HX#
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M9CNLGT0TRALZVU03>QM?B.%P>?UTW^WK'$L"R+<C42O61];[;BD.J7JYY/\
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M,_7_ /&.,BMNH[PSC8].\/>/&?/Y_MO?/_#S^B9\_FQY_-C_ -?_  \^?_\
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MB7I]1F5KETK#9=4W+RCKC20LA/\ U4H-R!:/8F?!+Q(>FJ_)KI%(D'L,5A%
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M%P,WQ5$1*#$?($@<3U.MD7I90*V?VQT^7F-N%K$:G]XQ H"X"B+I4+ZC7.5
MFPYBW"^QC>*LBAV0=M9K$PSU<KUXHZ=3&\PKW3UNW;L.P-QLC<0D%4?>OF2+
M0VSKXFM=]LEVS9V^9C"-XUFFV18^RXQ1<!J1_I!)^AV^VI%HBB,H/^L@)/\
M]1K?[Z#UL8GA(&^CW;B9F9)&"AR*7=2U<0>*2IL$=G0@$M59FXC\P@4O4:MG
M2$5&R01/1\BC98OJV"RDBSD<=>OT# ^*#3E_U&^H(T^W$??C&;_( "!E))'
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MUJ+;3S;2DW0GK<<>(?A_XMJQI07L1R?A[)*Q=A&NX:J]0H%=<HE8I>%L"2F
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M=>^QEL0>40"[.PU:' 189&60Q&N.O)2"X5*1^=Q*8J2>6YDEX6.Z+$'#.+*
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M[IP.^ZSQ8G7>CR/641(I104D,PN64OE"M4X\H>A8^_@9UE9P1W5D?)/96!L
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M2QBED5_!CL)?'"QJ?Q2OK-$V&V,2RRG5CRYU I=I?ZI5 5(E76PDQ%;35M<
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M9+YQ(2L>$#X*)L]Y;0,'$G8M)V0>R*8IR:J"(U9*-*$8UD8N[/YDR;- $C*
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M "@'%%U"&W&LI*OM.-,$^&GAC.XRJE5PI4,64Q?C9XA>'&'Z,C$<_26:!A[
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MM)RDNPRVVQ+RLI+L2TLPVVRPTVTA*!LGH[C\A;X6_P!/.>.IAZ.X_(6^%O\
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M2+:/D%E3&S$4BX*/=1FFFSW+0:W7?N,(919HJN-T]-D(_*W54NQ3_6GL/55
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MW%CL?8PN-Q[B/FE,(,AG.47#9'.<ZYSE(2\3SG.FV-],YSHQQG.=-\8WU_\
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MO+S":>AMQ;;\WG^&9R*<0M;CWEK#:4)45%-K7(!Q<H[%T7"DHFO++4A<>1G
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g377019g01g01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377019g01g01.jpg
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MJ8IU=.H9LD? /TV$X\ZY&BR&G6VG%FX@B61**YV'C70<6%4XXW4D&8A44"4
MJ#R2QI4 :^W-DY::8&QT*8)84BB3E%AV^JA:,4NAVS%*PTU2:::.\U2*8R<$
MV8,9KH;PW.&HTE)1>>2Q(-HBP23>(OY16TUGE2C-1F8U<_29?]5*[4U*[Z[/
M*_%4M5X<^3W9!W#T#<4[1TU(W34;S=+6H^<&B-+45!):90AM"$)L%ZXD5ZQL
M%P#X\IF#C9:%T'HEDJMF"PB-/+TH7)GO;RJ.6,$A3J8ZY$NFU+ND7HU"0"8T
M+TX*P@"O&6I!BN4.*VU/Z%):I$RH&E3\Z-'9<<-1.\(HU-.D;2R7K.)4E2=4
MR<6K&M@RW\+2[<4ZH6<6D1VH:2[6LI#[-*M&O5VJ0X3;#L$H33;-0ISK51BK
MB<%#>CO-O*<0<&.R9G')32J[Q-XR0?B%1D1HV JESHUQP3FX.<A=24I#M)I$
M^+SW)X>W$I$66F)$<<<!&A2%:&%O:$3<W:.4:2=^9=H='C4*FL4V*I2T-:ZU
MNK))./.N*-;CBR21$63,DI26=5M*$9/5R>#I;TGUW3#?=8ONX&F(LJI%%CQ:
M=$6ZN)2Z= CHBPH,9;ZE.K)#:#>?=4:3D3'Y,G4;X;@TY(9MAUJ& # !@ P
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MJWPHEN<DZQ6-Z"<A0K#9.['F@E"A2042/4$7EB5GCR9'U\;L%N+!;,[,8+C
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M-UK6W(@V3&).O8-$B7@&4K;7$@(](GM@=4HR7-@?VT1@S&U[:%2-R1#$/N5
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M],^G'W#6'_J"'EWI)O1APD^F^]/X!XX6[?0=O=\:C]6ASCS-/IGTX^X:P_\
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M7M;YON/L&%^%\+LM5_.]]O1/;]DL?:]B2(SSCD,S[ @\;,\I8[(DG($A@ P
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M/]V<^<'B>H'4.C][(7@ _.!//=M+OG(\_;<<]2?1#_=G/G!XGJ!U#H_>R%X
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M"2_-GRI$V9)<4])ERWW9,F0ZL\K=??>4MUUQ1[5+<6I2CVF9BH96,<, & #
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M#?\ )EA>Q'E?O=@J!!!*8DI,F)*3ITY8"2"""P%$DDE!T LHHHO00%EE@#H
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M,),A7#BE9*9V9%V8Q.UE&$+F]O*0""-;!&1$19(B,RSDRZ^W'KD1&-GF!2&
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MM]:L9S07OY@KA[,#^\H ])\QQ^,_HK_7W3\2;E'%[GE8?H%# !@ P 8 , &
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MN9CU+YS)'J6R=V-+*)&XOL@<5#HZ*^X( 6G3@.6*CAEIDQ129,7L!"<HLDL
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M & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@
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M4,>]:WU!WU;P:5%M-*B+E,C^0!)^4@& # !@ P 8 , & # !@ P 8 , & #
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MJ80TIQC\FD:9-9-=I)/#'B6QM2,M(<R2YM<XJ[R9.V2G<? 98SUCQ]NS@_\
M$9JX$!@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@
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M9#S*YM-$K%&F4C2TQ,QQM&1)CFMKVJE9YC< U&><[S/)GR_X8]89XX$!@ P
M8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & #
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M@DHG9Z@>C%!W=@"#O3QZ"#0SC.SVS1Z"'0AB%O00ZWU:"D>[ !@ P 8 , &
M# !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8
M , & # !@!H>_*&_:4UO_B=A/U77-G6NE/S/1/VQ&_<Z@/>WW.O^>ZY/ZKZY
M\:;+'&AG0(^T08 , & '?CT1?]G1QC^#4N^LR;9Z;L7S)T?]5(_?9(_/US7_
M .,?I0_:='^+%#&Q_.6CS8& # !@!&5EU\;8&H!W3H6U^9-FQ.P3.\2"5^42
MHUM=L;6#LJ$_AC%GC-=E6+OPD]WOK3F]K^3)'C/7(R[8@RSCK&1]H2;D"0P
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MYQAN.NHQS::-LTX@U1#AFRE2&.$>11TO/< A:FV"=<63"%&AHD)/ RH=V63
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M<B/^4T>_? C.PM%'_F-6_P"29_\ [QXE^Z0^831S_P"K:E_<ZQUPYWB/D,&
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M # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P
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MU8JG?"7X8/,F&>Y&,?(#5]DQSO'_ "#/<D?-#HY6NK%4[X2_#!YDPSW(QCY
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ME)F7(>"+(QI-0GS$I3+FRY24&:D)DR7GTH498-22=6HDF9;#,B(S+8*ME8Q
MP 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , &
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ME@T(6C-&$F[V'0=@WNE2=4RVYR62[9E_@ G;*0# !@ P 8 , & # !@ P 8
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MW_Q.PGZKKFSK72GYGHG[8C?N=0'O;[G7_/=<G]5]<^--ECC0SH$?:(, & #
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MBX+$G1>42SL$#.,*5EJ%8-I%)QZ?6M4X,DJV']ZC9JF6TE;2,CWF7+NP>W>
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MF#:@*PML<#R$B\L.PDN;=L7>MCJGUOV=I75O,2N*47_SIE)0]>P+( 6]@ P
M8 , & # !@ P WO]&)_J!E/_ #;D'[HP3+;F]/Z/^90#8SEL P 8 , & # !
M@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 ,
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MXA+K[<!AA#KB4>42MQ*E$GRI&1;!O[SLX?/P, & # !@ P 8 , & # !@ P
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MQ&_Q&T[^_C'EBV?-%0OVM3_WIH;;F@/YC-+_ /5O>7]P3A^BSGJP?G%# !@
MP YN><OMJ;9_WR+?N-&,O(^]+U_A,!B;E0!@ P R#XH^V0IGX=LW_<%D*W'V
M#^ !TZY8 :'ORAOVE-;_ .)V$_5=<V=:Z4_,]$_;$;]SJ ][?<Z_Y[KD_JOK
MGQILL<:&= C[1!@ P 8 =^/1%_V='&/X-2[ZS)MGINQ?,G1_U4C]]DC\_7-?
M_C'Z4/VG1_BQ0QL?SEH\V!@ P 8 1M9$Y00?4#VO9?+/G?9,5@R+]827Y*7R
M 2W2=Z_7$']YX#PH]]V5W)P^]Z@'E]6][DBSGK$9]H09XQUS(OD$DY D, &
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M4S\.V;_N"R%;C[!_  Z=<L -#WY0W[2FM_\ $["?JNN;.M=*?F>B?MB-^YU
M>]ON=?\ /=<G]5]<^--ECC0SH$?:(, & # #OQZ(O^SHXQ_!J7?69-L]-V+Y
MDZ/^JD?OLD?GZYK_ /&/TH?M.C_%BAC8_G+1YL# !@ P C:R(W$)'J!^=S_I
MA\@V3%9)&.MT;&SRS+VL2W;(P:\IDG>4-N6SE.O);?W3FK[K^:'%[+'UR1F6
M<<AD?8$&1'C/*1EV1).0)# !@ P QDG7ME*=_P"!2'_[=(,V#7_E\K]8W_;;
M&*Y^%,?HN?V5#)O->,H, & # !@ P 8 , & # !@ P 8 , & # !@ P 8 ,
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MF.(XXYN)IC\WO6Y'$$"U0]2/=2MR&(SXU5-2&)N<HK$G=O.9E%9N+VV:='-
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M/O2]?X3 8FY4 8 , ,@^*/MD*9^';-_W!9"MQ]@_@ =.N6 &A[\H;]I36_\
MB=A/U77-G6NE/S/1/VQ&_<Z@/>WW.O\ GNN3^J^N?&FRQQH9T"/M$& # !@!
MWX]$7_9T<8_@U+OK,FV>F[%\R='_ %4C]]DC\_7-?_C'Z4/VG1_BQ0QL?SEH
M\V!@ P 8 0[<$5D\JU5WFR'8O-RXH/*I!U+BT/5&&<3EMV%OO#2O&:UI01UH
M0=X8H_\ E*'V-]4D>,]<C+MX$&1GC'$>?6VB8L@2& # !@!JPZ2+^J4OP82_
MO6FS9QOP&3^FG_(,5S\*8_1<_LJ&E;,090K#)'9!)50T,<8GA_6EDB4&(V1L
M6NJH"< @@&>-.@(/."2$8P!$:(&@!$,(=BUL6M;&9$63,B+E/87;$&9%O,B[
M(NK\T=K>C&POF7)/NW*=='GD^R+Y0R7*7;(?,LK"RVY(H7N%>3E"A2$F*%:Q
M9$G]*D2IR@[&:>H4'MX"2"2P:V(PTT80 #K8A"UK77@E)/82DF?(1E\H9+E+
MMD+&RH2& # !@ P 8 , ,MZ,IBM;0KVQ)"\&69YRUZQKGI2AB@XJL)=Q# >-
MG;V=B4%*)(M.T4E5*WI;HHIM;D:8PTQ46,119CDZYXV[BZ^<'UM^_.SC 7 P
M\;:\E+#3LJ:9=+TD=E$/MN:64M=&IH\>SM]0)F8Q]31-J1J3@*3%BU<J0-Y[
MDY&"-)\*XG)$^P'-YD9VF6_:1)P>\U;LF9;,<>SK=<!$%OUM#XS&ZVL6NG:1
M+X-9J64%MZ&8)VTF4,CS#'1*U/J!Q,9]^2UJ8W:]"L;EB4!/>$GC).) <0+8
MA9VYWEC.-VTLEOV\N=G%OV@)%!PVFNF\QR7633340A1PER?2W*5O:=1&VNPT
M9*B*+WHGS6'LD#DJ/+:BR$VU2OQP@F:($V""X[9+=Y;.3+86<XY-I9/[9SL
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MA&]ZDE]Z,\C'=(Z[\4ACT+\]O5XW\V*$E3H_L]WJ5;&Z]QM$+34%KJY?>+Y
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MT;S['^)#:;EH71Q_]*Y[?2U/@G6OUN='#@7$;B_2/^R8P4AW_G>,?\T:8_\
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M!MKSE&W5R62,L\=K>G#15;ET>(NMWA"I]S\_TZF%2GH=5-PY]61&<IT5,AJ
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MUK_9K^C6!!)2G.J1%DS,\$19,]YGC>9\9[QXX$A@ P 8 , & # !@ P 8 ,
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M@0M_T[V<9O?L>QKV=P[_ -,N\/3?0SG:+PPHX.;^5;]D?@AX_FXY2>DN+_\
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M@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 ,
M& # !@ P IS=_P"%;_Q%9_W, *C@ P 8 , & %J3S_R/,_@I(O\ [0LP B_B
MM[6/CO\ \D*K_<=CP GO !@ P 8 , & # #6%TSO]F%R]^ #)^_\0P*D??%Z
M_P !C9[@4A@ P 8 , & &KODQ_:D]%M_RQZ0[]R^/.!/$?9+X%#:)@0& # !
M@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 ,
@& # !@ P 8 , & # !@ P 8 , & # !@ P 8 , /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g377019g01g02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377019g01g02.jpg
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M 0$! 0$! 0$!_\  $0@!%0'U P$1  (1 0,1 ?_$ !X  0 " P # 0$
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MJ*4HB41*(E$2B)1$HB41*(E$2B)1$HB41*(O'/\ (R_NY?X7HBP$1_FK&OS
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M"LDV!A<&13R;'B \(S+*OWR;;-];770.I(*6S5^I:>FF$IJJ6Y4,/[3@I9.
MQ=U4RTX>QL,XDS)&V:,AT,;Y71AC2<$[/[+K:P5=7=H;#4.IS!]UJ*"N>;?-
M5 R-E$D$4Y8\O@[LALKHG#AF>R)LA>\"]S6O3"\:B<B1UWR*C^S.&VUK=A)U
M$>0<2)QT-FXOEV<E!\S2:W&8BK7Z[I&)0TB39Q;&^2..6&262FK;AV77^. U
MUBGM^JK:<EM58ZF.>4 >#Z4N[PR]8J9U4YI."0<XV]2:ZM+Y12W6*KL-;R,%
MT@?%'G)W;4</ &;;23-@:3RSL3:/&Y/&YB%822(2$'*HZ41LX&'XV68' I%O
ME\F*[ H,<.F+Q&]_Q*MUU,+_ -F5:[GIZBEE?3U4$U-/&>&2&>)\,L;O\+XY
M&M>T^3F@K,8IHIXVRP2QS1/&62Q/;)&\=6O87-</,$A9RN%<B41*(O'/\C+^
M[E_A>B+ 1'^:L:_, ?\ R]O4NYGTGXJ&\AZ!\%L-0I2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB@STGO]6WS_P#T+^3O^B\THK,_.W]3?B%.:BJE$2B*F;G,
MTU#LGE".UQL&1\4]3F8+I6#SYG,N0.TMEPDYM0--Y9N6'+P=M%M:[IT8WF^O
MX,W!2#&0#YX9G@'-3;C\/C$ S(\5>2@K#(&0"=\; >&_,@^S'AGP5O$1\!W4
MC'BJ\>=->[P7Q9S$4,&L4<(?!K;P*\8;)NGR;>/*I]E0*@F]>8(C<FR>+IQC
MC97,JGF?Z\_6MAHB41*(E$4&N'W]+'2,_IRM_P#95PRHK.Y,_2?YW*<M%5*(
ME$2B)1$HB41*(E$2B)1$HB41*(E$2B)1%KL6_P"5K_GZ5_\ 5)FB@<O6[XE;
M%12E$2B)1$HB41?BY;-WC==H\;HNFCI%5NY:N4DUV[ANMADFL@NBKCDFLBJG
MEDFJDICE@IAEECEC?&][5():0YI+7-(+7 D$$'(((W!!W!&X*J]C)&.CD:U[
M'M+7L>T.8]KAAS7-<"'-<"00000<$859.[>B;XN[*/\ QC:K;2;BKNAHJJ\$
M[0X[%EH"Y;D<^O*R[Z+C<D(XNFJM?)4@H&:QXT1OGG9<Y:^7:MF-NUQ>J.+[
MI6NAO=O< U]%=HQ5-+.C9GYF! V8)'2QLP,1;86G=1]AVC+Q5?M:RLK-%:A8
M7/@O.E)W6M[)3DA\E%"6TC@7$NE=3LI*F7)#JGD1P^^QNE,X1_R>UX,'Z0?1
M0S\'+8>JV5HKR# B4?P+.CT'00<)259NVPS74;#1\A<+VPNN9G;7)3//'T?N
MFB]1[T-3)I:YO_\ A*UW?6J60X_#%4G!A!)P"]\0&<1TQ WQPW?MI[.MKW;:
M?M3TU#SNUDC%#JFF@&!QU-M:US:MS&!SBR&&K<['%47-A<<>O+.GSX,1@?&'
M#9CNV1ES62R<CBPO7K(:?UTNV<>+.64OM*9-'A*Y!-2RE\6\2*R=+LI*66<H
M*>#34M!V8:DF?.TOML,<0!AG?5/?%6!PR'4_<032!A'C/'"<D8!&2*5WVGNS
M>CBHGLBU'5U%07"LHH;5'%56ES'\#XZ_[[64D#I6G/X*&>L;AKN)[7<(=;AJ
M7:L$WAK>';:UF<1DD$G89 ['3"*2S>[AHKFHBL@Y:.<$G+$@/>(.1Q,>Z23=
M#R+1TR<IIKH*86P6NHJFVU=10UD1AJ::0Q31D@X<,$%K@2US'-(>Q[26O8YK
MFD@@K>EBO=LU):+??;/4MJ[9<Z=M323M:YA<QQ+7-?&\!\4L4C7PS1/ ?%-&
M^-X#FD+RV5J75VY8ZM$MLZ\AFR(TMV[W"S6."9&P25SQ[%W+5$JU<V9/,+6M
M=%\SN@\0SQP40734PPRQO;[G<;5.*JV5U705#<?OJ2>6!Y .>%QC<WC8?%C^
M)C@2'-()"[E70T=?$8*VEIZN$_\ NZB)DK0>K0]IX7#P<W#@=P055O).B'C&
MNS3^<\$^0FXN&DS<K7>JQ^.GR,[T^:=8=6>"1Z!R4C=R^054QMA9-^<+"&"=
M\+M8]GBW20OL2G[3JBNB91ZQL=JU52-' )YX&4=TB:3N8*VG8&L(&^60Q2OW
M#IQQ%RPZ;0\-+(ZITW=*ZP5!/$8HI'U-#(X>$M-,\EP/(!\DD;.8B. %@+\J
M>DPXC?R'+/B^+Y1ZR'==G6]>)N>2TK;#T>K-8K)-6.V[5=PX31ZU7JK0-!(X
MRQ[79)N,$,U5.?\ LYV?ZG_%IK4,FG;@_=MGU*,4SGG9L5/<FN<UK2=F!TM;
M4/V_=M) '$;UJVQ[7NSLO%&W\UQLF3,UHW+Y:-P:20-W$1TT+=\2$ E3;XU=
M()Q,Y8XHLM1;:"KS'+#+QK6DKMG#]D,5DK7NZ;]U#GBSLO9E>W9>/HTH<%(Y
MWMA<A?*_56(W_1.IM-9?<[9,VES^&X4V*J@>#^5WWF'B9%Q\VLJ!#*1OW>%D
M-IU/9+UAM#6QF?\ BI)_W%6TC\P[F3#G\/)SHC(P'^)2>%[#@!N3%H6%G,.+
MS$!ADH=B8N3!7\F"X8YX)Y9E@+1ZJ4&X8YJ)X99/&J-K9YX8WOUY8VOCLE%6
M101U4M)4QTTQQ#4202L@E)!($<SF"-Y(!/X7'8$^"]:.MHY9Y*:*KII:F$9F
MIXYXGSQ#(&9(FO,C!D@?B:-R%MV?Y&7]W+_"]=9=E8"(_P U8U^8 _\ E[>I
M=S/I/Q4-Y#T#X+8:A2E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1%!GI/?ZMOG
M_P#H7\G?]%YI169^=OZF_$*<U%5*(E$5+CSF#B-FUXIM,9-RI$')^D)CTK(/
M^+>RY0H-QA_(XJ-XF#Q<D#ZE)#'@AQJU9=4 \"O7X\^/2;E#;UX_4NZ<%8CI
MCD/XATW\>O/IRV5H_'\A)RVAM)%9MB\PF1/4>MR$MP(CL!!#"3O(:&<GL7PE
M-JR3&/,2JCNSD<FS:8,E[9ML6K?%*R6!0>9QRR<+%[\W<GH&$/=A$M;SN>Q@
M(R*EI:_A974P="& 0S#,@]/R-[MK:&KQ:8O%%-3#&XL@4>^%PO91DFGEBID0
M#/B!Z<_)<9V'S/4UKK2-[<-\7.3SB#GH7#9>\<MQFCA<@BK^=$6PD#KV10B5
M[UC<WOLQ4H1""KQ"/QT^Y<FSPJ.C%R$AS="FA,>&1[_CC"Z-%N1>4UVM*M:1
MK2FXR(.$S-_ 9/N.V.J&VKADE&1<9*'S7L.]K(;->HH8&1H7)T/UJ[1N<<9(
M6RNP;NB*!,;9R-_#?//'3'O4D**%!KA]_2QTC/Z<K?\ V5<,J*SN3/TG^=RG
M+152B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41:[%O\ E:_Y^E?_ %29HH'+
MUN^)6Q44I1$HB41*(E$2B)1$HB^>SI'.A8EW+7D.]W_IS9T*ASV<LH^UV-'9
MVT.I-TR,=$,8ZA(HT]CHPM=VJ^!#!B3P(09CL?A%DX(6.*?"F;=EM327:'!8
MK4VUW"BJ*AM,Z5U)-3.B)+)I'3&&9LKH^$-E>\ME:YYX'!G=C@!=\K]K/V>:
M_7.JY-46"\VZ@DN4=*R[4ES94AK9:2".D;5T<E+#/QNDIH86R4TL<([V-\OW
MD]\6Q[5KC3W2/]&'"PT/U(TAG.KC!&,7SW+70X1CK?=L,^%R3R0R7.&HHK&O
MA]H[/%"3]!CDZG1=VJZS09  J/6KCP5EPTEK*HDJ*YU1IJ\S<+15O>:RW5'=
ML$4(J"1'W3FQ,8PN#:6-H:"Z60['N6BP=K?8W;J>@L<=O[2M&T?>R&TPT_[(
MU%;^_FDJZPV]C75)JF25,TTC(^.Z5$CGEL=)3MW$]>+_ $C_ !CY2/[PZ/R9
M]KG<3-91B:T?MME:$;)'E6W7@\'L1K]:[&2+-E,%;JHQY^0(-$4_"E1XS.]T
M<<8O.DKQ96?>)86U=O< Z.Y4#OO-&^,_E>Y[!Q0@C&#*UC'$X8]XW6S]&]K>
MCM:2FWTM9+:;_&YT51IR^QBW7>*=A(DBCAE<8JMS"'<3:266:-HXIXH2>$3T
MK&5LU*(J_.9/1U\=>5D2F)=_K"+BM[7CQIQ -L@/#PV6CYRD-<Y10B?/QR[-
MS(AS(U9GFNVD29A)%MX?-FFW<^#73S72^N;[IRHIX8[C426<S1,K+;/PU5,^
MD+VBH9!#.'M@D=%Q<+H#$2[ <7-RTXMJ'2MKO=-5.-)#'<S!,:2NC+J>9E5W
M;NXDEEA+3*UDO"2)1(  >$ X(^/'CMQLZ0'07*.-;1%\9>1;J5Z(G#*>SK 9
M$9&BL?CP,PDO,@S*4J-%@THPFP+(J)22#O3MY0P).51S<LVS4RO]&7:]:/O-
MCEMTE^LD=-=Z5U'2NEJ8"V"66,MII7TX<V2G^ZR]W(3(V'[N]C0]T;@%\V6*
MPZOM>H:>M99;P)[76,JJMPIYFB2&*4&JC;4%ICJ!51=Y&!$^7[PQY+!(TDK[
M7>*7-70?,F(/)#I^3J7.@\<49MK>3(8!-C0(A?+)'-G)XTHLLHFC9Q@HV0,C
M5R(%XX27;-2:KML[;M_F/4FD[UI6I;!=*<=S-DTE?3N,U!6LQD.IZ@  GA(<
MZ*1L<S6D.=&&N:YWU#9=06R_0F6AF/>QX%123 1U=,[."V:')(&<M$C"^-Q!
M#7D@@23B/\U8U^8 _P#E[>L;=S/I/Q7M-Y#T#X+8:A2E$2B)1$HB41*(E$2B
M)1$HB41*(E$2B)1%!GI/?ZMOG_\ H7\G?]%YI169^=OZF_$*<U%5*(E$47IU
MR2'PK86ZX"2PA$?^*?CI&-[LI%/I\E$!)_.1FMN!7+%YX4(_R$0^*+:S&J2V
M:H*E5!%Y>.1SCV>6+7,@4XVSYX^'QRNW:XE^6PM>0.?9@BL7RG$,B\ORC1U+
MP)N.Y24&Q-7!&4>SAX(J)N]NP()=C#P;MNMAV<>KJL4+C/*'7<ZVE#&,-CVM
M-&;DAY)^BM.-;[PE4UU\Q(KAB0B10F21N?PR%[.<@B\.E 5N829K:]?N7[ZP
MLB)E,3>@;9%RD>DCT?\ ,+G,6XU;-6"\/X;M;8K/8,6X]"[338+U^^D1*0[.
MW?%Q@X3J==\YD%R3XS"( N5E4T3*RL^1FI;8,5U3*"2SDH),OW),C?;GR\AS
M^7JRM%(<3IH2Y/Q[;8W6/&/6J(/<+W9ASD'K->4!N1&SXFK$S$>PU+.XKC V
MHAX-,^/B$)A(BNY94 ,)1Y(V*U?'Y*Z$OXN^OKW)G;&3Z/#X_P!!\[&:*% 7
MB:$%D]N](LL^:V743YQ-D\,O#+I]6'D6<-,NSU)*IXW_  LLK]=[7O\ +U=?
M5U45G<F?I_\ [O\ FIK]TH]YNMZ2]_B**J=TH]YNMZ2]_B*(G=*/>;K>DO?X
MBB)W2CWFZWI+W^(HB=TH]YNMZ2]_B*(G=*/>;K>DO?XBB)W2CWFZWI+W^(HB
M=TH]YNMZ2]_B*(G=*/>;K>DO?XBB)W2CWFZWI+W^(HB=TH]YNMZ2]_B*(G=*
M/>;K>DO?XBB)W2CWFZWI+W^(HBP$HPUS"0)&42]Z(C,=$HV7)&S9A0:-9)9*
M8))W7=NGB:.&2RRB:""?:NHNNHD@C@HLIAAE(!<0&@DGD ,D^I"<;E:]KN4Z
M6VT)<'-:R2.S06S<^)O7($TN\R8.KXWSP;OV^+K%TQ643MX5%-VBCDLCU*I6
MS3O;*\N8]AP]I:?#(QGT>!]2@$'DN@=TH]YNMZ2]_B*JI3NE'O-UO27O\11%
M@8Y& 2XY;-5C;/*QJ2I6OXP[M_)H20J@ECU8KVM^ DGAAU]77EV>O*]\KWO=
M]>Q0.7K=\2L]W2CWFZWI+W^(HI3NE'O-UO27O\11$[I1[S=;TE[_ !%$3NE'
MO-UO27O\11$[I1[S=;TE[_$41.Z4>\W6])>_Q%$3NE'O-UO27O\ $41.Z4>\
MW6])>_Q%$3NE'O-UO27O\11$[I1[S=;TE[_$41.Z4>\W6])>_P 11%%#DET?
M?%;E0/SQVAK=LE+44D\ VSHHZ6CFRX^LVM;Q)<=*6UE57B;#*UE&@L^W-!$U
M>I6XO)7''/'W[-J:\V)W^H5;A XGO*.<=_1R@_F#X'G#2X;.?$8Y"-N/&0L!
MUGV9Z.UW%_Z=M4?W]C0*>]4)%'>:4M_NW15T;2Z5L1_%'!5LJ:9KOQ=P78*K
MW<PSI"NC[54=LT'O2)\71^5U%V#I=\,Y/Z^#)WO?*[55%8@M/&H]'+&UL,,)
M0\?V;WQ2'P<9ADMAD_%I#56SPW2EZ?L'MP^S5<A\7 \#:4N/G UF02^I><+6
M/=]KO95O$^7M7T7"<F)_%%K.U4PS^1W[Y]T9$T@8'WV2;@PV*VP N$_^+'+3
MBES""+/M/29)63"T?"2G64G4=1[9<05P4LBX2.15R_474;MG&5FJAD*N7 9.
MNMLD64<8*)88M>M-W:P2!M?3$0O.(*R$F6CJ!C(,4X  )'XA'((Y>'\1C ()
MVCHKM'TGKZF=+8;B#60MS6V>M:*6\4#@0UPJ:)[G.<QCCP&HIGSTI?EC9R\%
MHEQW2CWFZWI+W^(KPEG:=TH]YNMZ2]_B*(JT>8/1M!]F'DN1'%B0X<>.7T4\
M*2#SP'DLTC6R[IXXJ*QC:PM+!R@69EL4L6*QU5B^<7;9XM3S"1BD&P]ML/2^
MN76ZF=I_4=.;YI2I CEH9SQU%O!.U1;97.:Z)\1/&V$2,:'#C@?3RESW8??=
M+-K)Q=[-,+7?X,NBJHL,AJS@?N:U@:YLC7@!ID+'DMPV5DK UC8KP'IA=":K
MAB$%YMZWV#I7DE"%Q4;F4%#14](!<C0S88J-=B1$DD^P&XQ0RVQ1?IMERBRU
MK/4<H^YDPK+ KEZ]=V65M;4,K-)5U%=]/UL;JBBK9:J.&:$<6#1U<?"'BIB)
M+'$1-&6N$S*>4&(>$.TJVVJ+[IJ:GJK;>8'MBJ*.&G?.V0$?^UPO!X!3OQQ!
MIE<=QW+IV?C5Q6G9KI??NMHKMS4A=C,(!,V.;\"=9+%4,5\4'*[%ZT=LGN39
M^-)#2#5T.)C'[9L^'OVKAJZ0352RQMK.Y6VMM%;46ZXP.IJRF>&31/+3@EH>
MUS7-+F/8]CFOC>QSF/8X.:2"L_MMRHKO14]QMT[:FCJ6%\,K0X9PXL>US7AK
MV/8]KF/8]K7,>TM< 0NF=TH]YNMZ2]_B*Z*[R=TH]YNMZ2]_B*(G=*/>;K>D
MO?XBB)W2CWFZWI+W^(HB=TH]YNMZ2]_B*(G=*/>;K>DO?XBB)W2CWFZWI+W^
M(HB=TH]YNMZ2]_B*(G=*/>;K>DO?XBB)W2CWFZWI+W^(HB=TH]YNMZ2]_B*(
MG=*/>;K>DO?XBB)W2CWFZWI+W^(HB=TH]YNMZ2]_B*(G=*/>;K>DO?XBB*#W
M2;1@&WZ.'GRX18VP60X9\FE4L_&'>7943TS,\\,NSDOEC?LY6M?JRM?&_5U7
MM>WR45F?G;^IOQ"L$HJI1$HBHRVELL)NO;SJ%;@9\HHE)-%-T90%3<=&>5Y.
ML!DEDNY-YC!1F%2EGP^V@S'X"X? 84D!GL/D.4<F ?(9DP*E)C'YV\HK8.-B
M-^8X@.G/?S5V,97S=1N/.E'I0DHY!B5U")L(O&C3_-9@W4S>EXXZ'"'0 HZR
MRNN_".1(M<4[458K#F2B&39(JK.41*(E$2B*#7#[^ECI&?TY6_\ LJX945G<
MF?I/\[E.6BJE$2B)1$HB41*(E$2B)1$HB41*(H(](;HO8V^]$-H[K+&Q _')
MD,EBT:N]08928>S%FABS%LN[6;,\GS10JB3:MWCA%!Q9HJFG?)]=GAEV*61L
M<F7[ M+<XS@D@Y/EMC8>[*J\$C;PWQU587'CAWTC.MV!R<::/132AQ\HU'$(
MYL-P,>N9B*9W77PM<5>,34:RLU=*7P:N"604C_+.;M'*35;-1QVYIZ9_"UX,
M@Y@MR.$GSRT^D;\AD95 UPY8'I\O45)#R@NEIU1^#L/BI!-OB&WY177KQ/,V
M_P </R\L&\8E9M=.^5K=>&.4%;9WO>_93SMU8VX>[I'_ )97,..3N0]H'\RM
MEX\ <>_W_P!/4O8:],""B#A)AR!XM;WTX^RSLBKCD/2*II+?BRODG*V>NGW@
M[7M?*^*+1PM;'KMBFK>WX3[F2,QRL?[O@7)Q]6D?/IX>"[WJKI->%<K8XLU-
MQ,XF3<%3KOX/FX"1QNR*)$Z1?-;K&'0O.-XWR;N4KJ6P-J>"ROE;/L]77?B=
M2SM_@R.K2#[LY]R!S>OB?><_65-J&[6U?L9+%?7^QX).$LL/"6SB,M 2.UL.
MKKO?+X((/+X=FWY5LK6OA?KME:U[7M7"6N;^9KF^D$?$*^0>1RM^JJ)1$HB4
M1*(E$2B)1$HB41*(E$5>/*OHW=*<D#:.TXN]-\?^2857X1B_(#4:N<>EB)=+
M#+!NXE;,:X&H2]#JOBBNX<N6$D\2PLP921BRR5;JY59-77&T1FBF;'=+1(."
M:UUP[V QDY(@<\/-.<[@-#HN/\;HG.P1JG6W9'IW5M2V]44E1I;5].[OJ+5-
MB)I:YM0&X8^NCA?"VO;R:Y[WQ5G=CNHJR*,N:ZGG=72\<V>!LK>\8M[P/3&Z
M=J0A40]OM]D4."6,T@Y<>D]"NB<8#M!"3*5ND,^T]?I?!;5O?&R&<=?9V^&2
M&?6[0FG-30-O-LJ;C;J*IXV_<',B>ZGJ(W%LC632.D+H ?R-/>..Y[UH_=LT
M)J'MV[1>S*NET;J:V:?U#>K<Z"3]O1S5,$=QML\39*=\U'3L@;'7/:<R2M[A
MC#^ TDA'WB:^[AARB <Q^.L"WX! NXKWI3*L#<7>.L2"D?DD>*NPIL<B2P;M
M<";#QMGD[%D+-6JCH8Z:*NF;)Y=PS;ZQU#99;!=JJURRMG[@L=',UO")896-
MDC>6$N+'<+N%[,N#7M<&N<W#C].=GNLZ;7^D[9J>FI7T/WT3Q5-%)()32UE)
M/)3U$39@U@FB+X^\@EX&.?#)&7QQR<<;)29_D9?W<O\ "]>*LU7SA])YT1NY
M>9&P-:;XT1+(5B55U?#X/,8C/BQ0&FWL!Q>+BY#'BC$.:06;KM2N38L(<HL5
M6RS'!^Q6(J$G#9EN7L^[1+9IJVU%INU/5=V*J6JIJFDCCE+N]:P20S,=+$X.
M#H\QR-+@X/X'A@C:YVF^T'L[N>I;E3W:TU%+WAI8J6IIJN22(#NG/,<T,C8Y
M006R<,D;@PM+ ]A>7N:WVN*NR]L]#B #\;>9NO&[OCI(94\+PSEAJ6\@E<+C
MTDE?BRQ*-[#%NF#<R+;8.TE/$72(<60O9)=4>$DS7-Z4&=N^VNV]IKI+YI6O
M(OT%.(ZS3=R[FFJIX*?B$<]!('F*0\! >UTLC-QWDU,X-BD[&G):[L\I(;+J
M"F#[9).^6"]T/>STT4]1PNDAJ6.8)&-:X'A=W;'D ED4H+GL^A.)RV+3R-AI
MC"9$%EL4D3%$F!DD=)LS 0P/<6ZT7@XFP67:.V^?5>UE$5<\;9XY89=6>.6-
MM+5--4451+2U<$M-4P/,<U//&Z*:*1O-DD;P'-<.A VP>1"VO!/#4Q1ST\L<
M\$K0^*6)[9(Y&GDYCVDM</,'GMS6PUP+E2B)1$HB41*(E$2B)1$HB41*(E$2
MB*#/2>_U;?/_ /0OY._Z+S2BLS\[?U-^(4YJ*J41*(JLN0*FF NT]K1/9&T-
M@ZKQUSQQ8[AADBD/._E/I<%,2LRV)O@K)6:X.%[=BPTI&M=%A0%L8,#OAJ0Q
M>-3.$01D-!Q #KP6O&,]?:1\%89VQXG'('D!U^MB>JL,U(:7DNJM92)R D,3
M<G]?0PTXBTN)$3$KC2Y6.#7RH"3ES"BQ<K(0RB^0XT2*+*D7Q)LY=/E,W*JN
M5Y55T&B)1$HB410:X??TL=(S^G*W_P!E7#*BL[DS])_G<IRT54HB41*(E$2B
M)1$HB41*(E$2B)1$HB41*(O7=-&KYNJT>MF[QHXPNFNV=(IN&ZR=_P >"J*N
M.::F%_[<<\<L;_VVH"1N#@]0BB<4X:\5=EC7BLRT%K$@\7-RE-<HPC#&.FEL
M,)*723LH<C6 @OGX)/'%-*^3V]TL,<<4[XVM:U<K9I6\I'^@N)'L.0J@ \QG
M<_$CX*+DRZ'#B(?6R>1+/9NL'R>?AF>43FF9)JV7QOVD\KIS,?)R&6&&75>U
MD2C9;Y+=E?&_RUS"LF'/@=Z6X_E('NQY*.!OF/KSRM!_X=7+[67\IH/GY/D6
MJ'_V&,;!2D*H1O;'_N\5.H_+ RMKVM;'/+"'(V[-NJZ>>/X-I^\0N_O*=OI;
MC/P!Z^/S3A=X./K_ .9PN8[CG?2Q<?M=2)[M*6ZVE,*R1;"'FT8,-"7DD?5(
M/$&K1TUP:!H@L/\ ',\O@_(LZB3GQ15VE=)PS(JLW:?)$VDD> UK@[F&N)P<
M;XYN!QSQG< \QE0>,#<CIM\>7J_S7*>(W2!;HUT^E&.S$-F[X@?B3==PM9R\
MD4@AY55U;Q=]\.%,7*F(H@T2?H9BB)%!ODX;MUQRC;P+Y-URSTT;\<'!&[?P
M #AZ!C<=0/2H:XC.<D?#U_-61Q3I3>*,ANG@9*3>"*Y7MBIC*8<[=X)9_BRM
MDI#W,J_!ME\G;RPPZK?+GCA\MK=1U',.0:[]+O\ B#5;C;YCTCY94F8GRNXU
MS?P6,<W?K=RNOV? L7\H' 2:M\OQ8IBCZHPEGE_YX8M;Y8_BRM:N(PS-YQO]
M321[1D*P<#R*[RT>-'[=)VQ=-GK1;&V:+EHNDY;JX7_%DDLCEFFIC?\ LRPR
MO;_XUQ$$;$8/0J5[-$2B)1$HB41*(E$597-GHI^.7.29Q_9$]*3N"ST**;1U
M](]?$ C7.31UFY<.63 ZP/@CK)5X,S=N\!A=HDT>IH./%']R3-H.;LLQT[K:
M[:;IY:2F935-+(]TK8:IDA[F5P <^)\4D;@U_"TOC<7-)'$S@<YY=IWM%[$]
M)]I%QI;O<Y[G;;G3P,I)*NU2T[#64D;WOCBJ8JJFJ8G20F200SQMCD#7\$IF
MCCA9'#AL(VKT+TG:*,7LOW5T:TQ/HI&\7R29G8W%^4'G>"2IS/(:S:8%X49(
MJ^&=>*LFC-V]<9-_%1LL5:KSSWS)1=H4+@YL%OU?3Q$QEI,='>8(FDB+\;G&
M.HC:,-XG.+6@'B?!Q"EU^R"]_9ZK8W1R5^HNR&X536U/>M%1=M&5M4\--23#
M'&V>W5,SN)_!%'')([N^"&O=&ZZ7M1:61J=Q8',X:<&2:*2@0S.1Z0!G:3X6
M8$$F^#IB_8NT<LDUF[A!3#/#+&_7;KOCG;'/'+&VM)X)J::6GJ(WPSPO='+%
M(TM?'(PD.:YIW!!&"OIBAKJ.YT=+<+?4PUE#6P1U-)54[VRP5$$S0^.6)[20
MYCVD$$>@X((7]B/\U8U^8 _^7MZXW<SZ3\5V6\AZ!\%YRB+1J;1XQ$IB #2J
M+2%@N+.QV0C69@(8'.<>PNR)#'Z*[-XU5Q_+1<(J87O:U^KKM:]N6GJ:BDGB
MJJ6>6FJ8'B2&>"1\4T4C=VOCD86O8X>!:05QS0PU$4D%1%'/#*TLDBE8V2.1
MAYM>QP+7 ]""%1MN#C)NSHP&T[Y-<%9D@5XY@FY.=;JX>;0.O7$19A&*=W9^
M1:FD;U5P]!%&S!/);%DJM\+Y>*)X9/)DVP'1%/;UMU%:.T#[I8=94KH[Y)P4
MEJU3;H6-JGRN_##3W*G8&LFC<\AO$!W0+R>&D)DJCKBY6JOT9'5WO3U0)+3
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M):6Y#)3+:>9-M%B6T]EQ4M"]A3EH;@.3O9,!%);! VA,>&QUZ;7NLSC16!V
M!P<]#D\L<AOX[*RCCXYV"MIK7C7:@"71_8 6+AX[*;3DA!R<G/&(^/;"7TO)
MN-=RV;Q7!67.6BLALU8R-\JTL0\7=V1<)J)8E!YG'U[5[&UM)P[<.,?4DA+8
M0 I%EB2H*0ZSVCL35,B9I&4&[8P/7+Z\DL;=%A!-%HTR=!S61$9B\9#BS9J@
M8%C2#0F<>O'@#R]/UX<ER,_P<X[2$#'X>N#G@N"@X$)U<[U]'-S;ACD!FFO
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MKW(M VIO;3.C6P-YN+:$'UFVDSUV.CJTTD0V/X&WS!KX\^:#+D%T;O5V;/\
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MI$C'(],X88F+T"%DP(L2)CZ]6?H^*\7W.?3XH<<(&Q$ZC*@B.P*9L1\U81>
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M<Z,R-<8,>4;TNG_X=FM/O):V]\ZQC]L:_P#^Z%%_OJC_ //6]_\ 1M]D#_\
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MR9ZI.2\>C,:D4YLXUG<GM[5Y#4L[F[-=,8V6B"+#;D5A\RE0)]8H-8)L4&9
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MC[,.FQ/1K"2$29.WER]P_H%^,DX<3F>Y;!>;)VY!)T7F$XA\L'NC&F)#B.2
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M'6 P3K)N7'IR4H7417,O6KQ4BIXT0($R2HQ%^*1[4\78EPFS1,9>);*@@>)
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MD /A\>2E5!=<(0Z0;)ESPLM(91LV68'2A5RU3:V&  PQI'X7"A"-EG2C8#&
KK+)Q='QFZ!&7'9E+<&@YS*7C)$HZ>7U]>@+I=$2B)1$HB41*(E$2B+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g377019g01g03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377019g01g03.jpg
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MU-;7"B1"87.!L;@E,Y&AM31#4B8UTE2"LL'P_\0 '0$!  $% 0$!
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M,X#_ .6:?)">'Q\Q;WZ6\U?YAZ>Q_P )^Y:O?#$OVRGU:GT2?\83'Y&<!_\
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M+!MFVP1[D.['UZK48WE,@7^(1/UI>T+[-OG!6TL4J4@VCUIJ%5.=GY9)OP^
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M5#=RW95(<HJ87KN0#,58N1-3_;DJ[C$'*01)9DDD$>4CQ44F_ML5B& @F<G
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MZ95(N3V^&KM?TV2$7(DJ S=>>SS=@F:*-,J20QQTXQN+A )H%E#&5$CE(#%
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MJRZEY8=1=7:E*N0%@R;=_,4NVYEI:0E*DD)$6O>&OCVY8Q6SNKVPNL/QO@3
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M>9_5Y=YZ S6G['X^/B 3A?\ PQQA&G\G,0#5O'#MR/6?DQ"!]E]HM(=90((
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M)DI@R3O_ $Q4T)GNB)Y)B*/F -THQ2J2A6P)F*"":BLDX*"XK<*'<*)*)BB
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MF3)#+0DB- X_'HUUY[UYH !9,QSN[P^EJRZUZ9M65%32E-*4TI32E0;\*/\
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MKKEYZC<<M"#R)/3;G46D()K*R+!#LMSKF53(4) 5722J97":A#BB@# Y^%R
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MW\VG2?3\-2IQPGQ($.!"E,6.=$YYZCE*<[4_28>"@("!@,7T*(@(#TZ\X\+
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MZA1  ,10<3XE*)#"!S 82E(7WO=YY] XX$=G<?OMWO;;_P!H_7G*?WA;C_\
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M-?G%1=4<RC29BU&3N.:(\( =1V)3D3Z7J"SKJ0*L4RA/)(KJ"F4AS HB@H'
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M2 X2WF*!VI@)9FL*%LM!GI6)E3RQC)&=*%5<*?ZFV !!14ZBYQ$.H"@(F$0
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ML05=)K'.)MS]D[2JOI)J9>#=OX"405C@.63;;^TP3A_ K/C7#\;82_A%QB^
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MK9R=H1*V#MLE%DN5$3&7DFSA))8"%[C7EJ51(3 =<@K*$,H*1$4R6B251L!
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M&,LR*V%- Z9E>X<B9]Q@V!8MCK[[6$6PN'K1CU4^3<VMH&60XVUVI=NW[=L
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MI*DX3::) EQH.R( DAW.F>_).HW)FO'U8YC"PL'$[H2<TA66-X$HW$QH,H^
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M+/(.V#=1R5JV?I-7)$!Z7!',J72E!1E!E05F)5F$%)@:QKE$Z?#49;!4%21
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M!@Y=ONMX/?X<PA2'+?U'C]\^5$!2EI<9OF+@,I"PG+_A-TXL**I;RA*J3IT
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MW35CG[FY_H*_U37\TJ%BNLW84;%  Z0Y.43#W -Z'$_)0/[I0YZ!] 'I$H%
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M[HCUO3*>X@[2)&G(:\@>@'PU61J-9&XZ3MI'=OT'GKM2OXA4Z0D/(LB D'?
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MDG8?I^?P5K!CE]X=TV*_!F1NJZ;)*G12.1(B:JI"*B*P&='*4@&$>LB#@Y.
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M'D,J/AMY[,NBH]FL41B15"*'!Y=7+@P]L_<.0WLZ'D ,)Q 2 !S@)E.V/3T
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MDV$[.(0DPW,"*I@40=QT@X(H14#@ IIG)VQ1)K6XG;(&'WRAF/\ @RS!).J
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M.VV^W?5.S4-E ^5/IV(W/=6G;QX"N\3#&/8"$Q7AK;7DRU"/V-3V2,3Y5R1
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M@0  Q0 ON$   I03((:Q;<E25.%4#3EI!C7F 9T/*0><U(I,)CH).G/KS/\
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M!@$$]CU3&75 J+)!2<7GEU$TA3%;N,4@Z^LJ1#EZ!'96I24:GQB/M<A@^1*
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M16X21&H($B=MS.D@'4Z=-R*2!^D[:<QTCS5LW"$@O]MW%A3 8IPR?C,AC%4
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M1W==)U F)T)K5\3NWIE#A8Y[=KU/QC24M\F=-=P^?0L8RC/;C;AO*QEQ*,N
MR;B310%0\>@\5%9W(NU4@8R+AO!=K39J96I #+JRE;Q4VEMA&0D..$J"4R<H
MC,9*O%Y5-;I5<)<"%*4MM.9+9"RMTZ%2 D JE*95H-!OL8DE<+1'YBH@2=*F
MHAJN6)0EV,DL6,L["'D4Q579K*F!N[C7PL7D>J14&O<,7MJ>X7K3ZK[9;;[2
M'4+0ZE<PIM04@ZQ (,&-"1WQ5'T+;66R@H*#LM,*B!XQ!D@;P-#IH!K4#=X$
MU@3$U<IV>]RLA>Y1S5%*<PKUNJ1O(14S.62Q@HS2)%1CV)3=KL"H.9UZU1Z%
MF]?:JK-_-.^AJME!U3"")A,PH?;$_P!AZ=]83ENTZXVXX"I:(*%C1,SF&FA,
M:D 3/>09G!CG(<3D"&HV8L.V!&SU:S(LSNY:74F$',A$0C><C42%;RHMW,9*
MIS*J[&;!^P!P\.0QW_<5CV2R42@O,F  -U<O%4 1&QG4$0.6X&^:TMA;2UG.
M5.('J=8/B=HEP)*5CQB$E.8%2B@I5$!<R/Q?+<*METB<B]([O,.R &,$UB6X
MO_8TXXD$HX[-5*S*^<:E<1SHJ[X8D5"@S>'!L0Q3=NJFR" 5))@&9'?N,NDZ
M@"8/.H>TU&D!4E*<IG<@#-F/23IIYS4JVMWAY"0=1+=V"DLRCHV5>L^E<!;L
MY95^W9JBH9,J)N\O&/T^V10RJ8MQ,J0A%$3*6@+TZ3&D;")_/4H(//YG:N76
MI0KFZOV8' 3?8RW="4/Q%E5T@'_EU@'KR(<Z@>.L=(\L1U[^>GGVF]'MCY-_
M./S5KG(SMS'W%]/,W;J0;QA(J-DX:--&O7Z!SLCO3]EB[3>(-U2-WC%T91VW
M!=8CU 4TCHD26#5O!)?!*@"E.OBMD@DI(G,"K8$^338BI25A*H!()D".0B3R
MV\O,=]1TL&4W*&2G-=:TN1ML4U>-HA\JYLM4B7L=(2$ PEBM9%1E(&3:E<L9
M)%Q'$",<+OC "2"?0<ZJ1VW=&1XLN=DZ"A#@+<+6G18"4I)3!ZB )@DB*J%)
MDC/!&60)TG029YQUT[N7ZI+HUZ:3?PL0U?-F3PSH:S.6.4ZV?>023D%$3,#N
M8XPM6[@X*+-RNSF3,HMY0A (<T2$/,K2I* I("I0MQ14,H)4 #I($[':(-7J
M#>2059IW@]\?.(T,]#WLOCEM:(A6S4R)BPB9M@\?.8YG8IAE(L%%%ER%=@HI
M$H>:;JA[@=E I$EB' $D4CE($Q"74%:="H9B!H2F1K!W@]T_"189$@@C3Y_W
M\ZU?AR/EXB_I5&3@8F3*>9;MS*R3Z1> B HD!4Q'*7=5$4P 5$A*D@FDH4YB
MI*& Q1-IS*2G[:>D3 F>G+;OY:5#(2HQJHF()WF-=AST_36_;!&OK98K!/LZ
M]&1JH E&1I7*#XKIV1%R#@[^2<.G:BQRN$BMSM')FRCQ5)0%3<%,<@X5TH0I
ML@ AQ#C:MQ+>:)&Y09@C?::RFTI44E2E!$E*PC1>4[Y3.D$"=1O%<I.'G(V!
MD(ED$7*&=*F=-HN;06-%-7Z9RF:J*J)J.%%VB29E4U&J31!510>X5PD0>WK'
M:?##+A S'.2VE1$(*H)"NJ<TD1.A&DU>L]HK[C8$[RD"$Z"#[4">1,]\;#PR
M[N:UFMZ5M5@Q1+&5\T&V@U'Z+9D@F5VE(MR12Z";)D@5WT>6606=.W2 )>=6
M 44B%VED\Z\%+=RS"?:E6768A)@)  TR@2-]:C<" ?$CO\L $[ ;@_V[U&K<
MD]S!)WB[0-7C\<1L8FSB4:_:)JU64DN@HI7&#I1>1KC&@NFP$;RSIV4I6=O$
M'3!NT,)&3E9SVIG64.$]HHZQ&0',F -21MJ#.HT/D)JE82$Y1D4)S+400N3*
M1E.AR@$1'VTZZQ7/*3V\BA)K5ZU[^<78_%Z_9S0,HG&ENDIE./6.[1;H,C/<
MRQ38D6Z48/2$2<P3Q$569BK"OVCIC6V0TROQ0ZZ9,R2=@%$>+&AS ZF8.\[7
M.**SXR0F=1( )!U!   UD#0P!H!I6=W6 ?5BKKA>\FVS(UBB*9+3=DL<;5V$
M;99A9W)3+@SUDSB[?7VZ+QJ1^R0C&+1HFP#V69P\?JKO3)C(MBW6DO*0%%:3
M$#-,@Z@!)F!R(Z<B:2L:I,!)@@'8@ZZ<QIRUYUI._7'$E0QIBJ1R/ES-]999
M27MPTFMMH>MXSF)"8J4N$>]83DC+R[YN3S#L[=6/]K/7T>NT<)*E5[:@=4C+
M#"4P"I'B@P,R=)^Y$#F#E(3U@&K2XI1!5)(W&W,:F3Z)B#&M:7Q3 T?+VY#)
MF&7=.S16C8]);+)#95#+6-)R2MKK%F286K.&/V,0E!:RU=3FW*XJ@WE)$#NH
M_N(%351=>:3HZRTE)44DK2?%)((*N_G$'4&)],$J5,S&X'?L?S<X !@CI4W*
M;;6]EH6W".F]K>99#[-+%8ZXZ6R+!UUI9L"0L-[1.C/7I!D]1:1$78%XUJK$
MEK[0SA49!L94R2:BI#8I4M0[-2D@)]J DA$:*T V@S)(V$"JD$&4F#S$ @^6
M3I'=UTZ5DF2Y?;EBVMMVF36;6I,9F7AJVWD6-57L*,4XF$SJQ[D[1M'OC@+!
MRD=\X RATG1&A6I4_OOEU\= ;4I>@#I *BDJD#H$C>.>X&O?5YS>*I*E$B1"
ME$@'H,VB003H- ==Y(DYLMR]B62SAGK;WCZXQT]/X:%1E;XAC3#5H(B2:SZD
M6Z*#X]7@BR)$G(BW,#5X^;@8"J"(F$JHYK:4) "5*)RB<PCSQY=NHUJ%87)4
MK62=1$;DU9IJ6K*KY\.[]5OXI/[^6)_Z/I/7I/&?V*>#C^1L3_KZ*XGAK[(.
M-?Y2L/ZHJK=M>;5VU-*5YVMW3XB.ZS<$F"A4^B\T[N")P*/4.WW!)R\#R
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M_I,XEE/9EC.4J:;S*<0V,S@3*^S4C0H$B)U@#E-6V,SF!8@<>G4(<"/P 1$
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M%I\ESB7Y_P#>A_.5MG]TT]DS%O</A'\GK;X]/I%PWW3XA]^'OBT^2YQ+\_\
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M+?J(O7<^]!TKPDR.[1:+"[*(8C-O<$)2I2R-8!"= 9)!/68V VV-7.7* %@
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M!3+*$(4R[A4J*")3',4#*KK*)HHD 1,JJ<J9.3F !SC)R"#).4""29Y^;II
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M2;M$EW2ZA$R'$$6[=5=3HZ2)F4X#6X=25Y01J9@<N0UG0$D]=MX@FM0E)4H
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MT<)6Q<=7&?$:KYV_5B"RM^T78NVI0CUN59KL_4"K;UOCU(EKU, D)2T,JP'
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MCS4!H2=3YA7%\'C(]Q6TG1M'%>)*0GDGM$6ZE = 3RV'*L:MWZ]:C_!GI_\
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MI"AR(@&O.?,3W#4UVE0_F<TVZ3(=NY(T8ME!.)4D6ZB90*;\ F4.8RHE3.
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MN6C%$QU>7"?(=M9TH<IS(J$*JB1%/J IU%"!SM^^EQ26T*S);))4-BH@"!U
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MIB"-=.?IJEP%I)6D%23&8#D1I)[A$R>?,3(C<863]R3S).QV4BK$5[A@Z0.
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M]NG"Z\\T2J  %*#KB#E $$P 1XPTU[ADYLSTRF('>9)ND=76KUV@P9*V!V9
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M2(8W^WHQ2B)D%6XRBST%0$Q?]7(%C0ES=!_<* IJ@/(<<]( (0+<2E.4J)
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M43'1<-G*"B:R"Z1SI+)'(HF8Q3 (^:N-K:6MIU"FW&UJ;<;6DI6A:"4K0M)
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M*-?M4F8_S020/15+]GR-N)9S],?M[5:Q@$LY1U0GRF1;-6BL'%7BN4VSL7Q
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M1=K5"D-BV"4RX<P<2^1*4I2$:I(*BM14J#XHU%0J*4Z)4J<V@GQ8&X(/W7=
M&T&16P-I^3<D;@,S1&1;E@VS8>Q_ P]E:+)3-7JV%EW%Z195]5:3^QVFSTDC
M)Q)H$LDFJ22BTA5>QS*19OSG,[9-XV[:Y;0\TM9=+SJERH+F"0&T#Q<OB!*4
MYM"N,RO&)-7+4A79G*E&1L).602009F=.D':#KK-6\#E>$L\ACUS5Y$CYFQ6
MFX\[@HKE$7+$&D<]15*X214(HU>IN&QP,0H]Q)3U'XZC7F6ZP! .915.@U1/
MMB.L#;?70;VB<JIV)'+7<:_FYCGK6>X0K\^TR!D"=?)$",DG<R"9T6\B=-)Z
MZD8Q^DW6?G8$BC.QCU$EE6K22<JI]8=28"184]@TTI$K.2%"!E5)DF3(@=-=
M3&F@!UC"@24B?%)UY?,Q\'=4J-356H%^%W^FWQ&_X0#+G_PE4UZ-Q]^\N ?Y
MCX5_M;JN,X2_?7%W\Z;_ /V5O5G5ZI%4R73;1CZ]0;*R4VYP4G6[- R*8J,Y
M6&EVJK-\T6 IB*)BH@J;M+H*).6RP)N&RJ3A)-0G!6=W<V%U;WUF\NWNK1YN
MXMWFS"VW6E!:%#<&% 2""E0E*@4D@]9<VS%Y;O6MRVEZWN&UM/-+$I6VL%*D
MGF)!T(((,$$$ U1S"6W+'A4ORXGSNPN&5-C 2 M\,[CX2,>6:Q81AGCD?)XX
MS5$Q:"TA["AA5(TK]F8M3)G;@@SAVKI%<E8I_JMWAV&^$I!Q3!%VN&\99 K%
ML ><1;V^,.I3X]_A#KJ@@/.QF?MUJ!S2IU25 W%UP-O>7O!*A88HFXO>&LQ&
M'XNVA3SV&MJ5XMIB+: 5EEH&&GDI]K"6TJ!#+%G.-<P8JS)!H67%.1*;D.$7
M235!_4;#&39$ 4 !!)\DQ<JN(YVF(]"[*01;/&RH&1<()*D,0/,<1PG%,(>5
M;XIA]W8/))!1=,.,DQS05I"7$G=*VRI"A!2H@@UW-GB-AB+0>L;RVNVB)S6[
MR'8YPH)42A0YI6$J2=" :V/K7UF4TI32E-*4TI32E-*4TI32E-*4TI32E-*4
MTI32E-*4TI32E-*4TI32E-*5H'.&Z7;[MQA74WF;*]/I16Z!ET(5[*(N[9*=
M)1,5&$J$<+NRS*Q_0 +'1;@J8&!18Z20&4+O<&X9Q[B!Y+.$87=WF902IY#2
MDVK4D:O72PFW:2)F7'$D[)!.E:K$\;PG!VR[B-];VT"0VI84^YW-6Z,SSA/1
M"#&Y@:U!VD8RRWXG.1:9DS--#L.'MB&-YYG<<=8?NC88^_;E+3'B*D#;\BP8
M'.6&QPQ _FHZ"<F72G$%C$0/+LI,9>,[UZ[POP=6%W883>L8KQIB#*[2_P 5
MM%=I8\/VR]'[3#WH!=OUQE<?2$EE0DAI;8:<Y%IB_P",[NWN[^V>P_ABS=%Q
M:V%RG)=8P^C]RN+MK7L[-,YFVC(<!,%:5YT7GE*4A2D(4"E* %*4H 4I2E#@
M"E .           #@->2[[UZ'7[I2FE*:4II2FE*:4II2FE*:4II2FE*:4II
M2FE*I=\)3]1^T_?DSO\ TI6/7HWA3^RQ?\DX)_NVWKB^ ?L>1_*&*?UYZK"[
MD FK4F #P/#7C_D^;#_[\<:\W5[4_/YSM7:57SEF8;Q=OATI K-5F^@?+O4'
MI#N$G3<SQT46ZC4043714145*JB8A@5(8X& Q0Z1P7E97$2="-9 .;4::@B9
M\8&1[63I(-0"=MS$;3SU!.T17G^VX;%LF;?]]N8-P>1;W6XK".1I2Y&KT'&R
M<G$52>6R%:/*U.K69A*Q<(9ZK'G<1B+!*%46*P=-6K<C@S$OE5XD8JS?-/6U
MLYG5:.):?2%R6WUI0M4A))0I#:VUJ!^U6V<Q)($RF2T$KTE<@Q$Y1$A1VC41
MKS/45?"UCD(Z]T./9H#!.266(F)EJ0JQX]\ZL%.FEI]$XI'65<@U4<NCMV[H
M$&BJS)F7S($;IMU)GT(1=O@) Y""2E4*(*DYI,$2#&D@Z5 V<S25E1))F9$'
M:!ITUCH(Y5@NV2.QU-TRR1S&S'NUP3BI>MWZR-I&73*Z)(VZR':QQHUVDVCX
MU]$MV)(OI8,4.VV9H@"9$3I -Z0VM*TI(2H908&OM1/7F9Y]XWJY<C+.NP^&
M#T)[O+Y:TS;I)_6WEFK\;/H1:2[B>K\<+X(TX"DBJZ8 FLX>M5DC'*D)15-Q
MW3\&,DF<X=&M,IU2'U-I(.1:D@G38Q/*)CGTW%2!&8" 1(D<A,<O)K G2356
MNQS;3O6Q#E$K[-V?%;UB&IQ&-\<TPE;NSA>K1RE]R@TY@$H]PVC9V-L!))TZ
M:-Y5>(69K-K \$))TFX<H-]@YBMJY=MX>G/ZH*#B*VLAE+"W4L=JA9&11"UH
M!;D+"5I<*,NXLK"%+&AU29WS 23U*8VG>?)5OF29A*$QKEYBX2EHHD6^G92I
M3DR[;2XMK"SPXH]*D95B]6D#-O9T5-J297+/MNQ4<I)(R'G"LR=!PNTU>X_@
M]F\V^M-SB%HT4VSJ6;@A;P$(=*T!"S RKSH F9$2-3BRUL8;?.H4@+:MGE@N
MI"F]$2"08!&I$&1,::34./ VOR]YSO<9%VR9-';_  K=EETF2HG21&/R!B7I
M*D3M)%*1;VN8PD*FF5'LD*F0"G$I/<?"+Q _Q!P#@=X]8&PS\1.LI;+SCYR6
M-E=M-J4XM""I3@?45YDA6="O;#6O/>$L.3AW%.)L(N!<(1A8<S]FE&8W5TPN
M01J0@- :$@Y@2$F <+\25V=MO"W&ME7HJ$>#C!5JBT4,H+04<18Z [1^'<(#
M<5>VL[ @%5$R+ELI[O>$2]GX+4NW/"O#2F2T6["YQEN[S.N(<"G;VX=:;2RA
MI3;V9+X6I3KK?9C+D#F903J>.K9;F.LNH"@MIZU=((:"%VYM\CB^T4^' M#B
M$);0FW=#A[0J+80E3E5!I0S8I?4?@'PY'C_=_O\ _?U#]T->U!&:=M#UY^;?
M\U<]MMJ>\D>>(TGGH.^OK$Y*+7Q6CTVS\'KUVD^3F6\W-QK=JBS(=/R2K2'?
M1QEG#APX(Z:.U5S^7*U<HE2$7 '+B7&&&[>0IQ-N[:IMW$*9<M6WG"Z5ME*P
M^\5H2WV>9*F0P%*7"RZD(*#DM.K:;*D+<2X%I42E621"LT(3)\520 HJ@),0
M5&:S*K3[JP7*$E7P#/,80[-!^QL%AMTFP;1<B+R-CE?)J6,53)-Y1X"\>S!4
M6BS\#=;=9,7/'%\?8E:\,\*XJJTN6,-Q!]L"T-LS:MW#CZG&B\ &V4*)5;]H
M5."'$"#G"HG;8+8*Q;$[5-RP;MAM65XO!Q24M"2A.:3XJ7$H.I"22-/M1KR=
M4R']MF2JEZL[_'U6N:=JDD)6*3R+$L&3F(C6K.#@V+2<F6KB6!0[%Q*IL&JW
ME)B+9NRH';'5 4/C6V[1S$+9QZ'5+O$**UK\9Q1<0D+=425J@GM%DDA7C QF
M$>Q%(1:E#8A"6PD)0E"4C/(@)3! $C* 8! D$),X-;)"V"QA']EE[4_;$:&A
M*JG8Y68?E:P$2Y4:M6T02833718E*1OU'; 1J*H@ IH"?RZ/Z 8'8X9:.8@+
M!+(=N;@7E_V;;39]4NH@YTM0D*"$QD/C>+F (4%'PRX?NWDVR;DN0RCL&@J2
M3EDY05'*4F!! *23 @@UU5-D6;Z2;B\F(]GWEGIVC5>5/$N%)-LG&IQ@'=)0
MD\F8SARY[J2;EHBDZ08N6_G6BHD,$7%-U>6>%XF+*QNG'T6@R7#=D;QE0?:N
ME.96T7=HL%E+(0MSM0&5OLJ"7$DI$F&L-NW%LIQYIM"W)4VIU+*P4.M)2DJ+
M+HE948E&I28R^V,_,&+Q*V.*C(9 L=>FY['GV$W5Y$0LM,2A7MW<R)&<S*3$
M6CWE'K90\@H)4G *11E@0!L@D[:M^?@*_P .(?>#J76%/W-\RY;W*2VXTIDH
M=*G'%!30!+I24]J5)*#($IGV]#_BIRID);:*5)(6E68N E.424C*(T',ZZ5Z
M2M\%UL%6\.BQW6HSDA69YM1<1/HR9A'*T<^8G?V"DI'%HLD8BB)56[I1N8GH
M HJF3.40$0U'8)1V[:% %&528,$0&R!R@QI!B.=2N$Y3!@DC4B)DZR"4D3TF
M1TWKQR;BMR^8D,Y'AVF0[*C%LLDPCIDV]J.Q%26\]%O1=++D=$6.X4>I*.57
M2XJJ'6(10QA.!1"2\>*7W4 @))2$@)3ND0-(V/7^ZO(',8O_ *9[BV.(7@:;
MNG4I90Z0WE2@&,I2H#O"5=T$UZ<,"9^B+OA^DK,B3;&?;PD4VG3N.EVN5Z1L
MNFY6).NE1>R*;AVF=QU.3]P $"%(!0XUS[C3N9O(XOVKJ5)A&0YBA4K 1(*<
MD((@ $R"0#7KUD^'+=M2Q)5E<),R5(S  ]0K,3N)(T(YP$RK?,OW^8R@R12A
M*X V2=BJK<P@ ?RK.HQ.0JVA//G"-39/K+(\G,R1;-3(&.\?*I(F4;IK'7)"
MVZA^Z<9#A2VDG.?^S0I,)E0RDZA.P(,SW5E]FH-!63-"3"A),*4K<F8&ND\H
MKG,)*FGC6$%*9JF458PK5@\6NV/+3%%F4$T".6<C'B[DZ:5N#A)$J1XI)=^H
MDLAVA>OCJ+N J+-L.C(M*E$0%!>4P""% %M4$_H/.(N"U@$E),B>HU_,.[YG
M2N9*_5<7;?<\[BCTJJY$LU"G2L$RW:B9-KTG+JLYU" D(T)*)W /)%7VI(6Y
MA[-L2;H[%!!!T@M%H@+I9MGH<>;)3G22DE0SA*@V"02/%"095*I5)G:-JQU#
M,I)@@]W.>?*9'?R.U0TV+YASSNKR_)S.)ZH^P13*\-#A+PE7'>1)2FRTA.S\
M75F#-123^V%-&?+1J[<L@C(22L9[.9.7JSA@@JJH%X4/&<5"EI/BA(B2=M)D
M$F(Y"-M*N((D1WR1K'EGEH=-_2*]'-)G5T("NO71$ZP_4DK[)!&/W+9)<QYJ
MT/))%NB=0K?S!VI7 HF,B!BBL@L4  "B :M)4%V\@^+G!D25 DR28 ) $:B)
MGH*I)B =!!_3UW[@?-O4]-LN07%TF+@V=1#F#<19EDG**$]-.H69=-W+6-&>
M;P+P?9<:Y<LV;$O?;&<.%2"IU+]I00-MTN9]A 3H(  /?  U T_740$*5J25
M>-K&FVT '4R:F#JZKZ@7X7?Z;?$;_A ,N?\ PE4UZ-Q]^\N ?YCX5_M;JN,X
M2_?7%W\Z;_\ V5O5LFO.:[.N.[9M)!HY8/VK=ZQ>MUFKQF[02<M';5PF9)=L
MY;K%.BNW72.=)9%4ATU4S&(<IBF$!N2I2%)6A2D+0H*0M)*5)4DR%)4""E0(
M!!!!!U%44E*TJ2M(4E0*5)4 I*DD00H&001H01!&]5SY'\)+P_\ )<VM9WN
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M\)(*3K:-C8\DA'LI]9LR,J(NU!(LDDH2%%I"''VY0IRX2,J0!JDMA2U #64
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M,L\,X:1^);1D:?K=_@I:L2ZCF3R6TIT?+,)"NNSPP&@X@:JBZ(L5R5T)W!Q
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M>7;IMW&'G$+>+?:-..)="84AQQ3J1 3V<*FL=+!?N#G6E#+;@6SD;<,.(3"
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M';*&!$D+'1L8@B/"3>/9M6!2@ !P5,J*!4TRCQQZ%$/4!X]-9 .F4ZI2-!I
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M2D,!S /2(B)CB!:M^*I*I$@Z:$".>\=TQMOMM H1(UVU\^G*?*/1KSESMCP
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MYC"7PK8<.[J,0RQI5O/9,LT=DR!N>*X:'DHU&2@%(4H._0N?H_3\]_1S^)0
M4DQKO/+3EH9!UT$&3$Z;:IVK[_[#A_*FU:R;Q=P]XKN*KI@GQ)6<V\R&]M\M
M!3N2:=XC9:IB'VFU:L)-16=K^((F<@:@Z=-RBRJ#5PR9K%9F(0]"0-R!Y:J4
MC*8&LH\OM-=/](Z]]<7(FY?-CN<O:.5=PN?L0;+'WBL;F:!F7<'C5W8VEPQ=
MAV!VYXJM.W>@Q-V8PD]/XEPS=,H2TFUG+E 1K$D8[.UACS]?0LCYT>M!U@3E
MD Z?;1/0D#6#ON9BLGRSG2G,I[:Y7;[OUWM8\\.B:VZY8LM!W<1CF\4O*6:=
MQ\5F-["Q=*RGE=CB&/MXQ57QH"TIB!@^JL+'9K123E74MD([)F69?/Y_W\_)
M0#> ,TCQ=Q$;B9'EUTG2*T'";I?%8BW^W3*!%\FWY>B^'?E?+F=,$SM;<5"Z
MYQQ<WW.VW&U+RO#5!)!A&U7=%'X5<XXS0W@B-8^1L*L98*.1&/7L2<8"A"-1
M('C:'>-/*24SI,]#/(S'RGDG=_:?"-\,&=Q)FRYT+=#FRW>'U69S+DT$K.2+
MFPY)CH9&QR.4&1^IY9:U*S;E-S?HJ4*JE,,!>H/DU15$AE $YUR)2,Y F-IB
M#^:HW$WU[W;KA#>G2)*A;A*3NUS7O>HFUG&^(L?.&MBON#(6$VVXDL6Y^X[?
MW-DGZ[6C5>!@JQF#(.([4ZM5=@I*?N-$GW<VQ<3)U=*0F4Z@C*2228W5$QJ?
MM00!/YZ_VWW;>(SD*N>&Q&XI6NL;NKP=(;PZ#NTP+DE,8)IN(MFV.E8L?)TW
M(JS&1F:[%7',^-)M*Z4*W(2,U7JWDB[MG$=).HEH[D2J0!FG8@$$<LVL\MMM
MO-K6N\7[M<FY'QIM,L6]G<WN_P!I.U7(M(WNW'[:]1?6VE9)FMPT)O9R?6<;
MX3R]D:$K-QLM0+CW K9@I0* H$7$724CG$*=Q8DZTP@%U(W@ D0.Z(!D3$R=
MST/(FL]NN?\ Q*ZGMDV2Y.-8,QR>1]Y>/LT[!FB<[#.ZE)U7)64,MK#LIWB7
M"@-$H]G1LC?:5AK'9[[)G91_94=Q@2;9H=-)@P4A,JT&D'16D :@$G620!K.
MGFK'X7<!OYL^VW<CD*]9$S-2[=LZN.Q3P\G!XB8G(Q+*F:Z7OBQI%;H=P!D6
MJPFEW.3<56+'D,:Q) J@ZJ]BN3,BB;*2D/,*K"<PT$$*5OL"DP.4$$?F@\SW
MV$\P[RU_$9C6LMD7<?6L8V_Q*-\F+T[CDO,@6C;';<0XD-D(\%MUJ.%3UB6?
MT/)CH5:U(XOMTK9:E#2<94["RK)YY\B6)"GS_N_MJV!!VT2-(,R8DSSTGF1J
M-.=;#\ +<!?\U$25S-N!NN3LLJX!;3DW4[CNQR[E^73<&MU=;6"Q6/!]VPC2
M*ABF;C'+B"C6[BNY0R&Y30G7\:01;/'#M-(.Q!\]57 )@&)^Y &D[$$R#WBL
MMKN^;<X[\4-++3VLY[)X=]PRM.;#*[,.8:"';P6R0SYK7*QG6*=(VS[*SW:Q
M[I(:\XC=6%U1D*:MBR3K#].X.G;-&,3K5(&7EFC,=Y@\M-(B%:F9,143=ONZ
M;Q/XN8V1U.W2=^RC4\Z;I-V-VQ3DMR_E6B$C$XXJ^[JF#M/W"NE'""[N.;9
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MTI3@ XX  X#@/0/0/Q!^(/0/3X>FE*=)1 0$ $!]1#@.!'\8_C^ ?'\6E*_
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MK$UEJK!(4&L6R29R-LAZ>Q<SC\B2K%1IUC74'6>H _3 @34;L:R6<LE[)?#
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M%!/5,&OYXV5F3*.OMB9Q[1JQ:(/UB(M6;=)JV1("AP B2"!"))E    *0H
M!P :^X,,6MRR86XM2U% )4M14HF!J5$DGSFOE>]2E%RZE"4I2%:)2 D#R 0!
M6O-9]8M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI
M32E-*5Z;_ HP_B6\3TA,W7%V.KA,0L>I(P\K::36K!)1,@@=,4'T:^EHQVZ8
M/$1$12=-54ETQ$1(<!U\^>&/%,3LVD,VF(WUJTZYV;K5O=W##;J"%2AQ#3B4
MK0>:5 @\Q7L7@VL+&Y<<<N+*T?<;!4VMZV9=6VH$0I"EH4I*AR*2".M>M$
M       X  ]   ^  'X #7S57MU-*4TI32E-*4TI32E-*4TI32E-*4TI32E-
M*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI
332E-*4TI32E-*4TI32E-*5__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g377019g01g04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377019g01g04.jpg
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M.7)XE[&R)"5!49C6V!E"15.3)S0U0T9D<XB1P=+_Q  = 0$  @(# 0$
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M#%+F9.E)=IDX^U4Y2>F)ZO(FG&V*&[+JF )=UK8$L#+AE ?[7LK=4M1:ML[
MY/%/2=B>G5;%+LIB:CR4SAFJT.0H> W:5+S$]CJ4J#<@M4_+32GEU(BH&;>5
M(FD)6U*M,H3-[6WUZKY8>VO;X3NNTV>-MNNIU)3_ (2_7'4![3DS5U5=F$Z)
ML:#5USIDG8<9UHU&GUWVQE8/U2+F0[/<ER#)4L/Q"%,8VJ'05TYADR+W;IC!
M\W7A4$SKP2B:E%/[*1**!;*'>KL[M*L$A*6VVU[3AV)K'&/&,0SLZBNRGQ%(
M=+])P&K#[E&DBX]3:LU)%UQ=501,(=E.T7ENK1METN+F'WV@VPG;[X43;=DJ
M&@A^E];P+B<VQVALJ-1UD'KB T7V$FD9A/'=RV2JB7IPQJ9.":W@F(,9QTH-
M8A%CPB5(GQ([;LAO@<&2++]454)M4NW(T9DS[SDVHHE3,!0;I[+RPE92ER;4
MVI0"%E3;3B0E1(![YTRUV;D,,LX>I#4_-5S&<X*%)RU);2_5!3NK5,X@G))A
M3C*7'):DMOM(4IYE+3\U+N+=;0E2QUW:N[7;]U[UQU[UJJ9FVZAW;K+O3I'K
M'AW>%("GKZUUSWL3L)/3Y^[5*42G0%D/=94<)+: V%M>44_+(ZRM9G9G9[7.
MT2ES=6FZP^VQ/TZ<PU4:R139AQJ6-6IB&D3[4N^$)6$E\*<276B+S%ULG9V8
M\IHN-L44K"5*PA(S$]0L1T?I)P[@[:Q)3I::J:<)XE>FWJ!-5&14ZXR7>Q;,
MLM,K-@D2!#4XDN];&9M]V>SPFOC-5;$W_1M<+'][^P_5J^]U[)K2I0058J^H
M:0$N-*=)T^;(BZUKUJV65,2*W"(&5Y B8(E]U]N;,2\3SKG#M&6ZN=E*7,S@
M5AJE5F5PZS-OJ=>?GYAR7F-B82%3CK$FAL/*0V.M<6X "E-D1R">D3&3$HS1
M*MBBFTDL])>*L%5/I$FZ1(-RTG)T*FR]0IRGI!U;=(E)ZL//KE&W7[RLNVPI
M2DN+"GHHHG?KL-9*KUXKUB[ :WTI2KSOWL_K,QWG(:ZKN:'L:G:)@B9.M;*
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M.WN-L;3J'?X<7@]N(>Z!1#X/*)LC7E4' :8-K/9ZP@3&PTHI]!&@R<@1BPV
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M1EL\]%4G>&,QW3:%*07<:RA9)"LIF9>QG.."TDW!KDH0H-A0/QQ\H-&[0/\
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M00YLE: FK!"R@W25I%-LK9))3<&Q-Q:,JJE-K=:?7@VMK>8#@8>4[A)3K(=
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MJ?0>3PQX0EI*'%/(KDHAU6UM.I^.$N*V_G[2Q3@H[7W5S\K?>)=FEO2Z)-[
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MI;^MJ?\ FZK_ (9#XYJ/X)X@_2<*_P"9H?&C>/P<-S_3G7C]?/'8I;^MJ?\
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M''9SR&_CQ%O+A$#:.M]1N&AO]5];>$9;91)1Z[XFD0EIL(54 &W7/=L][*C
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MHDJ2"=E12)%022+$I"E!)-MI5KGV%/115RE)5B4)44@J2&)E02HC-(5VI.T
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MT^N[/NT:._*HVL[%:WKX4:K8#8=P9"4PV<=AJ:%BS<N:X_#0RJ;'K$DKL;I
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MA.?'&(SX#TGV1.TK[V?[R?;&_'5VB4F@:1W =HNUJ?MVPVJXT6CWJ13AVQ!
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M%3&A.GNG?6?L#KN7KIX*Q.K]\]M%-QFR.(9!V3*N@Y,,<')@X\5)&1%_+7T
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M"LI](TI759"E-K\/,A2DISE.<9RG&?FPB]S_ +)__K[8WAZSZVHFLM/;BL]
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MM+V&7WFL+PAU:5(7(T-HLK^J]811K#$75E#D,A7W"X83'J%68;CEVJXS5FI
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MB3\HI!!3G>Y(OD- 4DD'/7+*XWQ#?RQ]N?<AU6_\"O2+_P!/7$3LCBK^^O\
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MZ]40J,78FKZ*Z=U]LSV0()?&7*A[+V15+S6'9Q*K JJ_5SU$<&V<C-FI2/\
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M@3[4PU2&TSW;%.+:<:F74I1L*3LTG*YBMR>E0FG3#"I=Q#QIS,E.J0_>B.S
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MUD(25$(0D%2U$"R4I!4HV !)B[:"XXAM)2%.+2@%:@E(*U!(*E&P2D$YJ)
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M\VL0_D.K?J$Q'*T+[>4;\JT[];9C^B%VD^UE[%_B)V[_ &?V'GPWA[[?T/\
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M3<.3E(P'.T]Q1XDOS$R;7R)(B2M&@X$&VW@-E"$LVSL?8M=QD9^?"82-%=H
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M^4>FGSN^4RY*;)YVZA/HM&/I0K,PU_I ^BX)61V*FX?H[8OI+U2GXDZ](O\
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MBR"Z>XIN::K[-ZBOLZUC>(MW#FTQV[&MZE6ZQ:W*&+(.%#G;,;I$M(4U9!:
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MA.PI*%IWY^UF<8J-7J<_*RR926G9^;FF)9.C#3[ZW$-ZD I2H;039 5<(2E
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MUAV9)E37<+E27G7.FX5G9VJXQHS\_,O3;X=4D./K+B@VS+3"TH%_FI2=I5@
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M#!UV6]I_5SM%8LI!2ELE+\U;G*>$[D/]3Y[28JA+P=NRSVY8V_CW\RW1<<1
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MHC+^(I51I](+R!RYINY#+7&M*MCQH,>7*6Q&U_4Q=GIKI)28TI;^X&8$%R3
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M)+B$H 4/E..%05FK+/5D>E6NRR2F;EI*?4-C8<4A4NL%-]I2PR>K65'9(LA
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M]]Y>7'7GG7,J<===<4I;CBU*6M:LJ5G*LYSSW-*4I2$I 2E("4I2 $I2!8
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M[YZG=]43Q\(_7:^UUGV3;&P0=NTS<:YKTRRH&0D'Y8 ;L"&1' Y)E+&"+X>
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M7#I_V(KG9VCJFC(X;.OKW53EH+#+.',RW@SQF$C$"*& $"%FGJNT>4BO(@R
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MLN66^]M+>9.X03[<QI?/@+^(MF;<8FDH6'V-BOVH*AR/7K15*V9K@YV+"A*
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M+Z1/[)..2=#?A"-5HV[NJ_Q\HMK6CY,42HRC+%V58)61T6R>OX6C;.=.I@*
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MA9U7:8POVRCU>VNVF%G6<>S^T,.M[$7H_P!T?;+=63-\I+-$5M"0*CQ\9>R
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MO^+PWVX7/K(OQ-\X7L=U_('CO\O#=%Q[,Z/[.6?L[L*S#*[=+<W*V"5D5'8
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M\5@O8G:U#KV!I&!%9R+L6;,,F,% 8TZRG$UX/7YD8H/;))A%8$D4VVAUMF;
MESH$Z.[BJD[)M>^OD?4=T2E5_?+W][QL)RL6AQ"'$(<0AQ"'$(<0B(-4?O.S
MOQLWG^DA<LK[G\4?3%4_=?C'Z(\B+G[XY_KJ_P";/-U.@[AZHPQ=*_@QD\$Q
M7?6,6#)<;@%F+E*96#&9K.!GJREYPA,CUWT'H<JSA.'/+E6<8\>2;6-]+9]T
M(AD/"Z*$MT1&!+EK=O<BS,>S8;V1;75J=<G""<1H ]UZ/[_>ZDDBIIH8P95
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MK;IO;*P[[F_,@[O1IK>++VFZ]-6S:==NPS:&N*4/VA7=?YAUO<5VAU*V5.-
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M-3HI3 &'*FQF80P(HG 'SG&X@U!:4[!C-D#,V*WB/RJ=D&Y)-M+@<\_.'O\
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M'P),E#B&VGO.I2%)3EIMYE'B[C_/N0H*)O;7<+FT$E(%KZ;SE>_")X]_*/\
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A.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g377019g01g05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377019g01g05.jpg
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M 0$! 0$!_\  $0@ K@(9 P$1  (1 0,1 ?_$ !X  0 " P$! 0$!
M   )"@8'" 4$ P(!_\0 9!    8! P$$! 4)$P<)!@<  0(#! 4&!P ($1()
M$R$Q%!5!42(R.&&V%A<V<71WEK&U&",D,S4Y0E978G)V>(&"@[/"U I2=9&R
MM-49)2:2E:&BT=,G-#=#5<%35&-SDY3A_\0 '0$!  (" P$!
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M/IV&AIYF)%01*FW"4B6VPD6Z4$JA,K0^IIIAZ2IE(2XA[+24\C8]5=%-^TC
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M&63,+4H$L)08FM4S#Q[M)PP!JY@ 0%O75HILJLDIRR]/VE9D%44DRF[BR_\
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MBM5YG5,,8GR59:S(85M?I.5U;5NTON$C.X@LE8V<YCEE;\3Q-9RD$&\9STW
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M-<KTLZSM^K]4(:TZT[#T1I2W1M):$M[N4N1],VA3B8\V4CA3_P!Z7Z6[+O\
M>'% N+N5SD)4M:6T8Z<US%:PK7,MEW&<&^4C9.ZP+=ZB84UVY'8.CH* /!DW
M M"KD05*/@=-8Q#D_9%#2E9I$S$3.LDI*%DF,LP6Y[IY'.D7C8XAQU%!9 YR
M=9>0 Y!$#D'P,4!\-*5Z6E*:4K_!$  1$0   1$1'@  /$1$1\   \1$?+2E
M:U>YDQ;'/3Q[N\UXCI,_=J%3>@Y234 >#$5<MBK-DS$-R50IUBBF8!*?I$!
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M0[NN99+&R[8%VT(KE&M2<U!7MY%,&CZ>0FY.35=)V%5"9;JD*(QOD#L/+O\
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M<HNFO4KRHBB@F((%57)[T>LU/MV:&_=EF8"HG;.:Z*,K'0-YI;F0&090[Z;
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M  /T'(\\  <CZ\DPY'CS$>.1'S$>1'QT^?7SJY).Y))P!DG.P  &_8   .P
M ;"MS:5%5QNVV3.YIEV1Y$2A9<:%Z>1X$@1B"O2(>(<=X/7QY=0 /GXZ5!Y=
MOHYU3*W%24]7KMMX90\S*Q+6P9-8QDPVC9!VQ0EF*DO6DCLY%)LJDF]:G3<K
M)F0<E42$BRI1+TJ' 57:2"',Y)""1Q$'!':,9'K]N]2[[ 61VFZG'9R\%*=E
M=DU. #X1!H]B.!1\/+O$TS>' \E#V<@*L8&#^MZ2"/8:O<8I,8^,<?";GGZC
M*V7Q\? D2T(7_P )0TJU9_I2JL';<)'=M2I"83%#,[8PE$1Z1[JESR28B7Q
M1(0PE*(AR4!, " &$!5!&>_GV8![>^JF&6)*?BMPN!(!A,RK&'G1G?6T4SD'
M;:.E.X((I>L&2*I&[SNAX$GI"2G1^QXTJZ$CJW"<Y'#@D@D9.^-_"IMNS09F
M:;AY,Y?@@IC2RI' OAU%]<U=0"F\N2]:9#<#S\(I1\P 05C P?UO201[#5YZ
MMF$]=@3&'DQH6+,81\Q$6* B(_;$=*M7M:4JGYVSB"CRWTT#")@^N%F=0Y1$
M1*93UG70*80\0$Q0,H!1\P Q@#P$=*@[]_H('O-5E;#(S[?=Y1*FC,RJ5>?8
MR>23J!3D'9(9R^(K<0*\<1A509K.B@T; 5<Z)E0]'0X. )$Z57 '4G8Y"AOM
MQ8..W/F]OC5@#LI&QV64LB&*(D U7@3<%$0*)T[$D)#"'@ F)U' H^90,;@0
MY'E6,#&?TO20?5BKMNE6II2FE*:4II2FE*:4II2L$R;DRC8<HEDR9DJP-ZK1
MJBR)(6&?=-WSQ&/:JNF[%$WHD8U?2+M5P]=MFC=LR9N7+APNDDBB<YP**H)
M&3L!45]@[<O8[#.E6\<?+]M13,8I'U?Q^U;-5P > .D2U62LO0*;S*"S-$X
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M,8;I]@!U=P ^7CT#QX .E, \QFJP5L8"&_3&+;CQ/AN14XX\?!?('L_HZ5D
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M7">3R)>$NMG=MLAPGAWKZI?DU=*D&))N4JVVUNTQ)=VC/W8W-DVY+-GT2KI
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MHASY<?L>/^[YM1W>/P/G_'P[1E']RK[_ ,!5DWLWH(0N<D/3^J-VQBP#G_\
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MOD<[</;R,5T::83#3U<S5:K$6$"%(0!()0$Q%$C% IDU$S !TU""4Y#@!B"
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MF64OOR5*#)=><<?=?DNK<>>><<X.JCH*(T>.RUNO7(UTFFE*C_W\1'K&H0@
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M=\4O)H^UL^L>.0*W>1DJB?G[:Y6H>X>?M:4JDKVH,-Z!N$[-MIT"'5NVA&O
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M8VQN=O'>MH@9^3\ :E+V_;H6T?2&,>W?D*B+-,H%*J !QT '''/^KP\^!\N
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M)8.'C=![*'8MQ=/2QS550J[TS-J N716R:HMVX"LJ!$P$VA6A*D(4M*5N<7
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MJ4G!!]>.[M]G]=J@C(([ZJG5?.%TPS*S.*\G1<I2KU37:D+8JY,E,V=L7;<
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MJM,Q%_7D@[C0D&/H?5U-_0 'J-\?3JT_YE>H?C5@\H)4G ^MX[> S\[5(?\
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M/K:YTDGUW^WCXUQ+V,]$IN0NS.I=1OU5KUTJL]<<I$E:[:(=A.0L@F6[21"
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M?^!TR>\^LTP.X>H4^MOCO]H5+_!:#_P.F3WGUFF!W#U"GUM\=_M"I?X+0?\
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MQPM($.(E]Y$%ETX'V679MUS8XWS-:9&=C[S?KK>K/4(&TH-E45XC$E0LCQC
M0ZI'#9 6L[87[ 9ZXD8BK&J.FL"Q:K.DX4CUUNGI#UV_JY5JCH97#A1(<>2]
M&*@4N7.2PE;[H(4KB990OJ8I7AP)4\M0272A/D31.D&=-BX/J=3)E2)3T=I\
M)(+<&.\I#39! X775)ZV1P_4)#24DAOB5+OK6E=\II2FE*:4II2FE*:4K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g377019g01g07.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377019g01g07.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X4!^:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QP9&8Z4')O9'5C97(^061O8F4@
M4$1&(&QI8G)A<GD@,38N,#<\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z
M1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T
M/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z>&UP1TEM9STB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(^"B @(" @(" @(#QX;7 Z
M0W)E871O<E1O;VP^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO
M>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R
M,BTP-BTP.50P,CHT-3HU.2LP-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @(" @
M(" @(#QX;7 Z0W)E871E1&%T93XR,#(R+3 V+3 Y5# R.C0U.C4X*S U.C,P
M/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^
M,C R,BTP-BTP.50P,CHT-3HU.2LP-3HS,#PO>&UP.DUE=&%D871A1&%T93X*
M(" @(" @(" @/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @(" @(" \<F1F.D%L
M=#X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.G=I9'1H/C(U-CPO
M>&UP1TEM9SIW:61T:#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z:&5I
M9VAT/C8T/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @/'AM
M<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @(" @
M(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%05-!
M0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!04)!
M05-!04%!045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!1U1!04%!
M04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#=V]+
M)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(>#AF
M2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF2'@X9DAX.&8O.$%!15%G05%!14%!=T52)B-X03M!04E205%-4D%F+T5!
M84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%04%G
M241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!0T%1
M341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC645537!'
M:$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#3E51
M;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT+U!%
M)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD-&58
M<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ8FY*
M,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!341B
M445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C133D-&
M5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG6DIJ
M6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E75G!B
M6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A984AI
M26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+;7%Q
M-GET<G$K=B]A04%W1$%104-%44U2040X03E5-'$W1E=096)F2G1N-6PK<F97
M)B-X03MB;6$S*W%R2T4Y13AE4FPT9F%P.6]$,"]S.41M4&XP-'E66C5/=S!0
M845T3F1!2&ER;C58*W1,2"],<3=A8WHO04])<CAY3DI',&IS)B-X03LR-WAX
M4WEY0TIU2E5&5SEE:D-L3FAS0G1L6#51+W=!-'533S%O9U8T54LS*UI%4F8R
M2SEZ*UAD;$QC4&1W,S Y<&9T1&(R>5AT=GA3)B-X03M627)F:E9686A0>#A!
M5"]%5D)K9$E/9&M(8C='14\Q<$%C2FE*4752;SAR4#9K,CAT95A9=$-S-3=A
M2UIP>%!/,#5:9T%15U)5<'0O)B-X03MQ6F)G=RM'2W9Q-&US,5IZ>45I2V]6
M.2\V,#-Y-7A(67$W1EA9<3=&6%EQ9SE:,#%.53!E*S!Y4GI';#EB>3)Z>4M+
M;%)-:%%S069$)B-X03ML:UIX<T5D-V1P.'AX6DEZ1R]$24@U1S)*>&9L;$Q!
M6%,R.'<V:D9B;$I"1D5S:$A'4C57;%-5<T=(3FLU53-(>$0W5F$U:412,7EK
M)B-X03MA9'),=&M3,VQI9U1T,#965F56+UHP5F12+TQI4R]D;6PX=V%J=V8Q
M0DQ#6DMO-G5X6E9),C)5<V1U:#9F6F]!>C!F1B]%5T](=&-9)B-X03MX=&IH
M,#9F:CAE939985@U349L-C!C*W S9#E:,T9S8F%7,&UK8FAU-69M:$)$3',S
M2%DY37-X-F)H,DI*1E4T*V9T1&IO:459>45R)B-X03MS1'DO0E%%;C5A5TUD
M-6-4-EAF5&%61F1U5W5B93!!:41R-DUC4VAN5&I)4W)2=$E'3&9A9&HQ3F-J
M3%,O=T$P.$QE3S)*1TE%-&E:)B-X03MJ>4UT-C-*-6-U;TA,:T%O3"M7=#4V
M.&9Q*UER-F$S:&ET1E)*2DAK67I7,7HY6DUJ;#-92&MY:6TQ5C=';3)$.')+
M+W%,664R23!A)B-X03MX44)*;#!R855E1W1H+V(W,694+T%-=69Q-THY6C%M
M.'99,EE'.6EN67-T>6]I35!'4W!/=U=L4$0W<4-/:G)N26YV.#)V3#)V>&94
M)B-X03MJ:DAU<BM(93EV>"LR5S)L<&(R9'!$85<P66ET<F5.66]);#9+:4%+
M<6HU05IM04%#9S9R2DUZ:UI33FMM>7$T5T1S5F1I<G-646UR)B-X03LV6D1Q
M96Y45TTR,&,Q3C9!,$MS1U5G2'=+9S5$2D1J:5$S64UX>'I%:#!9,R]W07$T
M=&5+2S)P6&-I<6)O;$I(3$LO,7!/1D=O461H)B-X03MU,4-/5&)N35@X;4\X
M.69T+TAX9&HO2SAV-6M2.5 X07-D+S=/-&)/=79Y-V=U3DUT3E!K,4=:;W)3
M4S5K5U(P:EHR*W-H:#A7=T)+)B-X03LX+W1%5D\O5'-Y,%E-44PU6#EQ=S=7
M35IY;4EI-4-09B]$*T]82E%H+TQ2-V$S;FAT3F1V8E9B:&UD+U)0<&IK,%5-
M5F9G2SEO3C8K)B-X03M/,41V:4Y'44M%:4=C=3)/26=Y>'AL6&9V,6MF.3DK
M=3!A9DEZ3G!T-UEY-G1D6$,S;#$Y8C580D5O52MO6#E-;S-W1TUG9V-104YQ
M)B-X03LP<FMZ<')I4GA(8W10.'!E=4UH0TDT63A/,C-4;F9/+U!M:&(S.'5R
M;3=*5U1Z1'%"='I*4$EB8W920TIL05)#1DLO0D=Y:&=0=7!K)B-X03M*85%N
M8FE,8FHW5VI$;&EH9$1F,V1F969X86<S-6)8.$MW4C)7=C-554-4,C!K,$IA
M5&=9<F-C5VI25611=G%$-UAB>')G1VI),D5T)B-X03MM9CA!3$5$6FQJ:515
M<35C>C$U9$=6-DYO96TV3F)08F%F15EO6DI$2S9L;6(T>6]5;C1I858T.4UY
M<V5+34)19%9Q3E103DQI;6)))B-X03M&22],1V@R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMP6C5M.'AA9C5C,$<Y,795968Q2WAJ.5=C4D%-+T5%1#11
M4W14=C0T<6U%)B-X03M%>51W4GI*.6E6438Q-C!95D=+<%1996).2W9V32MQ
M95<T4%4O4T]K4G=46%I:44DK3GE#>6-'<E5N8F9B1EAE8V9.;6QE579,=#,U
M)B-X03MG,5@Q1%E79G K<4E61'EF=EI&:5AI<$LQ*TIX,WA63V-64V$V.#(V
M5F)E83=,>7A*-FXV5'8W95<W9V]O369P=VUJ8VUR54AF8F)&)B-X03M5,G5*
M,&=G:VYK+W4T;$QV5'=55D]+<&(U5CAZ86(U;CAV,F5U-F%*0EDS>7,X06Q5
M2SE&66]E4V=T5&1F2$95,7A6,DMU>%8R2W-5)B-X03LO36YZ;&,K52],-3%'
M,G0Q=5HR8TEI3U-&1S%35%1&55 K5F9N,C4X-F58,C%+-'1287E)>6EI:VM-
M2%%/1%$Q<#$X8U99<#5G+T\W)B-X03M59$TO34903%5E;6\Y<U=)37)-95I6
M5VE6;7%$468S-&]+67%Z+WIR-6QL.'9E5V)J5C190F-3>#A22$5X;TMU86)K
M67%X-SAP9GI+)B-X03MV4$]T;&-Y,V1M='1*069H6D-A34LP-D5M;C,T<6MV
M-6<O;E)Q6&QN>EA$;S%T<'E4=VMG3DI)4T-X-&QZ4V@R1D8K+T98;V5T-C8R
M)B-X03MN958W;E<Q:#E2;TQB-G=S0DY!5'A"-#$K;D9712]L3"MB5CDU,G5R
M-C-U-T9,8C9Q.&E,26A/-6EK84YG45-D<7!S8U9E;31Q-T98)B-X03M9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T970B]N<B\U2V9Z1B]Z1&8X8D1&5UEA3"]!
M36-A>"\U:#1V.$%I07A6-3,U3B]W1$HU*V4O)B-X03LK65149BM)3FER9B]!
M1&MP+W=#4V,Q=B]!1C=4+W%,:7A54%19=C=T4#E59G%X5C5J<F8O04LP2C5B
M+S=9.3<O04U31TMV461F+S0T)B-X03ME;V8X=SAV+T%"031Q=WHX9U X07E5
M4&PS+VI&3"]Y9FMX5C9&:7)S5F1I<G-664XK8U9H.6(X;GDW5DUB9V=F46-6
M4S,X:$Q-5V9K)B-X03M3,F1Y1E=D25-#9'0O4U59<7=8>FIO:E,O;F9:<U9R
M-C!6,TPY0WHR47A3.60O35-Z4S@X;S-T=71'.4U)>DQ7<$9$=%A&1$-V*V-E
M)B-X03MB05=N;#(U=4A)4EAB:5-D:#ET<U931#@T3D8K<V9M3G!,57%S.&Q+
M+W=$4G9)8U9E=6593%):+TIT,UDQ0F8V;45:2S<P0VHK;4MV)B-X03M,4#A!
M;D<W5$1$3')C-49!3#(O:D@K>'9P4FEL-VYI:#)+=7A6,DMU>%8R2W5X5C)+
M=7A6:6YN3'IZ8BM6.5@P3TLY0W)P=7!V3D1C)B-X03MZ;G)%>2MN-F(O-G18
M4$PR,S=9<7ES145!9S%",T)'2W5X5F=F-3=F*U-N.'AF.$%-3B]X<TU64V)8
M9%1V-%!Z2B]+<7EH=4I)-U,U)B-X03MT=%-.>F)O-TQ(3'AS54ME;V]01G5*
M,U=V5$965'EE869N;#4X4#A!>34V8B]W05%B1EAN9FU457(K+R]!0T(X.5-8
M='A*8W9(-6EL)B-X03MJ:F%6,F-R1W0Y0GA24WA.1EAS359$,'9Z:G%D+T0K
M8C,U8E=53GA*2&%82S9U8FTS4C)73UAJ6G%5.5)184YX3S8Q-EEQ;S8S+S8P
M)B-X03M*-6(O04\R4&4O<D=+<5!L8E4W*S<X>F9M;D)C6$5K<T9T2D%T=$4W
M<WE22V)2<6E.4V%+0V1Z5$-Q869K0B\U2TAY-R]W05EP9CA!)B-X03MK+TIG
M5C9&:7)&9E!8;F%0>6TR:UA.>6=A=W9,;S(Y-'="3$EH46M/=% U5T934$1&
M5U524WA3>$I,139Y4E-+1VIK56AL6E=&45%2)B-X03MS45)I<3=&56TX-%=Q
M,U!L<E5%27)X:%HO=T1G4E4O:%A&6&Q7=F586'5V>6,X;WAX5E5M-S!Q46AD
M<2MQ,&-1*SA.:7)*.6(P;4YV)B-X03MZ;#AV3E-V4%,Y46MQ9CA!:7%E=T(O
M-&HK3TMR4$LO;#964$TS-6=33TMR95A+8U(T;C!H2W8X07A01E=,,U=H9E=0
M>41U4DA51G!4)B-X03M+0W4Q5E,T2R]R2GA6:W9M:E%L2&U(>4I!=W$S23(W
M13=K;4MZ:T)**VI&559P,F=Y2#@S4$UD,C(P9'IP8T-!.78S:$LO.$%-=D96
M)B-X03M,.&M,1EE.23%U54Q1;E<Y56HK6$,K;7%0>$=+<6XK3&9/,R]!1EIR
M>B]P2&8O;6Y#<G8X5RMD=BMR3F5F.4DW+W=$3D]+=2]X8C4R)B-X03LO=T-R
M3F5F.4DW+S@P-'$W+T9V;F(O<7I8;B]33R\X07I4:7)V.%<K9'8X07%Z6&XO
M4T\O+TY/2W4O>&(U,B\V<S$U+S!J=B]!33 T)B-X03MQ-R]&=FYB+T%+<S$U
M+S!J=B]Z5&EQ2C S>E(U=FTQ1S%H=4Y*=6\T2DIO,&QK84(Q5E5:9T=9:VI9
M05E&6C-I<GAB+T%*>54O=T(U)B-X03MT02\Q-W(Y55=+<S O2CEF35$X:3))
M,78W5E Y0416.5%7;$(V465V+T,O-4Y-5EIR:7)Y,WI0-7<Q1T]#4S Q>E-3
M,FTS8W=T56IV)B-X03M903!->G4Q230K36DX6$Q5,DAF0W%(;3@Q6&IA-UDR
M."MH<3)U,F--:S)M4G9A<6)Q1T)Q4E-004-V<4EH*WEX6&)T:7$O5&9.96]Z
M)B-X03LS*V]8*VUA2C9M;T-4-G!Q;#%B,GEM8C%9440V33AI3'DU27)J-%=/
M,6-64W8O1FUL>F563&DX+U%D;DHU5'5P1W5,<6(V<D-B0U=4)B-X03LQ94Q3
M>4AJ-E1.-G%B<V0K43AC5E1'*S@S,VXV5C!M82LP64A66$UI-DA,3F)+8FER
M2BLY1G%Z3'HS:BLQ=S=D8U981'IB9C-(;4DP)B-X03LP6#%V359J1%5N-G-R
M6&M-17 X95!Q26HO8V-643%T-3-%54]S-FYB851%:TUC<GAE64QY3S-12TIR
M9&%32F1Y0F9T4G$R-&M/=WA6)B-X03M.9$$X=S8U0EHR5G9P5V=Y5S)K<T5A
M,E,Q=&94='A&26582D)';U%+95A,8D%R,'I&6&MF+T]2,R]+3V%6+WI'2"]K
M,#)+<'HK4FDK)B-X03M9;#AK>&9P6"]E4754<%%E=G%F5GHT,2]9-699.79A
M;4MV43A6960K62]/4&U$5&IQ8C-/;7I$4V)1>D=7-6MH4&]F5C1Y875Z16-E
M)B-X03M(059Q9'%9<6=:9DY'=5$R.6Q9>39%.&1S6&IJ,"LQ83%P2'IH2'%2
M3$5N1VQ9>$9Y6&HP<'0P=W$R,VY$6%I.85-.=$=K8E=R93-:)B-X03MO=V)E
M='EL=$TV:'EV=S@Q:F0T;'(R2E5E1TMR-'9/6&U29G)6>$1P17DX6% Q,EIB
M8VHT-#%!4'%-1C9Q;T$S-D1&54MV;7I55C!3)B-X03M"13!3;6E86'!I,VI&
M<4)B4T,T8T=-2W9(9V959'A4>$IX5D584&Y$6&XQ3WIG=61';&)5,5=7-'-)
M-4QE<W=607-C,&M65C5#9VU6)B-X03M72R]Z53<T<7%W*V)V3D0S8S=W-DY/
M,3)N1TLU6F)C*V]+1&UI3U%T9&<Y440T-'%O-E U<S$P,F9R85!O:V=S-VU3
M4V-V83(Q235*)B-X03M:2$IL:TI284UZ4U9,3C%*-C1Q.5)W2S=&6%EQ-T98
M67$W1EA9<3=&6%EQ>&9Z9#5(=&9-,G-A2%!F1E<P+U-N;6UM='IU6EAF,"]4
M)B-X03M1.75&54IB-W4K>7)+04%"46)!9$)I<G-695EF;C)4*VE03% O9U)A
M9"]Y8T]+<3$W66%G,S4K-F)F3&)Y;7A445IO6'5G:D=)4T=C)B-X03M-14PP
M-&AI3C96>%94+TM.:5DO4'AR=B]!26MV5"]Y46=X5F=G<TPO044O+T%*>$AL
M=$PK,FQT3'%.2G95=#4P84M295=P37DX:V-")B-X03MH5E-#355S,3@R5TXO
M8V5C4'EU=4QE,VQL9W1:2C)U<&\P6FMI5G)25E5Y34)2451S2S153"],>% O
M2R]V3E@O04=Y3% O:5IX5FED)B-X03MT66%H6B]L4"MB6#%Y,VQT=G)/<V%V
M8U<O<DEY97!$26MF1U)/44A*1V]A34YJ9U8V+S5#2E!K9GDO6"]!2W0Q<B]Y
M6EA&53EX5FDO)B-X03MN9GE40C5R9E-93'1W3E!S<F\S3C-(=4=K54E127A4
M<'E*,U!H-S1Q>6%/3T]/3EDT,4-2;T%Q26]!04%&04%",$%X5F1I<D-0>G!U
M)B-X03ML:"],1'I'<% Y.7 Y,FXP0S-D=C%J1E5M.#1A-TY(92]L*UE69'A*
M<5)$<V]*031W=D-+;B]:-'%R,BMP;V9Z=G5&-6)(4VMG4#!4)B-X03MV="]W
M4S1Q:%!,979Z5"M7+T]$5&=P>'9P-#$U06EV<4-J9&8X:UEQ;$]S83=,0BM4
M+VQ.;T9:>70Q<&%(9T-A0TIO-64S9T)I<DI.)B-X03MB,5)&+T]0>2M#84=0
M4SE1:G T97!0658O=T-*67$W>3-R:S4X=RMF16M"5DQA-5@P,DE)1E1'26Q)
M+S1(1E5W+THK-U-B>5AB>'%F)B-X03LW<5-79SA!,&I(.61C5EIT:7)S5F1I
M<G-69&ER<U9D:7)S5F1I<G-69&ER<U9E6"]!2BMF.&-J>7HO-$5/;F8X;D1I
M<C W9VY,;GA()B-X03M/;$]896U+=D]0>5E!379N:TAC2'I.968X;5E-5E90
M>B]212]+1'I!<4%+;VEI;T)S4#<Y359:>&\V23)K,D1-05=7,VEO5#%(=T1&
M)B-X03M8;FYL,R]Y9B]M<B]!3%I.;B]X33165'HX-&M24'ES.#!"5D,Q<TIY
M86)B.&-#<'0U0B\U469Y+R]W0G,V,2\U37)I<699<3=&6%EQ)B-X03LW1EAK
M+W=$>FMH9B]!1F)Y0F5X03!-,7!E2U(W9E8R>%9L;C5:6&XQ>GEP1$LR-45S
M9T@P1VU+=DIR2%A4+WEV0FU9-VU.27HY1G<K)B-X03M+=E1F>F9V:%HK55I+
M9D-:2' X.6II<5AF:TYE+U<O23%S<#-%36-#:79J-E,T<7=B>FAR8E(O;EA:
M<GEP-DU.-48Y1%0R4C=9<&5U)B-X03MF;4AE:3$X<%AC-#)$.$%4.'IT:6AH
M9B]!1&HQ<4IU3D%U26$Q0TAL+W=!3S,Y8U9E=%EQ-T9867$W1EA9<3=&6%EQ
M-T9867$W1EA9)B-X03MQ-T95:C@R955D3CAZ45=-1BM8.4]W=DEB-DE),T4K
M<D%A<%@R>%9035935'EZ-59S4$PU,5$R:%EN5F(R5%5,;FMA+W9P5E97<#1#
M)B-X03MI1&)&5B]M-WEX665A4$PY,V]D*U=&;F5"5FTT2&DQ1EE0<U(W<FEQ
M85<P0S(Y=D9!;C)):U9&*U-I9WA62G),>6AP,7 U=78O33A:)B-X03MB-B]Q
M145D=$Y5;FIW:4Y6;W5+;W9Z2F]6<'(K:%AU:EAL9G%T+T4P33-%,%!&:%$P
M3TMO:E-D3V<P>E,W5%1O2RMH6G=P0D95,5!')B-X03M.47$Q4'E'2V]R1EA9
M<3=&6%EQ=V8X,2]Y-6LX.#9'3D]I=2]Q:D%327I%5D1*2VA29U!!-S=9<6TS
M:U1Y<DHU6C!#4%1:8FHV,4M')B-X03M:,VM!-')6:E=I9SES5EE282]K:&-1
M+VU"+VE9-F]$8FAW=V=#9D913UA#*TA6=75+<W@O35!Y9$PU<C!%-F1$8VDQ
M;41H,&M98VPV)B-X03M524Y-5E$S-5@K435F2FUG2%1:8G8V,TEX53AW2T%"
M14-G9FAV:7)'9&8X07E4=615."]*-6U857A(07!.64-H3$)784IM2'HO8TQ1
M)B-X03LO4$979"MC9DQ495E03',K:W!0.5AE5&E5;4DU049$559'2W-E+TMR
M.'1:+TI6;F-26$8V3'539EI1;V]&1E-E+U4T<2]W1"\R43T]/"]X;7!'26UG
M.FEM86=E/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z06QT/@H@(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R
M9R]D8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F9O<FUA=#YA<'!L
M:6-A=&EO;B]P;W-T<V-R:7!T/"]D8SIF;W)M870^"B @(" @(" @(#QD8SIT
M:71L93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^4')O:F5C="!!<G1E;6ES("T@
M<VQI9&4@,#,@,C R,BTP-BTP,3PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D
M9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @(" @(#QD8SIC<F5A
M=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D
M9CIL:3YS:'9A<G1S83PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^
M"B @(" @(" @(#PO9&,Z8W)E871O<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I
M;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @
M(" @(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O;6TO(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @
M(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S
M5'EP92]297-O=7)C945V96YT(R(^"B @(" @(" @(#QX;7!-33I$;V-U;65N
M=$E$/GAM<"YD:60Z1C1%,C$Y,C@W,$4W14,Q,3DW,3!&,48R,D)$,S<V0C0\
M+WAM<$U-.D1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$
M/GAM<"YI:60Z1C1%,C$Y,C@W,$4W14,Q,3DW,3!&,48R,D)$,S<V0C0\+WAM
M<$U-.DEN<W1A;F-E240^"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M
M96YT240^=75I9#HU-S U868P,BTT.3=E+31C,# M8C(R."UF93$W-#ED93,T
M9C4\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-
M.E)E;F1I=&EO;D-L87-S/F1E9F%U;'0\+WAM<$U-.E)E;F1I=&EO;D-L87-S
M/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N
M:6ED.CE!-D9",SE!-C9%-T5#,3$Y-S$P1C%&,C)"1#,W-D(T/"]S=%)E9CII
M;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N
M9&ED.CE!-D9",SE!-C9%-T5#,3$Y-S$P1C%&,C)"1#,W-D(T/"]S=%)E9CID
M;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N
M=$E$/G5U:60Z-3<P-6%F,#(M-#DW92TT8S P+6(R,C@M9F4Q-S0Y9&4S-&8U
M/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E
M9CIR96YD:71I;VY#;&%S<SYD969A=6QT/"]S=%)E9CIR96YD:71I;VY#;&%S
M<SX*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @(" @/'AM
M<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED
M.C1E.#$P-C<Q+3$S83(M8V,T.2TX.#-D+39F,C8P,C)A83@P9CPO<W1%=G0Z
M:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R
M,BTP-BTP,50P.3HT,CHR,2TP-#HP,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T
M;W(@,C8N,R H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.F1C-&%A,30W
M+3=D8V0M,V0T.2TY,S8W+3$U,&1D8S,V8V8P9CPO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,BTP-BTP,50Q
M,#HT-SHS,"TP-#HP,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@,C8N,R H
M5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]P;W-T
M<V-R:7!T('1O(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YI;&QU<W1R871O<CPO
M<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V
M=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$
M/GAM<"YI:60Z.34X8C%E,60M9F0Q,BTV9C0R+3@R8S<M.#DX-3@R.6$Y9C,Y
M/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M=VAE;CXR,#(R+3 V+3 Y5# R.C S.C$S*S U.C,P/"]S=$5V=#IW:&5N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!)
M;&QU<W1R871O<B R-BXP("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N
M=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z
M8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E9#PO<W1%=G0Z86-T
M:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYF<F]M
M(&%P<&QI8V%T:6]N+W!O<W1S8W)I<'0@=&\@87!P;&EC871I;VXO=FYD+F%D
M;V)E+FEL;'5S=')A=&]R/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA
M8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HY039&0C,Y038V13=%0S$Q.3<Q
M,$8Q1C(R0D0S-S9"-#PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.G=H96X^,C R,BTP-BTP.50P,CHQ,#HT-BLP-3HS,#PO
M<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E
M06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z
M<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG
M960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E
M9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R
M86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W!O<W1S8W)I<'0@=&\@87!P;&EC
M871I;VXO=FYD+F%D;V)E+FEL;'5S=')A=&]R/"]S=$5V=#IP87)A;65T97)S
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I&-$4R,3DR
M.#<P13=%0S$Q.3<Q,$8Q1C(R0D0S-S9"-#PO<W1%=G0Z:6YS=&%N8V5)1#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,BTP-BTP.50P,CHT
M-3HU.2LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD
M;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @
M/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @
M(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @
M>&UL;G,Z>&UP5%!G/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O="]P
M9R\B"B @(" @(" @(" @('AM;&YS.G-T1&EM/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O<U1Y<&4O1&EM96YS:6]N<R,B"B @(" @(" @(" @('AM
M;&YS.GAM<$<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G+R(^"B @
M(" @(" @(#QX;7!44&<Z3E!A9V5S/C$\+WAM<%109SI.4&%G97,^"B @(" @
M(" @(#QX;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3Y&86QS93PO>&UP
M5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^"B @(" @(" @(#QX;7!44&<Z
M2&%S5FES:6)L94]V97)P<FEN=#Y4<G5E/"]X;7!44&<Z2&%S5FES:6)L94]V
M97)P<FEN=#X*(" @(" @(" @/'AM<%109SI-87A086=E4VEZ92!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=$1I;3IW/C8Q,BXP
M,# P,# \+W-T1&EM.G<^"B @(" @(" @(" @(#QS=$1I;3IH/C<Y,BXP,# P
M,# \+W-T1&EM.F@^"B @(" @(" @(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO
M<W1$:6TZ=6YI=#X*(" @(" @(" @/"]X;7!44&<Z36%X4&%G95-I>F4^"B @
M(" @(" @(#QX;7!44&<Z4&QA=&5.86UE<SX*(" @(" @(" @(" @/')D9CI3
M97$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0WEA;CPO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI/DUA9V5N=&$\+W)D9CIL:3X*(" @(" @(" @
M(" @(" @/')D9CIL:3Y996QL;W<\+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:3Y";&%C:SPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^
M"B @(" @(" @(#PO>&UP5%!G.E!L871E3F%M97,^"B @(" @(" @(#QX;7!4
M4&<Z4W=A=&-H1W)O=7!S/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P3F%M93Y$969A=6QT(%-W871C
M:"!'<F]U<#PO>&UP1SIG<F]U<$YA;64^"B @(" @(" @(" @(" @(" @(#QX
M;7!'.F=R;W5P5'EP93XP/"]X;7!'.F=R;W5P5'EP93X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @
M/"]X;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" \+W)D9CI$97-C<FEP=&EO
M;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @
M(" @(" @>&UL;G,Z:6QL=7-T<F%T;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO
M:6QL=7-T<F%T;W(O,2XP+R(^"B @(" @(" @(#QI;&QU<W1R871O<CI#<F5A
M=&]R4W5B5&]O;#Y!9&]B92!);&QU<W1R871O<CPO:6QL=7-T<F%T;W(Z0W)E
M871O<E-U8E1O;VP^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D
M9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @"CP_
M>'!A8VME="!E;F0](G<B/S[_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!#
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "- DX# 1$  A$! Q$!_\0 'P !
M  (" @,! 0            D*!P@%!@(#"P0!_\0 ;!    4# @,"!P01#0H)
M#0$  0(#! 4 !@<($0D2(1,Q"A05&")!DU%58=(6(S(Y5%AQ='9W@9:QM;:W
MT1<D,S0U-S@Z0E)S=7@9)S9RAY&ALKC!)4-E@J*FL[3P&BI$8F>#DI>8HZC#
MX?'_Q  = 0$  P # 0$!             0(#! 4&" <)_\0 11$  0($ P,'
M"0<"!04! 0   0 " P0%$082(3%!40=A<7*QT? 3(H&1H:+!X>(4,C-2DK+2
M"((5(S1"\18D0T3"8B7_V@ , P$  A$#$0 _ +_%$2B)1$HB41:EZ\Y.3A=%
M>JF7AI!]$RT;@;)KV.DXQVX82+!XWM224;NV3UJHDY:N4%"E41705352.4#D
M.4P -='B9[X>'JU$AO=#>RF3CF/8XM>QP@/(<US2"UP.H(((.Q?K?()*RT[R
MV<E$G.R\";E)G'^%H$S*S4&',2\Q!B5B59$@QX$5KX46%$:2U\.(US'M)#@0
M;*'VSX?6_8&9] KC,^2'=W8_M.Z)['.'X>#F7C64SG;\A@2]<EM;URB8))9-
MU<,:U)9V,62$TDY.$M:MQ7 )3C)A-W!X.!#Q'*U##)J$VZ/*P(\64D60XCA$
MJ4)]-F9P3$[YQS16-$O)M$0$^4@18MKO\I%^Q:S.\AN(,%?U 0\%89A4C$56
MI,AB7&$Y/R4&-*8#J$MC^AX8BT/"H^S,="ITS%=6<4QXDBZ&#*5:G4Z[?LOV
M&G=-CM:FL?/>GC5D#O(,5"R</IAO')4RA:#2R+:R7@2_K7O1D1Y8D1!6G>TE
MD6)AY6TV]RV^XF,C,(F_;<EF#:YFARMUDVQL68@K]3I5<S33(;X=&F)N(V V
M6A3E,FH,P,TLR% F'3<.'$EVQH1B3;&34%[!&;H0%W,QR)\C6 >4;DC\CAV;
MGY6<Y4J+AJ2B5B-7*GAG'^'ZK18Q@UZ;GZM0Y;#DW.2E7B4RHPY+#D>;H%3E
M)B+2XP,1CHHR%FKB)94Q/#8@'&6H*"R0K;.(L.7M=I[DL?&4+ 9W2OK(TG;,
M@>T'+Z\F^09MS"1#%W%W(KCF#?-K8>PB<S.R2QY9ZA&\FH8JG9*'(?8ZI#F_
M(2,A,1S%EI-D*IB8FGP7^0<Z8$U$=#8TLC&4AN;!?#SQ7DQ"UOG\$?TYX4Q;
M.8Q&)^3R?PTRIXOQG0Z0*;7,43M0P"^@X;EJG+MK,*!1(N'9&%/3D>#-4UN)
M)Z!$JD&>=)T^58V3@/F=_P#1](/U;3XABJKUXHJPUL:H4&*JCE8ZC)!M:MDG
M;(M#F.)FZ3<YC'031$A$CB)DP*(B->HH#G&#BDESB6XBK :222T"!+6#3N .
MP#0;E\^<L4O+MJ_].[&P(+63'(CR6Q([6PF!L9\6JUP17Q6AH$1\0 "(YX<7
M@ .)"C7TJP^H7".C=]K-B\91MUW8UTY*W#9-WN=1>HK*]P7%-3D];T=(7#>>
M"IXR5@Q\=;UJ+W'>4JA;#YV]1&VT8V+%).3=/&OD:*RJTZ@.K[)-D>.VE&++
M1W56K3T6+$BQ83'Q9BFQ2)5K(4 Q9AX@.+QY$,9;.XCZ8Y5YWD[QQRSR_(M-
MXGF:12(O*2RFURCP^3?DXPE3Z=)2$A49B7IU%QY(!^()B9J-693:-*1*I @P
M'_XF^9F@YTK"@Q>\SNJ3(V0X61M5QE>S-4^-+/U1:%$[4U"V[CX; AY"<R/D
M<A+UQXHQ@Y(8"5F+,;-(F5;NHE8[F%2GD(ZZDW$@*)"<F+69J:AO@&=EZU*0
M*SAL0:I"E?LL-T6;G+3$KEAO\D]\NUL-X=#.:'Y7)&S/L!T$CR5X<P[/2U5A
MX2K7)5B:L\EG+RZK<G52Q#_U!.2\CAK#3G43$39B>E14)23K46+.2D2%-L$*
M>?3WS-)="EA$)D5X<CMV\Q#E]1XY<.E$]7NJUNF=RLJN=-NWS+<J3= AE3&,
M5%%,I4T4BB":9  A"E* !7J\*.<Z1GBYQ<17:V 22; 5&, !?8 - -@W+YR_
MJ/@PH.+\'-@PH<)KN1[DEB.;"8V&UT2)@JEOB1'!@ +XCB7/>?.<XESB2;J0
M&O3KY]2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HBCMXIZMQ$T:W>UM2[)^QIV
M7R/@2 9W7:\@\BYV$"X,X8_AG#U@\8.F;HBB;=ZKS)D<HE<)\R"I@34/7E,:
M&,*!'$"/%EHKYNF0FQH+G,BP_*U&6AES7-+77LXZ7&8:'0KZ,_I4937<L]'B
MU:D4^NR$GAK']0C4FJ2\&:D)XT[ N(9V' F(,Q"C0BUT2 RSG0GF&ZT1HS-"
MC@)JGU'8CRWJI<YZ>W):F3L%:5,,XU<73;\3%3]CWC<DMGF8@K;U!6_;-U3E
MNV1'6_=]OW;;[N\)6;?Q3*UWC&Y&;TA2P*4&'E!6JM(SM:-3=&@3E-HE/E#&
MA,9%EH\:)4XD*#5(4&-$A2S(4>%'A.F(D5S&P7,C-<+0Q"7TD>2GDWQ?A#DH
MAX!@TRK87QYRKXUQ-#I50FYNGUVC4V4P#)5"I<GE0J=*D:C7)FH4:HTBHP:/
M*2,O-1ZK!CTV- <34'SQ[=B+6=JYS<MB#%4!FBPH6Z+JU3ZB<%R&9(W'MCWW
M&W!:&.]/D%F"U[C:P\!<"EDR$D5Y,NF;.7M6<2MR5;H14BJT?M1>,GV\A7ZY
M4?L$E#J$M"CQZU5:8^?9*2TRR+ E*7#GX,9L.%%^SO>'1"UL2!$$%X#'EKVY
MFOZ?&'(OR0X'AXRQ94,$X@GJ52>2GDYQY+X,FL1UR@S-/K&(^42?P=5*;%G9
M^G-K<O*F!)0HT:3JT@^I2D6)-RS(TO%$&/ ZLOQ&M14SB?#]UW-F+'VGIW+:
M49G,,-<<SB?Y,([4IFNW,@7=9CC$D$FL^;L8!1=E;,"_D(2U@^3!1W>J3N';
MIQ+9L@&!Q758DE(1XT_*THOHD2?AQHDCY=M7J,*:F)<R,(%X9"S-@PGNAP1]
MH)F Y@\F&A=K#_INY.9+%N,:32\'8BY1(4IRLR6#IVFR6+11IGDTP/4L/4BM
M0\7S[F2\2/4&LCU2H2\O/57_ /C-@T-T&<B&;BQ8B[+E'B&:R<5Y!0BKBL K
M>(MJT,):PLI0'R-,$YBV=,%SVS8]K9?QDP4<(%.K=%FY<G;J\0EWRB,R$;;"
MB;Q^9-)TT/M.XJK\E-B'%E;0X,O3J].0O(M$2#1XT&6@S\FPEH)C0)Z+'R1'
MVB98-G.L'!=;A7^G?D8Q9AZ)-TW$)?-U*L8XY&\*U U..Z3JG*E3*I7*K@[%
M$=D.(6MI5:P?(4D3$G #Y+[356N@R^=T**WJ&1M36I3&K&2S9./;=;9^'A>V
M)ET\JI;+,J4+*9 U:,B,+77@C?\  IFMO6E<;2!<%7C3OE9)@J_<.U'!S[\>
M;K%7E ZH17P14S@V5GS$,%H$-\U7&AL$PM8>6% C-A&["XO9G+BZZ[C#?)?R
M9XFCRV")"#4HO)^/ZI:_@]LJRIQ7/G93#W))&,>JPY\?]Z(M2J]-BU"&63(E
MVRTPR7AP6PVMMDG.FKS6[@_/-N80DKVQU)71"V[B:6A?*EK8[Q[:.I2?R)?,
MBWNZ%B'=[WVQN.(BK,8*,K#@$L<I7!<"4FQ&[+Y.W8R ()<RI5W$5.J<&G.F
M)1\:'"DHD//!E)6!5XDU,O;'APW3,RV-#9+MRRT(2@BQ0YACS)#7V'F,"<C_
M "'XYP#4L<RU#Q)+4J=J.+I.=^RU7$6(JQR9T_#E!EHE'GIR#0Z!,4R<FZU,
M-CUZH/Q&ZGTY\K'_ ,(H+8DQ+&(Z4;4II_OW.2UIGLS.D]AM&W;6S1".TH2"
M=S"DI/9+QT]LFSKQ1<-;MM<\9-8JEGJMU0:A2O%WRRCF/;/(%5QY52]E5Z7-
M5(P/L]2BT\0H%0AN$.$Z(7Q9R4=+R\P"(\')$DHCC'AFSBXDM:Z$3G'RUR:<
MH.'\"LJPK> Y#&CZC5<%3T%\]/PI-LK(89Q) KE:HL2'%I%4;-2.+). VDS[
M28,. QL*8B09]L/[(^.34!I;LR&U:Z/K,</LI7,;(N)-0;[)$1;>9LP6)%9"
MNK!V,\7(6,M$0<)D(&%B)+/UWJ@Q5N+-6*RDB(2YI84@6-Y2J4>!#KE!ERZ=
MC?:Y*J.G(<&H3\LR:C4Z2E!+&'"AS>26!>3YD(M:2_\ S/*'4_2')[RIUJ<Y
M(N6*LPH&%*8,.8OY/(&&IRIX*P;7IK#M*QUB?%<2NLG)Z=PZ9BO/9 9 ;]KJ
M3(L>&V6'V,28>6#6RTN)%K%EL)ZD,BNKGL1S,V3@9?(3F&/"8U8W%@S*:>48
M*UT+)5LB+NJX;L7ME6$D)M@Y1RQ"L+P;3$(T?FY&4F5&NH@8MK[Z=5IMT:5=
M$EZ:9IT/R<FV+39W[;"@B7,O#CQ8Q@^2=%:1/0VQVQ(;7'S7V7Z75_Z:^1N3
MQQR;8;A4NOPI*MX_AX=A3HG<31Z;CO"CL+3]4B5ME<FJ33J2RILGI>1F(;\)
M3LQ1XLE/1I<$QY4O.=G^IC6SCK-%W6Q=.<K"O>U\2:P=*N%;@BFV$8BV'%^V
MGJ@A+8FY)(9-O<LDXMD+ 2G2M+7.Q(\DY!P5R[N27E41;,$.R=6,0RM1CP8U
M2EIB!(UZBTZ*P4Z'!,S K,.#$>"\1GF#]E$3+!RASW&[HT2("&CP<OR8\B.(
M\$T>J4K M?H=5Q?R.<K&-Z?-1<<3E4AT"K\ED]59&6?]EB4N6AU/_J!\@8M5
M;'=!E9>&84&FR<H\18\3J&&=>&>\@7]8-N/LV69DN5OO*^HG&%^Z=H;%3>#N
MG'6+K'3R&:!S*YO>-< L=*,5@85@Y<+LT;>EVDB6(;(J71%S4D&,AB6I3,W+
M075&7G'S,]5I.:I3)(0HTK)2WVOR4^Z98;D,,*&TDM$*(U_DP/+,B/7<8UY!
M, X?P]B&I0,$5K#$I0<)<G.**!RC3N*XD_2L28JKIPZ*A@N%0YF'D:^:;4)V
M8APX<9]1DHLL9R(]M*FY*5. (_7OEO3YIFTJ16.+_:QLC96FC$F0;JL>_+>L
M%:-RLA=F0Y>WW#.W)ZY;NC\E7(]:Q#!Z:?3Q[ NB6DFU;RDI)*E<N6\?U3<3
M3U+I%%AR<TUCY:CR$U'EIF%*EDZ(\R^$YL*)&F&3<9S6-<8HE83O(90^(\YB
MUOZ#,<@&$N4+E/Y5YO$F'HLS*UOE-QAAVE5R@5#$#)G"46D8=E*C#C5*0IE(
MF,,TV!%G)B *><13\(U=T6)*2DLPPH42/F:>U3:B<$O->GDS-;N\+BM_6;;5
MJGMNY;:AY)Q@3#%^MK0.7,\>2Y[@8P<;9Z;9=*RX")GGT/CQE-D7O.47*F_F
M 'GQ*U5::[$V2HNCQ86((,'R4:"QYIE/F6P"*@T1HK8;(&5S9>$R*Z'*-B7F
M'FSHB\7(<E7)SCR#R!?:<$0J/3JCR+52JMJ5+J<Y+0\?XUH$6L@X+F'4NGS$
M],UET2&ZMU";D($YB*-(N91)6&72\E;:+%&/\S:\L(6UD'(.:65KR=NMM2>*
M[6N_&ZR#]ED6W+X-%VE"Y'N%'%.66=E-YZVF,7))MXF >N6Z5W1S6XX&XFEM
MNG4/<'=2,K4,2TZ#-351;!?";5Y*#'E"'MFX4SY.!#G(HDIYLN(L%K'@0X3B
M!,,$:%%;!)AQ?RO%F(<%\@F.:GA[#V"8]4E:A%Y,\5U6C8F8^7CX;J5#;-5>
M>PW3WXLPC&K;Y"IQYN6=$FZA!AQ'T>8BTVH4V+4X4*=I\M\!$)P$%"P*3IX^
M2A(F-B$WL@MXP_>)QK-%F1T^7V+V[QP5$%7*W*':+'.?8.;:O<0H8A0H<(.<
MX0X;(8<XW<X,:&ASCO<;7)WFZ^1:A-NJ$_.S[H4& Z=FYF;= EV>3EX+IF,^
M,84"'<Y(,,O+(3+G*P-;<V7+5HN(E$2B)1$HB41*(E$2B)1$HB415W,TN;WQ
M==_$*M:WLA9G3Q3%ZC-#1\Q7.C?-[W7?=@X!R+;);FSC)VG.+OI.Y(&/1"6.
MW<! "3R+:IUVR":4:Q^5?E50,S)S&*H,*:J D65;#9GXPF9F-,RU,FX/EJD^
M7B%SXL)HSY3Y*WDX%V@!C=/Z+8*AT/%-'_IWJM1P[@IV+)KDWY=1@VEOH5#I
M-!Q!R@X<J;J7@66J\BR!+4R?F'NDVQ(9J =]MJS8<5[GS4<%W49._)".QMGM
MAA?)66G_  \([5]IAMUUE"+N[(=P2MLX+F[<<*ZI&5B9(DWDAD(<=PE[DL^,
MD)>+DW?DYE-74FQ=NT7#Y9UD^9>V4J;:?-SS\+,KM'A&=9'FXKX--B0B:TV6
MFWN=-_98<QY!CXC'NR-BQLCG O)[B5H,O,XFP!,8VPSA&7_J+F>1[E1J,'"L
MW1\.TZ4JF.Y&I,;R51Z]AJ5@RV'1B.>H9K,U+2<U+0?M,:1I+IB#"?#@,A=M
MBH56_L):H38JU Y"A-).+L_1JFFRYY60RA?\A?9KFP\YL>X,?8UE$[\M#(5[
M%M;.%YQ,K@Q$;ODX62R7!131V65*9R]9ZL89JG5G[#5)IE#DJFPTB,]TY,NF
M3&D'2\64DX@FH$U,^0J4Q#?308[X;IR$QKLX)<WIYN=9A_'')9_U9R>8=G>5
MW%/)_,MY3*7*R^%\/2]!%+QE#KE/Q%B:5=0*QARAFJX%HLW*8[B?X-+3LKAB
M>FXT%TH6PH$;>71-G"X+ES7F?%>4HBXE<W(-E)Z]I-W=L;.Q5G1UE&M.WH/'
M);8C^R-:#%!G>:,G;5TKMDR9PED<D9#8(QD4E'P['TF'JE%C5&H24ZR,:B&^
M5F'.CPXK)=DOY"##E!!808#0(X?!C%H%1B"<FVAC U@_"N6W U/IF"<%XKPM
M-TYN!HD5M/H<M!I$U(3=9F:V*O49[$AJDSF%8CQ(U%B2M3I3(KC@64?AK#DP
M^:FW3,[,::.LAQ]C<3($Y"_G.=IZ]M23"RHFV+:R[GW'V6\)P\O:A(\T#<6#
MG:"&'\BZ?;/,V6N-Y=4*FF9ZHLYF).7D$R&BE>@=--EL7@.FC4XDQ5F2\.#!
MGJI*S].AQ((88<:G.#9":I4O8QC'ACSKE[XCQ=A_:(6')BN_TQE\OA^%@*GT
M/DUF*W-U2IX/Y/L180QQ.R=7=,"?IV.H+XF,L-\H=9$2'38%)G7/;!;#A24M
M)RQ+9MFK$9?LR?"D7<@(,TQ0X:FO"5"#3-)A;ZCZ&UCI,FBRS(TD9PHH** "
MHIXX"VZJQ4E4DC@F7I(<U$_PYD8!HMA'$S_)#/Y*\.OAK26Y[GS1J<U]3J ;
M+]6FZ!)-QO,TWRD=_E/ZFN0*3,^X2IJ#8$[R,OC1X;(XEA#:W/$\UOD<GF,+
MVO>W.9&K.U7Y0<:A)+'$[FFS<4EL9'',+BK2[(XS3E+KU+V_+X:9W8%RP>0I
M"30?QPSMU*/K?B)"WTG$+:WD$S&YV;^2= +CUD"MSAJKY.)4)>2$L)6%)4=\
MF'QZO"?3VQQ&AS3WM<TQ8Y="8Z$##@^3RQ6N>;N^;ZSR387A<G<MB20P56L6
MFNOQ'/8LY4I;$SI2D\F50D\:1J0:9/X=EI6) F/L%); J,W+U%T*=JO^("8I
M<:7E81$/7&VN(;J5=6->-SQ>6[(RK<[C27GW,V2;'@\/FM)WHKRGCJ);O+/L
M^YG+]T_4GFTG-N).T5H*^4E+@>R%O&GFR_D9V"2_4P<4U=TM,1F3TO.QC0ZG
M/S<M#D# =AZ=E(8= @1G/+O*M?%+X!AS(,5SH7E&GR;M?TFI_P!.W)G!KU&I
M<WA"NX4I</E=Y/\ !6&:Y/8Q;5X/+;A7$<Y%@UFLTN%+P9<2$66D8<K6&3]"
M>VG0)>I"0BP_ML+/#D"T39GSW>&6,XXLSA?ENY'^13&>FG+%K3\'8C&P5(HF
M;K5NN6GK45CX^2DTI&.A7UO-PAY%VX/**(K.!?+K=HBDU]1AVH5.//5&2J,S
M"F_(2=(GH$6'+-E2P5&#'?%@%C'O#FPW0FB&YQ+R"2XFX#?GOEOP7@"CX2P+
MBO U J6&Q5\3<IF$ZK3Y^O1\0-FW8'JM(E)"K,F)B6E72TS.P*C$,[+08;95
MKV0Q 8S*]T737#=TX&F,]74ZU=9FS3;&MJ/U9S,!96.F5_9GM]NTLLMZ$;XF
MM>P<>6:M\B,_ABZ+4+'.K@GW4,^;2#-Y-OI^X&C5=9XMT$A'ICZG'=7:A4(.
M(F5N)!EY5LS4(0;+_:+2,&5E)<^0BT^/ R.BQ70WA[71'1(K0<Q_9\:4G'TE
M@&DPN2#!>"JIR'S/)))5"M8DCX?P54(D:MFB&)BZJX@Q'6F&KT[&M*JQF85.
MIT*>@19>-!D9>GTZ-%8R"S]V+=?^=)#*5MK77>T/=KZ8G]1C;-VD.T\0N$<D
MZ7K)Q#$WE*6Y=9[G\>"3GI21^1RW6JB5UI(1%Z2-Y-(RSTFSDB9TK26)ZF^=
M@F/,PXSHD6K-J-"@2!$W1I>1AS#X,<QL^>+$?Y*$+1@(<R^8$.7#2 1ABK^G
MW LOA2ILI%#G*1 DZ=R<1<#<L%6QA#?AGE3KF,)NBRM2I+:7]G^RR$I+FI5*
M*U])?$G*)+T6+-5E\2&YS7ZFW9KDU+Y;TYZEV2>?4%FUH6+I>S? Y'L:&L:$
MO*W(*],V1MM7A9<XOB.\[@BX/R,Q!A.W)&N90+H@48N?LRZA=QT@\<UTD;$=
M7GJ35V_XF"V!+4:HPIN7ART*9@PIBHM@QY>(9&8BLA>3:&Q(K'/,:$(<67CY
MFO<5^M4CD+Y,L(\H_)C'?R?Q&1:Q7N53 U0PW79RO3U%J<_0\$3-3HU:D(>+
MZ)3IJ?\ MLP9B0ILU"E/\+GWS5/K5)$&9EX,-;(W#J&RS:F7<S+8AR?:$Q<5
M_P"1>%1C9KFLUCL92)O:#SC9UV,I>^#V@$JG$$83)%F\]&1L$]B3-6+HS)I+
M$$47J7;1:K/0)^HF1G($2-,S6"9,5'[,U[)F'49>,V),F7SAF2)F$5C(3H9:
MUV1L38X?FM.Y.L)57!^"VXPPM6).G8?PY_5AB6-@D5R/*3E#G\"UFDQY2A-K
M!E'3AF)(PWR$S,S\"<$6/"$>-*.&> _F4]86K5!C:MHW7DSY'8.TM3NJ_!>3
MM2MHZ:I/*3N8D,)R,(SQ1 /L66<64;6RODM>4F&[I>-:G66"";1\5(L7QGLD
MYT%=K@; @1YOR4.!6*W39VKP*0^==$=3GPVR,)TE+YFP#.%[P2P7/DPUCVNS
M/=PG\CG)&^/5JQ2<,BHSU7Y+^2;'F%^3.K\IDIA6%)R^-Y:?C8MGX&*ZT92)
M4X>&&2LE$A0YF(UC/M\68FY>/ $"6AY/TXV;E_6_@6P<[Y7F+2FIK(N,+9CH
M^9>QSF(6Q_>.(=55Z7+*.[>L]BS4BV[7)EH,K08RLHUD&<HRDL8VZ603FF[Q
MLXA^929>?Q%3)6IST2!$B34G!:R(YKH9EH\A6YB,]T*7:W(&SD!LNU[PYKVO
MDX.<10YIA^7Y2:S@[D.Q_B# 6$I*KR4EAO%-4F9F2@3,.<9B"C8PY**)3)2#
M4:Q'C-FHL;"]9C5F/*2L67C2L>6Q143+ND8D"+#G9+< V#<>-[!<6]<RL<DY
M=7QD:YHJ AI![*PMEVS=E\SUQVU9,1(OV<<X<,+:AI)G'II)L&4;'*$5BH)H
MW@6$8D7UU,EHTI*F%&+ YTS-QF0H;W/AR\&/,Q8L&78][6DM@PWM98-:QI!9
M":(36!?,W*!7Z;B3$$.HTMLR^%"H6&Z9-U"=EX,I.UJITBA4^FU.MSDM+QIF
M'#CU.=EHTPY[IB/-3+7,FY^-$J$Q-..:Z[%>)2B)1$HB41*(OX8I3 )3% Q3
M ("4P (" ]X" [@(#ZP&B D&X-B-01M!XK^"0@\NY2CR#N3<H#R#L)=R]/1'
M81#<-N@B'=13<ZZG7;KMZ>/I7K(V;IF7.FW13.Z,!W)R))E,X.! 2 ZYBE 5
MC F4J8&4$P@0H$ >4 "HL!<@ %VTV&N[7CIIJK.B1'"&UT1[A"&6$'/<1#:7
M%Q$,$V8"XEUFV&8D[3=>(,VA>RV:M@[!$6Z&R"0=B@(IB*"6Q?E:(BDD(IDV
M((I)B)?0+LRMT\T:"PT&@TT' :#39H."GRL7SO\ ,B>>_P H_P ]WGQ!FL]V
MOG/&=_G&[O/=KYQO[@(0O-RE*',(F-L4 YC#WF-L'41V#<1W$=NM2J$DVN2;
M"PN;V V < ."_I2E(4"E*!2E#8"E  * >X !L !\ 40DDW)))VDZD^E>E)JV
M02*@BW011*<RA44D4TTBG,<53'*F0H$ YE#&4,8  1.83B(F$1J  !8  #8
M !MOL&FW7IU5GQ(D1Q>^(][R TN>YSG%H:&AI<220&@- O8-  T%E[2E*0!
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ML. U%CIM'#HYD;$>VP:][0UP>T-<1E>- \6.C@  '#7G7]%%(W0R29@$@)B
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M.<";@0#F .8P$ Q@*!A'EYAVVW&IL-MM3M/&VQ07.(#2XEK22UI)L"ZV8@;
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MTE28L4O#S$B%[2US7E[B]KF!H80Z]P6AK0T@W:&M L %Y@BB&VR*0;<FVR9
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MV5S88Q=/7NDW\8<LTU4FNZ8+E0.FP?23AT+<QTP<';L8YVHW;F.0BSH$$U3
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M'7BM9]SC"$NQ@_A96/=-T)=-)E=DM-Q,UY.(Z(IV7B1"/>J36<0$QEDR><"
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M"BS((T.U62:*%"KQ<[6&8MN,>=ESD1C[<<?,\P HSN"88G/UZ;@2<1((^H!
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MKD:(E$2B+Y<3E0Z3]PJD<Z:B;Q51-1,PD.F<BQC$.0Y1 Q3E, &*8H@)1 !
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M.3F%EYG?I^:@A]SYOK)OZ?-6K'$MPO9>O_$N,<<1N2V>-)+'>>,;9?\ +\A
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M5%)!!(O0B9"E#H%$7-41*(E$7S(L9XLOG-V4[8Q/C6#<7'?%]W*G V_$MP$
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M')^/V$0@A:EV2[& C'L7,3\87Y0_>6ZE-(KQZB@"+1=MS$V4YJ*X \FXVUS
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M $4I1$HB41*(N'N*72M^ FYU?;L8:)D910##L!B,&BSH2=X"(G!+E  ZB(@
M=1"B*I3C.=5BN-5ENYP5,K*1^C'$\\93F])=XVS2]>JE'N#=4"D$X#T'8P#T
M$:+0_AMZSE9_U!W4C;V LG76@L MF]B2CM-8!V*=L^9@B!P$>G*=%UN&_38>
MM%FJ_O YR>>8S-J&M\[CM1FK\R7)@03;[[3+!VHH "(B(F%ND C\&V_NE=Y!
MMMV<VH/1XX<\B_%ZGB%TCYIM?M0 CC F>I]XGS;?M+&%QL8[</6"QG<B0/6
MD';J/0JMVCI':L2<"Z>(GHET[6OVG,1SILPQ/-DQ-\PJTM.,828@&_><[Y@
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MM?UW=JWZ=QK%\8AG39)8R8[D,<H&$/\ . U-R-A(0@': OUIID2(5-,H$(0
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M\EPS&0>-5%6JTD+=0Z8D MQ])NIGRE*4I2E*!2E "E*4  I2@&P%* ;
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4/U029I%9,&[%F)T#%-K+=:B+_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g377019g01z05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377019g01z05.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1D\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &2"^9#(X0DE-! 0       \< 5H  QLE1QP"   "    .$))300E
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M36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP
M     $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C
M:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M    1W)N(&1O=6) ;^            !";" @9&]U8D!OX            $)R
M9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M %)S;'15;G1&(U!X;$!]TR;P        "G9E8W1O<D1A=&%B;V]L 0    !0
M9U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M        5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M           08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T
M=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E
M8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M
M       0 [_^-0 "  $#O_XU  (  3A"24T$)@      #@             _
M@   .$))300-       $    'CA"24T$&0      !    !XX0DE- _,
M  D           $ .$))32<0       *  $          3A"24T#]0
M2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:
M    !@       0 U     0 M    !@       3A"24T#^       <   ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@     ____________
M_________________P/H   X0DE-! @      !     !   "0    D
M.$))300>       $     #A"24T$&@     #-0    8             !SL
M  JD          $                          0             *I
M!SL                      0                         0     0
M     &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M!SL     4F=H=&QO;F<   JD    !G-L:6-E<U9L3',    !3V)J8P    $
M      5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L
M;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O
M1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M.#-H$[3X:I*;W[0@^QNG>3*A9E9#R7$P.($PJC!:>&%3?3D%H$0DIM5Y=S0
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M8,S*F,BENL&>ZR_5=XC1.+7_ +P'S24Z5F0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUD68K3Z)>P]8":\V(TIK93DVN"*RSR/(/N:T7V6UIL8'VW!DWU]")"[<I&2
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M<J_-JK9+ SCK$K;"P.-J5D+ >/7"#V7EP1-B4!L4OK^A8<43@O&+ 217/_M
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M9C&N61,CUR,5K,Y?;L?.M)\014NKR&5W)RT70, B*SZ_MY+8IE/<XQ2R!:;
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MS6E_;!(KSUN<V0@IL/6)595!ZB+6%SS4E5)]GUM7!L%J++%GVD1@A(E:*%B
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MJ36EE?[B2ZH+()$6^THV)UTD4'0KTZ<XKG7/VR!,FO-R)J]YCIU;I =-9_\
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M<&>*BCV@Q->#O=3&-MGNS9[LX+<9BLR5D.,V6"J;UH$"O;=$"/K6#$BSS*:
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M7Q1*$_\ -AZBYJ8AZYQ/^I5JKN,Y+C M]V4!,^Z5@A5> ,D1#'R7"$6LC)8
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M$5VQ_P"\>W*2I>Y(&HO>A@3 Q:8QEZ&SC5$!Z)3F(P:Q?HF&L37FIJRCT03
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M3:?<:4RZB$752_R("(6E,V3?%?LRC%7NQ#66C)YD/<4V;O21):D0]T,7-<O
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MQ6:$&HG7;ZYEY"/<5[?NLI)7ZV:E+W9I7)%A'NV1&/N>M28E4A 513LLW9G
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M-F*2"<XZ= 7?;,%L(*(PB5*,[#7PK+?-<3:G#6I6%N<JV7K4^/HC%WIDZ<G
MB?49?):NO8+&QG%3?>,5DZ,E"7MB9]MI79;&0_SHQW8]0DLL*R*TX[[H1C7]
MV41/T,#&1E.+2E;859R?"#(!B[^D.>4BJ4[5"0/W-<$5K1CK$),:IS7^N+*T
M9V*\8!4YECV.@PQ4[VQ'W:X]49*7ZU!K@UD%I(LRYQ^W=M5K:&6H.(DV888Z
M1Z&%ZV048$!BYJ]97!0+)+FDN6V<PDBC)8>\TO@V1:"E*GL"S)4).V"I0KP6
MOHSJQPJ1"HZE-KIM];B+-1QQIEZ9.U+V(392$@(2B)M5&$YQ4EDXPKQ8$I>5
M*,Q&00L?HD194\')DZ;%MA[JU(C-*TF<%^VR#&1LK:J29L@YAA0/JBV<ECUA
MVI&!%+8_!-%@>X405&'KM20%U9S(K- DY+$L],8/;7,8UU,9!7K,HLA.*VD7
MO_)$2$V2$I+V[U;M69ME08OVYJF)F4$S6RO[JY((FPQ]TI/^8%D6+#&"0A<A
MJ+#7%F3&3]U2I5E^Y"$))]$XL?$V7>W*$8PLJ8J<Y2;HD64S!$RBN9J0]P*@
ME,H@@Q$1%:DEWZXU!!\?>K1<Y+"H6YPBR,RLBCI8&"H+7< C)#8!$Y%)C[+R
MM,?6UZ]DSFV</:1:2(>ZUOVTY>W8\$4O*G3K+=%<F37.#)>T$P2N4E:;!=BN
MB(E(M7&?5,XLG>)FHR9ZF)(DO'>V91>RB)+35:(652A56T6H**)+<^:Q%@DE
MY:P6'P1,3E+<)%A$Z5:@M8<NQ3KN5."Y)_1 19::(V%>D33.<%A</1.2/\J)
M1*$HJVB1%CO13@^4DS7-9(,DSE 2$XR]4+M9WLQ>P!4% Q,&%RJOI7*$Y39,
MBC+%6G[@%CTL3&=J*YJG0JP9ZA)Y,PR1C,^L7%D-_082*_=BR?JD1%-"@I<F
M>N2A&%R7NZ]2TQ=  ?\ =WVC3=-%<S2IJQ(-9)4)L]2 J)%XA6*A*:%+$J<O
M6U3362@LDJ<(Q283BUL)+D/48UY,KQJM48THP'JD5QSX\KSBG%P7"M-U-\HQ
M(@OUKE"45?<3'O**J\C#3_8?[H#&RDZ:]JKETBBCKHH>XHU8J843E(R3"$8F
M2[ EZH&+&&4D,DYQ>%R=-RX)%J'ZF,)SF.WHO6$<77]*72B?=?*-FF^2TN95
M78?!D4N9*$YQ6D3H3FB*2F4J_M3]DL7$BV!6R-"NH+0C'6U#TE3F5$O)480]
MH1"7>A$0KT:KB4PLDF,C"40"+AZ[0N2O2 $Y,B6*)$?4Q9]5E<Q+TC4Y"<F0
MG'W2!ZG2,3 08PKGK\Z[>Z\4XHHE&;01!<$RF! S],%,!]MOIC&9 +6AC)K@
MIZU ^[,2U74V2IW/*^Y7O3HS2V,)."9"*X1@F$@7 KBGT+<N=0PLLBZ#8Q8%
MAGN,9.O!Y@@D^>5/KW69_+6>GT0]N"80,B0(VP24,DTR;!4I6%R,72:OUB$H
M>U!BF,89B$..>ET!;7P?HP\9O16#"8Z+[*O;A)KXS=-:H^ZJQ)@4Z9E6TQ<X
MJ#81_4N48J+)*?*2HEL;S?:?5.;>/1;+4F$JTBZ:DLG:8*TIRE%;# Q+V&?2
MO&<4Q1,-BZ#6UD%HE&*Y))1>!@M$)?;V)^Y"(8%(9[52O;@U8BI+XQ];K%<G
MWI)5:D81'ME<9+ELB\JZZD)3]"VMBL,U" 0FSNY> W"Y)#H$J@N!6B/L;DW[
M<)7.-9LB*\X]XJH5&2P)0DZS&O\ ]U"XPA6A"5F<8>EH,XQ2P1]<HRB8-9*N
MTQ"2*.R($9UXKK3E8="N#)L'V$O0:[JLZ[ZT$27.VL26V,3",&&:E!L8M/W9
M%56/E;MNC68(LBN98%P,E+C]RM7N^A\38FV$9&:;!E8E$F3E0@E;9$BAC B9
M763-46I8HMW(>@D,DSUR]PET@G_/*U*+0/==%\F3-;P12\'B1DQX,IQLJ7*B
M&!8?7](DV?KD$3CZ(UQ)TG+C)A]:D+FYL(>"*1A,!,&>VHR:F+G/DESI%,&.
M@K4GR*I0(J5%,1$FR:\5Q7]Q!H2HGNLNA::@5II2YDXQ8F4U)%-5>NZ7N-?=
M:L(9,$DKDE+6L:R*@M9D^3 13,<IZ)@03.<T!C%&7JB^7J?[Z_M2(/9%12R3
M&",%R#911.0,2?!%B1S%JU$UO\F3=/C,S:9+W);O4\>ZL^P9>HUI1F2H1A)L
MS"41 D4=>K6;-/T2 C);/9LQ]'H]B24@>[)<M1*0F%>-C_+#8>W.!C,)?HBC
MRD)DMC413#45F209KG!)6F,&1BU\7+,U$1A7A/U08)1A"(A+P1-R#/0J)*9^
MY&17(S2=?;Z:L3B*<6DJ.[EAA3**8+7!K)K9^I9%KG*RL2K$L4F *8JB@0"_
M=<S4"3#]:@R,8CVU/G()$I^GJYDO$X*^>>5?-7^IG/TJ;8C<9&)"V,D)2D!-
M4XG<IR4R2Y2]L13+W!Z)3;+TS)5N/N>F#I[[:N/>I0M;7R.@8[ M44"?]A9@
M)!BYF6MP9%B#&"_;F)Q"!7:T^\)PU[GLPB)-]7J"U>L6AX?5ND&?*-B>G,=N
MH&)/%6)TQ%D2D2EZ0XK$2*[?6M#$&#8*L3G,P8$JE/?HF6+W%Q*G<X]OLE^P
MG6PB9-/3T89,1#'69N@J!]"[)C.$IM(#%EQG%@6?1*07*"9&,A[3)"2H2D(F
M$')CG'5?-H;W=W=]P'.64C+%^EDA)@WI4A7DB0A&=>,/T,A%HD5PC$G]<O3&
M 587$_J]AEYZ=[//51Z 6I:\/+0ZPSAQ:]<!&*IP]] >$2CZ3)GOUF6 WTN#
M$ODD2;$A38RA!Z9D6X.!^5;Y'5VU0WIHU+4^"S>$1@;S)RLLC[.HPLV4Q,MJ
MU[<7>J;(^FPQ<?7J)]Q:I&$V/:TN]1GXU;R[$6Q15Y=]"*](8$'2F*.^.$N1
M*V1+9ZBITF^_ZO4LS2]BVLG,^ZE1_P L5O1.;9RK02Z7NRB\03<UVW$3EIW*
M ^ 0 P-3 >^L"'#2LTX*QH+2;<"E4:\2\1#8RF1Z[4PJ"HS$YA3"5+BS]*XJ
MDXE;H1F;2H<G+-M:):S!'N>^P$&\P*AGU7BO!L6(1:QC%J@8,9&(8U4;$)33
M,#_+=&816L>N,"B2A[C*L)(*_3>7Z>[J/S-7>\P(+,]U(KP8(4VK!D4AI;%8
MZ&/J</?2W:[+93M2EJ)2T1]#7"4TS]04[.&!ZD/WL@+Q.?$5H!?38)QQ=A,P
MNQ)A:LP<9+E[JY!4ERLQ_P!75DXQDMOH6)R( ,825)G@VN)Y$[)V;D9;UL;K
M*;4$S[4 YLF>VIJIQC)*S-(FXL5Z(202T+'LSA Q/J8Z?V.H2C3-;TF*D:Z:
M8BOL!9WAL$/YHY9G*\%4XKK,9",]RF&"$_:FEZO1 5X>G82&F(4]SGQBQ7J4
MN=@SFJ0N?G?9C/@2HXANIW &KB^KT:%)NC*3*<E/$F,9$L$7B*/5-IBZ=@I$
MEP]<C"$UP@8!8,Q.,HQC(><QGA0<?[CD2L45[/NNGJ:Y6# >L'UMC B,IA?3
MU03)28AHL089S>'>R_U/+7E['SN*;=@F-S[3O\!9@ISE-J)L>A4VB08TB'JA
M"2UR6!& $F+E!UJ!$/2R"XM3.2X,KE[W'BO=J5ZNT;^V>]++UG6L5F5T-4;4
M)B$&J>1!$UV)JM226#W(S4V;A!4U+DJ+ ]L#)/M1@;;MFO=.#/AN%/7C:\%B
M4W28V,(I>WTI>%-$5IG*<E?J]ST[G >DRF8ATYRC'9JBD(XNNYCR)CTQDU<I
MAM=BS()>(O:728]4&^DA8A7*XQ"?\PD+$7.>$6<O'4O08$HE#_*+E,'H,/:B
M8RG9E!LJ\)(@N,TKG +FV9E.+;)W%SC)SC^%+HC3:61?-4Z\Y+3*:?:,E>F2
M?\L.!TW9G):ESC!<_<!+BV/J21$(I0]<(E;O7Z7"N6>U&,X@1F"U1C'1<Q<(
MS,S"*90C$S60"194/L=Q+9P!G,2DO]9B6R)2Q<EQ,061 ^[5",IF*U1C)H,7
MCP1>DK>*:A?JFNOZY H$S%DF0]TJ,!8:8E<E,,_>6I(2P+BO0TJ?@B]QG<=&
M<)3L>IHA;5%#)F"8PA"4JRU1$H2@82FX0-A%98:IRYJ)$)DG.=UD(YEBDI],
M2/:5818BML9M2?9A6:J ;%A@5/A!X:QJHH^Y>YD&P]<-D4@>?XZE&U"%E,JY
M,W04YD(+-I@@V#/34#),7[:8#VG>@&*XRGN"?2DJU-8Z\91ECS0Q\GQ6+82M
MA6 5S7*2Y33&$5P@V8,&B:W-;%K9SFJ:52@J,9SD=O11EBU?.'&-BFNBQ(!W
MICHLB\:K)D?1/UJ8V!8(A2U";B8L1,>T$NE G3CU]E)UO-+$LAZ+61BN48SE
M .E(LG%C9"(4IS)ETY,9$P:QGJ,ROVW/DP%CG=$CYPX:*Y_<,KMBET?=>F 7
M"7NG]4XH-0(,&"251-86)K0E;F2,@]S2,@_SOQH8J4;24+6MGJ,)[:V!_7-\
M6B$!";5S0H)=)D*\1!\7L"#7F?Q55O@;Q\J&=YT8PP2X70LA5:U#<T2G.TV<
M(22N<AZF-,6B90WW(>N<HP,&ME")1N>?WA>#?//'DL"S02'1FU\VSK@%8BR4
MY6@EC)P!A**-F7IVL2=8]6YP<+HK!PKF/*_-'D=?B?E[QK*\MY1;F*M6C@ZR
MKTI,FR?^?:9&:J]"O.4E+#WV8@G7O:]:I2*D$5#+;WG!Y.?4[Y(<?3RGS+\G
M^68C /\ 5[F96O'YS%TDSTJ?WM_"2RB*"Q"3(+C?0N.C[D6R*NKG-N2HN2Y^
M?E148O;<@^'M26/<*E+F09RW"0E7!$)SKN*YB<@U(9$@R=&+GAYQ^LJMSJT9
M^BHN?G_7G SE<K3C*7O2B1*3![PFR<F[G%+)'UB$5Q]4%0/J]L^[!$Y]^.1I
M*>6P-;]]<4419^H*A#447UQ0OVHS,7SBV2TP:(JBV4" (NF1%D($+)L@*(DL
MS O4,+%Q,\ZJG\6XW9RY[2T:1MKZBJ)FM,LG6DGU>V(,5N=G0AZA"89*4FR9
M-C+$YR9+_6N<?;#!%]5->/WPHV^K2 SMS'987_RQ2UP@NM=0/:$I0B;4"N2S
M"-4M*9,!C.;/6Q*U26 %Q$_:,"TALW+<?1&$35M]7F&W8Y6'8^HE(>V*LBHJ
M7!DXZ15*IMF/\L"4F"#)-/Z%"0FK:C*.I3:7G[6[D5I,0[Z*M L;OFT6B[--
M<1,_J,K25!)R,)DDJ$X1FGVX175252:7NC,,<A;9"*UP*FB1!C"!)P-])89.
M,E_*?ZO2C166MJ:_ EHJ_P#4PN!299""PJ$(SFHB,A%,BL23(?J9)8@52:A@
MDR4VK=)C!/TGN\"L: UV8CKT,\--KE]7,#T '6';]2%=4$@9"#/4"82$ON"2
M'ET&JC$^E;EE+H1E& 8MQ+/TS7I;7TG7W_<(W?9AK4 !@"\UZK#_ /ED*:DB
M!O09(^VY:P^*HD)]V$EDR$Y+G8DH2LQDML3.=:4#Z5^F27K^\#>MV U!0B##
M2;G7TH]"2',$'WK_ %.>Y[Q?)SY!HC!@R$A+V@E7HA/=N),E#:@3&)]$( @$
M:\7G94 BPZ@GR RZI8ID6Q]Y\/=G8M0,;3)E9FJPQ; 8Q09)(C/[>(0Q<6QK
MKD)*)8(%A>OH$V3-: #(F<:WW'NB3?<D75)2N06*\XKC*7W4I0;#VA88S3I1
MF2)U7%7H>KU6++T QDH2A* ;"##(.:/08P9%+S?3."MVI02P R8U;&><_:<Y
M/L$JU::$P1*%LD05"4F3F"LEDI 0 *6)K1<V"5+@Z)<MTY,DM,62\$5@QU+V
MK-2%B,TS4BT^4:D6-G"4E?:UFNG[K517*9A38V+$64O=[2$(3$2F16Y$R];2
MQDW,DA@A"36S@M*Q!;60]'HVP0C=9[4YQ;-CW*7[*Y+58(LA6)-Z5F<(L0S<
M_<]:K)7!$A-;8VF3_4L=90BQL&2,(Q7,M]PR!%[1J58P>9PK05&TB$(S5)D&
M,DCUMD@31*4+#80G.<@FNJ4R^=6"X":YD5RIUD2A!JZR2F0G!@:(LG!%J,(R
MFM*A.L^+)P-;VIK7Z5M@>L53FLBP+5&M8B;@"8FXB6G,<A45QBR1@%I4:TRQ
MK"(2@+,EJ4"IB9,8E+2+!&)0'3AZ_<9); V$F1A[47NG/U3FF,)+FN$_219E
M7KS!E[8B61FDBP3Q^!E,B5>1C)<X,A;3$O04^W7BF6Q%3%1A$2%A;4VY*]"U
MM@)Z(O"KA_1 BU*,63;ZHQ:D%=I)]T!JY(]N8:9+E&1]P(KQA.3JH*8,\$5C
M9CEA34&2O\^R9>ET&_Y/K1.5U=92X(5"(]%>NAJ_\PL9*K%JXL:(%?OSP_"C
M4X]89-$W2FI,714PL]==*U26Q<6PM;+Q[LEJ7'T+@F<8I:Z1E%:2BEA0QEJO
M&)NP=),("+(0%E8:8DK6)2C&4:P,BAL8Q@LJBQ81!D@^!%[&I27)L5%2HF37
M>T8"4)*AN$H>@2C&($+0C&3I!,I+=&,H2<IH(L2*J9];RTOA]JRS,37 BU"3
M(RF%^DVHJAZ1(,4=0?&Q,B! (B1>,Z^,E.4#*VX>ZQ4V+]":\9,]AE&NMK?;
MFQLX,!G""VTY2T:\X%<R\BCG_:S@Z+&*,%/@]ZH,6VTN3$K]R,H+BOW0LME.
M4=F"C7)"Q,RV14#(5*,2U;V$R^T4U3703(2_0A,D>Y&95,0G-MIOJ*YI:JK*
M4(P5-0F_EDPU=%6S''!A8)KFDLF( 360MQ#E0?-9C]MZ35@A)*JZPGVF0G*4
M3$>+SG=.<\)K7X^$8P4^,28#UUA%D&Q5.:9R8EJ83<("$5Q=&:I>\ALA"(8L
MS@JB\F9*B"6*U!C9^ZB3_86N?MS]6M@24)Q4V7HE!BY@QF6&!3(^)XF]]IYA
M6NL=F4*VYC#+<GKA7#;#*Y]YQ<(L=8N39*%7T3DVK.<F!BX"$) UB\S@I<'4
M5-/.;UI*=,5\>+%UYNR&-KAS9^B$(PFUMEBI>[Z@U.U3B71"HDADXUO:]3&%
MH4^"5E;AYM?X1_1L6;F;KP?E:"_784]DI$*CLI7&?W#/=A&4)ER_;D8K]48P
M"WLG-RH*A[4F-.!R3[EO=3G/1>TN2X^!6834^%2;#$V8UIB.E36#*4"9.8#,
M"4E23.!#&L*V!C0<,[P?=5BYBCOHRQ?\98S0$BD&3&1&O8T?UA<?U'TF<55H
M *A,!C9QBUC_ %09X7RW@T;RWRZ<T_?S:_D_E>&E,2-BL/0J"I$LCZ0E["J%
MF7I1H&1_RC.$I"/OL,  WWF'G@_?3(B71H.C;3[_ '=8C.:XY)5"3*\XEC7)
MA&:)R0F<"NPP^B/JL&'_ ,[ DPKG;CN('MCP> [!]:0]=D;#G5C2GS?W49+S
M$H.F8I<L$590KRDR(]48"2US;/W8^BS"0^[C*4F#J%Q)EZ9*._BI9BU_&2YI
M16G3%Q=CWP&%5A3YWCE+;".045HG)DDSD8R, 9-;"4(+@AD(I6WTL>U4)&#(
MLDZ;VF4Q0P=#44TZS!="*U%-IR2TW[PP=81Y[B_4]?W#%-BN18:RUIB/2XR?
MJ$Q/UF371BR?NAL93!@(0KF!NCNQ!MT?U.;822:.X8.YZN]9FP-@L3_M!Q@E
M.4K ]R1#IS#4FO"4B)BPMTX+G6])A"$#$1A",HM'N3!9--GG-H?<]#G 1FJW
M2]"- ]06<M0WQ#YBT(*@87$10VP1[NS->H*@U;3&0)E!<R&J,'K@);A,LE&:
MP>MJ&?<6@7]B%*>1&V>I<"K;%94_,ZG",WRM(0V+63($ 8SISW)<&@+A.!@F
M3E1.EN<(K<#*4Y2,O2["]:G M<0_6V9]PX^6_(_0VP7>:&(BP1A?G Q9!K$5
MFSGZ 9^V5,B08R8M#+,EF,3$PGZ 8@1$KG3;[]JQE0QZ&?C[D.:LFCSCI(@O
MT/5"3380W;T"R 9&4C*2PS2BY$8Z[B30M>D"<(PEF<Z0UW9Y<,U?TK^(=Q#[
MT9GL07Z_."?.;' 06FZ1[@@::_5'TL9!0C&1@M9A%<_=@7UV-43,F7J6[9\6
ME;/XO\L+H!5AAYR8 Q:N*V6,?/'%#W#"S[H9#4F*$E"$%;D(1;&R2'U9Q"Y2
MFYNVR])TN&EA?()[$QXI^T($6@&DO.F=<&E,!_G]1*V0%E8BL.;%SI(#6,]2
MHR9'4RF 88Q@-+C*40\D1:(L,>U&J&=J%NU^PP8:MP.[C0R )% 0L.]]05?_
M "H+O*'^4Y,)!H)C$AGJ6L0,?\V6_<,X^ZU;$%@EN1@:[C=Z ]I[2TXHJT@Z
MB#T82^N8#T(40SZBJ+8-G*X@/G(SCZ+3O7Z6* C[,BW_ "2->[7D3$SKR*9,
M$RR3(^'T((G1R9,.=IP8S6H!J[[0(+ ]II&VOJ.HDP(R,@U?JBEJWDL4J481
M;"#3*)6/3ZC"8-B$YADX[#!-:6N35F;NYTD!O*,.E9();9ZZ$'&\*[ZCDJ_6
MJVZ&AZB=KF)-]4)J4EID!"/ID0?5()]1E7"Q >Y(<%_&6, :N=X8A6@#5?(@
MAV?R1VF"H:U]3'J<]_W]N$6J6/97.4#.0]:_2SU,,FQ]!DL,],3-,Q DD S3
M0"U89Z:4X*/(T(>DO>(S:3ZJ!=]2#B"86Y5U K8!"<3'87"3@9,VS;'P,022
M83ALCU2$UT/.KZR[79PVT"'=(B:-FE;.QM#UH&=0[OJ.Z,(N2,"(0$IVD^^N
M$5$2 9.4=P=$S@/5+O$1;",2?<3,#$T(]8Q%2CA@_9B#1G=VMKEJA5RSY_V'
M&<DV&L5*($0R#F+G_J]47,7.<?5"4H0+#J$9"4H+ZGU21AM :W-(T'<JPW<T
M_$5!H]9@D"T,HQOG?DZ,$QR4LE6@R/OU9.%E(?\ Z8D1,X582$HSD(1CO1CO
MU:E&44V;X+3+$F@=VH)LH&/_ )58I1V&!4D1#G=)GU$,FGTR>^,O69*"Y-F/
M5*)!A[IC-4$S)/J$8D1C/U*5(CT,LBC4IJ.SV%MQ 5@R7=WM(GM1FG0&TM0\
MT^99E4+./J9-M:;(KB(3;,>I9)"Y2D),+%K(<Q8)]J"IL4(B3)RF;UZ3$,*!
MC5\(P> 8+!FEX=S5VHS,^7&(WG_F7>BV%3C'+LC[$YSLRIXS+W(HC!DO=F&5
M:DU+B=QFY@D09>VQPA"(W??SDPU7LH8FFADTC\<LV6P:!2.!=YY<R.^(>7W.
M\]73.-9K,1@\C>JKF5L]"&OBHUX27)+&1$F P@N<YRA%3)$V*^I9L>@0EK6R
M:&=#?C.;SCO+KZB+UO#8W(</S&";E+]/'P=DEQ5* L6:U5C0FM[DEE3+$/5[
MM81D[9,I,@"(!N&+3>:ZO6GEB#[&(V9VS!R7P)+_ -B7TE^1?"OI=^GKCF8H
M,H8?S4S-*K8RV8R57[FS&]Z3883*PJ3K1I03!4HK2RK!DF1-;W%2C+2RNEY?
M5=E<OP[/\=\[<32YMQ2]!M7'_<8W'5YWHR3:?!:*:EA4J9/M8\6("Y*92R<2
M9B*F$;XX3[KXW?4?] 7DCY]X.1\BG)\N?-:[&Q=H\:JUZU/[N!A]U;I*J+,D
M6ZR[$_7.T&+"Q,#U1AZ01#JN?W([<D+X5?41]!OUO?3NIK^9<#;F<4US$*N<
M<N2R3+*0^)6TP"H6(>X'57%5=C0N%E)#F!B]1AC3]YZ^Z N:C=A&3 KM.L*7
M\FOH5^J/S+XU'E+N'<M5CK'VS$+IT#LL8NW-2)+G-EF=B9KS9-2U!8$3[[JL
MU&0=&MZ4K'Q15]7U:6(D&:T#O2A4SG/X:'UC0R5:EBN/7+:L@4BM)B;D?:39
M2MP<QBI0*T+)G[RBC=9"@+44RA",#;"7R_Q8Q?R)NY?H&ZWOA]%?J?\ "#^L
M2[BFW&OJKS*E2L2P#9N3>%>):QECWH+L5K'HC78UD![C3*$%+C[\XJ6[5^!\
MT]RH^XAHOR'KX 52A_"D^LB601BXXO(K>]L4I8RJQ"%R+V!M8,8XZN"2F&-5
M\/NYR]4HUA &<W0:_O2:B7W5?4Z%Z=/%:675O _X)7G9E9PQF9YOQ[(\B8NE
M*SQS"\CQF0S6.@ZQ72VO;H4[C)UX0B&S6]L!7>Q<#7]:W&5@0]>W+ZAD_P!M
M]"\O4[@X]W)Z^Q/\![F57#Q-:%;)6XPLB]7O7;4[D(UFLE'V7!,8!+*_^9*"
MO=?#4?MVL/J54C")V<T;%*=\T3_8M6.[]W^-%"\$_P#@^7(W<Y4KF.5R8KW)
M.N?9KKVTXK&P6/=C]S8BQ*UL]2Y2DF3F^E35H!JS_P"\2H#<&FFG(:$WH7=^
ML<VU>R^>_P#\'PQE:*,/Q7S0H\<Y-D(-9@:%'$W\E8R1EH1=)6,#8_816"RW
M8976FG7,GM<HJ'MWG/VCY%WA@?2FBT!2_P#@]GFKC$>QG^7O1<9.3ERA.Z/N
MJ\M+%N:Z@9!4G/78_P MDY.$8QE(F,H$QAKW/RC[=A\0J0U.)1,-;$RC&Q:@
M^=2,IK9(^RTMC)RHDP2PJ9^E'IE)X6(JOS4V5Y[J<]EZ>]A::4B5Q83"16ZP
MAGOD!:HR4:?LQDF*DJA-((A#T^T[[3TMA*"BO3ISLI:KF\76#GCVPYWN,E.#
M4/L2G-D'&-=B6R6R+-3A&M"C"$5URA5<>V[911MGDF!JP7&!K1DLS1:_R5SC
M%$2KJ(3A)M5:604+$H24V-T^XWTK5";B-SQ&5Y_XYHPE-J'(K*%R4IL?, @R
M>UJY3]+2NPRN9&"[+)0L(K-FN<+,C4^V@F>>'"$,@WS"Q:&K$WK<8^[J2#"#
M(37"'V[ESFJLNHML1*$O4#=7[TT"->N/MX5ZZ*L8BO-^%J+S3YAXWVI1@^:7
M/*0%Q*J\V2A;T8A^FR9$ADH>Q.=:6Y!TYM&_#G9"&YF1W2L>:M%<U^NRF+D3
M389[+Q%85*#H1D@^B4(+(BF7MQ]4D-MRL29NQ&$#MZI[,_)^'7D[S@I1JP^U
M;MLP"J<I >@^VQ_H&BJ;U!DX,@STJ!;[:8>W&N)*>4:FM^:U]U%1\UJTX18;
M2&K2TF:T%7LKBIR 1" 4M<WOBMT]Q$@+2IQ*B$@QCG&TU\1'F,$FOQ^5W&R\
MSYV8ZNLL-\UZZ%*0I;K*9D17#WJY_P U9A+U1D(>MI<QP7-1D1(R<]NO#Y[H
MQYSABJPKGGKB(.; 640DT3CJLNQ%/MEYG'9:0WW*R?>CZ2&1E$J49-,B34;V
M:*OCDJ/9YZ8N<[!%@+=-<YQDVP5L7!D "N$83G:%6*S,RK2;8F8C_)K&R%MA
M'^]/NB-]'XIS5DS_ +>L',J=9R*' .;]Q*$F;>*Y]?J)E"3%:DV0B(5US97K
MN=%RYMEZ3^K1[HQX1EN:31>4O/O&"38.?79'U-L1B9+LR07(@K[JNLRBI<A.
M'KG%D#%(,[+5RL",IU&]OWM=[*.=]0E+W8:LQKR68K$:\/4GTN7-9]L^J"Q[
M9/J'_=V!:)00H&$291]<=\( _GH,OBO90SOJ0JE/N)M1D'DL6E[Q!0A[L=,C
M"),HSB%=X0V($1"H'I 2S[=S8<%PRH#Z'72KQ$9+Q20HUWU'5Y1]QEEHE$36
MO5@%J WK)2YJ*(+C%9$%$)$E")U(D/,@+V^Q$B*,>A@Y4;7]S&\=;/ ,([ZA
MJ$R6&\!(-D%&;P2F:F3]?MK!U)<'>DK5+V@)2]>V>YN3@K2*Z^?*H%:%MV[X
MK.E0X*BK/U%@+<97(2FR?Z"#,R*P0%F47RB=0UZRHQTV*8B:VQ$2#^1%6[M3
M6^$_UK6*AIJV:^ +V5-S'U$UF,]3;*EPD+%=*1(*BV4_0%/BP0G):UD15)8D
M/:*8"#90UZ -FQH.CM O<(Q$E[ZN?2O</H];N>?]FK/WK'W,8L4Y238BY89Z
M8RC_ );8*K_J,8+]!6+"O45^EB9$"<+S+2^L1$4,&]:9H$32!6'JY8L6\[J
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M;Z$218O"%:PJ,'.ZJZNN?2Q].G,\<KC/,<1Q3-6<M35EL:[$(KW:S*EJ*?\
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MY.QC*=1A77+YHYCH%VQ3^MKR2Y@K*\LX#6<_BU9BL)YJ6\+RS'>5>=\M</\
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M1*[D\BKZWG5:0L5LMR+G',>9X#D='!V_\(<-R]G"Y8WV)N9O(7Z;>-9G'&K
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M=>CD53_F5S$QK)A"+7)"U1KP$',MZT1Q[?+L<0::Z]T<J\VL:G \WY=EQ?\
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M+./6IY!6*QQ8O[O%X>_'V[6!&2E7G8EC;2#*-F%:-9DH-L5T231=]K"M39L
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MOK.)(M$[(T=_L2>I&]#<MZ(^-=#^_@H2; OT;-3ZM?-#&R>OR92T1V&MCL0
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M>O[COTWU.OV/@E8G>GP?84T3M _N=#6M;'8 1^?QK?3H1^H#1)0=3ZE\\PB
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MZ/4_W_MO7]?P#K?]_!$/Z_W_ #_?P1+U'MLZ[:_;K_[[=?[#P1+?;?4#H?\
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M=.G7ILZ^.NO!$-]" .G3OWW^?_+^FO!$3'73X_)Z=3^/V_/?L>V_!$M:W_\
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M8$]AOYB= CM\['@F7I7/8,0126! -7HPQUH=STUVZ].N^Q'4;V.G;P0_D]P
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M@=Z&SK8^20>_;X['P1 '7]/[ZZ[!Z?/_ "V!KY\$1,?CH3\:U^-]>P!/?1[
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M2"=$$'X/_(?OV.]]1HZ!Z>"J0 ,M@:Z]3^=]#V/;1Z'7QO8UOP3?G,2G$?\
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M-Z'?X/[]!T_._G7@J\Q)I4"=*D4N0["L(@'J""3L ;Z_[_M\ 'IK??P3:(U
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M(@1Z>A)_(B!TV1KH=CIWT >NM?._!$MCOL?G6NI_\(^?R>W8ZZ=!X(CH @]
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MK1.CU/\ 7Y_H0]G=ZBU>V>\!WQ!U^H #KU(WH]0=[.NG0].Y ._!0G$P+5?
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MC>]^D]AX(_,\S-Z,@ >QZ G]0(Z[V-'X )U'IUUOH/!7A32.H _T]23WZ@[
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M;Z#Y&]==$=]DCXT.W@J8IAJ[0'N9;5G1]O4MCH.PZG]77?X V0=1ZZZ?MX(
MU-*B:-Z19$@$D=SU.AO1Z#1]0U+_ )_J)_N"<'CK5IV1 T1Z0 ?@G1,>^M@]
M>_IWT.][]7@D>WP/,)\29=Q^V^NMQZ]3W![#70;!T>N_!5/])V.OSO7P?QT(
M[@'>]^G\=O!.<Y[I&(![]MZ[^D;UK>B-DCY _8$>"($$:'4#O_?0 _KT(_<
M#9/@B;K>A^QV #H['0;Z [WVWN/7>]]"930#N6S_ ,QH@=-F.OW('ZNO0^"@
MOOAK#OATO2!W'3>ALZ)UU&@ -G8.NO;73IX(P @6Z^TE Q!&HF)!UK1^9=#H
M'Y.MZ.]_GP0\I:;\V33ZP>@W^3Z0=GYZG1_ZZ[;/@CZ'L3Z!0@V!U!&AL[_!
MUU![G9[@]1O_ '*IP'<1![CM_;N-:('3J3KX]/QX(@-#1(/3J/ZC?3IHZWH@
M?B737@B] ?GL#L_)/JZ;( !)[Z ^>N_GP1 GIH;/?N#U ))_?X!V.IZ]=:\$
M2(/4]2/3\:[C77>];&CKOL'7Y((@ =_J)U\D=1\@#N==@>FQV_/@B/?1W^>X
M)T!L]^Q UU&NY_KX)YV3# @C8Z=R-C_ET[@; &QU /@B?$['4 'X/SW/_/7R
M#U['OX(D?D;V!H'J=;)V3( =>FAU)/?0\$YSG=#9T/P-Z .M:['\_P!!L_CP
M1#U$ Z)(V=:)_J):(UK?QH_L#T/@B,I: /4=M]@?CH>HT-_&M:V3U\%(;(+^
M4T>HG>_GL?R.YZ$D#N=Z/;^_@JD-[V>H[?';YWU^1H _![ =?!$\'N#H;['0
M.MG7SL?GJ?Q^W@G-TZ&_49=='IWWHZ).];![Z'8 #74^"AF/WN$B0#^XV3K8
MWO\ ?KL=M= .O7OH$'.<]RAN6QT!))_?4NNNW<@ Z!/;J>P\$YS1-,=CMOY)
M!V"?_$-C\#1V3U/3OKP3KS7?I5. '3>CL;T?CIWV-: B=@>"O.539"779U$'
MJ3L]/C>C\ #>QOJ-[\% &'Q3HB0#_P ).Q_S!_U;ZGY_ V#VUT\%4!H;[Z.Q
MK6M=>W<=>A'Y!'3>O!.?2:0#K8T-Z[GKH#>] ==]=CX'Y)\%.?0[<A.'I_\
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M="?V([COO7@H#J"!RI)=(=-D#H#V T/GH-_'<'776NI/<FD[\CYPR;L@[/0
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M<_)*[5#7W^#7NQ W+]CZ3VD-Z[G?X!T1H ;^-CJ5YZ\MNCZ0-?@= =GN3T
M[#IUT1OY['P4IXOTOTW*(B/@:WUZ@#7SK6B-]>X[G>R->"=37@I3?NGZZ]#\
M[[=1LZ'7>]GXT.@![_!7G.>R>!L:(('7>_G0[G\ ?&^FP?[D2 _8'OT[@G]]
M_&CL;)^1T)Z$3M$;(^=] 2.A_KV/]OCIKY(CH@C7;Y_OWWT[G6]]R>FNY\$2
M,0?Z?@'I\_!Z:([Z&P?GKOP1$ ?_ %?V[#IW_;?;KUZ^")=#O73KKIK?3\G7
M_K_3MX(D.OS\]>GX_O\ W_!'^_@B&NI/SO\ <?&OD?MOM^/CP1-$0 0">PWL
M=N@'4= -@'KTUH#P1$ ZW^=Z'QH]1T[?GY'XWUZ$0T?4=;!!&NI(Z@#??MTZ
M[W\G7R2(D$]>Q&]?UZ'H>FP1TZ]!X(F'])WV[G7SH==;'??;9_\ "!X(EKYU
ML:!WVZ[ZC\=#OIK1!UUWT(FD2WT/3XV1'ILGH""==>AW_P _$=L]B?0*%[>H
M_P#=*A!T!_;J-'N.V]=>A.M?VZ#J#4KD2.C,6ZYI* ULG1Z?JV=[&P.@[C1'
M3730WX*\IW^O=*7I(V!L]]_)T) ;.N^@1V_Y>"@Z=/)YW2&NI'3\]^G30^.I
MZ=SO7X/@KSG(2 [CU=>A/66OR2-]AO78].O] 1 @R&QK?0CIH'?4#9&CT(&Q
ML'Y UX*=-(AO3PB#UZ]2.IUOH=Z/X) ![:^?]BOGG9(RV>@&M:WU!/3?0[WW
MZ:[D_ML^"(@:CU&QL=?@;_WUK1.]]=_'7P3[YU3=$GH3V[$@$[Z'J>FN@UWW
ML:Z]?!*) #H0(D#6NFM_'7^NC'\CX'SX*/+?''O1'0/30(]0.S+X[?)_3KIT
MV.O77?P53=>G?4 CL"-_GY['L-'MOOKP2O&3M>G6^A(.O[Z&OSH^HG0_?OT\
M%.1S1NED/TDC7Z1O7;1)/7<= D_[?'[^"8X.3X1T1KL3^X)(WUZ?GJ#\;^=#
MKX(X-Q^Z=T=F6^IZ[UOL=]NH)ZQ Z]/V\$Z#G.41/Z0#T 'P!TT.IT-_ ).O
MR>O@F:U^!TMBY$2D"-;WOX&ATZ?MO]B=_/8?'@G#UGEY31\C_BV!T[:ZDZ[:
MWK^A/7MX)V:7YW=&0.P=GXWUZ:'<Z[;T?WV#VZ>"1Y\F9Q6Z$I? .R-$C]NI
M].B#K](T-Z^-:&_!-\[Z<PZ ZC7P==">W79)/^D:!T2#^-CP51D2>@UOI\;/
M]NX.MCL1\D>"<YS=+>^A(_<'L3U^>_0:&]_'SX*:SY].80]/4:([#?3>MGOW
M.OC\?D'6]%>=N<*('R1HC9B.OYWK_G^/R-=.I35XZ?'7Z3HC\C1'J&^VQT^=
M;V>G4#XV?G9"_//U63A+77?SH=]=/V^=@'J#L$_MV\$[:=V?SWAY3C\'MUZD
M]=C1Z=NVP>OQO7@H\M-)EJD8N =Z,93M$0[#6M[_ 'T=#?J!'[:!T-]-^"LN
M\U;ILV3V#NU6Z_!V>G7?3^_3I^#T&NO]B8+[L*NS&_+L$X?@;T>G[D['?L.O
M]AK>OG92*Q!),-+5SK>MX9")'7\$=/[CIT^>VN_?]M>"KNVHM7>T5G+)T8;
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MXUV/?7?IOMWZ]3^>A$__ -_/_7O_ 'Z>"(@'\=.W]_\ WV'@B'7^WS^_[?\
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M4=_^?7P4-039VQ(I30S'64M #9';MH;/[=^O38Z:Z===O!:YSFZ1[]A\@_\
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M3A RUU!)[['^K9^=_$1V^-;Z;/4@)-&.#+6[&NT5E&.CL$:/3N-Z)'<]>@T
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M@CP__2[8H]]@<0&<V0V=]=[WU)D-'6SHD:T>X&M=2-G9&R,#,-4?\;4IVWL
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MWWUU)/?P]:BOIUI:$7J8$D#TZ_?K+8V=?I!V>A.A'L.W7?BH@ >D22 =]=$
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M20 .FR#\]=Q(^"=ZWX(3L7JT9ML*G\K1@C1Z@D=P"1V_L=D_!ZC_ &^/!2]
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M 3_29#1^"-#1&^G6('< =.I'7O\ CP34F0]F]2>^UG<@$ ]N^^OZ>A)UT](
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MOJ.PWZO]('79WL]=:T-[\$1!Z#IHC?4ZWU/QH'X/Y^!V._!$B1U,0-].A^-
MG7^HC?4=QV)/;7@I]0>O;Z2Z=S(]?C6_42>XT-[/X&@=_P"Q5'6CU_([CJ 1
MH].O^X/3?;OX(G:]/I/P =;W\G](WH#6B>FAH  ]/!2FW/%?#(B(Z]"!\Z]6
MSL]01UZ=^Q/?P51$3UV0>A[_ ->@_)&B-C9Z]?#W_?LB<.OQHC8[C0Z;Z;_H
M.A'[#?8P^XYRNM$2_.NIZ;'3?_O7BB.<Z(D-G>AK^VN_R._4?D[!/]=@B/\
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M_#\@""#_ *_E^(+$$%I!"Y/[_P#)^?\ #_1_N_R_Q_E_K_)_%_4_L_R?Q_D
M"?Q_/\/X?S_+\?R8@@M^0!8@B)!"^*?_ ,(-M6,A_!#^J2[<876KN#^F.W:<
M1");8L?4UY#.>R48B*Q[C)RE*,8QB-D1 &@/7^C_ "?G_+_2_I_R_P GY'\O
MY/Y/ZO\ 7_D_/\B #^7Y_G_%^'Y?D6  #DDP %Z?U?S_ "_D_K?U_P _S/\
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M48]OR?!7N?3L_&S42[[.]:V=;&H#>M[WHD?GIOH/!+\8G5@+4J-(7KH:Z?\
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M1$#>^N]&)([_ )_?Y\=C@7 \+JK4MN\W>!K?X5+@!^D'>B>A T 3T.A_3O\
MG?YUXJ\Y)P+BK&*FF"#-&RE(Z)$AV/\ TV>IZ [_ ""=G74;'@K.CP'B9KZP
M;P'32= '?3\ ZZ$[)].M '8'3KWV?!)]8:C@,*Z5=B8V6^O^YV-]>AV3WWU_
MWWT\%D&I)#T(+6M6]Z37")(.B!L@]NH (/77QL@?/J'4@ >"T0!4UO=\OB-
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MQMSGA.<^TX[[=/C74_UWT'3YT?R/!$@ !KMTT/SH?CH/Z_L?!$O_ )/Q_O\
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MTZGIV\2X&A\-\J)RV2)D- :GZ 1L="?3VV1L#H.G8 :UT\5%ZELH^N/0B,B
D#O70?(! V?GIW\%7-.?$6U*QC<:">D#U_P#C#]OB8'@HO__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
